<SEC-DOCUMENT>0000927066-21-000074.txt : 20210429
<SEC-HEADER>0000927066-21-000074.hdr.sgml : 20210429
<ACCEPTANCE-DATETIME>20210429170648
ACCESSION NUMBER:		0000927066-21-000074
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		72
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210429
DATE AS OF CHANGE:		20210429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAVITA INC.
		CENTRAL INDEX KEY:			0000927066
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				510354549
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14106
		FILM NUMBER:		21871879

	BUSINESS ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
		BUSINESS PHONE:		310-536-2668

	MAIL ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA HEALTHCARE PARTNERS INC.
		DATE OF NAME CHANGE:	20121107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA INC
		DATE OF NAME CHANGE:	20001005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TOTAL RENAL CARE HOLDINGS INC
		DATE OF NAME CHANGE:	19950524
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dva-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:0eedf026-4cb7-43f6-a1e9-99f3721c46b9,g:375f77ab-f095-4ce1-bcc5-25c9315fbffb,d:22c52c47d5ba457da94184e7670ca7e6--><html xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dva="http://www.davita.com/20210331" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dva-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF8xLTEtMS0xLTA_ad85acc2-6729-4849-86c9-706a6d8984d4">false</ix:nonNumeric><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF8yLTEtMS0xLTA_e09dfcf0-874c-45d1-93cc-6bc16774224b">2021</ix:nonNumeric><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF8zLTEtMS0xLTA_a4e6e7be-b58e-4d2f-a00f-ef08193b40bf">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF80LTEtMS0xLTA_308474b7-c2c2-49d7-a8b0-b7802808b53e">0000927066</ix:nonNumeric><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF81LTEtMS0xLTA_4b50e5f7-aa85-46e4-ab03-8f4333e37cdc">12/31</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMS0xLTEtMS0w_beca8491-7fd1-4410-9638-ee94df32d141">4,622,798</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMS0zLTEtMS0w_8478bc07-c186-4704-964f-fc742ce09beb">4,480,429</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMi0xLTEtMS0w_75a704f6-0cb1-4596-ae0f-d831a55f39b0">69,691</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMi0zLTEtMS0w_90d525a3-2763-4df8-a28a-3415a40c65cb">70,141</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMy0xLTEtMS0w_435e368f-bfda-4d1e-8816-ba1c605fd216">0.001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMy0zLTEtMS0w_68840324-39f2-4a56-b938-5990fa30b712">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNC0xLTEtMS0w_e7d3342f-737e-4b20-8114-b396da2cb558">5,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNC0zLTEtMS0w_1416e4af-91ea-4b7b-91db-f39b295a26c7">5,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNS0xLTEtMS0w_b43e4661-f21a-466e-a3bf-a0566f10d81a">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNS0zLTEtMS0w_bff84d8d-57ca-4ffe-9247-dd7c154205df">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNi0xLTEtMS0w_3c11f04b-d681-43ed-9b2b-6f70e8f29e87">0.001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNi0zLTEtMS0w_7ce940eb-5dfa-4eef-993e-9d17ea08a350">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNy0xLTEtMS0w_fa8aed1f-830c-45d8-b172-233909f8bec3">450,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNy0zLTEtMS0w_aefa4649-bf36-4bd0-9454-e9fa124605e7">450,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfOC0xLTEtMS0w_cc7c0f0e-f1f1-430c-b345-e18921b641e5">110,027</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfOC0zLTEtMS0w_48037170-1f67-4df2-8d0b-fb77f52fb009">109,933</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfOS0xLTEtMS0w_1cc6c04f-923f-4d33-9b2b-8942a5bcf356">107,078</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfOS0zLTEtMS0w_59eb8c59-81d2-4ee9-9cad-215f48d8c15f">109,933</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockCommonShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMTAtMS0xLTEtMA_fb3604e7-907f-4ba7-a0c2-ecf4a73ea6e7">2,949</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:TreasuryStockCommonShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMTAtMy0xLTEtMA_7d2d7d93-514e-4e34-b770-efbfd88b1dc3">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81NS9mcmFnOmVmMDYzNjE3NDAxYjQyMjhhYWVkOWFhM2E2OGM2NGIzL3RleHRyZWdpb246ZWYwNjM2MTc0MDFiNDIyOGFhZWQ5YWEzYTY4YzY0YjNfMjk_fcc15041-7473-4f8e-9ba8-d30edd88e6d0">0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81NS9mcmFnOmVmMDYzNjE3NDAxYjQyMjhhYWVkOWFhM2E2OGM2NGIzL3RleHRyZWdpb246ZWYwNjM2MTc0MDFiNDIyOGFhZWQ5YWEzYTY4YzY0YjNfMTgxNDE5NDE4NTg0MjE_8884a11e-c5a9-4e60-9463-12383374291a">0</ix:nonFraction><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt-sec:durwordsen" name="dva:CorporateIntegrityAgreementPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl83MC9mcmFnOjliYTQ4OTdlZjRiZDRjZDNiMWMxNjkxYTdiZGE5ZDc1L3RleHRyZWdpb246OWJhNDg5N2VmNGJkNGNkM2IxYzE2OTFhN2JkYTlkNzVfMjE3_408657d9-e6f5-4bfe-8afb-4e0bbac89802">five years</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i8f9b78b5f5fc4575a3e804c564b6679b_I20201210" decimals="-3" format="ixt:numdotdecimal" name="dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNzE3L2ZyYWc6MGI1YTVlYzhiMjExNDZhYmE3OGRlZGNmMjE4N2IzZmQvdGV4dHJlZ2lvbjowYjVhNWVjOGIyMTE0NmFiYTc4ZGVkY2YyMTg3YjNmZF8xODE0MTk0MTg1ODQ5Mg_b269c9c0-d037-472a-ada5-a81b823c3678">329,302</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dva-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia925779a41b04416bebac5d08f6cde4c_I20210426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if25c609ea75c4c068d67fe57512ea434_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if09729cbfcb64401a6be3f8ffe616fc5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeca89f1d034430482dee49030acec85_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c63462618b841479c213bb2713220cf_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if227b8854b5d464699191a415580aefe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26a083ee5fdf4ec99abc3850e10e37ff_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057fbe978e34415294c2d4a792413761_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8529c41e847743e48bb56774c5d6f476_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7542b28699c64b3d8ad0d845de0fa0d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb912ac405a7429e8d9f894a52d31c82_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61057af670f54badb9c6da85fd10624c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0cd9ddbeee04401adc2305188ef344a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28f0aec10f4641fbba7afcf164b721c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54e17a5f75d24145bae682ee23ef20b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a019ed8480b437c8577677faace157d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cd348fa8b2c42d1a42ef7fd2cf4aab3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf07ea63041c4c928f8da459f8e85559_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e319b3a1dea46d48da73779ff5ed197_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48461f3f7e034478b38bf2bd95c2c8b6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41b777f2cb434154b0b873e82c5fce50_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if76ff822a85c4644b659c3e32c6a6ed3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0320aabb1784267b2d621187040cf79_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73666b7ee2b24d4fa2f93200e6e07664_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7cf27bbb13c4c3890e90cd1e469e381_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d5e5c6b5c5c4b67b3a716761c125e8f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15cd87973cef469c8ae16c443d6af67f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic81bcf50eda945c8941046c875428878_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic075cfce513548e597924c070afcd2ae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85b41e0034a64dab9acb0cac6ac941ad_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc0c1697a60d44e08102a4bc72e7baee_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic19fe60e1ba04922b0a626ce23e8b7e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i475dc8640ab8472db6136e6d67675a03_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6f5500e00234fdf8025a48470c3f347_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92b1c7e075c3458393c45dcc6b3ae765_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f8b5aef473d4c39a93eee476090c527_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9328309adf540c1a97c8d647b34233a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cedd257a01c493c994727193e679c26_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i932b6e9e1cd94560abb849f93670e5aa_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33019354c85e44cc941da40445b2afa3_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a780a7182840f4a2262cae00e03efc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8318a79043d44ffa9a6a4993763b2528_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd3cc5d411a64abca391702baae8a9df_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a8529f1d6484e20963d6f0e69c67f53_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1db5c6df63c341089b1c1dc195a6ffa0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8e9b75a76f41589cb3e7fd00a42d30_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9afc760e9c5848eab9e7da50701226de_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b19644a307d4aaf8b1b4bc4cb0d62f8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id80771daad6c4b07a10321fc37cea825_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a2736318f0c409aa240efd57c2ef68e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5bccfe449ed4991b0e4e2588ce7a9a9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1a9b926a0d4f38a1427bdd4d8a03a8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9dd874b0d744ba2a90acc5b316f6054_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6c7c388a128487ab6d0234da86f133a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c7afd963ec5440498a90eb4972fdf5d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83641efa6174426994832609d4cfde1c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3b745665f334ec782e1b4c00dce1968_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98660f7731974d069a340250cea5bcac_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13ff0fa657884449b2488b3757779baf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i803f842bbc824ff58114df1a63ffbf0a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2e28eaf39154728a43e3d45a96bc8a7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf913e95c60d44908d164dce5b236b5e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i608146c8b3ec4ec88cbc9d9bb1b096e2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96fded0bba7f4935af31ff42cf27ef96_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i680ca482559e41b29995e9ec3a942053_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaebf99e2b1f14c34a8a126def6ffbd2f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8f49aa1abb4d72a402bed74053e73d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e312d2270449af94812bdb09bce332_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0542fe9de33a45f1add8d0843709862e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6511e83e307f484e924d0db239adc3be_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdf3f726deb741c5811a90556bb9bc5a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f2200f0ed2d46558e31ace6797c599f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id66622c2d23c48d793cd014811006a41_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf38ac334ee84f118afa50f51593b348_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i790610c5a3ee4281a8434d08b7887b14_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6339430398b74ca2afee569cb8b0f426_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c6c61591ec419c8a4f894e55b0bf58_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i187374d6f1b34e62b52bf9d95907b97a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if13419d218e54ae4a8ae1993a6172f7c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb6bac2e9afd461aa4604a702da5b510_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1a323c6052043f39e3e7d90a6c1e149_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f1ae32f350f41b5b4c94e873d2ac8ab_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d4cbc4b3cb3440baae8caf684d727be_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i804d8967231546a69cb45a38bfa5a7de_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0707e2f78ab64721ab34ecd08e6b7faf_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb32ded36f5647b8bf00bcd206f6b64a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb49ac86f6b746d990ed1e8d57025774_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaaa1dbe5bd548efb96a1fb6dc9d1fdc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b2618e51ff246e6a032f57f479d2741_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic12d5b97b6be470aa5f5bc280eb39678_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0172e2194a649be8e17948010a20139_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6402f5beaf314d64a2e3fc70b66cbbc8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c6ecda7f7b34fc8a0c5a23d786773f2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5382ab7913ba4b97b4e5b4674fb7d89a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i882e39dba68b41538058accf2ecc1ed8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i352ee731e6ad4fb098d97efc97fa8dd5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7da2c28df84d498d901a73b1bd176f75_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45e602ff596428d999df57f32972301_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i512b152939674415aeb4fcd3ff232747_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ffaa425a944fc7816ad190e4ae8372_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4da2355fcf964251b943aab7dc93c0b6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icab86a87e7ca432ca27ef7f2f0802e4e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2498e561a5854842a6d62e0b719f9b52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f587b5b943b44b8b00940ad481105ea_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>dva:segment</xbrli:measure></xbrli:unit><xbrli:context id="ic7ea4fefb3604f5383d022830fb054b2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c92060a34e484cb1a910bc6a98a92b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied03f6f7ffa1498b908a85322c500f3f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i788aadfa599242a796deae74047ca158_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32e240900d2a4a45aa25dd2ec99f1da9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i504bca0dc6a34e968df9a1ef2d17533a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaac6bcb52a00428d87b88838a3a4bb73_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8d83ec226e84558a394e404422907ea_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37efecfb533c4ce8b0c977360ba10261_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e6f67d8fc604e5db4da237cb3d52d86_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i194f9194e246431c9dde99195297777e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1bbaa73972045d38fd77a293d92478b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97a89b88b52c40e7aebc3bba7e72d037_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="iabd355c7251147dca43bf684d5040e60_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i553adc006f9e4d1691c2e2bfc277dc41_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86de953a450f43afb93313b5cccf48ff_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91ebf3bf2b02476fb9efaac73b3d3dc5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c9698c484b14a119356f8182f5757c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1acbfcadeb1d433b9e81c9d3af8e55db_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie12c3787f705434183585a7eb161899e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibff9b7fea3cc4a2c8cc8c9400ffa6dfd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8f84ec8dbbe47a885cecad8d415599b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id253887c65fb490bb3a75adbfae3b9f6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3a230004914446ebc401ea9c9effdd8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id61c0e835e604a309d4b0804349af819_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i606827500ec64b88b0b08567f4f6a0db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcf13ba1953646bfbb5a0cec0cd092de_I20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76a9d85fd0654e91a77f38adc13569bd_D20200609-20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-09</xbrli:startDate><xbrli:endDate>2020-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6985ae730434382a11199004a394f1a_D20210226-20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-26</xbrli:startDate><xbrli:endDate>2021-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0dc9c50975b46389c8201b72173f3f0_I20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9d50577324f44dd9a01b491e9e47a09_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59aadc5542964885b2a0e3bc85b2fdbc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfd9c5748c524a73b8cf26558b198cb0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8ab840ca2984e1cbd4b736f943c4d22_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife4fde46bad1452eb6abb85e1eda2e52_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3300c03f30af4697aeb5cc0111c808e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeb4f066dfab44019e66a8db209e19eb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00538c1ebb6745ca9520ef56fcbcb7e0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">dva:BilateralSecuredLetterOfCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1298eb35e47242399f1ae29c789cb247_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0196845c80ec4c118ab2c0f6b32fe811_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:IncrementalCashPortionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37f0d1d0eb764865859330a4621cb724_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:CashPaidForPortionPreviouslyRefundedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a970640a33c4ad991ff8f3c6c172d83_D20170815-20170815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:StockholderDerivativeLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-15</xbrli:startDate><xbrli:endDate>2017-08-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2781197970dd4a92a8d85c696520a666_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f826db477234354ba1256988298cd45_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d49ed528d08456d847b8513e95864e5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d7725640db9488db340c97bfa388a99_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97d0c8af8a944946a42c942ce28c581d_D20210401-20210428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f9b78b5f5fc4575a3e804c564b6679b_I20201210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa346157c398428ab51f508528dc7f0d_I20210428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a08055277f468fa3da1c205ef85947_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4709116f7724bc9ad71c5bfd6776322_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a80756affc64b969267ec3c56bb81ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7913425dd41a462fb453af0206275331_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7550f2fc99ab46e1b842231f6e90d788_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i798ec441c1634f7dbbe04fccf4900538_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e992d644be94534b183789d6b781637_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7639fee9f6714447997016db991f797c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84115112998e4c6ab8350b671c96944b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f5f0eab21a44845a44f238f8ff448c7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i009808e6a6064e15a4b9a0b821c2bdfa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b8ca49829314b1c86c5e23c209360a8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6516fe61d14b40988955d5922b34c110_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>dva:clinic</xbrli:measure></xbrli:unit><xbrli:context id="i27908b3ff2f44d9283aa1440a2b3ae17_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bfeeb71e92742cda00237cd50a46e64_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73bc0a8523dd4554aa03d767a5adeba8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i631f28de3213466e9bbd705c5fbefdc9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57247936e4d94d5da5ca8c68117d7722_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i355c4c0d9e274392b8117ea1ede7a7eb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if907602d375846b0b24b8a53b7ca0a19_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e0275ee13fa4083b1696201c4b78acb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79e508f7f8044bb5bcad2876847bcc76_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i495ea84f47aa48bcbf441d81513cb962_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e5449f4136e4a069e013c4a12fa4b96_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f2d7535539145679656b6f1f8c6109d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b44264ea668489b8330c31d2a995fa5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3cd95724eb3494bb6e72cb6132e8c7d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15e9456343284b0183c0a4c3be1bb14e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f92b2fa92fe417aa409a3b1a97cb245_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a92bc0f852f4670a2b1907f3d705ae2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i332c7d42021f4f6da272ea3d938d6af0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeec13c830464d468215c66930e23ec9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i979f0469490346ea8c2367f07d1340a4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6fe8af182b14048858164d9709baa1d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2601990fe363422986c39fb1866d5dcd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a051b6561614f1e8e342da9d47552e7_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9286623196349739c21994952f69f6a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6e9959083a844ce9f5568612f3be925_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a29181b883436aa54dd8cb74f27dfa_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i063d84a2e30e427c986c99aacd98b664_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec56217c36c846509f6a12afa76de49b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i22c52c47d5ba457da94184e7670ca7e6_1"></div><div style="min-height:9pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.419%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODc3_ea46f6cb-9cef-4ba9-a570-7c2f9f27e47d">10-Q</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM3MzBhYWQ1NjA2NDdhZGI3MzUyMzU0NWQ5OTNhYzcvdGFibGVyYW5nZToxYzczMGFhZDU2MDY0N2FkYjczNTIzNTQ1ZDk5M2FjN18wLTAtMS0xLTA_a9318afc-105c-4305-805c-3b96826dafb6">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xMjg_75be89e9-2cae-44f0-bddc-aa08622da872">March&#160;31, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6NDhjYWJiY2IwMzMxNDhlOGEyZTc1NDZjODlhZWY1YTYvdGFibGVyYW5nZTo0OGNhYmJjYjAzMzE0OGU4YTJlNzU0NmM4OWFlZjVhNl8wLTAtMS0xLTA_4e57bcf8-6e45-4ef9-9d14-fd478313f3e6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ___________ to ___________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODc4_d62ba832-faf5-4b0c-a2d9-5163ae446813">1-14106</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><img src="dva-20210331_g1.jpg" alt="dva-20210331_g1.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:182px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODc5_9637905d-bf7e-4393-b6b3-b6702454589b">DAVITA INC.</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.000%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MDMwMzZmZjA4YmY1NDhlYWE2MDY4YTRhZjRmZjViMmYvdGFibGVyYW5nZTowMzAzNmZmMDhiZjU0OGVhYTYwNjhhNGFmNGZmNWIyZl8wLTAtMS0xLTA_de1b3e30-fbbf-4b52-a4ca-1819b40fadcd">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MDMwMzZmZjA4YmY1NDhlYWE2MDY4YTRhZjRmZjViMmYvdGFibGVyYW5nZTowMzAzNmZmMDhiZjU0OGVhYTYwNjhhNGFmNGZmNWIyZl8wLTItMS0xLTA_89713f55-27c9-4b4e-9bb3-28f95a4e3dac">51-0354549</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State&#160;of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:18.103%"><tr><td style="width:1.0%"></td><td style="width:42.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM2NjE2ZDdjZjMxNDc5Yjk0NjFiMTliZTBhYjJiMzcvdGFibGVyYW5nZToxYzY2MTZkN2NmMzE0NzliOTQ2MWIxOWJlMGFiMmIzN18wLTAtMS0xLTA_107f86ae-981e-42a5-a19c-a80b06945f95">2000 16th Street</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM2NjE2ZDdjZjMxNDc5Yjk0NjFiMTliZTBhYjJiMzcvdGFibGVyYW5nZToxYzY2MTZkN2NmMzE0NzliOTQ2MWIxOWJlMGFiMmIzN18xLTAtMS0xLTA_701d8c60-2555-49db-9a04-8af2c04fda8d">Denver,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM2NjE2ZDdjZjMxNDc5Yjk0NjFiMTliZTBhYjJiMzcvdGFibGVyYW5nZToxYzY2MTZkN2NmMzE0NzliOTQ2MWIxOWJlMGFiMmIzN18xLTEtMS0xLTA_1c3bdb61-9bc6-46fe-af77-b4f253080c33">CO</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM2NjE2ZDdjZjMxNDc5Yjk0NjFiMTliZTBhYjJiMzcvdGFibGVyYW5nZToxYzY2MTZkN2NmMzE0NzliOTQ2MWIxOWJlMGFiMmIzN18xLTItMS0xLTA_923d4082-845b-4295-8be8-9baf45fb2fa2">80202</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Telephone number (<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODgw_b19c4deb-2b2a-4f76-8238-c133e25a35f3">720</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODgx_48842761-6d3c-4775-ab16-8306a28e16bf">631-2100</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.217%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading symbol(s):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MGI4Nzc5OGIxOWNhNDI4MGE5MGU3MjU0MmJlZjBmNzMvdGFibGVyYW5nZTowYjg3Nzk4YjE5Y2E0MjgwYTkwZTcyNTQyYmVmMGY3M18xLTAtMS0xLTA_b7271bab-c825-426d-b862-a31c5f97564c">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MGI4Nzc5OGIxOWNhNDI4MGE5MGU3MjU0MmJlZjBmNzMvdGFibGVyYW5nZTowYjg3Nzk4YjE5Y2E0MjgwYTkwZTcyNTQyYmVmMGY3M18xLTItMS0xLTA_20aedb21-57a6-4c69-9793-e775ecb638ae">DVA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MGI4Nzc5OGIxOWNhNDI4MGE5MGU3MjU0MmJlZjBmNzMvdGFibGVyYW5nZTowYjg3Nzk4YjE5Y2E0MjgwYTkwZTcyNTQyYmVmMGY3M18xLTQtMS0xLTA_8ef862d7-de78-41b8-8f82-a155924dee1a">NYSE</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODgy_abc99e97-0f14-4031-be2a-07c398c23ab8">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744; </span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODgz_715a08e0-310f-40ca-b272-8f91092fde15">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.873%"><tr><td style="width:1.0%"></td><td style="width:31.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6ZTdjOTk2YjhjYzRiNDRlZThlMGRiYWQzOWZkMmNjODEvdGFibGVyYW5nZTplN2M5OTZiOGNjNGI0NGVlOGUwZGJhZDM5ZmQyY2M4MV8wLTAtMS0xLTA_6e2a0a1c-eeef-4757-8fc5-0580c9dedae7">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6ZTdjOTk2YjhjYzRiNDRlZThlMGRiYWQzOWZkMmNjODEvdGFibGVyYW5nZTplN2M5OTZiOGNjNGI0NGVlOGUwZGJhZDM5ZmQyY2M4MV8yLTMtMS0xLTA_73fc9a35-dd9c-456e-a259-f012880ec84a">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6ZTdjOTk2YjhjYzRiNDRlZThlMGRiYWQzOWZkMmNjODEvdGFibGVyYW5nZTplN2M5OTZiOGNjNGI0NGVlOGUwZGJhZDM5ZmQyY2M4MV80LTEtMS0xLTA_d667ad46-3d7d-4fb4-b416-683c5698475a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODc2_7a46b48a-0eb2-4bdf-bd47-16075f1aa664">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of April&#160;26, 2021, the number of shares of the Registrant&#8217;s common stock outstanding was approximately <ix:nonFraction unitRef="shares" contextRef="ia925779a41b04416bebac5d08f6cde4c_I20210426" decimals="-5" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODY1_e09be5ce-6d3d-4d45-b1b5-4e9363f3a9b6">106.2</ix:nonFraction> million shares.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_10">Condensed Consolidated Financial Statements:</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_13">Consolidated Statements of Income for the three months ended March 31, 2021 and March 31, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_16">Consolidated Statements of Comprehensive Income for the three months ended March 31, 2021 and March 31, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_19">Consolidated Balance Sheets as of March 31, 2021 and December 31, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_25">Consolidated Statements of Cash Flow</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_25"> for the three months ended March 31, 2021 and March 31, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_25">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_28">Consolidated Statements of Equity for the three months ended March 31, 2021 and March 31, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_118">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_118">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_157">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_157">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_163">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_163">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II. OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_169">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_169">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_172">Risk Factors</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_172">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_175">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_175">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_178">Exhibits</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_178">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i22c52c47d5ba457da94184e7670ca7e6_181">Signature</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i22c52c47d5ba457da94184e7670ca7e6_181">36</a></span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note: Items 3, 4 and 5 of Part II are omitted because they are not applicable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_13"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMi0xLTEtMS0w_ae7789e8-8b3f-498c-b373-0a14660addc9">2,714,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMi0zLTEtMS0w_a457d67a-3d48-4982-82a4-1e2a0804f192">2,713,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMy0xLTEtMS0w_0616ea1c-11e1-4d2c-ba67-fd5371a07211">105,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMy0zLTEtMS0w_37abe127-df8e-4a03-ba06-aa147a59e4c4">127,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNC0xLTEtMS0w_28488703-4323-4fd6-a4e0-d2403396f3fe">2,820,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNC0zLTEtMS0w_f95549c3-80fd-4251-9798-c1be7cf85e10">2,841,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient care costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:PatientCareCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNi0xLTEtMS0w_2268486b-2ce1-49ce-a655-28c37de7661a">1,938,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:PatientCareCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNi0zLTEtMS0w_de02b360-3b81-4bab-bf44-88bcab70fb5b">1,975,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNy0xLTEtMS0w_2569f0dd-a66a-43ed-95cd-9261408b5002">281,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNy0zLTEtMS0w_231afbf9-9a58-4be4-9429-6d62430141db">263,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfOC0xLTEtMS0w_7efe3bdd-45e2-4db4-b6d6-8e1b7db6c78e">165,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfOC0zLTEtMS0w_8815a94a-119e-4aca-b41a-00117529a750">154,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfOS0xLTEtMS0w_ea0e727b-9cbd-445b-8e38-22fd76743196">8,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfOS0zLTEtMS0w_0d78157c-a0db-4ae2-a2d0-9db5d2964219">17,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTItMS0xLTEtMA_a095b48e-cf2c-4006-81fa-6f642a047c28">2,377,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTItMy0xLTEtMA_ae1fd555-4381-4c11-8914-142d7bca7e27">2,375,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTMtMS0xLTEtMA_591a12f4-0519-4e2a-a1ae-f937a5df3f3f">442,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTMtMy0xLTEtMA_c9bc5918-8a7f-4af3-b33d-2c7279a09be7">465,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTQtMS0xLTEtMA_13ec5460-07ea-4a2f-a315-9bdfdecd8b3c">67,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTQtMy0xLTEtMA_a5e297bc-6fad-4fcd-a5af-5f7df7caaef3">88,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt refinancing charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTUtMS0xLTEtMA_6145d9f6-6e0e-4c2c-a24b-c8b576bfeda5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTUtMy0xLTEtMA_ca4600f0-e54e-4ae0-9248-67f4e83e2004">2,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTYtMS0xLTEtMA_8a01de7c-dbfe-488d-b0cd-6673920909df">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTYtMy0xLTEtMA_f414dce8-e7ac-4e73-a8b6-544abf15c950">4,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTctMS0xLTEtMA_d37cae4b-b5e8-49b5-9158-4d63a5b34017">376,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTctMy0xLTEtMA_7d58d5b6-1a8f-4ec4-bddd-13013d77de0b">369,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTgtMS0xLTEtMA_a9f81f3a-89da-4664-80a3-1f12f7d399ba">85,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTgtMy0xLTEtMA_047f09eb-af4b-4ba8-97e6-cc8611990760">91,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTktMS0xLTEtMA_ed361f02-0254-408b-93f1-86af3e454724">291,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTktMy0xLTEtMA_8a664f02-c71e-4b10-8c32-af975aed8c19">277,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjAtMS0xLTEtMA_5c840270-2e15-4b6e-a6cf-9de9d6e7b6f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjAtMy0xLTEtMA_eb2f2e20-fe20-4dff-a194-9d7bb767b9db">9,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjEtMS0xLTEtMA_9a83e7c2-079d-4230-8f98-fb06ea52f931">291,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjEtMy0xLTEtMA_70861cc5-40eb-4373-b7fb-1dcc85f5926e">287,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjItMS0xLTEtMA_520b409b-1f12-4cad-af29-afacdbf0e2cf">54,142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjItMy0xLTEtMA_3706193c-ca6e-409d-bca0-ec848d242116">48,302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjMtMS0xLTEtMA_60cedbfb-217a-4347-89fd-514eefeb7814">237,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjMtMy0xLTEtMA_8447b0fe-6bd5-4adb-9537-b1e9b936599b">239,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjYtMS0xLTEtMA_215a98e5-deef-4db5-bcde-32f9253e5ebd">2.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjYtMy0xLTEtMA_a19cbfe9-dcbc-4c04-bb1f-c06f90822f90">1.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjctMS0xLTEtMA_f7833545-af05-4cac-abaa-0499585c6d9f">2.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjctMy0xLTEtMA_806f60fd-31b4-4469-82af-a7a623d60157">1.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income from continuing operations</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjgtMS0xLTEtMA_008f5610-c477-4a3d-85e7-3dc81ed242e8">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjgtMy0xLTEtMA_8a53004a-008d-41e2-946d-aef8e879d384">1.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjktMS0xLTEtMA_e619b9dd-1b8d-4aeb-adb6-8fe9e2f5b429">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjktMy0xLTEtMA_13d35d18-67fd-41d5-a7cf-643dea09cbc2">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares for earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzItMS0xLTEtMA_2976c4b1-888c-43a4-97b0-9aec0170e580">109,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzItMy0xLTEtMA_7b4a3aab-f79f-4065-a971-037ed66ae452">124,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzMtMS0xLTEtMA_8e5df6c3-465c-49fe-a0e5-fbb3b87a1fc4">113,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzMtMy0xLTEtMA_52fc16e0-9b72-4a7f-98c8-3345df877b81">126,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzYtMS0xLTEtMA_6bd9b536-ff6d-463b-8a24-9d3018def404">237,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzYtMy0xLTEtMA_6ff01982-97cd-4350-a012-a100e1c5ebd6">229,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzctMS0xLTEtMA_12b6e495-9a7a-4b05-8e66-301ed37227ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzctMy0xLTEtMA_c1ff6fe3-1407-4891-bb1e-a25528ad4ed5">9,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzgtMS0xLTEtMA_64c32125-4afe-48f1-8f54-2fa2ad1911f2">237,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzgtMy0xLTEtMA_00db9d6e-db88-4a5f-8f4e-092f7d60867d">239,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_16"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:68.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.961%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMi0xLTEtMS0w_9a83e7c2-079d-4230-8f98-fb06ea52f931">291,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMi0zLTEtMS0w_70861cc5-40eb-4373-b7fb-1dcc85f5926e">287,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses) on interest rate cap agreements:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfNS0xLTEtMS0w_a95b923a-4814-465d-b735-12d41c156817">4,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfNS0zLTEtMS0w_d86a74fe-36e3-4679-90aa-32541d7653e4">13,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassifications of net realized losses into net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfNi0xLTEtMS0w_256f303b-e83b-439b-86b7-36f76b30c8da">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfNi0zLTEtMS0w_2d247b24-53b7-4ba7-b677-2e31b04d661f">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized losses on foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfOC0xLTEtMS02MDQ4_927fbe02-bf20-43e9-a7d7-170d59348bd2">62,544</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfOC0zLTEtMS02MDQ4_2582fb50-ba1c-4def-939c-5f0f193525f0">81,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfOS0xLTEtMS0w_97604065-fdbe-45f9-b282-a0018d4b94ea">56,629</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfOS0zLTEtMS0w_8efa218d-57d3-4d45-bcf9-eea77731a846">93,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTAtMS0xLTEtMA_1e1216dc-cdd5-4beb-8e11-7a932a39e595">234,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTAtMy0xLTEtMA_476a8012-9c07-45a0-aa2b-23721f7cf06e">194,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTEtMS0xLTEtMA_a719505c-1dbe-40c5-b57b-9e1dcfb75839">54,142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTEtMy0xLTEtMA_9815ada3-e331-4252-b5e5-f49f0c8db06b">48,302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTItMS0xLTEtMA_dc81abe5-dd52-4c76-9e23-6379470657a5">180,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTItMy0xLTEtMA_0172053b-7562-4fe3-bf7f-2741b9a23135">146,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_19"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMi0xLTEtMS0w_ab1680ad-1628-4e63-ba33-418b2fdc3b26">884,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMi0zLTEtMS0w_75e289e9-9546-4837-8d21-3339107c6e27">324,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMy0xLTEtMS0w_98978768-ded8-41c4-b836-a1faead40e22">176,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMy0zLTEtMS0w_ad75edc7-2aa8-4b22-bd9d-d4691d3a5965">176,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNC0xLTEtMS0w_ba31046d-2adf-4598-9f99-496d0dd31c01">11,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNC0zLTEtMS0w_b58adf18-fec7-4571-b5ef-4620bba52355">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNS0xLTEtMS0w_ee1d9b2e-28b8-4ab6-8676-3ca5de588ecb">2,040,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNS0zLTEtMS0w_e3b2b8fd-1626-4ea1-84f6-aef7dd1fd948">1,824,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNi0xLTEtMS0w_d362e10c-720e-4efa-af3b-f6b6c3db013f">116,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNi0zLTEtMS0w_7e54ff44-71e8-4498-920a-a93b2075ba43">111,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNy0xLTEtMS0w_ef36f398-167f-4abe-a4c5-7043ca0f9acf">535,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNy0zLTEtMS0w_9efdd1cd-1319-4ea7-81ef-e653d011d40c">544,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfOC0xLTEtMS0w_64275662-77bc-42be-a19f-9e2e910beb42">73,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfOC0zLTEtMS0w_d7e89918-cb02-48ab-b20d-9b0eece5a4fd">76,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfOS0xLTEtMS0w_3113c1dd-0c00-4d83-b466-f2e2e236d0ee">28,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfOS0zLTEtMS0w_5df9754a-4fb6-48b7-b912-888825c3c2ed">70,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTAtMS0xLTEtMA_5a2f9842-f5a4-4102-a1ab-151d55432e29">3,866,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTAtMy0xLTEtMA_1d65070c-4c89-436b-9d2f-34324517ea94">3,148,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation of $4,622,798 and $4,480,429, respectively</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTEtMS0xLTEtMA_6e860769-03af-4a63-92dc-b006b6955093">3,490,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTEtMy0xLTEtMA_2cf0b321-b46a-4ff1-9f30-af439671f7b8">3,521,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTItMS0xLTEtMA_e08f2246-a814-4d0a-bff3-34b974dbe8f4">2,868,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTItMy0xLTEtMA_a0a68d1b-f005-455b-9fa0-e742647a6245">2,863,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net of accumulated amortization of $69,691 and $70,141, respectively</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTMtMS0xLTEtMA_eea9cf60-d427-497a-bb97-b04c130c5da5">150,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTMtMy0xLTEtMA_cc321014-babd-4c9b-abd7-d6519967b3bb">166,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTQtMS0xLTEtMA_3730999f-7afe-44d4-9bdd-bad942b339c9">257,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTQtMy0xLTEtMA_02e5fadf-291e-4eb0-a452-d4657f2da3e1">257,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTUtMS0xLTEtMA_cfcbd529-8f72-4eca-9f53-274fac82d909">31,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTUtMy0xLTEtMA_32b0a425-2db0-4a8e-963a-e2cce8af00cc">32,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTYtMS0xLTEtMA_e38232bf-0aec-4457-8445-f9e3b10b7f3c">90,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTYtMy0xLTEtMA_d3b234f9-19fa-43ae-8ded-eea36124b4e1">79,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTctMS0xLTEtMA_8b2bcdee-b997-4243-bbe7-a40e9c5bc0a5">6,891,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTctMy0xLTEtMA_aa1f875e-4f96-4b54-a1fd-317161382540">6,919,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTgtMS0xLTEtMA_437bebe9-5b10-4f5a-acce-0869d25a32d4">17,647,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTgtMy0xLTEtMA_708c1bdf-9bfe-4455-a031-346b9f6e9ec8">16,988,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjAtMS0xLTEtMA_e45c7a2a-129c-48f3-b867-1ff2dda580b7">348,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjAtMy0xLTEtMA_f8489b13-ae4c-4a3f-9b72-9911abb3ac74">434,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjEtMS0xLTEtMA_333055e5-3f4f-4c41-a346-a88d727b2935">846,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjEtMy0xLTEtMA_e137909c-3924-48ef-915b-c06f0aab9770">810,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjItMS0xLTEtMA_71b0de3c-1e40-47b6-8f92-9dd7de211cc3">550,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjItMy0xLTEtMA_0ab9f251-733c-4689-9528-5876ed6920d9">685,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjMtMS0xLTEtMA_26522b6d-e068-49be-b5ba-ae492687e170">372,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjMtMy0xLTEtMA_c0fef722-c3ca-4de2-bed0-8f82f6be54bf">369,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjQtMS0xLTEtMA_b2c2efb8-7b1f-4c52-85eb-ede8fe4268b8">168,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjQtMy0xLTEtMA_e66cbf4d-b3fb-4076-9f1d-6ff7f9043428">168,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjUtMS0xLTEtMA_4b889f55-0ba4-4f0e-815e-fc108d8b3e67">28,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjUtMy0xLTEtMA_767814b4-fd9e-4cf7-8422-2ab898aa788f">7,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjYtMS0xLTEtMA_751f1e39-23ec-42d5-8320-d6726a17f85a">2,314,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjYtMy0xLTEtMA_74ea3ae1-db09-46f4-98bb-adb071b8c6b8">2,476,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjctMS0xLTEtMA_42f87992-5571-4202-b6b5-e0d1320d72cd">2,739,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjctMy0xLTEtMA_ca3a15fe-4ecb-4eed-9ab6-7efa21e9e4a5">2,738,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjgtMS0xLTEtMA_d71e7647-d423-4370-acd3-1e2b8fc5e278">8,829,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjgtMy0xLTEtMA_25db3635-69dd-4720-ab38-f1154f8e1117">7,917,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjktMS0xLTEtMA_8721ea57-10dd-49a7-9300-458a02a88a93">150,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjktMy0xLTEtMA_cb186c5e-70b0-40ac-aad3-4d17ea65bf46">150,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzAtMS0xLTEtMA_ebce0257-262f-43f5-9139-1ae73351d1f0">830,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzAtMy0xLTEtMA_39a41b2b-48ae-48e8-819f-174ad6967d82">809,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzEtMS0xLTEtMA_58384000-7681-4c9a-97a8-2df53d8fcb2b">14,864,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzEtMy0xLTEtMA_f281e007-e877-45b9-a256-f741a65cdb7a">14,091,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzMtMS0xLTEtMA_09b1c7bb-1ec4-4cda-8021-2879b97e572e">1,349,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzMtMy0xLTEtMA_1d19217d-192a-4f48-a6a0-18288dd8f133">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock ($0.001 par value, 5,000 shares authorized; none issued)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzUtMS0xLTEtMA_3f88a99f-2322-4020-9c9f-a701ac1eff95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzUtMy0xLTEtMA_74d58a7b-9fea-4c5b-bc8c-aad0718500f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock ($0.001 par value, 450,000 shares authorized; 110,027 and 107,078 shares issued<br/> and outstanding at March 31, 2021, respectively, and 109,933 shares issued and outstanding at<br/> December 31, 2020)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzYtMS0xLTEtMA_123d7943-f75c-423c-95e2-a5797bbffad8">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzYtMy0xLTEtMA_9bd6c6c2-c71b-481a-a6a5-e43c6fd171c6">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzctMS0xLTEtMA_e434b959-87d2-4e99-9d24-75a66ed30632">603,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzctMy0xLTEtMA_59278445-6597-4497-bb16-188ee4cbfcb0">597,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzgtMS0xLTEtMA_300600f0-06e3-4140-93c1-c5982fd8ece2">1,089,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzgtMy0xLTEtMA_cb7ee528-89bd-48b3-937d-df6baf8e17e3">852,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock (2,949 and zero shares, respectively)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzktMS0xLTEtMA_48b9a35c-0d99-40a8-8e40-d773ad30761e">322,333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzktMy0xLTEtMA_7a6fd462-67a9-4bb2-ab36-c48483920ac5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDAtMS0xLTEtMA_4aeb91f3-bea2-4a08-9b84-21e0760f3e6d">122,783</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDAtMy0xLTEtMA_983c83d3-08fc-4a18-aab0-ebb32b3fbba8">66,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total DaVita Inc. shareholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDEtMS0xLTEtMA_df4e5f5d-c6b6-47dc-8595-72a0b6457ab6">1,248,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDEtMy0xLTEtMA_7b51dc17-e0d9-4584-8d0e-dedba4a70dc0">1,383,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests not subject to put provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDItMS0xLTEtMA_2acdee71-3f54-4b14-9de3-6a8bd64bc950">185,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDItMy0xLTEtMA_e592498c-7960-41d8-8121-e09bd787ecc9">183,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDMtMS0xLTEtMA_e0bc0833-501b-41df-9257-778467f60f89">1,433,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDMtMy0xLTEtMA_ddfb8cb0-3d77-4af6-9cda-85f9a973bef9">1,566,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDQtMS0xLTEtMA_1c842a7f-bb27-4060-b13d-f2c2e715eaf4">17,647,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDQtMy0xLTEtMA_bf70b406-d4d4-45e8-b1e6-54c875be01e2">16,988,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOW</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMy0xLTEtMS0w_3d910e39-d013-4867-b5d6-81b895ea3be2">291,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMy0zLTEtMS0w_60bd169a-d196-4f0b-8e37-a53e181bd088">287,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNS0xLTEtMS0w_87465f42-4b4f-4dc0-b7ff-eb88eff754bd">165,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNS0zLTEtMS0w_471f7b49-79f8-4cb3-a5bb-5c542f7373da">154,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt refinancing charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="dva:DebtRefinancingCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNi0xLTEtMS0w_185d6a84-cf8a-4e4f-8cfe-9a519b6e70a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" name="dva:DebtRefinancingCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNi0zLTEtMS0w_dbc0f822-29fe-4976-8d10-ab7775720243">884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfOC0xLTEtMS0w_388ca227-dd63-4c50-956c-3e5a12722eb8">23,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfOC0zLTEtMS0w_c230ce37-5ea4-4555-8e63-57bf4a9b54de">19,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfOS0xLTEtMS0w_73f8c8ae-d22b-4981-a3f7-22166ec4f9e5">18,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfOS0zLTEtMS0w_d3940ca9-9f36-4e28-845e-daffb0437642">103,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:AdjustmentIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTAtMS0xLTEtMA_2a31f72e-25de-41c7-9c0a-a51e0d5997b3">2,924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:AdjustmentIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTAtMy0xLTEtMA_9746d2eb-4514-4226-a115-aefed312e903">9,482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTItMS0xLTEtMA_b3b13b51-19e0-4220-a042-0ec5c00a0dd0">3,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTItMy0xLTEtMA_7212cc57-7387-4331-85a6-8331b156b3c8">5,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTQtMS0xLTEtMA_eda6bbde-4253-4b2b-8970-93547dd25022">224,274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTQtMy0xLTEtMA_a9f637d0-8332-42cb-a933-c50ade336743">32,966</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTUtMS0xLTEtMA_36be80a9-f58f-4539-8d4b-7053c43127f5">5,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTUtMy0xLTEtMA_19e0b73a-99d1-4446-8faf-21585f9634ba">1,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables and prepaid and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTYtMS0xLTEtMA_45f72e83-8d99-4dc4-ae53-ea5203225c23">13,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTYtMy0xLTEtMA_03659b18-2570-4c54-a8ef-3bc268f21c1f">24,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTctMS0xLTEtMA_620f7271-7d60-4793-ae9b-3f7e08fdbc81">6,521</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTctMy0xLTEtMA_eeb58756-9dca-4d8a-9d7b-7be93b3b73a0">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTgtMS0xLTEtMA_3295b37e-3062-4ad1-b28d-e8cb4a1fab80">75,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTgtMy0xLTEtMA_4fffb328-4c6f-44e8-99e8-17172991c74b">24,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTktMS0xLTEtMA_9c06a983-a055-4e65-8c9c-f5bb1a731439">126,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTktMy0xLTEtMA_d1b3cd28-8990-4237-829e-e11f27d774fc">96,428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjAtMS0xLTEtMA_ca773af8-835b-4bc9-b7c6-98739167a134">26,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjAtMy0xLTEtMA_3dd65821-8bfd-4692-b160-cfe3c3bc32a9">3,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjEtMS0xLTEtMA_71e7ae88-4063-495b-b715-2eb6335ec86b">62,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjEtMy0xLTEtMA_52c86b7e-70df-4302-9a1d-159ac75df75b">32,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjItMS0xLTEtMA_a6012eca-8bb3-413a-a3d5-eeb030ba26dc">11,793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjItMy0xLTEtMA_e52b1d28-7cbb-4827-b5d9-ea701f3640de">709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjMtMS0xLTEtMA_36724147-e85a-449b-a032-b42ee7295159">154,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjMtMy0xLTEtMA_8f8d4879-38ee-4c7b-836c-37252c64fb41">360,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjUtMS0xLTEtMA_12c2e88b-cfd9-48d4-9f2b-1dce832fccd3">144,913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjUtMy0xLTEtMA_44f5b566-38c4-4c58-ad0a-70e496db7989">154,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjYtMS0xLTEtMA_6f4137b1-efc0-4193-804e-6c598dbad9e6">3,668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjYtMy0xLTEtMA_aa9d7f58-fdac-425a-ad0f-7b9f04e99d4c">34,107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from asset and business sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjctMS0xLTEtMA_2b0f7ab6-9557-4a43-8eda-d3baf9e0da39">16,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjctMy0xLTEtMA_8fa907ec-39e3-426a-98e4-1e0a8feec7a1">31,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjgtMS0xLTEtMA_c7d37c44-cd68-465f-b2e1-d9622e93a939">5,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjgtMy0xLTEtMA_4a1fbd16-6e0b-4a80-9a4d-52fd757f3690">5,049</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of other debt and equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjktMS0xLTEtMA_e2813b41-0b96-405c-8c2e-96ec6cd0a8e1">1,779</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjktMy0xLTEtMA_d0c88293-25a5-4a93-8273-a65a2f468515">2,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzAtMS0xLTEtMA_dbb06841-6a5f-4c7d-a0d1-b4ca11e531db">5,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzAtMy0xLTEtMA_0a051150-6e74-4b3c-bd52-1eba8d423264">5,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of other debt and equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzEtMS0xLTEtMA_95c10c30-8e27-43e5-b36d-33d7314bd7a9">11,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzEtMy0xLTEtMA_56eb4ae0-a128-4d6e-87f3-57ea224f397a">3,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzItMS0xLTEtMA_d4fed74f-90dc-485c-a120-9e939f02560d">3,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzItMy0xLTEtMA_47b2755e-31ad-417d-b782-f7cbaf890db2">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzMtMS0xLTEtMA_88e6890c-d202-4875-b9fc-81729c0e1c90">978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzMtMy0xLTEtMA_3a60923d-92ca-4352-b029-28ed9dc3357b">445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzQtMS0xLTEtMA_f6a28649-49ff-4ace-8387-d126d1823b2e">124,366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzQtMy0xLTEtMA_ed66fb97-70ee-41ce-976f-81916014b5ca">162,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzYtMS0xLTEtMA_62dfa10d-77fa-474e-bd88-03b013546f51">1,606,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzYtMy0xLTEtMA_3772f518-d14e-4472-824b-46363e366f12">570,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzctMS0xLTEtMA_8339ae37-a0a6-45a4-9d70-2c571c48f15e">698,298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzctMy0xLTEtMA_792e2281-b02c-4342-86b4-3ffd1d6fd6e3">104,592</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzgtMS0xLTEtMA_ba959ace-dc5d-4ac9-822d-8d6a02b6722a">8,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzgtMy0xLTEtMA_df60032d-89ee-4279-9e77-885b41162af4">350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzktMS0xLTEtMA_bef72ed3-e8f0-4f04-af3f-8007032d05cf">316,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzktMy0xLTEtMA_c994ef8b-6468-4f58-9f5d-e8712ab9eff2">321,798</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDistributionsToAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDAtMS0xLTEtMA_0ca9dff0-7096-4a6b-8554-37ca9418e5cc">53,867</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDistributionsToAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDAtMy0xLTEtMA_e37b34e9-71a6-45d6-b65d-d4c381411000">58,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (payments) receipts related to stock purchases and awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDEtMS0xLTEtMA_e4fd8938-d588-4df6-b77c-45ffe781376a">2,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDEtMy0xLTEtMA_8b5cf2da-7c3d-4189-8f75-1ce608c098a6">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromContributionsFromAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDItMS0xLTEtMA_4663b313-d972-462d-8ca6-647ef77ef7c4">10,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromContributionsFromAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDItMy0xLTEtMA_1081b2d9-7b94-4172-b279-07996c4351ee">9,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDQtMS0xLTEtMA_4a3e9d4f-5e92-4e29-968f-17b11852013f">1,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDQtMy0xLTEtMA_22514aae-2590-4e7e-9748-381e4938c359">700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDUtMS0xLTEtMA_1f87651d-2a80-4692-b2b7-191556ac2f0b">537,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDUtMy0xLTEtMA_8f53fb85-5c0b-49a0-bcdf-109d5edc4851">96,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDYtMS0xLTEtMA_5729dd90-33db-40b1-bffe-62fa9e40f495">7,966</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDYtMy0xLTEtMA_d3b9adef-8365-4356-89c4-6099e12087f0">14,978</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDctMS0xLTEtMA_59094385-6e11-4ce4-8a9a-136e06d8cb59">559,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDctMy0xLTEtMA_2550dd54-e47c-4823-b850-de181a45c3aa">279,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25c609ea75c4c068d67fe57512ea434_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDgtMS0xLTEtMA_96aef7f5-c1aa-42cb-a6b2-1bb1d20d1be2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09729cbfcb64401a6be3f8ffe616fc5_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDgtMy0xLTEtMA_f649cadc-4048-4833-ac0a-a32859792f9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeca89f1d034430482dee49030acec85_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDktMS0xLTEtMA_9406b206-23e0-45bf-af3a-4ddaaa2113c5">559,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c63462618b841479c213bb2713220cf_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDktMy0xLTEtMA_f81392b9-a075-428a-9b0a-f92722eb5c5a">279,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash of continuing operations at beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNTAtMS0xLTEtMA_3fda15fb-42cc-43d6-96b4-c952a86a5796">501,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if227b8854b5d464699191a415580aefe_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNTAtMy0xLTEtMA_ce9e34df-13b8-451f-883f-c6ca3d8bed81">1,208,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash of continuing operations at end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNTEtMS0xLTEtMA_8a5728c9-5b4c-4b5d-8059-328259a2cecf">1,061,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a083ee5fdf4ec99abc3850e10e37ff_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNTEtMy0xLTEtMA_12283e45-a041-4c60-b517-7aa5fb61b764">1,488,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.230%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.259%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests<br/>subject to<br/>put provisions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="45" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fbe978e34415294c2d4a792413761_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xLTEtMS0w_c06b77c1-fd85-4ce5-8288-f4e664692bbf">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8529c41e847743e48bb56774c5d6f476_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0zLTEtMS0w_fa28e555-e4ae-4c6f-834f-641aa737664c">109,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529c41e847743e48bb56774c5d6f476_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS01LTEtMS0w_6c9ad9cf-3f90-4e51-9377-fb3809e76d15">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7542b28699c64b3d8ad0d845de0fa0d6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS03LTEtMS0w_46fd9f10-786e-40ca-bdd4-68e9833ec245">597,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb912ac405a7429e8d9f894a52d31c82_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS05LTEtMS0w_a3fc30b2-be78-42be-bab5-e85381a8fdd3">852,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61057af670f54badb9c6da85fd10624c_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xMS0xLTEtMA_13299cfa-df3f-4e47-9ac2-7022c2844313">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61057af670f54badb9c6da85fd10624c_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xMy0xLTEtMA_e6b5ad79-5c45-4713-8f16-e08303848e42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0cd9ddbeee04401adc2305188ef344a_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xNS0xLTEtMA_42f2d834-7931-48d9-af0d-6c5a80a4e3a2">66,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f0aec10f4641fbba7afcf164b721c2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xNy0xLTEtMA_c447e707-4981-4b60-94b6-732759448f86">1,383,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54e17a5f75d24145bae682ee23ef20b0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xOS0xLTEtMA_d5d3dcd9-ea10-42d9-9a39-250605bf2ae4">183,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNy0xLTEtMS0w_7a1829f9-2c47-45fd-a3e1-db23c9d61817">35,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd348fa8b2c42d1a42ef7fd2cf4aab3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNy05LTEtMS0w_14a64c8e-f229-4df1-8b5b-42523d375cfe">237,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNy0xNy0xLTEtMA_6c29a738-941a-4ddc-b454-6823c7beeb74">237,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNy0xOS0xLTEtMA_284e7b37-eb43-408e-aafd-f2e1e2e73a63">18,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf07ea63041c4c928f8da459f8e85559_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOC0xNS0xLTEtMA_e6ff384a-435d-445f-ade9-1adaa322aad2">56,629</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOC0xNy0xLTEtMA_5670c5eb-1cda-473e-a890-1bd8face8dde">56,629</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock award plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e319b3a1dea46d48da73779ff5ed197_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOS0zLTEtMS0w_3a499e24-4e5b-484c-bf9c-ba867bec9a91">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOS03LTEtMS0w_48d2b710-f45b-4b03-b448-dd27a71bad6a">6,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOS0xNy0xLTEtMA_a92e0e7d-bdc2-4f7a-ae57-e3ec36f3a911">6,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTEtNy0xLTEtMA_a3c69b81-8c58-4451-858f-257a6c1c287e">23,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTEtMTctMS0xLTA_911bc80d-3ea1-47f0-8575-630b93576ace">23,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTMtMS0xLTEtMA_15a67b44-40d2-4534-8626-d9732287ea02">34,259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTMtMTktMS0xLTA_05a65a22-46f9-4eec-9dfb-3c4376f401f6">19,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTQtMS0xLTEtMA_cb3b02b0-4855-4172-a78c-44f354274375">7,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:NoncontrollingInterestIncreaseFromContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTQtMTktMS0xLTA_cb5cbddd-2f15-4d24-aec5-0e794e27efaa">2,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331" decimals="-3" name="dva:TemporaryEquityDecreasePurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTYtMS0xLTEtMA_f56393bb-6874-4331-a648-e5c7e5329fde">201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTYtNy0xLTEtMA_b982fbb8-425d-4ff5-a99f-e34a7967e9c7">889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTYtMTctMS0xLTA_108eec58-4233-41ee-84da-e9a55beabb1e">889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTYtMTktMS0xLTA_0a4cf4a1-c2fc-4c29-948e-4dab25f60157">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTctMS0xLTEtMA_05bc26f3-8bed-48da-97d6-a315b26e37a1">10,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTctNy0xLTEtMA_b9538b5d-43b2-4081-b298-6d4a6ac64dd8">10,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTctMTctMS0xLTA_73c41ac1-5df2-4072-ab3f-285d709c14cc">10,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i48461f3f7e034478b38bf2bd95c2c8b6_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTgtMTEtMS0xLTA_cc024efc-ef03-42b8-b9f8-8bdc9dd6a3a8">2,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48461f3f7e034478b38bf2bd95c2c8b6_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTgtMTMtMS0xLTA_afeb3024-3d82-46de-aff6-85f13a93641e">322,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTgtMTctMS0xLTA_5b0faf09-7bea-4888-b67c-87e1a7236f1f">322,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41b777f2cb434154b0b873e82c5fce50_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMS0xLTEtMA_fa0edbbd-d462-4d58-a77f-a6cd238f08fc">1,349,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if76ff822a85c4644b659c3e32c6a6ed3_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMy0xLTEtMA_fda9ba6f-bc47-46d9-b7db-d2d957d8dcda">110,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76ff822a85c4644b659c3e32c6a6ed3_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktNS0xLTEtMA_07647d66-7bb5-4278-af5b-1db2b148b581">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0320aabb1784267b2d621187040cf79_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktNy0xLTEtMA_d395709c-7a19-4d23-8470-b933a1926ecc">603,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73666b7ee2b24d4fa2f93200e6e07664_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktOS0xLTEtMA_2f76ad4b-e6b6-4248-ac81-18d40123717b">1,089,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia7cf27bbb13c4c3890e90cd1e469e381_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTEtMS0xLTA_b88d925a-a4b7-4ab5-a310-ddacf55fd37a">2,949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7cf27bbb13c4c3890e90cd1e469e381_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTMtMS0xLTA_4a8bb7ab-7b0d-4286-a32d-b1770e760e01">322,333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d5e5c6b5c5c4b67b3a716761c125e8f_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTUtMS0xLTA_1dd725bc-fd54-44c0-b9b1-096bbd13e153">122,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15cd87973cef469c8ae16c443d6af67f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTctMS0xLTA_2e587d6f-69ad-4dea-9017-6384ac1fef1b">1,248,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic81bcf50eda945c8941046c875428878_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTktMS0xLTA_bf52be48-0fe5-47a0-b517-b1b9ab0fed39">185,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.834%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests<br/>subject to<br/>put provisions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="45" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic075cfce513548e597924c070afcd2ae_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xLTEtMS0w_f4a135ef-aa27-48b1-b368-65a3b9bd3cc9">1,180,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85b41e0034a64dab9acb0cac6ac941ad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0zLTEtMS0w_cec3d280-fbb2-4e0d-bc5e-928f4fdf7824">125,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85b41e0034a64dab9acb0cac6ac941ad_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS01LTEtMS0w_b4a68bc0-397b-4ab9-88e8-ffad382e38ad">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc0c1697a60d44e08102a4bc72e7baee_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS03LTEtMS0w_5538f1ec-9317-4903-9f54-b99f0db1a1e6">749,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic19fe60e1ba04922b0a626ce23e8b7e7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS05LTEtMS0w_bf45a1c0-fcb9-4cbb-bd86-d7fac6fe49ad">1,431,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i475dc8640ab8472db6136e6d67675a03_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xMS0xLTEtMA_74644050-42e0-46eb-96fa-601ca994cd47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i475dc8640ab8472db6136e6d67675a03_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xMy0xLTEtMA_e14e0573-deb9-4e1f-82ea-da8cff049f55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6f5500e00234fdf8025a48470c3f347_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xNS0xLTEtMA_c3f61899-8746-48fb-b50f-3df8233d6016">47,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1c7e075c3458393c45dcc6b3ae765_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xNy0xLTEtMA_3315e8bc-5962-473d-9f49-a8ec0de6302a">2,133,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8b5aef473d4c39a93eee476090c527_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xOS0xLTEtMA_399138e8-a324-4914-bcfb-18a5bc9e5a59">185,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNy0xLTEtMS0w_fb18e520-8e0e-4dcf-9d55-3785185bdf6c">32,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9328309adf540c1a97c8d647b34233a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNy05LTEtMS0w_defd7de2-4ce6-4fc4-9f99-a37cee4c3c07">239,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNy0xNy0xLTEtMA_71146efe-7127-41c6-b702-0430d0172d79">239,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i932b6e9e1cd94560abb849f93670e5aa_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNy0xOS0xLTEtMA_5733fca4-9b93-4ae0-9726-fd04b5f69d95">16,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33019354c85e44cc941da40445b2afa3_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOC0xNS0xLTEtMA_813647c0-9a90-4299-9c66-016285d7954b">93,027</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOC0xNy0xLTEtMA_e05494e7-a5f9-49b3-aeba-b11635639246">93,027</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock award plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0a780a7182840f4a2262cae00e03efc_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOS0zLTEtMS0w_b8cf1a51-e7c9-4c56-8230-93788bea716c">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOS03LTEtMS0xMDcz_64e12464-7e14-47dc-8120-123e396bc5fc">320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOS0xNy0xLTEtMA_e448546d-4304-4602-8dd2-690c03be8bdd">320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTAtNy0xLTEtMA_f7d74180-0364-4657-b4ca-c9b15d8ce851">19,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTAtMTctMS0xLTA_470cfc87-f7e6-4783-a20d-b927e833667f">19,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTItMS0xLTEtMA_e6565dd9-d79e-40bb-98a9-ce36de55932a">37,566</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i932b6e9e1cd94560abb849f93670e5aa_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTItMTktMS0xLTA_8c2c26bc-a046-418f-a751-8840dc691919">20,565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTMtMS0xLTEtMA_b177e98e-db4a-4985-afb6-d478a942b230">5,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i932b6e9e1cd94560abb849f93670e5aa_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:NoncontrollingInterestIncreaseFromContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTMtMTktMS0xLTA_212ff9c5-f49a-47ef-87ab-5917444f50fe">4,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331" decimals="-3" name="dva:TemporaryEquityDecreasePurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTUtMS0xLTEtMA_7210bb61-68ae-467a-beb0-165f5392db4e">255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTUtNy0xLTEtMA_8443bd90-bf26-4a10-b298-9613405e033b">445</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTUtMTctMS0xLTA_436fc9ef-f880-45a4-a05d-4da39d29774d">445</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTYtMS0xLTEtMA_026d31c7-f9eb-49cb-b72a-45f9df8f5ed7">48,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTYtNy0xLTEtMA_f33c8b86-9d5e-4f88-b116-663199cf3040">48,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTYtMTctMS0xLTA_8700948c-425e-45c4-b01e-644c466ffa82">48,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8318a79043d44ffa9a6a4993763b2528_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTctMTEtMS0xLTA_5b35b398-2d73-4452-9e21-a60cfdfd5acb">4,052</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8318a79043d44ffa9a6a4993763b2528_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTctMTMtMS0xLTA_6f582566-483c-4ec3-a73a-c31580754ea6">303,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTctMTctMS0xLTA_cfb97628-9a61-49fe-83a9-85230a8c9ccc">303,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd3cc5d411a64abca391702baae8a9df_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMS0xLTEtMA_e4a186fb-21d5-4d64-9126-7d39ca297dce">1,228,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a8529f1d6484e20963d6f0e69c67f53_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMy0xLTEtMA_134d4e10-5128-4cfe-a59f-b7fdfe911988">125,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a8529f1d6484e20963d6f0e69c67f53_I20200331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtNS0xLTEtMA_98fee55f-004d-420c-aa82-1350c43df73a">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db5c6df63c341089b1c1dc195a6ffa0_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtNy0xLTEtMA_7034b045-53ef-47e2-91d7-ae94d2413255">720,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8e9b75a76f41589cb3e7fd00a42d30_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtOS0xLTEtMA_ad74a21f-59a8-4dd2-a90f-0217cbb0c565">1,671,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9afc760e9c5848eab9e7da50701226de_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTEtMS0xLTA_3412956a-38bb-4aec-acd7-eae9e8eb950e">4,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9afc760e9c5848eab9e7da50701226de_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTMtMS0xLTA_619dae01-1036-4ca7-a468-59599087b59d">303,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b19644a307d4aaf8b1b4bc4cb0d62f8_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTUtMS0xLTA_b5ac4418-60d8-4235-b0df-2ae04e620d3d">140,525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80771daad6c4b07a10321fc37cea825_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTctMS0xLTA_969a537e-31ff-4695-8496-08af73077d06">1,947,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2736318f0c409aa240efd57c2ef68e_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTktMS0xLTA_694c60a4-51f0-4b19-8421-c6b784b8d657">185,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_31"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated in this Quarterly Report on Form 10-Q "the Company", "we", "us", "our" and similar terms refer to DaVita Inc. and its consolidated subsidiaries.</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_34"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNC9mcmFnOjczN2RhMTE1OWZkODQ4MTQ4ZTEyYzUxOGUxYzVmMWJlL3RleHRyZWdpb246NzM3ZGExMTU5ZmQ4NDgxNDhlMTJjNTE4ZTFjNWYxYmVfMTU1Ng_822a7ae3-7db5-4f1d-974c-60a54565b592" continuedAt="i352097f9831d403393a43c06dfd3b173" escape="true">Condensed consolidated interim financial statements</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i352097f9831d403393a43c06dfd3b173"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNC9mcmFnOjczN2RhMTE1OWZkODQ4MTQ4ZTEyYzUxOGUxYzVmMWJlL3RleHRyZWdpb246NzM3ZGExMTU5ZmQ4NDgxNDhlMTJjNTE4ZTFjNWYxYmVfMTU2Mg_0d4eef69-3e57-4b43-a05f-662c6c81e9eb" escape="true">The unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, certain fair value estimates and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (2020 10-K). Prior period classifications have been conformed to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.</ix:nonNumeric></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_37"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RleHRyZWdpb246YTBiMDY4ZTJmZGIwNDg2ZmE1ZjVkYjc0ZDVmNzA0ZmNfMjE3OA_c435ba83-b9db-4c6a-a9c9-4d04299404b3" continuedAt="i9cc53fe5df03466bb808fb920fc4ae79" escape="true">Revenue recognition</ix:nonNumeric></span></div><ix:continuation id="i9cc53fe5df03466bb808fb920fc4ae79" continuedAt="i34580081ba954e9d80d44b7dc39e1cf8"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RleHRyZWdpb246YTBiMDY4ZTJmZGIwNDg2ZmE1ZjVkYjc0ZDVmNzA0ZmNfMjE4NQ_e18230ec-ce86-48e1-9ac0-5ee207b2e3d4" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's segment revenues by primary payor source:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bccfe449ed4991b0e4e2588ce7a9a9_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMy0xLTEtMS0w_e1d39fea-f061-479c-8500-92babc661331">1,480,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1a9b926a0d4f38a1427bdd4d8a03a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMy01LTEtMS0w_7de31e85-2af5-4d85-8b06-f6bb60b820d7">1,480,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9dd874b0d744ba2a90acc5b316f6054_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMy03LTEtMS0w_60730dff-6e5e-4978-b6ac-b4dc0fbeb67d">1,531,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c7c388a128487ab6d0234da86f133a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMy0xMS0xLTEtMA_59e2c75c-4420-493c-b0b3-784cc00487be">1,531,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c7afd963ec5440498a90eb4972fdf5d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNC0xLTEtMS0w_e498d119-1ad3-45b4-9d61-2e41f1b9f990">187,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83641efa6174426994832609d4cfde1c_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNC01LTEtMS0w_9f8edb60-0789-4d4a-b52c-0bb8976e88ad">187,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3b745665f334ec782e1b4c00dce1968_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNC03LTEtMS0w_54057156-29da-4cbb-a70e-501d6627c49c">171,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98660f7731974d069a340250cea5bcac_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNC0xMS0xLTEtMA_ced02efb-306b-425a-96af-f86ec5d454a6">171,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13ff0fa657884449b2488b3757779baf_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS0xLTEtMS0w_23cc2df0-a67f-434f-af63-abb8ea33a63b">80,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i803f842bbc824ff58114df1a63ffbf0a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS0zLTEtMS0w_30d891a9-baca-473d-b85a-97dbb555e627">106,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e28eaf39154728a43e3d45a96bc8a7_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS01LTEtMS0w_7d0451b5-2c59-4f50-b604-7d6228019f1a">187,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf913e95c60d44908d164dce5b236b5e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS03LTEtMS0w_018c1c10-d370-4eed-ae37-2f769d8ca6f1">83,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i608146c8b3ec4ec88cbc9d9bb1b096e2_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS05LTEtMS0w_64b27860-1cb7-416e-b4ee-8228e063be75">94,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96fded0bba7f4935af31ff42cf27ef96_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS0xMS0xLTEtMA_725ceec4-a39c-4082-ad0d-54aa8136ff4c">177,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i680ca482559e41b29995e9ec3a942053_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi0xLTEtMS0w_47b09ebe-244e-4385-bdc7-40ae52d3dd65">835,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaebf99e2b1f14c34a8a126def6ffbd2f_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi0zLTEtMS0w_8aa6b193-580f-4f43-80b1-2158114c5d27">51,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8f49aa1abb4d72a402bed74053e73d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi01LTEtMS0w_17b9a38f-97ca-40a1-8012-1d0d9b350d62">886,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e312d2270449af94812bdb09bce332_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi03LTEtMS0w_05b9421f-27ee-4ff8-8bee-94cab73be6fd">825,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0542fe9de33a45f1add8d0843709862e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi05LTEtMS0w_2d7f82aa-9c7f-438a-b0a2-9d3455f1b5e5">39,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6511e83e307f484e924d0db239adc3be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi0xMS0xLTEtMA_69523297-fced-4138-bf18-907931746584">865,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf3f726deb741c5811a90556bb9bc5a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOC0zLTEtMS0w_12d663ac-0d2d-49ac-95e7-5d95a2b0c3fd">85,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1a9b926a0d4f38a1427bdd4d8a03a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOC01LTEtMS0w_86afed49-f95e-49d3-8c67-f5ec4faf5cec">85,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f2200f0ed2d46558e31ace6797c599f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOC05LTEtMS0w_fb79fb6b-508a-4b87-bc2e-10e84e7b1130">98,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c7c388a128487ab6d0234da86f133a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOC0xMS0xLTEtMA_654e2cdf-6f43-46ba-95bd-e61c19fb4ebc">98,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id66622c2d23c48d793cd014811006a41_D20210101-20210331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOS0zLTEtMS0w_65bfd9ac-7b9e-427d-8942-4847ba1ba910">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83641efa6174426994832609d4cfde1c_D20210101-20210331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOS01LTEtMS0w_55379540-ac27-46d2-bb84-0420704c7b4d">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf38ac334ee84f118afa50f51593b348_D20200101-20200331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOS05LTEtMS0w_8496c83b-719f-4a73-8d76-102933640cd8">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98660f7731974d069a340250cea5bcac_D20200101-20200331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOS0xMS0xLTEtMA_a0a42828-32d0-4f40-be15-542ece88de2d">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaebf99e2b1f14c34a8a126def6ffbd2f_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTAtMy0xLTEtMA_d69deca2-cd7c-4f0d-ad9f-a049ad1fb5fd">6,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8f49aa1abb4d72a402bed74053e73d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTAtNS0xLTEtMA_570545bc-7fa7-4094-b2e9-838538306f93">6,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0542fe9de33a45f1add8d0843709862e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTAtOS0xLTEtMA_ca91b50e-8a1c-4b7f-b5ac-0a1cc7da5291">10,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6511e83e307f484e924d0db239adc3be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTAtMTEtMS0xLTA_2ed75baa-bd2b-44e4-9e60-f13893da6487">10,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790610c5a3ee4281a8434d08b7887b14_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtMS0xLTEtMA_3983fb55-8abb-4c20-ae0f-2cd35c8c7943">6,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6339430398b74ca2afee569cb8b0f426_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtMy0xLTEtMA_f7d70bd0-9b7b-4faa-8536-85bfcbbcd218">11,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c6c61591ec419c8a4f894e55b0bf58_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtNS0xLTEtMA_06fe0b6b-6abb-40a9-a522-bd84cbac6688">17,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i187374d6f1b34e62b52bf9d95907b97a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtNy0xLTEtMA_c5550133-ba8f-42d9-9f7a-8222c8a6d161">5,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if13419d218e54ae4a8ae1993a6172f7c_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtOS0xLTEtMA_4a81f0b7-edf7-4975-8471-a424c9ff5f01">17,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb6bac2e9afd461aa4604a702da5b510_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtMTEtMS0xLTA_7f1e49b0-99a9-483c-a309-3cea034a6994">23,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1a323c6052043f39e3e7d90a6c1e149_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItMS0xLTEtMA_809d63c4-2a5a-4b4f-9875-c1bfa989c853">27,003</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f1ae32f350f41b5b4c94e873d2ac8ab_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItMy0xLTEtMA_e9db334e-4efd-48d0-8618-378b91c2bfe5">4,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d4cbc4b3cb3440baae8caf684d727be_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItNS0xLTEtMA_d1bfd08c-e574-4596-9e96-e41a69879663">31,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i804d8967231546a69cb45a38bfa5a7de_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItNy0xLTEtMA_b5fa073e-ff1d-4fbf-b1f8-4c92daad0cec">32,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0707e2f78ab64721ab34ecd08e6b7faf_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItOS0xLTEtMA_1f8577a6-ea2c-468f-b175-684c62abf798">4,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb32ded36f5647b8bf00bcd206f6b64a_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItMTEtMS0xLTA_aa9101df-d7e4-4668-8d36-922ff489160e">36,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtMS0xLTEtMA_65f44629-4de4-41d8-98a3-67b11d092d92">2,562,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtMy0xLTEtMA_7a33dc09-973a-4542-bb84-149e85d30732">257,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtNS0xLTEtMA_3414f215-2de4-4855-976c-203427d0e8f5">2,820,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb49ac86f6b746d990ed1e8d57025774_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtNy0xLTEtMA_c4fc3730-631b-4b36-b2f9-70297ed909ff">2,584,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaaa1dbe5bd548efb96a1fb6dc9d1fdc_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtOS0xLTEtMA_82570354-5cd2-49c9-8224-b69be260e69b">256,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtMTEtMS0xLTA_76720938-ac70-4fc7-a07b-63a0bbd3be89">2,841,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the &#8220;Other government&#8221; category to the &#8220;Medicare and Medicare Advantage&#8221; category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the three months ended March 31, 2020 has also been recast to conform to the current period presentation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant uncertainties associated with estimating revenue, which generally take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i34580081ba954e9d80d44b7dc39e1cf8" continuedAt="iee6ed75acfac452e93fec7e370861a0e">maintained for the Company&#8217;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</ix:continuation></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="iee6ed75acfac452e93fec7e370861a0e" continuedAt="idcdb77d7eadf465091bd3521af61b334">Other revenues. </ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idcdb77d7eadf465091bd3521af61b334">Other revenues consist of fees for management and administrative support services provided to outpatient dialysis businesses that the Company does not own or in which the Company owns a noncontrolling interest as well as revenues associated with the Company's non-dialysis ancillary services. Revenues associated with dialysis management services, integrated care services, clinical research programs, physician services, and end stage renal disease (ESRD) seamless care organizations are estimated and recognized in the period services are provided.</ix:continuation> </span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_40"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RleHRyZWdpb246ZmRhNWZjNTQ4OWIyNDcwZTljZmFkYWZjZTZiZjM4MjhfOTM3_80633e22-9e39-40c9-98f4-fadfeda62cda" continuedAt="i3521707b1e9e45d2942ed2382d199376" escape="true">Earnings per share</ix:nonNumeric></span></div><ix:continuation id="i3521707b1e9e45d2942ed2382d199376"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RleHRyZWdpb246ZmRhNWZjNTQ4OWIyNDcwZTljZmFkYWZjZTZiZjM4MjhfOTQx_e0fc1835-bf90-43b9-afdc-23114b715e10" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RleHRyZWdpb246ZmRhNWZjNTQ4OWIyNDcwZTljZmFkYWZjZTZiZjM4MjhfOTQz_ad289ffb-4a1d-4e78-807a-6ad976bf3fa6" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"></td><td style="width:66.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.486%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.489%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMy0xLTEtMS0w_6bd9b536-ff6d-463b-8a24-9d3018def404">237,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMy0zLTEtMS0w_6ff01982-97cd-4350-a012-a100e1c5ebd6">229,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNC0xLTEtMS0w_12b6e495-9a7a-4b05-8e66-301ed37227ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNC0zLTEtMS0w_c1ff6fe3-1407-4891-bb1e-a25528ad4ed5">9,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNS0xLTEtMS0w_b58967a4-8e27-4f10-9f3e-f1a6508f2ef5">237,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNS0zLTEtMS0w_ab1b52ec-afaf-41dd-878d-2edf95e1e3b2">239,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNy0xLTEtMS0w_bc94a9b0-7c7c-43c6-a0c2-1ef73c589bdd">109,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNy0zLTEtMS0w_bbda6f44-f56b-4deb-bc33-572cd148ae3d">124,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfOC0xLTEtMS0w_c1678204-aff3-4fb6-a696-1173e6752f32">4,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfOC0zLTEtMS0w_c868699d-7ab7-4b52-8036-c2f78bbef3bf">1,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfOS0xLTEtMS0w_3173f54e-43bb-480a-8e7e-086bb62095b1">113,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfOS0zLTEtMS0w_e2601239-30e3-4cc7-9e7a-1896bafd4bfc">126,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic net income attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTItMS0xLTEtMA_215a98e5-deef-4db5-bcde-32f9253e5ebd">2.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTItMy0xLTEtMA_a19cbfe9-dcbc-4c04-bb1f-c06f90822f90">1.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTMtMS0xLTEtMA_5f6e0388-2080-4500-a960-717de07b7b0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTMtMy0xLTEtMA_9a490a0b-5abe-452c-95e2-c7a04aab54c2">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTQtMS0xLTEtMA_f7833545-af05-4cac-abaa-0499585c6d9f">2.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTQtMy0xLTEtMA_806f60fd-31b4-4469-82af-a7a623d60157">1.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted net income attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTctMS0xLTEtMA_008f5610-c477-4a3d-85e7-3dc81ed242e8">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTctMy0xLTEtMA_8a53004a-008d-41e2-946d-aef8e879d384">1.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTgtMS0xLTEtMA_650e17c3-d260-4fb1-991b-542a9161061c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTgtMy0xLTEtMA_f2d82385-0a5e-4d36-b075-8ebcff323a45">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTktMS0xLTEtMA_e619b9dd-1b8d-4aeb-adb6-8fe9e2f5b429">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTktMy0xLTEtMA_13d35d18-67fd-41d5-a7cf-643dea09cbc2">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMjEtMS0xLTEtMA_0f374b0e-4ca8-4258-9837-25a5e3efda2d">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMjEtMy0xLTEtMA_b2626084-5b79-4a03-9406-d665597a111f">3,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_1672"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGV4dHJlZ2lvbjowMmJmZTIzNTBhZGQ0MTQ0YmE0MDNkYzNhZTAzYzM2ZF8xODE0MTk0MTg1OTE0MA_dc7388cc-4ba6-4685-836f-4614755d9fa9" continuedAt="ie9533e961d604eb6b99a4eb1912d873d" escape="true">Short-term and long-term investments</ix:nonNumeric></span></div><ix:continuation id="ie9533e961d604eb6b99a4eb1912d873d"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGV4dHJlZ2lvbjowMmJmZTIzNTBhZGQ0MTQ0YmE0MDNkYzNhZTAzYzM2ZF8xODE0MTk0MTg1OTE0MQ_1cae8693-bf13-49a1-8363-998fa99ad5dd" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:37.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2618e51ff246e6a032f57f479d2741_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTEtMS0xLTY2MzU_03645b1f-229e-433b-ad8a-caba4ff9c148">8,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2618e51ff246e6a032f57f479d2741_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTMtMS0xLTY2MzU_d0b64bb7-f010-479f-9ac1-127806b1779d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2618e51ff246e6a032f57f479d2741_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTUtMS0xLTY2MzU_f0df30df-bc54-4aee-bb92-76ade25290fb">8,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic12d5b97b6be470aa5f5bc280eb39678_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTctMS0xLTY2MzU_592efc29-88e4-461f-acac-55a45032db3f">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic12d5b97b6be470aa5f5bc280eb39678_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTktMS0xLTY2MzU_57538029-3a4e-4b35-9d94-c9dd3d1e083d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic12d5b97b6be470aa5f5bc280eb39678_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTExLTEtMS02NjM1_995a6d19-faba-4d38-ac0d-9f6564c3f059">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in mutual funds and common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0172e2194a649be8e17948010a20139_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTEtMS0xLTY2MzU_cff0c252-10c9-40f8-aaca-336f71613119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0172e2194a649be8e17948010a20139_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTMtMS0xLTY2MzU_8dcd5e3d-10f7-46dd-b3c6-6153a7ec2aec">34,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0172e2194a649be8e17948010a20139_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTUtMS0xLTY2MzU_dcc68ad3-5a36-483d-baf1-fb6fe42736b1">34,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6402f5beaf314d64a2e3fc70b66cbbc8_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTctMS0xLTY2MzU_06322a27-3f28-4af8-9ef9-84ccf01bba12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6402f5beaf314d64a2e3fc70b66cbbc8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTktMS0xLTY2MzU_9cbfe252-8f08-4548-adf6-3a8624299293">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6402f5beaf314d64a2e3fc70b66cbbc8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTExLTEtMS02NjM1_f2eb08bd-9675-4022-86a9-a595a5411f4a">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTEtMS0xLTY2MzU_003322ea-a9c0-473c-ba96-e316714d0b19">8,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTMtMS0xLTY2MzU_f7a6fa04-6759-4056-9417-bb1813259269">34,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTUtMS0xLTY2MzU_53e6f728-5eaa-444a-8109-33ccde0d5b06">42,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTctMS0xLTY2MzU_2cef07ba-d83b-4f53-8179-b8b081b32970">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTktMS0xLTY2MzU_098cf5f1-7712-44a2-8b5b-dd1e9d0034c2">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTExLTEtMS02NjM1_c017b698-451b-4ce6-99e0-6e8b2c5aa011">52,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTEtMS0xLTY2MzU_48c70cea-f3f8-42ce-b9a4-98c2aca46a31">8,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c6ecda7f7b34fc8a0c5a23d786773f2_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTMtMS0xLTY2MzU_6ca35939-68fa-4ba3-bf63-155132a7e4a9">2,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTUtMS0xLTY2MzU_63d0be87-8808-4630-bf2b-1106341dc9f3">11,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTctMS0xLTY2MzU_6bca4204-0a58-4154-90b5-16e1109fbd1a">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5382ab7913ba4b97b4e5b4674fb7d89a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTktMS0xLTY2MzU_4ac85f6e-362a-41ea-b86f-46dc85c1f9d6">11,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTExLTEtMS02NjM1_c14a0a99-3675-48df-bbf7-61a0bd26ffb4">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTEtMS0xLTY2MzU_9d456534-46cb-485a-8aaa-158177d4c81c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882e39dba68b41538058accf2ecc1ed8_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTMtMS0xLTY2MzU_e02192ea-dd70-48d1-b6e7-d57d80242e07">31,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTUtMS0xLTY2MzU_de526f16-9fb0-49b2-bbc2-e566ec57e9af">31,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTctMS0xLTY2MzU_e4609643-4942-4050-939c-bc4f5cd9bc36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i352ee731e6ad4fb098d97efc97fa8dd5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTktMS0xLTY2MzU_1355756b-5c70-4921-b0e7-d188f43d91b4">32,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTExLTEtMS02NjM1_0ad17058-f9a7-4794-87ed-12775cd18566">32,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTEtMS0xLTY2MzU_05de06c3-4c3f-4cb7-8541-f441a64046a4">8,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTMtMS0xLTY2MzU_a42e8449-5b0b-4e4a-bbe7-76bace32c903">34,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTUtMS0xLTY2MzU_d97587c2-6487-432c-a2ca-a16ec6d72716">42,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTctMS0xLTY2MzU_aae10678-1d39-4699-9da1-6d19f2eeee6c">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTktMS0xLTY2MzU_a1f08b8e-0c89-4139-b596-11d5d97d022c">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTExLTEtMS02NjM1_15f48252-6192-4540-9c47-eef9cf19f5a1">52,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGV4dHJlZ2lvbjowMmJmZTIzNTBhZGQ0MTQ0YmE0MDNkYzNhZTAzYzM2ZF8xODE0MTk0MTg1OTE0Mg_f2299357-9a21-4e3a-8543-f71f59aef43b" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held to maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#8217;s non-qualified deferred compensation plans.</span></div></ix:nonNumeric></ix:continuation><div id="i22c52c47d5ba457da94184e7670ca7e6_52"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RleHRyZWdpb246OGQxMjg2YjgxNWQ2NDM0ZTllNjUzZjdlMzk2MDdlZGZfMzA3MA_9974f532-bdfe-4256-9bbb-b5334b70e51a" continuedAt="i9393b83363e945e0b78ee168662476a0" escape="true">Goodwill</ix:nonNumeric></span></div><ix:continuation id="i9393b83363e945e0b78ee168662476a0" continuedAt="i7b19df26f7234615a6e030296e922be9"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RleHRyZWdpb246OGQxMjg2YjgxNWQ2NDM0ZTllNjUzZjdlMzk2MDdlZGZfMzA3Mw_ce622c42-e43c-4642-88cf-1b44581ba7aa" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill by reportable segments were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"><tr><td style="width:1.0%"></td><td style="width:39.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da2c28df84d498d901a73b1bd176f75_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMS0xLTEtMS0w_ecdcbacb-555c-4b75-bb54-0fc7b514ea93">6,287,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie45e602ff596428d999df57f32972301_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMS0zLTEtMS0w_9d963b32-937c-4ce5-b605-92bb710f24e8">500,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if227b8854b5d464699191a415580aefe_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMS01LTEtMS0w_fedbc5f8-bef4-4fc5-bcb6-bb3c717fc1a1">6,787,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512b152939674415aeb4fcd3ff232747_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMi0xLTEtMS0w_903bb93c-15e5-4b62-91e0-16829059191a">24,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ffaa425a944fc7816ad190e4ae8372_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMi0zLTEtMS0w_83a94ef4-a317-4794-8e1e-88bb49e87810">105,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da2355fcf964251b943aab7dc93c0b6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMi01LTEtMS0w_6a3e96e5-468c-4c8b-ad17-b3e47d177f40">130,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i512b152939674415aeb4fcd3ff232747_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMy0xLTEtMS0w_6f664f96-b3c6-4ef3-8c08-6cc789170f1e">1,549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ffaa425a944fc7816ad190e4ae8372_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMy0zLTEtMS0w_901435f4-b400-42a7-8a27-ffb3598ad8a9">6,744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4da2355fcf964251b943aab7dc93c0b6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMy01LTEtMS0w_641c2ebb-540a-4118-915f-1ca1e07fbcc7">8,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512b152939674415aeb4fcd3ff232747_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNC0xLTEtMS0w_9f429ad6-b35c-4f74-8abf-88a7bc7aa98e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ffaa425a944fc7816ad190e4ae8372_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNC0zLTEtMS0w_11893493-423c-418d-95e7-c8ddca46a1c4">9,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da2355fcf964251b943aab7dc93c0b6_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNC01LTEtMS0w_57e262a4-0db4-436f-bc61-50ce0d8474b8">9,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab86a87e7ca432ca27ef7f2f0802e4e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNS0xLTEtMS0w_528a085c-4167-4fea-adc6-6c8089bfd67e">6,309,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2498e561a5854842a6d62e0b719f9b52_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNS0zLTEtMS0w_75caefc4-96cb-4bc2-a0a3-a77528393d8f">609,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNS01LTEtMS0w_21e32fe8-288f-433c-be07-6d61750f69d5">6,919,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNi0xLTEtMS0w_8748f308-ba1b-4f28-8dde-1ee9d0175cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNi0zLTEtMS0w_f9746de2-4a32-44d9-b361-a86dbd7d528b">5,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNi01LTEtMS0w_ca31d600-ddda-4c73-912c-095015fd9439">5,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOC0xLTEtMS0w_18a763e5-a537-4fa6-8a62-4dbc7cbc6d5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOC0zLTEtMS0w_9b5b553b-21d5-4d44-ae2c-2dcc0fc45e70">33,356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOC01LTEtMS0w_fa1804d4-446e-4f75-be7b-bc3b4c249476">33,356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOS0xLTEtMS0w_af10cb79-495c-4ad9-9d5a-0bfbe61f6714">6,309,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOS0zLTEtMS0w_4f4d2f42-f7ea-4de0-88e7-8cd5e58ebfa8">581,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOS01LTEtMS0w_73f45d6b-0b00-4e74-9e91-2afb7fefb998">6,891,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTItMS0xLTEtMA_816b8e6d-4676-4f66-8cad-06cd110801e5">6,309,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTItMy0xLTEtMA_315ad7f3-bd52-41e4-b70d-ee0d96b482d7">711,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTItNS0xLTEtMA_0796d2dd-d9ed-4749-a96e-4c56a33def0d">7,021,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTMtMS0xLTEtMA_f7de8043-c477-4863-8f22-f9bc5f34f1c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTMtMy0xLTEtMA_3c0e571b-fd74-421c-b97c-907aa7d4bf58">130,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTMtNS0xLTEtMA_babc491e-91bf-425a-ad51-4697f7288431">130,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTQtMS0xLTEtMA_88e9bc79-88c7-4d37-ae6b-8ce3eef04041">6,309,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTQtMy0xLTEtMA_ad154349-eca7-4b1f-87c1-2d91c6811ca2">581,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTQtNS0xLTEtMA_7775c472-8edf-4145-b4c9-a737717acd4a">6,891,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not recognize any goodwill impairment charges during the three months ended March 31, 2021 and 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of the dynamic and evolving COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the ultimate severity and duration of the pandemic, further spread or resurgence of the virus (including as a result of the emergence of new strains of the virus), its impact on the chronic kidney disease (CKD) patient population and the Company's patient population, the availability, acceptance, impact and efficacy of COVID-19 vaccines and other treatments, or therapies, the pandemic&#8217;s continuing impact on the U.S. and global economies and unemployment, the responses of the Company's competitors to the pandemic and related changes in the marketplace, and the timing, scope and effectiveness of federal, state and local governmental responses. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7b19df26f7234615a6e030296e922be9">Developments, events, changes in operating performance and other changes in circumstances since the dates of the Company&#8217;s last annual goodwill impairment assessments have not caused management to believe it is more likely than not that the fair values of any of the Company's reporting units would be less than their respective carrying amounts as of March&#160;31, 2021. Except for the Company's Germany kidney care reporting unit as described further in Note 10 to the Company's consolidated financial statements included in the 2020 10-K, <ix:nonFraction unitRef="segment" contextRef="ic7ea4fefb3604f5383d022830fb054b2_D20210101-20210331" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RleHRyZWdpb246OGQxMjg2YjgxNWQ2NDM0ZTllNjUzZjdlMzk2MDdlZGZfMjk0Nw_0b342780-0937-4b15-962f-9ff5956312a4">none</ix:nonFraction> of the Company's various other reporting units were considered at risk of significant goodwill impairment as of March&#160;31, 2021.</ix:continuation>&#160;</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_61"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTkxNA_095b8202-25ce-40bd-9bc1-76995001aab4" continuedAt="i3edaec1278494e269ea14e8e47ead154" escape="true">Long-term debt</ix:nonNumeric></span></div><ix:continuation id="i3edaec1278494e269ea14e8e47ead154" continuedAt="i539683b799a1426e974c5659cab69db4"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTkyNw_7ab93d28-3cb6-425e-b03c-04414fc90b16" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c92060a34e484cb1a910bc6a98a92b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy0xLTEtMS0w_1b21f8cc-2b0b-4bac-a01f-e8d34699777e">1,662,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied03f6f7ffa1498b908a85322c500f3f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy0zLTEtMS0w_94307672-1717-4532-912a-340032fad08c">1,684,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i788aadfa599242a796deae74047ca158_D20210101-20210331" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy01LTEtMS0w_49dcc8c9-03e2-4555-9550-bad156922344">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i788aadfa599242a796deae74047ca158_D20210101-20210331" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy03LTEtMS0w_dc0abcfd-88cf-4ec3-b229-cf026569b879">LIBOR + 1.50%</ix:nonNumeric> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c92060a34e484cb1a910bc6a98a92b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy05LTEtMS0w_70d6b772-5f33-4d5f-84b0-6afab824dbb9">1,666,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32e240900d2a4a45aa25dd2ec99f1da9_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC0xLTEtMS0w_9a3f639d-97d1-4485-b0d7-f06e315131e5">2,708,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504bca0dc6a34e968df9a1ef2d17533a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC0zLTEtMS0w_2e3767be-dbf7-4568-87ad-677bd610345a">2,715,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaac6bcb52a00428d87b88838a3a4bb73_D20210101-20210331" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC01LTEtMS0w_20d25a82-1c3f-4fd6-913c-c781a8b34899">8/12/2026</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaac6bcb52a00428d87b88838a3a4bb73_D20210101-20210331" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC03LTEtMS0w_e2617525-6739-44e7-a28c-364ab947af71">LIBOR + 1.75%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32e240900d2a4a45aa25dd2ec99f1da9_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC05LTEtMS0w_4ec0d26e-f13a-44c5-8d20-e79c4f164fd0">2,698,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8d83ec226e84558a394e404422907ea_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNi0xLTEtMS0w_5bc10bee-74b9-472c-a32e-5012f33eea14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37efecfb533c4ce8b0c977360ba10261_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNi0zLTEtMS0w_9e7a1fc7-0fd0-4028-ba2b-7e35fc5c9c4a">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e6f67d8fc604e5db4da237cb3d52d86_D20210101-20210331" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNi01LTEtMS0w_27d95057-2dc6-4395-8d6b-d405e5d3ce0f">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e6f67d8fc604e5db4da237cb3d52d86_D20210101-20210331" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNi03LTEtMS0w_14a0d319-72d7-4df9-9d94-53772e1540ec">LIBOR + 1.50%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i194f9194e246431c9dde99195297777e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC0xLTEtMS0w_3eeb07da-c6e7-435c-8649-54cb26bb6a07">2,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1bbaa73972045d38fd77a293d92478b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC0zLTEtMS0w_f905b517-1e31-4000-a095-17625c24b83d">1,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97a89b88b52c40e7aebc3bba7e72d037_D20210101-20210331" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC01LTEtMS0w_555da010-eaba-47aa-b6a3-39f65922df18">6/1/2030</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97a89b88b52c40e7aebc3bba7e72d037_D20210101-20210331" decimals="5" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC03LTEtMS0w_494d86b5-0735-42cf-8970-9febed2c835f">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i194f9194e246431c9dde99195297777e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC05LTEtMS0w_ab3ac3ba-9a2c-49da-b5ba-58cec5aea038">2,801,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd355c7251147dca43bf684d5040e60_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS0xLTEtMS0w_0942f306-bcff-45d1-97f4-fe71e904b320">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553adc006f9e4d1691c2e2bfc277dc41_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS0zLTEtMS0w_4ecf8b2d-f293-4e70-b3a8-9392ce4c1fc3">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i86de953a450f43afb93313b5cccf48ff_D20210101-20210331" format="ixt:datemonthdayyear" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS01LTEtMS0w_6cbcb723-97cb-4205-8d20-8d6ed597061b">2/15/2031</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86de953a450f43afb93313b5cccf48ff_D20210101-20210331" decimals="5" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS03LTEtMS0w_5323c7c4-8b3e-4f7b-b3bf-4c3d3ae30cfa">3.750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd355c7251147dca43bf684d5040e60_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS05LTEtMS0w_5d2d03bf-ca12-4af3-82d7-bdaa338ac2d7">1,436,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition obligations and other notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ebf3bf2b02476fb9efaac73b3d3dc5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:AcquisitionObligationsAndOtherNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItMS0xLTEtMA_3a94b6f4-9caa-4e1b-bd43-df1d9693a26a">152,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9698c484b14a119356f8182f5757c2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:AcquisitionObligationsAndOtherNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItMy0xLTEtMA_067c1455-37d9-492b-8a38-31f2a7793653">164,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1acbfcadeb1d433b9e81c9d3af8e55db_D20210101-20210331" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItNS0xLTEtMA_b36519e3-600f-4664-8a1c-84a58a7c069f">2021-2036</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91ebf3bf2b02476fb9efaac73b3d3dc5_I20210331" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItNy0xLTEtMA_38f2024e-a008-4fe8-902b-d855140158d4">4.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ebf3bf2b02476fb9efaac73b3d3dc5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:AcquisitionObligationsAndOtherNotesPayableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItOS0xLTEtMA_e5493a6e-8cc1-4262-8a4e-36ecb691ed25">152,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie12c3787f705434183585a7eb161899e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTMtMS0xLTEtMA_a8f98393-bb6b-43ff-8120-02b37bf776ee">289,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibff9b7fea3cc4a2c8cc8c9400ffa6dfd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTMtMy0xLTEtMA_15d8d6d3-e44e-48cf-819e-cf976ff9029b">274,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if8f84ec8dbbe47a885cecad8d415599b_D20210101-20210331" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTMtNS0xLTEtMA_9a4b211e-fae0-40ca-9140-be6d953ea38c">2022-2038</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie12c3787f705434183585a7eb161899e_I20210331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTMtNy0xLTEtMA_292f7df4-7d4a-4cef-994f-cae0e13c72c1">4.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTQtMS0xLTEtMA_e76d9d38-3cc3-4e77-bcc5-a5a02a1c1118">9,063,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTQtMy0xLTEtMA_473b518a-db31-4515-880c-30bcdb89d510">8,163,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount, premium and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:DiscountAndDeferredFinanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTUtMS0xLTEtMA_04d6666e-6ca4-4155-8d6d-d27b13818fa6">65,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="dva:DiscountAndDeferredFinanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTUtMy0xLTEtMA_8936fa74-36ca-4a3a-8870-430223476024">77,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTYtMS0xLTEtMA_1ed356e9-aa2b-4bae-aff0-50a26aba0e1b">8,997,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTYtMy0xLTEtMA_66929ccc-efbb-4224-b02b-b6433ed52aeb">8,085,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTctMS0xLTEtMA_0e79ffd2-d265-4d52-ba57-6bf4f6d461be">168,191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTctMy0xLTEtMA_40be6c5f-d615-48ac-b37b-a271374f9e6f">168,541</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTgtMS0xLTEtMA_fd340054-f2e9-46d1-8926-d3eeb005445a">8,829,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTgtMy0xLTEtMA_98166afc-252f-43dd-a72e-7cd335ad772d">7,917,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of March&#160;31, 2021.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">As of March&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities includes a discount of $<ix:nonFraction unitRef="usd" contextRef="id253887c65fb490bb3a75adbfae3b9f6_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTE4MQ_a1db229e-abd9-4cae-a71c-3013c2d39879">5,212</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="id253887c65fb490bb3a75adbfae3b9f6_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY1OQ_ef946e8f-3073-4de9-b7ef-cd3c1954fd80">33,650</ix:nonFraction> and the carrying amount of the Company's senior notes includes a premium of $(<ix:nonFraction unitRef="usd" contextRef="ie3a230004914446ebc401ea9c9effdd8_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNjA0NzMxMzk3OTU3MA_f29706c9-9dd8-4622-8309-71bc2bbc9fcb">17,327</ix:nonFraction>) and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="ie3a230004914446ebc401ea9c9effdd8_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY3NA_dbeda289-493d-4994-bcc2-93d0e5e5c93f">43,700</ix:nonFraction>. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities included a discount of $<ix:nonFraction unitRef="usd" contextRef="id61c0e835e604a309d4b0804349af819_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY4Mw_18877fb7-8e6b-48eb-8804-2efb116b9018">5,461</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="id61c0e835e604a309d4b0804349af819_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY4OQ_8cc04a87-c472-4b60-a66d-b955ad920620">35,825</ix:nonFraction>, and the carrying amount of the Company's senior notes included deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i606827500ec64b88b0b08567f4f6a0db_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredOfferingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY5NA_11ab5ea0-909f-42d6-86f3-518cad5f8a41">36,431</ix:nonFraction>.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first three months of 2021, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $<ix:nonFraction unitRef="usd" contextRef="i788aadfa599242a796deae74047ca158_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfMzA1MQ_ee8b3ea9-a2c6-4ad5-837f-08e72cb9aa84">21,875</ix:nonFraction> on Term Loan A and $<ix:nonFraction unitRef="usd" contextRef="iaac6bcb52a00428d87b88838a3a4bb73_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfMzA3Mw_a5deddce-fe5f-4004-b22b-e386fb44a88b">6,858</ix:nonFraction> on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2021, the Company completed an unregistered add-on offering of $<ix:nonFraction unitRef="usd" contextRef="ifcf13ba1953646bfbb5a0cec0cd092de_I20210226" decimals="-6" format="ixt:numdotdecimal" name="dva:AdditionalDebtPrincipalAmountDueToNewAgreement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODI0NjMzNzIzNTQxNg_55ec3835-7497-4261-b2e6-e4189bb3f6fe">1,000,000</ix:nonFraction> aggregate principal amount to the existing <ix:nonFraction unitRef="number" contextRef="i76a9d85fd0654e91a77f38adc13569bd_D20200609-20200609" decimals="5" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfMzE2Mw_0c18f69e-f77d-4688-b82e-c586a2f66fb2">4.625</ix:nonFraction>% senior notes due <ix:nonNumeric contextRef="ib6985ae730434382a11199004a394f1a_D20210226-20210226" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfMTgxNDE5NDE4ODU0NDU_7f0bf401-bbb0-4656-96ce-042a2f02ef31">June&#160;1, 2030</ix:nonNumeric> (the Additional 2030 Notes) pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Additional 2030 Notes were issued at an offering price of <ix:nonFraction unitRef="number" contextRef="ib6985ae730434382a11199004a394f1a_D20210226-20210226" decimals="5" name="dva:DebtInstrumentOfferingPricePercentageOfFaceAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODI0NjMzNzIzNTQyOA_0b0ff165-f0e4-4f6d-84f0-b08c954861f8">101.750</ix:nonFraction>% of face amount, plus an interest payment advance to the Company for interest that would have accrued from December 1, 2020 (the last interest payment date) through the closing date. These Additional 2030 Notes will then bear full six months' semi-annual coupon interest payments beginning June 1, 2021. The terms of the Additional 2030 Notes, other than their issue date, offering price and first interest payment date, are identical to the terms of the $<ix:nonFraction unitRef="usd" contextRef="ic0dc9c50975b46389c8201b72173f3f0_I20200609" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODI0NjMzNzIzNTQwNA_0015c235-1f90-4ac7-8cb6-87425b08be09">1,750,000</ix:nonFraction> principal amount of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i76a9d85fd0654e91a77f38adc13569bd_D20200609-20200609" decimals="5" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODI0NjMzNzIzNTQzOA_48974f5f-9d45-4609-98ad-731e2cda72f9">4.625</ix:nonFraction>% Senior Notes due June 1, 2030 previously issued by the Company on June 9, 2020. The Additional 2030 Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. During the three months ended March&#160;31, 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i194f9194e246431c9dde99195297777e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNjA0NzMxMzk3OTU4NQ_ac421550-17b8-4092-a1c4-612d9db12b9a">8,346</ix:nonFraction> in fees and other professional expenses associated with this transaction, which were capitalized and will amortize over the term of the Additional </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i539683b799a1426e974c5659cab69db4"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2030 Notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company's 2019 interest rate cap agreements have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on equivalent amounts of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $<ix:nonFraction unitRef="usd" contextRef="ic8c92060a34e484cb1a910bc6a98a92b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODAwMA_e358cfc2-6a3a-4760-b93c-e1fb298f7578">871,336</ix:nonFraction> outstanding principal balance of Term Loan A is subject to LIBOR-based interest rate volatility. <ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTkxMg_8714cc59-18c4-414b-84a2-257424b784d1" escape="true">These cap agreements are designated as cash flow hedges and, as a result, changes in the fair values of the cap agreements are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date.</ix:nonNumeric> These cap agreements do not contain credit risk-contingent features.</span></div><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTkyNg_08eaf46e-bc3f-4569-addc-a8c038e5a9e4" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of March&#160;31, 2021 and December&#160;31, 2020, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:17.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.012%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.012%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended <br/>March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI gain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9d50577324f44dd9a01b491e9e47a09_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0xLTEtMS0w_c08ba0f1-c887-4a89-aa62-24b50e662e97">3,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59aadc5542964885b2a0e3bc85b2fdbc_D20210101-20210331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0zLTEtMS0w_7775edca-1b45-420e-a7cd-aae6f74908e5">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibfd9c5748c524a73b8cf26558b198cb0_D20210101-20210331" format="ixt:datemonthdayyear" name="us-gaap:DerivativeInceptionDates" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi01LTEtMS0w_4d64efea-0c00-4b14-949d-23244b9d352b">6/30/2020</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibfd9c5748c524a73b8cf26558b198cb0_D20210101-20210331" format="ixt:datemonthdayyear" name="us-gaap:DerivativeMaturityDates" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi03LTEtMS0w_4ba9b33a-5b75-4b0d-b5fd-ae1ef8394d0f">6/30/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ab840ca2984e1cbd4b736f943c4d22_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi05LTEtMS0w_8615f3e5-8854-4e15-b131-3b988f8ea68b">1,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ab840ca2984e1cbd4b736f943c4d22_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0xMS0xLTEtMA_967d256c-d12a-479f-a52e-ca6a00a52b84">6,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4fde46bad1452eb6abb85e1eda2e52_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0xMy0xLTEtMA_b3d437f4-9127-4f80-8f5f-f5a29fe52d8b">9,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3300c03f30af4697aeb5cc0111c808e9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0xNS0xLTEtMA_8c63329b-432f-4af9-87b2-9bcfa15fcfbb">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 for further details on amounts reclassified from accumulated other comprehensive loss and recorded as debt expense related to the Company&#8217;s interest rate cap agreements for the three months ended March&#160;31, 2021 and 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of the first quarter of 2021 was <ix:nonFraction unitRef="number" contextRef="id253887c65fb490bb3a75adbfae3b9f6_I20210331" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTEyMQ_116908ca-055c-4227-bfac-67fdfa8a3f60">1.97</ix:nonFraction>%, based on the current margins in effect for Term Loan A and Term Loan B-1 as of March&#160;31, 2021, as described above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s overall weighted average effective interest rate for the three months ended March&#160;31, 2021 was <ix:nonFraction unitRef="number" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTMyNg_f9be4c97-26b8-4669-b389-105771817dbc">3.08</ix:nonFraction>% and as of March&#160;31, 2021 was <ix:nonFraction unitRef="number" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTM2OA_30fc0d50-882e-4098-9c03-c35480fca5e3">3.18</ix:nonFraction>%.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company&#8217;s interest rates were fixed on approximately <ix:nonFraction unitRef="number" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="4" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTQzOA_f07021a2-e9ff-4a90-a744-07a5a571d7f5">51</ix:nonFraction>% of its total debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had an undrawn $<ix:nonFraction unitRef="usd" contextRef="if8d83ec226e84558a394e404422907ea_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTQ5Nw_c7cb3bd4-09a2-454d-9a18-4a4af071159f">1,000,000</ix:nonFraction> revolving line of credit under its senior secured credit facilities. Credit available under this facility is reduced by the amount of any letters of credit outstanding under this facility, but there were <ix:nonFraction unitRef="usd" contextRef="ifeb4f066dfab44019e66a8db209e19eb_I20210331" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:LettersOfCreditOutstandingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNjQ1Ng_c37e345f-2d60-4fff-80fc-b9e9433196cd">no</ix:nonFraction> such letters of credit outstanding as of March&#160;31, 2021. The Company also had approximately $<ix:nonFraction unitRef="usd" contextRef="i00538c1ebb6745ca9520ef56fcbcb7e0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTgwOA_72381030-e68a-40c8-82a9-5fd0913f1642">64,650</ix:nonFraction> of outstanding letters of credit under a separate bilateral secured letter of credit facility as of March&#160;31, 2021.</span></div></ix:continuation><div id="i22c52c47d5ba457da94184e7670ca7e6_67"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfMTUzNjY_78135a10-7d6a-4fb5-a32a-4083d8a27854" continuedAt="i7dc52f3f0ba4435a870198b69af9d18f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">contingencies</span></ix:nonNumeric></div><ix:continuation id="i7dc52f3f0ba4435a870198b69af9d18f" continuedAt="i7239c61709ed49e082e2f8f95ed94ce2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from qui tam suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of March&#160;31, 2021 and December&#160;31, 2020, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i7239c61709ed49e082e2f8f95ed94ce2" continuedAt="ic4c9dd1a5b904ebcad6b75353d3fd4b2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. The government&#8217;s investigation covers the period from January 1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government&#8217;s investigation and that included total monetary consideration of $<ix:nonFraction unitRef="usd" contextRef="i1298eb35e47242399f1ae29c789cb247_D20171201-20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNDAwNg_a3f7a75d-44a6-4178-970f-017061fb4797">63,700</ix:nonFraction>, as previously disclosed, of which $<ix:nonFraction unitRef="usd" contextRef="i0196845c80ec4c118ab2c0f6b32fe811_D20171201-20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNDA0NA_d8b43827-1d8c-4059-b114-1559bc606718">41,500</ix:nonFraction> was an incremental cash payment and $<ix:nonFraction unitRef="usd" contextRef="i37f0d1d0eb764865859330a4621cb724_D20171201-20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNDA4Mw_609c4132-30b3-452a-bac5-0b57678178fd">22,200</ix:nonFraction> was for amounts previously refunded, and all of which was previously accrued. The government&#8217;s investigation is ongoing with respect to issues related to DaVita Rx&#8217;s historic relationships with certain pharmaceutical manufacturers, and in July 2018 the Office of Inspector General (OIG) served the Company with a subpoena seeking additional documents and information relating to those relationships. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018 and May 2019, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2018 U.S. Attorney Florida Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2018, DaVita Labs received two CIDs from the U.S. Attorney&#8217;s Office, Middle District of Florida that were identical in nature but directed to the two different labs. According to the face of the CIDs, the U.S. Attorney&#8217;s Office is conducting an investigation as to whether the Company&#8217;s subsidiary submitted claims for blood, urine, and fecal testing, where there were insufficient test validation or stability studies to ensure accurate results, in violation of the FCA. In October 2018, DaVita Labs received a subpoena from the OIG in connection with this matter requesting certain patient records linked to clinical laboratory tests. On September 30, 2019, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Middle District of Florida, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Lorne Holland, et al. v. DaVita Healthcare Partners, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The court then unsealed the complaint, which alleges violations of the FCA, by order dated the same day. In January 2020, the private party relators served the Company and DaVita Labs with an amended complaint. On February 24, 2020, the Company and DaVita Labs filed a motion to dismiss the amended complaint. On June 25, 2020, the court denied the motion to dismiss. The Company and DaVita Labs answered the complaint on July 23, 2020. The Company and DaVita Labs dispute these allegations and intend to defend this action accordingly.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired <ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt:datemonthdayyearen" name="dva:CorporateIntegrityAgreementExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNzQ0NA_f1a51ec8-6406-45a7-a668-adfa920efbdf">October 22, 2019</ix:nonNumeric>. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020. The subpoena, as revised, requests information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="ic4c9dd1a5b904ebcad6b75353d3fd4b2" continuedAt="i61e0425a6a134fbb9921370d60d6f993"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is cooperating with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to a False Claims Act investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to qui tam complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder and Derivative Claims</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Peace Officers&#8217; Annuity and Benefit Fund of Georgia Securities Class Action Civil Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On February 1, 2017, the Peace Officers&#8217; Annuity and Benefit Fund of Georgia filed a putative federal securities class action complaint in the U.S. District Court for the District of Colorado against the Company and certain executives.&#160;The complaint covers the time period of August 2015 to October 2016 and alleges, generally, that the Company and its executives violated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal securities laws concerning the Company&#8217;s financial results and revenue derived from patients who received charitable premium assistance from an industry-funded non-profit organization.&#160;The complaint further alleges that the process by which patients obtained commercial insurance and received charitable premium assistance was improper and "created a false impression of DaVita&#8217;s business and operational status and future growth prospects."&#160;In November 2017, the court appointed the lead plaintiff and an amended complaint was filed on January 12, 2018. On March 27, 2018, the Company and various individual defendants filed a motion to dismiss. On March 28, 2019, the court denied the motion to dismiss. The Company answered the complaint on May 28, 2019. On January 31, 2020, the plaintiffs filed a motion for class certification and the Company filed its opposition on June 29, 2020. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company continues to dispute the allegations, in July 2020, it reached an agreement in principle to resolve this matter without admitting to any liability.&#160;Settlement of this matter was covered primarily with insurance proceeds. The Company contributed an amount that did not have a material impact on the Company&#8217;s consolidated financial position, results of operations or cash flows. On April 13, 2021, the court granted final approval of the settlement. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">In re DaVita Inc. Stockholder Derivative Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On August 15, 2017, the U.S. District Court for the District of Delaware consolidated <ix:nonFraction unitRef="number" contextRef="i2a970640a33c4ad991ff8f3c6c172d83_D20170815-20170815" decimals="INF" format="ixt-sec:numwordsen" name="dva:LossContingencyNumberofLawsuitsConsolidatedIntoOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfMTIzMjk_f4bd388b-5f94-4ea4-b41d-ff3e4df403d1">three</ix:nonFraction> previously disclosed shareholder derivative lawsuits: the Blackburn Shareholder action filed on February 10, 2017, the Gabilondo Shareholder action filed on May 30, 2017, and the City of Warren Police and Fire Retirement System Shareholder action filed on June 9, 2017. The complaint covers the time period from 2015 to present and alleges, generally, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, corporate waste, and misrepresentations and/or failures to disclose certain information in violation of the federal securities laws in connection with an alleged practice to direct patients with government-subsidized health insurance into private health insurance plans to maximize the Company&#8217;s profits. An amended complaint was filed in September 2017, and on December 18, 2017, the Company filed a motion to dismiss and a motion to stay proceedings in the alternative. On April 25, 2019, the court denied the Company's motion to dismiss. The Company answered the complaint on May 28, 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the defendants continue to dispute the allegations, in July 2020, an agreement in principle was reached to resolve this matter without admitting to any liability. The Company&#8217;s Board of Directors (Board) approved the settlement on October </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i61e0425a6a134fbb9921370d60d6f993"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20, 2020. The court approved the settlement on January 29, 2021. As part of the settlement, the Company agreed to certain corporate governance policies, but did not make any financial contribution towards the settlement.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the foregoing, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 7, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div></ix:continuation><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:CommitmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfMTgxNDE5NDE4ODIyMjg_771f82ca-784d-4790-a21b-c5efc8c187a4" escape="true"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated outpatient dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $<ix:nonFraction unitRef="usd" contextRef="i2781197970dd4a92a8d85c696520a666_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherCommitment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNzE0NjgyNTU5NjczNw_4204c168-4541-4ada-b24d-338e8806cffe">8,449</ix:nonFraction>.</span></div></ix:nonNumeric><div id="i22c52c47d5ba457da94184e7670ca7e6_82"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTgxNDE5NDE4NjE3NjI_4377360a-1a55-4f05-8a99-538a4013a96a" continuedAt="i96226e2f14924d5da459c364494f9588" escape="true">Shareholders' equity</ix:nonNumeric></span></div><ix:continuation id="i96226e2f14924d5da459c364494f9588"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company granted <ix:nonFraction unitRef="shares" contextRef="i0f826db477234354ba1256988298cd45_D20210101-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzM5Nw_2692b113-8e3a-4c47-8597-b3870f4d2f16">706</ix:nonFraction> restricted and performance stock units with an aggregate grant-date fair value of $<ix:nonFraction unitRef="usd" contextRef="i0f826db477234354ba1256988298cd45_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzQwNA_0737b8fa-b88c-4806-9d3f-bea7f265f460">77,279</ix:nonFraction> and a weighted-average expected life of approximately <ix:nonNumeric contextRef="i0f826db477234354ba1256988298cd45_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzQxOA_4448899f-c915-4596-ac40-8c874a332526">3.5</ix:nonNumeric> years and <ix:nonFraction unitRef="shares" contextRef="i5d49ed528d08456d847b8513e95864e5_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzM4MQ_2ff5a89c-4225-43b5-a66b-0dc99eb65643">132</ix:nonFraction> stock-settled stock appreciation rights with an aggregate grant-date fair value of $<ix:nonFraction unitRef="usd" contextRef="i5d49ed528d08456d847b8513e95864e5_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzM5MA_f3f9ea3a-4ac8-46c3-b03a-fe6c2bd3309c">4,250</ix:nonFraction> and a weighted-average expected life of approximately <ix:nonNumeric contextRef="i5d49ed528d08456d847b8513e95864e5_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzQxMQ_c58187e8-3df3-4d00-8c5f-4755fda81116">4.5</ix:nonNumeric> years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTI2NDQzODM3MjI4MjQ_14cc45de-0798-4c6c-a35f-86bd2a3c6142">230,270</ix:nonFraction> in total estimated but unrecognized stock-based compensation expense under the Company's equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of <ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTI2NDQzODM3MjI4NTY_3c3d4f4e-ec75-4007-a8de-a726c606422e">1.5</ix:nonNumeric> years.</span></div></ix:continuation><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTI5Ng_ead75a6c-9f1f-4761-9433-c2126f4b22c7" escape="true"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchases</span></div><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTI5Mg_6908868b-d9d5-4ce0-882a-f1ffb7d01af7" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's common stock repurchases during the three months ended March&#160;31, 2021 and 2020: </span></div><div style="margin-top:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:27.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.931%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.774%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares repurchased</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount paid</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average paid per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares repurchased</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount paid</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average paid per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Open market repurchases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy0xLTEtMS0w_a59b307d-2d10-45df-b501-8bdd71c7de59">2,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy0zLTEtMS04NTk_101b3352-8c93-464e-a49a-bad8ef97bd16">322,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy0zLTEtMS0w_b86ee04a-250b-47a3-b8c5-9b1375a8c54f">109.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d7725640db9488db340c97bfa388a99_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy01LTEtMS0w_659a49a6-7980-492f-b1cc-e4d03e72be8e">4,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d7725640db9488db340c97bfa388a99_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy05LTEtMS04NDI_8df0b648-62eb-4b06-9250-a67be5298b68">303,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d7725640db9488db340c97bfa388a99_D20200101-20200331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy03LTEtMS0w_9c8b6634-401d-4e90-826a-c2bd4e92977c">74.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company repurchased <ix:nonFraction unitRef="shares" contextRef="i97d0c8af8a944946a42c942ce28c581d_D20210401-20210428" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNjU5_2a49f244-6e72-438d-b4f9-1c8b1853f2c0">991</ix:nonFraction> shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i97d0c8af8a944946a42c942ce28c581d_D20210401-20210428" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNjkz_f98ae82e-0613-47d5-a189-407440c2e85c">108,892</ix:nonFraction> at an average cost of $<ix:nonFraction unitRef="usdPerShare" contextRef="i97d0c8af8a944946a42c942ce28c581d_D20210401-20210428" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE4_455922ce-ad24-4738-a58e-f37b2227adfe">109.91</ix:nonFraction> per share subsequent to March&#160;31, 2021 through April&#160;28, 2021. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on December 10, 2020, the Company's Board of Directors (Board) terminated all remaining prior share repurchase authorizations available to the Company and approved a new share repurchase authorization of $<ix:nonFraction unitRef="usd" contextRef="i8f9b78b5f5fc4575a3e804c564b6679b_I20201210" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfODc5NjA5MzAyNjA5NA_d15cf830-2cfd-4a17-ab52-7dd1de499e89">2,000,000</ix:nonFraction>. As of April&#160;28, 2021, the Company had a total of $<ix:nonFraction unitRef="usd" contextRef="ifa346157c398428ab51f508528dc7f0d_I20210428" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfOTk5_8d587f12-2b2e-4536-8f3d-9d2fe8b207d3">1,498,730</ix:nonFraction> available under the current authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company remains subject to share repurchase limitations including under the terms of its current senior secured credit facilities.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_88"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RleHRyZWdpb246MjE4ZmQ2NjRhM2MwNGJiNjkwZjVjZTczM2EwNjI2NTNfMjg5_684ec2b8-4d0d-4820-9d53-3e22560e24bc" continuedAt="i17b690bf2c924ce28e7f63e9f45cc89f" escape="true">Accumulated other comprehensive loss</ix:nonNumeric></span></div><ix:continuation id="i17b690bf2c924ce28e7f63e9f45cc89f"><div style="margin-top:6pt;padding-left:27pt"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RleHRyZWdpb246MjE4ZmQ2NjRhM2MwNGJiNjkwZjVjZTczM2EwNjI2NTNfMjg3_bce371e1-7c19-4939-a093-208261608622" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"></td><td style="width:27.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9a08055277f468fa3da1c205ef85947_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi0xLTEtMS0w_e0cdaa45-a216-4ac1-b3fb-10b648903dd0">12,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4709116f7724bc9ad71c5bfd6776322_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi0zLTEtMS0w_98bfac4c-5dda-4f33-acd6-e752f20b35b0">53,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a80756affc64b969267ec3c56bb81ee_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi01LTEtMS0w_5f3f555d-e4a5-40f6-9072-b9ccf2dbc291">66,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7913425dd41a462fb453af0206275331_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi03LTEtMS0w_e7ad1f2c-d67f-41f8-9c9f-aa51b26c4948">1,433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7550f2fc99ab46e1b842231f6e90d788_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi05LTEtMS0w_5fba09e6-396c-4d9d-953c-15892645a343">46,065</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i798ec441c1634f7dbbe04fccf4900538_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi0xMS0xLTEtMA_eb0e9c34-2bc6-4c07-90e7-b7872cc77cfc">47,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy0xLTEtMS0w_0f364e7a-164b-42c4-993d-f25330f3cf43">6,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy0zLTEtMS0w_4b19822a-322e-4f0d-ba85-07670dce0653">62,544</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy01LTEtMS0w_8303a620-8e89-4e24-9791-f055aeda69ab">56,039</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy03LTEtMS0w_79a3f36b-5118-4dfa-804b-902a4e54c034">17,346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy05LTEtMS0w_18b0bcad-ac24-4662-a9fa-3333535ea0b9">81,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy0xMS0xLTEtMA_a7b406f4-08ce-48b0-b02b-95b87859e260">98,978</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC0xLTEtMS0w_f9ec7114-ff50-4684-8974-a901b541df47">1,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC0zLTEtMS0w_467ccfa2-6434-4994-be3e-5295c971ff37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC01LTEtMS0w_5b91dbea-b01b-4cdc-90d2-2db3f0e0ec9c">1,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC03LTEtMS0w_499fb317-5aa9-4e6b-8428-c33c4d5e83b0">4,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC05LTEtMS0w_ad5ca7e4-de71-4fc5-b85c-d83bbe9b6ec4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC0xMS0xLTEtMA_230e8884-ba42-462e-b211-5634f06bf2ba">4,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS0xLTEtMS0w_93eaf987-26ad-40c6-850a-a669dfb66c73">4,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS0zLTEtMS0w_ef372d3a-3f73-4e59-b4cc-16560216ee1f">62,544</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS01LTEtMS0w_a552f64d-aa90-49fa-a197-f2347c7f7e2f">57,662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS03LTEtMS0w_9bfbf0b5-3ce4-4c59-aa12-202e385f800c">13,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS05LTEtMS0w_2b6ccc95-5058-4ba5-b7f9-3190b90068b3">81,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS0xMS0xLTEtMA_bcd68b50-b61e-4af7-8130-caa53a435cb6">94,650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi0xLTEtMS0w_d37d9f16-0a6a-4c1b-8dd5-fe92d573bb4c">1,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi0zLTEtMS0w_4bf38440-083e-467a-9d14-1b9e041f94f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi01LTEtMS0w_bd24f9b3-5be0-433a-84e2-ff2923c93e00">1,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi03LTEtMS0w_3c5e2103-f7eb-4b03-8fa1-941289f3251f">2,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi05LTEtMS0w_e7453ec1-1d2c-475b-8ed0-9229efa6dd8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi0xMS0xLTEtMA_e16c6bea-35e6-4731-a906-bf3fcd6bfffc">2,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy0xLTEtMS0w_6a720173-c39d-4b9c-b103-abd71e4bf710">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy0zLTEtMS0w_caf5e157-d675-4e63-b7ab-33d708e63f84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy01LTEtMS0w_2e93b515-c8e2-4ea8-afb5-f3608ca5c8be">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy03LTEtMS0w_c70b8b73-a803-4cab-871f-f350afd5aeb5">540</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy05LTEtMS0w_869c4f7b-f950-47e7-b571-2ba8f82b1c5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy0xMS0xLTEtMA_9b5f3ff8-9106-43db-99fe-a4503345d06c">540</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC0xLTEtMS0w_59cb0160-1229-4b54-baf4-2826473a8543">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC0zLTEtMS0w_9c37bddc-2f76-4a99-b680-62dee892e520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC01LTEtMS0w_0b1072b8-4438-459a-9719-10a1d4fef92d">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC03LTEtMS0w_2932c172-82e1-4337-b195-3ac3889c4ba0">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC05LTEtMS0w_7fccd0ff-8190-4d62-ae2e-0374abb5e9fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC0xMS0xLTEtMA_fd4b5b61-1032-41df-bb1d-e5cddff0d100">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7639fee9f6714447997016db991f797c_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS0xLTEtMS0w_d15bf753-8939-4cc2-bbe5-0ed9bd59c210">6,551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84115112998e4c6ab8350b671c96944b_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS0zLTEtMS0w_b22e0da8-01ae-4f2f-b604-23107c25ef43">116,232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f5f0eab21a44845a44f238f8ff448c7_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS01LTEtMS0w_6daf2059-ebaf-4529-a9ba-a1a047de78d9">122,783</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i009808e6a6064e15a4b9a0b821c2bdfa_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS03LTEtMS0w_b3409b30-6629-4081-b1cf-9248646bdb7b">12,828</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b8ca49829314b1c86c5e23c209360a8_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS05LTEtMS0w_1b53dc2d-5cb0-4308-96a8-2d3025481ab8">127,697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6516fe61d14b40988955d5922b34c110_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS0xMS0xLTEtMA_1a3b2fc8-f366-4869-afd1-95eae35f434f">140,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RleHRyZWdpb246MjE4ZmQ2NjRhM2MwNGJiNjkwZjVjZTczM2EwNjI2NTNfMjk3_de9623c4-db20-426f-afb3-df6c6cb9dbe9" escape="true">The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income.</ix:nonNumeric> See Note 6 for further details.</span></div></ix:continuation><div id="i22c52c47d5ba457da94184e7670ca7e6_91"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjUzNg_04a6d3af-3ba3-4f98-9b47-2477ed9d76e6" continuedAt="i9f1217422e7044e5a3a5419196b6af1f" escape="true">Acquisitions and divestitures</ix:nonNumeric></span></div><ix:continuation id="i9f1217422e7044e5a3a5419196b6af1f" continuedAt="i27ccc0c7102f4614b74955cc3491763f"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Routine acquisitions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company acquired dialysis businesses consisting of <ix:nonFraction unitRef="clinic" contextRef="i27908b3ff2f44d9283aa1440a2b3ae17_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTkx_f3a962a6-2a5b-42b5-b39a-57e402c7284a">two</ix:nonFraction> dialysis centers located outside the U.S. for a total of $<ix:nonFraction unitRef="usd" contextRef="i5bfeeb71e92742cda00237cd50a46e64_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjUx_8d8e9f12-5691-449e-8530-e68e18052bb2">3,668</ix:nonFraction> in net cash, contingent earn-out obligations of $<ix:nonFraction unitRef="usd" contextRef="i5bfeeb71e92742cda00237cd50a46e64_D20210101-20210331" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTQyOTM2NTExNzAxMDQ_348f5b74-fff3-48a1-96c2-f20ed6c30c12">538</ix:nonFraction> and deferred purchase price and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="i5bfeeb71e92742cda00237cd50a46e64_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTQyOTM2NTExNzAxMDk_dd260f48-45a2-480c-8e89-0652891c498c">1,094</ix:nonFraction>. The assets and liabilities for these acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#8217;s condensed consolidated financial statements, as are their operating results, from the designated effective dates of the acquisitions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial purchase price allocations for these transactions have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. In particular, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of intangibles, leases and certain other working capital items relating to several of these acquisitions are pending final quantification.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill deductible for tax purposes associated with acquisitions completed during the three months ended March&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTQyOTM2NTExNzA0MTQ_11b41b73-3977-419d-8273-b026d27ee64b">5,456</ix:nonFraction>.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired companies a total of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i73bc0a8523dd4554aa03d767a5adeba8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:BusinessCombinationContingentConsiderationAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjA1NQ_214a2b10-a717-4f69-923a-aa5356a7b639">40,173</ix:nonFraction> if certain performance targets or quality margins are met over the next <ix:nonNumeric contextRef="i631f28de3213466e9bbd705c5fbefdc9_D20210101-20210331" format="ixt-sec:durwordsen" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjE0MA_5009fd44-3446-4439-b5ac-765e762f5479">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="i57247936e4d94d5da5ca8c68117d7722_D20210101-20210331" format="ixt-sec:durwordsen" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjE0Ng_6b652b42-205a-423f-8bd9-5f4fdc4bd4fb">five years</ix:nonNumeric>.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. As of March&#160;31, 2021, the Company estimated the fair value of these contingent earn-out obligations to be $<ix:nonFraction unitRef="usd" contextRef="i355c4c0d9e274392b8117ea1ede7a7eb_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjIyOQ_0d6014d1-babe-422a-808c-aa168bbc310f">28,225</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="if907602d375846b0b24b8a53b7ca0a19_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjI0Mg_965a0328-ba16-427a-9890-e9b8814aedc4">11,613</ix:nonFraction> is included in other current liabilities and the remaining $<ix:nonFraction unitRef="usd" contextRef="i0e0275ee13fa4083b1696201c4b78acb_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjMwNA_f4ae096e-3c2a-43e7-bbb3-226c05b45ac1">16,612</ix:nonFraction> is included in other long-term liabilities in the Company&#8217;s consolidated balance sheet.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i27ccc0c7102f4614b74955cc3491763f"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjUzNQ_060b38cc-bd32-4789-9072-7cb468122cea" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of changes in contingent earn-out obligations for the three months ended March&#160;31, 2021:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:74.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfMS0xLTEtMS0w_99f2b141-b165-4788-b9fb-407c641c74ff">30,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfMi0xLTEtMS0w_dcff48a0-2d42-44e0-a425-38c9d10a1b1d">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfMy0xLTEtMS0w_57ce1fc0-64d3-4b1d-bfe9-0027dd3f4def">2,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfNC0xLTEtMS0w_24b95f43-3872-4c95-98ef-5b6ffbf51f8e">214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfNS0xLTEtMS0w_f67b806d-8a03-4ea2-bddc-b06948613096">267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfNi0xLTEtMS0w_44564232-c588-4983-aafc-60845288ebb7">28,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTgxNDE5NDE4NjgwMDY_16293d4f-8ad6-4451-a407-b5ed88e63b0d" escape="true"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company completed the sale of its DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. At close of the DMG sale, the Company's ultimate net sale proceeds remained subject to resolution of certain post-closing purchase price adjustments described in the equity purchase agreement, which adjustments were finalized in the fourth quarter of 2020. In the first quarter of 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfNzE0NjgyNTU4OTM0Nw_eb2f2e20-fe20-4dff-a194-9d7bb767b9db">9,980</ix:nonFraction> in additional tax benefits under the Coronavirus Aid, Relief, and Economic Security Act related to its period of DMG ownership, which were recognized as an adjustment to the Company's loss on sale of the DMG business.</span></div></ix:nonNumeric><div id="i22c52c47d5ba457da94184e7670ca7e6_97"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85Ny9mcmFnOjc2NmI4YWNhMmQxMTQzNTI4ZTVlMGFmYzkzN2NlMDY5L3RleHRyZWdpb246NzY2YjhhY2EyZDExNDM1MjhlNWUwYWZjOTM3Y2UwNjlfNDQ5_75daec62-a3f5-4e40-9cef-49bea5fd149e" continuedAt="ic92b58077cd14ed99d2fd08e3dabf809" escape="true">Variable interest entities (VIEs)</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic92b58077cd14ed99d2fd08e3dabf809">At March&#160;31, 2021, these condensed consolidated financial statements include total assets of VIEs of $<ix:nonFraction unitRef="usd" contextRef="i79e508f7f8044bb5bcad2876847bcc76_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85Ny9mcmFnOjc2NmI4YWNhMmQxMTQzNTI4ZTVlMGFmYzkzN2NlMDY5L3RleHRyZWdpb246NzY2YjhhY2EyZDExNDM1MjhlNWUwYWZjOTM3Y2UwNjlfMTMy_ae0b3614-7a67-42f2-bce0-f681b2191979">300,849</ix:nonFraction> and total liabilities and noncontrolling interests of VIEs to third parties of $<ix:nonFraction unitRef="usd" contextRef="i79e508f7f8044bb5bcad2876847bcc76_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85Ny9mcmFnOjc2NmI4YWNhMmQxMTQzNTI4ZTVlMGFmYzkzN2NlMDY5L3RleHRyZWdpb246NzY2YjhhY2EyZDExNDM1MjhlNWUwYWZjOTM3Y2UwNjlfMjE0_ec834a67-0d0a-4d20-ba3e-62aca628c8f8">207,527</ix:nonFraction>. There have been no material changes in the nature of the Company's arrangements with VIEs or its judgments concerning them from those described in Note 23 to the Company's consolidated financial statements included in the 2020 10-K.</ix:continuation></span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_100"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90ZXh0cmVnaW9uOmQ0Nzk2YzM4M2JmZTQwMzU5MGM2NzYwZGQxNDRkMjU1XzQ1NTg_1370153f-c76e-4299-8122-531feff41776" continuedAt="if2fb338e36034c7fb93d95faaf54839a" escape="true">Fair values of financial instruments</ix:nonNumeric></span></div><ix:continuation id="if2fb338e36034c7fb93d95faaf54839a" continuedAt="i31fab1024bdc4985885f04f5671262e6"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equities that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB).</span></div><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90ZXh0cmVnaW9uOmQ0Nzk2YzM4M2JmZTQwMzU5MGM2NzYwZGQxNDRkMjU1XzQ1NzI_f5ffd73d-1b6e-427f-bd0e-55dcf40f4d2f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2021:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:44.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted prices in<br/>active&#160;markets<br/>for identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495ea84f47aa48bcbf441d81513cb962_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzItMS0xLTEtMA_5ab2210b-7279-450a-93e5-17980d587fa8">34,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5449f4136e4a069e013c4a12fa4b96_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzItMy0xLTEtMA_a7bdb1a3-505a-4631-b9b5-8930b9cdf1db">34,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f2d7535539145679656b6f1f8c6109d_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzItNS0xLTEtMA_1a273ac2-7e53-462a-94a6-75828811f017">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b44264ea668489b8330c31d2a995fa5_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzItNy0xLTEtMA_c45f2289-b715-4b8f-9c31-cbd2090e84ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3cd95724eb3494bb6e72cb6132e8c7d_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzMtMS0xLTEtMA_6940ddd8-ec81-4875-8410-3bbcfb29b743">9,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e9456343284b0183c0a4c3be1bb14e_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzMtMy0xLTEtMA_c8eb5593-7f9f-4796-bf8e-95e72b15f242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f92b2fa92fe417aa409a3b1a97cb245_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzMtNS0xLTEtMA_2d70a9ff-9e03-4378-875c-9737d3f33482">9,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a92bc0f852f4670a2b1907f3d705ae2_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzMtNy0xLTEtMA_77cb44b9-c1c3-441e-a93c-f25527fdcbb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495ea84f47aa48bcbf441d81513cb962_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzUtMS0xLTEtMA_678c424e-9619-4a36-a911-95f70407fa6c">28,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5449f4136e4a069e013c4a12fa4b96_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzUtMy0xLTEtMA_0eb1c9dc-3015-4af6-9c81-1c4512a943bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f2d7535539145679656b6f1f8c6109d_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzUtNS0xLTEtMA_840890f9-6bbf-47bc-8683-074499984e87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b44264ea668489b8330c31d2a995fa5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzUtNy0xLTEtMA_6e9d416b-81a2-468f-a4c5-b34270e8d418">28,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495ea84f47aa48bcbf441d81513cb962_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzctMS0xLTEtMA_56798edd-fc2f-4283-9d2d-501c368fc023">1,349,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5449f4136e4a069e013c4a12fa4b96_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzctMy0xLTEtMA_a2c5e1b0-545c-4e0b-ad5a-2470e6bd4b34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f2d7535539145679656b6f1f8c6109d_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzctNS0xLTEtMA_a8cf9640-3833-428f-81c0-67a2ac2a6472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b44264ea668489b8330c31d2a995fa5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzctNy0xLTEtMA_ea7d3505-9ce0-4b39-a4c7-7f924292a50f">1,349,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the three months ended March&#160;31, 2021, see Note 10 and the consolidated statement of equity, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stock which are held within a trust to fund existing obligations associated with several of the Company's non-qualified deferred compensation plans. These investments are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 4 for further discussion.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i31fab1024bdc4985885f04f5671262e6"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90ZXh0cmVnaW9uOmQ0Nzk2YzM4M2JmZTQwMzU5MGM2NzYwZGQxNDRkMjU1XzQ1NjM_b8979e9d-f427-4573-8ebe-dddc35acd1bb" continuedAt="ifd845544806242bca62ee59820bc2976" escape="true">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifd845544806242bca62ee59820bc2976">The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA) and revenue. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value.</ix:continuation> See Note 10 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of March&#160;31, 2021, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90ZXh0cmVnaW9uOmQ0Nzk2YzM4M2JmZTQwMzU5MGM2NzYwZGQxNDRkMjU1XzM2MDI_7b5f2243-52c3-4306-81a0-7bedabcfe18f">170,000</ix:nonFraction>. See Note 17 and Note 24 to the Company's consolidated financial statements included in the 2020 10-K for further discussion of the Company&#8217;s methodology for estimating the fair value of noncontrolling interests subject to put obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon bid and ask quotes for these instruments, typically a level 2 input. See Note 6 for further discussion of the Company's debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in these condensed consolidated financial statements at March&#160;31, 2021 at their approximate fair values due to the short-term nature of their settlements.</span></div></ix:continuation><div id="i22c52c47d5ba457da94184e7670ca7e6_103"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwMjU_bd71cc65-463b-47a5-9876-9b32220ea798" continuedAt="i504d77bbf2344078ac0ddcbb75b6831d" escape="true">Segment reporting</ix:nonNumeric></span></div><ix:continuation id="i504d77bbf2344078ac0ddcbb75b6831d" continuedAt="icea3815364824177a2aa2e22965b3d42"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its various ancillary services including its international operations (collectively, its ancillary services), and its corporate administrative support. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, each of its ancillary services, its kidney care operations in each foreign sovereign jurisdiction, its other health operations in each foreign sovereign jurisdiction, and its equity method investment in the Asia Pacific joint venture (APAC JV). The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other ancillary services operating segments, including the international operating segments, have been combined and disclosed in the other segments category. See Note 25 to the Company's consolidated financial statements included in the 2020 10-K for further description of how the Company determines and measures results for its operating segments.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="icea3815364824177a2aa2e22965b3d42" continuedAt="i5181446341014ecfa17d837ff2f7f513"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwMTQ_5b629282-55ec-4ae9-84bb-92160617e3f9" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment net revenues, segment operating income (loss), and a reconciliation of segment operating income (loss) to consolidated income before income taxes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332c7d42021f4f6da272ea3d938d6af0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzUtMS0xLTEtMA_fefc8eb8-844a-462e-9fa8-567bf26ab21e">2,556,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeec13c830464d468215c66930e23ec9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzUtMy0xLTEtMA_bc4000c6-b29f-4515-9af7-8a266785d99c">2,579,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979f0469490346ea8c2367f07d1340a4_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzYtMS0xLTEtMA_3a245975-d7af-4d5c-937f-d1406cce32d2">26,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6fe8af182b14048858164d9709baa1d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzYtMy0xLTEtMA_beb20d25-2a11-43b0-a691-05fa45cff523">31,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2601990fe363422986c39fb1866d5dcd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzktMS0xLTEtMA_f4eac59e-dc74-47ad-9b99-316abe7ce688">2,583,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a051b6561614f1e8e342da9d47552e7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzktMy0xLTEtMA_93cdf517-f27e-4b7d-9d05-c9d2fc4c8f3b">2,611,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332c7d42021f4f6da272ea3d938d6af0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzExLTEtMS0xLTA_2157aae7-a175-4a51-86cb-2aaac96cf20b">6,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeec13c830464d468215c66930e23ec9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzExLTMtMS0xLTA_ea9c76ed-75fe-4b0f-a3a2-0baa2234077a">5,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979f0469490346ea8c2367f07d1340a4_D20210101-20210331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzEyLTEtMS0xLTA_8c2d1110-ac3c-4fe1-bf3d-2cc15a39fb2d">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6fe8af182b14048858164d9709baa1d_D20200101-20200331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzEyLTMtMS0xLTA_54c302fb-6121-492e-99dc-811fae879e97">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2601990fe363422986c39fb1866d5dcd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzEzLTEtMS0xLTA_010bf3ed-b254-4fe1-ad2b-696e7e2bd7fd">2,589,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a051b6561614f1e8e342da9d47552e7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzEzLTMtMS0xLTA_2130628a-3d4b-4f07-b131-0bffb232ff2d">2,616,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9286623196349739c21994952f69f6a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE1LTEtMS0xLTA_ec282a46-37f3-4845-acc2-48d32af54b07">158,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE1LTMtMS0xLTA_b56ec077-63de-45a0-a9c2-6fff11e41f9b">134,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9286623196349739c21994952f69f6a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE2LTEtMS0xLTA_8403bcbc-4787-4115-864e-1b3ff64a876a">98,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE2LTMtMS0xLTA_aafe738e-99fd-42f7-bd00-d6905834eb06">122,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6e9959083a844ce9f5568612f3be925_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE3LTEtMS0xLTA_277f5eeb-2abe-4c93-a860-4eaf2bbc7771">4,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05a29181b883436aa54dd8cb74f27dfa_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE3LTMtMS0xLTA_4e758f8d-c34d-4f97-a1a8-c80f061625ef">4,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9286623196349739c21994952f69f6a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE4LTEtMS0xLTA_73d3ec9c-3c7f-4787-a2ea-317a961ae60f">261,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE4LTMtMS0xLTA_df025ba3-9edb-4596-a795-70bfe0d6f5d1">261,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063d84a2e30e427c986c99aacd98b664_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE5LTEtMS0xLTA_e0f409c1-4ddb-4b9c-8089-99da9c1f7c0e">2,851,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec56217c36c846509f6a12afa76de49b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE5LTMtMS0xLTA_3257b8d7-ed07-42e4-815b-12af04e4a438">2,877,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d4cbc4b3cb3440baae8caf684d727be_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIwLTEtMS0xLTA_b64fff91-8159-4c09-9da7-c97a58c24b4b">31,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb32ded36f5647b8bf00bcd206f6b64a_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIwLTMtMS0xLTA_b843aaba-86c9-4e70-93f7-8d2b66da16e7">36,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIxLTEtMS0xLTA_0b9113a4-96ce-4b28-be33-1f5e7aa6a45e">2,820,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIxLTMtMS0xLTA_92c20f57-bc17-48ba-9c20-565f4850bfca">2,841,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2601990fe363422986c39fb1866d5dcd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIzLTEtMS0xLTA_9fa9d670-c183-4d63-b4ac-ea10b794c67f">479,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a051b6561614f1e8e342da9d47552e7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIzLTMtMS0xLTA_17db06d4-5fbe-4bab-9619-616bd1e8dad7">491,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9286623196349739c21994952f69f6a_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI0LTEtMS0xLTA_12ca73a1-f36c-41a5-b617-88c218250af1">11,860</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI0LTMtMS0xLTA_f8e0bed1-69ea-42c0-ac79-1dc6faa8b428">2,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063d84a2e30e427c986c99aacd98b664_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI1LTEtMS0xLTA_4d1bf4b0-6de3-478e-a79c-249838ab882d">468,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec56217c36c846509f6a12afa76de49b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI1LTMtMS0xLTA_f48442b6-7f68-442b-8335-53de91f8f6d8">488,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of segment operating income to consolidated income from continuing <br/>&#160;operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="dva:SegmentReportingInformationCorporateExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI3LTEtMS0xLTA_cde4260e-bcb0-4742-b915-f7cdd0995710">25,444</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:SegmentReportingInformationCorporateExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI3LTMtMS0xLTA_8ecf61b6-99c0-4c74-a00a-9e73b3ba2596">23,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI4LTEtMS0xLTA_001d20d8-10bb-4554-a332-86638e91baf3">442,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI4LTMtMS0xLTA_4e55b636-1c23-455c-af74-bcf91facba87">465,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI5LTEtMS0xLTA_68892e38-83fe-4866-93b8-42c053a38dec">67,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI5LTMtMS0xLTA_a5e297bc-6fad-4fcd-a5af-5f7df7caaef3">88,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt refinancing charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMwLTEtMS0xLTA_6145d9f6-6e0e-4c2c-a24b-c8b576bfeda5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="dva:DebtPrepaymentRefinancingRedemptionCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMwLTMtMS0xLTA_ca4600f0-e54e-4ae0-9248-67f4e83e2004">2,948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMxLTEtMS0xLTA_8a01de7c-dbfe-488d-b0cd-6673920909df">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMxLTMtMS0xLTA_f414dce8-e7ac-4e73-a8b6-544abf15c950">4,350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMyLTEtMS0xLTA_97b8df42-b071-43d8-84d9-32c8773a6177">376,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMyLTMtMS0xLTA_a8813ad7-d284-4bd9-918b-d7aaf7c84aac">369,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Includes management fee revenue from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling equity investment or which are wholly-owned by third parties.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt;text-indent:-9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i5181446341014ecfa17d837ff2f7f513" continuedAt="i9118780ee636480db0e7fb7aa541df4f"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwNDQ_0de2ce83-a943-44e0-94c6-5d240d9885a9" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"><tr><td style="width:1.0%"></td><td style="width:63.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.077%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.822%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzItMS0xLTEtOTE0Nw_340800d1-d6a3-4dfa-8b3e-9bccdaf82bb9">155,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb49ac86f6b746d990ed1e8d57025774_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzItMy0xLTEtOTE0Nw_bc885670-4c9a-4e4c-93dd-ac1ccebc8984">146,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzMtMS0xLTEtOTE0Nw_721c8ff8-354a-48d3-9120-1b59af39110a">9,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaaa1dbe5bd548efb96a1fb6dc9d1fdc_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzMtMy0xLTEtOTE0Nw_4cd12b23-fad4-4ab7-a006-2121b1afcfe1">8,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzQtMS0xLTEtOTE0Nw_91eb46fb-c787-4e0b-a9d7-6e20a101d9aa">165,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzQtMy0xLTEtOTE0Nw_ab90a531-e02a-4ed6-9d02-f1c98950c0da">154,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwMzQwOTY1MTE4NTc4_c7847db3-ffb1-4d9a-aee7-41a8fed2e7e5" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of assets by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"><tr><td style="width:1.0%"></td><td style="width:63.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.077%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.822%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzEtMS0xLTEtMA_80e64c1f-7c6b-4b6a-8613-c64228a50359">16,036,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab86a87e7ca432ca27ef7f2f0802e4e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzEtMy0xLTEtMA_6d980d11-29f3-45f2-a4cc-d5855d30e48c">15,344,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzItMS0xLTEtMA_028dde15-727b-4a1f-964d-ee01e9505f7c">1,610,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2498e561a5854842a6d62e0b719f9b52_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzItMy0xLTEtMA_56d84149-c649-4cba-979a-3e6d1a45c542">1,643,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzMtMS0xLTEtMA_43faf222-1adf-4acd-886b-7e5d25cf65ad">17,647,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzMtMy0xLTEtMA_e1f58e75-b88f-4a14-92df-681eaeb93dcc">16,988,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwMzY_0e782bf9-2088-41c1-8508-53d9fa8c729b" continuedAt="i56f98556bf97461a8937d2c97844d9c5" escape="true">Expenditures for property and equipment by reportable segment were as follows:</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:6pt;padding-left:27pt"><ix:continuation id="i9118780ee636480db0e7fb7aa541df4f"><ix:continuation id="i56f98556bf97461a8937d2c97844d9c5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"><tr><td style="width:1.0%"></td><td style="width:63.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.077%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.822%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzItMS0xLTEtMA_e1674939-6bba-45d5-9c75-fbbfc334d93d">133,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb49ac86f6b746d990ed1e8d57025774_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzItMy0xLTEtMA_293dd5a1-c163-4cb1-94d9-be7ca2b51a3e">148,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzMtMS0xLTEtMA_689db337-0e1a-42bc-9b62-38b2241b243b">11,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaaa1dbe5bd548efb96a1fb6dc9d1fdc_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzMtMy0xLTEtMA_38833ab3-8ad0-4482-ae98-51d73084b53e">6,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzUtMS0xLTEtMA_54d1c4dd-5418-48b5-b155-63092c50a0ea">144,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzUtMy0xLTEtMA_b8058e19-e9fd-4a10-9c08-b7d81b6ac229">154,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_112"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMTIvZnJhZzplZGU4ODI0YzRmNzg0NzFmODFhYjM0MDc5MGEwYTU0Ni90ZXh0cmVnaW9uOmVkZTg4MjRjNGY3ODQ3MWY4MWFiMzQwNzkwYTBhNTQ2XzQxNDU_749bf623-d584-4ded-a829-58cac628434c" continuedAt="i275c361e3b894c04ba5d31e2f23ef38f" escape="true">New accounting standards</ix:nonNumeric></span></div><ix:continuation id="i275c361e3b894c04ba5d31e2f23ef38f"><ix:nonNumeric contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMTIvZnJhZzplZGU4ODI0YzRmNzg0NzFmODFhYjM0MDc5MGEwYTU0Ni90ZXh0cmVnaW9uOmVkZTg4MjRjNGY3ODQ3MWY4MWFiMzQwNzkwYTBhNTQ2XzQxNTQ_fd2383d2-6a5d-4102-809b-3d1b134d0d0f" escape="true"><div style="margin-top:9pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards recently adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU No. 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU No. 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The adoption of ASU No. 2019-12 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_118"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_121"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-looking statements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, including this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, contains statements that are forward-looking statements within the meaning of the federal securities laws and as such are intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements could include, among other things, DaVita's response to and the expected future impacts of the novel coronavirus (COVID-19), including statements about our balance sheet and liquidity, our expenses and expense offsets, revenues, potential need, ability or willingness to use any funds under government relief programs, availability or cost of supplies, treatment volumes, mix expectation, such as the percentage or number of patients under commercial insurance, the availability, acceptance, impact and administration of COVID-19 vaccines and other treatments or therapies, and overall impact on our patients and teammates, as well as other statements regarding our future operations, financial condition and prospects, expenses, strategic initiatives, government and commercial payment rates, and our ongoing stock repurchase program. All statements in this report, other than statements of historical fact, are forward-looking statements. Without limiting the foregoing, statements including the words "expect," "intend," "will," &#8220;could,&#8221; "plan," "anticipate," "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on DaVita's current expectations and are based solely on information available as of the date of this report. DaVita undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may be required by law. Actual future events and results could differ materially from any forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things:</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the continuing impact of the dynamic and evolving COVID-19 pandemic, including, without limitation, on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition and results of operations; the government&#8217;s response to the COVID-19 pandemic; the availability, acceptance, impact and efficacy of COVID-19 vaccines and other treatments or therapies; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus; the continuing impact of the pandemic on our revenue and non-acquired growth due to lower treatment volumes; the consequences of an extended economic downturn resulting from the impacts of COVID-19, such as a potential negative impact on our commercial mix, which may persist even after the pandemic subsides; and continuing COVID-19-related costs, such as costs to procure equipment and clinical supplies and higher salary and wage expense, any of which may also have the effect of heightening many of the other risks and uncertainties discussed below;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the concentration of profits generated by higher-paying commercial payor plans for which there is continued downward pressure on average realized payment rates, and a reduction in the number or percentage of our patients under such plans, including, without limitation, as a result of restrictions or prohibitions on the use and/or availability of charitable premium assistance, which may result in the loss of revenues or patients, or our making incorrect assumptions about how our patients will respond to any change in financial assistance from charitable organizations;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">noncompliance by us or our business associates with any privacy or security laws or any security breach by us or a third party involving the misappropriation, loss or other unauthorized use or disclosure of confidential information;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which the ongoing implementation of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof or related litigation result in a reduction in coverage or reimbursement rates for our services, a reduction in the number of patients enrolled in higher-paying commercial plans or that are enrolled in or select Medicare Advantage plans or other material impacts to our business; or our making incorrect assumptions about how our patients will respond to any such developments;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">a reduction in government payment rates under the Medicare End Stage Renal Disease program or other government-based programs and the impact of the Medicare Advantage benchmark structure;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">risks arising from potential changes in laws, regulations or requirements applicable to us, such as potential and proposed federal and/or state legislation, regulation, ballot, executive action or other initiatives, including those related to healthcare and/or labor matters, such as AB 290 and AB 650 in California and HB 2322 in Oregon;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the political environment and related developments on the current healthcare marketplace and on our business, including with respect to the future of the Affordable Care Act, the exchanges and many other core aspects of the current healthcare marketplace, as well as the composition of the U.S. Supreme Court and the new presidential administration and congressional majority;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully implement our strategies with respect to home-based dialysis, value-based care and/or integrated kidney care, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">changes in pharmaceutical practice patterns, reimbursement and payment policies and processes, or pharmaceutical pricing, including with respect to hypoxia inducible factors;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">legal and compliance risks, such as our continued compliance with complex government regulations;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">continued increased competition from dialysis providers and others, and other potential marketplace changes;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain contracts with physician medical directors, changing affiliation models for physicians, and the emergence of new models of care introduced by the government or private sector that may erode our patient base and reimbursement rates, such as accountable care organizations, independent practice associations and integrated delivery systems;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to complete acquisitions, mergers or dispositions that we might announce or be considering, on terms favorable to us or at all, or to integrate and successfully operate any business we may acquire or have acquired, or to successfully expand our operations and services in markets outside the United States, or to businesses outside of dialysis;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the variability of our cash flows, including without limitation any extended billing or collections cycles; the risk that we may not be able to generate or access sufficient cash in the future to service our indebtedness or to fund our other liquidity needs; and the risk that we may not be able to refinance our indebtedness as it becomes due, on terms favorable to us or at all;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">factors that may impact our ability to repurchase stock under our stock repurchase program and the timing of any such stock repurchases, as well as our use of a considerable amount of available funds to repurchase stock;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">risks arising from the use of accounting estimates, judgments and interpretations in our financial statements;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">impairment of our goodwill, investments or other assets; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainties associated with the other risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2020 (2020 10-K) and the risks and uncertainties discussed in any subsequent reports that we have filed or furnished with the Securities and Exchange Commission from time to time. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following should be read in conjunction with our condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_124"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal business is to provide dialysis and related lab services to patients in the United States, which we refer to as our U.S. dialysis business. We also operate various ancillary services including our international operations, which we collectively refer to as our ancillary services, as well as our corporate administrative support. Our U.S. dialysis business is a leading provider of kidney dialysis services in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;19, 2019, we completed the sale of our DaVita Medical Group (DMG) business to Optum, a subsidiary of UnitedHealth Group Inc. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented and DMG is not included below in this Management's Discussion and Analysis.</span></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 and its impact on our business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that COVID-19 will continue to impact our business and financial performance during 2021 and we continue to closely monitor these various impacts on our patients, teammates, physician partners, suppliers, vendors, business partners and the economic and political environment. The magnitude of these impacts remains difficult to predict and subject to significant uncertainty due to a number of factors, including, among others, the ultimate severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus; its impact on the chronic kidney disease (CKD) patient population and our patient population; the availability, acceptance, impact and efficacy of COVID-19 vaccines and other treatments or therapies; the pandemics' continuing impact on the U.S. and global economies and unemployment; the responses of our competitors to the pandemic and related changes in the marketplace; and the timing, scope and effectiveness of federal, state and local government responses. The continued impacts and disruptions to our business as a result of the COVID-19 pandemic could have a material adverse impact on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition, results of operations, cash flows and/or liquidity. </span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operational and Financial Impacts</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, treatment volumes reflected continued pressure primarily driven by the ongoing impact of COVID-19 on mortality rates for dialysis patients that has had a negative impact on our patient census. Because ESRD patients may be older and generally have comorbidities, several of which are risk factors for COVID-19, we believe the mortality rate of infected patients is, and will continue to be, higher in the dialysis population than in the general population, and COVID-19 also could impact the CKD population differently. COVID-19 case counts and new infections within our dialysis population have significantly declined from the peak prevalence rates experienced during the winter surge in late 2020 and early 2021. Over the longer term, we believe that changes in mortality in both the CKD and ESRD populations due to COVID-19 will depend primarily on the infection rate, case fatality rate, the age and health status of affected patients, the access to and efficacy of vaccinations as well as willingness to be vaccinated. We expect that these changes are likely to continue to negatively impact our revenue and non-acquired growth even as the pandemic subsides. However, determining the extent to which these impacts should be directly attributable to COVID-19 is difficult due to testing and reporting limitations, and other factors that may drive treatment volumes and new admissions over time, such as the number of transplants or deferred admissions. The magnitude of these cumulative impacts has been substantial, and depending on the ultimate severity and duration of the pandemic, could be material.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continued to experience increased costs in the first quarter of 2021 due in part to the protocols and initiatives we implemented in response to COVID-19 to help us safely maintain continuity of care for patients. Among other things, we continued to incur higher salary and wage expense and experienced significant cost inflation on PPE in the first quarter of 2021, though certain of these costs have decreased as a whole since the peak of the most recent COVID-19 surge in the fourth quarter of 2020. We believe that the cost of these medical supplies will remain elevated at least through the end of the year due to limited supply and high demand. In addition, as we have done in prior periods, we may provide substantial financial support associated with relief reimbursement to our teammates in the future. As our COVID-19 response continues, we expect to continue to incur extended and significant additional costs. On the other hand, our COVID-19 response has reduced certain other expenses, such as those related to teammate travel, though it remains uncertain how much of these reductions, if any, will persist after the pandemic subsides.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the COVID-19 pandemic and efforts to contain the virus have led to global economic deterioration and rapid and sharp increases in unemployment levels, which ultimately could result in a materially reduced share of our patients being covered by commercial insurance plans, with more patients being covered by lower-paying government insurance programs or being uninsured. These effects may persist after the pandemic subsides as, among other things, our patients could experience permanent changes in their insurance coverage as a result of changes to their employment status. In the event such a material reduction occurs in the share of our patients covered by commercial insurance plans, it would have a material adverse impact on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our business, results of operations, financial condition and cash flows. Despite the broader economic conditions in the U.S. in the three months ended March 31, 2021, our commercial mix in the first quarter of 2021 was slightly improved as compared to our commercial mix in the first quarter of 2020, which we believe was largely due to the fact that older, higher-risk patients who tend to disproportionately have government health insurance coverage, have been more adversely impacted by COVID-19 to date. The ultimate impact of COVID-19 on our commercial mix will depend on future developments that are highly uncertain and difficult to predict.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal, State and Local Government Response</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The government response to COVID-19 has been wide-ranging and will continue to develop over time, particularly in light of the new federal administration. As a result, we may not be able to accurately predict the nature, timing or extent of the impact of such changes on the markets in which we conduct business or on the other participants that operate in those markets, or any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern our business. We have worked with certain government agencies to respond to the COVID-19 pandemic, and in certain cases have sought waivers of regulatory requirements. We also have contracted with the federal government for direct administration of COVID-19 vaccines to our patients and teammates at our clinics. These vaccines are currently available under emergency use authorizations, and there can be no assurance that our patients and caregivers will choose to receive a COVID-19 vaccine or that the vaccines will prove to be as safe and effective as currently understood by the scientific community. In addition, we may encounter difficulties with the availability and storage of the vaccines, or experience other complications related to administering the vaccines, some of which have multiple dose requirements. We operate in a complex and highly regulated environment, and the novel nature of our COVID-19 response, including, for example, with respect to regulatory waivers and our administration of the newly developed COVID-19 vaccines, may increase our exposure to legal, regulatory and clinical risks.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal COVID-19 relief legislation suspended the 2% Medicare sequestration from May 1, 2020 through March 31, 2021, and in the three months ended March 31, 2021 our revenues increased due to this suspension as further described below. The Medicare Sequester Relief Act, signed into law on April 14, 2021, extended the suspension of the 2% Medicare sequestration from March 31, 2021 until December 31, 2021. While in effect, the suspension of sequestration has significantly increased, and will continue to significantly increase our revenues. At the state government level, a bill was recently introduced in California in connection with the ongoing COVID-19 state of emergency that would require health care employers with more than 100 employees to pay all non-executive employees a recognition bonus each quarter in 2022, with the amounts specified by employee status (i.e., full-time, part-time, per diem). The bill, AB 650, which was sponsored by the Service Employees International Union-United Healthcare Workers West, remains subject to change through the course of the legislative process. Additionally, though not directly related to COVID-19, another bill, HB 2322, was recently introduced in Oregon that specifically targets the dialysis industry and would impose a rate cap on private pay reimbursement for dialysis. If signed into law and implemented in substantially their current forms, these bills could have a significant adverse impact on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional discussion of the COVID-19 pandemic and our response, including its impact on us and related risks and uncertainties, please see the discussion in Part I Item 1 "Business" of the 2020 10-K under the headings, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 and its impact on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Managemen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t", as well as the risk factor in Part I Item 1A. Risk Factors of the 2020 10-K under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, any of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_127"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Results</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below includes analysis of our financial condition and results of operations for the quarter ended March&#160;31, 2021 compared to the quarters ended December&#160;31, 2020 and March&#160;31, 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated results of operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our revenues and operating income by line of business. See the discussion of our results for each line of business following this table:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q4 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q1 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_130"></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. dialysis results of operations </span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:21.154%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q4 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q1 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis treatments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,286,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,574,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,513,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(287,283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(226,387)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average treatments per day</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treatment days</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average patient service<br/>&#160;revenue per treatment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">354.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Normalized non-acquired</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;treatment growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Normalized non-acquired treatment growth reflects year over year growth in treatment volume, adjusted to exclude acquisitions and other similar transactions, and further adjusted to normalize for the number and mix of treatment days in a given quarter versus the prior year quarter.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis revenues for the first quarter of 2021 decreased from the fourth quarter of 2020 primarily due to a decrease in dialysis treatments, partially offset by an increase in our average patient service revenue per treatment. The decrease in our U.S. dialysis treatments was primarily driven by two fewer treatment days, higher mortality and missed treatments caused by the winter storms in the first quarter of 2021. We believe the increased mortality is largely attributable to the impact of COVID-19 on our patient population. Our U.S. dialysis average patient service revenue per treatment was positively impacted by favorable changes in government rates related to an increase in the Medicare base rate in 2021 and the inclusion of calcimimetics in the Medicare bundle, favorable changes in government mix due to shifts to Medicare Advantage plans, as well as favorable changes in commercial mix and increased hospital inpatient dialysis revenue driven by COVID-19, partially offset by a seasonal decline from co-insurance and deductibles.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis revenues for the first quarter of 2021 decreased from the first quarter of 2020 primarily due to a decrease in dialysis treatments, partially offset by an increase in our average patient service revenue per treatment. Our U.S. dialysis treatments decreased primarily due to a decline in non-acquired dialysis treatments due to higher mortality, and a decrease in treatment days. Our U.S. dialysis average patient service revenue per treatment increased primarily driven by favorable changes in government rates related to an increase in Medicare base rate in 2021 and the temporary suspension of Medicare sequestration, as well as favorable changes in government mix due to shifts to Medicare Advantage plans and favorable changes in commercial mix.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q4 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q1 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient care costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses and charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient care costs per treatment</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.69&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245.06&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237.35&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.37)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient care costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> U.S. dialysis patient care costs are those costs directly associated with operating and supporting our dialysis centers and consist principally of compensation expenses including labor and benefits, pharmaceuticals, medical supplies and other operating costs of our dialysis centers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs per treatment for the first quarter of 2021 decreased from the fourth quarter of 2020 primarily due to a decrease in COVID-19-related expenses, including a decrease in compensation and medical supply expenses that had been driven higher in the fourth quarter of 2020 by the winter COVID-19 surge, a decrease in utilities expense driven by our virtual power purchase arrangements, as well as decreases in health benefit expenses, pharmaceutical unit costs and other direct operating expenses associated with our dialysis centers. These decreases were partially offset by an increase in labor costs due to lower productivity levels at our dialysis centers and a seasonal increase in payroll taxes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs per treatment for the first quarter of 2021 increased from the first quarter of 2020 primarily due to an increase in labor costs driven by lower productivity levels at our dialysis centers, an increase in COVID-19-related expenses, including an increase in medical supply expense, as well as higher other direct operating expenses associated with our dialysis centers. These increases were partially offset by a decrease in pharmaceutical unit costs and intensity, a decrease in utilities expense driven by our virtual power purchase arrangements, decreased health benefit expenses due to reduced claims volume and a decline in travel expense.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis general and administrative expenses in the first quarter of 2021 decreased from the fourth quarter of 2020 primarily due to decreases in costs related to COVID-19, including a decrease in compensation expenses, as well as decreases in contributions to our charitable foundation and professional fees.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis general and administrative expenses for the first quarter of 2021 increased from the first quarter of 2020 primarily due to an increase in labor costs related to increased headcount and labor rates, and increased professional fees. These increases were partially offset by decreases in travel expenses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and amortization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense is directly impacted by the number of dialysis centers we develop and acquire. U.S. dialysis depreciation and amortization expenses for the quarter ended March&#160;31, 2021 compared to the quarters ended December&#160;31, 2020 and March&#160;31, 2020 increased primarily due to growth in the number of dialysis centers we operated in the first quarter of 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity investment income. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis equity investment income for the first quarter of 2021 decreased from the fourth quarter of 2020 and from the first quarter of 2020 primarily due to a decrease in profitability at our nonconsolidated joint ventures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:22.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q4 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q1 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income for the first quarter of 2021 increased from the fourth quarter of 2020 primarily due to an increase in our average patient service revenue per treatment, as described above, as well as decreases in COVID-19-related expenses, health benefits expense, utilities expense, pharmaceutical unit costs and other direct operating expenses associated with our dialysis centers, as described above. Operating income was negatively impacted by a decrease in dialysis treatments, and increases in labor costs and payroll taxes, as described above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income for the first quarter of 2021 decreased from the first quarter of 2020 primarily due to a decrease in dialysis treatments, as described above, and increases in labor costs, COVID-19-related expenses and other direct operating expenses associated with our dialysis centers, as described above. These decreases to operating income were partially offset by an increase in our average patient service revenue per treatment, as described above, and decreases in pharmaceutical unit costs and intensity, utilities expense, health benefit expenses and travel expense, as described above.</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_133"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other&#8212;Ancillary services</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other operations include ancillary services that are primarily aligned with our core business of providing dialysis services to our network of patients. As of March&#160;31, 2021, these consisted primarily of integrated care and disease management, ESRD seamless care organizations (ESCOs), clinical research programs and physician services, as well as our international operations. These ancillary services, including our international operations, generated revenues of approximately $261 million in the three months ended March 31, 2021, representing approximately 9% of our consolidated revenues for the period. If any of our ancillary services, such as our international operations, are unsuccessful, it could have a negative impact on our business, results of operations, financial condition and cash flows, and we may determine to exit that line of business, which could result in significant termination costs. In addition, we have in the past and may in the future incur material restructuring, write-off or impairment charges on our investment in one or more of these ancillary services, including goodwill.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to add additional service offerings to our business and to pursue other ancillary service opportunities in the future as circumstances warrant, which could include, among other things, healthcare services not related to dialysis. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, our international dialysis operations provided dialysis and administrative services through a total of 323 outpatient dialysis centers located in ten countries outside of the United States. </span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ancillary services results of operations</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q4 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q1 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. ancillary</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. ancillary</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services operating loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The reported operating income (loss) for the three months ended March&#160;31, 2021, December&#160;31, 2020 and March&#160;31, 2020, includes foreign currency gains (losses) embedded in equity method income recognized from our APAC joint venture of approximately $3 million, $(6) million and $10 million, respectively.</span></div><div style="margin-top:9pt;padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. ancillary services revenues for the first quarter of 2021 decreased from the fourth quarter of 2020 due to a decrease in revenue in our integrated care and disease management business primarily related to the reduction in members in our special needs plans, and the recognition of certain revenue in the fourth quarter of 2020 in our ESCO joint ventures that did not recur in the first quarter of 2021. International revenues for the first quarter of 2021 increased from the fourth quarter of 2020 primarily due to acquisition-related growth, partially offset by higher mortality driven by COVID-19.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. ancillary services revenues for the first quarter of 2021 decreased from the first quarter of 2020 due to a decrease in revenues in our integrated care and disease management business primarily related to the reduction in members in our special needs plans, as well as a decrease in revenues in our clinical research programs and our vascular access business due to the sale of RMS Lifeline, Inc., our vascular access business, effective May 1, 2020. Our international revenues for the first quarter of 2021 increased from the first quarter of 2020 primarily due to acquisition-related growth, partially offset by higher mortality driven by COVID-19.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating loss:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. ancillary services operating loss for the first quarter of 2021 were relatively flat from the fourth quarter of 2020 which was driven by a decrease in operating loss in our integrated care and disease management business offset by an increase in operating loss in our ESCO joint ventures. International operating results for the first quarter of 2021 increased from the fourth quarter of 2020 primarily driven by an increase in equity income from fluctuations in foreign currency at our APAC JV and acquisition-related growth in our international business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. ancillary services operating loss for the first quarter of 2021 increased from the first quarter of 2020, primarily due to a decrease in operating results at our integrated care and disease management business, as described above. International operating results for the first quarter of 2021 decreased from the first quarter of 2020 primarily due to a decline in equity income from fluctuations in foreign currency at our APAC JV, partially offset by acquisition-related growth in our international business.</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_136"></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate administrative support</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support consists primarily of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">labor, benefits and long-term incentive compensation expense, as well as professional fees for departments which provide support to all of our various operating lines of business. Corporate administrative support expenses are included in general and administrative expenses on our consolidated income statement. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q4 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q1 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support expenses for the quarter ended March&#160;31, 2021 compared to the quarter ended December&#160;31, 2020 were impacted by an increase in professional fees. Corporate administrative support expenses for the first quarter of 2021 increased from the first quarter of 2020 primarily due to an increase in insurance expense. </span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_139"></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate-level charges</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:32.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.187%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.523%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q4 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q1 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt refinancing charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate from continuing<br/> operations attributable to DaVita Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling<br/>&#160;interests</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our effective income tax rate from continuing operations attributable to DaVita Inc., see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt expense</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense for the first quarter of 2021 increased from the fourth quarter of 2020 as a result of completing an unregistered add-on offering of $1.0 billion aggregate principal amount to our existing 4.625% senior notes due June 1, 2030 (the Additional 2030 Notes) and higher average borrowings under the revolving line of credit, which increased interest expense for the quarter.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense for the first quarter of 2021 decreased from the first quarter of 2020 primarily due to a decrease in our overall weighted average effective interest rate on our debt, including as a result of refinancing our 5.125% senior notes and 5.0% senior notes with lower cost debt, a reduction in the LIBOR component of the interest rate on debt under our senior secured credit facilities and a repricing of the interest rate margin applicable to the Term Loan B component of our senior secured credit facilities. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our overall weighted average effective interest rate for the first quarter of 2021 was 3.08% compared to 3.07% for the fourth quarter of 2020 and 4.35% for the first quarter of 2020. See Note 6 to the condensed consolidated financial statements for further information on the components of our debt.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt refinancing charges</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">March&#160;31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> include $3 million of refinancing charges comprised partially of fees incurred on the repricing of our Term Loan B and partially of deferred financing costs written off for the portion of this debt considered extinguished and reborrowed.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (loss)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (loss) consists primarily of interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income for the first quarter of 2021 decreased from the fourth quarter of 2020 primarily due to a decrease in gains recognized on investments in addition to recognized losses on foreign currency transactions in the first quarter of 2021 compared to recognized gains in the fourth quarter of 2020. Other income for the first quarter of 2021 increased from the first quarter of 2020 due to recognized gains on investment in the first quarter of 2021 compared to recognized losses in the first quarter of 2020 in addition to a decrease in losses recognized on foreign currency transactions. </span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effective income tax rate</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the first quarter of 2021 was relatively flat from the fourth quarter of 2020. The effective income tax rate from continuing operations attributable to DaVita Inc. for the first quarter of 2021 decreased from the fourth quarter of 2020 primarily due to a reduction in nondeductible advocacy spend in 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate and the effective income tax rate from continuing operations attributable to DaVita Inc. for the first quarter of 2021 decreased from the first quarter of 2020 primarily due to a reduction in nondeductible advocacy spend and an increase in equity compensation deductions recognized in the first quarter of 2021.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in net income attributable to noncontrolling interests for the first quarter of 2021 from the fourth quarter of 2020 was primarily due to decreased earnings at certain U.S. dialysis partnerships. The increase in net income attributable to noncontrolling interests for the first quarter of 2021 from the first quarter of 2020 was primarily due to improved earnings at certain U.S. dialysis partnerships and reimbursements we made to certain of our U.S. dialysis partnerships for certain COVID-19-related expenses. </span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_142"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated accounts receivable balances at March&#160;31, 2021 and December&#160;31, 2020 were $2.041 billion and $1.824 billion, respectively, representing approximately 66 and 59 days sales outstanding (DSO), respectively, net of allowances for uncollectible accounts. Consolidated DSO increased primarily due to temporary billing holds related to winter storms and changes in calcimimetics reimbursement. Our DSO calculation is based on the current quarter&#8217;s average revenues per day. There were no significant changes in the first quarter of 2021 from the fourth quarter of 2020 in the amount of unreserved accounts receivable over one year old or in the amounts pending approval from third-party payors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_145"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the summary of our major sources and uses of cash, cash equivalents and restricted cash:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:54.765%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2021 vs. Q1 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions and shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash items in net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other working capital changes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(700.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash (used in) provided by investing activities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Routine maintenance/IT/other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Development and relocations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition expenditures</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of self-developed properties</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(900.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt issuances net of (payments) and financing costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions from noncontrolling interest</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">453.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Free cash flow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our free cash flow, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated cash flows</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated cash flows from operating activities during the three months ended March&#160;31, 2021 were $154 million, compared to consolidated operating cash flows for the three months ended March&#160;31, 2020 of $360 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The decrease in operating cash flows was primarily driven by an increase in total DSO of seven days for the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> three months ended March&#160;31, 2021 compared an increase of one day for the three months ended March&#160;31, 2020, in addition to timing of other working capital items.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow during the three months ended March&#160;31, 2021 decreased from the three months ended March&#160;31, 2020 primarily due to a decrease in net cash provided by operating activities as described above. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other significant sources of cash included proceeds from the issuance of $1.0 billion in aggregate principal amount of the Additional 2030 Notes as an add-on offering to our 4.625% senior notes due 2030 that were issued at an offering price of 101.750% of face amount, and other significant uses of cash included the repayment in full of borrowings under our revolving line of credit during the first quarter of 2021. Other net debt payments during the three months ended March&#160;31, 2021 primarily consisted of regularly scheduled mandatory principal payments under our senior secured credit facilities totaling approximately $22 million on Term Loan A and $7 million on Term Loan B-1 and additional required principal payments under other debt arrangements. In addition, we incurred bond issuance costs of approximately $8 million in cash. See further discussion in Note 6 to the condensed consolidated financial statements related to our debt financing activities. For the three months ended March&#160;31, 2021 we used cash to repurchase 2,949,482 shares of our common stock.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By comparison, the same period in 2020 included a net draw on our revolving line of credit of $500 million. Net debt payments during the first quarter of 2020 primarily consisted of regularly scheduled mandatory principal payments under our senior secured credit facilities totaling approximately $11 million on Term Loan A and $7 million on Term Loan B-1 as well as additional required principal payments under other debt arrangements. In addition, we incurred refinancing costs related to the repricing of our Term Loan B-1 of approximately $3 million. For the three months ended March&#160;31, 2020 we used cash to repurchase 4,052,298 shares of our common stock.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis center footprint and growth </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the growth in our dialysis operations by number of dialysis centers owned or operated:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.742%"><tr><td style="width:1.0%"></td><td style="width:54.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.278%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of centers operated at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired centers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed centers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in non-owned managed or administered centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sold and closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of centers operated at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,772&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;padding-right:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers which we manage or provide administrative services to but in which we own a noncontrolling equity interest or which are wholly-owned by third parties, including our Asia Pacific joint venture centers. </span></div><div style="margin-top:3pt;padding-left:45pt;padding-right:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were sold and/or closed for which the majority of patients were not retained.</span></div><div style="margin-top:3pt;padding-left:45pt;padding-right:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were closed for which the majority of patients were retained and transferred to one of our other existing outpatient dialysis centers.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our common stock repurchases during the three months ended March&#160;31, 2021 and 2020: </span></div><div style="margin-top:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:27.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.692%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.962%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.962%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares repurchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount paid (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average paid per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares repurchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount paid (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average paid per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Open market repurchases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,949,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,052,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion of our stock repurchases in Note 8 to the condensed consolidated financial statements.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available liquidity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, we had an undrawn $1.0 billion revolving line of credit under our senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding thereunder, but there are currently no letters of credit outstanding under this facility. We separately have approximately $65 million of outstanding letters of credit under a separate bilateral secured letter of credit facility. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 to the condensed consolidated financial statements for components of our long-term debt and their interest rates. We may from time to time seek to obtain funds or refinance existing debt through additional debt financings or other capital alternatives.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and efforts to prevent its spread have dramatically reduced global economic activity and driven increased volatility in the financial markets. We have maintained business process continuity during the COVID-19 pandemic by enabling most back office teammates to work remotely, and as of the date of this report, we have not experienced material deterioration in our liquidity position as a result of the COVID-19 crisis. In addition, we elected not to accept approximately $250 million in funds available to us through the CARES Act Provider Relief Fund and returned the funds we received in May 2020. There can be no assurance that we will be able to continue to forgo the receipt of financial or other assistance under the CARES Act or similar subsequent legislation or that similar assistance will be available from the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">government if we have a need for such assistance in the future. The ultimate impact of the pandemic will depend on future developments that are highly uncertain and difficult to predict.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash flow from operations and other sources of liquidity, including from amounts available under our senior secured credit facilities and our access to the capital markets, will be sufficient to fund our scheduled debt service under the terms of our debt agreements and other obligations for the foreseeable future, including the next 12 months. Our primary recurrent sources of liquidity are cash from operations and cash from borrowings, which are subject to general, economic, financial, competitive, regulatory and other factors that are beyond our control, as described in Item 1A Risk Factors of our 2020 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_148"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliations of non-GAAP measures</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide reconciliations of our effective income tax rate on income from continuing operations attributable to DaVita Inc. excluding noncontrolling owners' income, which primarily relates to non-tax paying entities. We believe this adjusted effective income tax rate is useful to management, investors and analysts in evaluating our performance and establishing expectations for income taxes incurred on our ordinary results attributable to DaVita Inc.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our free cash flow represents net cash provided by operating activities, less distributions to noncontrolling interests and all capital expenditures (including development capital expenditures, routine maintenance and information technology), plus contributions from noncontrolling interests and proceeds from the sale of self-developed properties. Management uses this measure to assess our ability to fund acquisitions and meet our debt service obligations and we believe this measure is equally useful to investors and analysts as an adjunct to cash flows from operating activities and other measures under U.S. generally accepted accounting principles (GAAP).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These non-GAAP or &#8220;adjusted&#8221; measures are presented because management believes these measures are useful adjuncts to our GAAP results. It is important to bear in mind that these non-GAAP &#8220;adjusted&#8221; measures are not measures of financial performance under GAAP and should not be considered in isolation from, nor as substitutes for, their most comparable GAAP measures.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:64.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.947%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Noncontrolling owners' income primarily attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense for continuing operations</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Income tax attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense from continuing operations attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate on income from continuing operations attributable<br/>&#160;to DaVita Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:66.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash provided by operating activities attributable to DaVita Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Expenditures for routine maintenance and information technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Expenditures for development </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Proceeds from sale of self-developed properties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Free cash flow</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum due to the presentation of rounded numbers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_151"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-balance sheet arrangements and aggregate contractual obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the debt obligations and operating lease liabilities reflected on our balance sheet, we have commitments associated with letters of credit, as well as certain working capital funding obligations associated with our equity investments in nonconsolidated dialysis ventures that we manage and some that we manage which are wholly-owned by third parties. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have potential obligations to purchase the noncontrolling interests held by third parties in many of our majority-owned dialysis partnerships and other nonconsolidated entities. These obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods as outlined in each specific put provision. For additional information on these obligations and how we measure and report them, see Note 12 to the condensed consolidated financial statements and Note 17 and Note 24 to the consolidated financial statements included in our 2020 10-K.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of these off-balance sheet contractual obligations and commitments as of March&#160;31, 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:45.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Remainder of 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022-2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025-2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">After<br/>5 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potential cash requirements under other commitments:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letters of credit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-owned and minority owned put provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating capital advances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase commitments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,748&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information on the maturities and other terms of our long term debt, see Note 6 to the condensed consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the commitments listed above, in 2017 we entered into a sourcing and supply agreement with Amgen USA Inc. (Amgen) that expires on December 31, 2022. Under the terms of this agreement, we will purchase EPO from Amgen in amounts necessary to meet no less than 90% of our requirements for erythropoiesis-stimulating agents (ESAs) through the expiration of the contract. The actual amount of EPO that we will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that we serve.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase commitments in the table above represent our agreements with various suppliers to purchase set amounts of dialysis equipment, parts, and supplies. If we fail to meet the minimum purchase commitments under these contracts during any year, we are required to pay the difference to the supplier.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements of existing income tax liabilities for unrecognized tax benefits of approximately $90 million, including interest, penalties and other long-term tax liabilities, are excluded from the table above as reasonably reliable estimates of their timing cannot be made.</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_154"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See discussion of new accounting standards in Note 14 to the condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_157"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_160"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest rate and foreign currency sensitivity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no material change in the nature of the Company's interest rate risks or foreign currency exchange risks from those described in Part II Item 7A of our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide information about our financial instruments that are sensitive to changes in interest rates as of March&#160;31, 2021. For further information on the components of the Company's long-term debt and their interest rates, see Note 6 to the condensed consolidated interim financial statements included in this Quarterly Report on Form 10-Q at Part I Item 1.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:13.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.133%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expected maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average interest rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="57" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents the fair value of the Company&#8217;s long-term debt excluding financing leases. See Note 6 to the condensed consolidated financial statements for further details.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.240%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contract maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Receive variable</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="57" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR&#160;above 2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i22c52c47d5ba457da94184e7670ca7e6_163"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Controls and Procedures</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has established and maintains disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that it files or submits pursuant to the Securities Exchange Act of 1934 (Exchange Act) as amended is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms, and that such information is accumulated and communicated to the Company&#8217;s management, including its Chief Executive Officer (CEO) and Chief Financial Officer (CFO) as appropriate to allow for timely decisions regarding required disclosures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of the Company&#8217;s CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures in accordance with the Exchange Act requirements as of March 31, 2021. Based upon that evaluation, the CEO and CFO concluded that the Company&#8217;s disclosure controls and procedures were effective as required by the Exchange Act as of such date for our Exchange Act reports, including this report. Management recognizes that these controls and procedures can provide only reasonable assurance of desired outcomes, and that estimates and judgments are still inherent in the process of maintaining effective controls and procedures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in the Company's internal control over financial reporting that was identified during the evaluation that occurred during the fiscal quarter covered by this report that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_166"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_169"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Part II, Item 1 is incorporated herein by reference to the information set forth under the caption &#8220;Commitments and Contingencies&#8221; in Note 7 to the condensed consolidated financial statements included in this report. </span></div><div id="i22c52c47d5ba457da94184e7670ca7e6_172"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">There have been no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K (2020 10-K) for the year ended December&#160;31, 2020 filed with Securities and Exchange Commission. You should carefully consider the risks included in our 2020 10-K, together with all the other information in this Quarterly Report on Form 10-Q, including the forward-looking statements in Part I, Item 2 of this Quarterly Report on Form 10-Q under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_175"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our repurchases of our common stock during the first quarter of 2021:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.830%"><tr><td style="width:1.0%"></td><td style="width:26.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total number<br/>of shares<br/>purchased</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average price<br/>paid per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total number<br/>of shares<br/>purchased as<br/>part of publicly<br/>announced<br/>plans or programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Approximate dollar<br/>value of shares that<br/>may yet be<br/>purchased under the<br/>plans or programs</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars and shares in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 1-31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,860,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 1-28, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,745,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 1-31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,607,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on December 10, 2020, the Board terminated all remaining prior share repurchase authorizations available to us and approved a new share repurchase authorization of $2.0 billion. We are authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;28, 2021, we had a total of $1.499 billion available under the current authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, we remain subject to share repurchase limitations including under our current senior secured credit facilities. </span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items 3, 4 and 5 are not applicable</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_178"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-33121ex31110xq.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated April 29, 2021, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-33121ex31210xq.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated April 29, 2021, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-33121ex32110xq.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated April 29, 2021, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-33121ex32210xq.htm">32.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated April 29, 2021, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation, Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"></td><td style="width:2.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed or furnished herewith.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i22c52c47d5ba457da94184e7670ca7e6_181"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:56.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DAVITA INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JOHN D. WINSTEL</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John D. Winstel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Accounting Officer*</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date:  April&#160;29, 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr.&#160;Winstel has signed both on behalf of the Registrant as a duly authorized officer and as the Registrant&#8217;s principal accounting officer.</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>dva-33121ex31110xq.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i79018ad22dcb49348e8a670f38c05850_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Javier J. Rodriguez, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.00pt"><tr><td style="width:1.0pt"></td><td style="width:277.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;29, 2021 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>dva-33121ex31210xq.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="idcf34d3b4cd647b0b49e3649fdebccf2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Joel Ackerman, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;29, 2021 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>dva-33121ex32110xq.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="idc087a1920a1469287319770d1245f48_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Periodic Report&#8221;), I, Javier J. Rodriguez, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2021</font></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>dva-33121ex32210xq.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib00b4caed62a4893a317996da1d51e3c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Periodic Report&#8221;), I, Joel Ackerman, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2021</font></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>dva-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0eedf026-4cb7-43f6-a1e9-99f3721c46b9,g:375f77ab-f095-4ce1-bcc5-25c9315fbffb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dva="http://www.davita.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.davita.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.davita.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSunauditedParenthetical" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical">
        <link:definition>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements">
        <link:definition>2101101 - Disclosure - Condensed consolidated interim financial statements Condensed consolidated interim financial statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies">
        <link:definition>2202201 - Disclosure - Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionRevenueRecognition" roleURI="http://www.davita.com/role/RevenueRecognitionRevenueRecognition">
        <link:definition>2103102 - Disclosure - Revenue Recognition Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSegmentrevenuebymajorpayorTables" roleURI="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables">
        <link:definition>2304301 - Disclosure - Revenue Recognition Segment revenue by major payor (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSegmentRevenuebyPayorDetails" roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails">
        <link:definition>2405401 - Disclosure - Revenue Recognition Segment Revenue by Payor (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareNotes" roleURI="http://www.davita.com/role/EarningspershareNotes">
        <link:definition>2106103 - Disclosure - Earnings per share (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspersharePolicies" roleURI="http://www.davita.com/role/EarningspersharePolicies">
        <link:definition>2207202 - Disclosure - Earnings per share (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareEarningsPerShareTables" roleURI="http://www.davita.com/role/EarningspershareEarningsPerShareTables">
        <link:definition>2308302 - Disclosure - Earnings per share Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails">
        <link:definition>2409402 - Disclosure - Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investmentsindebtandequitysecurities" roleURI="http://www.davita.com/role/Investmentsindebtandequitysecurities">
        <link:definition>2110104 - Disclosure - Investments in debt and equity securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsindebtandequitysecuritiesTables" roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables">
        <link:definition>2311303 - Disclosure - Investments in debt and equity securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsindebtandequitysecuritiesDetail" roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail">
        <link:definition>2412403 - Disclosure - Investments in debt and equity securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.davita.com/role/Goodwill">
        <link:definition>2113105 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.davita.com/role/GoodwillTables">
        <link:definition>2314304 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillChangesinGoodwillbyReportableSegmentsDetail" roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail">
        <link:definition>2415404 - Disclosure - Goodwill - Changes in Goodwill by Reportable Segments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillNarrativeDetails" roleURI="http://www.davita.com/role/GoodwillNarrativeDetails">
        <link:definition>2416405 - Disclosure - Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Longtermdebt" roleURI="http://www.davita.com/role/Longtermdebt">
        <link:definition>2117106 - Disclosure - Long-term debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtTables" roleURI="http://www.davita.com/role/LongtermdebtTables">
        <link:definition>2318305 - Disclosure - Long-term debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtDetail" roleURI="http://www.davita.com/role/LongtermdebtDetail">
        <link:definition>2419406 - Disclosure - Long-term debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtScheduleofDerivativeInstrumentsDetails" roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails">
        <link:definition>2420407 - Disclosure - Long-term debt Schedule of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtAdditionalInformationDetail" roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail">
        <link:definition>2421408 - Disclosure - Long-term debt - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.davita.com/role/CommitmentsandContingencies">
        <link:definition>2122107 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>2423409 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Shareholdersequity" roleURI="http://www.davita.com/role/Shareholdersequity">
        <link:definition>2124108 - Disclosure - Shareholders' equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharerepurchasesShareRepurchasesTables" roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables">
        <link:definition>2325306 - Disclosure - Share repurchases Share Repurchases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermincentivecompensationDetails" roleURI="http://www.davita.com/role/LongtermincentivecompensationDetails">
        <link:definition>2426410 - Disclosure - Long-term incentive compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharerepurchasesShareRepurchaseTableDetails" roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails">
        <link:definition>2427411 - Disclosure - Share repurchases Share Repurchase Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharerepurchasesDetails" roleURI="http://www.davita.com/role/SharerepurchasesDetails">
        <link:definition>2428412 - Disclosure - Share repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accumulatedothercomprehensivelossincome" roleURI="http://www.davita.com/role/Accumulatedothercomprehensivelossincome">
        <link:definition>2129109 - Disclosure - Accumulated other comprehensive (loss) income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedothercomprehensivelossincomeTables" roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables">
        <link:definition>2330307 - Disclosure - Accumulated other comprehensive (loss) income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedothercomprehensivelossincomeDetail" roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail">
        <link:definition>2431413 - Disclosure - Accumulated other comprehensive (loss) income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitionsanddivestitures" roleURI="http://www.davita.com/role/Acquisitionsanddivestitures">
        <link:definition>2132110 - Disclosure - Acquisitions and divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddivestituresTables" roleURI="http://www.davita.com/role/AcquisitionsanddivestituresTables">
        <link:definition>2333308 - Disclosure - Acquisitions and divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddivestituresContingentEarnoutobligationsDetails" roleURI="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails">
        <link:definition>2434414 - Disclosure - Acquisitions and divestitures Contingent Earn-out obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddivestituresAdditionalInformationDetail" roleURI="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail">
        <link:definition>2435415 - Disclosure - Acquisitions and divestitures - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Variableinterestentities" roleURI="http://www.davita.com/role/Variableinterestentities">
        <link:definition>2136111 - Disclosure - Variable interest entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableinterestentitiesAdditionalInformationDetail" roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail">
        <link:definition>2437416 - Disclosure - Variable interest entities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Fairvalueoffinancialinstruments" roleURI="http://www.davita.com/role/Fairvalueoffinancialinstruments">
        <link:definition>2138112 - Disclosure - Fair value of financial instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueoffinancialinstrumentsTables" roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables">
        <link:definition>2339309 - Disclosure - Fair value of financial instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail">
        <link:definition>2440417 - Disclosure - Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails">
        <link:definition>2441418 - Disclosure - Fair value of financial instruments Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segmentreporting" roleURI="http://www.davita.com/role/Segmentreporting">
        <link:definition>2142113 - Disclosure - Segment reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingTables" roleURI="http://www.davita.com/role/SegmentreportingTables">
        <link:definition>2343310 - Disclosure - Segment reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail">
        <link:definition>2444419 - Disclosure - Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail">
        <link:definition>2445420 - Disclosure - Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofAssetsbySegmentDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail">
        <link:definition>2446421 - Disclosure - Segment reporting - Summary of Assets by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail">
        <link:definition>2447422 - Disclosure - Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Newaccountingstandards" roleURI="http://www.davita.com/role/Newaccountingstandards">
        <link:definition>2148114 - Disclosure - New accounting standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dva_AdditionalDebtPrincipalAmountDueToNewAgreement" abstract="false" name="AdditionalDebtPrincipalAmountDueToNewAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SegmentReportingInformationCorporateExpenses" abstract="false" name="SegmentReportingInformationCorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DebtExpenseMember" abstract="true" name="DebtExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayableFairValue" abstract="false" name="AcquisitionObligationsAndOtherNotesPayableFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TermLoanB1Member" abstract="true" name="TermLoanB1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_RevenuesbymajorpayorAbstract" abstract="true" name="RevenuesbymajorpayorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_NoncontrollingInterestIncreaseFromContributions" abstract="false" name="NoncontrollingInterestIncreaseFromContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" abstract="false" name="ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dva_AdjustmentIncomeLossFromEquityMethodInvestments" abstract="false" name="AdjustmentIncomeLossFromEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OtherGovernmentPayorsMember" abstract="true" name="OtherGovernmentPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_OtherSourcesofRevenueMember" abstract="true" name="OtherSourcesofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" abstract="false" name="ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" abstract="false" name="RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OtherCompaniesMember" abstract="true" name="OtherCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayable" abstract="false" name="AcquisitionObligationsAndOtherNotesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitions" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_FinanceLeaseMember" abstract="true" name="FinanceLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_OtherReportingUnitsMember" abstract="true" name="OtherReportingUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_DebtPrepaymentRefinancingRedemptionCharges" abstract="false" name="DebtPrepaymentRefinancingRedemptionCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_IncrementalCashPortionMember" abstract="true" name="IncrementalCashPortionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" abstract="true" name="SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SeniorSecuredCreditFacilitiesMember" abstract="true" name="SeniorSecuredCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_SegmentRevenuebyMajorPayorAbstract" abstract="true" name="SegmentRevenuebyMajorPayorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_CorporateIntegrityAgreementPeriod" abstract="false" name="CorporateIntegrityAgreementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_StockholderDerivativeLitigationMember" abstract="true" name="StockholderDerivativeLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_OpenMarketPurchasesMember" abstract="true" name="OpenMarketPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" abstract="false" name="IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TemporaryEquityDecreasePurchaseOfInterests" abstract="false" name="TemporaryEquityDecreasePurchaseOfInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" abstract="false" name="DebtInstrumentOfferingPricePercentageOfFaceAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" abstract="true" name="TemporaryEquityRedeemableNoncontrollingInterestsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" abstract="false" name="TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_MedicareandMedicareAdvantageMember" abstract="true" name="MedicareandMedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" abstract="true" name="EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_USAttorneyPrescriptionDrugInvestigationMember" abstract="true" name="USAttorneyPrescriptionDrugInvestigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_CommitmentsToProvideOperatingCapitalMember" abstract="true" name="CommitmentsToProvideOperatingCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_USDialysisAndRelatedLabServicesMember" abstract="true" name="USDialysisAndRelatedLabServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_CorporateIntegrityAgreementExpirationDate" abstract="false" name="CorporateIntegrityAgreementExpirationDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_ForeignDialysisCentersMember" abstract="true" name="ForeignDialysisCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_ExternalSourcesMember" abstract="true" name="ExternalSourcesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_BilateralSecuredLetterOfCreditFacilityMember" abstract="true" name="BilateralSecuredLetterOfCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne" abstract="false" name="LossContingencyNumberofLawsuitsConsolidatedIntoOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" abstract="true" name="A2019InterestRateCapAgreementsEffectiveJune302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" abstract="true" name="CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" abstract="false" name="PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PatientCareCosts" abstract="false" name="PatientCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" abstract="true" name="SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_MutualFundsAndCommonStockMember" abstract="true" name="MutualFundsAndCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_MedicaidandManagedMedicaidMember" abstract="true" name="MedicaidandManagedMedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_CashPaidForPortionPreviouslyRefundedMember" abstract="true" name="CashPaidForPortionPreviouslyRefundedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" abstract="false" name="BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_DiscountAndDeferredFinanceCosts" abstract="false" name="DiscountAndDeferredFinanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DebtRefinancingCharges" abstract="false" name="DebtRefinancingCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_CommercialPayorsMember" abstract="true" name="CommercialPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>dva-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0eedf026-4cb7-43f6-a1e9-99f3721c46b9,g:375f77ab-f095-4ce1-bcc5-25c9315fbffb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="dva-20210331.xsd#DocumentandEntityInformation"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d0985073-5821-4bc1-ab67-3510927b2fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_be8a0a4c-a263-4396-9ecb-479dd8a61b95" xlink:href="dva-20210331.xsd#dva_PatientCareCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d0985073-5821-4bc1-ab67-3510927b2fb7" xlink:to="loc_dva_PatientCareCosts_be8a0a4c-a263-4396-9ecb-479dd8a61b95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5f4799de-34b7-40f2-a24e-28a60f8bac0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d0985073-5821-4bc1-ab67-3510927b2fb7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5f4799de-34b7-40f2-a24e-28a60f8bac0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_04d2a67c-8a33-4ac5-b1e2-7e519032d70c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d0985073-5821-4bc1-ab67-3510927b2fb7" xlink:to="loc_us-gaap_DepreciationAndAmortization_04d2a67c-8a33-4ac5-b1e2-7e519032d70c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a5b77177-0813-47ac-9162-41cff7328481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d0985073-5821-4bc1-ab67-3510927b2fb7" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a5b77177-0813-47ac-9162-41cff7328481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_26ba1608-35d2-4880-bea2-378db4b48724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6bfdbdd8-3c67-490b-9eaa-1358651f27c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_26ba1608-35d2-4880-bea2-378db4b48724" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6bfdbdd8-3c67-490b-9eaa-1358651f27c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_42a8ea68-1f62-4dec-9412-1e0218095e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_26ba1608-35d2-4880-bea2-378db4b48724" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_42a8ea68-1f62-4dec-9412-1e0218095e55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9e24ec0f-d619-490f-8ff1-fa289430b7a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c503745f-9b94-4e75-8174-1b5c455ae4ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9e24ec0f-d619-490f-8ff1-fa289430b7a3" xlink:to="loc_us-gaap_ProfitLoss_c503745f-9b94-4e75-8174-1b5c455ae4ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec4c3242-7fe6-4cc8-b284-3b6228702d49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9e24ec0f-d619-490f-8ff1-fa289430b7a3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec4c3242-7fe6-4cc8-b284-3b6228702d49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e070cab4-2503-4b77-81d8-83aecdefb3c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b7b7bfbf-bc53-447d-aa3e-fea82e0392f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e070cab4-2503-4b77-81d8-83aecdefb3c4" xlink:to="loc_us-gaap_Revenues_b7b7bfbf-bc53-447d-aa3e-fea82e0392f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_2c7b3cc2-01c6-401d-a1a7-b2512ac4fb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e070cab4-2503-4b77-81d8-83aecdefb3c4" xlink:to="loc_us-gaap_CostsAndExpenses_2c7b3cc2-01c6-401d-a1a7-b2512ac4fb1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1b20aba0-557b-48d5-a9c7-951777482904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e4b76b0c-e549-42b0-b7b6-43ceec5364ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1b20aba0-557b-48d5-a9c7-951777482904" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e4b76b0c-e549-42b0-b7b6-43ceec5364ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d95ccd74-3d51-491e-b572-fa6c7373ff41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1b20aba0-557b-48d5-a9c7-951777482904" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d95ccd74-3d51-491e-b572-fa6c7373ff41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ce450f5d-c217-4698-9e7c-7b308346a3b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_feb1eda9-4a1a-4c5e-8e40-9bc088d3f832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ce450f5d-c217-4698-9e7c-7b308346a3b9" xlink:to="loc_us-gaap_OperatingIncomeLoss_feb1eda9-4a1a-4c5e-8e40-9bc088d3f832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_23b96af4-fe6e-438d-b1f2-4c5f73d99675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ce450f5d-c217-4698-9e7c-7b308346a3b9" xlink:to="loc_us-gaap_InterestAndDebtExpense_23b96af4-fe6e-438d-b1f2-4c5f73d99675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_85585308-3a09-4474-af78-61d97b94c2c1" xlink:href="dva-20210331.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ce450f5d-c217-4698-9e7c-7b308346a3b9" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_85585308-3a09-4474-af78-61d97b94c2c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ac35699b-9cc0-4250-a4e1-d4e513a8eb9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ce450f5d-c217-4698-9e7c-7b308346a3b9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ac35699b-9cc0-4250-a4e1-d4e513a8eb9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_40ce5e70-cd66-46d6-afcf-989759fbc03d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_121bef6c-f98a-4c0f-b1d9-ca32d690cb4d" xlink:href="dva-20210331.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_40ce5e70-cd66-46d6-afcf-989759fbc03d" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_121bef6c-f98a-4c0f-b1d9-ca32d690cb4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_74724629-3e37-4d5c-9706-f6283ede06fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_40ce5e70-cd66-46d6-afcf-989759fbc03d" xlink:to="loc_us-gaap_OtherIncome_74724629-3e37-4d5c-9706-f6283ede06fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_48d7bf4a-7fa2-4574-b117-ef9866e60e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_efe95961-60f5-40a7-9513-231286142d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_48d7bf4a-7fa2-4574-b117-ef9866e60e0a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_efe95961-60f5-40a7-9513-231286142d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_4cd47bd2-11e7-4ed8-979b-667b2ad7d20b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_48d7bf4a-7fa2-4574-b117-ef9866e60e0a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_4cd47bd2-11e7-4ed8-979b-667b2ad7d20b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e1fb7bdc-ac92-494b-90e4-2fbede75f47d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0ed6984e-0740-4c92-b8c2-f464df041bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e1fb7bdc-ac92-494b-90e4-2fbede75f47d" xlink:to="loc_us-gaap_ProfitLoss_0ed6984e-0740-4c92-b8c2-f464df041bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4d69c55f-cca7-4b02-a231-452776c49985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e1fb7bdc-ac92-494b-90e4-2fbede75f47d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4d69c55f-cca7-4b02-a231-452776c49985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_377ef2ed-1a56-4204-8037-8bd0130c273f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8863d881-8096-4760-9cd1-7c44fe3970ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_377ef2ed-1a56-4204-8037-8bd0130c273f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8863d881-8096-4760-9cd1-7c44fe3970ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0d0744d1-cb8e-4983-80eb-51c848934c75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_377ef2ed-1a56-4204-8037-8bd0130c273f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0d0744d1-cb8e-4983-80eb-51c848934c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_33ab22bc-27f1-40e8-9705-727ad75029be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_ba1e1b04-d510-41aa-b16d-44999445322b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_33ab22bc-27f1-40e8-9705-727ad75029be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_ba1e1b04-d510-41aa-b16d-44999445322b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_c694a14d-bd40-478a-abb6-a266086abdea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_33ab22bc-27f1-40e8-9705-727ad75029be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_c694a14d-bd40-478a-abb6-a266086abdea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c8a90261-32cf-41a9-aa9d-a5975c3d6d99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_33ab22bc-27f1-40e8-9705-727ad75029be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c8a90261-32cf-41a9-aa9d-a5975c3d6d99" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ebc28d2-8c08-4050-9868-01d58a8f2b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_40266ec4-d919-4b79-b1f0-98c1cf773a3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ebc28d2-8c08-4050-9868-01d58a8f2b5f" xlink:to="loc_us-gaap_StockholdersEquity_40266ec4-d919-4b79-b1f0-98c1cf773a3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ef026476-05bb-41e9-b550-29443a8c1e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ebc28d2-8c08-4050-9868-01d58a8f2b5f" xlink:to="loc_us-gaap_MinorityInterest_ef026476-05bb-41e9-b550-29443a8c1e4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9711a443-fa77-4e30-a412-161f4150506a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c63e5efb-bd0b-4d12-b5ea-a0da498a20a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9711a443-fa77-4e30-a412-161f4150506a" xlink:to="loc_us-gaap_Liabilities_c63e5efb-bd0b-4d12-b5ea-a0da498a20a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3b4b5e18-ef23-47aa-bfa3-1f3265fdbba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9711a443-fa77-4e30-a412-161f4150506a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3b4b5e18-ef23-47aa-bfa3-1f3265fdbba5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5c4c0c04-e78b-48ac-8aa8-de030ef19982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9711a443-fa77-4e30-a412-161f4150506a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5c4c0c04-e78b-48ac-8aa8-de030ef19982" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_24c9e2e9-7b51-429f-9947-e3150b6c2b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a1cd52df-ae82-440a-a425-d134caf03fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24c9e2e9-7b51-429f-9947-e3150b6c2b5f" xlink:to="loc_us-gaap_LiabilitiesCurrent_a1cd52df-ae82-440a-a425-d134caf03fd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_73bf8b12-953d-4f0c-854c-daa2eb5ecfba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24c9e2e9-7b51-429f-9947-e3150b6c2b5f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_73bf8b12-953d-4f0c-854c-daa2eb5ecfba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9193201a-1031-403c-b936-4e9c59997027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24c9e2e9-7b51-429f-9947-e3150b6c2b5f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9193201a-1031-403c-b936-4e9c59997027" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_07cd224a-f0d4-4e6e-83fb-b0e1e6e25e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24c9e2e9-7b51-429f-9947-e3150b6c2b5f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_07cd224a-f0d4-4e6e-83fb-b0e1e6e25e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a394321b-790c-47c0-8538-b8fa2d5602cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24c9e2e9-7b51-429f-9947-e3150b6c2b5f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a394321b-790c-47c0-8538-b8fa2d5602cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_80573493-544c-43db-8fac-6768c9567bc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d4af57d4-2940-4068-b0b7-21df7c2665d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80573493-544c-43db-8fac-6768c9567bc5" xlink:to="loc_us-gaap_AccountsPayableCurrent_d4af57d4-2940-4068-b0b7-21df7c2665d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1f15fe27-069b-41b3-a101-560a7d291e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80573493-544c-43db-8fac-6768c9567bc5" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1f15fe27-069b-41b3-a101-560a7d291e3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_644267be-6ccc-45d8-b861-ab8ecfd6c82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80573493-544c-43db-8fac-6768c9567bc5" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_644267be-6ccc-45d8-b861-ab8ecfd6c82d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_ae1ab7a9-f8a3-4ab9-84d4-c58003444cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80573493-544c-43db-8fac-6768c9567bc5" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_ae1ab7a9-f8a3-4ab9-84d4-c58003444cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f7e59ca1-371e-4cf7-a0ec-40a9070c287e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80573493-544c-43db-8fac-6768c9567bc5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f7e59ca1-371e-4cf7-a0ec-40a9070c287e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_72f8e482-7f20-44f0-9acf-f78ea061aa0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80573493-544c-43db-8fac-6768c9567bc5" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_72f8e482-7f20-44f0-9acf-f78ea061aa0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0db6290f-e0b3-4bac-9aea-bf24fe04c249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bcc2bb1e-000b-4e89-af97-3487726bb978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0db6290f-e0b3-4bac-9aea-bf24fe04c249" xlink:to="loc_us-gaap_AssetsCurrent_bcc2bb1e-000b-4e89-af97-3487726bb978" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_635e647b-661a-4557-80aa-fe45bdafc69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0db6290f-e0b3-4bac-9aea-bf24fe04c249" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_635e647b-661a-4557-80aa-fe45bdafc69b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_f5025f23-8205-4076-9cc0-267741693565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0db6290f-e0b3-4bac-9aea-bf24fe04c249" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_f5025f23-8205-4076-9cc0-267741693565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c5adeb7e-af38-4ccd-8776-bfa32c97fc6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0db6290f-e0b3-4bac-9aea-bf24fe04c249" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c5adeb7e-af38-4ccd-8776-bfa32c97fc6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_fd4f5a96-ff91-4511-b893-340dd5a391d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0db6290f-e0b3-4bac-9aea-bf24fe04c249" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_fd4f5a96-ff91-4511-b893-340dd5a391d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5fc785c5-6993-4822-a82c-b50323def6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0db6290f-e0b3-4bac-9aea-bf24fe04c249" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5fc785c5-6993-4822-a82c-b50323def6bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ea356599-6c0c-4b91-a165-62951feb2724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0db6290f-e0b3-4bac-9aea-bf24fe04c249" xlink:to="loc_us-gaap_Goodwill_ea356599-6c0c-4b91-a165-62951feb2724" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_058d1346-1a34-46e4-91ea-e573fd33e5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0db6290f-e0b3-4bac-9aea-bf24fe04c249" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_058d1346-1a34-46e4-91ea-e573fd33e5a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_721a1882-3638-4a6e-a979-cb1b7befdda7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_36403ded-691d-4278-b04c-ea57a04bcb6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_721a1882-3638-4a6e-a979-cb1b7befdda7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_36403ded-691d-4278-b04c-ea57a04bcb6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_b68b29b1-404b-4be5-8976-38e8ca881a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_721a1882-3638-4a6e-a979-cb1b7befdda7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_b68b29b1-404b-4be5-8976-38e8ca881a99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_80ee56f3-3ed0-4396-a71b-10f529e753d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_721a1882-3638-4a6e-a979-cb1b7befdda7" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_80ee56f3-3ed0-4396-a71b-10f529e753d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4fb1686e-55dd-4193-b539-8288e5abd027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_721a1882-3638-4a6e-a979-cb1b7befdda7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4fb1686e-55dd-4193-b539-8288e5abd027" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f67c8baf-e858-4a14-8287-dfd0065c533f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_721a1882-3638-4a6e-a979-cb1b7befdda7" xlink:to="loc_us-gaap_InventoryNet_f67c8baf-e858-4a14-8287-dfd0065c533f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_92d72c27-9362-45d1-a254-875528615469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_721a1882-3638-4a6e-a979-cb1b7befdda7" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_92d72c27-9362-45d1-a254-875528615469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b0e3a593-9c61-4bac-a279-a0fea77a0559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_721a1882-3638-4a6e-a979-cb1b7befdda7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b0e3a593-9c61-4bac-a279-a0fea77a0559" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_23b330c2-9a82-4c77-8a0b-f49c906b382a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_721a1882-3638-4a6e-a979-cb1b7befdda7" xlink:to="loc_us-gaap_IncomeTaxesReceivable_23b330c2-9a82-4c77-8a0b-f49c906b382a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2af1a0a5-2b96-42d9-8e1f-2b382afde3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_61b54122-48f7-42b1-9860-61e525ba7fbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2af1a0a5-2b96-42d9-8e1f-2b382afde3c7" xlink:to="loc_us-gaap_PreferredStockValue_61b54122-48f7-42b1-9860-61e525ba7fbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_dd81b4e9-c816-483c-bedf-384a69418d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2af1a0a5-2b96-42d9-8e1f-2b382afde3c7" xlink:to="loc_us-gaap_CommonStockValue_dd81b4e9-c816-483c-bedf-384a69418d0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a848c1fe-a464-4ea4-a79a-1ae20ab18da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2af1a0a5-2b96-42d9-8e1f-2b382afde3c7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a848c1fe-a464-4ea4-a79a-1ae20ab18da9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b4d5afeb-d7a7-41d3-a34f-950bfb73b8f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2af1a0a5-2b96-42d9-8e1f-2b382afde3c7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b4d5afeb-d7a7-41d3-a34f-950bfb73b8f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_8be03139-9821-4762-bd06-13dd41b63800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2af1a0a5-2b96-42d9-8e1f-2b382afde3c7" xlink:to="loc_us-gaap_TreasuryStockValue_8be03139-9821-4762-bd06-13dd41b63800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6fa7e458-1fd2-4fad-a677-0bc2990081de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2af1a0a5-2b96-42d9-8e1f-2b382afde3c7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6fa7e458-1fd2-4fad-a677-0bc2990081de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDBALANCESHEETSunauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28570a97-ca16-4999-a519-0f7fdb29c887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ac259fb4-6671-4100-903e-48f72da702d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28570a97-ca16-4999-a519-0f7fdb29c887" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ac259fb4-6671-4100-903e-48f72da702d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_7d43393f-542e-491a-bac9-2866b2ec2b7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28570a97-ca16-4999-a519-0f7fdb29c887" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_7d43393f-542e-491a-bac9-2866b2ec2b7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78f845cc-0122-49d4-9f03-e11411f01dde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28570a97-ca16-4999-a519-0f7fdb29c887" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78f845cc-0122-49d4-9f03-e11411f01dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63afcd01-4ae5-4117-bc18-bb411624cd4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28570a97-ca16-4999-a519-0f7fdb29c887" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63afcd01-4ae5-4117-bc18-bb411624cd4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_76fda3c0-56a2-40f0-aab7-fefbca58f1d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_76fda3c0-56a2-40f0-aab7-fefbca58f1d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_c9a1e44a-52c1-419d-a11e-529e5ddc0653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_c9a1e44a-52c1-419d-a11e-529e5ddc0653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_16c86b64-30e8-4d09-a133-15b9af7c6774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_16c86b64-30e8-4d09-a133-15b9af7c6774" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4b3c12d3-b16e-4b2b-9e2f-339e3b25b2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4b3c12d3-b16e-4b2b-9e2f-339e3b25b2cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_66567cf1-0710-4d5f-bd91-9ace76295425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_66567cf1-0710-4d5f-bd91-9ace76295425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1ec05259-f0f8-4b94-852b-c1cce5e64ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1ec05259-f0f8-4b94-852b-c1cce5e64ea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3b3f674e-173d-4c74-9097-ecb08fa671de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3b3f674e-173d-4c74-9097-ecb08fa671de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_8bd54c12-9ad3-44c9-a37e-4df27dcadb63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_8bd54c12-9ad3-44c9-a37e-4df27dcadb63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_7443c02e-b425-46ac-b730-93a972d58e50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f79502-03e9-4f07-8bf4-090eed6cfb6d" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_7443c02e-b425-46ac-b730-93a972d58e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4f6073d7-14d0-45ef-95ba-18b62e58ccf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4f6073d7-14d0-45ef-95ba-18b62e58ccf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d7848726-eff3-42ff-9b7a-088e87cda4a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d7848726-eff3-42ff-9b7a-088e87cda4a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_fd445d5e-aaa6-42ac-a234-15fdb225821c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_fd445d5e-aaa6-42ac-a234-15fdb225821c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_7a851452-24ed-4529-989c-4f4d3d07677f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_7a851452-24ed-4529-989c-4f4d3d07677f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_32f8d85c-4e73-4485-9c93-3c276ddd0a19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_32f8d85c-4e73-4485-9c93-3c276ddd0a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_67c2b846-36d8-4242-848f-e8ce292d7c8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_67c2b846-36d8-4242-848f-e8ce292d7c8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_63b889f9-29e6-414b-974f-e57e1e5f474a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_63b889f9-29e6-414b-974f-e57e1e5f474a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_588b0bbe-7cf1-4b23-85ee-48956135e531" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_588b0bbe-7cf1-4b23-85ee-48956135e531" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_076e2caf-9e4b-4dee-b5bb-9d25b024a1a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c61acb25-eda8-453c-9993-2b8e71863ef3" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_076e2caf-9e4b-4dee-b5bb-9d25b024a1a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f8fc27f3-7d3f-432c-a5af-9d9e52299ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_ProfitLoss_f8fc27f3-7d3f-432c-a5af-9d9e52299ed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_42144579-151d-44dd-bd9b-a858b89e0962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_42144579-151d-44dd-bd9b-a858b89e0962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_eee676e5-0753-47b4-8b3d-98e9484131a9" xlink:href="dva-20210331.xsd#dva_DebtRefinancingCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_dva_DebtRefinancingCharges_eee676e5-0753-47b4-8b3d-98e9484131a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d28a2bfe-adb4-478d-b12a-d8385843d20a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_ShareBasedCompensation_d28a2bfe-adb4-478d-b12a-d8385843d20a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d5e8ecfd-d504-4220-af80-500be7e41759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d5e8ecfd-d504-4220-af80-500be7e41759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_1bb84695-9858-4969-b83e-5c9b38d4b17f" xlink:href="dva-20210331.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_1bb84695-9858-4969-b83e-5c9b38d4b17f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_98c663df-b1a1-4654-85a3-3db0ba3fc48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_98c663df-b1a1-4654-85a3-3db0ba3fc48e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_503ec860-97a2-4b55-b716-d70b35c5b6ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_503ec860-97a2-4b55-b716-d70b35c5b6ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d5fa0593-f0f8-4ba3-9aa2-45d5cacaeb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d5fa0593-f0f8-4ba3-9aa2-45d5cacaeb2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_5c2b5457-86ce-4a34-8431-f35c6c7050c8" xlink:href="dva-20210331.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_5c2b5457-86ce-4a34-8431-f35c6c7050c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_59dfa4a8-ca00-48ab-bcdc-385a0f79be05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_59dfa4a8-ca00-48ab-bcdc-385a0f79be05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6d82daa8-5209-4831-902b-9f262f065957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6d82daa8-5209-4831-902b-9f262f065957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_22751aa1-3454-4a24-81fa-c75aef2cd769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_22751aa1-3454-4a24-81fa-c75aef2cd769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_bfab7562-5609-4bcd-b3ae-088bf3cbc9da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_bfab7562-5609-4bcd-b3ae-088bf3cbc9da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_33bf9cc1-3af0-4c5f-b291-99361d23ea77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_33bf9cc1-3af0-4c5f-b291-99361d23ea77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_4c1c4aee-2fe7-4603-92ea-d73783b7e6f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_618489f5-4f3e-4e68-8df0-7ea741433a99" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_4c1c4aee-2fe7-4603-92ea-d73783b7e6f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="simple" xlink:href="dva-20210331.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="simple" xlink:href="dva-20210331.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="simple" xlink:href="dva-20210331.xsd#RevenueRecognitionRevenueRecognition"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="simple" xlink:href="dva-20210331.xsd#RevenueRecognitionSegmentrevenuebymajorpayorTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#RevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareNotes" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspershareNotes"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningspershareNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspersharePolicies" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspersharePolicies"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningspersharePolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspershareEarningsPerShareTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_26d33d62-6d8f-4c5c-b84e-e59ce3941f58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6ac9733e-4180-4760-bfc6-873a0d11fbb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_26d33d62-6d8f-4c5c-b84e-e59ce3941f58" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6ac9733e-4180-4760-bfc6-873a0d11fbb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_b12dfa2b-7e4d-4468-bc36-fc66c33458b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_26d33d62-6d8f-4c5c-b84e-e59ce3941f58" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_b12dfa2b-7e4d-4468-bc36-fc66c33458b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f3c85fbe-9701-45d8-8bc2-c1db17ae9a11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_27161f4a-4d3c-4fc0-a063-c5c1f252c631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_f3c85fbe-9701-45d8-8bc2-c1db17ae9a11" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_27161f4a-4d3c-4fc0-a063-c5c1f252c631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_cacbc76d-f89f-455a-9044-6566f5180721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_f3c85fbe-9701-45d8-8bc2-c1db17ae9a11" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_cacbc76d-f89f-455a-9044-6566f5180721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acce9921-8c49-4376-b1b8-98131ae6834f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_b55a4f9d-ec6d-400b-95be-12252d576b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acce9921-8c49-4376-b1b8-98131ae6834f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_b55a4f9d-ec6d-400b-95be-12252d576b98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a483a6e1-e247-4ecc-b340-4d0a746ea4d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acce9921-8c49-4376-b1b8-98131ae6834f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a483a6e1-e247-4ecc-b340-4d0a746ea4d5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="simple" xlink:href="dva-20210331.xsd#Investmentsindebtandequitysecurities"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="simple" xlink:href="dva-20210331.xsd#InvestmentsindebtandequitysecuritiesTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#InvestmentsindebtandequitysecuritiesDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_638bbbf4-2d0d-40bf-bb21-cf293a72d8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_9c9638c3-860f-4078-ae7b-15ff3148d1c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_638bbbf4-2d0d-40bf-bb21-cf293a72d8f6" xlink:to="loc_us-gaap_HeldToMaturitySecurities_9c9638c3-860f-4078-ae7b-15ff3148d1c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_940fa8a9-a538-4837-ae92-902e22b10571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_638bbbf4-2d0d-40bf-bb21-cf293a72d8f6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_940fa8a9-a538-4837-ae92-902e22b10571" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Goodwill" xlink:type="simple" xlink:href="dva-20210331.xsd#Goodwill"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Goodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillTables" xlink:type="simple" xlink:href="dva-20210331.xsd#GoodwillTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/GoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#GoodwillChangesinGoodwillbyReportableSegmentsDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#GoodwillNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Longtermdebt" xlink:type="simple" xlink:href="dva-20210331.xsd#Longtermdebt"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Longtermdebt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtTables" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermdebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermdebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b206c285-e8c0-4fb7-8d65-f5dab2cb3a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_e8c772d3-9ec2-49b6-bb91-67f395c36c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b206c285-e8c0-4fb7-8d65-f5dab2cb3a86" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_e8c772d3-9ec2-49b6-bb91-67f395c36c25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3ee85342-d35e-44e3-afc7-f2dbeebf8ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b206c285-e8c0-4fb7-8d65-f5dab2cb3a86" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3ee85342-d35e-44e3-afc7-f2dbeebf8ffd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtScheduleofDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="dva-20210331.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Shareholdersequity" xlink:type="simple" xlink:href="dva-20210331.xsd#Shareholdersequity"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Shareholdersequity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables" xlink:type="simple" xlink:href="dva-20210331.xsd#SharerepurchasesShareRepurchasesTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermincentivecompensationDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#SharerepurchasesShareRepurchaseTableDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#SharerepurchasesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="simple" xlink:href="dva-20210331.xsd#Accumulatedothercomprehensivelossincome"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="simple" xlink:href="dva-20210331.xsd#AccumulatedothercomprehensivelossincomeTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#AccumulatedothercomprehensivelossincomeDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7f3b9f1f-5e1f-432e-b043-38d755b10f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_fb625e32-e478-4cf6-aa30-bf2867c15faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7f3b9f1f-5e1f-432e-b043-38d755b10f1c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_fb625e32-e478-4cf6-aa30-bf2867c15faa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ff76398c-ee22-4475-a582-0f2c937264c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7f3b9f1f-5e1f-432e-b043-38d755b10f1c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ff76398c-ee22-4475-a582-0f2c937264c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3025dea2-6767-4bf2-9190-4d4b1756d76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_797a148c-651d-4c86-b879-4c89077d72c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3025dea2-6767-4bf2-9190-4d4b1756d76e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_797a148c-651d-4c86-b879-4c89077d72c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b07edd0b-e5b8-4d43-a761-c8da8a850c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3025dea2-6767-4bf2-9190-4d4b1756d76e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b07edd0b-e5b8-4d43-a761-c8da8a850c33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Acquisitionsanddivestitures" xlink:type="simple" xlink:href="dva-20210331.xsd#Acquisitionsanddivestitures"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Acquisitionsanddivestitures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresTables" xlink:type="simple" xlink:href="dva-20210331.xsd#AcquisitionsanddivestituresTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#AcquisitionsanddivestituresContingentEarnoutobligationsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#AcquisitionsanddivestituresAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Variableinterestentities" xlink:type="simple" xlink:href="dva-20210331.xsd#Variableinterestentities"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Variableinterestentities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#VariableinterestentitiesAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="simple" xlink:href="dva-20210331.xsd#Fairvalueoffinancialinstruments"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="simple" xlink:href="dva-20210331.xsd#FairvalueoffinancialinstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Segmentreporting" xlink:type="simple" xlink:href="dva-20210331.xsd#Segmentreporting"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Segmentreporting" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingTables" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingTables"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentreportingTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofAssetsbySegmentDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/Newaccountingstandards" xlink:type="simple" xlink:href="dva-20210331.xsd#Newaccountingstandards"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/Newaccountingstandards" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>dva-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0eedf026-4cb7-43f6-a1e9-99f3721c46b9,g:375f77ab-f095-4ce1-bcc5-25c9315fbffb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="dva-20210331.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="extended" id="i9638464269d745ed984111bf8834c7e9_DocumentandEntityInformation"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="extended" id="i2ec47ede1327489c8e77d42f60bd8b25_CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="extended" id="ibfebee6d4a234840b99d677f778aa934_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended" id="ic3572cafd21a4c609eb6ea745be7b801_CONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDBALANCESHEETSunauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="extended" id="i14f9a83b28584fc78fa4a8a4be394fb5_CONSOLIDATEDBALANCESHEETSunauditedParenthetical"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="extended" id="ic1115e26206243d2afb7dafc2e3f25a1_CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_349a7a27-3f8e-49ed-8e4c-1c2b37180a11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:to="loc_us-gaap_ProfitLoss_349a7a27-3f8e-49ed-8e4c-1c2b37180a11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_ec030cd1-2662-41e5-8baf-f0e20c12c3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_ec030cd1-2662-41e5-8baf-f0e20c12c3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_f28afa8c-8f8b-43f5-af9c-4aa86dc4cf5c" xlink:href="dva-20210331.xsd#dva_DebtRefinancingCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_dva_DebtRefinancingCharges_f28afa8c-8f8b-43f5-af9c-4aa86dc4cf5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_496df375-b26b-41db-96bc-7c38926d2070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_ShareBasedCompensation_496df375-b26b-41db-96bc-7c38926d2070" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_47c0633b-785a-46e8-a2f7-2183c14394ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_47c0633b-785a-46e8-a2f7-2183c14394ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_a07a0132-8aa1-4333-821d-729c71754b0c" xlink:href="dva-20210331.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_a07a0132-8aa1-4333-821d-729c71754b0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dcdfbdd8-f7f6-4816-9b21-d57155e7f45e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dcdfbdd8-f7f6-4816-9b21-d57155e7f45e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b58b0a3e-c5b3-4183-b8c4-2612a55fcfe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b58b0a3e-c5b3-4183-b8c4-2612a55fcfe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e6a56a77-6645-41db-a8a9-f3368636adc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e6a56a77-6645-41db-a8a9-f3368636adc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_6378e334-2b32-4a3f-a2bc-6fb861446994" xlink:href="dva-20210331.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_6378e334-2b32-4a3f-a2bc-6fb861446994" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2cadb038-19ba-4ba9-948f-ed593aeb7b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2cadb038-19ba-4ba9-948f-ed593aeb7b9c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0044ad75-fd91-4817-aa2f-c92f962151dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0044ad75-fd91-4817-aa2f-c92f962151dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_30a804de-e9c6-4f06-a2e0-50d7f43211e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_30a804de-e9c6-4f06-a2e0-50d7f43211e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_1201fc6c-cc13-4be1-8ba8-5ef045f283b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_1201fc6c-cc13-4be1-8ba8-5ef045f283b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1f1dc93a-5c11-4da8-8c48-80accc3fc988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1f1dc93a-5c11-4da8-8c48-80accc3fc988" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_dcb4491d-7380-411f-b32d-c28760021b05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_dcb4491d-7380-411f-b32d-c28760021b05" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ad79760-ce80-4f54-995d-b6439a816762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ad79760-ce80-4f54-995d-b6439a816762" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_54c1d331-aabc-42ff-ae3b-b5beda432efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_54c1d331-aabc-42ff-ae3b-b5beda432efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_fcbb9380-f3cb-444f-9ac6-e44422faaa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_fcbb9380-f3cb-444f-9ac6-e44422faaa71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_2c47e9d5-b61d-4350-8a91-035faf4df0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_2c47e9d5-b61d-4350-8a91-035faf4df0aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_314aa149-b6cb-41b3-9596-038a1d67965c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_314aa149-b6cb-41b3-9596-038a1d67965c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_58ab1579-2804-45ce-88a9-9db4452632f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_58ab1579-2804-45ce-88a9-9db4452632f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_dab1c046-1a47-4a92-85d2-87a3ff671316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_dab1c046-1a47-4a92-85d2-87a3ff671316" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_55f5f380-be6b-462c-84a1-5b55e82aabdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_55f5f380-be6b-462c-84a1-5b55e82aabdb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_88dcaad2-d105-4d07-a1ce-5f4787a88db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_88dcaad2-d105-4d07-a1ce-5f4787a88db7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_5da261a6-ed54-499a-9b8d-cb78c4cbee37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_5da261a6-ed54-499a-9b8d-cb78c4cbee37" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d27d6d2-676c-4191-9f4e-fe77e8d6b2d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d27d6d2-676c-4191-9f4e-fe77e8d6b2d4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1ab93c2f-75f7-4af5-bbe0-52dede81bd47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1ab93c2f-75f7-4af5-bbe0-52dede81bd47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_aa24aced-120e-4334-86b1-21ebfefb158b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_aa24aced-120e-4334-86b1-21ebfefb158b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_4686a28b-7b26-41d1-bd9e-786f1f3c6f57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_4686a28b-7b26-41d1-bd9e-786f1f3c6f57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d233413f-fde4-4a40-84dd-a73cfe06c272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d233413f-fde4-4a40-84dd-a73cfe06c272" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_cdb75845-2892-40b5-bea7-153e72779803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_cdb75845-2892-40b5-bea7-153e72779803" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_36d7c941-fff3-4a44-a217-1bb16893035b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_36d7c941-fff3-4a44-a217-1bb16893035b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_b8ed0b18-fcb9-422f-a0c3-cbb81f76bf33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_b8ed0b18-fcb9-422f-a0c3-cbb81f76bf33" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_e2bff8fc-a271-4f08-a3f2-bc8346b382af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_e2bff8fc-a271-4f08-a3f2-bc8346b382af" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_023de977-6b2d-40cd-b444-05a0f330fa5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_023de977-6b2d-40cd-b444-05a0f330fa5b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58390b37-da74-478a-8aec-d668bb1eec6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58390b37-da74-478a-8aec-d668bb1eec6b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_81e9b601-4d8f-4991-a79c-f9dfb5a96f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_81e9b601-4d8f-4991-a79c-f9dfb5a96f40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bbdf6b54-f290-4b0f-af2b-7762798ff5d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bbdf6b54-f290-4b0f-af2b-7762798ff5d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_05ac3e37-f0bd-414a-92fd-9e9dd7ae9500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_05ac3e37-f0bd-414a-92fd-9e9dd7ae9500" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ca43a311-3440-4e9f-9873-97aa3a076c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c2839935-9436-4c38-8310-c52e67d0154a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_StatementTable_c2839935-9436-4c38-8310-c52e67d0154a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_f3e107ab-9dc0-4e0b-8b9d-db05b1f01d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c2839935-9436-4c38-8310-c52e67d0154a" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_f3e107ab-9dc0-4e0b-8b9d-db05b1f01d26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_f3e107ab-9dc0-4e0b-8b9d-db05b1f01d26_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_f3e107ab-9dc0-4e0b-8b9d-db05b1f01d26" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_f3e107ab-9dc0-4e0b-8b9d-db05b1f01d26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_d292f779-dce0-426a-9bde-643a28b27b8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_f3e107ab-9dc0-4e0b-8b9d-db05b1f01d26" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_d292f779-dce0-426a-9bde-643a28b27b8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_29827c7e-3ebc-4122-9cec-93bd7b8e37f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_d292f779-dce0-426a-9bde-643a28b27b8b" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_29827c7e-3ebc-4122-9cec-93bd7b8e37f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_cb668667-9582-4cbb-b712-ce444470271c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_d292f779-dce0-426a-9bde-643a28b27b8b" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_cb668667-9582-4cbb-b712-ce444470271c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="extended" id="i4b0fd7a2d9ac4205b3d3ce3a4628f9b4_CONSOLIDATEDSTATEMENTSOFEQUITYunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_1111ef64-ebaf-42dd-983a-acd606ca5fc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_1111ef64-ebaf-42dd-983a-acd606ca5fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_70f235ff-f42d-4080-bd89-672719d7b8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_70f235ff-f42d-4080-bd89-672719d7b8bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_000c4781-37a3-4fd3-9971-0f95f5212001" xlink:href="dva-20210331.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_000c4781-37a3-4fd3-9971-0f95f5212001" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_ff79c634-f638-49ba-bc79-56f960795c0e" xlink:href="dva-20210331.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_ff79c634-f638-49ba-bc79-56f960795c0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_b14919c6-837d-410c-811a-a4a87458aafe" xlink:href="dva-20210331.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_b14919c6-837d-410c-811a-a4a87458aafe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_ca140865-cd4d-41b6-b8ba-686d0842cb05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_ca140865-cd4d-41b6-b8ba-686d0842cb05" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0a6a9eab-660a-4d2a-abe9-4af1c1325e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c886939-7d48-4069-96a0-5e7d767b9a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c886939-7d48-4069-96a0-5e7d767b9a64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b52044f0-8d4f-4504-8144-2c5475e5f2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b52044f0-8d4f-4504-8144-2c5475e5f2aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_5b494040-0d88-4a87-949b-32493a59cb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_5b494040-0d88-4a87-949b-32493a59cb1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_c45182f4-0086-490b-acac-71c117fe70d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_5b494040-0d88-4a87-949b-32493a59cb1e" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_c45182f4-0086-490b-acac-71c117fe70d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c6261d59-5c9a-4ba5-87a5-68aedac8abb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_5b494040-0d88-4a87-949b-32493a59cb1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c6261d59-5c9a-4ba5-87a5-68aedac8abb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6d438c2f-bf8c-4439-9261-d544d296dd21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6d438c2f-bf8c-4439-9261-d544d296dd21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b1b50d5b-b1f0-41fb-b3e1-6b7dc58b67d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b1b50d5b-b1f0-41fb-b3e1-6b7dc58b67d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_95c5d8d9-2c35-40b1-bbef-54321ce1de66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_95c5d8d9-2c35-40b1-bbef-54321ce1de66" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_55f723d0-48da-4897-a097-44271636c610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_55f723d0-48da-4897-a097-44271636c610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_fa25ae6e-0553-40c4-9477-7df08411ad4f" xlink:href="dva-20210331.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_fa25ae6e-0553-40c4-9477-7df08411ad4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_20e1eff8-c40e-4bfe-aafd-5c594a1b5f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_20e1eff8-c40e-4bfe-aafd-5c594a1b5f60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d9356620-536b-44d2-bf36-ffb1a492b8dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d9356620-536b-44d2-bf36-ffb1a492b8dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c47d1249-8af8-4d5f-9c44-6815e2a8da3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c47d1249-8af8-4d5f-9c44-6815e2a8da3f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_5a76b5ce-31a2-4985-bb40-7d327a60eb24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_5a76b5ce-31a2-4985-bb40-7d327a60eb24" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_83e950a8-73a1-425d-ad23-6cd61ea41e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2c1da91e-c312-455b-9fc8-e8216431d657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e56f24fd-1bcc-4f1a-ace3-6fd6cf710e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:to="loc_us-gaap_StatementTable_e56f24fd-1bcc-4f1a-ace3-6fd6cf710e7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_024a1d4a-3064-4303-9231-8465ff3d3439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e56f24fd-1bcc-4f1a-ace3-6fd6cf710e7c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_024a1d4a-3064-4303-9231-8465ff3d3439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_024a1d4a-3064-4303-9231-8465ff3d3439_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_024a1d4a-3064-4303-9231-8465ff3d3439" xlink:to="loc_us-gaap_EquityComponentDomain_024a1d4a-3064-4303-9231-8465ff3d3439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5b69f3ee-5dad-4f06-ab04-c285c37866eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_024a1d4a-3064-4303-9231-8465ff3d3439" xlink:to="loc_us-gaap_EquityComponentDomain_5b69f3ee-5dad-4f06-ab04-c285c37866eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5b69f3ee-5dad-4f06-ab04-c285c37866eb" xlink:to="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_0b96099e-257b-4c67-bd71-f2d5c7359b38" xlink:href="dva-20210331.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_0b96099e-257b-4c67-bd71-f2d5c7359b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_79341415-c364-4608-aa5b-e2ae5c003e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_CommonStockMember_79341415-c364-4608-aa5b-e2ae5c003e31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3f23ecec-3727-4d17-9388-bc485640ba0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3f23ecec-3727-4d17-9388-bc485640ba0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_50d6dee6-6239-4fb3-9f6b-573f37d64a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_RetainedEarningsMember_50d6dee6-6239-4fb3-9f6b-573f37d64a1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_985d73a7-4702-4ef7-b06a-8b248106c0d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_TreasuryStockMember_985d73a7-4702-4ef7-b06a-8b248106c0d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0e23a371-29ca-4a1b-bb4a-45415ba0ccc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0e23a371-29ca-4a1b-bb4a-45415ba0ccc9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6d469abb-4956-4053-8f4e-0350eafd1161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6d469abb-4956-4053-8f4e-0350eafd1161" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="simple" xlink:href="dva-20210331.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="extended" id="i76b8dd3f8b594fffa42825caf1564e95_CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements"/>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="simple" xlink:href="dva-20210331.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="extended" id="i309f0ded49d14dc3ac295e75beb50b8e_CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="simple" xlink:href="dva-20210331.xsd#RevenueRecognitionRevenueRecognition"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="extended" id="i03701eeb0768492087bf711d7e043c60_RevenueRecognitionRevenueRecognition"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="simple" xlink:href="dva-20210331.xsd#RevenueRecognitionSegmentrevenuebymajorpayorTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="extended" id="ib9c93ee9fb1c44809b423aaf84418e27_RevenueRecognitionSegmentrevenuebymajorpayorTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#RevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended" id="id31eb9781303471c88af33b226d10f85_RevenueRecognitionSegmentRevenuebyPayorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8229a6be-071a-469c-8f3e-cb939c0574ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8229a6be-071a-469c-8f3e-cb939c0574ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_b2749609-d646-48ac-a022-14af1d27e845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:to="loc_us-gaap_OtherIncome_b2749609-d646-48ac-a022-14af1d27e845" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8b0cddbe-4a2d-402f-860c-f63c5fbd495c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:to="loc_us-gaap_Revenues_8b0cddbe-4a2d-402f-860c-f63c5fbd495c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a8e301b9-01ba-41b4-aa6e-1da33e2e49ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a8e301b9-01ba-41b4-aa6e-1da33e2e49ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a8e301b9-01ba-41b4-aa6e-1da33e2e49ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a8e301b9-01ba-41b4-aa6e-1da33e2e49ba" xlink:to="loc_us-gaap_SegmentDomain_a8e301b9-01ba-41b4-aa6e-1da33e2e49ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cc17f0aa-5bef-4aa8-93bc-b935b6e3babb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a8e301b9-01ba-41b4-aa6e-1da33e2e49ba" xlink:to="loc_us-gaap_SegmentDomain_cc17f0aa-5bef-4aa8-93bc-b935b6e3babb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_74daf12c-aa92-4b62-bc86-8b6a452981e0" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cc17f0aa-5bef-4aa8-93bc-b935b6e3babb" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_74daf12c-aa92-4b62-bc86-8b6a452981e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_4b7a58cb-8224-4c25-8a30-e053a793710a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cc17f0aa-5bef-4aa8-93bc-b935b6e3babb" xlink:to="loc_us-gaap_AllOtherSegmentsMember_4b7a58cb-8224-4c25-8a30-e053a793710a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_c3583263-3a0c-4ec0-a112-d63c04b987f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_c3583263-3a0c-4ec0-a112-d63c04b987f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_c3583263-3a0c-4ec0-a112-d63c04b987f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_c3583263-3a0c-4ec0-a112-d63c04b987f8" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_c3583263-3a0c-4ec0-a112-d63c04b987f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_c3583263-3a0c-4ec0-a112-d63c04b987f8" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_6d675ab2-7fec-4c1e-99cb-22a3276e52d3" xlink:href="dva-20210331.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_6d675ab2-7fec-4c1e-99cb-22a3276e52d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_9ae402c7-c35b-4530-bd3f-fc86324e10d3" xlink:href="dva-20210331.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_9ae402c7-c35b-4530-bd3f-fc86324e10d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_e0b45ce2-3b34-442f-84ad-7cbaf8b06a97" xlink:href="dva-20210331.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_OtherGovernmentPayorsMember_e0b45ce2-3b34-442f-84ad-7cbaf8b06a97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_d0911c7a-1fd2-41a7-b08e-beae7ed9a5c6" xlink:href="dva-20210331.xsd#dva_CommercialPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_CommercialPayorsMember_d0911c7a-1fd2-41a7-b08e-beae7ed9a5c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_9c3f9714-a406-4136-ba8d-5fa7a3161302" xlink:href="dva-20210331.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_OtherSourcesofRevenueMember_9c3f9714-a406-4136-ba8d-5fa7a3161302" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f3caab97-7c3a-43a8-996a-4d268435d103" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:to="loc_srt_ConsolidationItemsAxis_f3caab97-7c3a-43a8-996a-4d268435d103" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f3caab97-7c3a-43a8-996a-4d268435d103_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f3caab97-7c3a-43a8-996a-4d268435d103" xlink:to="loc_srt_ConsolidationItemsDomain_f3caab97-7c3a-43a8-996a-4d268435d103_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3286cb97-5d6e-4315-b7e9-350472986169" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f3caab97-7c3a-43a8-996a-4d268435d103" xlink:to="loc_srt_ConsolidationItemsDomain_3286cb97-5d6e-4315-b7e9-350472986169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_fe2d453b-bb2a-4aa1-a4e7-d4262b5c6351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3286cb97-5d6e-4315-b7e9-350472986169" xlink:to="loc_us-gaap_IntersegmentEliminationMember_fe2d453b-bb2a-4aa1-a4e7-d4262b5c6351" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareNotes" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspershareNotes"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EarningspershareNotes" xlink:type="extended" id="i73e516b9d9154d138fb65a7eb4a3d6f4_EarningspershareNotes"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspersharePolicies" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspersharePolicies"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EarningspersharePolicies" xlink:type="extended" id="i5cf9ede436e846a495ad55d06672ab6b_EarningspersharePolicies"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspershareEarningsPerShareTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="extended" id="i85ae43ed4fb0432aa8e85e32642cc463_EarningspershareEarningsPerShareTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="extended" id="iec926f89b71c49018509aca9a740a398_EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="simple" xlink:href="dva-20210331.xsd#Investmentsindebtandequitysecurities"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="extended" id="i61d2509abf274107a6a82db76307c627_Investmentsindebtandequitysecurities"/>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="simple" xlink:href="dva-20210331.xsd#InvestmentsindebtandequitysecuritiesTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="extended" id="i637bcba166e848d59af24cc49663b192_InvestmentsindebtandequitysecuritiesTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#InvestmentsindebtandequitysecuritiesDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="extended" id="iaa970f53349b47c6bda6a306ff5a1a8a_InvestmentsindebtandequitysecuritiesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_5cd4731b-8fe3-4d92-a938-3db8bb307f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_HeldToMaturitySecurities_5cd4731b-8fe3-4d92-a938-3db8bb307f36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_d0e2e187-af71-458e-a934-f486107292fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_d0e2e187-af71-458e-a934-f486107292fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_2eaa8ca7-ead0-40be-a755-25dbc9a03e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_MarketableSecurities_2eaa8ca7-ead0-40be-a755-25dbc9a03e3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_6dfec9a4-9845-4f6f-a445-d57503438bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_6dfec9a4-9845-4f6f-a445-d57503438bbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_8d5efafd-ac3a-4572-abe6-439fdcb84e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_8d5efafd-ac3a-4572-abe6-439fdcb84e39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_c1418fa8-7d7c-4d11-bb43-b9441047d24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_c1418fa8-7d7c-4d11-bb43-b9441047d24d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_b433b076-8051-432c-9daa-2661d18343fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_b433b076-8051-432c-9daa-2661d18343fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_e547ae72-9d7c-4110-8885-b0d1348f4f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_InvestmentHoldingsTable_e547ae72-9d7c-4110-8885-b0d1348f4f3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_db0cd036-5090-427b-996b-ac1e36d8c712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentHoldingsTable_e547ae72-9d7c-4110-8885-b0d1348f4f3a" xlink:to="loc_us-gaap_InvestmentTypeAxis_db0cd036-5090-427b-996b-ac1e36d8c712" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_db0cd036-5090-427b-996b-ac1e36d8c712_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_db0cd036-5090-427b-996b-ac1e36d8c712" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_db0cd036-5090-427b-996b-ac1e36d8c712_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_db0cd036-5090-427b-996b-ac1e36d8c712" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_ad0a0ec8-41ed-4981-beba-b3d95afcd1ae" xlink:href="dva-20210331.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_ad0a0ec8-41ed-4981-beba-b3d95afcd1ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_fe68d7a5-4e1f-4d33-b482-1a32a4449b47" xlink:href="dva-20210331.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:to="loc_dva_MutualFundsAndCommonStockMember_fe68d7a5-4e1f-4d33-b482-1a32a4449b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_2587b4d7-341c-4979-96a9-5445d24a817e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_2587b4d7-341c-4979-96a9-5445d24a817e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_c4ee0e7a-af5f-4999-8fc4-a90a89c43458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_c4ee0e7a-af5f-4999-8fc4-a90a89c43458" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Goodwill" xlink:type="simple" xlink:href="dva-20210331.xsd#Goodwill"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Goodwill" xlink:type="extended" id="i25da3df886004c58aafd624e4e5aeb6d_Goodwill"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillTables" xlink:type="simple" xlink:href="dva-20210331.xsd#GoodwillTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillTables" xlink:type="extended" id="i770366714dcd46349efbe86ef88b817f_GoodwillTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#GoodwillChangesinGoodwillbyReportableSegmentsDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="extended" id="if47e5342a23e4bee8cc8819ed2dffb1c_GoodwillChangesinGoodwillbyReportableSegmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:to="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ff207301-d10c-4880-ab45-6ec0ed989a92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:to="loc_us-gaap_Goodwill_ff207301-d10c-4880-ab45-6ec0ed989a92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3b01a33a-113f-46ea-845a-981005c54ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3b01a33a-113f-46ea-845a-981005c54ae7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_cdbe645b-d9bd-4c16-ae04-467bab79d107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_cdbe645b-d9bd-4c16-ae04-467bab79d107" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3cf271ce-2fee-40cf-adae-6e974c14f4e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3cf271ce-2fee-40cf-adae-6e974c14f4e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e2fcb454-f68b-40ee-b46e-d967754f69ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_1c56806a-230f-4454-8a39-639071101fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:to="loc_us-gaap_GoodwillGross_1c56806a-230f-4454-8a39-639071101fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_dc65de63-8293-4f5f-8d0c-5500b1f1a492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_dc65de63-8293-4f5f-8d0c-5500b1f1a492" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a19012ba-7c57-40fd-9393-60c2a6bb4d37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4c06a86a-15b2-467c-85c2-82be4e4abfc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4c06a86a-15b2-467c-85c2-82be4e4abfc8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8bcb3f96-2ecc-4495-81aa-34484555eb36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4c06a86a-15b2-467c-85c2-82be4e4abfc8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8bcb3f96-2ecc-4495-81aa-34484555eb36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8bcb3f96-2ecc-4495-81aa-34484555eb36_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8bcb3f96-2ecc-4495-81aa-34484555eb36" xlink:to="loc_us-gaap_SegmentDomain_8bcb3f96-2ecc-4495-81aa-34484555eb36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b8272384-f09b-44d2-9712-4213aa6e335a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8bcb3f96-2ecc-4495-81aa-34484555eb36" xlink:to="loc_us-gaap_SegmentDomain_b8272384-f09b-44d2-9712-4213aa6e335a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_06a77839-6b80-4076-86fd-e7adc12dbae7" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b8272384-f09b-44d2-9712-4213aa6e335a" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_06a77839-6b80-4076-86fd-e7adc12dbae7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_1e0dd87b-ff60-4f94-ba8e-1ea61cfdc029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b8272384-f09b-44d2-9712-4213aa6e335a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_1e0dd87b-ff60-4f94-ba8e-1ea61cfdc029" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#GoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="extended" id="i8eebba820ab44bf6ab71d2ea58d5e325_GoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_33d6ba44-67fa-4aaa-821f-e61c554cf6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_085a8878-f506-456b-9add-65f5fef000cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_33d6ba44-67fa-4aaa-821f-e61c554cf6df" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_085a8878-f506-456b-9add-65f5fef000cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b3c2f53c-91bc-426a-94df-5f004d99bb0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_33d6ba44-67fa-4aaa-821f-e61c554cf6df" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b3c2f53c-91bc-426a-94df-5f004d99bb0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_93aeb92b-9f57-41b6-b030-49f34b2a10a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_33d6ba44-67fa-4aaa-821f-e61c554cf6df" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_93aeb92b-9f57-41b6-b030-49f34b2a10a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f7ed3dee-c1c9-43d4-906d-de7f661943ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_93aeb92b-9f57-41b6-b030-49f34b2a10a3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f7ed3dee-c1c9-43d4-906d-de7f661943ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f7ed3dee-c1c9-43d4-906d-de7f661943ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f7ed3dee-c1c9-43d4-906d-de7f661943ba" xlink:to="loc_us-gaap_SegmentDomain_f7ed3dee-c1c9-43d4-906d-de7f661943ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6a97397a-98f5-4325-baad-77fee3c6ee14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f7ed3dee-c1c9-43d4-906d-de7f661943ba" xlink:to="loc_us-gaap_SegmentDomain_6a97397a-98f5-4325-baad-77fee3c6ee14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_febc3770-decc-4d5a-8c0f-b49111d7e110" xlink:href="dva-20210331.xsd#dva_OtherReportingUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6a97397a-98f5-4325-baad-77fee3c6ee14" xlink:to="loc_dva_OtherReportingUnitsMember_febc3770-decc-4d5a-8c0f-b49111d7e110" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Longtermdebt" xlink:type="simple" xlink:href="dva-20210331.xsd#Longtermdebt"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Longtermdebt" xlink:type="extended" id="i1eb9f40430ce467e98543b960e1edd89_Longtermdebt"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtTables" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtTables" xlink:type="extended" id="idbedcee5c013417095d1953797c0bb10_LongtermdebtTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtDetail" xlink:type="extended" id="i496a21448c35415c928e51b70a5641bc_LongtermdebtDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_d17cfa4c-d7ce-4be2-951d-9b86e0f98970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentsAbstract_d17cfa4c-d7ce-4be2-951d-9b86e0f98970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_85ae4098-d386-49af-af97-416e88d5b997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_SecuredDebt_85ae4098-d386-49af-af97-416e88d5b997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_479538e8-6352-49ee-9a69-2acd57d0e4f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_479538e8-6352-49ee-9a69-2acd57d0e4f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_11f43954-b545-4502-a564-e772b3641d98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_SeniorNotes_11f43954-b545-4502-a564-e772b3641d98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_b8236eca-f47d-4af7-a734-472714948063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_b8236eca-f47d-4af7-a734-472714948063" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_88a82194-9510-45f5-9d3b-130de79a0fcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_88a82194-9510-45f5-9d3b-130de79a0fcf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_0b52c183-498e-4178-b453-0e87e3f052d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentFairValue_0b52c183-498e-4178-b453-0e87e3f052d9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_08e2aaf2-176e-47d0-b31e-bbb609f5c6fb" xlink:href="dva-20210331.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_08e2aaf2-176e-47d0-b31e-bbb609f5c6fb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4653a2fc-d03f-4f2f-8366-bab7a0d3cd2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_FinanceLeaseLiability_4653a2fc-d03f-4f2f-8366-bab7a0d3cd2a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_0fcd49b7-7110-49d1-9e7c-21def35eb5a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_0fcd49b7-7110-49d1-9e7c-21def35eb5a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_3764a75d-f237-4f94-a3c4-67994da6d1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_3764a75d-f237-4f94-a3c4-67994da6d1e6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_568c7b86-b4d5-47ac-a2e6-75d30292cc90" xlink:href="dva-20210331.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_568c7b86-b4d5-47ac-a2e6-75d30292cc90" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ec344809-10e1-4f2b-b239-42f846d9f758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ec344809-10e1-4f2b-b239-42f846d9f758" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d7050525-8e5f-4936-96d2-ceb3c0a960b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d7050525-8e5f-4936-96d2-ceb3c0a960b8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts_3920950d-5537-4183-9e62-432fa6645b3c" xlink:href="dva-20210331.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_dva_DiscountAndDeferredFinanceCosts_3920950d-5537-4183-9e62-432fa6645b3c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_ba3afae5-2fe8-4ffd-9194-34f01cf82a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_ba3afae5-2fe8-4ffd-9194-34f01cf82a2d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5e31d97b-111c-4882-bf8e-516fd504866b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5e31d97b-111c-4882-bf8e-516fd504866b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0902aba7-82ee-4969-b553-f9a59d87aa3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0902aba7-82ee-4969-b553-f9a59d87aa3f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ed6fe28f-3b36-4de9-9d53-01c2a00d933e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ed6fe28f-3b36-4de9-9d53-01c2a00d933e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_3efd3b81-14ba-4e4a-9138-8c16a95868aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_3efd3b81-14ba-4e4a-9138-8c16a95868aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_6a57c493-2f6b-48df-afaf-89dc2f630316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:to="loc_us-gaap_DeferredOfferingCosts_6a57c493-2f6b-48df-afaf-89dc2f630316" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b673091b-2fae-412e-a483-77ea962c3d47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b673091b-2fae-412e-a483-77ea962c3d47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b673091b-2fae-412e-a483-77ea962c3d47_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b673091b-2fae-412e-a483-77ea962c3d47" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b673091b-2fae-412e-a483-77ea962c3d47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b673091b-2fae-412e-a483-77ea962c3d47" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_5d3f1387-27c1-4cc1-8da9-533b6040814c" xlink:href="dva-20210331.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:to="loc_dva_TermLoanAMember_5d3f1387-27c1-4cc1-8da9-533b6040814c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_87cf65d9-2f9c-4dd2-8faa-b81bb67c0c15" xlink:href="dva-20210331.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:to="loc_dva_TermLoanB1Member_87cf65d9-2f9c-4dd2-8faa-b81bb67c0c15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_89dab7df-1b51-4c5f-b27b-3cca912f2aa6" xlink:href="dva-20210331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_89dab7df-1b51-4c5f-b27b-3cca912f2aa6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_51c82ffb-9abd-4747-b5c5-97d78ef813f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:to="loc_us-gaap_SeniorNotesMember_51c82ffb-9abd-4747-b5c5-97d78ef813f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9deffca9-f0a6-4101-a17b-03ac2f584b57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:to="loc_us-gaap_CreditFacilityAxis_9deffca9-f0a6-4101-a17b-03ac2f584b57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9deffca9-f0a6-4101-a17b-03ac2f584b57_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_9deffca9-f0a6-4101-a17b-03ac2f584b57" xlink:to="loc_us-gaap_CreditFacilityDomain_9deffca9-f0a6-4101-a17b-03ac2f584b57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8961c854-7c70-4129-a480-c9f41295d571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_9deffca9-f0a6-4101-a17b-03ac2f584b57" xlink:to="loc_us-gaap_CreditFacilityDomain_8961c854-7c70-4129-a480-c9f41295d571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fc8c49af-fae8-451b-a32e-cf601ef74c9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8961c854-7c70-4129-a480-c9f41295d571" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fc8c49af-fae8-451b-a32e-cf601ef74c9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_337ff5ff-b047-46a1-a08f-a81882b235af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:to="loc_us-gaap_DebtInstrumentAxis_337ff5ff-b047-46a1-a08f-a81882b235af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_337ff5ff-b047-46a1-a08f-a81882b235af_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_337ff5ff-b047-46a1-a08f-a81882b235af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_337ff5ff-b047-46a1-a08f-a81882b235af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_337ff5ff-b047-46a1-a08f-a81882b235af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_1c5de288-838f-44d5-84fd-07815e916ca6" xlink:href="dva-20210331.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_1c5de288-838f-44d5-84fd-07815e916ca6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_2a6501d8-1c6d-4da9-9aeb-915e88b90dda" xlink:href="dva-20210331.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_2a6501d8-1c6d-4da9-9aeb-915e88b90dda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_16908099-6126-49a1-ab9d-decc80688266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_16908099-6126-49a1-ab9d-decc80688266" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_e019fa11-1269-47b8-99a9-61b911567e92" xlink:href="dva-20210331.xsd#dva_FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:to="loc_dva_FinanceLeaseMember_e019fa11-1269-47b8-99a9-61b911567e92" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtScheduleofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="extended" id="ib76b1eaa98f548c8a337f08207307a1a_LongtermdebtScheduleofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_677489ef-fe71-42d7-803d-e6bb812b066a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_677489ef-fe71-42d7-803d-e6bb812b066a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b4faffd8-85cb-4984-804e-2c07c505dca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b4faffd8-85cb-4984-804e-2c07c505dca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_6e464b07-acf8-4949-9f2f-65cd340ade28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeInceptionDates_6e464b07-acf8-4949-9f2f-65cd340ade28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_965c9afa-9ef3-41fa-8932-179e4b4a8cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeMaturityDates_965c9afa-9ef3-41fa-8932-179e4b4a8cea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_0d21299f-9565-460e-b9c5-4c386582ede9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_0d21299f-9565-460e-b9c5-4c386582ede9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_f7fbf6a3-3160-4207-aa66-2d516eb551de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_f7fbf6a3-3160-4207-aa66-2d516eb551de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7fbdabba-e7f3-452a-b460-6faf7088068d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7fbdabba-e7f3-452a-b460-6faf7088068d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ee4f2a04-2b19-42dc-8646-5cde9178f739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_DebtInstrumentAxis_ee4f2a04-2b19-42dc-8646-5cde9178f739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ee4f2a04-2b19-42dc-8646-5cde9178f739_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ee4f2a04-2b19-42dc-8646-5cde9178f739" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ee4f2a04-2b19-42dc-8646-5cde9178f739_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_afd23c1d-8d17-4493-a941-ff3b0d5aeabe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ee4f2a04-2b19-42dc-8646-5cde9178f739" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_afd23c1d-8d17-4493-a941-ff3b0d5aeabe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_347ac49c-cbe8-40cb-a820-bb7f3932a27e" xlink:href="dva-20210331.xsd#dva_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afd23c1d-8d17-4493-a941-ff3b0d5aeabe" xlink:to="loc_dva_TermLoanFacilityMember_347ac49c-cbe8-40cb-a820-bb7f3932a27e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_df3e90a8-8af0-449f-b402-3e4541c826f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_srt_RangeAxis_df3e90a8-8af0-449f-b402-3e4541c826f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_df3e90a8-8af0-449f-b402-3e4541c826f8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_df3e90a8-8af0-449f-b402-3e4541c826f8" xlink:to="loc_srt_RangeMember_df3e90a8-8af0-449f-b402-3e4541c826f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73036eb5-88cd-4292-af58-243d52865b9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_df3e90a8-8af0-449f-b402-3e4541c826f8" xlink:to="loc_srt_RangeMember_73036eb5-88cd-4292-af58-243d52865b9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_28e6ea67-a94b-47f4-b07e-951361ae1033" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_73036eb5-88cd-4292-af58-243d52865b9d" xlink:to="loc_srt_MaximumMember_28e6ea67-a94b-47f4-b07e-951361ae1033" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c7c2612c-43e8-44f1-90e9-12a85d960bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c7c2612c-43e8-44f1-90e9-12a85d960bd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c7c2612c-43e8-44f1-90e9-12a85d960bd5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c7c2612c-43e8-44f1-90e9-12a85d960bd5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c7c2612c-43e8-44f1-90e9-12a85d960bd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b3553cf7-592e-4820-88d7-c36c894c8557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c7c2612c-43e8-44f1-90e9-12a85d960bd5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b3553cf7-592e-4820-88d7-c36c894c8557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_7b419316-3b00-4696-860d-92565f1b0e5c" xlink:href="dva-20210331.xsd#dva_DebtExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b3553cf7-592e-4820-88d7-c36c894c8557" xlink:to="loc_dva_DebtExpenseMember_7b419316-3b00-4696-860d-92565f1b0e5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed56dcc-9eaf-4fc2-8026-258510b94a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed56dcc-9eaf-4fc2-8026-258510b94a90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7ed56dcc-9eaf-4fc2-8026-258510b94a90_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed56dcc-9eaf-4fc2-8026-258510b94a90" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7ed56dcc-9eaf-4fc2-8026-258510b94a90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b133453e-50e4-4611-a20e-b7b94b8478b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed56dcc-9eaf-4fc2-8026-258510b94a90" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b133453e-50e4-4611-a20e-b7b94b8478b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_07f6d680-a6b3-4e5b-be5f-acaa74425294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b133453e-50e4-4611-a20e-b7b94b8478b6" xlink:to="loc_us-gaap_CashFlowHedgingMember_07f6d680-a6b3-4e5b-be5f-acaa74425294" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_74ddad0d-8915-4fff-a987-94ced6a87ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_74ddad0d-8915-4fff-a987-94ced6a87ab4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_74ddad0d-8915-4fff-a987-94ced6a87ab4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_74ddad0d-8915-4fff-a987-94ced6a87ab4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_74ddad0d-8915-4fff-a987-94ced6a87ab4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f14eb82a-b5e8-4e97-bb93-13e89abed606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_74ddad0d-8915-4fff-a987-94ced6a87ab4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f14eb82a-b5e8-4e97-bb93-13e89abed606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_e1e99b49-496a-47e4-8581-5fa1b8708f72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f14eb82a-b5e8-4e97-bb93-13e89abed606" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_e1e99b49-496a-47e4-8581-5fa1b8708f72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9fbf2971-1ac0-44f1-837c-8c9e505c1692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9fbf2971-1ac0-44f1-837c-8c9e505c1692" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9fbf2971-1ac0-44f1-837c-8c9e505c1692_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9fbf2971-1ac0-44f1-837c-8c9e505c1692" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9fbf2971-1ac0-44f1-837c-8c9e505c1692_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0af89952-336a-4a42-866b-1e8ab99fff2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9fbf2971-1ac0-44f1-837c-8c9e505c1692" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0af89952-336a-4a42-866b-1e8ab99fff2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_0af8902d-d015-4c0e-aef3-a727fb5644b9" xlink:href="dva-20210331.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0af89952-336a-4a42-866b-1e8ab99fff2d" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_0af8902d-d015-4c0e-aef3-a727fb5644b9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="extended" id="i47a2d29d494a4c0ebeebf685502fc5ee_LongtermdebtAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_63417e8b-d4a6-409c-9bab-5ee38c98a146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_63417e8b-d4a6-409c-9bab-5ee38c98a146" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_5141a930-5c24-4329-830e-69ea13aa9ef4" xlink:href="dva-20210331.xsd#dva_AdditionalDebtPrincipalAmountDueToNewAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_5141a930-5c24-4329-830e-69ea13aa9ef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_664dff8e-75a4-4518-9bb5-c32628c94687" xlink:href="dva-20210331.xsd#dva_DebtInstrumentOfferingPricePercentageOfFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_664dff8e-75a4-4518-9bb5-c32628c94687" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_cd67a1e6-6e65-4083-8f43-eccbe0e91d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_cd67a1e6-6e65-4083-8f43-eccbe0e91d4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_8646723c-d9dc-430c-964d-ab931fabcd73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_SeniorNotes_8646723c-d9dc-430c-964d-ab931fabcd73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_1f20a7d6-a6a0-43b0-83c3-3187ff038073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_1f20a7d6-a6a0-43b0-83c3-3187ff038073" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_3300d5a9-1cc2-47d2-91c1-0f143f3912bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LineOfCredit_3300d5a9-1cc2-47d2-91c1-0f143f3912bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_55d8635a-d61e-4760-a9cc-79a51db89c96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_55d8635a-d61e-4760-a9cc-79a51db89c96" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_d9930da7-1a58-4c21-aa0c-3e9390ff4c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_d9930da7-1a58-4c21-aa0c-3e9390ff4c87" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_7669ae2c-dadd-46e0-bd6d-17ad57b07d31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_7669ae2c-dadd-46e0-bd6d-17ad57b07d31" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_11d9d9ee-7baa-4b00-9b45-e1e9ae51905d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_11d9d9ee-7baa-4b00-9b45-e1e9ae51905d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_02088a83-a34e-4730-816c-afb71fa822e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_02088a83-a34e-4730-816c-afb71fa822e1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d9fba480-9576-4f27-893d-644d61d817b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d9fba480-9576-4f27-893d-644d61d817b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d9fba480-9576-4f27-893d-644d61d817b1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d9fba480-9576-4f27-893d-644d61d817b1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d9fba480-9576-4f27-893d-644d61d817b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d9fba480-9576-4f27-893d-644d61d817b1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_0a027c13-3906-48db-8dd9-93856f865ca1" xlink:href="dva-20210331.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:to="loc_dva_TermLoanAMember_0a027c13-3906-48db-8dd9-93856f865ca1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_c5fe4e21-e364-4e63-85d8-e0c4765d0761" xlink:href="dva-20210331.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:to="loc_dva_TermLoanB1Member_c5fe4e21-e364-4e63-85d8-e0c4765d0761" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_412e6456-c31f-43dc-988b-01fab42a7d8c" xlink:href="dva-20210331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_412e6456-c31f-43dc-988b-01fab42a7d8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4e338af1-c778-41c5-9c0c-677f8321b6a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:to="loc_us-gaap_CreditFacilityAxis_4e338af1-c778-41c5-9c0c-677f8321b6a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4e338af1-c778-41c5-9c0c-677f8321b6a2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4e338af1-c778-41c5-9c0c-677f8321b6a2" xlink:to="loc_us-gaap_CreditFacilityDomain_4e338af1-c778-41c5-9c0c-677f8321b6a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4e338af1-c778-41c5-9c0c-677f8321b6a2" xlink:to="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_803f591f-ef3f-4c79-b000-b243f01f43d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_803f591f-ef3f-4c79-b000-b243f01f43d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ad96b1f5-1d5f-43bc-a3e3-cc09d476aac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:to="loc_us-gaap_LetterOfCreditMember_ad96b1f5-1d5f-43bc-a3e3-cc09d476aac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_616eae25-7a94-4ae2-bf58-641553317593" xlink:href="dva-20210331.xsd#dva_BilateralSecuredLetterOfCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:to="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_616eae25-7a94-4ae2-bf58-641553317593" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c4ac3cf1-fccf-4bff-84eb-6f57fcbb8ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:to="loc_us-gaap_DebtInstrumentAxis_c4ac3cf1-fccf-4bff-84eb-6f57fcbb8ed1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c4ac3cf1-fccf-4bff-84eb-6f57fcbb8ed1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c4ac3cf1-fccf-4bff-84eb-6f57fcbb8ed1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c4ac3cf1-fccf-4bff-84eb-6f57fcbb8ed1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6bf35c20-5d66-440c-a984-07e80a02bc9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c4ac3cf1-fccf-4bff-84eb-6f57fcbb8ed1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6bf35c20-5d66-440c-a984-07e80a02bc9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_1457598a-11f5-4e56-a616-73db886e7eca" xlink:href="dva-20210331.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6bf35c20-5d66-440c-a984-07e80a02bc9a" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_1457598a-11f5-4e56-a616-73db886e7eca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="dva-20210331.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="extended" id="i2e38c0d65af644da98ed2a283562d6a6_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended" id="ie9c324d1fb864014b1f9002b6d96e6ec_CommitmentsandContingenciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8ce775da-2af6-4623-a24d-ae9024a904be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8ce775da-2af6-4623-a24d-ae9024a904be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementPeriod_f0e91eb9-7287-4cce-b4c2-bc9c48b0ce7c" xlink:href="dva-20210331.xsd#dva_CorporateIntegrityAgreementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_dva_CorporateIntegrityAgreementPeriod_f0e91eb9-7287-4cce-b4c2-bc9c48b0ce7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementExpirationDate_8e638d56-887e-4bb3-86e8-c80f54b8500d" xlink:href="dva-20210331.xsd#dva_CorporateIntegrityAgreementExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_dva_CorporateIntegrityAgreementExpirationDate_8e638d56-887e-4bb3-86e8-c80f54b8500d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne_ddd2f32b-4e84-4e8d-9cb7-961cac71105d" xlink:href="dva-20210331.xsd#dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne_ddd2f32b-4e84-4e8d-9cb7-961cac71105d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_783ff057-ce10-4ff0-8bf1-149d4b1514f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_us-gaap_OtherCommitment_783ff057-ce10-4ff0-8bf1-149d4b1514f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_880542b6-c944-42fe-897e-1942b5794de4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:to="loc_us-gaap_TransactionTypeAxis_880542b6-c944-42fe-897e-1942b5794de4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_880542b6-c944-42fe-897e-1942b5794de4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_880542b6-c944-42fe-897e-1942b5794de4" xlink:to="loc_us-gaap_TransactionDomain_880542b6-c944-42fe-897e-1942b5794de4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_d264edf0-65c9-4b99-a67b-459beccb8e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_880542b6-c944-42fe-897e-1942b5794de4" xlink:to="loc_us-gaap_TransactionDomain_d264edf0-65c9-4b99-a67b-459beccb8e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember_68d3072f-a79b-4ceb-9bf2-8e80f7bb9599" xlink:href="dva-20210331.xsd#dva_IncrementalCashPortionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_d264edf0-65c9-4b99-a67b-459beccb8e39" xlink:to="loc_dva_IncrementalCashPortionMember_68d3072f-a79b-4ceb-9bf2-8e80f7bb9599" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember_8e7cd962-7562-4172-87ca-f4a5a4b52669" xlink:href="dva-20210331.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_d264edf0-65c9-4b99-a67b-459beccb8e39" xlink:to="loc_dva_CashPaidForPortionPreviouslyRefundedMember_8e7cd962-7562-4172-87ca-f4a5a4b52669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f56079ae-5345-4c02-9a8a-afe71fb096e8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:to="loc_srt_LitigationCaseAxis_f56079ae-5345-4c02-9a8a-afe71fb096e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f56079ae-5345-4c02-9a8a-afe71fb096e8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_f56079ae-5345-4c02-9a8a-afe71fb096e8" xlink:to="loc_srt_LitigationCaseTypeDomain_f56079ae-5345-4c02-9a8a-afe71fb096e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_27c4264a-2a4f-4e4c-ada4-d81b7bb5062f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_f56079ae-5345-4c02-9a8a-afe71fb096e8" xlink:to="loc_srt_LitigationCaseTypeDomain_27c4264a-2a4f-4e4c-ada4-d81b7bb5062f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_b572fbab-22b7-4932-8d35-c815554c70bb" xlink:href="dva-20210331.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_27c4264a-2a4f-4e4c-ada4-d81b7bb5062f" xlink:to="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_b572fbab-22b7-4932-8d35-c815554c70bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockholderDerivativeLitigationMember_09ec66aa-43d5-483f-8271-d8520fabdd16" xlink:href="dva-20210331.xsd#dva_StockholderDerivativeLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_27c4264a-2a4f-4e4c-ada4-d81b7bb5062f" xlink:to="loc_dva_StockholderDerivativeLitigationMember_09ec66aa-43d5-483f-8271-d8520fabdd16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_804d0ce5-1edd-42c3-9d83-77105e3529e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:to="loc_us-gaap_OtherCommitmentsAxis_804d0ce5-1edd-42c3-9d83-77105e3529e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_804d0ce5-1edd-42c3-9d83-77105e3529e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_804d0ce5-1edd-42c3-9d83-77105e3529e1" xlink:to="loc_us-gaap_OtherCommitmentsDomain_804d0ce5-1edd-42c3-9d83-77105e3529e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_8017d664-63cf-4757-ade3-8c9f12a14016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_804d0ce5-1edd-42c3-9d83-77105e3529e1" xlink:to="loc_us-gaap_OtherCommitmentsDomain_8017d664-63cf-4757-ade3-8c9f12a14016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_2335627f-b3d3-44a5-9b9d-3b823d348d60" xlink:href="dva-20210331.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_8017d664-63cf-4757-ade3-8c9f12a14016" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_2335627f-b3d3-44a5-9b9d-3b823d348d60" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Shareholdersequity" xlink:type="simple" xlink:href="dva-20210331.xsd#Shareholdersequity"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Shareholdersequity" xlink:type="extended" id="i7dafdbee8876435b8bf0d73a8c9d74ff_Shareholdersequity"/>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables" xlink:type="simple" xlink:href="dva-20210331.xsd#SharerepurchasesShareRepurchasesTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables" xlink:type="extended" id="ibd1f940cc8f14d54a81aedbdd92fac7e_SharerepurchasesShareRepurchasesTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermincentivecompensationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="extended" id="ie9914aa1526f4d0e81f3c94439edb413_LongtermincentivecompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a3e9784d-45fa-4973-a761-7c8893e01e71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a3e9784d-45fa-4973-a761-7c8893e01e71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_dcb95a96-df3f-4756-a2f1-c17e9a7c3baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_dcb95a96-df3f-4756-a2f1-c17e9a7c3baa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_d269833c-088b-43a8-96e9-00694ead4889" xlink:href="dva-20210331.xsd#dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_d269833c-088b-43a8-96e9-00694ead4889" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3c51b4a5-378b-4846-af4e-f840081fd423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3c51b4a5-378b-4846-af4e-f840081fd423" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d23521a5-8f64-41ce-9cd2-6381b065c582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d23521a5-8f64-41ce-9cd2-6381b065c582" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e76c5d7e-6cbc-4c11-9363-6a526f8c7da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e76c5d7e-6cbc-4c11-9363-6a526f8c7da2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d318826-3cf8-4886-887a-36e1c0e83d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d318826-3cf8-4886-887a-36e1c0e83d06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d213a70e-feb3-49f6-9984-9f111e640f82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d318826-3cf8-4886-887a-36e1c0e83d06" xlink:to="loc_us-gaap_AwardTypeAxis_d213a70e-feb3-49f6-9984-9f111e640f82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d213a70e-feb3-49f6-9984-9f111e640f82_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d213a70e-feb3-49f6-9984-9f111e640f82" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d213a70e-feb3-49f6-9984-9f111e640f82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4be0293-b6be-4605-b1bb-0d725ec80c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d213a70e-feb3-49f6-9984-9f111e640f82" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4be0293-b6be-4605-b1bb-0d725ec80c7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1e37bbfe-0f40-46a5-89c4-957d1c8106ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4be0293-b6be-4605-b1bb-0d725ec80c7d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1e37bbfe-0f40-46a5-89c4-957d1c8106ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_3f382da7-a070-422c-a75e-7a8cd5f862db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4be0293-b6be-4605-b1bb-0d725ec80c7d" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_3f382da7-a070-422c-a75e-7a8cd5f862db" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#SharerepurchasesShareRepurchaseTableDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="extended" id="ife855389d9a948b284a5a8097dac0b6a_SharerepurchasesShareRepurchaseTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c9994b49-17eb-4b58-b1b9-265dadd2aa56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c9994b49-17eb-4b58-b1b9-265dadd2aa56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_acae9c50-6d22-47c6-ad7b-6dfe3798a0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_acae9c50-6d22-47c6-ad7b-6dfe3798a0ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38056c65-ffd6-43b4-995d-42195703075f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38056c65-ffd6-43b4-995d-42195703075f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_8d610f5c-d906-46b4-b18d-d631aa7677f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_8d610f5c-d906-46b4-b18d-d631aa7677f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_dea0a900-2037-4dd3-986a-53847c19f8eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_8d610f5c-d906-46b4-b18d-d631aa7677f5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_dea0a900-2037-4dd3-986a-53847c19f8eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_dea0a900-2037-4dd3-986a-53847c19f8eb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_dea0a900-2037-4dd3-986a-53847c19f8eb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_dea0a900-2037-4dd3-986a-53847c19f8eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_fa0a68d3-2072-4cc5-9a1d-4a3e076606cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_dea0a900-2037-4dd3-986a-53847c19f8eb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_fa0a68d3-2072-4cc5-9a1d-4a3e076606cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember_751edb2d-2c87-4372-a80a-e1d942fdfaa8" xlink:href="dva-20210331.xsd#dva_OpenMarketPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_fa0a68d3-2072-4cc5-9a1d-4a3e076606cd" xlink:to="loc_dva_OpenMarketPurchasesMember_751edb2d-2c87-4372-a80a-e1d942fdfaa8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#SharerepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="extended" id="i5a9f9d776de848ed98da72c552103558_SharerepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_2bb1daba-c9a9-4ab4-89e9-f65a555cb5b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_2bb1daba-c9a9-4ab4-89e9-f65a555cb5b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_742753bd-6c7c-4c9c-9964-b82a6c39778d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_742753bd-6c7c-4c9c-9964-b82a6c39778d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_55d4f158-70ed-4d82-9051-20bac971b241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_55d4f158-70ed-4d82-9051-20bac971b241" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_74e4e517-85c8-4a07-8e9b-101b78454da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_74e4e517-85c8-4a07-8e9b-101b78454da1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_6e7fa760-53ea-468c-b06e-7f4d28ed00a4" xlink:href="dva-20210331.xsd#dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_6e7fa760-53ea-468c-b06e-7f4d28ed00a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_547a522c-8555-4c85-a5cc-6eba2254c19e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_547a522c-8555-4c85-a5cc-6eba2254c19e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_3c90ee4c-6e46-4f0d-9315-320bf3e326d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_3c90ee4c-6e46-4f0d-9315-320bf3e326d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c9ada7bd-ecd3-46be-a95a-469aafd1bbaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_3c90ee4c-6e46-4f0d-9315-320bf3e326d6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c9ada7bd-ecd3-46be-a95a-469aafd1bbaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c9ada7bd-ecd3-46be-a95a-469aafd1bbaa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c9ada7bd-ecd3-46be-a95a-469aafd1bbaa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c9ada7bd-ecd3-46be-a95a-469aafd1bbaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_dee6e50d-6d90-4dd9-b652-cdc162dad20d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c9ada7bd-ecd3-46be-a95a-469aafd1bbaa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_dee6e50d-6d90-4dd9-b652-cdc162dad20d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4d51ec1e-b9a1-446c-85e8-69e93a468aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_dee6e50d-6d90-4dd9-b652-cdc162dad20d" xlink:to="loc_us-gaap_SubsequentEventMember_4d51ec1e-b9a1-446c-85e8-69e93a468aa3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="simple" xlink:href="dva-20210331.xsd#Accumulatedothercomprehensivelossincome"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="extended" id="ie2390c0884654fa6bbc627be4ebcf6bc_Accumulatedothercomprehensivelossincome"/>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="simple" xlink:href="dva-20210331.xsd#AccumulatedothercomprehensivelossincomeTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="extended" id="i8a3aaa5d9c544a1dba551f2aeacc0406_AccumulatedothercomprehensivelossincomeTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#AccumulatedothercomprehensivelossincomeDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="extended" id="ibae4138ba4524495a3c475f4a0f7d7ba_AccumulatedothercomprehensivelossincomeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ee2f1fe2-972c-4a83-bcf3-67716426f185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ee2f1fe2-972c-4a83-bcf3-67716426f185" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cb45adc8-2cad-4e7f-9e56-7a9093262488" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cb45adc8-2cad-4e7f-9e56-7a9093262488" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_68f220ed-3283-4d51-bd6b-a1ce279e80f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_68f220ed-3283-4d51-bd6b-a1ce279e80f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_68bd9a52-6e16-4390-a1cb-3b83e96cd4af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_68bd9a52-6e16-4390-a1cb-3b83e96cd4af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2de5663b-442e-4424-9840-0c0859dfff99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2de5663b-442e-4424-9840-0c0859dfff99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7d8b5a96-174b-4b40-96ea-c2b514d37910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7d8b5a96-174b-4b40-96ea-c2b514d37910" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_1930c67d-338f-40b3-888e-323d46a41cdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_1930c67d-338f-40b3-888e-323d46a41cdc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_160add15-0a43-4600-affd-0bf4d35de08a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_160add15-0a43-4600-affd-0bf4d35de08a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3f24f7d9-a0d3-47e4-b52b-a977d7662efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bb71da31-0660-4a7c-9ed8-d4e1704994d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ee2f1fe2-972c-4a83-bcf3-67716426f185" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bb71da31-0660-4a7c-9ed8-d4e1704994d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_62d9a724-9caf-419e-b94b-d595d92c570b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bb71da31-0660-4a7c-9ed8-d4e1704994d4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_62d9a724-9caf-419e-b94b-d595d92c570b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_62d9a724-9caf-419e-b94b-d595d92c570b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62d9a724-9caf-419e-b94b-d595d92c570b" xlink:to="loc_us-gaap_EquityComponentDomain_62d9a724-9caf-419e-b94b-d595d92c570b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62d9a724-9caf-419e-b94b-d595d92c570b" xlink:to="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_b0db9c1a-da71-4e77-89d3-ec4e4907a960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_b0db9c1a-da71-4e77-89d3-ec4e4907a960" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_def94da1-8c51-4a2b-a51c-2abb13ccff81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_def94da1-8c51-4a2b-a51c-2abb13ccff81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c351b92e-2180-4785-86a7-a635cea7e30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c351b92e-2180-4785-86a7-a635cea7e30d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Acquisitionsanddivestitures" xlink:type="simple" xlink:href="dva-20210331.xsd#Acquisitionsanddivestitures"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Acquisitionsanddivestitures" xlink:type="extended" id="id0e8dd3951494ddaa5969db89bf21e3c_Acquisitionsanddivestitures"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresTables" xlink:type="simple" xlink:href="dva-20210331.xsd#AcquisitionsanddivestituresTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresTables" xlink:type="extended" id="i63d583b8851f4f4495ce799759889804_AcquisitionsanddivestituresTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#AcquisitionsanddivestituresContingentEarnoutobligationsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="extended" id="i40b41a1112da4a62be4cc0f872b92c6d_AcquisitionsanddivestituresContingentEarnoutobligationsDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#AcquisitionsanddivestituresAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="extended" id="ia14b68f824db4793871910832ab8cc5e_AcquisitionsanddivestituresAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_27ebd729-6366-4c8c-a49d-39a42a242ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_27ebd729-6366-4c8c-a49d-39a42a242ac8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d5154a79-2d9c-4eec-848f-a17e63af11e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d5154a79-2d9c-4eec-848f-a17e63af11e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_14336322-9208-4cda-ac73-07a218c8f834" xlink:href="dva-20210331.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_14336322-9208-4cda-ac73-07a218c8f834" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_22993491-39dd-4b7a-aab9-be1b0a0ecd82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_22993491-39dd-4b7a-aab9-be1b0a0ecd82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_12580d73-4624-44b0-9a29-6fc1a94a07d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_12580d73-4624-44b0-9a29-6fc1a94a07d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_aba47fca-d3eb-4b33-9654-cf14fff2bf50" xlink:href="dva-20210331.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_aba47fca-d3eb-4b33-9654-cf14fff2bf50" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f06c42e5-b6e4-4180-8e2c-ce54541a7c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f06c42e5-b6e4-4180-8e2c-ce54541a7c45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_5d02c4d6-d68f-402a-a411-07776080da6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_5d02c4d6-d68f-402a-a411-07776080da6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_535e7dbe-f9e5-4d69-93ca-108e1a66034b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_535e7dbe-f9e5-4d69-93ca-108e1a66034b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_535e7dbe-f9e5-4d69-93ca-108e1a66034b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_535e7dbe-f9e5-4d69-93ca-108e1a66034b" xlink:to="loc_us-gaap_SegmentDomain_535e7dbe-f9e5-4d69-93ca-108e1a66034b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_75724212-3733-43c1-a49b-b56a32b92f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_535e7dbe-f9e5-4d69-93ca-108e1a66034b" xlink:to="loc_us-gaap_SegmentDomain_75724212-3733-43c1-a49b-b56a32b92f04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember_80cfa3e9-ba3a-4608-8029-12fc5db67ce4" xlink:href="dva-20210331.xsd#dva_ForeignDialysisCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_75724212-3733-43c1-a49b-b56a32b92f04" xlink:to="loc_dva_ForeignDialysisCentersMember_80cfa3e9-ba3a-4608-8029-12fc5db67ce4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_88b7700d-a09b-48ea-a86e-16b39b423c8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_88b7700d-a09b-48ea-a86e-16b39b423c8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_88b7700d-a09b-48ea-a86e-16b39b423c8f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_88b7700d-a09b-48ea-a86e-16b39b423c8f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_88b7700d-a09b-48ea-a86e-16b39b423c8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b09e7f4-5784-44a2-8524-fe6f37ab50cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_88b7700d-a09b-48ea-a86e-16b39b423c8f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b09e7f4-5784-44a2-8524-fe6f37ab50cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_dbe37905-ae36-4b39-a56c-ce582b2f3a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b09e7f4-5784-44a2-8524-fe6f37ab50cb" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_dbe37905-ae36-4b39-a56c-ce582b2f3a45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_333058a6-959c-40c9-87a9-538eee00fd10" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_srt_RangeAxis_333058a6-959c-40c9-87a9-538eee00fd10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_333058a6-959c-40c9-87a9-538eee00fd10_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_333058a6-959c-40c9-87a9-538eee00fd10" xlink:to="loc_srt_RangeMember_333058a6-959c-40c9-87a9-538eee00fd10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b8098ab-b4de-4f6d-9b76-99980ca0edf3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_333058a6-959c-40c9-87a9-538eee00fd10" xlink:to="loc_srt_RangeMember_1b8098ab-b4de-4f6d-9b76-99980ca0edf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dbaa23f5-1260-4318-b7e3-00648376d686" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1b8098ab-b4de-4f6d-9b76-99980ca0edf3" xlink:to="loc_srt_MinimumMember_dbaa23f5-1260-4318-b7e3-00648376d686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ffb3519e-c3fe-40e9-a832-4505587896d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1b8098ab-b4de-4f6d-9b76-99980ca0edf3" xlink:to="loc_srt_MaximumMember_ffb3519e-c3fe-40e9-a832-4505587896d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6648c07d-bde6-4434-85a8-69257a03a489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6648c07d-bde6-4434-85a8-69257a03a489" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6648c07d-bde6-4434-85a8-69257a03a489_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6648c07d-bde6-4434-85a8-69257a03a489" xlink:to="loc_us-gaap_RelatedPartyDomain_6648c07d-bde6-4434-85a8-69257a03a489_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f7483c69-3a4d-4e4c-9fb2-aaa682b62c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6648c07d-bde6-4434-85a8-69257a03a489" xlink:to="loc_us-gaap_RelatedPartyDomain_f7483c69-3a4d-4e4c-9fb2-aaa682b62c7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_ded7683e-5b54-454d-929e-b549ffecb0a6" xlink:href="dva-20210331.xsd#dva_OtherCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_f7483c69-3a4d-4e4c-9fb2-aaa682b62c7d" xlink:to="loc_dva_OtherCompaniesMember_ded7683e-5b54-454d-929e-b549ffecb0a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_c46d9a57-b00a-4528-8a32-702a735f6fd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_c46d9a57-b00a-4528-8a32-702a735f6fd0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c46d9a57-b00a-4528-8a32-702a735f6fd0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_c46d9a57-b00a-4528-8a32-702a735f6fd0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c46d9a57-b00a-4528-8a32-702a735f6fd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c618a91f-7ca8-4929-8730-533f253878a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_c46d9a57-b00a-4528-8a32-702a735f6fd0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c618a91f-7ca8-4929-8730-533f253878a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_88788e68-44f0-4d54-8f7c-0c4a23098c77" xlink:href="dva-20210331.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_c618a91f-7ca8-4929-8730-533f253878a4" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_88788e68-44f0-4d54-8f7c-0c4a23098c77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a8692c19-3dbe-4852-87fe-4729a748c7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a8692c19-3dbe-4852-87fe-4729a748c7fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a8692c19-3dbe-4852-87fe-4729a748c7fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a8692c19-3dbe-4852-87fe-4729a748c7fc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a8692c19-3dbe-4852-87fe-4729a748c7fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6cbb3ba9-dc16-427f-8636-f075dfe11391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a8692c19-3dbe-4852-87fe-4729a748c7fc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6cbb3ba9-dc16-427f-8636-f075dfe11391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b1e78023-5316-4079-9f51-2e965650edeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6cbb3ba9-dc16-427f-8636-f075dfe11391" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b1e78023-5316-4079-9f51-2e965650edeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_79425e1d-d5d3-4fa4-8b60-dd906cbbdafc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6cbb3ba9-dc16-427f-8636-f075dfe11391" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_79425e1d-d5d3-4fa4-8b60-dd906cbbdafc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Variableinterestentities" xlink:type="simple" xlink:href="dva-20210331.xsd#Variableinterestentities"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Variableinterestentities" xlink:type="extended" id="ie9109392a3c046e68d5db08ef9b468cf_Variableinterestentities"/>
  <link:roleRef roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#VariableinterestentitiesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="extended" id="icc1448ddca754d94b42bc1a07579b7b1_VariableinterestentitiesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4b0d1686-9118-4e50-9f47-088f9c9cc54e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_851393f4-3557-4d0b-9cd6-fe252ce03c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4b0d1686-9118-4e50-9f47-088f9c9cc54e" xlink:to="loc_us-gaap_Assets_851393f4-3557-4d0b-9cd6-fe252ce03c78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0d074ebe-c897-4756-8ed2-3223bcdb6583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4b0d1686-9118-4e50-9f47-088f9c9cc54e" xlink:to="loc_us-gaap_Liabilities_0d074ebe-c897-4756-8ed2-3223bcdb6583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_086c8f70-6398-4da9-8ebb-7cc66aaee45c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4b0d1686-9118-4e50-9f47-088f9c9cc54e" xlink:to="loc_us-gaap_StatementTable_086c8f70-6398-4da9-8ebb-7cc66aaee45c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9422f65f-c70d-4ef0-88fa-2cb61ac27e34" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_086c8f70-6398-4da9-8ebb-7cc66aaee45c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9422f65f-c70d-4ef0-88fa-2cb61ac27e34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9422f65f-c70d-4ef0-88fa-2cb61ac27e34_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9422f65f-c70d-4ef0-88fa-2cb61ac27e34" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9422f65f-c70d-4ef0-88fa-2cb61ac27e34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_bce0baf9-85bb-4645-be59-557ea25d7edd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9422f65f-c70d-4ef0-88fa-2cb61ac27e34" xlink:to="loc_srt_ConsolidatedEntitiesDomain_bce0baf9-85bb-4645-be59-557ea25d7edd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_51df4f8c-67ff-4c61-814d-cf66245a0cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_bce0baf9-85bb-4645-be59-557ea25d7edd" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_51df4f8c-67ff-4c61-814d-cf66245a0cf5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="simple" xlink:href="dva-20210331.xsd#Fairvalueoffinancialinstruments"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="extended" id="i9b49d53923f44de8b56603c9ff4b1372_Fairvalueoffinancialinstruments"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="simple" xlink:href="dva-20210331.xsd#FairvalueoffinancialinstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="extended" id="i1ff42548c69a48cdae916af26cccffd6_FairvalueoffinancialinstrumentsTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="extended" id="i2a510816ec3f4f81bcaae09e13cff8e1_FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_f2f4cbce-3cc1-422c-8dd5-5d15a9f12c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_f2f4cbce-3cc1-422c-8dd5-5d15a9f12c26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7cc32345-25d9-428d-9c5e-6445f0f1bf83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f2f4cbce-3cc1-422c-8dd5-5d15a9f12c26" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7cc32345-25d9-428d-9c5e-6445f0f1bf83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_a95350df-4580-49c6-9295-ceee16360ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f2f4cbce-3cc1-422c-8dd5-5d15a9f12c26" xlink:to="loc_us-gaap_DerivativeAssets_a95350df-4580-49c6-9295-ceee16360ca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_16ed694f-3f99-4a84-9bcc-ccaad066b648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_16ed694f-3f99-4a84-9bcc-ccaad066b648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_90d30d41-df18-4801-9919-ea4dd36e5276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_16ed694f-3f99-4a84-9bcc-ccaad066b648" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_90d30d41-df18-4801-9919-ea4dd36e5276" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_8c48cd8a-5c56-4788-aa0f-ca933c81202d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:to="loc_us-gaap_TemporaryEquityAbstract_8c48cd8a-5c56-4788-aa0f-ca933c81202d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_44f66efd-935a-4b81-95d1-a32504513317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_8c48cd8a-5c56-4788-aa0f-ca933c81202d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_44f66efd-935a-4b81-95d1-a32504513317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b1c8b3e-a9c7-4398-9fc7-b6586dfead35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b1c8b3e-a9c7-4398-9fc7-b6586dfead35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3b1c8b3e-a9c7-4398-9fc7-b6586dfead35_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b1c8b3e-a9c7-4398-9fc7-b6586dfead35" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3b1c8b3e-a9c7-4398-9fc7-b6586dfead35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c33c3ea2-f38a-4f2e-b896-8db8f63b52e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b1c8b3e-a9c7-4398-9fc7-b6586dfead35" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c33c3ea2-f38a-4f2e-b896-8db8f63b52e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_325c1cf4-64f6-423f-b44d-9ebba564aab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c33c3ea2-f38a-4f2e-b896-8db8f63b52e3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_325c1cf4-64f6-423f-b44d-9ebba564aab4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_70c55a4f-6782-4fb9-94fc-2502d6b28fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_70c55a4f-6782-4fb9-94fc-2502d6b28fab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70c55a4f-6782-4fb9-94fc-2502d6b28fab_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_70c55a4f-6782-4fb9-94fc-2502d6b28fab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70c55a4f-6782-4fb9-94fc-2502d6b28fab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_70c55a4f-6782-4fb9-94fc-2502d6b28fab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4bf0d3f7-bc7d-4a70-bf66-118c97e29812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4bf0d3f7-bc7d-4a70-bf66-118c97e29812" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7b100f95-0bf1-42d2-a99c-ef573b553f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7b100f95-0bf1-42d2-a99c-ef573b553f44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_06aaf190-0b99-449a-94a9-3f92bbcd8c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_06aaf190-0b99-449a-94a9-3f92bbcd8c89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f529c446-e50f-41e5-89df-963f09394557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f529c446-e50f-41e5-89df-963f09394557" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f529c446-e50f-41e5-89df-963f09394557_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f529c446-e50f-41e5-89df-963f09394557" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f529c446-e50f-41e5-89df-963f09394557_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd6a8ffc-85f4-466c-939e-94da9dc1c6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f529c446-e50f-41e5-89df-963f09394557" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd6a8ffc-85f4-466c-939e-94da9dc1c6ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_484daecf-6df0-4f2c-a6df-f06d23767dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd6a8ffc-85f4-466c-939e-94da9dc1c6ed" xlink:to="loc_us-gaap_InterestRateCapMember_484daecf-6df0-4f2c-a6df-f06d23767dce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" xlink:type="extended" id="i60fc281c89f44e73beb32b0be74890b6_FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails"/>
  <link:roleRef roleURI="http://www.davita.com/role/Segmentreporting" xlink:type="simple" xlink:href="dva-20210331.xsd#Segmentreporting"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Segmentreporting" xlink:type="extended" id="i55612e26ca5b431dbd6962d843b4ec5a_Segmentreporting"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingTables" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingTables"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingTables" xlink:type="extended" id="ia5fc44e410d94507ba71c77950bc615a_SegmentreportingTables"/>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="extended" id="i9649acc4c4284b89a430b48e0797725d_SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1f11ec60-e14c-404b-ad60-6e902780aac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1f11ec60-e14c-404b-ad60-6e902780aac1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_bd9d7202-96dd-4af5-bce4-bcc7453210c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_OtherIncome_bd9d7202-96dd-4af5-bce4-bcc7453210c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_977f2b24-b901-414b-93d8-1f8f501abc23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_Revenues_977f2b24-b901-414b-93d8-1f8f501abc23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_10b8e704-4233-478d-ab4d-d1c0f14bd299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_OperatingIncomeLoss_10b8e704-4233-478d-ab4d-d1c0f14bd299" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_5b0ac158-9dcd-46c8-b0e8-235516610eb3" xlink:href="dva-20210331.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_5b0ac158-9dcd-46c8-b0e8-235516610eb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_c74ee616-07e8-4457-8518-66e7c6726ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_InterestAndDebtExpense_c74ee616-07e8-4457-8518-66e7c6726ce7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_77fe2cef-ddc3-4d9d-bacb-3a9ece003f6e" xlink:href="dva-20210331.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_77fe2cef-ddc3-4d9d-bacb-3a9ece003f6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_cbe26d23-f314-4d10-81f5-f3ba47754f30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_cbe26d23-f314-4d10-81f5-f3ba47754f30" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1ae3f8e0-63a0-45dd-a768-f6fe0ff61ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1ae3f8e0-63a0-45dd-a768-f6fe0ff61ec4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0266ea9e-ebbf-4e23-99d3-a9de9795e351" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:to="loc_srt_ConsolidationItemsAxis_0266ea9e-ebbf-4e23-99d3-a9de9795e351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0266ea9e-ebbf-4e23-99d3-a9de9795e351_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0266ea9e-ebbf-4e23-99d3-a9de9795e351" xlink:to="loc_srt_ConsolidationItemsDomain_0266ea9e-ebbf-4e23-99d3-a9de9795e351_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3dd48e10-25c8-4aff-8758-5241d5eb387e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0266ea9e-ebbf-4e23-99d3-a9de9795e351" xlink:to="loc_srt_ConsolidationItemsDomain_3dd48e10-25c8-4aff-8758-5241d5eb387e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_bfb05548-233d-4ab9-bead-39b520e585c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3dd48e10-25c8-4aff-8758-5241d5eb387e" xlink:to="loc_us-gaap_OperatingSegmentsMember_bfb05548-233d-4ab9-bead-39b520e585c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_a51e637e-de80-4e97-bde8-50a057122743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3dd48e10-25c8-4aff-8758-5241d5eb387e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_a51e637e-de80-4e97-bde8-50a057122743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_baf29343-aa9f-475d-9a2f-100eac44b762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_baf29343-aa9f-475d-9a2f-100eac44b762" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_baf29343-aa9f-475d-9a2f-100eac44b762_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_baf29343-aa9f-475d-9a2f-100eac44b762" xlink:to="loc_us-gaap_SegmentDomain_baf29343-aa9f-475d-9a2f-100eac44b762_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_90656486-3c62-45c3-ad89-a6eefabda2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_baf29343-aa9f-475d-9a2f-100eac44b762" xlink:to="loc_us-gaap_SegmentDomain_90656486-3c62-45c3-ad89-a6eefabda2fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_9cf96748-778d-4b57-8dc1-3fc212e32275" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_90656486-3c62-45c3-ad89-a6eefabda2fd" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_9cf96748-778d-4b57-8dc1-3fc212e32275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_8fe248e2-8ca7-4d03-b789-dd87ca4011d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_90656486-3c62-45c3-ad89-a6eefabda2fd" xlink:to="loc_us-gaap_AllOtherSegmentsMember_8fe248e2-8ca7-4d03-b789-dd87ca4011d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_87d50cee-f849-4135-928a-bcf8c89909af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_87d50cee-f849-4135-928a-bcf8c89909af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_87d50cee-f849-4135-928a-bcf8c89909af_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_87d50cee-f849-4135-928a-bcf8c89909af" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_87d50cee-f849-4135-928a-bcf8c89909af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ca0e585f-b965-43a0-a354-af8d8456c958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_87d50cee-f849-4135-928a-bcf8c89909af" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ca0e585f-b965-43a0-a354-af8d8456c958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_4086372f-c2c5-4030-9f39-2ec1f76b38d9" xlink:href="dva-20210331.xsd#dva_ExternalSourcesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ca0e585f-b965-43a0-a354-af8d8456c958" xlink:to="loc_dva_ExternalSourcesMember_4086372f-c2c5-4030-9f39-2ec1f76b38d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_00da7440-701a-4fe6-ac94-eccf46938376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ca0e585f-b965-43a0-a354-af8d8456c958" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_00da7440-701a-4fe6-ac94-eccf46938376" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="extended" id="i3a54fab7958746c9959253ad4e28d239_SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_db251df8-b89b-49d1-92a7-8ea16f894dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_7f81ecc5-e1d6-4eef-b217-c340736154f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_db251df8-b89b-49d1-92a7-8ea16f894dbb" xlink:to="loc_us-gaap_DepreciationAndAmortization_7f81ecc5-e1d6-4eef-b217-c340736154f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_46b4118f-30e2-4752-8ff8-991c27460d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_db251df8-b89b-49d1-92a7-8ea16f894dbb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_46b4118f-30e2-4752-8ff8-991c27460d95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5d73be01-1525-424c-b0e5-42e213222e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_46b4118f-30e2-4752-8ff8-991c27460d95" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5d73be01-1525-424c-b0e5-42e213222e8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d73be01-1525-424c-b0e5-42e213222e8f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5d73be01-1525-424c-b0e5-42e213222e8f" xlink:to="loc_us-gaap_SegmentDomain_5d73be01-1525-424c-b0e5-42e213222e8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9f76264d-3c19-4b72-8777-edae15497f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5d73be01-1525-424c-b0e5-42e213222e8f" xlink:to="loc_us-gaap_SegmentDomain_9f76264d-3c19-4b72-8777-edae15497f07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_ef164fca-e592-4a32-bfcf-91fcfb018275" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9f76264d-3c19-4b72-8777-edae15497f07" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_ef164fca-e592-4a32-bfcf-91fcfb018275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_9c56c659-40a2-4e12-be1a-28dd505d988c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9f76264d-3c19-4b72-8777-edae15497f07" xlink:to="loc_us-gaap_AllOtherSegmentsMember_9c56c659-40a2-4e12-be1a-28dd505d988c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofAssetsbySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="extended" id="ifd7f27cb379a4e19a7ee4659a6ee3ff0_SegmentreportingSummaryofAssetsbySegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3b4342d3-9c70-4787-97ed-2972919de5d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c7668842-5d97-42a9-bd81-9b6e4f38958a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3b4342d3-9c70-4787-97ed-2972919de5d6" xlink:to="loc_us-gaap_AssetsAbstract_c7668842-5d97-42a9-bd81-9b6e4f38958a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_faf5df2c-10c0-4286-a05e-51fee9d7a54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_c7668842-5d97-42a9-bd81-9b6e4f38958a" xlink:to="loc_us-gaap_Assets_faf5df2c-10c0-4286-a05e-51fee9d7a54a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8547882-fb89-4436-bd3a-1a316eb2a0f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3b4342d3-9c70-4787-97ed-2972919de5d6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8547882-fb89-4436-bd3a-1a316eb2a0f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cae7fb3b-0608-42a7-ae8e-42eab2df1afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8547882-fb89-4436-bd3a-1a316eb2a0f2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cae7fb3b-0608-42a7-ae8e-42eab2df1afd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cae7fb3b-0608-42a7-ae8e-42eab2df1afd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cae7fb3b-0608-42a7-ae8e-42eab2df1afd" xlink:to="loc_us-gaap_SegmentDomain_cae7fb3b-0608-42a7-ae8e-42eab2df1afd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bcb23e9e-aca5-4178-ba3a-f3e6d97ecdcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cae7fb3b-0608-42a7-ae8e-42eab2df1afd" xlink:to="loc_us-gaap_SegmentDomain_bcb23e9e-aca5-4178-ba3a-f3e6d97ecdcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_bd03ed12-23ff-4b67-967d-2080037222d3" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bcb23e9e-aca5-4178-ba3a-f3e6d97ecdcb" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_bd03ed12-23ff-4b67-967d-2080037222d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_9c771c23-0859-4ffa-9276-5a7aa8d337b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bcb23e9e-aca5-4178-ba3a-f3e6d97ecdcb" xlink:to="loc_us-gaap_AllOtherSegmentsMember_9c771c23-0859-4ffa-9276-5a7aa8d337b7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="extended" id="ib0c0a3c06edb4997936a317e259eb04e_SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3b8187a5-7ca7-4aac-a3fb-2275f137af8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_467d187d-68fa-4c84-bb20-3f196dceff3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3b8187a5-7ca7-4aac-a3fb-2275f137af8d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_467d187d-68fa-4c84-bb20-3f196dceff3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31a54169-4433-4368-8334-ae3dfca3949c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3b8187a5-7ca7-4aac-a3fb-2275f137af8d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31a54169-4433-4368-8334-ae3dfca3949c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_26daa969-d76c-4ebb-8ec2-339109900664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31a54169-4433-4368-8334-ae3dfca3949c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_26daa969-d76c-4ebb-8ec2-339109900664" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_26daa969-d76c-4ebb-8ec2-339109900664_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_26daa969-d76c-4ebb-8ec2-339109900664" xlink:to="loc_us-gaap_SegmentDomain_26daa969-d76c-4ebb-8ec2-339109900664_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_83c0686e-d07e-4da2-a7c0-29a90303b447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_26daa969-d76c-4ebb-8ec2-339109900664" xlink:to="loc_us-gaap_SegmentDomain_83c0686e-d07e-4da2-a7c0-29a90303b447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_7f0ab9c1-ebf9-4014-800b-b9200e10624f" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_83c0686e-d07e-4da2-a7c0-29a90303b447" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_7f0ab9c1-ebf9-4014-800b-b9200e10624f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_e4d69449-c5c1-4d22-9b89-5169af9b3166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_83c0686e-d07e-4da2-a7c0-29a90303b447" xlink:to="loc_us-gaap_AllOtherSegmentsMember_e4d69449-c5c1-4d22-9b89-5169af9b3166" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/Newaccountingstandards" xlink:type="simple" xlink:href="dva-20210331.xsd#Newaccountingstandards"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/Newaccountingstandards" xlink:type="extended" id="i17da090db411438c81cc317edc6c5f96_Newaccountingstandards"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>dva-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0eedf026-4cb7-43f6-a1e9-99f3721c46b9,g:375f77ab-f095-4ce1-bcc5-25c9315fbffb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eac83c51-9ea4-4c7f-b5a6-d5a1b8efa601_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7734f985-3ea0-4630-b712-612837b4b62b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_3f35495f-6444-4b58-b484-8c8fda9038b4_terseLabel_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Portion Previously Refunded</link:label>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_label_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Portion Previously Refunded [Member]</link:label>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_documentation_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Previously Refunded [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:href="dva-20210331.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:to="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_de58c5c6-fab5-487f-bbea-5112c715d341_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4972e83c-374a-42eb-977b-1463b8cd27fd_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_e8a22d45-e455-44e0-90ef-15b56866289b_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_label_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpense" xlink:to="lab_us-gaap_InterestAndDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_5aa9e67a-f6ad-44b9-83f8-407d40244a55_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_417656fd-ea2d-44ca-8f6d-09eb2d0de340_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_547da08a-1635-4f31-8b5d-79e990786405_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ec1e6303-1b00-4cec-8748-99dce48fe1b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_d47655ec-de26-481e-ace4-0551fcb0a355_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_9c36eaa3-a9fe-4a5b-84b4-b4db7e497582_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_f88b131d-2b10-4664-9b76-8be0189a099a_terseLabel_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_label_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_documentation_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:href="dva-20210331.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:to="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_c40b7814-3da2-4b43-9184-e3742e073dc0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne_c58aa0d2-7c92-450f-be89-ec456dfa919d_terseLabel_en-US" xlink:label="lab_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Previously Disclosed Lawsuits Consolidated Into One</link:label>
    <link:label id="lab_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne_label_en-US" xlink:label="lab_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Lawsuits Consolidated Into One</link:label>
    <link:label id="lab_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne_documentation_en-US" xlink:label="lab_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Lawsuits Consolidated Into One.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne" xlink:href="dva-20210331.xsd#dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne" xlink:to="lab_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_7512430d-952a-491e-bdb0-b3615db4e7c6_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_051b98bc-41af-47d9-9417-5c41ec8f74df_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_4e795bd5-3116-4c04-9023-833168f19d1d_negatedLabel_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt refinancing charges</link:label>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_da7bface-99d5-40ed-a73c-5f19d21a690e_negatedTerseLabel_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt refinancing charges</link:label>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_label_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Prepayment Refinancing Redemption Charges</link:label>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_documentation_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment, refinancing and redemption charges related to long-term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:href="dva-20210331.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:to="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cde25ba3-9e47-4f4d-a3a3-997eeac16124_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e39864cd-9ff7-43b4-8608-994656a2cf78_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b8f48af0-f338-4c1d-81b3-9ab0a87405f7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_19d46601-12a3-4f7c-ac3e-5f90df8f694d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_06dda382-67dd-48d9-b814-fa7674c73425_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_3cb9ef17-fab7-43f3-82a3-65cafaf4e65c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_a4935736-d34f-4aa6-b79b-79938d14f7e4_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c0f51194-efb8-41b9-b28f-f9993cbe6d56_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6f327580-eb9b-4451-aad0-f0c34146417f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_5be76b64-c9e5-4e76-9516-7423abb46ceb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_18fc90b3-0f52-4308-8a9b-63c9db7ddf54_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_36c3b291-0451-454f-96e4-918103548eb2_terseLabel_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in mutual funds and common stock</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_label_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_documentation_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember" xlink:href="dva-20210331.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MutualFundsAndCommonStockMember" xlink:to="lab_dva_MutualFundsAndCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_69d51689-ec7c-4871-8409-f769eb9421f7_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdb29853-b3fc-4e90-9134-31d2532301bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OpenMarketPurchasesMember_8d9b9d2b-44d2-4f44-9ecc-7c343ff25fab_terseLabel_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases</link:label>
    <link:label id="lab_dva_OpenMarketPurchasesMember_label_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases [Member]</link:label>
    <link:label id="lab_dva_OpenMarketPurchasesMember_documentation_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember" xlink:href="dva-20210331.xsd#dva_OpenMarketPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OpenMarketPurchasesMember" xlink:to="lab_dva_OpenMarketPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncrementalCashPortionMember_b281908f-2f0c-48e2-a530-534bf7de4b74_terseLabel_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion</link:label>
    <link:label id="lab_dva_IncrementalCashPortionMember_label_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion [Member]</link:label>
    <link:label id="lab_dva_IncrementalCashPortionMember_documentation_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember" xlink:href="dva-20210331.xsd#dva_IncrementalCashPortionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncrementalCashPortionMember" xlink:to="lab_dva_IncrementalCashPortionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_26d2169e-4e1f-4739-b663-ea4880067264_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_4a0ea2c0-ade5-4260-bd0d-0e1a31ff38e6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_efc979a3-9bea-440f-bc05-2d965e6fde8f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_7181d443-9a16-4fba-b798-728019d4db1d_negatedTerseLabel_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_label_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment For Contingent Earn Out Obligations</link:label>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_documentation_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment For Contingent Earn-out Obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:href="dva-20210331.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:to="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_fc8b4155-1e4b-467b-a63b-eeed7b7704d3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b3c09efd-f7a3-4b4b-a82c-45d2ff2ffc13_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_f370ba23-8849-42b1-8c8c-83c1c525f8c0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_5c4ec0f5-3e2e-41cc-b39f-bf2fc65437a6_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3be43aa7-5fe5-406b-9645-a051b6b90db0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_36576fdd-0401-4c70-9d09-393d5692ad49_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerators:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_820048b0-6ff3-43a7-a55e-01894714ba52_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_6dab3bd2-7c6a-4445-9b35-4f117c24f774_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_d85ee5b5-45df-427e-bf1d-1c4c5d13e96b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_da832a89-849e-4c9b-ae68-7eb8129fc84f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebt_e8879b0c-17ad-4abf-bdaf-ebd62b25495b_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_label_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebt" xlink:to="lab_us-gaap_SecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_82a3cb20-42b7-4276-a44a-2a8e962b7020_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_a39b722c-7a47-43de-8380-0af509e26838_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_3b9ca2bc-52fb-4aeb-8e59-2403602065c7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_28a148e7-41c0-4869-be42-2967e0baf4d7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_08d8eb22-994e-4453-83b2-37dc9e95f480_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_692303d6-1ea2-421a-bb20-3f266b958b6b_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_99242888-e69d-460a-bc57-cc79aafebaf7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_911ddaf8-08f5-4c80-b6f1-695874713583_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d02b43a0-9913-4687-a3d3-c6456d559848_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2c7fce13-4088-4fdd-a368-96095bed8b4e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_c4429d21-8fd0-4667-bd8f-94e16b3cf9a2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_21919414-1910-4429-8225-3e32d4eddcfb_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_136ea293-cf23-4a66-a030-cc8996230542_verboseLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out obligations and liabilities assumed associated with acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:href="dva-20210331.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_28041aee-1f57-4557-97b3-67efe52d6d97_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_5a29e83f-e407-4f8d-b744-62a518ed8300_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_89a0c6dc-f706-498f-9fc1-67ea8658a518_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income from discontinued operations per share</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_2b5d8f86-ac94-4e29-a938-a0137fa75861_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_e5306625-d73a-4e24-bf05-5f7cfa382a49_terseLabel_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate grant-date fair value</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_label_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sharebased Compensation Arrangement By Sharebased Payment Award Grant Date Fair Value Of Options Granted</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_documentation_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, grant date fair value of options granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:href="dva-20210331.xsd#dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:to="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2dd64ff7-0024-4057-ab7f-603372ccddfd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_bd12a0e5-e99f-4c89-bfe3-6ae2c771df85_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_a91d71c8-804b-4050-baf6-598a41d98f61_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_022457f5-4c51-4df2-951e-6dfd0abb41ed_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6f640107-bbe3-4b9f-9d87-82509faf3a27_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_60846da4-a979-498c-b7b0-17ff7c6db96d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_5b77ed1f-7e7d-4283-913c-3767d3018712_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_986bfbfd-c9c6-40c1-9a87-1295f2c46e9e_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_f1f4440c-17d4-47f5-8268-dd8f3df73df3_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bcf52365-1dac-4d14-8e42-5451f650c6ad_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_3f99d699-5c75-415e-bda0-3c33e221094e_terseLabel_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_label_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage [Member]</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_documentation_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember" xlink:href="dva-20210331.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicareandMedicareAdvantageMember" xlink:to="lab_dva_MedicareandMedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_8aba2baa-9434-4744-9abb-fdf3e78e52b2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_3a6622e9-6a09-4830-9cf9-8d2af574acd0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_f34ef76b-d395-47ac-9819-1fe59df330ae_terseLabel_en-US" xlink:label="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Remaining Prior Share Repurchases Authorized, Amount</link:label>
    <link:label id="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_label_en-US" xlink:label="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Remaining Prior Share Repurchases Authorized, Amount</link:label>
    <link:label id="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_documentation_en-US" xlink:label="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Remaining Prior Share Repurchases Authorized, Amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:href="dva-20210331.xsd#dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:to="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_44f310d8-9462-4e03-8d5b-4b596780ae41_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of other debt and equity investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Available-for-sale Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b4ff4096-d35a-4a7c-bf52-48b56d8daf5d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_3a583cfa-4f4b-4c22-b814-bc6ed56bbddb_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_label_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Increase From Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest increase from contributions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:href="dva-20210331.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:to="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_6e72c787-4c97-4268-a2e8-f5d9c1937655_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ab2f3004-c878-4c18-9ffa-b63838073419_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_0edcd133-0ea7-420d-8ff2-39e09aa6b3d5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, weighted average interest rate, at point in time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_e321d887-e6ad-477a-87ec-85325b48ec82_verboseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average effective interest rate at quarter end</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_0eb3fbb3-a8e6-4274-b3e1-7004cd9be6bb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_fc97b9e0-0ecc-406e-91c8-5da910f6e757_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BilateralSecuredLetterOfCreditFacilityMember_9c20c102-dd81-4e15-984f-0c9aa54b39a4_terseLabel_en-US" xlink:label="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bilateral Secured Letter Of Credit Facility</link:label>
    <link:label id="lab_dva_BilateralSecuredLetterOfCreditFacilityMember_label_en-US" xlink:label="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bilateral Secured Letter Of Credit Facility [Member]</link:label>
    <link:label id="lab_dva_BilateralSecuredLetterOfCreditFacilityMember_documentation_en-US" xlink:label="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bilateral Secured Letter Of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:href="dva-20210331.xsd#dva_BilateralSecuredLetterOfCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:to="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_0053f75d-bddc-44d7-8dd7-7a287e8c31b2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_27306cd2-9ecd-4554-94dc-ed580e0b9239_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_f8e6adfb-7fec-4f0f-b466-c3836aa31251_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TextBlockAbstract_1ea18970-3535-4f78-a33b-4711f52e56fa_terseLabel_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:label id="lab_us-gaap_TextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanB1Member_ddfafcf0-fbac-4389-9c2a-b16bff6c30ec_terseLabel_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1</link:label>
    <link:label id="lab_dva_TermLoanB1Member_label_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1 [Member]</link:label>
    <link:label id="lab_dva_TermLoanB1Member_documentation_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member" xlink:href="dva-20210331.xsd#dva_TermLoanB1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanB1Member" xlink:to="lab_dva_TermLoanB1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_3d335ef0-f0b6-4f9b-a9d4-a3b6845ba78b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_7de94ea2-1084-4cf3-9953-8ae1c70e46ef_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and Long-term Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherCompaniesMember_8b6501d0-bfad-4594-b926-b9ad813702c0_terseLabel_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_label_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Companies [Member]</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_documentation_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember" xlink:href="dva-20210331.xsd#dva_OtherCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherCompaniesMember" xlink:to="lab_dva_OtherCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e7214d3d-2eef-4c6b-a979-37afd353ed11_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ed816683-4674-4ae0-9b44-3d43abdc2f67_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cc5a54e-df9d-4ff4-9b9d-d0fd8cb49406_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_0a98307c-dca4-423d-b7f3-fdcf6dc72906_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Held-to-maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_d0961960-c0ad-438d-ab2b-6c0370b2efec_terseLabel_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_label_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:to="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_41017c5d-e44a-490f-814f-a380eb89e7a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_344e4d32-8e94-4b06-8176-6c49ffaaec55_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_33a6dc74-2a4b-4ff8-a55c-24ad6351281f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f79f9112-8e42-4013-93c2-f0dfa660e7c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4a5b6392-f884-40b2-9f1e-309ed073fa07_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for earnings per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_8f603e36-48f7-4962-bfd3-744a56ac0e7a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions and other commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_eb4800e0-8732-406b-ba2a-508383b21253_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_5b867bbe-02a1-4205-b8ba-fde7a3355b09_terseLabel_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation</link:label>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_label_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation [Member]</link:label>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_documentation_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:href="dva-20210331.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:to="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_b08a9764-a985-43f9-b2fc-e21a58bafd47_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_97f8a66c-a2c1-43fb-a998-9b524c35bc41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_c9571cea-8e89-42e7-b635-ec3cab95ef28_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_33170463-2bfb-420a-8463-01e23906f056_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_1335d9bb-8093-4098-8d2a-a8062564ffba_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_52773709-e760-49fd-9d6a-dbb3ed762c04_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_65a13dfe-ccea-4efa-941f-e5c9dc2c394b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_46aa2862-2395-4c8c-acb8-73ff67eda361_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4f6fca2f-ea97-449e-962a-1cb495db3b50_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_6d0843dc-3563-479c-9fb8-97bb6c9d447c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtExpenseMember_b1fc263e-1668-467b-9ec5-5f9192f82518_terseLabel_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Expense</link:label>
    <link:label id="lab_dva_DebtExpenseMember_label_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Expense [Member]</link:label>
    <link:label id="lab_dva_DebtExpenseMember_documentation_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember" xlink:href="dva-20210331.xsd#dva_DebtExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtExpenseMember" xlink:to="lab_dva_DebtExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_214eb577-fa46-4fa0-ac1a-dc493852dfe2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_3d696aac-a415-4f29-bdbc-762a6ddf0ac0_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_901b5d46-0d51-4320-b260-ef9c1d512dc3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_bdf5ed2b-afe2-4f91-9172-83e45f63f735_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_2a5cfe72-7947-4ea2-bbfc-3ecdf2b7bbcb_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_d63ba226-d955-495c-ba17-7773cbe4c7de_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, effective date</link:label>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_label_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Inception Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInceptionDates" xlink:to="lab_us-gaap_DerivativeInceptionDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_bb86814c-33a1-4738-bd82-e12a163ff33a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on interest rate cap agreements:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_a544ad99-2725-44c4-9c41-deeb04a35a25_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_5183e306-3ec9-4c9e-8c18-d9584fe6b1a1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_33fd89e2-1bdf-48c7-abcf-51bff24f5fbb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_a9203056-b876-4b8c-a8ce-022ef9c68c62_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ca1d0ae4-455c-41b8-9577-6ffda1281897_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_238bf6b6-df99-4d5c-94f2-4845c32bcbb7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_8c11cf20-e02c-4d70-ad45-f2a3cfca7064_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies:</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_81c7467d-e99f-481f-84a2-e158cde3d673_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of long-term debt, net of unamortized discounts</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_78a1d79d-d7ea-462b-a841-4c9d8cee65c2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7c63b97f-38dc-4ded-ad1c-b2496158cfcd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_f34cccf3-00a9-4de8-876e-e632360b70b6_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_b82df6fe-b71a-43d7-9767-5cc5e8d60182_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_837e6868-5cd7-49fc-972f-8baf48816f29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_56b54386-9979-47c8-8a18-24ba14cab97d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from continuing operations attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c18d581d-b47b-404d-ab62-24e1fb8339b7_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_9ad2d64a-ea03-4d82-8780-4890f4b4a1a0_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_d0c34f7e-e9f0-483f-b323-452dc012543a_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ForeignDialysisCentersMember_3dfb450e-70c9-4819-842e-588dc4374fac_terseLabel_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Dialysis Centers</link:label>
    <link:label id="lab_dva_ForeignDialysisCentersMember_label_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Dialysis Centers [Member]</link:label>
    <link:label id="lab_dva_ForeignDialysisCentersMember_documentation_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign dialysis and other medical businesses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember" xlink:href="dva-20210331.xsd#dva_ForeignDialysisCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ForeignDialysisCentersMember" xlink:to="lab_dva_ForeignDialysisCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_445a1b9a-fee3-47e9-a78a-a48e9e00d1f4_terseLabel_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_label_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_documentation_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:href="dva-20210331.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:to="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8638f222-f7c4-4126-9b23-16393ed8b60d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_e723807c-7694-490c-9b60-74301a1b666c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_b065136f-72bc-4d1f-84ca-79c68d9528ba_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ExternalSourcesMember_15967294-94dc-4b4f-9dee-f69709dd3516_terseLabel_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_label_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources [Member]</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_documentation_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External sources.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember" xlink:href="dva-20210331.xsd#dva_ExternalSourcesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ExternalSourcesMember" xlink:to="lab_dva_ExternalSourcesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0c1a1722-c29c-498b-ab48-af5ca511ed5d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_4da3eb76-27bd-4716-8baa-dc301f174f44_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_6020e4ad-1180-4086-834c-bde7ab9a349d_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Depreciation and Amortization Expense by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_479da438-69d9-4889-ad1d-92b8ddfea095_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_b83a1477-d975-49c3-8603-b0be73390e82_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_35644aa2-83c3-4ed5-9201-754c71840bb2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_33375c0d-56a0-4b6d-8a7e-fadd61e8ac50_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_41f6715a-c8b8-4151-a0f9-0403f52ef4ea_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_b62a3f98-dcc3-4a60-aca4-899e3b5fe466_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:href="dva-20210331.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_b6d5df0b-53db-4fe2-892d-47ee9dfdaab4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_402e9c48-56d9-4f80-bbcd-a2b9c1e0e9e4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_da730908-c1b2-4d25-ae96-814b4540f99b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_0722f81f-33cb-447d-b816-9a534c55e7a4_verboseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#8212;Ancillary services</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_f9994670-fd11-48b4-9160-e9f2915110a7_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#8212;Ancillary services</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_7d8dd734-f35d-49ae-ac72-f6c3b366bef5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (payments) receipts related to stock purchases and awards</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_65ad941d-423c-42a8-9712-4aaa9a2e81e4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies:</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_38960ab5-35ba-4cab-8f89-d82eceafc801_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted prices in active&#160;markets&#160;for identical assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_b018eba4-912e-4340-a652-f726806e022f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_e956d49d-25e3-415d-9b19-39f0e788462d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_1ca212fc-4ae5-48f0-9cb4-3e4e5fc2f8f8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_75c509a3-0373-43cc-8714-0e3aa67517f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_9ab2d406-7fb4-4dd8-84d5-2175f186c100_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_34be3ba6-1b9d-4bfd-bdf2-ba35c56afda6_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_e0be9b30-c7ba-446d-9eda-a65a763ef36b_terseLabel_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Expenditures for Property and Equipment by Reportable Segment</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_label_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_documentation_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of capital expenditures for property and equipment from segment to consolidated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:href="dva-20210331.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:to="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_5f46d8ab-2d0b-4763-ad32-058afe8a9580_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_366306a7-1bae-4b73-a099-c9809b92e435_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_19213326-90f8-402e-b43e-4eb2bddea7c1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_de41ae38-7187-4c70-81b1-aad3bfce70b0_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_4b0a11a7-6087-4d63-9a36-912fe67859c6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_205974c2-b1ef-4f15-8ec5-25787d578284_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of net realized losses into net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ff3f35-ca72-4a65-a552-0c5b115b4623_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_63bd76c5-0583-4172-9608-7aec73eef709_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_1f56954e-f540-46ff-b7a9-e54c67b0762c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_955c7456-249b-40cd-a158-0c7d1b02d35e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from asset and business sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_683b3ca0-a4f9-4e27-a396-7e6a5457a02c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_73bae0d9-dbb9-429a-9a77-3efb239c406d_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_0705e523-6ce0-44ec-892d-b74a6debe6cb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_399e8720-dbdc-4f7c-8f3f-43d036cfca66_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b739103e-6d6a-44cc-a637-07951507ca12_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0ef26e02-0821-461a-8d9e-877f919b914f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_a79e5ff4-4bd6-4b01-9ebc-12f667db0a41_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving line of credit</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_0d28a6ac-64a5-48e5-89e2-145ab8f19713_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4d3304ad-45f7-4448-b939-ac1b7af6d2a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_b58ed956-d62d-451a-9a0e-92b731bfe7cf_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_c8423619-9907-4bd6-b457-8b76f3ed2014_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_848bef9f-11d5-4ade-b9f1-f11f8d4a4f19_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_6bb04937-6d20-4aa5-8323-488dc1517e0d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_97825887-8ffb-4542-93ee-b529fa153d03_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_64333be8-b897-4c6c-b4ce-f5c92b6a52ae_terseLabel_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out consideration payment period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_label_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration Revenue Earnout Period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_documentation_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition contingent consideration revenue earn-out period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:href="dva-20210331.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:to="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_a634fbb8-3a32-4c55-a93d-19db5a3e06ec_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_cf0a2090-2f37-4865-be09-97adc20c7836_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e285a2f9-a731-448d-b694-222f600c677b_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed incremental from stock plans</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_81bf07bb-a806-4962-8ff8-2b0aed3b959e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c9981905-7be0-4879-bd3e-a9fed35fccf4_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_c07f8cf9-16a5-4d7b-b5c4-63ab6a695d6b_terseLabel_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_label_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sources of Revenue [Member]</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_documentation_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember" xlink:href="dva-20210331.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherSourcesofRevenueMember" xlink:to="lab_dva_OtherSourcesofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_04f43297-511c-45d4-8196-37afb1c5e1b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred purchase price obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0d887ed5-cba8-4818-a01f-49451d434b4f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_70af4f4a-d987-4ca9-8b63-f0aa6f170287_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2ccea416-cfd3-4941-a350-2e920eb8c58e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CorporateIntegrityAgreementPeriod_403e3046-0c1b-4203-bc21-a17e91c1f392_terseLabel_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Period</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementPeriod_label_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Period</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementPeriod_documentation_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Period, in PnYnMnDn format.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementPeriod" xlink:href="dva-20210331.xsd#dva_CorporateIntegrityAgreementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CorporateIntegrityAgreementPeriod" xlink:to="lab_dva_CorporateIntegrityAgreementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e7d9ef3e-8855-4414-82b2-7f0a3c4e9689_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1d9d9c5-64f5-468e-8e3d-a3cd855466ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_027fad80-f5b7-459d-8ef4-02a6a8bd1fd2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_ad2ac226-70d3-4aa2-be1c-5434bc6afd8a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_8aa0ae63-2b6a-4aa3-95a5-c16dfc04b051_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes associated with acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8e01c859-23fe-424b-b5e5-7a2b4a99e8d8_verboseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_e7ad6041-0350-4364-bc14-fa2eb6d4097b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_47494b25-30c1-4e25-af7e-1c08d9fa3c31_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_ce77ff2b-e0b6-4c85-86ab-800215b61a0b_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_7629346e-d05a-49f5-aaa7-40daa8727a65_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, before accumulated impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_52b2d135-b088-45d6-baf1-acc9326dcce9_terseLabel_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_label_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_documentation_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential increase decrease In fair value of Noncontrolling interests related to contractual Put obligations due to the change In Weighted Average EBITDA multiple.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:href="dva-20210331.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:to="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_733616e6-1ec7-435b-9c1b-d72b60675777_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_00819d0f-0215-4a4e-9102-83276b25b9b8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_a96f4691-5770-45c0-90db-831dd6a85836_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_85dec141-75c5-47b9-aee8-dd9fd1361d4c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_db0b4cbd-0f14-4e23-9864-8f8f072378b5_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenditures for property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_3a70d540-37dc-4b4c-9de1-9828c8d981b7_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_9486694f-7230-4a44-b244-c11f8155bc65_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4803515b-e14d-4c99-bdfc-3e624f744984_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_57199c20-3194-4df3-9bc4-37221204e978_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_d3fc3c6f-666f-4188-839e-9a55b7c9c019_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_5594339c-da97-4b3d-be01-2c2d7baa430d_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_b53d96f4-be83-4e98-a11e-c63242cd575d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2a084d5a-afac-4054-9d60-4f4bea6aac79_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_02eda64d-e876-4262-aa1d-d5d0714fcd6a_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_812c3a70-6d46-400a-adfa-945d78c81798_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_33f15a41-6576-4adb-b686-48cd448ec85a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_da1af07e-bb10-4cf1-b27a-3e6315641dec_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d39b03ae-654c-489a-9f67-563ad81b0b89_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_df1a5050-defc-436b-9b2b-102a0d08e5ba_totalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive income into net income net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockholderDerivativeLitigationMember_821b7cc4-ee39-4c5e-a741-f280faeaea31_terseLabel_en-US" xlink:label="lab_dva_StockholderDerivativeLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholder Derivative Litigation</link:label>
    <link:label id="lab_dva_StockholderDerivativeLitigationMember_label_en-US" xlink:label="lab_dva_StockholderDerivativeLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholder Derivative Litigation [Member]</link:label>
    <link:label id="lab_dva_StockholderDerivativeLitigationMember_documentation_en-US" xlink:label="lab_dva_StockholderDerivativeLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholder Derivative Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockholderDerivativeLitigationMember" xlink:href="dva-20210331.xsd#dva_StockholderDerivativeLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockholderDerivativeLitigationMember" xlink:to="lab_dva_StockholderDerivativeLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_621b77a6-9ee3-4854-9c0f-a34361c3daf3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_19e4348c-e78e-4801-bd15-25b61e3f8215_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_3220d2cb-d6f0-4857-8cc1-f994b84434c3_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_ce667699-78a6-48e4-888f-edcf595ecf72_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4ee4b780-ce31-41c5-877c-f831187e3665_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_358bf3c9-8317-460b-b95d-54b7188136c0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2703e54c-13ac-45f2-af99-7750f50e0fd6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_5fe2f0c6-5652-4180-9249-c3646d9a2483_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_3604bb00-fab6-445b-a905-219a14963cfe_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment, Owned, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_c0ac5902-fb7f-45dd-9fef-492c3e12bde0_terseLabel_en-US" xlink:label="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Offering Price Percentage Of Face Amount</link:label>
    <link:label id="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_label_en-US" xlink:label="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Offering Price Percentage Of Face Amount</link:label>
    <link:label id="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_documentation_en-US" xlink:label="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Offering Price as Percentage Of Face Amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:href="dva-20210331.xsd#dva_DebtInstrumentOfferingPricePercentageOfFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:to="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_6c80ae22-8267-44ae-8db4-bad460dcd528_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_514096dd-6544-4634-947a-1ff19f28d11d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (payments) receipts related to stock purchases and awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_385929fd-1402-4223-b207-d9b15b02666d_negatedTerseLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dva-20210331.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_c0179111-3dca-4cfb-a767-c9161b113f10_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_ccc0addb-667b-4836-807c-13d037148e1c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c2223d24-e200-4a8c-8f10-87457d972239_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract_8165462b-2dc9-48b3-ab3a-9f9721163a81_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivative Instruments [Abstract]</link:label>
    <link:label id="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivative Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfDerivativeInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:to="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_6fa56819-b7c8-4d32-b8a1-f8791cc523a3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_2e686546-4ad5-4583-bdf4-54d2d12d8a8d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_0af62cf7-3eeb-479e-b47d-fb5043cd52f8_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_b64537e7-dd30-4f9b-bc4d-899e365e5ad1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a4106df7-212f-48d0-a640-47b06ebfc01d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_7470d8b2-8d52-48cb-8b45-c6bccfce6bc2_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis and other businesses</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ec718825-0eee-4301-abd7-c7caeb9b0363_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_431ba16a-1628-43ca-972a-891a9b04b1aa_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from discontinued operations attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_7b325f32-3da5-4348-b8e1-6d366656e453_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_dd898abd-b359-4922-998a-60c813b61e04_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtRefinancingCharges_d64c3b55-23a0-4f6b-9766-ebfd01ce3896_terseLabel_en-US" xlink:label="lab_dva_DebtRefinancingCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt refinancing charges</link:label>
    <link:label id="lab_dva_DebtRefinancingCharges_label_en-US" xlink:label="lab_dva_DebtRefinancingCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Charges</link:label>
    <link:label id="lab_dva_DebtRefinancingCharges_documentation_en-US" xlink:label="lab_dva_DebtRefinancingCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt refinancing charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges" xlink:href="dva-20210331.xsd#dva_DebtRefinancingCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtRefinancingCharges" xlink:to="lab_dva_DebtRefinancingCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a17dcd56-c53e-4185-8a52-3ac1759cc935_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_459ccee7-89e7-47ce-acf5-5168c88fc1d1_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_d4bc9f44-1424-47e8-8f17-7160367c018f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_249c5064-e999-46b2-a731-e58544ed0d21_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_338186f1-cf30-4e0c-8538-9069544b888a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommercialPayorsMember_7fc8b439-e1b1-4088-841c-b9270b0955e8_terseLabel_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_label_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors [Member]</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_documentation_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember" xlink:href="dva-20210331.xsd#dva_CommercialPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommercialPayorsMember" xlink:to="lab_dva_CommercialPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_ce281f73-c5ae-4973-b1df-0c1447b36cf9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e0a711f0-5b62-4990-9431-dc758ddede87_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_84862ca0-18a3-463b-a91c-24f284eef4c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, maturity date, description</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_5940ae53-b357-4654-bd27-efac303f4096_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_5927a421-68f2-4adc-86dc-dc44cccfc9ec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_713f76dc-51cd-4ca9-901c-a060f13ae978_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_3bf55212-1ed3-4284-8ecb-2305308a153c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_ca45fa86-de2b-4e39-a93a-dc62be3a7419_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ae21fbde-dcc8-423c-a6cb-81bd0dc47506_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_df394d73-1524-4bc8-9751-08d5a3bfc07f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_d586cc37-e91e-4580-8f08-7e44a8ca001a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_02a4637a-d6cf-4bf4-ada4-b6341728b23d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_61997ce2-33ba-4324-9271-e66c88a0208c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_f4a014bb-c772-4818-8c0e-d80721790460_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_738ab69d-5d6a-4fed-bd1c-50e521fe03fa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument related fees, discounts, and other professional expenses</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_f2b41648-c9cc-4bd3-858b-58d3d2fc00ff_verboseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elimination of intersegment revenues</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_52407246-2938-473f-a5b0-dd1ea7fea584_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_48f4fa0e-dffe-44e4-a7d9-cbc1b2c95e41_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4181b80c-a4dd-453f-afe3-07ea26d2b2f4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_7ed855f9-74ba-43f8-ac31-5f9fe6833177_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding during period</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_55e3e608-8717-4711-86e7-5bb2e0db2e95_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_231563d6-fc55-4a90-993a-611fddf1e928_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_1c803952-492c-4f9d-8ce6-4d3f44412dfa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenuesbymajorpayorAbstract_7e0cfe05-e55b-486a-9fb5-59e0f448fef7_terseLabel_en-US" xlink:label="lab_dva_RevenuesbymajorpayorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by major payor [Abstract]</link:label>
    <link:label id="lab_dva_RevenuesbymajorpayorAbstract_label_en-US" xlink:label="lab_dva_RevenuesbymajorpayorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by major payor [Abstract]</link:label>
    <link:label id="lab_dva_RevenuesbymajorpayorAbstract_documentation_en-US" xlink:label="lab_dva_RevenuesbymajorpayorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by major payor [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenuesbymajorpayorAbstract" xlink:href="dva-20210331.xsd#dva_RevenuesbymajorpayorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenuesbymajorpayorAbstract" xlink:to="lab_dva_RevenuesbymajorpayorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3152007b-4985-47c4-949b-513dfa37cfcf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_946ddbbb-f284-490b-91ac-dc9e8544e3de_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_9fffbc63-59be-4bf4-b4ea-91348196431f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_e69cd5e3-f20f-4960-b0d7-b1700af4c7ab_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract" xlink:to="lab_us-gaap_TemporaryEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_f80ba5b2-27ad-4fce-bafa-3f609eba916c_terseLabel_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. dialysis</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_label_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Dialysis And Related Lab Services [Member]</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_documentation_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US dialysis &#8203;and &#8203;related &#8203;lab&#8203; services&#8203;.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:to="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e3215464-9b88-46e8-ba76-d531dc62e05e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_63c64eb1-86c6-4c8b-b38a-5f6b66edd309_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_415a8157-750c-408e-a6d1-826c5320fa73_terseLabel_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_label_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_documentation_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:href="dva-20210331.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:to="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_abcdf52e-abc3-4e8d-8443-9da7b5b38e51_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_8872aebf-3e85-4b38-8c9c-be6e2aa37451_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_5fcf0376-526c-4927-8142-2151462c0a70_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_4b8783dc-e23a-45b9-a428-fa49640bb92d_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of debt expense reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ee30c496-6e04-430f-9720-c6e66bc032b7_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_b6884c01-2c08-4688-9bcb-6598862f83d4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value, gross asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_7fb16895-f872-486b-8bfb-054033fe16b9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_50b89d04-65c0-49c3-bef2-00f7f23c6a7e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant other observable&#160;inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_9f9fce18-a111-4f9e-8771-2a98730b7165_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_2e540025-e655-43ca-a71c-a3738391d030_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_1d85faf7-9c6c-434b-8707-8af1aeeff116_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill by Reportable Segments [Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_42da13ee-4dcf-47af-91ae-260c65a83df1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems" xlink:to="lab_us-gaap_InvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_02290f76-75a3-4b87-a9e8-059e9cc7286e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_7113f201-4518-4861-81de-4de9d4fe9952_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_1c5b7f34-5048-4f40-8ed5-ecbee45a4c2d_terseLabel_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_label_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid [Member]</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_documentation_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember" xlink:href="dva-20210331.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicaidandManagedMedicaidMember" xlink:to="lab_dva_MedicaidandManagedMedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_90c614f0-1ad8-49f0-9f6d-4d08cb25684a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of interest rate agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_0d953ef1-72f6-4118-94e8-e84e1e9bf709_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) from discontinued operations per share</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_46367119-e9c1-408f-93d7-517e411be216_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_84e48d4b-e15c-4218-abf6-32ff7cff376a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_9fec10be-efcf-4bc9-b146-894182bf3e48_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_effef181-9e77-422c-a794-d72668dc8f26_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4b55ed70-7f1e-4260-94c6-89f7a9c34f71_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for diluted earnings per share calculation</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_0d6e9e82-f95c-4f3f-941e-fd3ce3e4500f_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_731b4e2c-eb18-45a0-92b5-a09b1daa07fa_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c6a3eb4d-3704-4cbc-9004-cc1ea7b40c5e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_370bb554-379a-4624-a790-c6b88eed6cb5_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_9b38a2db-bd41-4081-957c-b2b692f889fd_terseLabel_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_label_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors [Member]</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_documentation_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other government payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember" xlink:href="dva-20210331.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherGovernmentPayorsMember" xlink:to="lab_dva_OtherGovernmentPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_992c853e-245f-4131-a35e-813e9522a941_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d3b71381-57b3-4dc4-a45b-734350ba6f16_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_019cb641-109c-4b17-86ff-e0de1784df3d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0674d9bf-200e-4a69-b8d5-cd90c78ca879_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_bec1140d-4970-4848-9676-ad269fc90bac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_ced436fc-4e51-482b-8698-c63e3dfd1ad7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_f6424293-3eb1-427d-9a51-7e6dfd1d8cbe_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_4039e948-8dd4-4065-84c7-a34f363ec8b3_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, short-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_4f55fecd-123f-4bbd-9a26-87e828962ecc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_990858ea-aa2d-4688-b48c-df827ea1a9d4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional tax benefits recognized under the Coronavirus Aid, Relied, and Economic Security Act</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_a9ff21f5-7feb-4db0-bbeb-cc711bec3165_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsTable" xlink:to="lab_us-gaap_InvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9655f339-828a-4cac-93ac-2428c94b9164_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d214b0b4-90c8-4da9-87f6-963373e48f6b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d5adebd7-6396-450a-a9aa-42b95e21f27e_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient service revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_988ed7d3-9877-4d82-82af-ab548af204dd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_35de9d98-c740-4700-ad09-42cc8e2427c2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_fc105891-a7fc-4404-8791-43795fdd288b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e8873a1-7c51-4b6c-ac38-92bfaabdfd76_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4bcca5d6-27db-4466-b0e3-d290f709556c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_81ace4ea-0f38-4ab3-9c47-f17bf0989d8a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_b145daa0-e3ea-4cf9-a05a-83153a8436d9_terseLabel_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA or Operating Income Performance Targets or Quality Margins</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_label_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E B I T D A Operating Income Performance Targets Or Quality Margins [Member]</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_documentation_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA operating income performance targets or quality margins.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:href="dva-20210331.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:to="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_609c82eb-1649-4b09-986d-e7008a377125_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_fd7bb480-bd6d-46ee-b3e5-9032581a5a47_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average effective interest rate during quarter</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_f1d601d1-e92f-418a-b9d2-ae470c4c7c22_negatedTerseLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:href="dva-20210331.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_6ea05db8-87ad-41c1-bc75-0460b53837dc_terseLabel_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit and other time deposits</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates Of Deposit Commercial Paper And Money Market Funds [Member]</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit, commercial paper, and money market funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:href="dva-20210331.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:to="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_f3f8b2ec-6f11-4751-83f5-2887dd633231_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_ed7d7fda-748a-41b7-b8b8-af1c7412844f_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable, fair value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:href="dva-20210331.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5906c934-fe6c-4678-bcec-afbace9bb404_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5ed00401-6f6e-4968-9dcf-fa64765e320d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_02349c20-5ebc-46b5-bec4-5ddb3741b1fa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_448b8d69-5d83-4c1d-811d-1579ad424e1b_negatedLabel_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables and prepaid and other current assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_label_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Current Receivables And Other Current Assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_documentation_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in other current receivables and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:href="dva-20210331.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:to="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_945aad44-48f9-4eb6-a36b-08684aaf5dee_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_a482d0b0-7342-46ed-88d4-624f3ea95d0a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_52628053-5f8a-4662-a6a0-8a8827863c09_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, start balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3ae84197-418c-47a3-86c2-19a66bc7c4fa_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5f5451d9-8f1f-45fb-a998-0e17a67e3e9d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_41c39594-f31c-45c8-9f97-1f9d7bd81bb1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_a312956c-f204-43ac-96f9-b01d39e678d8_negatedTerseLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:href="dva-20210331.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:to="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_d4285d0e-e61e-4831-b904-97bbba0eeb11_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_b8dd7b0b-554b-47f7-82aa-6337606b09e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_71283221-556d-4e93-afdc-8945ffb35ba9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_8592e669-1278-4d3e-bc5e-d183c8c78ab2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fa0bedee-eda1-4ecd-9874-9b577a842dfb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total DaVita Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_10970675-f8f7-40ce-b1a1-a4d4667bc5b4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_c05c3b49-c452-4b20-a9d0-ccb8af3dd0cc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_47f066fc-f6ce-4670-bb1e-5d9dc77dbc85_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_56d5306a-3136-4c9c-a773-606936d5f956_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_850fdc30-7bab-41e8-80d8-ad606ae2f197_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_129fe5d2-8ddd-43cf-9a60-28df47cd5fee_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ed5350f4-1aaa-4fbe-9e13-2f6efa0f8b7c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_458828c4-e066-4a21-af0a-5ce53cb5a19f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, table footnotes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:to="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_100fead4-e108-443e-afbe-7d574e07253f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_04450eaf-598c-4d0b-9315-579c4500ce90_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8d8ac52c-aa2e-482f-9f32-b9c64b95506b_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and Performance stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_9217746e-c994-4780-abd7-24108acfc7ac_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aaccea4a-b209-470b-a8ad-e6dc18855a01_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_53d32a99-df2c-49af-ae5c-8bee07630f43_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_aa609c54-47ef-4276-9bc1-504dcb9233aa_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive stock-settled awards excluded from calculation</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_fb343dc5-e3da-4d34-9cd5-1f508cf0e056_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_43e82a68-7f7e-42aa-aea9-e51c9fe87a53_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash charges, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_6eda69e6-d49a-460a-b3ce-39553b2c1d0f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_3b80c6e7-34ba-4583-99da-74bc11a9358f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_fd6ece9f-488d-4a49-9fd1-d6e215e88907_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- controlling interests subject to put provisions</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_label_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Redeemable Noncontrolling Interests [Member]</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_documentation_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests Temporary Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:href="dva-20210331.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:to="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_c030fa66-633b-4f93-a461-3a65d81f7b24_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_4a3d5d23-bf93-45b2-b96b-b428cb10ad63_terseLabel_en-US" xlink:label="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Debt Principal Amount Due To New Agreement</link:label>
    <link:label id="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_label_en-US" xlink:label="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Debt Principal Amount Due To New Agreement</link:label>
    <link:label id="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_documentation_en-US" xlink:label="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Debt Principal Amount Due To New Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:href="dva-20210331.xsd#dva_AdditionalDebtPrincipalAmountDueToNewAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:to="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8d4bac9b-18cd-477f-af21-4d85578924ef_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_935f44ef-93ae-42f3-a395-38b9c5abebe8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_74c96fa4-a2ae-44f1-b831-c72dddd583a5_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_70a35b21-f050-41af-8904-419e2b62dfaa_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term incentive compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_971bd787-5ad5-4a28-8e36-74354118ef68_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89dd2ff6-2740-405d-ab0d-768abac6dce9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_be2a8e22-bcfe-4be6-ae11-ab24eb7252dc_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_ddd54c68-720b-4585-8ece-6102e077cfa6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_78571736-0b6b-4a6c-bd28-058e94b67f7e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_971c9af4-91f0-421b-a8e7-b289e1e6e4d8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d082e6e6-6b27-40f4-acb7-a13f9b27ac62_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_9bc96671-824a-4b91-a888-f3d60727c266_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ab25eb51-1d22-4987-825c-f4bfd7cd9484_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_75610236-2c84-4a52-ba86-ff518fccdff2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f6041afd-87ad-453d-8b9a-0efaca543d18_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_635e3a18-463f-4733-8a92-34fcc9fa061d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_1d6b1bb0-da88-4ff4-8fd7-aa9cbd3d78d7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_43765633-eed7-4d4c-bf1b-80907396cfb9_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d73f7251-0c93-4652-be35-d4d07bd644f9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanFacilityMember_1cde883a-141e-41da-9f48-e6422b87a66a_terseLabel_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_label_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember" xlink:href="dva-20210331.xsd#dva_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanFacilityMember" xlink:to="lab_dva_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6c69a04d-f9ac-4082-a9db-313f1798d138_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_70987376-7f2c-4d4d-adc0-d23a9b832504_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d0eb9563-790a-4964-83a1-4bc2084f80e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_88fd5b91-797d-4c9c-a9a9-aa19dbcda0e6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_e9139553-f9b3-4029-adec-e02959a8f613_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of debt instruments bearing fixed interest rate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_f7ff083e-f1bc-473f-8dd6-5593b6cc48b4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of other debt and equity investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Available-for-sale Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_daabf0de-2ea0-4ac7-879b-983dd9539552_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_f72848ae-99a9-41dd-8f08-1dc56467bb32_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_b093b905-c031-499c-b0ca-fe65d458623c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_4c7b0e37-0de7-40b4-bfdb-8801449180f3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:to="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_fd340327-4670-42f1-82c2-2faf758cac5d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_928e76d6-0d25-40a2-a8ab-e8cfa5394ae2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_6837b3f7-5b5c-489d-a725-da23424b1ab6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_6358c692-da9c-4869-86c1-b62afa92ccd4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions from equity method investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_ace369dd-6761-4096-a0d4-674dd87108bd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_a0fb8205-a8c1-4399-aaa3-1a525188efad_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_label_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:href="dva-20210331.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:to="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a6515d9a-21ae-485b-ba0e-0300e585d685_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, weighted average discount rate, percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DiscountAndDeferredFinanceCosts_959095a4-ed43-4e7c-a05b-2090bacbecf6_negatedLabel_en-US" xlink:label="lab_dva_DiscountAndDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount and deferred financing costs</link:label>
    <link:label id="lab_dva_DiscountAndDeferredFinanceCosts_label_en-US" xlink:label="lab_dva_DiscountAndDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount And Deferred Finance Costs</link:label>
    <link:label id="lab_dva_DiscountAndDeferredFinanceCosts_documentation_en-US" xlink:label="lab_dva_DiscountAndDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount, premium and deferred finance costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts" xlink:href="dva-20210331.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DiscountAndDeferredFinanceCosts" xlink:to="lab_dva_DiscountAndDeferredFinanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_27086173-3f60-49b8-81e6-ba0fcb3b9f77_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_73e33da8-87ed-400a-af82-cb920eb66c70_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_5a4157bb-4796-4873-9d3b-506b8e2a7e92_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PatientCareCosts_067f36e6-97ac-44d1-aef1-8c71b8ee91d7_terseLabel_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_label_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Care Costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_documentation_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts" xlink:href="dva-20210331.xsd#dva_PatientCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PatientCareCosts" xlink:to="lab_dva_PatientCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_c6cf8a88-6e61-4e2e-a322-23d6e313a13f_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_deb7442f-ecec-484e-ae6c-0f891127a1c9_negatedLabel_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate administrative support</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_label_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Corporate Expenses</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_documentation_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:href="dva-20210331.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:to="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_362c09a9-e423-4717-a629-e2989d456f39_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_7ad85d1e-988b-44e3-93f6-34a19bf49c12_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentsAbstract" xlink:to="lab_us-gaap_DebtInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanAMember_c3e9977d-aef3-493f-a758-5d280a38fd49_terseLabel_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:label id="lab_dva_TermLoanAMember_label_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A [Member]</link:label>
    <link:label id="lab_dva_TermLoanAMember_documentation_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember" xlink:href="dva-20210331.xsd#dva_TermLoanAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanAMember" xlink:to="lab_dva_TermLoanAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_832e771d-c30a-4eac-9bec-c998e91f1f36_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAbstract_283f401d-beaf-4a1b-9ed8-9fd2e3bd5483_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAbstract_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAbstract" xlink:to="lab_us-gaap_TreasuryStockValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherReportingUnitsMember_4492623c-2e4b-4c93-ac62-ca6f34fbdd18_terseLabel_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Health Operations</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_label_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_documentation_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember" xlink:href="dva-20210331.xsd#dva_OtherReportingUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherReportingUnitsMember" xlink:to="lab_dva_OtherReportingUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_db5e64c6-d7aa-4d78-954a-a6bd88efdb80_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_b93b13c4-e77b-4057-b369-aa481cc189aa_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:href="dva-20210331.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_93293beb-0074-4331-9e99-be31a82b9858_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed consolidated interim financial statements</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_c0306be3-2040-4120-82f7-a3a93e5842fc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_857f1214-8878-4760-b5ae-3e5ef1f7c1d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_f1d4a947-17d5-4d71-884f-3114a3092e59_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in noncontrolling interest from:</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bef29533-1ef2-4b48-8a56-6b0de90e9716_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0fb7e799-3707-423f-bf6b-114003cf63ef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR plus interest rate margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_772d88e9-593f-4fb2-9e67-cbca8a4a890e_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b7aa8f6c-3e6b-46a4-be05-c4c72d22c688_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method and other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_23a00f88-c5a8-49d2-ae8f-eda244b95c7a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0193b127-3b23-42cf-84cc-cb46e3bfe82b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_00ea620c-8c70-4edd-8f37-f2246aee8147_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments_9d0fe000-b5de-406a-a949-482375cb5b45_negatedLabel_en-US" xlink:label="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment income, net</link:label>
    <link:label id="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment Income Loss From Equity Method Investments</link:label>
    <link:label id="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments_documentation_en-US" xlink:label="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents the entity's proportionate share for the period of the undistributed net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:href="dva-20210331.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:to="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_4fb72738-0be1-47bd-879c-fdd69d2473ee_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_a9ffd9a6-0d6e-4a2f-aca4-4b715d1ca6a2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_ac6d78dd-d541-41a6-b6a0-79bb9c6909c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fe2b4697-0213-4907-8519-f29f14866c53_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7af67a20-7878-49c3-8741-6fa9a4a791ed_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_15d154ec-7720-45a1-9060-17b04f2079ba_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1183da2a-60b5-44c0-a53d-0fbbe6ec6577_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_aff3d9e2-1328-4563-b49c-0c4707dbf518_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_13c88f7d-69f3-492b-832e-9fde5581156c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_287ce25b-f02a-40ee-99ed-8aa5208f7ef7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b3d17872-dc0f-4184-94ab-d1cf9c054af9_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash of continuing operations at beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1658e3c0-f669-4120-b6e4-3ac103a7a306_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash of continuing operations at end of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_f14daba3-d99d-4843-904d-42f2e8ec188f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, expiration date</link:label>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_label_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeMaturityDates" xlink:to="lab_us-gaap_DerivativeMaturityDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_3eecd60a-4b91-4528-b0e0-d7fc123f381a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_99fa10a8-bdc7-482a-bbd7-4d44a92c397a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_c0d8bae3-5da7-4b62-979b-39c78cf54325_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ea25c73b-c16f-4293-b0ab-353c518fdc05_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_f4974ae3-2ccb-4b9e-90e4-8b75bec11abd_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_fdca8562-4e29-4950-be81-3408911e6944_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_4765bd72-6a06-4d66-9451-6b7e591c7071_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification into net income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_5dee6f7b-538d-4214-95da-e1ec60199db2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_dcd1ee90-35d2-48ed-8709-92222e0e1b69_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to acquire businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_6beac973-b38e-4339-8d3c-6852b0c31175_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_e0973864-724f-4dd3-b541-f6bbccc34c5b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_07ca628d-5e33-4346-995a-3dd2cf243cc0_terseLabel_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_label_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities [Member]</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_documentation_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured credit facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:href="dva-20210331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:to="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_35aa74e5-2328-4174-a01e-c8cb699cc387_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_480b3b6c-a99a-4ca6-b0a1-8dfba2bcb458_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2c242b64-873c-40c6-8ca8-42c87c716f41_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d394a7e5-5a1c-475b-bc9c-deef524cd125_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_934105f6-6564-4ef1-a4aa-90f33dcabedb_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Earn-out Obligations, Beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6a4065d1-328a-45aa-9d74-518b544a8147_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Earn-out Obligations, Ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_cf2431b5-8930-4fe5-8af9-3ff141fd5a22_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_6863eece-69e6-4bb4-b1e5-5a8c7646589b_terseLabel_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to provide operating capital</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_label_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments To Provide Operating Capital [Member]</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_documentation_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to provide operating capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:href="dva-20210331.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:to="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fcde2b2e-3ad6-4019-8a21-057fa6cb28a8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity on the revolving credit facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_b7ebb59b-9cbb-4e28-946e-4d18aadbb399_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_7e693b9a-3749-4072-9957-6052de34fbf0_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_FinanceLeaseMember_67d6819b-7bfb-4991-9bf9-587865d7c10b_verboseLabel_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease obligations</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_label_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_documentation_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember" xlink:href="dva-20210331.xsd#dva_FinanceLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_FinanceLeaseMember" xlink:to="lab_dva_FinanceLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_53920ae3-7208-4f90-aa7f-7174831bd097_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_bc02ff55-21c8-4344-96f4-8cc855ef6321_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_e9f9c25d-45f8-4735-960b-344eb41c2d86_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_c635117b-f0eb-4f30-a01a-41c0ce19a28d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- controlling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_62cc9f70-cbea-4875-b42f-7c1bb44a466e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_c7026990-b697-4b44-b61d-b5c0d94ff6f2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_90a1fde9-f7f3-4a57-a1df-c659cb6e79c9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Distributions to Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:to="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ed1f0b5-9a42-4ec0-93be-986cad0b85f4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a4373ed-d78d-4157-8f15-bae4b67c1cde_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cb33d858-55bf-4325-a88c-b7f5632d8dca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CorporateIntegrityAgreementExpirationDate_4fc46cd6-2e4f-414a-9e0e-5410730659d4_terseLabel_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Expiration Date</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementExpirationDate_label_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Expiration Date</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementExpirationDate_documentation_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Expiration Date, in CCYY-MM-DD format.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementExpirationDate" xlink:href="dva-20210331.xsd#dva_CorporateIntegrityAgreementExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CorporateIntegrityAgreementExpirationDate" xlink:to="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_142299f7-3755-49f6-a7c7-8b4224e9477f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5d827d4a-e6b5-4ce5-b468-6b1fcad7f42e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_91052884-adb3-417a-8855-f8ec86d2dd0b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_3c2704fe-4a01-40b9-9fdb-287354b4d922_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, long-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_2add9014-4550-420a-93d5-d7be8db3d3a5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other potential commitments to provide operating capital to several dialysis centers</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_3a7533a1-494b-4b66-8d4b-24e7297ffb3c_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_label_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:href="dva-20210331.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:to="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_86c3bf73-356e-489f-b25b-141f9b275b82_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations</link:label>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentContinuingOperationsMember" xlink:to="lab_us-gaap_SegmentContinuingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_89361637-2a3b-4339-8e0c-54573cb861f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_ba389ef4-4c81-4ba2-b734-3521e8b3b392_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d63415d-fbcf-4fc2-b166-a1c069370ec2_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_bec65edc-3a28-4189-87e5-08b2b01f4554_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9c180db4-26a6-41f2-a676-0c7d6fd9dc66_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b4ec7523-08e8-421b-bf3a-21c0979aa499_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_f23007f4-42de-464b-a736-c4ebacbab976_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_79806e6b-0dbd-4bae-bd78-cd7b4d4ff7c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_7e67cbef-2a9f-4a85-be03-27e4d2a9a79e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b5fb673b-0ba0-4853-b3a8-c840b36f2b96_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_571d542a-d585-48cf-b6c9-1a9f49b11197_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>dva-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0eedf026-4cb7-43f6-a1e9-99f3721c46b9,g:375f77ab-f095-4ce1-bcc5-25c9315fbffb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="dva-20210331.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_203258c5-d6e2-41ef-a596-0762d91dc357" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_DocumentType_203258c5-d6e2-41ef-a596-0762d91dc357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_42f19f99-1e5e-4d1d-9054-b1802f1d7216" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_DocumentQuarterlyReport_42f19f99-1e5e-4d1d-9054-b1802f1d7216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_90835894-984d-4cf4-8e1d-438c0fa2ffa0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_DocumentPeriodEndDate_90835894-984d-4cf4-8e1d-438c0fa2ffa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e733d1de-b772-4492-a50e-cb2fc9342600" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_DocumentTransitionReport_e733d1de-b772-4492-a50e-cb2fc9342600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_709d4fa4-f1f4-4ce2-a4f3-cef3da452abc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityFileNumber_709d4fa4-f1f4-4ce2-a4f3-cef3da452abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_69c619ba-da62-4f9a-bbf5-3fd924da9624" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityRegistrantName_69c619ba-da62-4f9a-bbf5-3fd924da9624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_49024a83-afb7-4170-b78a-ed24a5a28d23" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityIncorporationStateCountryCode_49024a83-afb7-4170-b78a-ed24a5a28d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7d5f1bcc-9eb9-4590-ba91-156e6eb936c2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityTaxIdentificationNumber_7d5f1bcc-9eb9-4590-ba91-156e6eb936c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2f2d1cf8-d81f-40e1-8a10-b4efef3107be" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityAddressAddressLine1_2f2d1cf8-d81f-40e1-8a10-b4efef3107be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_360a3249-376e-4c9a-85f8-d664acb86c8c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityAddressCityOrTown_360a3249-376e-4c9a-85f8-d664acb86c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_db6e4bcd-ea04-467f-90af-d891af009b0e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityAddressStateOrProvince_db6e4bcd-ea04-467f-90af-d891af009b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_af7e466e-a448-4f47-9878-cdae5bd907ec" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityAddressPostalZipCode_af7e466e-a448-4f47-9878-cdae5bd907ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e73e0a3c-db9b-48ff-8eb8-e51048479d91" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_CityAreaCode_e73e0a3c-db9b-48ff-8eb8-e51048479d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_dcba2fb6-6101-4284-b3c0-40eec79996a6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_LocalPhoneNumber_dcba2fb6-6101-4284-b3c0-40eec79996a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ba4ec85b-24a6-4703-b343-6e800e6b5c12" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_Security12bTitle_ba4ec85b-24a6-4703-b343-6e800e6b5c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f4ec5202-2a07-40d0-bce2-13d92663b0fb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_TradingSymbol_f4ec5202-2a07-40d0-bce2-13d92663b0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_907c3f2a-f62b-4997-88fd-afe6f17eec29" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_SecurityExchangeName_907c3f2a-f62b-4997-88fd-afe6f17eec29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_e9aa65e1-b82b-4bb2-8b64-2850c6d4e0e0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityCurrentReportingStatus_e9aa65e1-b82b-4bb2-8b64-2850c6d4e0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_419c4453-c4cf-44e8-b173-73f3be2a91f7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityInteractiveDataCurrent_419c4453-c4cf-44e8-b173-73f3be2a91f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f014c849-a515-4407-a2ca-d85ca2ee8c13" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityFilerCategory_f014c849-a515-4407-a2ca-d85ca2ee8c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6612a3ce-08eb-4eb9-b787-a1501f51fa50" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntitySmallBusiness_6612a3ce-08eb-4eb9-b787-a1501f51fa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_95f7ae33-c034-4689-9f75-304cfdef58a4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityEmergingGrowthCompany_95f7ae33-c034-4689-9f75-304cfdef58a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3489c065-9481-4546-8cc3-d2a4390f8e4c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityShellCompany_3489c065-9481-4546-8cc3-d2a4390f8e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b09fa28f-02b4-4272-ab44-3debc9a97f87" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b09fa28f-02b4-4272-ab44-3debc9a97f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a005f74b-4e95-4e68-b0e6-f0c8c52ad8bf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_AmendmentFlag_a005f74b-4e95-4e68-b0e6-f0c8c52ad8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d1138c46-2955-4cd6-ac8d-4b4623a0468a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_DocumentFiscalYearFocus_d1138c46-2955-4cd6-ac8d-4b4623a0468a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9e52f762-6fe2-49d8-97ce-80ceca8ddfc0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9e52f762-6fe2-49d8-97ce-80ceca8ddfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2562de81-d14e-432a-8c4c-ad6ba8a08538" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_EntityCentralIndexKey_2562de81-d14e-432a-8c4c-ad6ba8a08538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_aa9dabdc-b0bb-4f9f-846f-b75b4617d675" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69ce8b3c-fa56-4225-961e-d7dd971c6587" xlink:to="loc_dei_CurrentFiscalYearEndDate_aa9dabdc-b0bb-4f9f-846f-b75b4617d675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_a4ad252d-1ccd-43c6-aff9-01832d2b6048" xlink:href="dva-20210331.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_a4ad252d-1ccd-43c6-aff9-01832d2b6048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_6afb9237-c7fe-4b1e-8da1-9f32a1fc77fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_OtherIncome_6afb9237-c7fe-4b1e-8da1-9f32a1fc77fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5875e1b7-fdc9-483b-b960-dee026a0ea14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_Revenues_5875e1b7-fdc9-483b-b960-dee026a0ea14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_9e38ee01-d679-4035-83ca-2b4f3adcadc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_9e38ee01-d679-4035-83ca-2b4f3adcadc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_a5f6cca1-49b8-4744-8040-475642c99058" xlink:href="dva-20210331.xsd#dva_PatientCareCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9e38ee01-d679-4035-83ca-2b4f3adcadc6" xlink:to="loc_dva_PatientCareCosts_a5f6cca1-49b8-4744-8040-475642c99058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_98a09cee-e422-4619-9665-fbf22d0a272c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9e38ee01-d679-4035-83ca-2b4f3adcadc6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_98a09cee-e422-4619-9665-fbf22d0a272c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_e8291323-467a-4b94-a0b7-b2301b729fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9e38ee01-d679-4035-83ca-2b4f3adcadc6" xlink:to="loc_us-gaap_DepreciationAndAmortization_e8291323-467a-4b94-a0b7-b2301b729fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d1cdc506-c321-48c6-811b-0c6569907d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9e38ee01-d679-4035-83ca-2b4f3adcadc6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d1cdc506-c321-48c6-811b-0c6569907d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6b3feaa8-a88c-4a46-908d-5b69f0edacd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9e38ee01-d679-4035-83ca-2b4f3adcadc6" xlink:to="loc_us-gaap_CostsAndExpenses_6b3feaa8-a88c-4a46-908d-5b69f0edacd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2c231a1d-e6a1-414d-bedd-3aeb68ca699f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_OperatingIncomeLoss_2c231a1d-e6a1-414d-bedd-3aeb68ca699f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_88b276ca-b1bf-4591-b008-08651e510ef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_InterestAndDebtExpense_88b276ca-b1bf-4591-b008-08651e510ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_2a4ed4e5-f149-48b4-acdc-85df48b530c5" xlink:href="dva-20210331.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_2a4ed4e5-f149-48b4-acdc-85df48b530c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_174c6f31-3139-41b1-8c64-31f9430694e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_174c6f31-3139-41b1-8c64-31f9430694e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_afa51746-c9ea-49de-a30a-fb294d18793c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_afa51746-c9ea-49de-a30a-fb294d18793c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c16817e3-f0c6-4923-9f3b-1c5dd3d9d2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c16817e3-f0c6-4923-9f3b-1c5dd3d9d2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5e878548-811c-4908-a3ae-eff48d05e917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5e878548-811c-4908-a3ae-eff48d05e917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b44500d9-44a5-4fc3-bc17-dc065f7000a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b44500d9-44a5-4fc3-bc17-dc065f7000a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a7c99151-4495-4aa9-aa82-a70119b60706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_ProfitLoss_a7c99151-4495-4aa9-aa82-a70119b60706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1bb40023-2282-42ab-ae87-d008b045aab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1bb40023-2282-42ab-ae87-d008b045aab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_da1b3c66-1890-4114-a2b0-f689b9df2775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_NetIncomeLoss_da1b3c66-1890-4114-a2b0-f689b9df2775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6e3e05d6-15ab-44e9-ad0c-315b1ad281af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_EarningsPerShareAbstract_6e3e05d6-15ab-44e9-ad0c-315b1ad281af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_53588e15-ccac-4470-bb7f-ec05e57d8a77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6e3e05d6-15ab-44e9-ad0c-315b1ad281af" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_53588e15-ccac-4470-bb7f-ec05e57d8a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_da385f7e-c15e-4697-86b4-05184586fd05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6e3e05d6-15ab-44e9-ad0c-315b1ad281af" xlink:to="loc_us-gaap_EarningsPerShareBasic_da385f7e-c15e-4697-86b4-05184586fd05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_85cd48a0-deb6-49cb-8d78-88fc8ae72e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6e3e05d6-15ab-44e9-ad0c-315b1ad281af" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_85cd48a0-deb6-49cb-8d78-88fc8ae72e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9950a497-292d-4f5d-ba88-bb4bd7381c0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6e3e05d6-15ab-44e9-ad0c-315b1ad281af" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9950a497-292d-4f5d-ba88-bb4bd7381c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5466a9a6-2e79-4c54-acf9-41304d562505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5466a9a6-2e79-4c54-acf9-41304d562505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_14e81ca8-78e1-4d08-b90f-9486dd3d4cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5466a9a6-2e79-4c54-acf9-41304d562505" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_14e81ca8-78e1-4d08-b90f-9486dd3d4cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ea836783-5f8c-4f8f-be96-025ad22d526b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5466a9a6-2e79-4c54-acf9-41304d562505" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ea836783-5f8c-4f8f-be96-025ad22d526b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_26c46677-337f-4c1a-ba41-fb9b5deb1311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9c53812a-c5eb-4020-841e-7a3a0f389c16" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_26c46677-337f-4c1a-ba41-fb9b5deb1311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_fc5db4c2-e696-44f2-a571-88f49a6a3cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_26c46677-337f-4c1a-ba41-fb9b5deb1311" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_fc5db4c2-e696-44f2-a571-88f49a6a3cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_be2c79bb-59d8-4f71-a445-701abb0347f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_26c46677-337f-4c1a-ba41-fb9b5deb1311" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_be2c79bb-59d8-4f71-a445-701abb0347f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_24219158-cad8-4af4-a5eb-1949f64c62ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_26c46677-337f-4c1a-ba41-fb9b5deb1311" xlink:to="loc_us-gaap_NetIncomeLoss_24219158-cad8-4af4-a5eb-1949f64c62ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2327752a-8682-4191-95fc-4c038a61fe95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c794379b-f77f-4853-a80d-c02b58efb7e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2327752a-8682-4191-95fc-4c038a61fe95" xlink:to="loc_us-gaap_ProfitLoss_c794379b-f77f-4853-a80d-c02b58efb7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_faf99515-6432-4278-b904-8f39a877f71c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2327752a-8682-4191-95fc-4c038a61fe95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_faf99515-6432-4278-b904-8f39a877f71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_531a79c1-ca14-4ebe-85fd-5f3b0e2a1ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_faf99515-6432-4278-b904-8f39a877f71c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_531a79c1-ca14-4ebe-85fd-5f3b0e2a1ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_8b95c0aa-7a14-49cc-af7d-d90549e13218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_531a79c1-ca14-4ebe-85fd-5f3b0e2a1ea3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_8b95c0aa-7a14-49cc-af7d-d90549e13218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_6fcfffed-5051-4708-9619-389897731c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_531a79c1-ca14-4ebe-85fd-5f3b0e2a1ea3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_6fcfffed-5051-4708-9619-389897731c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_e139b530-dcbc-42f3-aa9e-5e9dc58ed785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2327752a-8682-4191-95fc-4c038a61fe95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_e139b530-dcbc-42f3-aa9e-5e9dc58ed785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_35229fbb-29c2-4a53-bb38-ccac3c2ba67e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2327752a-8682-4191-95fc-4c038a61fe95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_35229fbb-29c2-4a53-bb38-ccac3c2ba67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c02340fd-b4c6-4df3-908d-f40ecb9fbc3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2327752a-8682-4191-95fc-4c038a61fe95" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c02340fd-b4c6-4df3-908d-f40ecb9fbc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3a2e981e-863b-43b4-b1c0-7240003c74ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2327752a-8682-4191-95fc-4c038a61fe95" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3a2e981e-863b-43b4-b1c0-7240003c74ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_24e2a812-76fa-49b6-b8fb-95c04462657a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2327752a-8682-4191-95fc-4c038a61fe95" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_24e2a812-76fa-49b6-b8fb-95c04462657a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d185d7b4-e596-46d5-b4c6-d1b16ababd81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d185d7b4-e596-46d5-b4c6-d1b16ababd81" xlink:to="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_53078e13-1ef7-4073-8d50-c0eba44023db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_53078e13-1ef7-4073-8d50-c0eba44023db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_57d7afbb-0313-4b7e-93c8-5eb1401ff2c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_57d7afbb-0313-4b7e-93c8-5eb1401ff2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_aec2e51a-f042-4055-8907-c4b20e33e872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_aec2e51a-f042-4055-8907-c4b20e33e872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1b23de58-1c47-4dce-91b9-1917646b53cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1b23de58-1c47-4dce-91b9-1917646b53cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a2224977-428e-4b4e-a62b-0b335eae473d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_InventoryNet_a2224977-428e-4b4e-a62b-0b335eae473d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_068aab1e-95c6-4037-8e82-2f104ebd0155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_068aab1e-95c6-4037-8e82-2f104ebd0155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b27f23b6-d78b-4e2e-85ec-6f802d10ece7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b27f23b6-d78b-4e2e-85ec-6f802d10ece7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_c55af6b2-0b8b-41a3-a6b7-45568b002a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_IncomeTaxesReceivable_c55af6b2-0b8b-41a3-a6b7-45568b002a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2a588414-896f-468d-a07e-7b8cf7331141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_AssetsCurrent_2a588414-896f-468d-a07e-7b8cf7331141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8d9ad5c4-0da9-4946-81ab-4e0ef135e36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8d9ad5c4-0da9-4946-81ab-4e0ef135e36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f1337df-cbd0-4f96-9aa3-a2b4d3e456f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f1337df-cbd0-4f96-9aa3-a2b4d3e456f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_efecb46c-a986-4d38-b2a8-a460d743e008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_efecb46c-a986-4d38-b2a8-a460d743e008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0f278063-7aa8-46ff-94ea-c1495e6e48a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0f278063-7aa8-46ff-94ea-c1495e6e48a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_a618a184-ee2b-4aba-a446-fdfecacda978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_a618a184-ee2b-4aba-a446-fdfecacda978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_06e2deac-a36c-4afe-9826-be4ec8c77332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_06e2deac-a36c-4afe-9826-be4ec8c77332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f6359022-f533-4e11-b820-597ee7631072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_Goodwill_f6359022-f533-4e11-b820-597ee7631072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_89f2d7e9-3a3b-434c-9e6a-b845160f793a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea5d7fe2-550f-4cad-8183-d98cd7377dbe" xlink:to="loc_us-gaap_Assets_89f2d7e9-3a3b-434c-9e6a-b845160f793a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d185d7b4-e596-46d5-b4c6-d1b16ababd81" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_724e0035-eafa-4624-a025-39c530961866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_AccountsPayableCurrent_724e0035-eafa-4624-a025-39c530961866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_72adaac7-77a3-49eb-9e2f-0b7ff6c4ae5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_72adaac7-77a3-49eb-9e2f-0b7ff6c4ae5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a847c5ae-062c-4c4f-9f0b-8fa2be1e996a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a847c5ae-062c-4c4f-9f0b-8fa2be1e996a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_cb289636-7ba7-4051-9252-3715342bab00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_cb289636-7ba7-4051-9252-3715342bab00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f01752dd-f5b3-40cf-8b7d-84bbe5a66fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f01752dd-f5b3-40cf-8b7d-84bbe5a66fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_244b2149-98de-40c1-8086-ef055b6a265c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_244b2149-98de-40c1-8086-ef055b6a265c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_37e3d8ef-2574-4159-ab1f-d3cbb32835be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_LiabilitiesCurrent_37e3d8ef-2574-4159-ab1f-d3cbb32835be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0fa7f41f-4831-4ae2-9a23-8a138fb688a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0fa7f41f-4831-4ae2-9a23-8a138fb688a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ad6077e9-8445-43c9-8d1e-95d8c23cf957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ad6077e9-8445-43c9-8d1e-95d8c23cf957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fcab8a92-2a00-48c8-aa57-7710d70f8c52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fcab8a92-2a00-48c8-aa57-7710d70f8c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c3391a10-a162-4d82-99a9-a9d75d8b4935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c3391a10-a162-4d82-99a9-a9d75d8b4935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c04a9732-6208-4e20-becc-91ef8c22dbb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_Liabilities_c04a9732-6208-4e20-becc-91ef8c22dbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d2ed9c1b-0390-4d41-ab4e-988bf8093778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d2ed9c1b-0390-4d41-ab4e-988bf8093778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_555de1e6-f5c4-4ea6-86fa-12a530c48c99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d2ed9c1b-0390-4d41-ab4e-988bf8093778" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_555de1e6-f5c4-4ea6-86fa-12a530c48c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_38fd70c9-5d31-42a9-bb87-c0dcdd256912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:to="loc_us-gaap_PreferredStockValue_38fd70c9-5d31-42a9-bb87-c0dcdd256912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_dee710e0-b021-45ac-942b-ca48c2e5ad6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:to="loc_us-gaap_CommonStockValue_dee710e0-b021-45ac-942b-ca48c2e5ad6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5be5747f-34cf-40ac-8653-d3752c615603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5be5747f-34cf-40ac-8653-d3752c615603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c238ee1-0314-494f-8e16-628b698cb7a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c238ee1-0314-494f-8e16-628b698cb7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_29e97104-053f-45f1-ad08-7f9322829bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:to="loc_us-gaap_TreasuryStockValue_29e97104-053f-45f1-ad08-7f9322829bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5b2564b4-ba77-4c38-aba6-b905a270e52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5b2564b4-ba77-4c38-aba6-b905a270e52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c5b391f8-bf53-4e10-be35-52ae26331497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:to="loc_us-gaap_StockholdersEquity_c5b391f8-bf53-4e10-be35-52ae26331497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d1e209a9-8471-488b-968e-2acfbeb02184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:to="loc_us-gaap_MinorityInterest_d1e209a9-8471-488b-968e-2acfbeb02184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4fed094f-33f5-4311-ab41-2c3e8381e82b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_755ef7f2-375a-4669-a99b-e2eca65be687" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4fed094f-33f5-4311-ab41-2c3e8381e82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d0b9710-7320-4fd7-bbc6-01ff8b20c426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06fab58f-71b9-4e32-b5b7-39b0c48e94bf" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d0b9710-7320-4fd7-bbc6-01ff8b20c426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDBALANCESHEETSunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_dc41c89d-0e33-471c-b845-e64e512c83fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_dc41c89d-0e33-471c-b845-e64e512c83fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_01523d91-f6f3-4d32-9fc9-07332bf29468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_01523d91-f6f3-4d32-9fc9-07332bf29468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5ae5c05c-6e41-412f-8b6a-0ce950f49e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5ae5c05c-6e41-412f-8b6a-0ce950f49e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ded6f8ed-e5ad-4a2c-b20f-4bacd2836296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ded6f8ed-e5ad-4a2c-b20f-4bacd2836296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_9ecdad91-b5dd-43d4-b053-9015a09fc6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_9ecdad91-b5dd-43d4-b053-9015a09fc6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e91d7c28-9adc-4e7b-ba5a-a5c2d2c38120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e91d7c28-9adc-4e7b-ba5a-a5c2d2c38120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_717d7c7f-d9ae-4d27-9123-716b3236e437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_717d7c7f-d9ae-4d27-9123-716b3236e437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2d627848-cb27-4315-8392-295cb8c8150f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_CommonStockSharesIssued_2d627848-cb27-4315-8392-295cb8c8150f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b38e5fc8-b839-4353-bbc5-4638dcd1a97b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b38e5fc8-b839-4353-bbc5-4638dcd1a97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_a3662428-2a9b-4f4a-9c0d-1e79e1ff62a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1318e514-31a7-48a7-937d-c8327ff13d9c" xlink:to="loc_us-gaap_TreasuryStockCommonShares_a3662428-2a9b-4f4a-9c0d-1e79e1ff62a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b35d4cc6-f715-4f36-a434-b414b022b18f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c2839935-9436-4c38-8310-c52e67d0154a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b35d4cc6-f715-4f36-a434-b414b022b18f" xlink:to="loc_us-gaap_StatementTable_c2839935-9436-4c38-8310-c52e67d0154a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_f3e107ab-9dc0-4e0b-8b9d-db05b1f01d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c2839935-9436-4c38-8310-c52e67d0154a" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_f3e107ab-9dc0-4e0b-8b9d-db05b1f01d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_d292f779-dce0-426a-9bde-643a28b27b8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_f3e107ab-9dc0-4e0b-8b9d-db05b1f01d26" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_d292f779-dce0-426a-9bde-643a28b27b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_29827c7e-3ebc-4122-9cec-93bd7b8e37f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_d292f779-dce0-426a-9bde-643a28b27b8b" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_29827c7e-3ebc-4122-9cec-93bd7b8e37f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_cb668667-9582-4cbb-b712-ce444470271c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_d292f779-dce0-426a-9bde-643a28b27b8b" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_cb668667-9582-4cbb-b712-ce444470271c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c2839935-9436-4c38-8310-c52e67d0154a" xlink:to="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_349a7a27-3f8e-49ed-8e4c-1c2b37180a11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:to="loc_us-gaap_ProfitLoss_349a7a27-3f8e-49ed-8e4c-1c2b37180a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_ec030cd1-2662-41e5-8baf-f0e20c12c3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_ec030cd1-2662-41e5-8baf-f0e20c12c3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_f28afa8c-8f8b-43f5-af9c-4aa86dc4cf5c" xlink:href="dva-20210331.xsd#dva_DebtRefinancingCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_dva_DebtRefinancingCharges_f28afa8c-8f8b-43f5-af9c-4aa86dc4cf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_496df375-b26b-41db-96bc-7c38926d2070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_ShareBasedCompensation_496df375-b26b-41db-96bc-7c38926d2070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_47c0633b-785a-46e8-a2f7-2183c14394ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_47c0633b-785a-46e8-a2f7-2183c14394ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_a07a0132-8aa1-4333-821d-729c71754b0c" xlink:href="dva-20210331.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_a07a0132-8aa1-4333-821d-729c71754b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dcdfbdd8-f7f6-4816-9b21-d57155e7f45e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dcdfbdd8-f7f6-4816-9b21-d57155e7f45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eccaa34b-dbce-48a6-b718-e136b013a71c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b58b0a3e-c5b3-4183-b8c4-2612a55fcfe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b58b0a3e-c5b3-4183-b8c4-2612a55fcfe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e6a56a77-6645-41db-a8a9-f3368636adc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e6a56a77-6645-41db-a8a9-f3368636adc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_6378e334-2b32-4a3f-a2bc-6fb861446994" xlink:href="dva-20210331.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_6378e334-2b32-4a3f-a2bc-6fb861446994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2cadb038-19ba-4ba9-948f-ed593aeb7b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2cadb038-19ba-4ba9-948f-ed593aeb7b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0044ad75-fd91-4817-aa2f-c92f962151dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0044ad75-fd91-4817-aa2f-c92f962151dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_30a804de-e9c6-4f06-a2e0-50d7f43211e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_30a804de-e9c6-4f06-a2e0-50d7f43211e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_1201fc6c-cc13-4be1-8ba8-5ef045f283b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_1201fc6c-cc13-4be1-8ba8-5ef045f283b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1f1dc93a-5c11-4da8-8c48-80accc3fc988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1f1dc93a-5c11-4da8-8c48-80accc3fc988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_dcb4491d-7380-411f-b32d-c28760021b05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_436db468-0a39-4844-bc3a-f4551c45399f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_dcb4491d-7380-411f-b32d-c28760021b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ad79760-ce80-4f54-995d-b6439a816762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_db9b6c9e-6d9e-4ed7-ac64-1f09582082a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ad79760-ce80-4f54-995d-b6439a816762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_54c1d331-aabc-42ff-ae3b-b5beda432efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_54c1d331-aabc-42ff-ae3b-b5beda432efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_fcbb9380-f3cb-444f-9ac6-e44422faaa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_fcbb9380-f3cb-444f-9ac6-e44422faaa71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_2c47e9d5-b61d-4350-8a91-035faf4df0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_2c47e9d5-b61d-4350-8a91-035faf4df0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_314aa149-b6cb-41b3-9596-038a1d67965c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_314aa149-b6cb-41b3-9596-038a1d67965c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_58ab1579-2804-45ce-88a9-9db4452632f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_58ab1579-2804-45ce-88a9-9db4452632f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_dab1c046-1a47-4a92-85d2-87a3ff671316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_dab1c046-1a47-4a92-85d2-87a3ff671316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_55f5f380-be6b-462c-84a1-5b55e82aabdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_55f5f380-be6b-462c-84a1-5b55e82aabdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_88dcaad2-d105-4d07-a1ce-5f4787a88db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_88dcaad2-d105-4d07-a1ce-5f4787a88db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_5da261a6-ed54-499a-9b8d-cb78c4cbee37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_5da261a6-ed54-499a-9b8d-cb78c4cbee37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d27d6d2-676c-4191-9f4e-fe77e8d6b2d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_38a1d247-9f1f-4714-8973-557d2d2f915c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d27d6d2-676c-4191-9f4e-fe77e8d6b2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1ab93c2f-75f7-4af5-bbe0-52dede81bd47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1ab93c2f-75f7-4af5-bbe0-52dede81bd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_aa24aced-120e-4334-86b1-21ebfefb158b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_aa24aced-120e-4334-86b1-21ebfefb158b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_4686a28b-7b26-41d1-bd9e-786f1f3c6f57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_4686a28b-7b26-41d1-bd9e-786f1f3c6f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d233413f-fde4-4a40-84dd-a73cfe06c272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d233413f-fde4-4a40-84dd-a73cfe06c272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_cdb75845-2892-40b5-bea7-153e72779803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_cdb75845-2892-40b5-bea7-153e72779803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_36d7c941-fff3-4a44-a217-1bb16893035b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_36d7c941-fff3-4a44-a217-1bb16893035b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_b8ed0b18-fcb9-422f-a0c3-cbb81f76bf33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_b8ed0b18-fcb9-422f-a0c3-cbb81f76bf33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_e2bff8fc-a271-4f08-a3f2-bc8346b382af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_e2bff8fc-a271-4f08-a3f2-bc8346b382af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_023de977-6b2d-40cd-b444-05a0f330fa5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_023de977-6b2d-40cd-b444-05a0f330fa5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58390b37-da74-478a-8aec-d668bb1eec6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_142424f0-26f6-4716-9e10-908a7205eb2c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58390b37-da74-478a-8aec-d668bb1eec6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_81e9b601-4d8f-4991-a79c-f9dfb5a96f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_81e9b601-4d8f-4991-a79c-f9dfb5a96f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bbdf6b54-f290-4b0f-af2b-7762798ff5d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bbdf6b54-f290-4b0f-af2b-7762798ff5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_05ac3e37-f0bd-414a-92fd-9e9dd7ae9500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_05ac3e37-f0bd-414a-92fd-9e9dd7ae9500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ca43a311-3440-4e9f-9873-97aa3a076c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2c3c647a-3110-4e34-b018-d882ae89e132" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ca43a311-3440-4e9f-9873-97aa3a076c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="simple" xlink:href="dva-20210331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ff0a7fab-6679-4d02-8d4e-cb987ef6c096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e56f24fd-1bcc-4f1a-ace3-6fd6cf710e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ff0a7fab-6679-4d02-8d4e-cb987ef6c096" xlink:to="loc_us-gaap_StatementTable_e56f24fd-1bcc-4f1a-ace3-6fd6cf710e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_024a1d4a-3064-4303-9231-8465ff3d3439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e56f24fd-1bcc-4f1a-ace3-6fd6cf710e7c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_024a1d4a-3064-4303-9231-8465ff3d3439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5b69f3ee-5dad-4f06-ab04-c285c37866eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_024a1d4a-3064-4303-9231-8465ff3d3439" xlink:to="loc_us-gaap_EquityComponentDomain_5b69f3ee-5dad-4f06-ab04-c285c37866eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5b69f3ee-5dad-4f06-ab04-c285c37866eb" xlink:to="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_0b96099e-257b-4c67-bd71-f2d5c7359b38" xlink:href="dva-20210331.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_0b96099e-257b-4c67-bd71-f2d5c7359b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_79341415-c364-4608-aa5b-e2ae5c003e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_CommonStockMember_79341415-c364-4608-aa5b-e2ae5c003e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3f23ecec-3727-4d17-9388-bc485640ba0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3f23ecec-3727-4d17-9388-bc485640ba0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_50d6dee6-6239-4fb3-9f6b-573f37d64a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_RetainedEarningsMember_50d6dee6-6239-4fb3-9f6b-573f37d64a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_985d73a7-4702-4ef7-b06a-8b248106c0d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_TreasuryStockMember_985d73a7-4702-4ef7-b06a-8b248106c0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0e23a371-29ca-4a1b-bb4a-45415ba0ccc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0e23a371-29ca-4a1b-bb4a-45415ba0ccc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6d469abb-4956-4053-8f4e-0350eafd1161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d2c7280-1e80-464a-98ae-3bea2d03d649" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6d469abb-4956-4053-8f4e-0350eafd1161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e56f24fd-1bcc-4f1a-ace3-6fd6cf710e7c" xlink:to="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_1111ef64-ebaf-42dd-983a-acd606ca5fc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_1111ef64-ebaf-42dd-983a-acd606ca5fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_70f235ff-f42d-4080-bd89-672719d7b8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_70f235ff-f42d-4080-bd89-672719d7b8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_000c4781-37a3-4fd3-9971-0f95f5212001" xlink:href="dva-20210331.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_000c4781-37a3-4fd3-9971-0f95f5212001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_ff79c634-f638-49ba-bc79-56f960795c0e" xlink:href="dva-20210331.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_ff79c634-f638-49ba-bc79-56f960795c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_b14919c6-837d-410c-811a-a4a87458aafe" xlink:href="dva-20210331.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_b14919c6-837d-410c-811a-a4a87458aafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_ca140865-cd4d-41b6-b8ba-686d0842cb05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_ca140865-cd4d-41b6-b8ba-686d0842cb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0a6a9eab-660a-4d2a-abe9-4af1c1325e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef351ca8-3e54-48ae-a20d-7bd1d24943b4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0a6a9eab-660a-4d2a-abe9-4af1c1325e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c886939-7d48-4069-96a0-5e7d767b9a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c886939-7d48-4069-96a0-5e7d767b9a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b52044f0-8d4f-4504-8144-2c5475e5f2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b52044f0-8d4f-4504-8144-2c5475e5f2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_5b494040-0d88-4a87-949b-32493a59cb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_5b494040-0d88-4a87-949b-32493a59cb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_c45182f4-0086-490b-acac-71c117fe70d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_5b494040-0d88-4a87-949b-32493a59cb1e" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_c45182f4-0086-490b-acac-71c117fe70d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c6261d59-5c9a-4ba5-87a5-68aedac8abb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_5b494040-0d88-4a87-949b-32493a59cb1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c6261d59-5c9a-4ba5-87a5-68aedac8abb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6d438c2f-bf8c-4439-9261-d544d296dd21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6d438c2f-bf8c-4439-9261-d544d296dd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b1b50d5b-b1f0-41fb-b3e1-6b7dc58b67d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b1b50d5b-b1f0-41fb-b3e1-6b7dc58b67d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_95c5d8d9-2c35-40b1-bbef-54321ce1de66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_95c5d8d9-2c35-40b1-bbef-54321ce1de66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_55f723d0-48da-4897-a097-44271636c610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_55f723d0-48da-4897-a097-44271636c610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_fa25ae6e-0553-40c4-9477-7df08411ad4f" xlink:href="dva-20210331.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_fa25ae6e-0553-40c4-9477-7df08411ad4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_20e1eff8-c40e-4bfe-aafd-5c594a1b5f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_20e1eff8-c40e-4bfe-aafd-5c594a1b5f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d9356620-536b-44d2-bf36-ffb1a492b8dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2e8dc0db-bf97-49c4-8c13-3b6fad59a939" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d9356620-536b-44d2-bf36-ffb1a492b8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c47d1249-8af8-4d5f-9c44-6815e2a8da3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c47d1249-8af8-4d5f-9c44-6815e2a8da3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_5a76b5ce-31a2-4985-bb40-7d327a60eb24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82de4c26-785e-4f7c-b885-befb2bbb7860" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_5a76b5ce-31a2-4985-bb40-7d327a60eb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_83e950a8-73a1-425d-ad23-6cd61ea41e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_83e950a8-73a1-425d-ad23-6cd61ea41e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2c1da91e-c312-455b-9fc8-e8216431d657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ee927895-e791-4241-8986-c9c4cddd7c19" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2c1da91e-c312-455b-9fc8-e8216431d657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="simple" xlink:href="dva-20210331.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_07d66568-c487-4f40-8995-27e5547bf49f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7f63765c-7986-4fa5-901d-7bf766254e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_07d66568-c487-4f40-8995-27e5547bf49f" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7f63765c-7986-4fa5-901d-7bf766254e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="simple" xlink:href="dva-20210331.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3a837433-3075-474d-9f2e-02195f1597e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_063e679b-8517-4aad-9a2c-867def1290d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a837433-3075-474d-9f2e-02195f1597e9" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_063e679b-8517-4aad-9a2c-867def1290d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_6cbc3155-2dc0-473b-851f-cd7bdb9c226a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a837433-3075-474d-9f2e-02195f1597e9" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_6cbc3155-2dc0-473b-851f-cd7bdb9c226a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_81152dfa-3350-48d3-b0e2-9db90243d154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a837433-3075-474d-9f2e-02195f1597e9" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_81152dfa-3350-48d3-b0e2-9db90243d154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_0f6d63a2-8fbd-4e80-8071-51a752238c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a837433-3075-474d-9f2e-02195f1597e9" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_0f6d63a2-8fbd-4e80-8071-51a752238c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_c1273b9e-758a-475b-acc5-6cdc1d3e9321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a837433-3075-474d-9f2e-02195f1597e9" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_c1273b9e-758a-475b-acc5-6cdc1d3e9321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_aff1e504-002c-4eeb-a864-a95241ef5aea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a837433-3075-474d-9f2e-02195f1597e9" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_aff1e504-002c-4eeb-a864-a95241ef5aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a9574841-6993-4002-9d43-31cba3df1020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a837433-3075-474d-9f2e-02195f1597e9" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a9574841-6993-4002-9d43-31cba3df1020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="simple" xlink:href="dva-20210331.xsd#RevenueRecognitionRevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_a75129ca-35f9-4820-95c8-0c23c369702c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0890ac2e-eb6c-4503-97c7-6a10608e4f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_a75129ca-35f9-4820-95c8-0c23c369702c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0890ac2e-eb6c-4503-97c7-6a10608e4f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="simple" xlink:href="dva-20210331.xsd#RevenueRecognitionSegmentrevenuebymajorpayorTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenuesbymajorpayorAbstract_09506b79-71d0-4947-83ce-bcfd9a09d63c" xlink:href="dva-20210331.xsd#dva_RevenuesbymajorpayorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_53149d0d-8082-4b52-8e32-2a77e8614348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_RevenuesbymajorpayorAbstract_09506b79-71d0-4947-83ce-bcfd9a09d63c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_53149d0d-8082-4b52-8e32-2a77e8614348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#RevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract_0ac78de8-982e-4a9c-942c-1f49d497f301" xlink:href="dva-20210331.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract_0ac78de8-982e-4a9c-942c-1f49d497f301" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a8e301b9-01ba-41b4-aa6e-1da33e2e49ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a8e301b9-01ba-41b4-aa6e-1da33e2e49ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cc17f0aa-5bef-4aa8-93bc-b935b6e3babb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a8e301b9-01ba-41b4-aa6e-1da33e2e49ba" xlink:to="loc_us-gaap_SegmentDomain_cc17f0aa-5bef-4aa8-93bc-b935b6e3babb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_74daf12c-aa92-4b62-bc86-8b6a452981e0" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cc17f0aa-5bef-4aa8-93bc-b935b6e3babb" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_74daf12c-aa92-4b62-bc86-8b6a452981e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_4b7a58cb-8224-4c25-8a30-e053a793710a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cc17f0aa-5bef-4aa8-93bc-b935b6e3babb" xlink:to="loc_us-gaap_AllOtherSegmentsMember_4b7a58cb-8224-4c25-8a30-e053a793710a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_c3583263-3a0c-4ec0-a112-d63c04b987f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_c3583263-3a0c-4ec0-a112-d63c04b987f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_c3583263-3a0c-4ec0-a112-d63c04b987f8" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_6d675ab2-7fec-4c1e-99cb-22a3276e52d3" xlink:href="dva-20210331.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_6d675ab2-7fec-4c1e-99cb-22a3276e52d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_9ae402c7-c35b-4530-bd3f-fc86324e10d3" xlink:href="dva-20210331.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_9ae402c7-c35b-4530-bd3f-fc86324e10d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_e0b45ce2-3b34-442f-84ad-7cbaf8b06a97" xlink:href="dva-20210331.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_OtherGovernmentPayorsMember_e0b45ce2-3b34-442f-84ad-7cbaf8b06a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_d0911c7a-1fd2-41a7-b08e-beae7ed9a5c6" xlink:href="dva-20210331.xsd#dva_CommercialPayorsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_CommercialPayorsMember_d0911c7a-1fd2-41a7-b08e-beae7ed9a5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_9c3f9714-a406-4136-ba8d-5fa7a3161302" xlink:href="dva-20210331.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_bbb46e51-5777-4927-b86b-98d96d649407" xlink:to="loc_dva_OtherSourcesofRevenueMember_9c3f9714-a406-4136-ba8d-5fa7a3161302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f3caab97-7c3a-43a8-996a-4d268435d103" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:to="loc_srt_ConsolidationItemsAxis_f3caab97-7c3a-43a8-996a-4d268435d103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3286cb97-5d6e-4315-b7e9-350472986169" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f3caab97-7c3a-43a8-996a-4d268435d103" xlink:to="loc_srt_ConsolidationItemsDomain_3286cb97-5d6e-4315-b7e9-350472986169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_fe2d453b-bb2a-4aa1-a4e7-d4262b5c6351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3286cb97-5d6e-4315-b7e9-350472986169" xlink:to="loc_us-gaap_IntersegmentEliminationMember_fe2d453b-bb2a-4aa1-a4e7-d4262b5c6351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ed7c0f2b-cd3f-4164-b1cf-32e379399c82" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8229a6be-071a-469c-8f3e-cb939c0574ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8229a6be-071a-469c-8f3e-cb939c0574ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_b2749609-d646-48ac-a022-14af1d27e845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:to="loc_us-gaap_OtherIncome_b2749609-d646-48ac-a022-14af1d27e845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8b0cddbe-4a2d-402f-860c-f63c5fbd495c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64c96f19-7e1f-4bb5-8065-19fe5dbf0d55" xlink:to="loc_us-gaap_Revenues_8b0cddbe-4a2d-402f-860c-f63c5fbd495c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareNotes" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspershareNotes"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspershareNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_675c0bf7-5ff6-476f-9e60-41cb91c29139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_82688f98-992b-4b69-b314-a8d283a0b16d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_675c0bf7-5ff6-476f-9e60-41cb91c29139" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_82688f98-992b-4b69-b314-a8d283a0b16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspersharePolicies" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspersharePolicies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspersharePolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspershareEarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_506edda3-9c76-4bc1-a129-2deed76eec4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8bd01025-11bc-4821-a488-4eb2cf5053eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_506edda3-9c76-4bc1-a129-2deed76eec4c" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8bd01025-11bc-4821-a488-4eb2cf5053eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_51e3ace6-2f71-4a67-9443-b64d1f530849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_185b0bf0-d84e-4355-a52e-d9158fd44df8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_51e3ace6-2f71-4a67-9443-b64d1f530849" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_185b0bf0-d84e-4355-a52e-d9158fd44df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_50a55f52-e191-4fd0-9dce-4d81da515c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_185b0bf0-d84e-4355-a52e-d9158fd44df8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_50a55f52-e191-4fd0-9dce-4d81da515c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_dd89ba4f-5be6-48bf-afc0-7c441e4e04d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_185b0bf0-d84e-4355-a52e-d9158fd44df8" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_dd89ba4f-5be6-48bf-afc0-7c441e4e04d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_745230b8-cce9-40d7-90d3-66aa5da9f414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_185b0bf0-d84e-4355-a52e-d9158fd44df8" xlink:to="loc_us-gaap_NetIncomeLoss_745230b8-cce9-40d7-90d3-66aa5da9f414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_008ca571-f940-4c2a-b83f-d12fde9fcfb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_185b0bf0-d84e-4355-a52e-d9158fd44df8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_008ca571-f940-4c2a-b83f-d12fde9fcfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3243d251-724b-4a59-8d05-dddd5c736957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_185b0bf0-d84e-4355-a52e-d9158fd44df8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3243d251-724b-4a59-8d05-dddd5c736957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_23c66e6a-a362-44bb-a40d-ca69c736896f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_185b0bf0-d84e-4355-a52e-d9158fd44df8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_23c66e6a-a362-44bb-a40d-ca69c736896f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_964ac388-6c9d-4774-bd2c-79667d71ec88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_51e3ace6-2f71-4a67-9443-b64d1f530849" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_964ac388-6c9d-4774-bd2c-79667d71ec88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_40c2e788-8064-4d45-a5de-9dd505cf2266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_964ac388-6c9d-4774-bd2c-79667d71ec88" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_40c2e788-8064-4d45-a5de-9dd505cf2266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_24f2c8e2-6010-43ea-ab57-226696d30aec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_964ac388-6c9d-4774-bd2c-79667d71ec88" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_24f2c8e2-6010-43ea-ab57-226696d30aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_708148b5-6687-429b-bd54-45dfc7dfe7ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_964ac388-6c9d-4774-bd2c-79667d71ec88" xlink:to="loc_us-gaap_EarningsPerShareBasic_708148b5-6687-429b-bd54-45dfc7dfe7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_9e7963dd-cfc7-4174-b2c3-1ab1ae1e4944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_51e3ace6-2f71-4a67-9443-b64d1f530849" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_9e7963dd-cfc7-4174-b2c3-1ab1ae1e4944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_52750029-bd08-4152-8f8d-6027f06c53fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9e7963dd-cfc7-4174-b2c3-1ab1ae1e4944" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_52750029-bd08-4152-8f8d-6027f06c53fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_9cc7a8f6-f7fb-4b68-b8c3-3ce33713b21f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9e7963dd-cfc7-4174-b2c3-1ab1ae1e4944" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_9cc7a8f6-f7fb-4b68-b8c3-3ce33713b21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_69477d80-d032-4627-8e0c-76013b297d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9e7963dd-cfc7-4174-b2c3-1ab1ae1e4944" xlink:to="loc_us-gaap_EarningsPerShareDiluted_69477d80-d032-4627-8e0c-76013b297d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_965f0616-fc47-4a02-9e5c-aebc418f8bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9e7963dd-cfc7-4174-b2c3-1ab1ae1e4944" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_965f0616-fc47-4a02-9e5c-aebc418f8bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="simple" xlink:href="dva-20210331.xsd#Investmentsindebtandequitysecurities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fa48ca13-231e-4b66-83b5-84d178545588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_95bbc2c1-9378-412b-be86-052ac00969eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fa48ca13-231e-4b66-83b5-84d178545588" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_95bbc2c1-9378-412b-be86-052ac00969eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="simple" xlink:href="dva-20210331.xsd#InvestmentsindebtandequitysecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3443c1fe-8160-4145-ac96-4ee1567515a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_f7e586d1-a933-4bd0-a376-6bfd06ad46be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3443c1fe-8160-4145-ac96-4ee1567515a9" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_f7e586d1-a933-4bd0-a376-6bfd06ad46be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#InvestmentsindebtandequitysecuritiesDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ff4e60f9-8de3-4654-a3c1-c38af15a4dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_e547ae72-9d7c-4110-8885-b0d1348f4f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ff4e60f9-8de3-4654-a3c1-c38af15a4dca" xlink:to="loc_us-gaap_InvestmentHoldingsTable_e547ae72-9d7c-4110-8885-b0d1348f4f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_db0cd036-5090-427b-996b-ac1e36d8c712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_e547ae72-9d7c-4110-8885-b0d1348f4f3a" xlink:to="loc_us-gaap_InvestmentTypeAxis_db0cd036-5090-427b-996b-ac1e36d8c712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_db0cd036-5090-427b-996b-ac1e36d8c712" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_ad0a0ec8-41ed-4981-beba-b3d95afcd1ae" xlink:href="dva-20210331.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_ad0a0ec8-41ed-4981-beba-b3d95afcd1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_fe68d7a5-4e1f-4d33-b482-1a32a4449b47" xlink:href="dva-20210331.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:to="loc_dva_MutualFundsAndCommonStockMember_fe68d7a5-4e1f-4d33-b482-1a32a4449b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_2587b4d7-341c-4979-96a9-5445d24a817e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_2587b4d7-341c-4979-96a9-5445d24a817e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_c4ee0e7a-af5f-4999-8fc4-a90a89c43458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8597ff4b-1c3f-44bc-a6a3-a5fb9f0d7159" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_c4ee0e7a-af5f-4999-8fc4-a90a89c43458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_e547ae72-9d7c-4110-8885-b0d1348f4f3a" xlink:to="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_5cd4731b-8fe3-4d92-a938-3db8bb307f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_HeldToMaturitySecurities_5cd4731b-8fe3-4d92-a938-3db8bb307f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_d0e2e187-af71-458e-a934-f486107292fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_d0e2e187-af71-458e-a934-f486107292fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_2eaa8ca7-ead0-40be-a755-25dbc9a03e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_MarketableSecurities_2eaa8ca7-ead0-40be-a755-25dbc9a03e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_6dfec9a4-9845-4f6f-a445-d57503438bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_6dfec9a4-9845-4f6f-a445-d57503438bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_8d5efafd-ac3a-4572-abe6-439fdcb84e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_8d5efafd-ac3a-4572-abe6-439fdcb84e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_c1418fa8-7d7c-4d11-bb43-b9441047d24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_c1418fa8-7d7c-4d11-bb43-b9441047d24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_b433b076-8051-432c-9daa-2661d18343fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_4d0dea03-1e97-44b3-8219-79542723d03e" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_b433b076-8051-432c-9daa-2661d18343fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Goodwill" xlink:type="simple" xlink:href="dva-20210331.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dea89ab1-a605-40a7-983e-faa0dec5d921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_e4f37007-1533-446a-8b7d-0b7f3ae8be42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dea89ab1-a605-40a7-983e-faa0dec5d921" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_e4f37007-1533-446a-8b7d-0b7f3ae8be42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillTables" xlink:type="simple" xlink:href="dva-20210331.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_98997251-2202-4655-abd6-b13f2de73545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_290429ec-dcc1-48b9-840d-d82496c8b943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_98997251-2202-4655-abd6-b13f2de73545" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_290429ec-dcc1-48b9-840d-d82496c8b943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#GoodwillChangesinGoodwillbyReportableSegmentsDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ab149173-3794-466c-80c1-b42d3cb1d624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4c06a86a-15b2-467c-85c2-82be4e4abfc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ab149173-3794-466c-80c1-b42d3cb1d624" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4c06a86a-15b2-467c-85c2-82be4e4abfc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8bcb3f96-2ecc-4495-81aa-34484555eb36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4c06a86a-15b2-467c-85c2-82be4e4abfc8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8bcb3f96-2ecc-4495-81aa-34484555eb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b8272384-f09b-44d2-9712-4213aa6e335a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8bcb3f96-2ecc-4495-81aa-34484555eb36" xlink:to="loc_us-gaap_SegmentDomain_b8272384-f09b-44d2-9712-4213aa6e335a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_06a77839-6b80-4076-86fd-e7adc12dbae7" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b8272384-f09b-44d2-9712-4213aa6e335a" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_06a77839-6b80-4076-86fd-e7adc12dbae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_1e0dd87b-ff60-4f94-ba8e-1ea61cfdc029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b8272384-f09b-44d2-9712-4213aa6e335a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_1e0dd87b-ff60-4f94-ba8e-1ea61cfdc029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4c06a86a-15b2-467c-85c2-82be4e4abfc8" xlink:to="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:to="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ff207301-d10c-4880-ab45-6ec0ed989a92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:to="loc_us-gaap_Goodwill_ff207301-d10c-4880-ab45-6ec0ed989a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3b01a33a-113f-46ea-845a-981005c54ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3b01a33a-113f-46ea-845a-981005c54ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_cdbe645b-d9bd-4c16-ae04-467bab79d107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_cdbe645b-d9bd-4c16-ae04-467bab79d107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3cf271ce-2fee-40cf-adae-6e974c14f4e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3cf271ce-2fee-40cf-adae-6e974c14f4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e2fcb454-f68b-40ee-b46e-d967754f69ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_53de7aa4-bc41-4c5a-bda0-c5f0c81ed22b" xlink:to="loc_us-gaap_Goodwill_e2fcb454-f68b-40ee-b46e-d967754f69ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_1c56806a-230f-4454-8a39-639071101fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:to="loc_us-gaap_GoodwillGross_1c56806a-230f-4454-8a39-639071101fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_dc65de63-8293-4f5f-8d0c-5500b1f1a492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_dc65de63-8293-4f5f-8d0c-5500b1f1a492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a19012ba-7c57-40fd-9393-60c2a6bb4d37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fa38ea50-cdde-4910-a509-2683abb72bff" xlink:to="loc_us-gaap_Goodwill_a19012ba-7c57-40fd-9393-60c2a6bb4d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#GoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e640ffc3-9032-41dc-95a0-4e168c924313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_93aeb92b-9f57-41b6-b030-49f34b2a10a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e640ffc3-9032-41dc-95a0-4e168c924313" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_93aeb92b-9f57-41b6-b030-49f34b2a10a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f7ed3dee-c1c9-43d4-906d-de7f661943ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_93aeb92b-9f57-41b6-b030-49f34b2a10a3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f7ed3dee-c1c9-43d4-906d-de7f661943ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6a97397a-98f5-4325-baad-77fee3c6ee14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f7ed3dee-c1c9-43d4-906d-de7f661943ba" xlink:to="loc_us-gaap_SegmentDomain_6a97397a-98f5-4325-baad-77fee3c6ee14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_febc3770-decc-4d5a-8c0f-b49111d7e110" xlink:href="dva-20210331.xsd#dva_OtherReportingUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6a97397a-98f5-4325-baad-77fee3c6ee14" xlink:to="loc_dva_OtherReportingUnitsMember_febc3770-decc-4d5a-8c0f-b49111d7e110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_33d6ba44-67fa-4aaa-821f-e61c554cf6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_93aeb92b-9f57-41b6-b030-49f34b2a10a3" xlink:to="loc_us-gaap_GoodwillLineItems_33d6ba44-67fa-4aaa-821f-e61c554cf6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_085a8878-f506-456b-9add-65f5fef000cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_33d6ba44-67fa-4aaa-821f-e61c554cf6df" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_085a8878-f506-456b-9add-65f5fef000cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b3c2f53c-91bc-426a-94df-5f004d99bb0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_33d6ba44-67fa-4aaa-821f-e61c554cf6df" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b3c2f53c-91bc-426a-94df-5f004d99bb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Longtermdebt" xlink:type="simple" xlink:href="dva-20210331.xsd#Longtermdebt"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Longtermdebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_673ee775-a649-470f-a135-3b8e3ffd1fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_6471f256-29b1-41fa-993e-115aef7431b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_673ee775-a649-470f-a135-3b8e3ffd1fc2" xlink:to="loc_us-gaap_LongTermDebtTextBlock_6471f256-29b1-41fa-993e-115aef7431b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtTables" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e795439a-95b7-4641-9f9d-846fe333e4ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e25fd4e0-7e08-420b-8f8c-85806981cd44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e795439a-95b7-4641-9f9d-846fe333e4ec" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e25fd4e0-7e08-420b-8f8c-85806981cd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_cedb516c-7df0-45ef-ae9a-6250470d7285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e795439a-95b7-4641-9f9d-846fe333e4ec" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_cedb516c-7df0-45ef-ae9a-6250470d7285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_90b41152-a8e6-4f50-a84c-99b9a9c27854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_90b41152-a8e6-4f50-a84c-99b9a9c27854" xlink:to="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b673091b-2fae-412e-a483-77ea962c3d47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b673091b-2fae-412e-a483-77ea962c3d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b673091b-2fae-412e-a483-77ea962c3d47" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_5d3f1387-27c1-4cc1-8da9-533b6040814c" xlink:href="dva-20210331.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:to="loc_dva_TermLoanAMember_5d3f1387-27c1-4cc1-8da9-533b6040814c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_87cf65d9-2f9c-4dd2-8faa-b81bb67c0c15" xlink:href="dva-20210331.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:to="loc_dva_TermLoanB1Member_87cf65d9-2f9c-4dd2-8faa-b81bb67c0c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_89dab7df-1b51-4c5f-b27b-3cca912f2aa6" xlink:href="dva-20210331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_89dab7df-1b51-4c5f-b27b-3cca912f2aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_51c82ffb-9abd-4747-b5c5-97d78ef813f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_faeb9e80-d2be-4bec-b90c-3f61db35828f" xlink:to="loc_us-gaap_SeniorNotesMember_51c82ffb-9abd-4747-b5c5-97d78ef813f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9deffca9-f0a6-4101-a17b-03ac2f584b57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:to="loc_us-gaap_CreditFacilityAxis_9deffca9-f0a6-4101-a17b-03ac2f584b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8961c854-7c70-4129-a480-c9f41295d571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_9deffca9-f0a6-4101-a17b-03ac2f584b57" xlink:to="loc_us-gaap_CreditFacilityDomain_8961c854-7c70-4129-a480-c9f41295d571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fc8c49af-fae8-451b-a32e-cf601ef74c9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8961c854-7c70-4129-a480-c9f41295d571" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fc8c49af-fae8-451b-a32e-cf601ef74c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_337ff5ff-b047-46a1-a08f-a81882b235af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:to="loc_us-gaap_DebtInstrumentAxis_337ff5ff-b047-46a1-a08f-a81882b235af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_337ff5ff-b047-46a1-a08f-a81882b235af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_1c5de288-838f-44d5-84fd-07815e916ca6" xlink:href="dva-20210331.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_1c5de288-838f-44d5-84fd-07815e916ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_2a6501d8-1c6d-4da9-9aeb-915e88b90dda" xlink:href="dva-20210331.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_2a6501d8-1c6d-4da9-9aeb-915e88b90dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_16908099-6126-49a1-ab9d-decc80688266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_16908099-6126-49a1-ab9d-decc80688266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_e019fa11-1269-47b8-99a9-61b911567e92" xlink:href="dva-20210331.xsd#dva_FinanceLeaseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8b23889-f499-4a21-b416-1ee61a4049fb" xlink:to="loc_dva_FinanceLeaseMember_e019fa11-1269-47b8-99a9-61b911567e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb9cc785-8526-4887-ab11-15c2434173c1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_d17cfa4c-d7ce-4be2-951d-9b86e0f98970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentsAbstract_d17cfa4c-d7ce-4be2-951d-9b86e0f98970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_85ae4098-d386-49af-af97-416e88d5b997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_SecuredDebt_85ae4098-d386-49af-af97-416e88d5b997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_479538e8-6352-49ee-9a69-2acd57d0e4f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_479538e8-6352-49ee-9a69-2acd57d0e4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_11f43954-b545-4502-a564-e772b3641d98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_SeniorNotes_11f43954-b545-4502-a564-e772b3641d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_b8236eca-f47d-4af7-a734-472714948063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_b8236eca-f47d-4af7-a734-472714948063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_88a82194-9510-45f5-9d3b-130de79a0fcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_88a82194-9510-45f5-9d3b-130de79a0fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_0b52c183-498e-4178-b453-0e87e3f052d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentFairValue_0b52c183-498e-4178-b453-0e87e3f052d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_08e2aaf2-176e-47d0-b31e-bbb609f5c6fb" xlink:href="dva-20210331.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_08e2aaf2-176e-47d0-b31e-bbb609f5c6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4653a2fc-d03f-4f2f-8366-bab7a0d3cd2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_FinanceLeaseLiability_4653a2fc-d03f-4f2f-8366-bab7a0d3cd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_0fcd49b7-7110-49d1-9e7c-21def35eb5a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_0fcd49b7-7110-49d1-9e7c-21def35eb5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_3764a75d-f237-4f94-a3c4-67994da6d1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_3764a75d-f237-4f94-a3c4-67994da6d1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_568c7b86-b4d5-47ac-a2e6-75d30292cc90" xlink:href="dva-20210331.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_568c7b86-b4d5-47ac-a2e6-75d30292cc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ec344809-10e1-4f2b-b239-42f846d9f758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ec344809-10e1-4f2b-b239-42f846d9f758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d7050525-8e5f-4936-96d2-ceb3c0a960b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d7050525-8e5f-4936-96d2-ceb3c0a960b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts_3920950d-5537-4183-9e62-432fa6645b3c" xlink:href="dva-20210331.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_dva_DiscountAndDeferredFinanceCosts_3920950d-5537-4183-9e62-432fa6645b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_ba3afae5-2fe8-4ffd-9194-34f01cf82a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_ba3afae5-2fe8-4ffd-9194-34f01cf82a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5e31d97b-111c-4882-bf8e-516fd504866b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5e31d97b-111c-4882-bf8e-516fd504866b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0902aba7-82ee-4969-b553-f9a59d87aa3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0902aba7-82ee-4969-b553-f9a59d87aa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4fd9e188-fa52-4cbd-8c97-9049c8767f1a" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ed6fe28f-3b36-4de9-9d53-01c2a00d933e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ed6fe28f-3b36-4de9-9d53-01c2a00d933e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_3efd3b81-14ba-4e4a-9138-8c16a95868aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_3efd3b81-14ba-4e4a-9138-8c16a95868aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_6a57c493-2f6b-48df-afaf-89dc2f630316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_9acd1e73-c9b7-49b9-9e5e-ffe2099563d7" xlink:to="loc_us-gaap_DeferredOfferingCosts_6a57c493-2f6b-48df-afaf-89dc2f630316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtScheduleofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract_2d2843a1-aee8-4607-a251-1c2b45301892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfDerivativeInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract_2d2843a1-aee8-4607-a251-1c2b45301892" xlink:to="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ee4f2a04-2b19-42dc-8646-5cde9178f739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_DebtInstrumentAxis_ee4f2a04-2b19-42dc-8646-5cde9178f739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_afd23c1d-8d17-4493-a941-ff3b0d5aeabe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ee4f2a04-2b19-42dc-8646-5cde9178f739" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_afd23c1d-8d17-4493-a941-ff3b0d5aeabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_347ac49c-cbe8-40cb-a820-bb7f3932a27e" xlink:href="dva-20210331.xsd#dva_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afd23c1d-8d17-4493-a941-ff3b0d5aeabe" xlink:to="loc_dva_TermLoanFacilityMember_347ac49c-cbe8-40cb-a820-bb7f3932a27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_df3e90a8-8af0-449f-b402-3e4541c826f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_srt_RangeAxis_df3e90a8-8af0-449f-b402-3e4541c826f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73036eb5-88cd-4292-af58-243d52865b9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_df3e90a8-8af0-449f-b402-3e4541c826f8" xlink:to="loc_srt_RangeMember_73036eb5-88cd-4292-af58-243d52865b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_28e6ea67-a94b-47f4-b07e-951361ae1033" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_73036eb5-88cd-4292-af58-243d52865b9d" xlink:to="loc_srt_MaximumMember_28e6ea67-a94b-47f4-b07e-951361ae1033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c7c2612c-43e8-44f1-90e9-12a85d960bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c7c2612c-43e8-44f1-90e9-12a85d960bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b3553cf7-592e-4820-88d7-c36c894c8557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c7c2612c-43e8-44f1-90e9-12a85d960bd5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b3553cf7-592e-4820-88d7-c36c894c8557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_7b419316-3b00-4696-860d-92565f1b0e5c" xlink:href="dva-20210331.xsd#dva_DebtExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b3553cf7-592e-4820-88d7-c36c894c8557" xlink:to="loc_dva_DebtExpenseMember_7b419316-3b00-4696-860d-92565f1b0e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed56dcc-9eaf-4fc2-8026-258510b94a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed56dcc-9eaf-4fc2-8026-258510b94a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b133453e-50e4-4611-a20e-b7b94b8478b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed56dcc-9eaf-4fc2-8026-258510b94a90" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b133453e-50e4-4611-a20e-b7b94b8478b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_07f6d680-a6b3-4e5b-be5f-acaa74425294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b133453e-50e4-4611-a20e-b7b94b8478b6" xlink:to="loc_us-gaap_CashFlowHedgingMember_07f6d680-a6b3-4e5b-be5f-acaa74425294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_74ddad0d-8915-4fff-a987-94ced6a87ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_74ddad0d-8915-4fff-a987-94ced6a87ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f14eb82a-b5e8-4e97-bb93-13e89abed606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_74ddad0d-8915-4fff-a987-94ced6a87ab4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f14eb82a-b5e8-4e97-bb93-13e89abed606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_e1e99b49-496a-47e4-8581-5fa1b8708f72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f14eb82a-b5e8-4e97-bb93-13e89abed606" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_e1e99b49-496a-47e4-8581-5fa1b8708f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9fbf2971-1ac0-44f1-837c-8c9e505c1692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9fbf2971-1ac0-44f1-837c-8c9e505c1692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0af89952-336a-4a42-866b-1e8ab99fff2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9fbf2971-1ac0-44f1-837c-8c9e505c1692" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0af89952-336a-4a42-866b-1e8ab99fff2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_0af8902d-d015-4c0e-aef3-a727fb5644b9" xlink:href="dva-20210331.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0af89952-336a-4a42-866b-1e8ab99fff2d" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_0af8902d-d015-4c0e-aef3-a727fb5644b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c3203ab4-fa1c-44c6-a70a-25e531f955b6" xlink:to="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_677489ef-fe71-42d7-803d-e6bb812b066a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_677489ef-fe71-42d7-803d-e6bb812b066a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b4faffd8-85cb-4984-804e-2c07c505dca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b4faffd8-85cb-4984-804e-2c07c505dca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_6e464b07-acf8-4949-9f2f-65cd340ade28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeInceptionDates_6e464b07-acf8-4949-9f2f-65cd340ade28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_965c9afa-9ef3-41fa-8932-179e4b4a8cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeMaturityDates_965c9afa-9ef3-41fa-8932-179e4b4a8cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_0d21299f-9565-460e-b9c5-4c386582ede9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_0d21299f-9565-460e-b9c5-4c386582ede9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_f7fbf6a3-3160-4207-aa66-2d516eb551de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_f7fbf6a3-3160-4207-aa66-2d516eb551de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7fbdabba-e7f3-452a-b460-6faf7088068d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1afbecfe-24c2-4498-b1b4-79751ce36e8d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7fbdabba-e7f3-452a-b460-6faf7088068d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermdebtAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a8b50d52-16d0-4b57-a6f9-9f066185be82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a8b50d52-16d0-4b57-a6f9-9f066185be82" xlink:to="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d9fba480-9576-4f27-893d-644d61d817b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d9fba480-9576-4f27-893d-644d61d817b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d9fba480-9576-4f27-893d-644d61d817b1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_0a027c13-3906-48db-8dd9-93856f865ca1" xlink:href="dva-20210331.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:to="loc_dva_TermLoanAMember_0a027c13-3906-48db-8dd9-93856f865ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_c5fe4e21-e364-4e63-85d8-e0c4765d0761" xlink:href="dva-20210331.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:to="loc_dva_TermLoanB1Member_c5fe4e21-e364-4e63-85d8-e0c4765d0761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_412e6456-c31f-43dc-988b-01fab42a7d8c" xlink:href="dva-20210331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d3d9913-12ca-4d8e-b557-2cf738393b72" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_412e6456-c31f-43dc-988b-01fab42a7d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4e338af1-c778-41c5-9c0c-677f8321b6a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:to="loc_us-gaap_CreditFacilityAxis_4e338af1-c778-41c5-9c0c-677f8321b6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4e338af1-c778-41c5-9c0c-677f8321b6a2" xlink:to="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_803f591f-ef3f-4c79-b000-b243f01f43d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_803f591f-ef3f-4c79-b000-b243f01f43d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ad96b1f5-1d5f-43bc-a3e3-cc09d476aac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:to="loc_us-gaap_LetterOfCreditMember_ad96b1f5-1d5f-43bc-a3e3-cc09d476aac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_616eae25-7a94-4ae2-bf58-641553317593" xlink:href="dva-20210331.xsd#dva_BilateralSecuredLetterOfCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a7898843-f7c9-4c37-83c7-187c3e5c1a7a" xlink:to="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_616eae25-7a94-4ae2-bf58-641553317593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c4ac3cf1-fccf-4bff-84eb-6f57fcbb8ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:to="loc_us-gaap_DebtInstrumentAxis_c4ac3cf1-fccf-4bff-84eb-6f57fcbb8ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6bf35c20-5d66-440c-a984-07e80a02bc9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c4ac3cf1-fccf-4bff-84eb-6f57fcbb8ed1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6bf35c20-5d66-440c-a984-07e80a02bc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_1457598a-11f5-4e56-a616-73db886e7eca" xlink:href="dva-20210331.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6bf35c20-5d66-440c-a984-07e80a02bc9a" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_1457598a-11f5-4e56-a616-73db886e7eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f751059e-d015-45d8-af76-304c600af73d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_63417e8b-d4a6-409c-9bab-5ee38c98a146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_63417e8b-d4a6-409c-9bab-5ee38c98a146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_5141a930-5c24-4329-830e-69ea13aa9ef4" xlink:href="dva-20210331.xsd#dva_AdditionalDebtPrincipalAmountDueToNewAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_5141a930-5c24-4329-830e-69ea13aa9ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_664dff8e-75a4-4518-9bb5-c32628c94687" xlink:href="dva-20210331.xsd#dva_DebtInstrumentOfferingPricePercentageOfFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_664dff8e-75a4-4518-9bb5-c32628c94687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_cd67a1e6-6e65-4083-8f43-eccbe0e91d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_cd67a1e6-6e65-4083-8f43-eccbe0e91d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_8646723c-d9dc-430c-964d-ab931fabcd73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_SeniorNotes_8646723c-d9dc-430c-964d-ab931fabcd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_1f20a7d6-a6a0-43b0-83c3-3187ff038073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_1f20a7d6-a6a0-43b0-83c3-3187ff038073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_3300d5a9-1cc2-47d2-91c1-0f143f3912bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LineOfCredit_3300d5a9-1cc2-47d2-91c1-0f143f3912bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_55d8635a-d61e-4760-a9cc-79a51db89c96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_55d8635a-d61e-4760-a9cc-79a51db89c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_d9930da7-1a58-4c21-aa0c-3e9390ff4c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_d9930da7-1a58-4c21-aa0c-3e9390ff4c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_7669ae2c-dadd-46e0-bd6d-17ad57b07d31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_7669ae2c-dadd-46e0-bd6d-17ad57b07d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_11d9d9ee-7baa-4b00-9b45-e1e9ae51905d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_11d9d9ee-7baa-4b00-9b45-e1e9ae51905d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_02088a83-a34e-4730-816c-afb71fa822e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_61d908e6-b6bb-42cd-9aea-678098321288" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_02088a83-a34e-4730-816c-afb71fa822e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="dva-20210331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_68dac976-4290-49a6-8880-b427291485ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_17a66bea-e76c-4127-b147-a652b47ed6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_68dac976-4290-49a6-8880-b427291485ff" xlink:to="loc_us-gaap_LossContingencyDisclosures_17a66bea-e76c-4127-b147-a652b47ed6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_49c92c6e-4cef-41ba-a06a-457fb82360c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_68dac976-4290-49a6-8880-b427291485ff" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_49c92c6e-4cef-41ba-a06a-457fb82360c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_20c391b7-8328-4cf3-8fed-26d6d5b4a767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_20c391b7-8328-4cf3-8fed-26d6d5b4a767" xlink:to="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_880542b6-c944-42fe-897e-1942b5794de4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:to="loc_us-gaap_TransactionTypeAxis_880542b6-c944-42fe-897e-1942b5794de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_d264edf0-65c9-4b99-a67b-459beccb8e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_880542b6-c944-42fe-897e-1942b5794de4" xlink:to="loc_us-gaap_TransactionDomain_d264edf0-65c9-4b99-a67b-459beccb8e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember_68d3072f-a79b-4ceb-9bf2-8e80f7bb9599" xlink:href="dva-20210331.xsd#dva_IncrementalCashPortionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_d264edf0-65c9-4b99-a67b-459beccb8e39" xlink:to="loc_dva_IncrementalCashPortionMember_68d3072f-a79b-4ceb-9bf2-8e80f7bb9599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember_8e7cd962-7562-4172-87ca-f4a5a4b52669" xlink:href="dva-20210331.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_d264edf0-65c9-4b99-a67b-459beccb8e39" xlink:to="loc_dva_CashPaidForPortionPreviouslyRefundedMember_8e7cd962-7562-4172-87ca-f4a5a4b52669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f56079ae-5345-4c02-9a8a-afe71fb096e8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:to="loc_srt_LitigationCaseAxis_f56079ae-5345-4c02-9a8a-afe71fb096e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_27c4264a-2a4f-4e4c-ada4-d81b7bb5062f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_f56079ae-5345-4c02-9a8a-afe71fb096e8" xlink:to="loc_srt_LitigationCaseTypeDomain_27c4264a-2a4f-4e4c-ada4-d81b7bb5062f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_b572fbab-22b7-4932-8d35-c815554c70bb" xlink:href="dva-20210331.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_27c4264a-2a4f-4e4c-ada4-d81b7bb5062f" xlink:to="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_b572fbab-22b7-4932-8d35-c815554c70bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockholderDerivativeLitigationMember_09ec66aa-43d5-483f-8271-d8520fabdd16" xlink:href="dva-20210331.xsd#dva_StockholderDerivativeLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_27c4264a-2a4f-4e4c-ada4-d81b7bb5062f" xlink:to="loc_dva_StockholderDerivativeLitigationMember_09ec66aa-43d5-483f-8271-d8520fabdd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_804d0ce5-1edd-42c3-9d83-77105e3529e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:to="loc_us-gaap_OtherCommitmentsAxis_804d0ce5-1edd-42c3-9d83-77105e3529e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_8017d664-63cf-4757-ade3-8c9f12a14016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_804d0ce5-1edd-42c3-9d83-77105e3529e1" xlink:to="loc_us-gaap_OtherCommitmentsDomain_8017d664-63cf-4757-ade3-8c9f12a14016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_2335627f-b3d3-44a5-9b9d-3b823d348d60" xlink:href="dva-20210331.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_8017d664-63cf-4757-ade3-8c9f12a14016" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_2335627f-b3d3-44a5-9b9d-3b823d348d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_aaeb7303-5a64-4ef7-b61c-9bf8b0cfc8c1" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8ce775da-2af6-4623-a24d-ae9024a904be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8ce775da-2af6-4623-a24d-ae9024a904be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementPeriod_f0e91eb9-7287-4cce-b4c2-bc9c48b0ce7c" xlink:href="dva-20210331.xsd#dva_CorporateIntegrityAgreementPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_dva_CorporateIntegrityAgreementPeriod_f0e91eb9-7287-4cce-b4c2-bc9c48b0ce7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementExpirationDate_8e638d56-887e-4bb3-86e8-c80f54b8500d" xlink:href="dva-20210331.xsd#dva_CorporateIntegrityAgreementExpirationDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_dva_CorporateIntegrityAgreementExpirationDate_8e638d56-887e-4bb3-86e8-c80f54b8500d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne_ddd2f32b-4e84-4e8d-9cb7-961cac71105d" xlink:href="dva-20210331.xsd#dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne_ddd2f32b-4e84-4e8d-9cb7-961cac71105d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_783ff057-ce10-4ff0-8bf1-149d4b1514f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_03c7519e-97c6-423e-981e-5ee4caeaafb3" xlink:to="loc_us-gaap_OtherCommitment_783ff057-ce10-4ff0-8bf1-149d4b1514f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Shareholdersequity" xlink:type="simple" xlink:href="dva-20210331.xsd#Shareholdersequity"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Shareholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_61e6a4b4-b793-4e05-a5e7-6e744b20f859" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019437e8-d0fd-4aea-a915-65663d37c869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_61e6a4b4-b793-4e05-a5e7-6e744b20f859" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019437e8-d0fd-4aea-a915-65663d37c869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_9e71a465-4703-4380-9592-110eca5481cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_61e6a4b4-b793-4e05-a5e7-6e744b20f859" xlink:to="loc_us-gaap_TreasuryStockTextBlock_9e71a465-4703-4380-9592-110eca5481cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables" xlink:type="simple" xlink:href="dva-20210331.xsd#SharerepurchasesShareRepurchasesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract_be24e521-30f3-4966-b0e8-0a2d6692670a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_1e37459c-2ce9-4e2f-bc14-554ddb0bb60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockValueAbstract_be24e521-30f3-4966-b0e8-0a2d6692670a" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_1e37459c-2ce9-4e2f-bc14-554ddb0bb60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#LongtermincentivecompensationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_f5857a6b-ea24-4417-a81a-6eb84ffb1dba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d318826-3cf8-4886-887a-36e1c0e83d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_f5857a6b-ea24-4417-a81a-6eb84ffb1dba" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d318826-3cf8-4886-887a-36e1c0e83d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d213a70e-feb3-49f6-9984-9f111e640f82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d318826-3cf8-4886-887a-36e1c0e83d06" xlink:to="loc_us-gaap_AwardTypeAxis_d213a70e-feb3-49f6-9984-9f111e640f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4be0293-b6be-4605-b1bb-0d725ec80c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d213a70e-feb3-49f6-9984-9f111e640f82" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4be0293-b6be-4605-b1bb-0d725ec80c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1e37bbfe-0f40-46a5-89c4-957d1c8106ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4be0293-b6be-4605-b1bb-0d725ec80c7d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1e37bbfe-0f40-46a5-89c4-957d1c8106ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_3f382da7-a070-422c-a75e-7a8cd5f862db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4be0293-b6be-4605-b1bb-0d725ec80c7d" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_3f382da7-a070-422c-a75e-7a8cd5f862db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d318826-3cf8-4886-887a-36e1c0e83d06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a3e9784d-45fa-4973-a761-7c8893e01e71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a3e9784d-45fa-4973-a761-7c8893e01e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_dcb95a96-df3f-4756-a2f1-c17e9a7c3baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_dcb95a96-df3f-4756-a2f1-c17e9a7c3baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_d269833c-088b-43a8-96e9-00694ead4889" xlink:href="dva-20210331.xsd#dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_d269833c-088b-43a8-96e9-00694ead4889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3c51b4a5-378b-4846-af4e-f840081fd423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3c51b4a5-378b-4846-af4e-f840081fd423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d23521a5-8f64-41ce-9cd2-6381b065c582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d23521a5-8f64-41ce-9cd2-6381b065c582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e76c5d7e-6cbc-4c11-9363-6a526f8c7da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_273db5cd-084b-446c-9e1c-f0ed8b0af5e9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e76c5d7e-6cbc-4c11-9363-6a526f8c7da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#SharerepurchasesShareRepurchaseTableDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract_0a810157-6a34-4bab-954c-408c49e28494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_8d610f5c-d906-46b4-b18d-d631aa7677f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockValueAbstract_0a810157-6a34-4bab-954c-408c49e28494" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_8d610f5c-d906-46b4-b18d-d631aa7677f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_dea0a900-2037-4dd3-986a-53847c19f8eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_8d610f5c-d906-46b4-b18d-d631aa7677f5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_dea0a900-2037-4dd3-986a-53847c19f8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_fa0a68d3-2072-4cc5-9a1d-4a3e076606cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_dea0a900-2037-4dd3-986a-53847c19f8eb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_fa0a68d3-2072-4cc5-9a1d-4a3e076606cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember_751edb2d-2c87-4372-a80a-e1d942fdfaa8" xlink:href="dva-20210331.xsd#dva_OpenMarketPurchasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_fa0a68d3-2072-4cc5-9a1d-4a3e076606cd" xlink:to="loc_dva_OpenMarketPurchasesMember_751edb2d-2c87-4372-a80a-e1d942fdfaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_8d610f5c-d906-46b4-b18d-d631aa7677f5" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c9994b49-17eb-4b58-b1b9-265dadd2aa56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c9994b49-17eb-4b58-b1b9-265dadd2aa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_acae9c50-6d22-47c6-ad7b-6dfe3798a0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_acae9c50-6d22-47c6-ad7b-6dfe3798a0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38056c65-ffd6-43b4-995d-42195703075f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_35cebbcf-9010-4181-9efa-a1b5465cb1ae" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38056c65-ffd6-43b4-995d-42195703075f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#SharerepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7568da09-123e-43a6-a948-fc48cd05d6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_3c90ee4c-6e46-4f0d-9315-320bf3e326d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7568da09-123e-43a6-a948-fc48cd05d6e4" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_3c90ee4c-6e46-4f0d-9315-320bf3e326d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c9ada7bd-ecd3-46be-a95a-469aafd1bbaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_3c90ee4c-6e46-4f0d-9315-320bf3e326d6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c9ada7bd-ecd3-46be-a95a-469aafd1bbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_dee6e50d-6d90-4dd9-b652-cdc162dad20d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c9ada7bd-ecd3-46be-a95a-469aafd1bbaa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_dee6e50d-6d90-4dd9-b652-cdc162dad20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4d51ec1e-b9a1-446c-85e8-69e93a468aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_dee6e50d-6d90-4dd9-b652-cdc162dad20d" xlink:to="loc_us-gaap_SubsequentEventMember_4d51ec1e-b9a1-446c-85e8-69e93a468aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_3c90ee4c-6e46-4f0d-9315-320bf3e326d6" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_2bb1daba-c9a9-4ab4-89e9-f65a555cb5b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_2bb1daba-c9a9-4ab4-89e9-f65a555cb5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_742753bd-6c7c-4c9c-9964-b82a6c39778d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_742753bd-6c7c-4c9c-9964-b82a6c39778d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_55d4f158-70ed-4d82-9051-20bac971b241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_55d4f158-70ed-4d82-9051-20bac971b241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_74e4e517-85c8-4a07-8e9b-101b78454da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_74e4e517-85c8-4a07-8e9b-101b78454da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_6e7fa760-53ea-468c-b06e-7f4d28ed00a4" xlink:href="dva-20210331.xsd#dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_6e7fa760-53ea-468c-b06e-7f4d28ed00a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_547a522c-8555-4c85-a5cc-6eba2254c19e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_67b2a932-de4f-4aa5-8066-1e6e777dd364" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_547a522c-8555-4c85-a5cc-6eba2254c19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="simple" xlink:href="dva-20210331.xsd#Accumulatedothercomprehensivelossincome"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9bcd0523-3f63-4313-be92-c65d0ae768f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_8a47c21d-3bc2-41e8-a8e2-0c40756c8b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9bcd0523-3f63-4313-be92-c65d0ae768f2" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_8a47c21d-3bc2-41e8-a8e2-0c40756c8b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="simple" xlink:href="dva-20210331.xsd#AccumulatedothercomprehensivelossincomeTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8d3a989-cb95-49d1-b9fb-01fc68472368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_32c3c306-d3bd-4527-bd69-65390d3cf6c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8d3a989-cb95-49d1-b9fb-01fc68472368" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_32c3c306-d3bd-4527-bd69-65390d3cf6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#AccumulatedothercomprehensivelossincomeDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3850dc1f-2493-4b70-87f6-91bf6d25d3ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bb71da31-0660-4a7c-9ed8-d4e1704994d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3850dc1f-2493-4b70-87f6-91bf6d25d3ce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bb71da31-0660-4a7c-9ed8-d4e1704994d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_62d9a724-9caf-419e-b94b-d595d92c570b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bb71da31-0660-4a7c-9ed8-d4e1704994d4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_62d9a724-9caf-419e-b94b-d595d92c570b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62d9a724-9caf-419e-b94b-d595d92c570b" xlink:to="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_b0db9c1a-da71-4e77-89d3-ec4e4907a960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_b0db9c1a-da71-4e77-89d3-ec4e4907a960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_def94da1-8c51-4a2b-a51c-2abb13ccff81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_def94da1-8c51-4a2b-a51c-2abb13ccff81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c351b92e-2180-4785-86a7-a635cea7e30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_afe7b9f9-ed13-4f09-bc52-15052d9c9687" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c351b92e-2180-4785-86a7-a635cea7e30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ee2f1fe2-972c-4a83-bcf3-67716426f185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bb71da31-0660-4a7c-9ed8-d4e1704994d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ee2f1fe2-972c-4a83-bcf3-67716426f185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ee2f1fe2-972c-4a83-bcf3-67716426f185" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cb45adc8-2cad-4e7f-9e56-7a9093262488" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cb45adc8-2cad-4e7f-9e56-7a9093262488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_68f220ed-3283-4d51-bd6b-a1ce279e80f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_68f220ed-3283-4d51-bd6b-a1ce279e80f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_68bd9a52-6e16-4390-a1cb-3b83e96cd4af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_68bd9a52-6e16-4390-a1cb-3b83e96cd4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2de5663b-442e-4424-9840-0c0859dfff99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2de5663b-442e-4424-9840-0c0859dfff99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7d8b5a96-174b-4b40-96ea-c2b514d37910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7d8b5a96-174b-4b40-96ea-c2b514d37910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_1930c67d-338f-40b3-888e-323d46a41cdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_1930c67d-338f-40b3-888e-323d46a41cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_160add15-0a43-4600-affd-0bf4d35de08a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_160add15-0a43-4600-affd-0bf4d35de08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3f24f7d9-a0d3-47e4-b52b-a977d7662efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_87f0a91f-9a32-49e7-a2e1-ba824bc9c8c1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3f24f7d9-a0d3-47e4-b52b-a977d7662efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Acquisitionsanddivestitures" xlink:type="simple" xlink:href="dva-20210331.xsd#Acquisitionsanddivestitures"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Acquisitionsanddivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_da06109d-b589-4d8e-aa0e-71b4dd578762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_cdccf41d-70e4-4a4b-a967-a287b5c4db25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_da06109d-b589-4d8e-aa0e-71b4dd578762" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_cdccf41d-70e4-4a4b-a967-a287b5c4db25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_bdcc6363-620e-4ad3-a1da-cef1307becde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_da06109d-b589-4d8e-aa0e-71b4dd578762" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_bdcc6363-620e-4ad3-a1da-cef1307becde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresTables" xlink:type="simple" xlink:href="dva-20210331.xsd#AcquisitionsanddivestituresTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6c03bf7e-e345-484c-b4bb-ff0c02811d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_7979ddb0-7135-45b4-a3be-dc804c67facc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6c03bf7e-e345-484c-b4bb-ff0c02811d7b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_7979ddb0-7135-45b4-a3be-dc804c67facc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#AcquisitionsanddivestituresContingentEarnoutobligationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_261b6609-a0fa-4ac0-9ebe-a86d20c8d164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_c26bd63d-94a1-4781-9d31-ab0fcc20d7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_261b6609-a0fa-4ac0-9ebe-a86d20c8d164" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_c26bd63d-94a1-4781-9d31-ab0fcc20d7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_e1b2ca97-1363-4e31-83a1-3f24c8c21dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_261b6609-a0fa-4ac0-9ebe-a86d20c8d164" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_e1b2ca97-1363-4e31-83a1-3f24c8c21dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_e3abf7e4-121b-4618-b2a1-e5100055b68f" xlink:href="dva-20210331.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_261b6609-a0fa-4ac0-9ebe-a86d20c8d164" xlink:to="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_e3abf7e4-121b-4618-b2a1-e5100055b68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_2ad0a362-0c78-49ad-b8d9-cd81e16ec59d" xlink:href="dva-20210331.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_261b6609-a0fa-4ac0-9ebe-a86d20c8d164" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_2ad0a362-0c78-49ad-b8d9-cd81e16ec59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f35a86c5-cc8f-4da9-97b5-b96fc9acb726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_261b6609-a0fa-4ac0-9ebe-a86d20c8d164" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f35a86c5-cc8f-4da9-97b5-b96fc9acb726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_5fafee2a-9768-49ca-993c-dfdd435ec395" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_261b6609-a0fa-4ac0-9ebe-a86d20c8d164" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_5fafee2a-9768-49ca-993c-dfdd435ec395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#AcquisitionsanddivestituresAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_959d1ec3-4935-43ba-927d-588b5c610e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_959d1ec3-4935-43ba-927d-588b5c610e09" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_535e7dbe-f9e5-4d69-93ca-108e1a66034b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_535e7dbe-f9e5-4d69-93ca-108e1a66034b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_75724212-3733-43c1-a49b-b56a32b92f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_535e7dbe-f9e5-4d69-93ca-108e1a66034b" xlink:to="loc_us-gaap_SegmentDomain_75724212-3733-43c1-a49b-b56a32b92f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember_80cfa3e9-ba3a-4608-8029-12fc5db67ce4" xlink:href="dva-20210331.xsd#dva_ForeignDialysisCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_75724212-3733-43c1-a49b-b56a32b92f04" xlink:to="loc_dva_ForeignDialysisCentersMember_80cfa3e9-ba3a-4608-8029-12fc5db67ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_88b7700d-a09b-48ea-a86e-16b39b423c8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_88b7700d-a09b-48ea-a86e-16b39b423c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b09e7f4-5784-44a2-8524-fe6f37ab50cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_88b7700d-a09b-48ea-a86e-16b39b423c8f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b09e7f4-5784-44a2-8524-fe6f37ab50cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_dbe37905-ae36-4b39-a56c-ce582b2f3a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b09e7f4-5784-44a2-8524-fe6f37ab50cb" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_dbe37905-ae36-4b39-a56c-ce582b2f3a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_333058a6-959c-40c9-87a9-538eee00fd10" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_srt_RangeAxis_333058a6-959c-40c9-87a9-538eee00fd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b8098ab-b4de-4f6d-9b76-99980ca0edf3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_333058a6-959c-40c9-87a9-538eee00fd10" xlink:to="loc_srt_RangeMember_1b8098ab-b4de-4f6d-9b76-99980ca0edf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dbaa23f5-1260-4318-b7e3-00648376d686" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1b8098ab-b4de-4f6d-9b76-99980ca0edf3" xlink:to="loc_srt_MinimumMember_dbaa23f5-1260-4318-b7e3-00648376d686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ffb3519e-c3fe-40e9-a832-4505587896d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1b8098ab-b4de-4f6d-9b76-99980ca0edf3" xlink:to="loc_srt_MaximumMember_ffb3519e-c3fe-40e9-a832-4505587896d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6648c07d-bde6-4434-85a8-69257a03a489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6648c07d-bde6-4434-85a8-69257a03a489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f7483c69-3a4d-4e4c-9fb2-aaa682b62c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6648c07d-bde6-4434-85a8-69257a03a489" xlink:to="loc_us-gaap_RelatedPartyDomain_f7483c69-3a4d-4e4c-9fb2-aaa682b62c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_ded7683e-5b54-454d-929e-b549ffecb0a6" xlink:href="dva-20210331.xsd#dva_OtherCompaniesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_f7483c69-3a4d-4e4c-9fb2-aaa682b62c7d" xlink:to="loc_dva_OtherCompaniesMember_ded7683e-5b54-454d-929e-b549ffecb0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_c46d9a57-b00a-4528-8a32-702a735f6fd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_c46d9a57-b00a-4528-8a32-702a735f6fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c618a91f-7ca8-4929-8730-533f253878a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_c46d9a57-b00a-4528-8a32-702a735f6fd0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c618a91f-7ca8-4929-8730-533f253878a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_88788e68-44f0-4d54-8f7c-0c4a23098c77" xlink:href="dva-20210331.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_c618a91f-7ca8-4929-8730-533f253878a4" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_88788e68-44f0-4d54-8f7c-0c4a23098c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a8692c19-3dbe-4852-87fe-4729a748c7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a8692c19-3dbe-4852-87fe-4729a748c7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6cbb3ba9-dc16-427f-8636-f075dfe11391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a8692c19-3dbe-4852-87fe-4729a748c7fc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6cbb3ba9-dc16-427f-8636-f075dfe11391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b1e78023-5316-4079-9f51-2e965650edeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6cbb3ba9-dc16-427f-8636-f075dfe11391" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b1e78023-5316-4079-9f51-2e965650edeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_79425e1d-d5d3-4fa4-8b60-dd906cbbdafc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6cbb3ba9-dc16-427f-8636-f075dfe11391" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_79425e1d-d5d3-4fa4-8b60-dd906cbbdafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3506d90c-40f2-4d65-9ffc-9235a5217be0" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_27ebd729-6366-4c8c-a49d-39a42a242ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_27ebd729-6366-4c8c-a49d-39a42a242ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d5154a79-2d9c-4eec-848f-a17e63af11e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d5154a79-2d9c-4eec-848f-a17e63af11e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_14336322-9208-4cda-ac73-07a218c8f834" xlink:href="dva-20210331.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_14336322-9208-4cda-ac73-07a218c8f834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_22993491-39dd-4b7a-aab9-be1b0a0ecd82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_22993491-39dd-4b7a-aab9-be1b0a0ecd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_12580d73-4624-44b0-9a29-6fc1a94a07d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_12580d73-4624-44b0-9a29-6fc1a94a07d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_aba47fca-d3eb-4b33-9654-cf14fff2bf50" xlink:href="dva-20210331.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_aba47fca-d3eb-4b33-9654-cf14fff2bf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f06c42e5-b6e4-4180-8e2c-ce54541a7c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f06c42e5-b6e4-4180-8e2c-ce54541a7c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_5d02c4d6-d68f-402a-a411-07776080da6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0afe3a4-7555-451b-bc76-bab14d98fe63" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_5d02c4d6-d68f-402a-a411-07776080da6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Variableinterestentities" xlink:type="simple" xlink:href="dva-20210331.xsd#Variableinterestentities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Variableinterestentities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_971a26f3-d94d-4b05-9ab9-82eb0822d671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_6b29ec83-95fb-410f-ac0d-b7e15feb36a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_971a26f3-d94d-4b05-9ab9-82eb0822d671" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_6b29ec83-95fb-410f-ac0d-b7e15feb36a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#VariableinterestentitiesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf30ddbf-9e1d-4645-9a4c-a779cb44efad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_086c8f70-6398-4da9-8ebb-7cc66aaee45c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf30ddbf-9e1d-4645-9a4c-a779cb44efad" xlink:to="loc_us-gaap_StatementTable_086c8f70-6398-4da9-8ebb-7cc66aaee45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9422f65f-c70d-4ef0-88fa-2cb61ac27e34" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_086c8f70-6398-4da9-8ebb-7cc66aaee45c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9422f65f-c70d-4ef0-88fa-2cb61ac27e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_bce0baf9-85bb-4645-be59-557ea25d7edd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9422f65f-c70d-4ef0-88fa-2cb61ac27e34" xlink:to="loc_srt_ConsolidatedEntitiesDomain_bce0baf9-85bb-4645-be59-557ea25d7edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_51df4f8c-67ff-4c61-814d-cf66245a0cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_bce0baf9-85bb-4645-be59-557ea25d7edd" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_51df4f8c-67ff-4c61-814d-cf66245a0cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4b0d1686-9118-4e50-9f47-088f9c9cc54e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_086c8f70-6398-4da9-8ebb-7cc66aaee45c" xlink:to="loc_us-gaap_StatementLineItems_4b0d1686-9118-4e50-9f47-088f9c9cc54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_851393f4-3557-4d0b-9cd6-fe252ce03c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4b0d1686-9118-4e50-9f47-088f9c9cc54e" xlink:to="loc_us-gaap_Assets_851393f4-3557-4d0b-9cd6-fe252ce03c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0d074ebe-c897-4756-8ed2-3223bcdb6583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4b0d1686-9118-4e50-9f47-088f9c9cc54e" xlink:to="loc_us-gaap_Liabilities_0d074ebe-c897-4756-8ed2-3223bcdb6583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="simple" xlink:href="dva-20210331.xsd#Fairvalueoffinancialinstruments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4f4cfa10-48ff-4564-913b-d3e1df11115f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_100d3158-2545-4ec9-bc55-3055ec64a168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4f4cfa10-48ff-4564-913b-d3e1df11115f" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_100d3158-2545-4ec9-bc55-3055ec64a168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="simple" xlink:href="dva-20210331.xsd#FairvalueoffinancialinstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8c72e662-3b9f-4839-9155-3b6052d72933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_073c5d5d-9888-4de5-9cee-232dfd6aaa5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8c72e662-3b9f-4839-9155-3b6052d72933" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_073c5d5d-9888-4de5-9cee-232dfd6aaa5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c8d1da50-8f75-4af4-af4d-df158bf9e402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c8d1da50-8f75-4af4-af4d-df158bf9e402" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b1c8b3e-a9c7-4398-9fc7-b6586dfead35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b1c8b3e-a9c7-4398-9fc7-b6586dfead35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c33c3ea2-f38a-4f2e-b896-8db8f63b52e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b1c8b3e-a9c7-4398-9fc7-b6586dfead35" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c33c3ea2-f38a-4f2e-b896-8db8f63b52e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_325c1cf4-64f6-423f-b44d-9ebba564aab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c33c3ea2-f38a-4f2e-b896-8db8f63b52e3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_325c1cf4-64f6-423f-b44d-9ebba564aab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_70c55a4f-6782-4fb9-94fc-2502d6b28fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_70c55a4f-6782-4fb9-94fc-2502d6b28fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_70c55a4f-6782-4fb9-94fc-2502d6b28fab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4bf0d3f7-bc7d-4a70-bf66-118c97e29812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4bf0d3f7-bc7d-4a70-bf66-118c97e29812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7b100f95-0bf1-42d2-a99c-ef573b553f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7b100f95-0bf1-42d2-a99c-ef573b553f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_06aaf190-0b99-449a-94a9-3f92bbcd8c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb4a62c5-32f2-47e1-9999-86bfd25b9ce8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_06aaf190-0b99-449a-94a9-3f92bbcd8c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f529c446-e50f-41e5-89df-963f09394557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f529c446-e50f-41e5-89df-963f09394557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd6a8ffc-85f4-466c-939e-94da9dc1c6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f529c446-e50f-41e5-89df-963f09394557" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd6a8ffc-85f4-466c-939e-94da9dc1c6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_484daecf-6df0-4f2c-a6df-f06d23767dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd6a8ffc-85f4-466c-939e-94da9dc1c6ed" xlink:to="loc_us-gaap_InterestRateCapMember_484daecf-6df0-4f2c-a6df-f06d23767dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d3fea03a-70b1-4f09-b550-d995358f524f" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_f2f4cbce-3cc1-422c-8dd5-5d15a9f12c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_f2f4cbce-3cc1-422c-8dd5-5d15a9f12c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7cc32345-25d9-428d-9c5e-6445f0f1bf83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f2f4cbce-3cc1-422c-8dd5-5d15a9f12c26" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7cc32345-25d9-428d-9c5e-6445f0f1bf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_a95350df-4580-49c6-9295-ceee16360ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f2f4cbce-3cc1-422c-8dd5-5d15a9f12c26" xlink:to="loc_us-gaap_DerivativeAssets_a95350df-4580-49c6-9295-ceee16360ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_16ed694f-3f99-4a84-9bcc-ccaad066b648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_16ed694f-3f99-4a84-9bcc-ccaad066b648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_90d30d41-df18-4801-9919-ea4dd36e5276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_16ed694f-3f99-4a84-9bcc-ccaad066b648" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_90d30d41-df18-4801-9919-ea4dd36e5276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_8c48cd8a-5c56-4788-aa0f-ca933c81202d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_74410832-5d34-489e-a6a5-4e8991c1a40a" xlink:to="loc_us-gaap_TemporaryEquityAbstract_8c48cd8a-5c56-4788-aa0f-ca933c81202d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_44f66efd-935a-4b81-95d1-a32504513317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_8c48cd8a-5c56-4788-aa0f-ca933c81202d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_44f66efd-935a-4b81-95d1-a32504513317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="dva-20210331.xsd#FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4a5a1149-ffd9-4ec2-aebb-0dcb6b9f6e83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_5be298f1-91e6-4c5b-962b-7e29b9674849" xlink:href="dva-20210331.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4a5a1149-ffd9-4ec2-aebb-0dcb6b9f6e83" xlink:to="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_5be298f1-91e6-4c5b-962b-7e29b9674849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Segmentreporting" xlink:type="simple" xlink:href="dva-20210331.xsd#Segmentreporting"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Segmentreporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_acc46717-bb12-4062-86ca-d660628aacb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_db8d74a5-1437-4021-9676-85918da7508c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_acc46717-bb12-4062-86ca-d660628aacb8" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_db8d74a5-1437-4021-9676-85918da7508c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingTables" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_75327a0e-39e3-4e15-a3e7-bb4ad960be7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_1889f9ed-c540-4299-97f5-d58648586d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_75327a0e-39e3-4e15-a3e7-bb4ad960be7e" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_1889f9ed-c540-4299-97f5-d58648586d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_8dc59a91-da5e-4181-9a32-05eeb713f477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_75327a0e-39e3-4e15-a3e7-bb4ad960be7e" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_8dc59a91-da5e-4181-9a32-05eeb713f477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_a431cbca-4ab8-4ab4-a349-1ebeffcc32e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_75327a0e-39e3-4e15-a3e7-bb4ad960be7e" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_a431cbca-4ab8-4ab4-a349-1ebeffcc32e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_b47cb865-dc17-4c77-bea2-0701179713bb" xlink:href="dva-20210331.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_75327a0e-39e3-4e15-a3e7-bb4ad960be7e" xlink:to="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_b47cb865-dc17-4c77-bea2-0701179713bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ccd5acb5-5c4a-4696-b7d6-7172183dea58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ccd5acb5-5c4a-4696-b7d6-7172183dea58" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0266ea9e-ebbf-4e23-99d3-a9de9795e351" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:to="loc_srt_ConsolidationItemsAxis_0266ea9e-ebbf-4e23-99d3-a9de9795e351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3dd48e10-25c8-4aff-8758-5241d5eb387e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0266ea9e-ebbf-4e23-99d3-a9de9795e351" xlink:to="loc_srt_ConsolidationItemsDomain_3dd48e10-25c8-4aff-8758-5241d5eb387e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_bfb05548-233d-4ab9-bead-39b520e585c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3dd48e10-25c8-4aff-8758-5241d5eb387e" xlink:to="loc_us-gaap_OperatingSegmentsMember_bfb05548-233d-4ab9-bead-39b520e585c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_a51e637e-de80-4e97-bde8-50a057122743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3dd48e10-25c8-4aff-8758-5241d5eb387e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_a51e637e-de80-4e97-bde8-50a057122743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_baf29343-aa9f-475d-9a2f-100eac44b762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_baf29343-aa9f-475d-9a2f-100eac44b762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_90656486-3c62-45c3-ad89-a6eefabda2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_baf29343-aa9f-475d-9a2f-100eac44b762" xlink:to="loc_us-gaap_SegmentDomain_90656486-3c62-45c3-ad89-a6eefabda2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_9cf96748-778d-4b57-8dc1-3fc212e32275" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_90656486-3c62-45c3-ad89-a6eefabda2fd" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_9cf96748-778d-4b57-8dc1-3fc212e32275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_8fe248e2-8ca7-4d03-b789-dd87ca4011d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_90656486-3c62-45c3-ad89-a6eefabda2fd" xlink:to="loc_us-gaap_AllOtherSegmentsMember_8fe248e2-8ca7-4d03-b789-dd87ca4011d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_87d50cee-f849-4135-928a-bcf8c89909af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_87d50cee-f849-4135-928a-bcf8c89909af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ca0e585f-b965-43a0-a354-af8d8456c958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_87d50cee-f849-4135-928a-bcf8c89909af" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ca0e585f-b965-43a0-a354-af8d8456c958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_4086372f-c2c5-4030-9f39-2ec1f76b38d9" xlink:href="dva-20210331.xsd#dva_ExternalSourcesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ca0e585f-b965-43a0-a354-af8d8456c958" xlink:to="loc_dva_ExternalSourcesMember_4086372f-c2c5-4030-9f39-2ec1f76b38d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_00da7440-701a-4fe6-ac94-eccf46938376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ca0e585f-b965-43a0-a354-af8d8456c958" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_00da7440-701a-4fe6-ac94-eccf46938376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5966d4b-62ee-402c-a4c4-987006a83613" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1f11ec60-e14c-404b-ad60-6e902780aac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1f11ec60-e14c-404b-ad60-6e902780aac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_bd9d7202-96dd-4af5-bce4-bcc7453210c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_OtherIncome_bd9d7202-96dd-4af5-bce4-bcc7453210c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_977f2b24-b901-414b-93d8-1f8f501abc23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_Revenues_977f2b24-b901-414b-93d8-1f8f501abc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_10b8e704-4233-478d-ab4d-d1c0f14bd299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_OperatingIncomeLoss_10b8e704-4233-478d-ab4d-d1c0f14bd299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_5b0ac158-9dcd-46c8-b0e8-235516610eb3" xlink:href="dva-20210331.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_5b0ac158-9dcd-46c8-b0e8-235516610eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_c74ee616-07e8-4457-8518-66e7c6726ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_InterestAndDebtExpense_c74ee616-07e8-4457-8518-66e7c6726ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_77fe2cef-ddc3-4d9d-bacb-3a9ece003f6e" xlink:href="dva-20210331.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_77fe2cef-ddc3-4d9d-bacb-3a9ece003f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_cbe26d23-f314-4d10-81f5-f3ba47754f30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_cbe26d23-f314-4d10-81f5-f3ba47754f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1ae3f8e0-63a0-45dd-a768-f6fe0ff61ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf021c77-e1eb-49c0-aa39-457672562752" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1ae3f8e0-63a0-45dd-a768-f6fe0ff61ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bae19e47-83e4-49a9-b60d-ca4b57d6f8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_46b4118f-30e2-4752-8ff8-991c27460d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bae19e47-83e4-49a9-b60d-ca4b57d6f8b7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_46b4118f-30e2-4752-8ff8-991c27460d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5d73be01-1525-424c-b0e5-42e213222e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_46b4118f-30e2-4752-8ff8-991c27460d95" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5d73be01-1525-424c-b0e5-42e213222e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9f76264d-3c19-4b72-8777-edae15497f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5d73be01-1525-424c-b0e5-42e213222e8f" xlink:to="loc_us-gaap_SegmentDomain_9f76264d-3c19-4b72-8777-edae15497f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_ef164fca-e592-4a32-bfcf-91fcfb018275" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9f76264d-3c19-4b72-8777-edae15497f07" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_ef164fca-e592-4a32-bfcf-91fcfb018275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_9c56c659-40a2-4e12-be1a-28dd505d988c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9f76264d-3c19-4b72-8777-edae15497f07" xlink:to="loc_us-gaap_AllOtherSegmentsMember_9c56c659-40a2-4e12-be1a-28dd505d988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_db251df8-b89b-49d1-92a7-8ea16f894dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_46b4118f-30e2-4752-8ff8-991c27460d95" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_db251df8-b89b-49d1-92a7-8ea16f894dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_7f81ecc5-e1d6-4eef-b217-c340736154f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_db251df8-b89b-49d1-92a7-8ea16f894dbb" xlink:to="loc_us-gaap_DepreciationAndAmortization_7f81ecc5-e1d6-4eef-b217-c340736154f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofAssetsbySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7e0e4096-aaf1-4e2b-84ec-d1b98dc9bf59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8547882-fb89-4436-bd3a-1a316eb2a0f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7e0e4096-aaf1-4e2b-84ec-d1b98dc9bf59" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8547882-fb89-4436-bd3a-1a316eb2a0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cae7fb3b-0608-42a7-ae8e-42eab2df1afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8547882-fb89-4436-bd3a-1a316eb2a0f2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cae7fb3b-0608-42a7-ae8e-42eab2df1afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bcb23e9e-aca5-4178-ba3a-f3e6d97ecdcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cae7fb3b-0608-42a7-ae8e-42eab2df1afd" xlink:to="loc_us-gaap_SegmentDomain_bcb23e9e-aca5-4178-ba3a-f3e6d97ecdcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_bd03ed12-23ff-4b67-967d-2080037222d3" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bcb23e9e-aca5-4178-ba3a-f3e6d97ecdcb" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_bd03ed12-23ff-4b67-967d-2080037222d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_9c771c23-0859-4ffa-9276-5a7aa8d337b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bcb23e9e-aca5-4178-ba3a-f3e6d97ecdcb" xlink:to="loc_us-gaap_AllOtherSegmentsMember_9c771c23-0859-4ffa-9276-5a7aa8d337b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3b4342d3-9c70-4787-97ed-2972919de5d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8547882-fb89-4436-bd3a-1a316eb2a0f2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_3b4342d3-9c70-4787-97ed-2972919de5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c7668842-5d97-42a9-bd81-9b6e4f38958a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3b4342d3-9c70-4787-97ed-2972919de5d6" xlink:to="loc_us-gaap_AssetsAbstract_c7668842-5d97-42a9-bd81-9b6e4f38958a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_faf5df2c-10c0-4286-a05e-51fee9d7a54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c7668842-5d97-42a9-bd81-9b6e4f38958a" xlink:to="loc_us-gaap_Assets_faf5df2c-10c0-4286-a05e-51fee9d7a54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="simple" xlink:href="dva-20210331.xsd#SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_69dada09-71c3-4018-a63d-30d7b80fbe11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31a54169-4433-4368-8334-ae3dfca3949c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_69dada09-71c3-4018-a63d-30d7b80fbe11" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31a54169-4433-4368-8334-ae3dfca3949c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_26daa969-d76c-4ebb-8ec2-339109900664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31a54169-4433-4368-8334-ae3dfca3949c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_26daa969-d76c-4ebb-8ec2-339109900664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_83c0686e-d07e-4da2-a7c0-29a90303b447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_26daa969-d76c-4ebb-8ec2-339109900664" xlink:to="loc_us-gaap_SegmentDomain_83c0686e-d07e-4da2-a7c0-29a90303b447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_7f0ab9c1-ebf9-4014-800b-b9200e10624f" xlink:href="dva-20210331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_83c0686e-d07e-4da2-a7c0-29a90303b447" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_7f0ab9c1-ebf9-4014-800b-b9200e10624f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_e4d69449-c5c1-4d22-9b89-5169af9b3166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_83c0686e-d07e-4da2-a7c0-29a90303b447" xlink:to="loc_us-gaap_AllOtherSegmentsMember_e4d69449-c5c1-4d22-9b89-5169af9b3166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3b8187a5-7ca7-4aac-a3fb-2275f137af8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31a54169-4433-4368-8334-ae3dfca3949c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_3b8187a5-7ca7-4aac-a3fb-2275f137af8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_467d187d-68fa-4c84-bb20-3f196dceff3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3b8187a5-7ca7-4aac-a3fb-2275f137af8d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_467d187d-68fa-4c84-bb20-3f196dceff3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Newaccountingstandards" xlink:type="simple" xlink:href="dva-20210331.xsd#Newaccountingstandards"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Newaccountingstandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_15b625e4-9e28-4e0c-a89b-c4869e474d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_9a22b0ec-bd72-4eb9-a991-d6cbc6fc2ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_15b625e4-9e28-4e0c-a89b-c4869e474d6d" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_9a22b0ec-bd72-4eb9-a991-d6cbc6fc2ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>dva-20210331_g1.jpg
<TEXT>
begin 644 dva-20210331_g1.jpg
M_]C_X  02D9)1@ ! @$!*P$K  #_X@0>24-#7U!23T9)3$4  0$   0.5VEN
M  (0  !M;G1R4D="(%A96B 'V0 %  \ #@ >  !A8W-P35-&5     !,3E8
M                        ]M8  0    #3*TQ.5B
M                                             !%D97-C   !4
M '9D;6YD   !R    &%D;61D   !4    '9V=65D   "+    (9V:65W   "
MM    "1L=6UI   "V    !1M96%S   "[    "1R6%E:   #$    !1G6%E:
M   #)    !1B6%E:   #.    !1R5%)#   #3    !YG5%)#   #;    !YB
M5%)#   #C    !YW='!T   #K    !1B:W!T   #P    !1T96-H   #U
M  QC<')T   #X    "YD97-C         !Q,96YO=F\@5&AI;FM0860@3$-$
M($UO;FET;W(                      -BR0       _____Q$!  ",#Y<
M                          ",#Y<      (P/EP                !D
M97-C          =,96YO=F\                      -BR0       ____
M_R ,B0#X"XD                           #X"XD      /@+B0
M            9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET
M:6]N(&EN($E%0S8Q.38V+3(N,0                 T     H(     ,[M
M ' &- #-      @   #Y$@ $     /#]?R0(        )@   #B,0@#*#D,
MV;=  /AU0@   '9I97<      !.D_@ 47RX $,\4  /MRP $$PL  UR>
M 5A96B       $P)5@!0    5Q_F;65A<P         "
M     0   H\    "6%E:(        %P+   RCP  "%%865H@        =#0
M +T0   195A96B         FG   $%\  +F"8W5R=@         )   "&0PK
M'3LV>5;D?ARTZ___  !C=7)V          D   ()"[L>&3D*6U"$<[FT__\
M &-U<G8         "0   AX+VR'>/BAA\(UAP.C__P  6%E:(        /-1
M  $    !%LQ865H@                     '-I9R      04U$('1E>'0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0D 9-+574YO)M
MI#W*X'X\5)9R>;!&WJB_RK/VL?:.G]I14ODW8KD?)S]+V^9-1116A(4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** ,7Q'_RQ_X'_P"RUG:==_9)E?/!
MX8#T]?PJ_P"(C\\8_P!EOYUC]J^;QU5TL=.I'>,H_A%'KX>"GAHP>S3_ #9V
M?6EJAHUS]HMU!/*?*?PZ?I5^OH:51581G':23/*G%PDXO=.P44459(5D:[>[
M%$"GEN6]AZ?C_GK5^]O%LHR[<GH!ZFN6DE:9V=SDDY->9FN+]E!T8/WYK7RC
M_P $[<#0YY>TE\,7IYO_ ( RNITI-EK$/]G/YDFN6(S78PIY:*OHH'Y"N;)8
MWG4GT44OO?\ P#7,9>["/=M_=_PX^BBBO</-"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44A(49
M/ %8FH^,M,T[(,OFL/X8L.?SR%_6JC"4W:*;?DKDSG&"O)J*\W8W**\[O_B/
M=3$BUB2-<\%LN^/T'Z'\>^#>>(=1O\^;<R>X#%5_[Y7 _2NF& JR^*T?75G+
M/,*4?AO+\%^/^1ZS<ZC:V?\ KIHT]F=5/Y$UF3^-=)@!_P!(W'T16;]<8_6O
M*"<TE=$<N@OBFWZ67^9SRS*;^&,5ZMO_ "/2)OB/IZ<)',_OM51^K9_2JDGQ
M-C'W+1C]9 O_ +*:X+-%:+ T5T;^;,GCZSV:7HE^IV[?$U\\6BXR?^6IS[?P
MBF'XEW&>+:/'^^QKBZ*KZG07V/Q?^9/UW$/[?X+_ ".W'Q,D[VJ_]_#_ /$U
M*GQ-4_>LR.G24'Z_P"N#I:3P5'^3[G(:QM?^?\(GHL7Q)L6^_#,/IL;^;"KL
M'CO29NLK(?\ :C?_ -E!KRW-)4/ 4GMS+T?_  Y<<PK+?E?JO\FCV6VUW3[S
M_57,3'TW@'\CS5X'->&?A5JUU*ZL>8)GCY_A<@9]>."/:LI9=_+/Y-?J;1S+
M^:'S3_0]JHKR^R\>ZG:X#LLH'9U&?S7!)^N?RKH;'XCVDV!<Q/&?[RD.OX]"
M/R-<\\'6ATYO\+O^&YT0QM&?VN7_ !:?CL=?152QU:TU,9MYD?V!^;\5/(_*
MK=8--.S5GYG0FFKIW7=!1112&%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !112,P4$DX ZF@!:*0$$9%+0 4444 %%%% !37<1J6
M/0 D_A3)[B.V&Z1@H]^OY5B:AK1N 8XAA2,$G[Q_P%<V*QE+"Q?-+WK:16K^
M[L;4:$ZS5EIU?0S9&,C%CU+$_F:2BBOE7=N[W>Y[:5EH ZYK6N]?9QM@&W_:
M;D_@!6316]+%5:$91IRY5+=K?3M]YG4H0J.+DK\NW85V+G+')/.3WI**,UAJ
M[W=VWN]S1*VG0!3HXS,P11DDX IF:V]!L=H\]QC/"@_J?Z5T8/#/$UE#9;R?
MD98BJJ,'+KT]34MH1;QK&/X0!GU]34M%%?5)**26B2LCPV[N[ZA1113 ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3WI=NA'!!';(L<2A%48"J, ?@*DHHKB.X**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** &R1K,I1U#*1@@C((],&N#\2^ S$&N-/!*]
M3%U(]U/4_3\J[ZBM*-:=&5XOU71F5:A"O&TEZ/JCPPC!P:2O3?%'@V/5PUQ;
M )/CD9VK)]<=#[_G[>;W%O):NT<BE64X92,$'T(_7Z<UZ]#$0KJZT?6/4\?$
M8>=!V>L7L^C(J***V, HHHH Z7PSXQFT8K#.3)!T _B3W&>P_NG_ /7Z3:7<
M5]$LT+AT89!!R*\1K7\/^(KC0)=T?S1L<O&3@'MD<<$5Q8K!J?O4])=5T?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 V2-95*.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ?\ H0KVVO-S'XH>C/4RWX9^J"BBBN ] **** "BBB@ HHHH **** "BBB@
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MU<O74?$3_D)C_KW3^;5R]>WAOX,/\)X.*_C5/\3"BBBMC$**** +%AQ<P_\
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MLT+E74\$<]>H(Z$'N/RYKU;P[KT>OVPE4;77 D3/W6Q_(]J\K$X5T7S+6#_
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MYK*)S_GFDHKU8PC!6BK+R/(G.4VW)MM]PHHHJB HHHH **** "BBB@ HHHH
M*N:=JMUI4GF6\K(<\XY5OJ#P?RJG12E%2335T^C*C)Q=T[-=4>G>'/&D.K[8
M+C$<Q]_D8^Q/0^WZFNFKPP'%>A>"_%IOL6=VW[P#Y'/\0'\)_P!KT]?KU\S%
M8/V:YX;=5V/3PF,]HU"I\71]SL:***XCO"BBB@ HHHH **** "BBB@ HHHH
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M]O#M2HP:[)?=H>#B8N-::?\ ,W]^HE%%%;&(&EK1L/#NH:E@P6[D'^(C8O\
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M$QEIFQZNO/\ WRHK!XZBNK?HC>. KO=)>K/,Z*].;X?:6>@D'T?_ !!JK/\
M#:T88BN)5_W@KC\@%I+'47W7J@>7UET3]&>=T8KJM0^'M_; F%DG')P#M?\
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M_M[(9GE2/_?8+_,T)-[:B;2U>A/16%<^-M)MN//WGT16;]< ?K6;/\2;)?\
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M\D**** "MGP=_P A>U_WV_\ 0&K&K9\'?\A>U_WV_P#0&K*O_"G_ (6:X?\
MBT_\2_,];HHHKPSWPHHHH \S^(G_ "$Q_P!>Z?S:N7KJ/B)_R$Q_U[I_-JY>
MO;PW\&'^$\'%?QJG^)A1116QB%%%% $]A_Q\P_\ 75/_ $(5[;7B5A_Q\P_]
M=4_]"%>VUYN8_%#T9ZF6_#/U04445P'H!1110 4444 %%%% !115;4;^/3+>
M2XE/RHI/N?0?4GBFDV[+=B;23;T2,SQ1XFCT"+"X:9P=B]@.FX^WIZG\2/+;
MN[EOI6FF<NS')8]?I[#T%2ZGJ,NJW$EQ*<LYZ=@.P'L.GO52O8P^'5"/>3W?
MZ'BXG$NO+M!;+]0HHHKH.8**** %S14UI93W\HB@C9W/0 9_'V%=GI/PXR ]
M]+@_W(S_ #<C] /QK*K7IT?C>O;=FU'#U*WPK3N]$<-5NVTB]O.8;:5QZA&*
M_GC%>L6.@6&G8\BW12.C8W-_WTV36A7'/,?Y8?>_T.V&6_S3^Y'E$7@G5Y1G
M[/CW9T'Z%LU:7X?:HW41#ZO_ ( UZ;163Q];R7R-5E]%?S/YGF?_  KO4_6'
M_OMO_B:YJ:,Q.R-U5B#[D'!KW&O$]0_X^9O^NK_^A&NK!XB=9R4K:6V1R8W#
MPH*/)?5O=W*]%%%=AQ!1110 5ZGX#_Y!$/\ O2_^AFO+*]3\!_\ ((A_WI?_
M $,UQYA_"7^-?DSNR[^,_P# _P T=#1117E'K!1110 4444 %%%% !1110!0
MU[_D'7G_ %ZS_P#HMJ\:KV77O^0=>?\ 7K/_ .BVKQJO2R[X:GJCS,R^*'HP
MHHHKO/."BBB@ KL_AI_Q\W/_ %R7_P!"KC*[/X:?\?-S_P!<E_\ 0JY\;_ E
M\OS.G!?QX?/\CT&BBBO&/;"BBB@ HHHH **** "BBD9@@+,0 !DD\ "@#&\7
M:N-(T^1@</("B>N6')_ ?KBO)JV_%NO'7+PE#^ZCRL?O_>;'8G^6*PZ]C"4?
M8TU?XI:O]$>+C*WMJFC]V.B_5A11172<H4444 %=5\/-.-S?M<$?+ A(/^TV
M5 _+-<L>E>J>"=+.FZ<A<8>8^8WJ ?NC\N?QKEQU3V=)QZRT^74[,!3YZJ?2
M.OSZ&_1117D'L#7=8U+,<  DGV'6O&=6U!]4NIKEC]]R0#V'8?@./\*]1\67
M1M-*NG'4Q[/^^R$_K7D>:]'+H:3GUV_5GFYE4=XP6UKO\A****] \T****
M9[5T?A'PN==D,LN5@C8 X_C. =H]!CK_ $/3GD4R$*!DD@ >YKV?2=/32K6*
MW0?<0 GU;JQ_$\UR8VLZ4%&.CGU\D=N"H*K-N6T+:>9/!!';(L<2A548"@8
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MRRO4_ ?_ ""(?]Z7_P!#-<>8?PE_C7Y,[LN_C/\ P/\ -'0T445Y1ZP4444
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M^E'\;#A?]U><?7D_G705Y^(QW-[M/1?S=?D>EA\#RVE4U?\ +T^8V.-845$
M554  #   P !3J**X#O"BBB@ HHHH *XSXAZ(9XUOHER4&V3'=<_*WX$G/L?
M:NSILD:RJ4< JP(((R"#P016E*HZ4U-=/R,ZU)5H.#Z]?,\-HK?\5^&GT*;=
M&"8')V'DX)Y*$^W;U_.L"O:A.-2*E%W3/"J4Y4I.,E9H****L@**** "BBB@
M HHHH ***.M !15[2-(N-:F$-NN3U9C]T#N2V#@>@[TW5M/.EW<ULQR8VQG&
M,CJ#CGJ.?_K5*J1<G!/WDKV+=.2ASM>ZW:Y3HHHJB HHHH *]C\.S_:--M'_
M .F" _51M/ZBO'*],^'EYY^G&$GF*1ACV;YA^N:XLPC>$9=I?G_PQWY;*U24
M?YH_D=11117EGJA1110 4444 -DC6561AD,""/8\&O%]3LFTVYEMV_Y9NR_4
M#H?QXKVJO._B/IWDW,=THXE3:Q_VD_Q!'Y5V8"IRU''I)?BCBS"GS4U/K%_@
MSCZ***]4\@**** "BBB@ HHH'% '>?#73QMGO"!G(B'KP S?S%=Q6%X+T[^S
MM,B!&&E)E(_WL8_\= K=KP\1/VE6;Z7T]$>]AH>SI076VOJPHHHK(V"BBB@
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MHFH1_>M)AS_SR?\ PIT>@ZC)C%I/SW\I\?GBMN>'\R^\P]G/^5_<RCTYKI/
MFJC3]0\IS\LZ[#_O _*?SR/QJ"V\%ZM<$?Z/L'J[!?TSG]*W=-^&[*5:[N.A
M!VQ YSZ[V_\ B:Y\16H.$HN2=UTUU.G#T*ZG&:@U9]=-#N:*11M &2< <GJ:
M6O(/9"BBB@ HHHH *Q/&.G?VEIDH RT?[Q?JO7_QW-;=(0&&#R#50DX24ENG
M<F<%.+B]FFCPW%&*[*?X;7)D?RIHPF\[0Q;.W)QGY>N..*C_ .%:WO\ SWA_
M\?\ _B:]A8NCI[Z_$\5X.NG\#?W'(8-&#77_ /"M;W_GO#_X_P#_ !-'_"M;
MW_GO#_X__P#$T?6J/\Z_$/JE?^1_@<A@TN*Z[_A6M[_SWA_\?_\ B:/^%:WO
M_/>'_P ?_P#B:/K5'^=?B'U2O_(_P.1&:N:/IYU.\@MQ_'(,X[+U8_D#71?\
M*UO?^>\/_C__ ,36UX5\&R:'<O<3NCG850+GC)Y/('88_.HJXNFH2Y9)R:LC
M2C@ZCJ1YXM1OK?L=4JA % P , 4M%%>0>P%%%% !1110 4444 %4]6TR+6+9
M[:7HPX/4JPZ,/<5<HIIN+36C0FE)-/5,\9U?29]'F,,ZX/)4_P +#/W@>_7G
M]:HU[9>V%OJ,9BN(UD7T(Z>X/4'W%<K??#:VE.;:=X_]E@)!_-3^>:].ECX-
M)5%RONMCS*V7S3_=OF79[GGN#1@UV#_#2[!^6XB(]PP_H:3_ (5K>_\ />'_
M ,?_ /B:V^M4?YU^)S_5*_\ (_P.0P:VO!P_XF]K_OM_Z U:O_"M;W_GO#_X
M_P#_ !-7]"\"W6E7T-R\L3*C$D+NSRI'<#UJ*V)I2IS2FFW%]S2CAJT:D&X-
M)25WH=M1117D'L!1110 4444 <WXG\'Q:UF>'"3@#D_=?'0-CH?0_P Z\XO]
M/GTR3R[B-D;T/?W!Z'ZBO:ZKWEA;ZC'Y=Q&KKZ,,X]P>H/TKJH8R5)*,O>C^
M*]#DQ&"C6?-'W9?@_4\4I*]"U'X<02Y:TF,?^RXW+^8P?SS7/W?@/5;;.V-9
M!ZHX_DV#^&*]"&+HS7Q)/L]#SYX2M"_NM^:U.=HJ_+H&HP?>M)A[^6Q'Y@8J
M Z?<@X,,G_?#?X5KSQ?VE]Y@X37V7]Q7HJPNG73G"P2$^R,?Z59A\.ZE/C9:
M3>Q*,H_-@*'."WDOO!4YO:+^XSJ.E=':> =5GQO1(O=W'3_@&X@UO6'PVACP
M;J=GQ_"@V#Z9.3CZ8K&6+HP^U?TU-X8.M/[-O70X&&&2X<)&A9CT51DG\*[3
MP_\ #]W(FU'@=?*!Y/\ O$=/H#^5=CI^DVFE+MMH5CXY('S'ZL>3^)JY7'6Q
MTIZ07*OQ.ZA@(T]9OF?;H-CC6)0B*%4   #  ],"G445Q':%%%% !7.>)?!T
M.M9FAQ'/CKT5_9L?S_/-='150J2IRYHNS)J4XU(N,E=,\6U#3+G2Y/+N8RC>
M_0X[@C@_A_.JHYKVV[LX+Z,QSQJZGLPR/K[&N4U+X<6T^6M96C.<A6_>+^!R
M"/UKT:6/A))5%RONM4>95R^<7>F^9=GHSSVDKHKOP)JEL3B)90.\;C^38;]*
MRYM#OX,[[688[^6V/SQBNN-:G)>[*+^9R2HU(/6$E\BC14_V"Y_YXR?]\-_A
M4L>CWTWW+:9OI$Y_I5<\>Z^\GDE_*_N*=+BMBW\'ZM<?=M6'^^53_P!"(/Y5
ML6?PVNI"#<31QC/1<R-CTYVC]364\32CO-?+7\C6&&K3V@]>^GYG'5J:-X;O
M-;(\E,)GF1N$'X]S],UZ!IO@C3=/PS(9F]9.5_[X&%_,&M]5"@ #  X%<M7,
M-U37SE_D==++MG4?RC_F8V@>%;70@& \R7&#(1T]E'\(_7U-2^)-&&N63P#&
M\8:,GLPZ?GTK5HKA]K-SYV[RO>YW^RAR."5HM6L>(3P26[F*12KJQ!4]0<XQ
M476O6]=\+6FNC<XV2 8$B]?H1_$/\YKB]0\ :C;,3$%F7G!4A6QGNK8_0FO4
MHXRG46K4)=4]ODSR:V"J4V^5.<>C6_S1S%%:,OA[4HOO6DW?I&S#W.0"*C71
M;]_NVLY^D3G^E='M(?S+[T<_LY_RO[F4JGLKM[">*>/[R.&'X'I^-:,'A+5;
MC[MHX_WL)_Z$16O9?#B[FYN)DB'HOSM_0#\S6<Z]**:E---;+5FE+#UI-.,&
MK/=Z+\3O[.Z2^ACGC.5D16'T(S4U4=&TB/1+<6\;LRABWS$<$\D  # SVJ]7
MBRM=VVOH>Y&]E?>VOJ%>?Z3-_P (AK,UM-\L,I^5CP,$YC;/MRI_$UZ!67KW
MA^WU^())\KKG8X&2I^G<'N*THSC'FC/X)JSMT[,RK4Y2Y90^.#NK];[KYF)X
MJADDUC3'1"0)8\D D#]ZN>1[5J>+-"&MV9"#]['EHSWSW7\<?GBL&WF\0^&!
MY+0_:H5X4C+8 ]"HW ?45.?'=[*-L6F2;^<9+-]. F3^E;<E1.FX.+4%I)26
MNM];F*G3M44^:+GJXN+TTMI;T+^@^)0VFM->AD>!0'+ @M_=(SU)Z?7V(K)\
M$V\NJ7]SJDHP"SA?3<QY ]E7C\:5="U?Q3*LFI-Y,(.1&, _@O.#[L<CWKLK
M2TBL8DAA4*B#  I5)0I1G&-G*;UMJDNR95.,ZLH2E=0@M+Z-ONT34445RG4%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>dva-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:dva="http://www.davita.com/20210331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dva-20210331.xsd" xlink:type="simple"/>
    <context id="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia925779a41b04416bebac5d08f6cde4c_I20210426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2021-04-26</instant>
        </period>
    </context>
    <context id="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if25c609ea75c4c068d67fe57512ea434_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if09729cbfcb64401a6be3f8ffe616fc5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ieeca89f1d034430482dee49030acec85_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4c63462618b841479c213bb2713220cf_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if227b8854b5d464699191a415580aefe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i26a083ee5fdf4ec99abc3850e10e37ff_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i057fbe978e34415294c2d4a792413761_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8529c41e847743e48bb56774c5d6f476_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7542b28699c64b3d8ad0d845de0fa0d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb912ac405a7429e8d9f894a52d31c82_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61057af670f54badb9c6da85fd10624c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0cd9ddbeee04401adc2305188ef344a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28f0aec10f4641fbba7afcf164b721c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54e17a5f75d24145bae682ee23ef20b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a019ed8480b437c8577677faace157d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6cd348fa8b2c42d1a42ef7fd2cf4aab3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibf07ea63041c4c928f8da459f8e85559_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6e319b3a1dea46d48da73779ff5ed197_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i48461f3f7e034478b38bf2bd95c2c8b6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i41b777f2cb434154b0b873e82c5fce50_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if76ff822a85c4644b659c3e32c6a6ed3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie0320aabb1784267b2d621187040cf79_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i73666b7ee2b24d4fa2f93200e6e07664_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia7cf27bbb13c4c3890e90cd1e469e381_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2d5e5c6b5c5c4b67b3a716761c125e8f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i15cd87973cef469c8ae16c443d6af67f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic81bcf50eda945c8941046c875428878_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic075cfce513548e597924c070afcd2ae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i85b41e0034a64dab9acb0cac6ac941ad_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc0c1697a60d44e08102a4bc72e7baee_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic19fe60e1ba04922b0a626ce23e8b7e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i475dc8640ab8472db6136e6d67675a03_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic6f5500e00234fdf8025a48470c3f347_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i92b1c7e075c3458393c45dcc6b3ae765_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7f8b5aef473d4c39a93eee476090c527_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic9328309adf540c1a97c8d647b34233a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5cedd257a01c493c994727193e679c26_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i932b6e9e1cd94560abb849f93670e5aa_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i33019354c85e44cc941da40445b2afa3_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id0a780a7182840f4a2262cae00e03efc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8318a79043d44ffa9a6a4993763b2528_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifd3cc5d411a64abca391702baae8a9df_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1a8529f1d6484e20963d6f0e69c67f53_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1db5c6df63c341089b1c1dc195a6ffa0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iff8e9b75a76f41589cb3e7fd00a42d30_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9afc760e9c5848eab9e7da50701226de_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2b19644a307d4aaf8b1b4bc4cb0d62f8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id80771daad6c4b07a10321fc37cea825_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4a2736318f0c409aa240efd57c2ef68e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic5bccfe449ed4991b0e4e2588ce7a9a9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a1a9b926a0d4f38a1427bdd4d8a03a8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if9dd874b0d744ba2a90acc5b316f6054_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic6c7c388a128487ab6d0234da86f133a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6c7afd963ec5440498a90eb4972fdf5d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i83641efa6174426994832609d4cfde1c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia3b745665f334ec782e1b4c00dce1968_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i98660f7731974d069a340250cea5bcac_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i13ff0fa657884449b2488b3757779baf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i803f842bbc824ff58114df1a63ffbf0a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie2e28eaf39154728a43e3d45a96bc8a7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibf913e95c60d44908d164dce5b236b5e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i608146c8b3ec4ec88cbc9d9bb1b096e2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i96fded0bba7f4935af31ff42cf27ef96_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i680ca482559e41b29995e9ec3a942053_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaebf99e2b1f14c34a8a126def6ffbd2f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6b8f49aa1abb4d72a402bed74053e73d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i19e312d2270449af94812bdb09bce332_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0542fe9de33a45f1add8d0843709862e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6511e83e307f484e924d0db239adc3be_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibdf3f726deb741c5811a90556bb9bc5a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7f2200f0ed2d46558e31ace6797c599f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id66622c2d23c48d793cd014811006a41_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idf38ac334ee84f118afa50f51593b348_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i790610c5a3ee4281a8434d08b7887b14_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6339430398b74ca2afee569cb8b0f426_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i55c6c61591ec419c8a4f894e55b0bf58_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i187374d6f1b34e62b52bf9d95907b97a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if13419d218e54ae4a8ae1993a6172f7c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ieb6bac2e9afd461aa4604a702da5b510_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib1a323c6052043f39e3e7d90a6c1e149_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1f1ae32f350f41b5b4c94e873d2ac8ab_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9d4cbc4b3cb3440baae8caf684d727be_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i804d8967231546a69cb45a38bfa5a7de_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0707e2f78ab64721ab34ecd08e6b7faf_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifb32ded36f5647b8bf00bcd206f6b64a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifb49ac86f6b746d990ed1e8d57025774_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iaaaa1dbe5bd548efb96a1fb6dc9d1fdc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4b2618e51ff246e6a032f57f479d2741_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic12d5b97b6be470aa5f5bc280eb39678_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0172e2194a649be8e17948010a20139_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6402f5beaf314d64a2e3fc70b66cbbc8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c6ecda7f7b34fc8a0c5a23d786773f2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5382ab7913ba4b97b4e5b4674fb7d89a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i882e39dba68b41538058accf2ecc1ed8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i352ee731e6ad4fb098d97efc97fa8dd5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7da2c28df84d498d901a73b1bd176f75_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie45e602ff596428d999df57f32972301_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i512b152939674415aeb4fcd3ff232747_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic1ffaa425a944fc7816ad190e4ae8372_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4da2355fcf964251b943aab7dc93c0b6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icab86a87e7ca432ca27ef7f2f0802e4e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2498e561a5854842a6d62e0b719f9b52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f587b5b943b44b8b00940ad481105ea_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic7ea4fefb3604f5383d022830fb054b2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic8c92060a34e484cb1a910bc6a98a92b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ied03f6f7ffa1498b908a85322c500f3f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i788aadfa599242a796deae74047ca158_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i32e240900d2a4a45aa25dd2ec99f1da9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i504bca0dc6a34e968df9a1ef2d17533a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaac6bcb52a00428d87b88838a3a4bb73_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if8d83ec226e84558a394e404422907ea_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i37efecfb533c4ce8b0c977360ba10261_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e6f67d8fc604e5db4da237cb3d52d86_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i194f9194e246431c9dde99195297777e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id1bbaa73972045d38fd77a293d92478b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i97a89b88b52c40e7aebc3bba7e72d037_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iabd355c7251147dca43bf684d5040e60_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i553adc006f9e4d1691c2e2bfc277dc41_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86de953a450f43afb93313b5cccf48ff_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i91ebf3bf2b02476fb9efaac73b3d3dc5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8c9698c484b14a119356f8182f5757c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1acbfcadeb1d433b9e81c9d3af8e55db_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie12c3787f705434183585a7eb161899e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibff9b7fea3cc4a2c8cc8c9400ffa6dfd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8f84ec8dbbe47a885cecad8d415599b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id253887c65fb490bb3a75adbfae3b9f6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie3a230004914446ebc401ea9c9effdd8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id61c0e835e604a309d4b0804349af819_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i606827500ec64b88b0b08567f4f6a0db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifcf13ba1953646bfbb5a0cec0cd092de_I20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-26</instant>
        </period>
    </context>
    <context id="i76a9d85fd0654e91a77f38adc13569bd_D20200609-20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-09</startDate>
            <endDate>2020-06-09</endDate>
        </period>
    </context>
    <context id="ib6985ae730434382a11199004a394f1a_D20210226-20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-26</startDate>
            <endDate>2021-02-26</endDate>
        </period>
    </context>
    <context id="ic0dc9c50975b46389c8201b72173f3f0_I20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-09</instant>
        </period>
    </context>
    <context id="ib9d50577324f44dd9a01b491e9e47a09_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i59aadc5542964885b2a0e3bc85b2fdbc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibfd9c5748c524a73b8cf26558b198cb0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie8ab840ca2984e1cbd4b736f943c4d22_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ife4fde46bad1452eb6abb85e1eda2e52_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3300c03f30af4697aeb5cc0111c808e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifeb4f066dfab44019e66a8db209e19eb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i00538c1ebb6745ca9520ef56fcbcb7e0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">dva:BilateralSecuredLetterOfCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1298eb35e47242399f1ae29c789cb247_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i0196845c80ec4c118ab2c0f6b32fe811_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:IncrementalCashPortionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i37f0d1d0eb764865859330a4621cb724_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:CashPaidForPortionPreviouslyRefundedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i2a970640a33c4ad991ff8f3c6c172d83_D20170815-20170815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:StockholderDerivativeLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-15</startDate>
            <endDate>2017-08-15</endDate>
        </period>
    </context>
    <context id="i2781197970dd4a92a8d85c696520a666_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0f826db477234354ba1256988298cd45_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5d49ed528d08456d847b8513e95864e5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5d7725640db9488db340c97bfa388a99_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i97d0c8af8a944946a42c942ce28c581d_D20210401-20210428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-28</endDate>
        </period>
    </context>
    <context id="i8f9b78b5f5fc4575a3e804c564b6679b_I20201210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2020-12-10</instant>
        </period>
    </context>
    <context id="ifa346157c398428ab51f508528dc7f0d_I20210428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-28</instant>
        </period>
    </context>
    <context id="id9a08055277f468fa3da1c205ef85947_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id4709116f7724bc9ad71c5bfd6776322_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a80756affc64b969267ec3c56bb81ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7913425dd41a462fb453af0206275331_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7550f2fc99ab46e1b842231f6e90d788_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i798ec441c1634f7dbbe04fccf4900538_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4e992d644be94534b183789d6b781637_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7639fee9f6714447997016db991f797c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i84115112998e4c6ab8350b671c96944b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1f5f0eab21a44845a44f238f8ff448c7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i009808e6a6064e15a4b9a0b821c2bdfa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7b8ca49829314b1c86c5e23c209360a8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6516fe61d14b40988955d5922b34c110_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i27908b3ff2f44d9283aa1440a2b3ae17_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5bfeeb71e92742cda00237cd50a46e64_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i73bc0a8523dd4554aa03d767a5adeba8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i631f28de3213466e9bbd705c5fbefdc9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i57247936e4d94d5da5ca8c68117d7722_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i355c4c0d9e274392b8117ea1ede7a7eb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if907602d375846b0b24b8a53b7ca0a19_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0e0275ee13fa4083b1696201c4b78acb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i79e508f7f8044bb5bcad2876847bcc76_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i495ea84f47aa48bcbf441d81513cb962_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3e5449f4136e4a069e013c4a12fa4b96_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0f2d7535539145679656b6f1f8c6109d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1b44264ea668489b8330c31d2a995fa5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id3cd95724eb3494bb6e72cb6132e8c7d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i15e9456343284b0183c0a4c3be1bb14e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2f92b2fa92fe417aa409a3b1a97cb245_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0a92bc0f852f4670a2b1907f3d705ae2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i332c7d42021f4f6da272ea3d938d6af0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieeec13c830464d468215c66930e23ec9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i979f0469490346ea8c2367f07d1340a4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia6fe8af182b14048858164d9709baa1d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2601990fe363422986c39fb1866d5dcd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4a051b6561614f1e8e342da9d47552e7_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic9286623196349739c21994952f69f6a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic6e9959083a844ce9f5568612f3be925_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i05a29181b883436aa54dd8cb74f27dfa_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i063d84a2e30e427c986c99aacd98b664_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iec56217c36c846509f6a12afa76de49b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>dva:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="clinic">
        <measure>dva:clinic</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF8xLTEtMS0xLTA_ad85acc2-6729-4849-86c9-706a6d8984d4">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF8yLTEtMS0xLTA_e09dfcf0-874c-45d1-93cc-6bc16774224b">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF8zLTEtMS0xLTA_a4e6e7be-b58e-4d2f-a00f-ef08193b40bf">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF80LTEtMS0xLTA_308474b7-c2c2-49d7-a8b0-b7802808b53e">0000927066</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80L2ZyYWc6M2Y4Mjc2NTE2YzJjNDMxM2FiOTYwY2E1ZTU4M2U1MjIvdGFibGU6YjE2ZDhkMzNiNDRhNDMzYTljYWU5ZGE3M2I1NzkwMGQvdGFibGVyYW5nZTpiMTZkOGQzM2I0NGE0MzNhOWNhZTlkYTczYjU3OTAwZF81LTEtMS0xLTA_4b50e5f7-aa85-46e4-ab03-8f4333e37cdc">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMS0xLTEtMS0w_beca8491-7fd1-4410-9638-ee94df32d141"
      unitRef="usd">4622798000</us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMS0zLTEtMS0w_8478bc07-c186-4704-964f-fc742ce09beb"
      unitRef="usd">4480429000</us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMi0xLTEtMS0w_75a704f6-0cb1-4596-ae0f-d831a55f39b0"
      unitRef="usd">69691000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMi0zLTEtMS0w_90d525a3-2763-4df8-a28a-3415a40c65cb"
      unitRef="usd">70141000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMy0xLTEtMS0w_435e368f-bfda-4d1e-8816-ba1c605fd216"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMy0zLTEtMS0w_68840324-39f2-4a56-b938-5990fa30b712"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNC0xLTEtMS0w_e7d3342f-737e-4b20-8114-b396da2cb558"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNC0zLTEtMS0w_1416e4af-91ea-4b7b-91db-f39b295a26c7"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNS0xLTEtMS0w_b43e4661-f21a-466e-a3bf-a0566f10d81a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNS0zLTEtMS0w_bff84d8d-57ca-4ffe-9247-dd7c154205df"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNi0xLTEtMS0w_3c11f04b-d681-43ed-9b2b-6f70e8f29e87"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNi0zLTEtMS0w_7ce940eb-5dfa-4eef-993e-9d17ea08a350"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNy0xLTEtMS0w_fa8aed1f-830c-45d8-b172-233909f8bec3"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfNy0zLTEtMS0w_aefa4649-bf36-4bd0-9454-e9fa124605e7"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfOC0xLTEtMS0w_cc7c0f0e-f1f1-430c-b345-e18921b641e5"
      unitRef="shares">110027000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfOC0zLTEtMS0w_48037170-1f67-4df2-8d0b-fb77f52fb009"
      unitRef="shares">109933000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfOS0xLTEtMS0w_1cc6c04f-923f-4d33-9b2b-8942a5bcf356"
      unitRef="shares">107078000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfOS0zLTEtMS0w_59eb8c59-81d2-4ee9-9cad-215f48d8c15f"
      unitRef="shares">109933000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMTAtMS0xLTEtMA_fb3604e7-907f-4ba7-a0c2-ecf4a73ea6e7"
      unitRef="shares">2949000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yMi9mcmFnOmM1YmE5YzJjM2M5NTQ2NjNhYWEyMmU1MWEwNjhhODkzL3RhYmxlOmIwY2VkYmRmODc3MTQwOWZhMDg0N2Y4OThhZjBlNDk0L3RhYmxlcmFuZ2U6YjBjZWRiZGY4NzcxNDA5ZmEwODQ3Zjg5OGFmMGU0OTRfMTAtMy0xLTEtMA_7d2d7d93-514e-4e34-b770-efbfd88b1dc3"
      unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81NS9mcmFnOmVmMDYzNjE3NDAxYjQyMjhhYWVkOWFhM2E2OGM2NGIzL3RleHRyZWdpb246ZWYwNjM2MTc0MDFiNDIyOGFhZWQ5YWEzYTY4YzY0YjNfMjk_fcc15041-7473-4f8e-9ba8-d30edd88e6d0"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81NS9mcmFnOmVmMDYzNjE3NDAxYjQyMjhhYWVkOWFhM2E2OGM2NGIzL3RleHRyZWdpb246ZWYwNjM2MTc0MDFiNDIyOGFhZWQ5YWEzYTY4YzY0YjNfMTgxNDE5NDE4NTg0MjE_8884a11e-c5a9-4e60-9463-12383374291a"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <dva:CorporateIntegrityAgreementPeriod
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl83MC9mcmFnOjliYTQ4OTdlZjRiZDRjZDNiMWMxNjkxYTdiZGE5ZDc1L3RleHRyZWdpb246OWJhNDg5N2VmNGJkNGNkM2IxYzE2OTFhN2JkYTlkNzVfMjE3_408657d9-e6f5-4bfe-8afb-4e0bbac89802">P5Y</dva:CorporateIntegrityAgreementPeriod>
    <dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount
      contextRef="i8f9b78b5f5fc4575a3e804c564b6679b_I20201210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNzE3L2ZyYWc6MGI1YTVlYzhiMjExNDZhYmE3OGRlZGNmMjE4N2IzZmQvdGV4dHJlZ2lvbjowYjVhNWVjOGIyMTE0NmFiYTc4ZGVkY2YyMTg3YjNmZF8xODE0MTk0MTg1ODQ5Mg_b269c9c0-d037-472a-ada5-a81b823c3678"
      unitRef="usd">329302000</dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount>
    <dei:DocumentType
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODc3_ea46f6cb-9cef-4ba9-a570-7c2f9f27e47d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM3MzBhYWQ1NjA2NDdhZGI3MzUyMzU0NWQ5OTNhYzcvdGFibGVyYW5nZToxYzczMGFhZDU2MDY0N2FkYjczNTIzNTQ1ZDk5M2FjN18wLTAtMS0xLTA_a9318afc-105c-4305-805c-3b96826dafb6">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xMjg_75be89e9-2cae-44f0-bddc-aa08622da872">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6NDhjYWJiY2IwMzMxNDhlOGEyZTc1NDZjODlhZWY1YTYvdGFibGVyYW5nZTo0OGNhYmJjYjAzMzE0OGU4YTJlNzU0NmM4OWFlZjVhNl8wLTAtMS0xLTA_4e57bcf8-6e45-4ef9-9d14-fd478313f3e6">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODc4_d62ba832-faf5-4b0c-a2d9-5163ae446813">1-14106</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODc5_9637905d-bf7e-4393-b6b3-b6702454589b">DAVITA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MDMwMzZmZjA4YmY1NDhlYWE2MDY4YTRhZjRmZjViMmYvdGFibGVyYW5nZTowMzAzNmZmMDhiZjU0OGVhYTYwNjhhNGFmNGZmNWIyZl8wLTAtMS0xLTA_de1b3e30-fbbf-4b52-a4ca-1819b40fadcd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MDMwMzZmZjA4YmY1NDhlYWE2MDY4YTRhZjRmZjViMmYvdGFibGVyYW5nZTowMzAzNmZmMDhiZjU0OGVhYTYwNjhhNGFmNGZmNWIyZl8wLTItMS0xLTA_89713f55-27c9-4b4e-9bb3-28f95a4e3dac">51-0354549</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM2NjE2ZDdjZjMxNDc5Yjk0NjFiMTliZTBhYjJiMzcvdGFibGVyYW5nZToxYzY2MTZkN2NmMzE0NzliOTQ2MWIxOWJlMGFiMmIzN18wLTAtMS0xLTA_107f86ae-981e-42a5-a19c-a80b06945f95">2000 16th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM2NjE2ZDdjZjMxNDc5Yjk0NjFiMTliZTBhYjJiMzcvdGFibGVyYW5nZToxYzY2MTZkN2NmMzE0NzliOTQ2MWIxOWJlMGFiMmIzN18xLTAtMS0xLTA_701d8c60-2555-49db-9a04-8af2c04fda8d">Denver,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM2NjE2ZDdjZjMxNDc5Yjk0NjFiMTliZTBhYjJiMzcvdGFibGVyYW5nZToxYzY2MTZkN2NmMzE0NzliOTQ2MWIxOWJlMGFiMmIzN18xLTEtMS0xLTA_1c3bdb61-9bc6-46fe-af77-b4f253080c33">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MWM2NjE2ZDdjZjMxNDc5Yjk0NjFiMTliZTBhYjJiMzcvdGFibGVyYW5nZToxYzY2MTZkN2NmMzE0NzliOTQ2MWIxOWJlMGFiMmIzN18xLTItMS0xLTA_923d4082-845b-4295-8be8-9baf45fb2fa2">80202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODgw_b19c4deb-2b2a-4f76-8238-c133e25a35f3">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODgx_48842761-6d3c-4775-ab16-8306a28e16bf">631-2100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MGI4Nzc5OGIxOWNhNDI4MGE5MGU3MjU0MmJlZjBmNzMvdGFibGVyYW5nZTowYjg3Nzk4YjE5Y2E0MjgwYTkwZTcyNTQyYmVmMGY3M18xLTAtMS0xLTA_b7271bab-c825-426d-b862-a31c5f97564c">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MGI4Nzc5OGIxOWNhNDI4MGE5MGU3MjU0MmJlZjBmNzMvdGFibGVyYW5nZTowYjg3Nzk4YjE5Y2E0MjgwYTkwZTcyNTQyYmVmMGY3M18xLTItMS0xLTA_20aedb21-57a6-4c69-9793-e775ecb638ae">DVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6MGI4Nzc5OGIxOWNhNDI4MGE5MGU3MjU0MmJlZjBmNzMvdGFibGVyYW5nZTowYjg3Nzk4YjE5Y2E0MjgwYTkwZTcyNTQyYmVmMGY3M18xLTQtMS0xLTA_8ef862d7-de78-41b8-8f82-a155924dee1a">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODgy_abc99e97-0f14-4031-be2a-07c398c23ab8">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODgz_715a08e0-310f-40ca-b272-8f91092fde15">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6ZTdjOTk2YjhjYzRiNDRlZThlMGRiYWQzOWZkMmNjODEvdGFibGVyYW5nZTplN2M5OTZiOGNjNGI0NGVlOGUwZGJhZDM5ZmQyY2M4MV8wLTAtMS0xLTA_6e2a0a1c-eeef-4757-8fc5-0580c9dedae7">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6ZTdjOTk2YjhjYzRiNDRlZThlMGRiYWQzOWZkMmNjODEvdGFibGVyYW5nZTplN2M5OTZiOGNjNGI0NGVlOGUwZGJhZDM5ZmQyY2M4MV8yLTMtMS0xLTA_73fc9a35-dd9c-456e-a259-f012880ec84a">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGFibGU6ZTdjOTk2YjhjYzRiNDRlZThlMGRiYWQzOWZkMmNjODEvdGFibGVyYW5nZTplN2M5OTZiOGNjNGI0NGVlOGUwZGJhZDM5ZmQyY2M4MV80LTEtMS0xLTA_d667ad46-3d7d-4fb4-b416-683c5698475a">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODc2_7a46b48a-0eb2-4bdf-bd47-16075f1aa664">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia925779a41b04416bebac5d08f6cde4c_I20210426"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xL2ZyYWc6YzdmYzMxNWI3YjI4NGI4ZTliYjFhYjU2NDMzNzA4MzkvdGV4dHJlZ2lvbjpjN2ZjMzE1YjdiMjg0YjhlOWJiMWFiNTY0MzM3MDgzOV8xODY1_e09be5ce-6d3d-4d45-b1b5-4e9363f3a9b6"
      unitRef="shares">106200000</dei:EntityCommonStockSharesOutstanding>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMi0xLTEtMS0w_ae7789e8-8b3f-498c-b373-0a14660addc9"
      unitRef="usd">2714587000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMi0zLTEtMS0w_a457d67a-3d48-4982-82a4-1e2a0804f192"
      unitRef="usd">2713281000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <us-gaap:OtherIncome
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMy0xLTEtMS0w_0616ea1c-11e1-4d2c-ba67-fd5371a07211"
      unitRef="usd">105414000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMy0zLTEtMS0w_37abe127-df8e-4a03-ba06-aa147a59e4c4"
      unitRef="usd">127956000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNC0xLTEtMS0w_28488703-4323-4fd6-a4e0-d2403396f3fe"
      unitRef="usd">2820001000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNC0zLTEtMS0w_f95549c3-80fd-4251-9798-c1be7cf85e10"
      unitRef="usd">2841237000</us-gaap:Revenues>
    <dva:PatientCareCosts
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNi0xLTEtMS0w_2268486b-2ce1-49ce-a655-28c37de7661a"
      unitRef="usd">1938330000</dva:PatientCareCosts>
    <dva:PatientCareCosts
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNi0zLTEtMS0w_de02b360-3b81-4bab-bf44-88bcab70fb5b"
      unitRef="usd">1975449000</dva:PatientCareCosts>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNy0xLTEtMS0w_2569f0dd-a66a-43ed-95cd-9261408b5002"
      unitRef="usd">281426000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfNy0zLTEtMS0w_231afbf9-9a58-4be4-9429-6d62430141db"
      unitRef="usd">263576000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfOC0xLTEtMS0w_7efe3bdd-45e2-4db4-b6d6-8e1b7db6c78e"
      unitRef="usd">165701000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfOC0zLTEtMS0w_8815a94a-119e-4aca-b41a-00117529a750"
      unitRef="usd">154679000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfOS0xLTEtMS0w_ea0e727b-9cbd-445b-8e38-22fd76743196"
      unitRef="usd">8058000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfOS0zLTEtMS0w_0d78157c-a0db-4ae2-a2d0-9db5d2964219"
      unitRef="usd">17843000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:CostsAndExpenses
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTItMS0xLTEtMA_a095b48e-cf2c-4006-81fa-6f642a047c28"
      unitRef="usd">2377399000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTItMy0xLTEtMA_ae1fd555-4381-4c11-8914-142d7bca7e27"
      unitRef="usd">2375861000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTMtMS0xLTEtMA_591a12f4-0519-4e2a-a1ae-f937a5df3f3f"
      unitRef="usd">442602000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTMtMy0xLTEtMA_c9bc5918-8a7f-4af3-b33d-2c7279a09be7"
      unitRef="usd">465376000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTQtMS0xLTEtMA_13ec5460-07ea-4a2f-a315-9bdfdecd8b3c"
      unitRef="usd">67014000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTQtMy0xLTEtMA_a5e297bc-6fad-4fcd-a5af-5f7df7caaef3"
      unitRef="usd">88603000</us-gaap:InterestAndDebtExpense>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTUtMS0xLTEtMA_6145d9f6-6e0e-4c2c-a24b-c8b576bfeda5"
      unitRef="usd">0</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTUtMy0xLTEtMA_ca4600f0-e54e-4ae0-9248-67f4e83e2004"
      unitRef="usd">2948000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTYtMS0xLTEtMA_8a01de7c-dbfe-488d-b0cd-6673920909df"
      unitRef="usd">1168000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTYtMy0xLTEtMA_f414dce8-e7ac-4e73-a8b6-544abf15c950"
      unitRef="usd">-4350000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTctMS0xLTEtMA_d37cae4b-b5e8-49b5-9158-4d63a5b34017"
      unitRef="usd">376756000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTctMy0xLTEtMA_7d58d5b6-1a8f-4ec4-bddd-13013d77de0b"
      unitRef="usd">369475000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTgtMS0xLTEtMA_a9f81f3a-89da-4664-80a3-1f12f7d399ba"
      unitRef="usd">85211000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTgtMy0xLTEtMA_047f09eb-af4b-4ba8-97e6-cc8611990760"
      unitRef="usd">91560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTktMS0xLTEtMA_ed361f02-0254-408b-93f1-86af3e454724"
      unitRef="usd">291545000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMTktMy0xLTEtMA_8a664f02-c71e-4b10-8c32-af975aed8c19"
      unitRef="usd">277915000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjAtMS0xLTEtMA_5c840270-2e15-4b6e-a6cf-9de9d6e7b6f7"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjAtMy0xLTEtMA_eb2f2e20-fe20-4dff-a194-9d7bb767b9db"
      unitRef="usd">9980000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjEtMS0xLTEtMA_9a83e7c2-079d-4230-8f98-fb06ea52f931"
      unitRef="usd">291545000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjEtMy0xLTEtMA_70861cc5-40eb-4373-b7fb-1dcc85f5926e"
      unitRef="usd">287895000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjItMS0xLTEtMA_520b409b-1f12-4cad-af29-afacdbf0e2cf"
      unitRef="usd">54142000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjItMy0xLTEtMA_3706193c-ca6e-409d-bca0-ec848d242116"
      unitRef="usd">48302000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjMtMS0xLTEtMA_60cedbfb-217a-4347-89fd-514eefeb7814"
      unitRef="usd">237403000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjMtMy0xLTEtMA_8447b0fe-6bd5-4adb-9537-b1e9b936599b"
      unitRef="usd">239593000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjYtMS0xLTEtMA_215a98e5-deef-4db5-bcde-32f9253e5ebd"
      unitRef="usdPerShare">2.18</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjYtMy0xLTEtMA_a19cbfe9-dcbc-4c04-bb1f-c06f90822f90"
      unitRef="usdPerShare">1.84</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjctMS0xLTEtMA_f7833545-af05-4cac-abaa-0499585c6d9f"
      unitRef="usdPerShare">2.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjctMy0xLTEtMA_806f60fd-31b4-4469-82af-a7a623d60157"
      unitRef="usdPerShare">1.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjgtMS0xLTEtMA_008f5610-c477-4a3d-85e7-3dc81ed242e8"
      unitRef="usdPerShare">2.09</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjgtMy0xLTEtMA_8a53004a-008d-41e2-946d-aef8e879d384"
      unitRef="usdPerShare">1.81</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjktMS0xLTEtMA_e619b9dd-1b8d-4aeb-adb6-8fe9e2f5b429"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMjktMy0xLTEtMA_13d35d18-67fd-41d5-a7cf-643dea09cbc2"
      unitRef="usdPerShare">1.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzItMS0xLTEtMA_2976c4b1-888c-43a4-97b0-9aec0170e580"
      unitRef="shares">109014000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzItMy0xLTEtMA_7b4a3aab-f79f-4065-a971-037ed66ae452"
      unitRef="shares">124902000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzMtMS0xLTEtMA_8e5df6c3-465c-49fe-a0e5-fbb3b87a1fc4"
      unitRef="shares">113852000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzMtMy0xLTEtMA_52fc16e0-9b72-4a7f-98c8-3345df877b81"
      unitRef="shares">126895000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzYtMS0xLTEtMA_6bd9b536-ff6d-463b-8a24-9d3018def404"
      unitRef="usd">237403000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzYtMy0xLTEtMA_6ff01982-97cd-4350-a012-a100e1c5ebd6"
      unitRef="usd">229613000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzctMS0xLTEtMA_12b6e495-9a7a-4b05-8e66-301ed37227ef"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzctMy0xLTEtMA_c1ff6fe3-1407-4891-bb1e-a25528ad4ed5"
      unitRef="usd">9980000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzgtMS0xLTEtMA_64c32125-4afe-48f1-8f54-2fa2ad1911f2"
      unitRef="usd">237403000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMy9mcmFnOjUwNWMwMWMyMGZiYzQ4YjA4ZDhmNWU5ZWYyMjAzZDAwL3RhYmxlOjVlMmVhZTViNmI1YjRlZjg4NTkxYjA3YzZmZjc3Y2IzL3RhYmxlcmFuZ2U6NWUyZWFlNWI2YjViNGVmODg1OTFiMDdjNmZmNzdjYjNfMzgtMy0xLTEtMA_00db9d6e-db88-4a5f-8f4e-092f7d60867d"
      unitRef="usd">239593000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMi0xLTEtMS0w_9a83e7c2-079d-4230-8f98-fb06ea52f931"
      unitRef="usd">291545000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMi0zLTEtMS0w_70861cc5-40eb-4373-b7fb-1dcc85f5926e"
      unitRef="usd">287895000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfNS0xLTEtMS0w_a95b923a-4814-465d-b735-12d41c156817"
      unitRef="usd">4882000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfNS0zLTEtMS0w_d86a74fe-36e3-4679-90aa-32541d7653e4"
      unitRef="usd">-13018000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfNi0xLTEtMS0w_256f303b-e83b-439b-86b7-36f76b30c8da"
      unitRef="usd">-1033000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfNi0zLTEtMS0w_2d247b24-53b7-4ba7-b677-2e31b04d661f"
      unitRef="usd">-1623000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfOC0xLTEtMS02MDQ4_927fbe02-bf20-43e9-a7d7-170d59348bd2"
      unitRef="usd">-62544000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfOC0zLTEtMS02MDQ4_2582fb50-ba1c-4def-939c-5f0f193525f0"
      unitRef="usd">-81632000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfOS0xLTEtMS0w_97604065-fdbe-45f9-b282-a0018d4b94ea"
      unitRef="usd">-56629000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfOS0zLTEtMS0w_8efa218d-57d3-4d45-bcf9-eea77731a846"
      unitRef="usd">-93027000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTAtMS0xLTEtMA_1e1216dc-cdd5-4beb-8e11-7a932a39e595"
      unitRef="usd">234916000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTAtMy0xLTEtMA_476a8012-9c07-45a0-aa2b-23721f7cf06e"
      unitRef="usd">194868000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTEtMS0xLTEtMA_a719505c-1dbe-40c5-b57b-9e1dcfb75839"
      unitRef="usd">54142000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTEtMy0xLTEtMA_9815ada3-e331-4252-b5e5-f49f0c8db06b"
      unitRef="usd">48302000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTItMS0xLTEtMA_dc81abe5-dd52-4c76-9e23-6379470657a5"
      unitRef="usd">180774000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNi9mcmFnOjFlMDcwNjI2YzhkYzQwNTZhMTJiZjJmYjY0NGFmYzkxL3RhYmxlOmFlYjVkNmM1YTllNTRmZjk4ZjY0YzY3MGE4YjA5NTRjL3RhYmxlcmFuZ2U6YWViNWQ2YzVhOWU1NGZmOThmNjRjNjcwYThiMDk1NGNfMTItMy0xLTEtMA_0172053b-7562-4fe3-bf7f-2741b9a23135"
      unitRef="usd">146566000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMi0xLTEtMS0w_ab1680ad-1628-4e63-ba33-418b2fdc3b26"
      unitRef="usd">884205000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMi0zLTEtMS0w_75e289e9-9546-4837-8d21-3339107c6e27"
      unitRef="usd">324958000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMy0xLTEtMS0w_98978768-ded8-41c4-b836-a1faead40e22"
      unitRef="usd">176835000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMy0zLTEtMS0w_ad75edc7-2aa8-4b22-bd9d-d4691d3a5965"
      unitRef="usd">176832000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNC0xLTEtMS0w_ba31046d-2adf-4598-9f99-496d0dd31c01"
      unitRef="usd">11060000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNC0zLTEtMS0w_b58adf18-fec7-4571-b5ef-4620bba52355"
      unitRef="usd">20101000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNS0xLTEtMS0w_ee1d9b2e-28b8-4ab6-8676-3ca5de588ecb"
      unitRef="usd">2040813000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNS0zLTEtMS0w_e3b2b8fd-1626-4ea1-84f6-aef7dd1fd948"
      unitRef="usd">1824282000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNi0xLTEtMS0w_d362e10c-720e-4efa-af3b-f6b6c3db013f"
      unitRef="usd">116322000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNi0zLTEtMS0w_7e54ff44-71e8-4498-920a-a93b2075ba43"
      unitRef="usd">111625000</us-gaap:InventoryNet>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNy0xLTEtMS0w_ef36f398-167f-4abe-a4c5-7043ca0f9acf"
      unitRef="usd">535521000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNy0zLTEtMS0w_9efdd1cd-1319-4ea7-81ef-e653d011d40c"
      unitRef="usd">544376000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfOC0xLTEtMS0w_64275662-77bc-42be-a19f-9e2e910beb42"
      unitRef="usd">73765000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfOC0zLTEtMS0w_d7e89918-cb02-48ab-b20d-9b0eece5a4fd"
      unitRef="usd">76387000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfOS0xLTEtMS0w_3113c1dd-0c00-4d83-b466-f2e2e236d0ee"
      unitRef="usd">28160000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfOS0zLTEtMS0w_5df9754a-4fb6-48b7-b912-888825c3c2ed"
      unitRef="usd">70163000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTAtMS0xLTEtMA_5a2f9842-f5a4-4102-a1ab-151d55432e29"
      unitRef="usd">3866681000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTAtMy0xLTEtMA_1d65070c-4c89-436b-9d2f-34324517ea94"
      unitRef="usd">3148724000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTEtMS0xLTEtMA_6e860769-03af-4a63-92dc-b006b6955093"
      unitRef="usd">3490442000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTEtMy0xLTEtMA_2cf0b321-b46a-4ff1-9f30-af439671f7b8"
      unitRef="usd">3521824000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTItMS0xLTEtMA_e08f2246-a814-4d0a-bff3-34b974dbe8f4"
      unitRef="usd">2868292000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTItMy0xLTEtMA_a0a68d1b-f005-455b-9fa0-e742647a6245"
      unitRef="usd">2863089000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTMtMS0xLTEtMA_eea9cf60-d427-497a-bb97-b04c130c5da5"
      unitRef="usd">150706000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTMtMy0xLTEtMA_cc321014-babd-4c9b-abd7-d6519967b3bb"
      unitRef="usd">166585000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTQtMS0xLTEtMA_3730999f-7afe-44d4-9bdd-bad942b339c9"
      unitRef="usd">257513000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTQtMy0xLTEtMA_02e5fadf-291e-4eb0-a452-d4657f2da3e1"
      unitRef="usd">257491000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTUtMS0xLTEtMA_cfcbd529-8f72-4eca-9f53-274fac82d909"
      unitRef="usd">31891000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTUtMy0xLTEtMA_32b0a425-2db0-4a8e-963a-e2cce8af00cc"
      unitRef="usd">32193000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTYtMS0xLTEtMA_e38232bf-0aec-4457-8445-f9e3b10b7f3c"
      unitRef="usd">90534000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTYtMy0xLTEtMA_d3b234f9-19fa-43ae-8ded-eea36124b4e1"
      unitRef="usd">79501000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTctMS0xLTEtMA_8b2bcdee-b997-4243-bbe7-a40e9c5bc0a5"
      unitRef="usd">6891209000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTctMy0xLTEtMA_aa1f875e-4f96-4b54-a1fd-317161382540"
      unitRef="usd">6919109000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTgtMS0xLTEtMA_437bebe9-5b10-4f5a-acce-0869d25a32d4"
      unitRef="usd">17647268000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMTgtMy0xLTEtMA_708c1bdf-9bfe-4455-a031-346b9f6e9ec8"
      unitRef="usd">16988516000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjAtMS0xLTEtMA_e45c7a2a-129c-48f3-b867-1ff2dda580b7"
      unitRef="usd">348105000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjAtMy0xLTEtMA_f8489b13-ae4c-4a3f-9b72-9911abb3ac74"
      unitRef="usd">434253000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjEtMS0xLTEtMA_333055e5-3f4f-4c41-a346-a88d727b2935"
      unitRef="usd">846710000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjEtMy0xLTEtMA_e137909c-3924-48ef-915b-c06f0aab9770"
      unitRef="usd">810529000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjItMS0xLTEtMA_71b0de3c-1e40-47b6-8f92-9dd7de211cc3"
      unitRef="usd">550671000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjItMy0xLTEtMA_0ab9f251-733c-4689-9528-5876ed6920d9"
      unitRef="usd">685555000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjMtMS0xLTEtMA_26522b6d-e068-49be-b5ba-ae492687e170"
      unitRef="usd">372737000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjMtMy0xLTEtMA_c0fef722-c3ca-4de2-bed0-8f82f6be54bf"
      unitRef="usd">369497000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjQtMS0xLTEtMA_b2c2efb8-7b1f-4c52-85eb-ede8fe4268b8"
      unitRef="usd">168191000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjQtMy0xLTEtMA_e66cbf4d-b3fb-4076-9f1d-6ff7f9043428"
      unitRef="usd">168541000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjUtMS0xLTEtMA_4b889f55-0ba4-4f0e-815e-fc108d8b3e67"
      unitRef="usd">28310000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjUtMy0xLTEtMA_767814b4-fd9e-4cf7-8422-2ab898aa788f"
      unitRef="usd">7768000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjYtMS0xLTEtMA_751f1e39-23ec-42d5-8320-d6726a17f85a"
      unitRef="usd">2314724000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjYtMy0xLTEtMA_74ea3ae1-db09-46f4-98bb-adb071b8c6b8"
      unitRef="usd">2476143000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjctMS0xLTEtMA_42f87992-5571-4202-b6b5-e0d1320d72cd"
      unitRef="usd">2739311000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjctMy0xLTEtMA_ca3a15fe-4ecb-4eed-9ab6-7efa21e9e4a5"
      unitRef="usd">2738670000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjgtMS0xLTEtMA_d71e7647-d423-4370-acd3-1e2b8fc5e278"
      unitRef="usd">8829765000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjgtMy0xLTEtMA_25db3635-69dd-4720-ab38-f1154f8e1117"
      unitRef="usd">7917263000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjktMS0xLTEtMA_8721ea57-10dd-49a7-9300-458a02a88a93"
      unitRef="usd">150724000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMjktMy0xLTEtMA_cb186c5e-70b0-40ac-aad3-4d17ea65bf46"
      unitRef="usd">150060000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzAtMS0xLTEtMA_ebce0257-262f-43f5-9139-1ae73351d1f0"
      unitRef="usd">830369000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzAtMy0xLTEtMA_39a41b2b-48ae-48e8-819f-174ad6967d82"
      unitRef="usd">809600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzEtMS0xLTEtMA_58384000-7681-4c9a-97a8-2df53d8fcb2b"
      unitRef="usd">14864893000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzEtMy0xLTEtMA_f281e007-e877-45b9-a256-f741a65cdb7a"
      unitRef="usd">14091736000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzMtMS0xLTEtMA_09b1c7bb-1ec4-4cda-8021-2879b97e572e"
      unitRef="usd">1349160000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzMtMy0xLTEtMA_1d19217d-192a-4f48-a6a0-18288dd8f133"
      unitRef="usd">1330028000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockValue
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzUtMS0xLTEtMA_3f88a99f-2322-4020-9c9f-a701ac1eff95"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzUtMy0xLTEtMA_74d58a7b-9fea-4c5b-bc8c-aad0718500f1"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzYtMS0xLTEtMA_123d7943-f75c-423c-95e2-a5797bbffad8"
      unitRef="usd">110000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzYtMy0xLTEtMA_9bd6c6c2-c71b-481a-a6a5-e43c6fd171c6"
      unitRef="usd">110000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzctMS0xLTEtMA_e434b959-87d2-4e99-9d24-75a66ed30632"
      unitRef="usd">603172000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzctMy0xLTEtMA_59278445-6597-4497-bb16-188ee4cbfcb0"
      unitRef="usd">597073000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzgtMS0xLTEtMA_300600f0-06e3-4140-93c1-c5982fd8ece2"
      unitRef="usd">1089940000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzgtMy0xLTEtMA_cb7ee528-89bd-48b3-937d-df6baf8e17e3"
      unitRef="usd">852537000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzktMS0xLTEtMA_48b9a35c-0d99-40a8-8e40-d773ad30761e"
      unitRef="usd">322333000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfMzktMy0xLTEtMA_7a6fd462-67a9-4bb2-ab36-c48483920ac5"
      unitRef="usd">0</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDAtMS0xLTEtMA_4aeb91f3-bea2-4a08-9b84-21e0760f3e6d"
      unitRef="usd">-122783000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDAtMy0xLTEtMA_983c83d3-08fc-4a18-aab0-ebb32b3fbba8"
      unitRef="usd">-66154000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDEtMS0xLTEtMA_df4e5f5d-c6b6-47dc-8595-72a0b6457ab6"
      unitRef="usd">1248106000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDEtMy0xLTEtMA_7b51dc17-e0d9-4584-8d0e-dedba4a70dc0"
      unitRef="usd">1383566000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDItMS0xLTEtMA_2acdee71-3f54-4b14-9de3-6a8bd64bc950"
      unitRef="usd">185109000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDItMy0xLTEtMA_e592498c-7960-41d8-8121-e09bd787ecc9"
      unitRef="usd">183186000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDMtMS0xLTEtMA_e0bc0833-501b-41df-9257-778467f60f89"
      unitRef="usd">1433215000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDMtMy0xLTEtMA_ddfb8cb0-3d77-4af6-9cda-85f9a973bef9"
      unitRef="usd">1566752000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDQtMS0xLTEtMA_1c842a7f-bb27-4060-b13d-f2c2e715eaf4"
      unitRef="usd">17647268000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xOS9mcmFnOmRhMDhiN2FhNjUzYTQyNWJiNGNjZDYyMjU5MDY4YTNiL3RhYmxlOjk3MGQ2NzkyM2E2MDRjYTRiMThjOTY3MmI1MDhmNzQxL3RhYmxlcmFuZ2U6OTcwZDY3OTIzYTYwNGNhNGIxOGM5NjcyYjUwOGY3NDFfNDQtMy0xLTEtMA_bf70b406-d4d4-45e8-b1e6-54c875be01e2"
      unitRef="usd">16988516000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMy0xLTEtMS0w_3d910e39-d013-4867-b5d6-81b895ea3be2"
      unitRef="usd">291545000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMy0zLTEtMS0w_60bd169a-d196-4f0b-8e37-a53e181bd088"
      unitRef="usd">287895000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNS0xLTEtMS0w_87465f42-4b4f-4dc0-b7ff-eb88eff754bd"
      unitRef="usd">165701000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNS0zLTEtMS0w_471f7b49-79f8-4cb3-a5bb-5c542f7373da"
      unitRef="usd">154679000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <dva:DebtRefinancingCharges
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNi0xLTEtMS0w_185d6a84-cf8a-4e4f-8cfe-9a519b6e70a1"
      unitRef="usd">0</dva:DebtRefinancingCharges>
    <dva:DebtRefinancingCharges
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNi0zLTEtMS0w_dbc0f822-29fe-4976-8d10-ab7775720243"
      unitRef="usd">884000</dva:DebtRefinancingCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfOC0xLTEtMS0w_388ca227-dd63-4c50-956c-3e5a12722eb8"
      unitRef="usd">23595000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfOC0zLTEtMS0w_c230ce37-5ea4-4555-8e63-57bf4a9b54de"
      unitRef="usd">19870000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfOS0xLTEtMS0w_73f8c8ae-d22b-4981-a3f7-22166ec4f9e5"
      unitRef="usd">18688000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfOS0zLTEtMS0w_d3940ca9-9f36-4e28-845e-daffb0437642"
      unitRef="usd">103301000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <dva:AdjustmentIncomeLossFromEquityMethodInvestments
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTAtMS0xLTEtMA_2a31f72e-25de-41c7-9c0a-a51e0d5997b3"
      unitRef="usd">2924000</dva:AdjustmentIncomeLossFromEquityMethodInvestments>
    <dva:AdjustmentIncomeLossFromEquityMethodInvestments
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTAtMy0xLTEtMA_9746d2eb-4514-4226-a115-aefed312e903"
      unitRef="usd">9482000</dva:AdjustmentIncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTItMS0xLTEtMA_b3b13b51-19e0-4220-a042-0ec5c00a0dd0"
      unitRef="usd">-3979000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTItMy0xLTEtMA_7212cc57-7387-4331-85a6-8331b156b3c8"
      unitRef="usd">-5055000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTQtMS0xLTEtMA_eda6bbde-4253-4b2b-8970-93547dd25022"
      unitRef="usd">224274000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTQtMy0xLTEtMA_a9f637d0-8332-42cb-a933-c50ade336743"
      unitRef="usd">32966000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTUtMS0xLTEtMA_36be80a9-f58f-4539-8d4b-7053c43127f5"
      unitRef="usd">5303000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTUtMy0xLTEtMA_19e0b73a-99d1-4446-8faf-21585f9634ba"
      unitRef="usd">-1835000</us-gaap:IncreaseDecreaseInInventories>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTYtMS0xLTEtMA_45f72e83-8d99-4dc4-ae53-ea5203225c23"
      unitRef="usd">-13756000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTYtMy0xLTEtMA_03659b18-2570-4c54-a8ef-3bc268f21c1f"
      unitRef="usd">24965000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTctMS0xLTEtMA_620f7271-7d60-4793-ae9b-3f7e08fdbc81"
      unitRef="usd">6521000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTctMy0xLTEtMA_eeb58756-9dca-4d8a-9d7b-7be93b3b73a0"
      unitRef="usd">-2673000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTgtMS0xLTEtMA_3295b37e-3062-4ad1-b28d-e8cb4a1fab80"
      unitRef="usd">-75504000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTgtMy0xLTEtMA_4fffb328-4c6f-44e8-99e8-17172991c74b"
      unitRef="usd">-24045000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTktMS0xLTEtMA_9c06a983-a055-4e65-8c9c-f5bb1a731439"
      unitRef="usd">-126330000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMTktMy0xLTEtMA_d1b3cd28-8990-4237-829e-e11f27d774fc"
      unitRef="usd">-96428000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjAtMS0xLTEtMA_ca773af8-835b-4bc9-b7c6-98739167a134"
      unitRef="usd">26970000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjAtMy0xLTEtMA_3dd65821-8bfd-4692-b160-cfe3c3bc32a9"
      unitRef="usd">3982000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjEtMS0xLTEtMA_71e7ae88-4063-495b-b715-2eb6335ec86b"
      unitRef="usd">62719000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjEtMy0xLTEtMA_52c86b7e-70df-4302-9a1d-159ac75df75b"
      unitRef="usd">-32616000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjItMS0xLTEtMA_a6012eca-8bb3-413a-a3d5-eeb030ba26dc"
      unitRef="usd">-11793000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjItMy0xLTEtMA_e52b1d28-7cbb-4827-b5d9-ea701f3640de"
      unitRef="usd">709000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjMtMS0xLTEtMA_36724147-e85a-449b-a032-b42ee7295159"
      unitRef="usd">154304000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjMtMy0xLTEtMA_8f8d4879-38ee-4c7b-836c-37252c64fb41"
      unitRef="usd">360381000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjUtMS0xLTEtMA_12c2e88b-cfd9-48d4-9f2b-1dce832fccd3"
      unitRef="usd">144913000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjUtMy0xLTEtMA_44f5b566-38c4-4c58-ad0a-70e496db7989"
      unitRef="usd">154942000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjYtMS0xLTEtMA_6f4137b1-efc0-4193-804e-6c598dbad9e6"
      unitRef="usd">3668000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjYtMy0xLTEtMA_aa9d7f58-fdac-425a-ad0f-7b9f04e99d4c"
      unitRef="usd">34107000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjctMS0xLTEtMA_2b0f7ab6-9557-4a43-8eda-d3baf9e0da39"
      unitRef="usd">16337000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjctMy0xLTEtMA_8fa907ec-39e3-426a-98e4-1e0a8feec7a1"
      unitRef="usd">31518000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjgtMS0xLTEtMA_c7d37c44-cd68-465f-b2e1-d9622e93a939"
      unitRef="usd">5349000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjgtMy0xLTEtMA_4a1fbd16-6e0b-4a80-9a4d-52fd757f3690"
      unitRef="usd">5049000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjktMS0xLTEtMA_e2813b41-0b96-405c-8c2e-96ec6cd0a8e1"
      unitRef="usd">1779000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMjktMy0xLTEtMA_d0c88293-25a5-4a93-8273-a65a2f468515"
      unitRef="usd">2633000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzAtMS0xLTEtMA_dbb06841-6a5f-4c7d-a0d1-b4ca11e531db"
      unitRef="usd">5349000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzAtMy0xLTEtMA_0a051150-6e74-4b3c-bd52-1eba8d423264"
      unitRef="usd">5049000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzEtMS0xLTEtMA_95c10c30-8e27-43e5-b36d-33d7314bd7a9"
      unitRef="usd">11879000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzEtMy0xLTEtMA_56eb4ae0-a128-4d6e-87f3-57ea224f397a"
      unitRef="usd">3268000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzItMS0xLTEtMA_d4fed74f-90dc-485c-a120-9e939f02560d"
      unitRef="usd">3200000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzItMy0xLTEtMA_47b2755e-31ad-417d-b782-f7cbaf890db2"
      unitRef="usd">6174000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzMtMS0xLTEtMA_88e6890c-d202-4875-b9fc-81729c0e1c90"
      unitRef="usd">978000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzMtMy0xLTEtMA_3a60923d-92ca-4352-b029-28ed9dc3357b"
      unitRef="usd">445000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzQtMS0xLTEtMA_f6a28649-49ff-4ace-8387-d126d1823b2e"
      unitRef="usd">-124366000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzQtMy0xLTEtMA_ed66fb97-70ee-41ce-976f-81916014b5ca"
      unitRef="usd">-162625000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzYtMS0xLTEtMA_62dfa10d-77fa-474e-bd88-03b013546f51"
      unitRef="usd">1606969000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzYtMy0xLTEtMA_3772f518-d14e-4472-824b-46363e366f12"
      unitRef="usd">570779000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzctMS0xLTEtMA_8339ae37-a0a6-45a4-9d70-2c571c48f15e"
      unitRef="usd">698298000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzctMy0xLTEtMA_792e2281-b02c-4342-86b4-3ffd1d6fd6e3"
      unitRef="usd">104592000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzgtMS0xLTEtMA_ba959ace-dc5d-4ac9-822d-8d6a02b6722a"
      unitRef="usd">8346000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzgtMy0xLTEtMA_df60032d-89ee-4279-9e77-885b41162af4"
      unitRef="usd">350000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzktMS0xLTEtMA_bef72ed3-e8f0-4f04-af3f-8007032d05cf"
      unitRef="usd">316250000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfMzktMy0xLTEtMA_c994ef8b-6468-4f58-9f5d-e8712ab9eff2"
      unitRef="usd">321798000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDAtMS0xLTEtMA_0ca9dff0-7096-4a6b-8554-37ca9418e5cc"
      unitRef="usd">53867000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDAtMy0xLTEtMA_e37b34e9-71a6-45d6-b65d-d4c381411000"
      unitRef="usd">58131000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDEtMS0xLTEtMA_e4fd8938-d588-4df6-b77c-45ffe781376a"
      unitRef="usd">2524000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDEtMy0xLTEtMA_8b5cf2da-7c3d-4189-8f75-1ce608c098a6"
      unitRef="usd">2397000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDItMS0xLTEtMA_4663b313-d972-462d-8ca6-647ef77ef7c4"
      unitRef="usd">10689000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDItMy0xLTEtMA_1081b2d9-7b94-4172-b279-07996c4351ee"
      unitRef="usd">9387000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDQtMS0xLTEtMA_4a3e9d4f-5e92-4e29-968f-17b11852013f"
      unitRef="usd">1095000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDQtMy0xLTEtMA_22514aae-2590-4e7e-9748-381e4938c359"
      unitRef="usd">700000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDUtMS0xLTEtMA_1f87651d-2a80-4692-b2b7-191556ac2f0b"
      unitRef="usd">537278000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDUtMy0xLTEtMA_8f53fb85-5c0b-49a0-bcdf-109d5edc4851"
      unitRef="usd">96992000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDYtMS0xLTEtMA_5729dd90-33db-40b1-bffe-62fa9e40f495"
      unitRef="usd">-7966000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDYtMy0xLTEtMA_d3b9adef-8365-4356-89c4-6099e12087f0"
      unitRef="usd">-14978000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDctMS0xLTEtMA_59094385-6e11-4ce4-8a9a-136e06d8cb59"
      unitRef="usd">559250000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDctMy0xLTEtMA_2550dd54-e47c-4823-b850-de181a45c3aa"
      unitRef="usd">279770000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if25c609ea75c4c068d67fe57512ea434_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDgtMS0xLTEtMA_96aef7f5-c1aa-42cb-a6b2-1bb1d20d1be2"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if09729cbfcb64401a6be3f8ffe616fc5_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDgtMy0xLTEtMA_f649cadc-4048-4833-ac0a-a32859792f9d"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ieeca89f1d034430482dee49030acec85_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDktMS0xLTEtMA_9406b206-23e0-45bf-af3a-4ddaaa2113c5"
      unitRef="usd">559250000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4c63462618b841479c213bb2713220cf_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNDktMy0xLTEtMA_f81392b9-a075-428a-9b0a-f92722eb5c5a"
      unitRef="usd">279770000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNTAtMS0xLTEtMA_3fda15fb-42cc-43d6-96b4-c952a86a5796"
      unitRef="usd">501790000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if227b8854b5d464699191a415580aefe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNTAtMy0xLTEtMA_ce9e34df-13b8-451f-883f-c6ca3d8bed81"
      unitRef="usd">1208718000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNTEtMS0xLTEtMA_8a5728c9-5b4c-4b5d-8059-328259a2cecf"
      unitRef="usd">1061040000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i26a083ee5fdf4ec99abc3850e10e37ff_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yNS9mcmFnOjAxZGEwOTc5ZTkwNjRkY2JiOGNhZjJjZTMyNTY0YTFiL3RhYmxlOjgwYTNkODZhYTIxODRmMTBhMjY3ZTVkMjYzYjAxMjgyL3RhYmxlcmFuZ2U6ODBhM2Q4NmFhMjE4NGYxMGEyNjdlNWQyNjNiMDEyODJfNTEtMy0xLTEtMA_12283e45-a041-4c60-b517-7aa5fb61b764"
      unitRef="usd">1488488000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i057fbe978e34415294c2d4a792413761_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xLTEtMS0w_c06b77c1-fd85-4ce5-8288-f4e664692bbf"
      unitRef="usd">1330028000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8529c41e847743e48bb56774c5d6f476_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0zLTEtMS0w_fa28e555-e4ae-4c6f-834f-641aa737664c"
      unitRef="shares">109933000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8529c41e847743e48bb56774c5d6f476_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS01LTEtMS0w_6c9ad9cf-3f90-4e51-9377-fb3809e76d15"
      unitRef="usd">110000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7542b28699c64b3d8ad0d845de0fa0d6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS03LTEtMS0w_46fd9f10-786e-40ca-bdd4-68e9833ec245"
      unitRef="usd">597073000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb912ac405a7429e8d9f894a52d31c82_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS05LTEtMS0w_a3fc30b2-be78-42be-bab5-e85381a8fdd3"
      unitRef="usd">852537000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i61057af670f54badb9c6da85fd10624c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xMS0xLTEtMA_13299cfa-df3f-4e47-9ac2-7022c2844313"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61057af670f54badb9c6da85fd10624c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xMy0xLTEtMA_e6b5ad79-5c45-4713-8f16-e08303848e42"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0cd9ddbeee04401adc2305188ef344a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xNS0xLTEtMA_42f2d834-7931-48d9-af0d-6c5a80a4e3a2"
      unitRef="usd">-66154000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28f0aec10f4641fbba7afcf164b721c2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xNy0xLTEtMA_c447e707-4981-4b60-94b6-732759448f86"
      unitRef="usd">1383566000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i54e17a5f75d24145bae682ee23ef20b0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNS0xOS0xLTEtMA_d5d3dcd9-ea10-42d9-9a39-250605bf2ae4"
      unitRef="usd">183186000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNy0xLTEtMS0w_7a1829f9-2c47-45fd-a3e1-db23c9d61817"
      unitRef="usd">35600000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i6cd348fa8b2c42d1a42ef7fd2cf4aab3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNy05LTEtMS0w_14a64c8e-f229-4df1-8b5b-42523d375cfe"
      unitRef="usd">237403000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNy0xNy0xLTEtMA_6c29a738-941a-4ddc-b454-6823c7beeb74"
      unitRef="usd">237403000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfNy0xOS0xLTEtMA_284e7b37-eb43-408e-aafd-f2e1e2e73a63"
      unitRef="usd">18542000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibf07ea63041c4c928f8da459f8e85559_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOC0xNS0xLTEtMA_e6ff384a-435d-445f-ade9-1adaa322aad2"
      unitRef="usd">-56629000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOC0xNy0xLTEtMA_5670c5eb-1cda-473e-a890-1bd8face8dde"
      unitRef="usd">-56629000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6e319b3a1dea46d48da73779ff5ed197_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOS0zLTEtMS0w_3a499e24-4e5b-484c-bf9c-ba867bec9a91"
      unitRef="shares">94000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOS03LTEtMS0w_48d2b710-f45b-4b03-b448-dd27a71bad6a"
      unitRef="usd">6270000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfOS0xNy0xLTEtMA_a92e0e7d-bdc2-4f7a-ae57-e3ec36f3a911"
      unitRef="usd">6270000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTEtNy0xLTEtMA_a3c69b81-8c58-4451-858f-257a6c1c287e"
      unitRef="usd">23555000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTEtMTctMS0xLTA_911bc80d-3ea1-47f0-8575-630b93576ace"
      unitRef="usd">23555000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTMtMS0xLTEtMA_15a67b44-40d2-4534-8626-d9732287ea02"
      unitRef="usd">34259000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTMtMTktMS0xLTA_05a65a22-46f9-4eec-9dfb-3c4376f401f6"
      unitRef="usd">19608000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTQtMS0xLTEtMA_cb3b02b0-4855-4172-a78c-44f354274375"
      unitRef="usd">7695000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTQtMTktMS0xLTA_cb5cbddd-2f15-4d24-aec5-0e794e27efaa"
      unitRef="usd">2994000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTYtMS0xLTEtMA_f56393bb-6874-4331-a648-e5c7e5329fde"
      unitRef="usd">201000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTYtNy0xLTEtMA_b982fbb8-425d-4ff5-a99f-e34a7967e9c7"
      unitRef="usd">889000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTYtMTctMS0xLTA_108eec58-4233-41ee-84da-e9a55beabb1e"
      unitRef="usd">889000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ie446389ea669404d9bbac65bb4e3d155_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTYtMTktMS0xLTA_0a4cf4a1-c2fc-4c29-948e-4dab25f60157"
      unitRef="usd">5000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i7a019ed8480b437c8577677faace157d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTctMS0xLTEtMA_05bc26f3-8bed-48da-97d6-a315b26e37a1"
      unitRef="usd">10297000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ic99849fc13b149ab996500e63c523aa3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTctNy0xLTEtMA_b9538b5d-43b2-4081-b298-6d4a6ac64dd8"
      unitRef="usd">-10297000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTctMTctMS0xLTA_73c41ac1-5df2-4072-ab3f-285d709c14cc"
      unitRef="usd">-10297000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i48461f3f7e034478b38bf2bd95c2c8b6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTgtMTEtMS0xLTA_cc024efc-ef03-42b8-b9f8-8bdc9dd6a3a8"
      unitRef="shares">2949000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i48461f3f7e034478b38bf2bd95c2c8b6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTgtMTMtMS0xLTA_afeb3024-3d82-46de-aff6-85f13a93641e"
      unitRef="usd">322333000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0135ba0733504cc68dec2b65835c8010_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTgtMTctMS0xLTA_5b0faf09-7bea-4888-b67c-87e1a7236f1f"
      unitRef="usd">322333000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i41b777f2cb434154b0b873e82c5fce50_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMS0xLTEtMA_fa0edbbd-d462-4d58-a77f-a6cd238f08fc"
      unitRef="usd">1349160000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if76ff822a85c4644b659c3e32c6a6ed3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMy0xLTEtMA_fda9ba6f-bc47-46d9-b7db-d2d957d8dcda"
      unitRef="shares">110027000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if76ff822a85c4644b659c3e32c6a6ed3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktNS0xLTEtMA_07647d66-7bb5-4278-af5b-1db2b148b581"
      unitRef="usd">110000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0320aabb1784267b2d621187040cf79_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktNy0xLTEtMA_d395709c-7a19-4d23-8470-b933a1926ecc"
      unitRef="usd">603172000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73666b7ee2b24d4fa2f93200e6e07664_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktOS0xLTEtMA_2f76ad4b-e6b6-4248-ac81-18d40123717b"
      unitRef="usd">1089940000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia7cf27bbb13c4c3890e90cd1e469e381_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTEtMS0xLTA_b88d925a-a4b7-4ab5-a310-ddacf55fd37a"
      unitRef="shares">-2949000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7cf27bbb13c4c3890e90cd1e469e381_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTMtMS0xLTA_4a8bb7ab-7b0d-4286-a32d-b1770e760e01"
      unitRef="usd">-322333000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d5e5c6b5c5c4b67b3a716761c125e8f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTUtMS0xLTA_1dd725bc-fd54-44c0-b9b1-096bbd13e153"
      unitRef="usd">-122783000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15cd87973cef469c8ae16c443d6af67f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTctMS0xLTA_2e587d6f-69ad-4dea-9017-6384ac1fef1b"
      unitRef="usd">1248106000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic81bcf50eda945c8941046c875428878_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOjQ0NjllMDdiN2Y5MzQzNGY5ZGUwY2RmMWRlNzM4ZGVmL3RhYmxlcmFuZ2U6NDQ2OWUwN2I3ZjkzNDM0ZjlkZTBjZGYxZGU3MzhkZWZfMTktMTktMS0xLTA_bf52be48-0fe5-47a0-b517-b1b9ab0fed39"
      unitRef="usd">185109000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ic075cfce513548e597924c070afcd2ae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xLTEtMS0w_f4a135ef-aa27-48b1-b368-65a3b9bd3cc9"
      unitRef="usd">1180376000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i85b41e0034a64dab9acb0cac6ac941ad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0zLTEtMS0w_cec3d280-fbb2-4e0d-bc5e-928f4fdf7824"
      unitRef="shares">125843000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85b41e0034a64dab9acb0cac6ac941ad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS01LTEtMS0w_b4a68bc0-397b-4ab9-88e8-ffad382e38ad"
      unitRef="usd">126000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc0c1697a60d44e08102a4bc72e7baee_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS03LTEtMS0w_5538f1ec-9317-4903-9f54-b99f0db1a1e6"
      unitRef="usd">749043000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic19fe60e1ba04922b0a626ce23e8b7e7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS05LTEtMS0w_bf45a1c0-fcb9-4cbb-bd86-d7fac6fe49ad"
      unitRef="usd">1431738000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i475dc8640ab8472db6136e6d67675a03_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xMS0xLTEtMA_74644050-42e0-46eb-96fa-601ca994cd47"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i475dc8640ab8472db6136e6d67675a03_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xMy0xLTEtMA_e14e0573-deb9-4e1f-82ea-da8cff049f55"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6f5500e00234fdf8025a48470c3f347_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xNS0xLTEtMA_c3f61899-8746-48fb-b50f-3df8233d6016"
      unitRef="usd">-47498000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92b1c7e075c3458393c45dcc6b3ae765_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xNy0xLTEtMA_3315e8bc-5962-473d-9f49-a8ec0de6302a"
      unitRef="usd">2133409000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f8b5aef473d4c39a93eee476090c527_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNS0xOS0xLTEtMA_399138e8-a324-4914-bcfb-18a5bc9e5a59"
      unitRef="usd">185833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNy0xLTEtMS0w_fb18e520-8e0e-4dcf-9d55-3785185bdf6c"
      unitRef="usd">32176000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ic9328309adf540c1a97c8d647b34233a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNy05LTEtMS0w_defd7de2-4ce6-4fc4-9f99-a37cee4c3c07"
      unitRef="usd">239593000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNy0xNy0xLTEtMA_71146efe-7127-41c6-b702-0430d0172d79"
      unitRef="usd">239593000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i932b6e9e1cd94560abb849f93670e5aa_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfNy0xOS0xLTEtMA_5733fca4-9b93-4ae0-9726-fd04b5f69d95"
      unitRef="usd">16126000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i33019354c85e44cc941da40445b2afa3_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOC0xNS0xLTEtMA_813647c0-9a90-4299-9c66-016285d7954b"
      unitRef="usd">-93027000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOC0xNy0xLTEtMA_e05494e7-a5f9-49b3-aeba-b11635639246"
      unitRef="usd">-93027000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="id0a780a7182840f4a2262cae00e03efc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOS0zLTEtMS0w_b8cf1a51-e7c9-4c56-8230-93788bea716c"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOS03LTEtMS0xMDcz_64e12464-7e14-47dc-8120-123e396bc5fc"
      unitRef="usd">320000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfOS0xNy0xLTEtMA_e448546d-4304-4602-8dd2-690c03be8bdd"
      unitRef="usd">320000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTAtNy0xLTEtMA_f7d74180-0364-4657-b4ca-c9b15d8ce851"
      unitRef="usd">19797000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTAtMTctMS0xLTA_470cfc87-f7e6-4783-a20d-b927e833667f"
      unitRef="usd">19797000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTItMS0xLTEtMA_e6565dd9-d79e-40bb-98a9-ce36de55932a"
      unitRef="usd">37566000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i932b6e9e1cd94560abb849f93670e5aa_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTItMTktMS0xLTA_8c2c26bc-a046-418f-a751-8840dc691919"
      unitRef="usd">20565000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTMtMS0xLTEtMA_b177e98e-db4a-4985-afb6-d478a942b230"
      unitRef="usd">5283000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i932b6e9e1cd94560abb849f93670e5aa_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTMtMTktMS0xLTA_212ff9c5-f49a-47ef-87ab-5917444f50fe"
      unitRef="usd">4104000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTUtMS0xLTEtMA_7210bb61-68ae-467a-beb0-165f5392db4e"
      unitRef="usd">255000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTUtNy0xLTEtMA_8443bd90-bf26-4a10-b298-9613405e033b"
      unitRef="usd">445000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTUtMTctMS0xLTA_436fc9ef-f880-45a4-a05d-4da39d29774d"
      unitRef="usd">445000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i50d643e219234e0f9f799ac02de7d11b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTYtMS0xLTEtMA_026d31c7-f9eb-49cb-b72a-45f9df8f5ed7"
      unitRef="usd">48022000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i595e6dfd7023441893e3059dae7d8efc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTYtNy0xLTEtMA_f33c8b86-9d5e-4f88-b116-663199cf3040"
      unitRef="usd">-48022000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTYtMTctMS0xLTA_8700948c-425e-45c4-b01e-644c466ffa82"
      unitRef="usd">-48022000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8318a79043d44ffa9a6a4993763b2528_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTctMTEtMS0xLTA_5b35b398-2d73-4452-9e21-a60cfdfd5acb"
      unitRef="shares">4052000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8318a79043d44ffa9a6a4993763b2528_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTctMTMtMS0xLTA_6f582566-483c-4ec3-a73a-c31580754ea6"
      unitRef="usd">303139000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5cedd257a01c493c994727193e679c26_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTctMTctMS0xLTA_cfb97628-9a61-49fe-83a9-85230a8c9ccc"
      unitRef="usd">303139000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ifd3cc5d411a64abca391702baae8a9df_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMS0xLTEtMA_e4a186fb-21d5-4d64-9126-7d39ca297dce"
      unitRef="usd">1228036000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1a8529f1d6484e20963d6f0e69c67f53_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMy0xLTEtMA_134d4e10-5128-4cfe-a59f-b7fdfe911988"
      unitRef="shares">125857000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a8529f1d6484e20963d6f0e69c67f53_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtNS0xLTEtMA_98fee55f-004d-420c-aa82-1350c43df73a"
      unitRef="usd">126000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1db5c6df63c341089b1c1dc195a6ffa0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtNy0xLTEtMA_7034b045-53ef-47e2-91d7-ae94d2413255"
      unitRef="usd">720053000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff8e9b75a76f41589cb3e7fd00a42d30_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtOS0xLTEtMA_ad74a21f-59a8-4dd2-a90f-0217cbb0c565"
      unitRef="usd">1671331000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9afc760e9c5848eab9e7da50701226de_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTEtMS0xLTA_3412956a-38bb-4aec-acd7-eae9e8eb950e"
      unitRef="shares">-4052000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9afc760e9c5848eab9e7da50701226de_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTMtMS0xLTA_619dae01-1036-4ca7-a468-59599087b59d"
      unitRef="usd">-303139000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2b19644a307d4aaf8b1b4bc4cb0d62f8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTUtMS0xLTA_b5ac4418-60d8-4235-b0df-2ae04e620d3d"
      unitRef="usd">-140525000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id80771daad6c4b07a10321fc37cea825_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTctMS0xLTA_969a537e-31ff-4695-8496-08af73077d06"
      unitRef="usd">1947846000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a2736318f0c409aa240efd57c2ef68e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8yOC9mcmFnOmQ4YTE4NWZlMDE1MTRjNzZiN2UxMmZjYzQ4NDJiODViL3RhYmxlOmUzM2MyMWQ1ZjNkOTQ3YzE5YzMwZTAwZmJlNzAyNWVjL3RhYmxlcmFuZ2U6ZTMzYzIxZDVmM2Q5NDdjMTljMzBlMDBmYmU3MDI1ZWNfMTgtMTktMS0xLTA_694c60a4-51f0-4b19-8421-c6b784b8d657"
      unitRef="usd">185498000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNC9mcmFnOjczN2RhMTE1OWZkODQ4MTQ4ZTEyYzUxOGUxYzVmMWJlL3RleHRyZWdpb246NzM3ZGExMTU5ZmQ4NDgxNDhlMTJjNTE4ZTFjNWYxYmVfMTU1Ng_822a7ae3-7db5-4f1d-974c-60a54565b592">Condensed consolidated interim financial statementsThe unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, certain fair value estimates and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (2020 10-K). Prior period classifications have been conformed to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNC9mcmFnOjczN2RhMTE1OWZkODQ4MTQ4ZTEyYzUxOGUxYzVmMWJlL3RleHRyZWdpb246NzM3ZGExMTU5ZmQ4NDgxNDhlMTJjNTE4ZTFjNWYxYmVfMTU2Mg_0d4eef69-3e57-4b43-a05f-662c6c81e9eb">The unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, certain fair value estimates and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (2020 10-K). Prior period classifications have been conformed to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RleHRyZWdpb246YTBiMDY4ZTJmZGIwNDg2ZmE1ZjVkYjc0ZDVmNzA0ZmNfMjE3OA_c435ba83-b9db-4c6a-a9c9-4d04299404b3">Revenue recognition&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's segment revenues by primary payor source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.179%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,531,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,531,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;835,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;886,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;825,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,562,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,820,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,584,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,841,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the &#x201c;Other government&#x201d; category to the &#x201c;Medicare and Medicare Advantage&#x201d; category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the three months ended March 31, 2020 has also been recast to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are significant uncertainties associated with estimating revenue, which generally take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dialysis patient service revenues. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is &lt;/span&gt;&lt;/div&gt;maintained for the Company&#x2019;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.Other revenues. Other revenues consist of fees for management and administrative support services provided to outpatient dialysis businesses that the Company does not own or in which the Company owns a noncontrolling interest as well as revenues associated with the Company's non-dialysis ancillary services. Revenues associated with dialysis management services, integrated care services, clinical research programs, physician services, and end stage renal disease (ESRD) seamless care organizations are estimated and recognized in the period services are provided.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RleHRyZWdpb246YTBiMDY4ZTJmZGIwNDg2ZmE1ZjVkYjc0ZDVmNzA0ZmNfMjE4NQ_e18230ec-ce86-48e1-9ac0-5ee207b2e3d4">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's segment revenues by primary payor source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.179%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,531,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,531,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;835,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;886,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;825,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,562,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,820,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,584,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,841,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic5bccfe449ed4991b0e4e2588ce7a9a9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMy0xLTEtMS0w_e1d39fea-f061-479c-8500-92babc661331"
      unitRef="usd">1480297000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5a1a9b926a0d4f38a1427bdd4d8a03a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMy01LTEtMS0w_7de31e85-2af5-4d85-8b06-f6bb60b820d7"
      unitRef="usd">1480297000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if9dd874b0d744ba2a90acc5b316f6054_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMy03LTEtMS0w_60730dff-6e5e-4978-b6ac-b4dc0fbeb67d"
      unitRef="usd">1531033000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic6c7c388a128487ab6d0234da86f133a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMy0xMS0xLTEtMA_59e2c75c-4420-493c-b0b3-784cc00487be"
      unitRef="usd">1531033000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6c7afd963ec5440498a90eb4972fdf5d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNC0xLTEtMS0w_e498d119-1ad3-45b4-9d61-2e41f1b9f990"
      unitRef="usd">187243000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i83641efa6174426994832609d4cfde1c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNC01LTEtMS0w_9f8edb60-0789-4d4a-b52c-0bb8976e88ad"
      unitRef="usd">187243000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia3b745665f334ec782e1b4c00dce1968_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNC03LTEtMS0w_54057156-29da-4cbb-a70e-501d6627c49c"
      unitRef="usd">171467000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i98660f7731974d069a340250cea5bcac_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNC0xMS0xLTEtMA_ced02efb-306b-425a-96af-f86ec5d454a6"
      unitRef="usd">171467000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i13ff0fa657884449b2488b3757779baf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS0xLTEtMS0w_23cc2df0-a67f-434f-af63-abb8ea33a63b"
      unitRef="usd">80184000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i803f842bbc824ff58114df1a63ffbf0a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS0zLTEtMS0w_30d891a9-baca-473d-b85a-97dbb555e627"
      unitRef="usd">106830000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie2e28eaf39154728a43e3d45a96bc8a7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS01LTEtMS0w_7d0451b5-2c59-4f50-b604-7d6228019f1a"
      unitRef="usd">187014000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibf913e95c60d44908d164dce5b236b5e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS03LTEtMS0w_018c1c10-d370-4eed-ae37-2f769d8ca6f1"
      unitRef="usd">83099000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i608146c8b3ec4ec88cbc9d9bb1b096e2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS05LTEtMS0w_64b27860-1cb7-416e-b4ee-8228e063be75"
      unitRef="usd">94574000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i96fded0bba7f4935af31ff42cf27ef96_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNS0xMS0xLTEtMA_725ceec4-a39c-4082-ad0d-54aa8136ff4c"
      unitRef="usd">177673000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i680ca482559e41b29995e9ec3a942053_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi0xLTEtMS0w_47b09ebe-244e-4385-bdc7-40ae52d3dd65"
      unitRef="usd">835479000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaebf99e2b1f14c34a8a126def6ffbd2f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi0zLTEtMS0w_8aa6b193-580f-4f43-80b1-2158114c5d27"
      unitRef="usd">51498000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6b8f49aa1abb4d72a402bed74053e73d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi01LTEtMS0w_17b9a38f-97ca-40a1-8012-1d0d9b350d62"
      unitRef="usd">886977000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i19e312d2270449af94812bdb09bce332_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi03LTEtMS0w_05b9421f-27ee-4ff8-8bee-94cab73be6fd"
      unitRef="usd">825582000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0542fe9de33a45f1add8d0843709862e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi05LTEtMS0w_2d7f82aa-9c7f-438a-b0a2-9d3455f1b5e5"
      unitRef="usd">39467000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6511e83e307f484e924d0db239adc3be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfNi0xMS0xLTEtMA_69523297-fced-4138-bf18-907931746584"
      unitRef="usd">865049000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="ibdf3f726deb741c5811a90556bb9bc5a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOC0zLTEtMS0w_12d663ac-0d2d-49ac-95e7-5d95a2b0c3fd"
      unitRef="usd">85595000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i5a1a9b926a0d4f38a1427bdd4d8a03a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOC01LTEtMS0w_86afed49-f95e-49d3-8c67-f5ec4faf5cec"
      unitRef="usd">85595000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i7f2200f0ed2d46558e31ace6797c599f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOC05LTEtMS0w_fb79fb6b-508a-4b87-bc2e-10e84e7b1130"
      unitRef="usd">98478000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ic6c7c388a128487ab6d0234da86f133a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOC0xMS0xLTEtMA_654e2cdf-6f43-46ba-95bd-e61c19fb4ebc"
      unitRef="usd">98478000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="id66622c2d23c48d793cd014811006a41_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOS0zLTEtMS0w_65bfd9ac-7b9e-427d-8942-4847ba1ba910"
      unitRef="usd">300000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i83641efa6174426994832609d4cfde1c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOS01LTEtMS0w_55379540-ac27-46d2-bb84-0420704c7b4d"
      unitRef="usd">300000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="idf38ac334ee84f118afa50f51593b348_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOS05LTEtMS0w_8496c83b-719f-4a73-8d76-102933640cd8"
      unitRef="usd">366000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i98660f7731974d069a340250cea5bcac_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfOS0xMS0xLTEtMA_a0a42828-32d0-4f40-be15-542ece88de2d"
      unitRef="usd">366000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="iaebf99e2b1f14c34a8a126def6ffbd2f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTAtMy0xLTEtMA_d69deca2-cd7c-4f0d-ad9f-a049ad1fb5fd"
      unitRef="usd">6034000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i6b8f49aa1abb4d72a402bed74053e73d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTAtNS0xLTEtMA_570545bc-7fa7-4094-b2e9-838538306f93"
      unitRef="usd">6034000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i0542fe9de33a45f1add8d0843709862e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTAtOS0xLTEtMA_ca91b50e-8a1c-4b7f-b5ac-0a1cc7da5291"
      unitRef="usd">10521000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i6511e83e307f484e924d0db239adc3be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTAtMTEtMS0xLTA_2ed75baa-bd2b-44e4-9e60-f13893da6487"
      unitRef="usd">10521000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i790610c5a3ee4281a8434d08b7887b14_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtMS0xLTEtMA_3983fb55-8abb-4c20-ae0f-2cd35c8c7943"
      unitRef="usd">6675000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i6339430398b74ca2afee569cb8b0f426_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtMy0xLTEtMA_f7d70bd0-9b7b-4faa-8536-85bfcbbcd218"
      unitRef="usd">11162000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i55c6c61591ec419c8a4f894e55b0bf58_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtNS0xLTEtMA_06fe0b6b-6abb-40a9-a522-bd84cbac6688"
      unitRef="usd">17837000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i187374d6f1b34e62b52bf9d95907b97a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtNy0xLTEtMA_c5550133-ba8f-42d9-9f7a-8222c8a6d161"
      unitRef="usd">5442000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="if13419d218e54ae4a8ae1993a6172f7c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtOS0xLTEtMA_4a81f0b7-edf7-4975-8471-a424c9ff5f01"
      unitRef="usd">17602000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ieb6bac2e9afd461aa4604a702da5b510_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTEtMTEtMS0xLTA_7f1e49b0-99a9-483c-a309-3cea034a6994"
      unitRef="usd">23044000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="ib1a323c6052043f39e3e7d90a6c1e149_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItMS0xLTEtMA_809d63c4-2a5a-4b4f-9875-c1bfa989c853"
      unitRef="usd">-27003000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1f1ae32f350f41b5b4c94e873d2ac8ab_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItMy0xLTEtMA_e9db334e-4efd-48d0-8618-378b91c2bfe5"
      unitRef="usd">-4293000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d4cbc4b3cb3440baae8caf684d727be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItNS0xLTEtMA_d1bfd08c-e574-4596-9e96-e41a69879663"
      unitRef="usd">-31296000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i804d8967231546a69cb45a38bfa5a7de_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItNy0xLTEtMA_b5fa073e-ff1d-4fbf-b1f8-4c92daad0cec"
      unitRef="usd">-32242000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0707e2f78ab64721ab34ecd08e6b7faf_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItOS0xLTEtMA_1f8577a6-ea2c-468f-b175-684c62abf798"
      unitRef="usd">-4152000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb32ded36f5647b8bf00bcd206f6b64a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTItMTEtMS0xLTA_aa9101df-d7e4-4668-8d36-922ff489160e"
      unitRef="usd">-36394000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtMS0xLTEtMA_65f44629-4de4-41d8-98a3-67b11d092d92"
      unitRef="usd">2562875000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtMy0xLTEtMA_7a33dc09-973a-4542-bb84-149e85d30732"
      unitRef="usd">257126000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtNS0xLTEtMA_3414f215-2de4-4855-976c-203427d0e8f5"
      unitRef="usd">2820001000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb49ac86f6b746d990ed1e8d57025774_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtNy0xLTEtMA_c4fc3730-631b-4b36-b2f9-70297ed909ff"
      unitRef="usd">2584381000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaaaa1dbe5bd548efb96a1fb6dc9d1fdc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtOS0xLTEtMA_82570354-5cd2-49c9-8224-b69be260e69b"
      unitRef="usd">256856000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8zNy9mcmFnOmEwYjA2OGUyZmRiMDQ4NmZhNWY1ZGI3NGQ1ZjcwNGZjL3RhYmxlOjU5ZjY0YThjMWQ4NjQ2OWY5NGVlZmQyYmEyNzlhZWVhL3RhYmxlcmFuZ2U6NTlmNjRhOGMxZDg2NDY5Zjk0ZWVmZDJiYTI3OWFlZWFfMTMtMTEtMS0xLTA_76720938-ac70-4fc7-a07b-63a0bbd3be89"
      unitRef="usd">2841237000</us-gaap:Revenues>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RleHRyZWdpb246ZmRhNWZjNTQ4OWIyNDcwZTljZmFkYWZjZTZiZjM4MjhfOTM3_80633e22-9e39-40c9-98f4-fadfeda62cda">Earnings per share&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic net income attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted net income attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RleHRyZWdpb246ZmRhNWZjNTQ4OWIyNDcwZTljZmFkYWZjZTZiZjM4MjhfOTQx_e0fc1835-bf90-43b9-afdc-23114b715e10">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RleHRyZWdpb246ZmRhNWZjNTQ4OWIyNDcwZTljZmFkYWZjZTZiZjM4MjhfOTQz_ad289ffb-4a1d-4e78-807a-6ad976bf3fa6">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic net income attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted net income attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMy0xLTEtMS0w_6bd9b536-ff6d-463b-8a24-9d3018def404"
      unitRef="usd">237403000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMy0zLTEtMS0w_6ff01982-97cd-4350-a012-a100e1c5ebd6"
      unitRef="usd">229613000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNC0xLTEtMS0w_12b6e495-9a7a-4b05-8e66-301ed37227ef"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNC0zLTEtMS0w_c1ff6fe3-1407-4891-bb1e-a25528ad4ed5"
      unitRef="usd">9980000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNS0xLTEtMS0w_b58967a4-8e27-4f10-9f3e-f1a6508f2ef5"
      unitRef="usd">237403000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNS0zLTEtMS0w_ab1b52ec-afaf-41dd-878d-2edf95e1e3b2"
      unitRef="usd">239593000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNy0xLTEtMS0w_bc94a9b0-7c7c-43c6-a0c2-1ef73c589bdd"
      unitRef="shares">109014000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfNy0zLTEtMS0w_bbda6f44-f56b-4deb-bc33-572cd148ae3d"
      unitRef="shares">124902000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfOC0xLTEtMS0w_c1678204-aff3-4fb6-a696-1173e6752f32"
      unitRef="shares">4838000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfOC0zLTEtMS0w_c868699d-7ab7-4b52-8036-c2f78bbef3bf"
      unitRef="shares">1993000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfOS0xLTEtMS0w_3173f54e-43bb-480a-8e7e-086bb62095b1"
      unitRef="shares">113852000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfOS0zLTEtMS0w_e2601239-30e3-4cc7-9e7a-1896bafd4bfc"
      unitRef="shares">126895000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTItMS0xLTEtMA_215a98e5-deef-4db5-bcde-32f9253e5ebd"
      unitRef="usdPerShare">2.18</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTItMy0xLTEtMA_a19cbfe9-dcbc-4c04-bb1f-c06f90822f90"
      unitRef="usdPerShare">1.84</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTMtMS0xLTEtMA_5f6e0388-2080-4500-a960-717de07b7b0c"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTMtMy0xLTEtMA_9a490a0b-5abe-452c-95e2-c7a04aab54c2"
      unitRef="usdPerShare">0.08</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTQtMS0xLTEtMA_f7833545-af05-4cac-abaa-0499585c6d9f"
      unitRef="usdPerShare">2.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTQtMy0xLTEtMA_806f60fd-31b4-4469-82af-a7a623d60157"
      unitRef="usdPerShare">1.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTctMS0xLTEtMA_008f5610-c477-4a3d-85e7-3dc81ed242e8"
      unitRef="usdPerShare">2.09</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTctMy0xLTEtMA_8a53004a-008d-41e2-946d-aef8e879d384"
      unitRef="usdPerShare">1.81</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTgtMS0xLTEtMA_650e17c3-d260-4fb1-991b-542a9161061c"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTgtMy0xLTEtMA_f2d82385-0a5e-4d36-b075-8ebcff323a45"
      unitRef="usdPerShare">0.08</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTktMS0xLTEtMA_e619b9dd-1b8d-4aeb-adb6-8fe9e2f5b429"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMTktMy0xLTEtMA_13d35d18-67fd-41d5-a7cf-643dea09cbc2"
      unitRef="usdPerShare">1.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMjEtMS0xLTEtMA_0f374b0e-4ca8-4258-9837-25a5e3efda2d"
      unitRef="shares">27000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl80MC9mcmFnOmZkYTVmYzU0ODliMjQ3MGU5Y2ZhZGFmY2U2YmYzODI4L3RhYmxlOmE2N2VkZDFmNjhhZTRmNjM4YWIyYjJjMWM0YWE1OGQ5L3RhYmxlcmFuZ2U6YTY3ZWRkMWY2OGFlNGY2MzhhYjJiMmMxYzRhYTU4ZDlfMjEtMy0xLTEtMA_b2626084-5b79-4a03-9406-d665597a111f"
      unitRef="shares">3207000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGV4dHJlZ2lvbjowMmJmZTIzNTBhZGQ0MTQ0YmE0MDNkYzNhZTAzYzM2ZF8xODE0MTk0MTg1OTE0MA_dc7388cc-4ba6-4685-836f-4614755d9fa9">Short-term and long-term investments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held to maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#x2019;s non-qualified deferred compensation plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGV4dHJlZ2lvbjowMmJmZTIzNTBhZGQ0MTQ0YmE0MDNkYzNhZTAzYzM2ZF8xODE0MTk0MTg1OTE0MQ_1cae8693-bf13-49a1-8363-998fa99ad5dd">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i4b2618e51ff246e6a032f57f479d2741_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTEtMS0xLTY2MzU_03645b1f-229e-433b-ad8a-caba4ff9c148"
      unitRef="usd">8221000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4b2618e51ff246e6a032f57f479d2741_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTMtMS0xLTY2MzU_d0b64bb7-f010-479f-9ac1-127806b1779d"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i4b2618e51ff246e6a032f57f479d2741_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTUtMS0xLTY2MzU_f0df30df-bc54-4aee-bb92-76ade25290fb"
      unitRef="usd">8221000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic12d5b97b6be470aa5f5bc280eb39678_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTctMS0xLTY2MzU_592efc29-88e4-461f-acac-55a45032db3f"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic12d5b97b6be470aa5f5bc280eb39678_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTktMS0xLTY2MzU_57538029-3a4e-4b35-9d94-c9dd3d1e083d"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ic12d5b97b6be470aa5f5bc280eb39678_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8yLTExLTEtMS02NjM1_995a6d19-faba-4d38-ac0d-9f6564c3f059"
      unitRef="usd">8217000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="if0172e2194a649be8e17948010a20139_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTEtMS0xLTY2MzU_cff0c252-10c9-40f8-aaca-336f71613119"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if0172e2194a649be8e17948010a20139_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTMtMS0xLTY2MzU_8dcd5e3d-10f7-46dd-b3c6-6153a7ec2aec"
      unitRef="usd">34730000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="if0172e2194a649be8e17948010a20139_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTUtMS0xLTY2MzU_dcc68ad3-5a36-483d-baf1-fb6fe42736b1"
      unitRef="usd">34730000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i6402f5beaf314d64a2e3fc70b66cbbc8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTctMS0xLTY2MzU_06322a27-3f28-4af8-9ef9-84ccf01bba12"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6402f5beaf314d64a2e3fc70b66cbbc8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTktMS0xLTY2MzU_9cbfe252-8f08-4548-adf6-3a8624299293"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i6402f5beaf314d64a2e3fc70b66cbbc8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV8zLTExLTEtMS02NjM1_f2eb08bd-9675-4022-86a9-a595a5411f4a"
      unitRef="usd">44077000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTEtMS0xLTY2MzU_003322ea-a9c0-473c-ba96-e316714d0b19"
      unitRef="usd">8221000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTMtMS0xLTY2MzU_f7a6fa04-6759-4056-9417-bb1813259269"
      unitRef="usd">34730000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTUtMS0xLTY2MzU_53e6f728-5eaa-444a-8109-33ccde0d5b06"
      unitRef="usd">42951000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTctMS0xLTY2MzU_2cef07ba-d83b-4f53-8179-b8b081b32970"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTktMS0xLTY2MzU_098cf5f1-7712-44a2-8b5b-dd1e9d0034c2"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV80LTExLTEtMS02NjM1_c017b698-451b-4ce6-99e0-6e8b2c5aa011"
      unitRef="usd">52294000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTEtMS0xLTY2MzU_48c70cea-f3f8-42ce-b9a4-98c2aca46a31"
      unitRef="usd">8221000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9c6ecda7f7b34fc8a0c5a23d786773f2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTMtMS0xLTY2MzU_6ca35939-68fa-4ba3-bf63-155132a7e4a9"
      unitRef="usd">2839000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTUtMS0xLTY2MzU_63d0be87-8808-4630-bf2b-1106341dc9f3"
      unitRef="usd">11060000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTctMS0xLTY2MzU_6bca4204-0a58-4154-90b5-16e1109fbd1a"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5382ab7913ba4b97b4e5b4674fb7d89a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTktMS0xLTY2MzU_4ac85f6e-362a-41ea-b86f-46dc85c1f9d6"
      unitRef="usd">11884000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV81LTExLTEtMS02NjM1_c14a0a99-3675-48df-bbf7-61a0bd26ffb4"
      unitRef="usd">20101000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTEtMS0xLTY2MzU_9d456534-46cb-485a-8aaa-158177d4c81c"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i882e39dba68b41538058accf2ecc1ed8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTMtMS0xLTY2MzU_e02192ea-dd70-48d1-b6e7-d57d80242e07"
      unitRef="usd">31891000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTUtMS0xLTY2MzU_de526f16-9fb0-49b2-bbc2-e566ec57e9af"
      unitRef="usd">31891000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTctMS0xLTY2MzU_e4609643-4942-4050-939c-bc4f5cd9bc36"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i352ee731e6ad4fb098d97efc97fa8dd5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTktMS0xLTY2MzU_1355756b-5c70-4921-b0e7-d188f43d91b4"
      unitRef="usd">32193000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV82LTExLTEtMS02NjM1_0ad17058-f9a7-4794-87ed-12775cd18566"
      unitRef="usd">32193000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTEtMS0xLTY2MzU_05de06c3-4c3f-4cb7-8541-f441a64046a4"
      unitRef="usd">8221000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTMtMS0xLTY2MzU_a42e8449-5b0b-4e4a-bbe7-76bace32c903"
      unitRef="usd">34730000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTUtMS0xLTY2MzU_d97587c2-6487-432c-a2ca-a16ec6d72716"
      unitRef="usd">42951000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTctMS0xLTY2MzU_aae10678-1d39-4699-9da1-6d19f2eeee6c"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTktMS0xLTY2MzU_a1f08b8e-0c89-4139-b596-11d5d97d022c"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGFibGU6MTZlMmNhYTZmNjFmNDc5YWI5Y2E1OWRjYjMzZDRmMjUvdGFibGVyYW5nZToxNmUyY2FhNmY2MWY0NzlhYjljYTU5ZGNiMzNkNGYyNV83LTExLTEtMS02NjM1_15f48252-6192-4540-9c47-eef9cf19f5a1"
      unitRef="usd">52294000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xNjcyL2ZyYWc6MDJiZmUyMzUwYWRkNDE0NGJhNDAzZGMzYWUwM2MzNmQvdGV4dHJlZ2lvbjowMmJmZTIzNTBhZGQ0MTQ0YmE0MDNkYzNhZTAzYzM2ZF8xODE0MTk0MTg1OTE0Mg_f2299357-9a21-4e3a-8543-f71f59aef43b">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held to maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#x2019;s non-qualified deferred compensation plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RleHRyZWdpb246OGQxMjg2YjgxNWQ2NDM0ZTllNjUzZjdlMzk2MDdlZGZfMzA3MA_9974f532-bdfe-4256-9bbb-b5334b70e51a">Goodwill&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in goodwill by reportable segments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,287,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,787,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,891,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;711,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,021,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(130,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(130,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,891,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not recognize any goodwill impairment charges during the three months ended March 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of the dynamic and evolving COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the ultimate severity and duration of the pandemic, further spread or resurgence of the virus (including as a result of the emergence of new strains of the virus), its impact on the chronic kidney disease (CKD) patient population and the Company's patient population, the availability, acceptance, impact and efficacy of COVID-19 vaccines and other treatments, or therapies, the pandemic&#x2019;s continuing impact on the U.S. and global economies and unemployment, the responses of the Company's competitors to the pandemic and related changes in the marketplace, and the timing, scope and effectiveness of federal, state and local governmental responses. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.&lt;/span&gt;&lt;/div&gt;Developments, events, changes in operating performance and other changes in circumstances since the dates of the Company&#x2019;s last annual goodwill impairment assessments have not caused management to believe it is more likely than not that the fair values of any of the Company's reporting units would be less than their respective carrying amounts as of March&#160;31, 2021. Except for the Company's Germany kidney care reporting unit as described further in Note 10 to the Company's consolidated financial statements included in the 2020 10-K, none of the Company's various other reporting units were considered at risk of significant goodwill impairment as of March&#160;31, 2021.</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RleHRyZWdpb246OGQxMjg2YjgxNWQ2NDM0ZTllNjUzZjdlMzk2MDdlZGZfMzA3Mw_ce622c42-e43c-4642-88cf-1b44581ba7aa">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in goodwill by reportable segments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,287,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,787,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,891,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;711,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,021,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(130,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(130,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,891,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i7da2c28df84d498d901a73b1bd176f75_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMS0xLTEtMS0w_ecdcbacb-555c-4b75-bb54-0fc7b514ea93"
      unitRef="usd">6287100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie45e602ff596428d999df57f32972301_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMS0zLTEtMS0w_9d963b32-937c-4ce5-b605-92bb710f24e8"
      unitRef="usd">500535000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if227b8854b5d464699191a415580aefe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMS01LTEtMS0w_fedbc5f8-bef4-4fc5-bcb6-bb3c717fc1a1"
      unitRef="usd">6787635000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i512b152939674415aeb4fcd3ff232747_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMi0xLTEtMS0w_903bb93c-15e5-4b62-91e0-16829059191a"
      unitRef="usd">24377000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic1ffaa425a944fc7816ad190e4ae8372_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMi0zLTEtMS0w_83a94ef4-a317-4794-8e1e-88bb49e87810"
      unitRef="usd">105680000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4da2355fcf964251b943aab7dc93c0b6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMi01LTEtMS0w_6a3e96e5-468c-4c8b-ad17-b3e47d177f40"
      unitRef="usd">130057000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i512b152939674415aeb4fcd3ff232747_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMy0xLTEtMS0w_6f664f96-b3c6-4ef3-8c08-6cc789170f1e"
      unitRef="usd">1549000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ic1ffaa425a944fc7816ad190e4ae8372_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMy0zLTEtMS0w_901435f4-b400-42a7-8a27-ffb3598ad8a9"
      unitRef="usd">6744000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i4da2355fcf964251b943aab7dc93c0b6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMy01LTEtMS0w_641c2ebb-540a-4118-915f-1ca1e07fbcc7"
      unitRef="usd">8293000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i512b152939674415aeb4fcd3ff232747_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNC0xLTEtMS0w_9f429ad6-b35c-4f74-8abf-88a7bc7aa98e"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic1ffaa425a944fc7816ad190e4ae8372_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNC0zLTEtMS0w_11893493-423c-418d-95e7-c8ddca46a1c4"
      unitRef="usd">-9710000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4da2355fcf964251b943aab7dc93c0b6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNC01LTEtMS0w_57e262a4-0db4-436f-bc61-50ce0d8474b8"
      unitRef="usd">-9710000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="icab86a87e7ca432ca27ef7f2f0802e4e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNS0xLTEtMS0w_528a085c-4167-4fea-adc6-6c8089bfd67e"
      unitRef="usd">6309928000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2498e561a5854842a6d62e0b719f9b52_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNS0zLTEtMS0w_75caefc4-96cb-4bc2-a0a3-a77528393d8f"
      unitRef="usd">609181000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNS01LTEtMS0w_21e32fe8-288f-433c-be07-6d61750f69d5"
      unitRef="usd">6919109000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNi0xLTEtMS0w_8748f308-ba1b-4f28-8dde-1ee9d0175cbf"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNi0zLTEtMS0w_f9746de2-4a32-44d9-b361-a86dbd7d528b"
      unitRef="usd">5456000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfNi01LTEtMS0w_ca31d600-ddda-4c73-912c-095015fd9439"
      unitRef="usd">5456000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOC0xLTEtMS0w_18a763e5-a537-4fa6-8a62-4dbc7cbc6d5f"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOC0zLTEtMS0w_9b5b553b-21d5-4d44-ae2c-2dcc0fc45e70"
      unitRef="usd">33356000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOC01LTEtMS0w_fa1804d4-446e-4f75-be7b-bc3b4c249476"
      unitRef="usd">33356000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOS0xLTEtMS0w_af10cb79-495c-4ad9-9d5a-0bfbe61f6714"
      unitRef="usd">6309928000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOS0zLTEtMS0w_4f4d2f42-f7ea-4de0-88e7-8cd5e58ebfa8"
      unitRef="usd">581281000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfOS01LTEtMS0w_73f45d6b-0b00-4e74-9e91-2afb7fefb998"
      unitRef="usd">6891209000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTItMS0xLTEtMA_816b8e6d-4676-4f66-8cad-06cd110801e5"
      unitRef="usd">6309928000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTItMy0xLTEtMA_315ad7f3-bd52-41e4-b70d-ee0d96b482d7"
      unitRef="usd">711854000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTItNS0xLTEtMA_0796d2dd-d9ed-4749-a96e-4c56a33def0d"
      unitRef="usd">7021782000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTMtMS0xLTEtMA_f7de8043-c477-4863-8f22-f9bc5f34f1c5"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTMtMy0xLTEtMA_3c0e571b-fd74-421c-b97c-907aa7d4bf58"
      unitRef="usd">130573000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTMtNS0xLTEtMA_babc491e-91bf-425a-ad51-4697f7288431"
      unitRef="usd">130573000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTQtMS0xLTEtMA_88e9bc79-88c7-4d37-ae6b-8ce3eef04041"
      unitRef="usd">6309928000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTQtMy0xLTEtMA_ad154349-eca7-4b1f-87c1-2d91c6811ca2"
      unitRef="usd">581281000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RhYmxlOjdkNWJmZTc2YmI1YjQxNmM5ZWNhYzcyYTQzNDMxZDBhL3RhYmxlcmFuZ2U6N2Q1YmZlNzZiYjViNDE2YzllY2FjNzJhNDM0MzFkMGFfMTQtNS0xLTEtMA_7775c472-8edf-4145-b4c9-a737717acd4a"
      unitRef="usd">6891209000</us-gaap:Goodwill>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ic7ea4fefb3604f5383d022830fb054b2_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl81Mi9mcmFnOjhkMTI4NmI4MTVkNjQzNGU5ZTY1M2Y3ZTM5NjA3ZWRmL3RleHRyZWdpb246OGQxMjg2YjgxNWQ2NDM0ZTllNjUzZjdlMzk2MDdlZGZfMjk0Nw_0b342780-0937-4b15-962f-9ff5956312a4"
      unitRef="segment">0</us-gaap:NumberOfOperatingSegments>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTkxNA_095b8202-25ce-40bd-9bc1-76995001aab4">Long-term debt&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,662,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,684,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50% &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,666,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,708,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,715,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,698,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,801,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,436,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;289,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022-2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,063,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,163,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount, premium and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(65,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,997,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,085,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(168,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(168,541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,829,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,917,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;As of March&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities includes a discount of $5,212 and deferred financing costs of $33,650 and the carrying amount of the Company's senior notes includes a premium of $(17,327) and deferred financing costs of $43,700. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities included a discount of $5,461 and deferred financing costs of $35,825, and the carrying amount of the Company's senior notes included deferred financing costs of $36,431.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first three months of 2021, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $21,875 on Term Loan A and $6,858 on Term Loan B-1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 26, 2021, the Company completed an unregistered add-on offering of $1,000,000 aggregate principal amount to the existing 4.625% senior notes due June&#160;1, 2030 (the Additional 2030 Notes) pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Additional 2030 Notes were issued at an offering price of 101.750% of face amount, plus an interest payment advance to the Company for interest that would have accrued from December 1, 2020 (the last interest payment date) through the closing date. These Additional 2030 Notes will then bear full six months' semi-annual coupon interest payments beginning June 1, 2021. The terms of the Additional 2030 Notes, other than their issue date, offering price and first interest payment date, are identical to the terms of the $1,750,000 principal amount of the Company&#x2019;s 4.625% Senior Notes due June 1, 2030 previously issued by the Company on June 9, 2020. The Additional 2030 Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. During the three months ended March&#160;31, 2021, the Company incurred $8,346 in fees and other professional expenses associated with this transaction, which were capitalized and will amortize over the term of the Additional &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2030 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company's 2019 interest rate cap agreements have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on equivalent amounts of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $871,336 outstanding principal balance of Term Loan A is subject to LIBOR-based interest rate volatility. These cap agreements are designated as cash flow hedges and, as a result, changes in the fair values of the cap agreements are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit risk-contingent features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of March&#160;31, 2021 and December&#160;31, 2020, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded OCI gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 9 for further details on amounts reclassified from accumulated other comprehensive loss and recorded as debt expense related to the Company&#x2019;s interest rate cap agreements for the three months ended March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s weighted average effective interest rate on its senior secured credit facilities at the end of the first quarter of 2021 was 1.97%, based on the current margins in effect for Term Loan A and Term Loan B-1 as of March&#160;31, 2021, as described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s overall weighted average effective interest rate for the three months ended March&#160;31, 2021 was 3.08% and as of March&#160;31, 2021 was 3.18%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company&#x2019;s interest rates were fixed on approximately 51% of its total debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company had an undrawn $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this facility is reduced by the amount of any letters of credit outstanding under this facility, but there were no such letters of credit outstanding as of March&#160;31, 2021. The Company also had approximately $64,650 of outstanding letters of credit under a separate bilateral secured letter of credit facility as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTkyNw_7ab93d28-3cb6-425e-b03c-04414fc90b16">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,662,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,684,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50% &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,666,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,708,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,715,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,698,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,801,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,436,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;289,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022-2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,063,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,163,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount, premium and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(65,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,997,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,085,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(168,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(168,541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,829,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,917,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt"&gt;As of March&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities includes a discount of $5,212 and deferred financing costs of $33,650 and the carrying amount of the Company's senior notes includes a premium of $(17,327) and deferred financing costs of $43,700. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities included a discount of $5,461 and deferred financing costs of $35,825, and the carrying amount of the Company's senior notes included deferred financing costs of $36,431.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:SecuredDebt
      contextRef="ic8c92060a34e484cb1a910bc6a98a92b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy0xLTEtMS0w_1b21f8cc-2b0b-4bac-a01f-e8d34699777e"
      unitRef="usd">1662500000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="ied03f6f7ffa1498b908a85322c500f3f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy0zLTEtMS0w_94307672-1717-4532-912a-340032fad08c"
      unitRef="usd">1684375000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i788aadfa599242a796deae74047ca158_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy01LTEtMS0w_49dcc8c9-03e2-4555-9550-bad156922344">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i788aadfa599242a796deae74047ca158_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy03LTEtMS0w_dc0abcfd-88cf-4ec3-b229-cf026569b879">LIBOR + 1.50%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic8c92060a34e484cb1a910bc6a98a92b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMy05LTEtMS0w_70d6b772-5f33-4d5f-84b0-6afab824dbb9"
      unitRef="usd">1666656000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="i32e240900d2a4a45aa25dd2ec99f1da9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC0xLTEtMS0w_9a3f639d-97d1-4485-b0d7-f06e315131e5"
      unitRef="usd">2708836000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i504bca0dc6a34e968df9a1ef2d17533a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC0zLTEtMS0w_2e3767be-dbf7-4568-87ad-677bd610345a"
      unitRef="usd">2715694000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="iaac6bcb52a00428d87b88838a3a4bb73_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC01LTEtMS0w_20d25a82-1c3f-4fd6-913c-c781a8b34899">2026-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="iaac6bcb52a00428d87b88838a3a4bb73_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC03LTEtMS0w_e2617525-6739-44e7-a28c-364ab947af71">LIBOR + 1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i32e240900d2a4a45aa25dd2ec99f1da9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNC05LTEtMS0w_4ec0d26e-f13a-44c5-8d20-e79c4f164fd0"
      unitRef="usd">2698678000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="if8d83ec226e84558a394e404422907ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNi0xLTEtMS0w_5bc10bee-74b9-472c-a32e-5012f33eea14"
      unitRef="usd">0</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i37efecfb533c4ce8b0c977360ba10261_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNi0zLTEtMS0w_9e7a1fc7-0fd0-4028-ba2b-7e35fc5c9c4a"
      unitRef="usd">75000000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i5e6f67d8fc604e5db4da237cb3d52d86_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNi01LTEtMS0w_27d95057-2dc6-4395-8d6b-d405e5d3ce0f">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i5e6f67d8fc604e5db4da237cb3d52d86_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfNi03LTEtMS0w_14a0d319-72d7-4df9-9d94-53772e1540ec">LIBOR + 1.50%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:SeniorNotes
      contextRef="i194f9194e246431c9dde99195297777e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC0xLTEtMS0w_3eeb07da-c6e7-435c-8649-54cb26bb6a07"
      unitRef="usd">2750000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="id1bbaa73972045d38fd77a293d92478b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC0zLTEtMS0w_f905b517-1e31-4000-a095-17625c24b83d"
      unitRef="usd">1750000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i97a89b88b52c40e7aebc3bba7e72d037_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC01LTEtMS0w_555da010-eaba-47aa-b6a3-39f65922df18">2030-06-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i97a89b88b52c40e7aebc3bba7e72d037_D20210101-20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC03LTEtMS0w_494d86b5-0735-42cf-8970-9febed2c835f"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i194f9194e246431c9dde99195297777e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOC05LTEtMS0w_ab3ac3ba-9a2c-49da-b5ba-58cec5aea038"
      unitRef="usd">2801150000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="iabd355c7251147dca43bf684d5040e60_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS0xLTEtMS0w_0942f306-bcff-45d1-97f4-fe71e904b320"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i553adc006f9e4d1691c2e2bfc277dc41_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS0zLTEtMS0w_4ecf8b2d-f293-4e70-b3a8-9392ce4c1fc3"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i86de953a450f43afb93313b5cccf48ff_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS01LTEtMS0w_6cbcb723-97cb-4205-8d20-8d6ed597061b">2031-02-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i86de953a450f43afb93313b5cccf48ff_D20210101-20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS03LTEtMS0w_5323c7c4-8b3e-4f7b-b3bf-4c3d3ae30cfa"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iabd355c7251147dca43bf684d5040e60_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfOS05LTEtMS0w_5d2d03bf-ca12-4af3-82d7-bdaa338ac2d7"
      unitRef="usd">1436220000</us-gaap:DebtInstrumentFairValue>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="i91ebf3bf2b02476fb9efaac73b3d3dc5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItMS0xLTEtMA_3a94b6f4-9caa-4e1b-bd43-df1d9693a26a"
      unitRef="usd">152531000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="i8c9698c484b14a119356f8182f5757c2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItMy0xLTEtMA_067c1455-37d9-492b-8a38-31f2a7793653"
      unitRef="usd">164160000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="i1acbfcadeb1d433b9e81c9d3af8e55db_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItNS0xLTEtMA_b36519e3-600f-4664-8a1c-84a58a7c069f">2021-2036</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i91ebf3bf2b02476fb9efaac73b3d3dc5_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItNy0xLTEtMA_38f2024e-a008-4fe8-902b-d855140158d4"
      unitRef="number">0.0495</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <dva:AcquisitionObligationsAndOtherNotesPayableFairValue
      contextRef="i91ebf3bf2b02476fb9efaac73b3d3dc5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTItOS0xLTEtMA_e5493a6e-8cc1-4262-8a4e-36ecb691ed25"
      unitRef="usd">152531000</dva:AcquisitionObligationsAndOtherNotesPayableFairValue>
    <us-gaap:FinanceLeaseLiability
      contextRef="ie12c3787f705434183585a7eb161899e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTMtMS0xLTEtMA_a8f98393-bb6b-43ff-8120-02b37bf776ee"
      unitRef="usd">289324000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ibff9b7fea3cc4a2c8cc8c9400ffa6dfd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTMtMy0xLTEtMA_15d8d6d3-e44e-48cf-819e-cf976ff9029b"
      unitRef="usd">274292000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="if8f84ec8dbbe47a885cecad8d415599b_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTMtNS0xLTEtMA_9a4b211e-fae0-40ca-9140-be6d953ea38c">2022-2038</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ie12c3787f705434183585a7eb161899e_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTMtNy0xLTEtMA_292f7df4-7d4a-4cef-994f-cae0e13c72c1"
      unitRef="number">0.0483</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTQtMS0xLTEtMA_e76d9d38-3cc3-4e77-bcc5-a5a02a1c1118"
      unitRef="usd">9063191000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTQtMy0xLTEtMA_473b518a-db31-4515-880c-30bcdb89d510"
      unitRef="usd">8163521000</us-gaap:DebtInstrumentCarryingAmount>
    <dva:DiscountAndDeferredFinanceCosts
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTUtMS0xLTEtMA_04d6666e-6ca4-4155-8d6d-d27b13818fa6"
      unitRef="usd">65235000</dva:DiscountAndDeferredFinanceCosts>
    <dva:DiscountAndDeferredFinanceCosts
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTUtMy0xLTEtMA_8936fa74-36ca-4a3a-8870-430223476024"
      unitRef="usd">77717000</dva:DiscountAndDeferredFinanceCosts>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTYtMS0xLTEtMA_1ed356e9-aa2b-4bae-aff0-50a26aba0e1b"
      unitRef="usd">8997956000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTYtMy0xLTEtMA_66929ccc-efbb-4224-b02b-b6433ed52aeb"
      unitRef="usd">8085804000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTctMS0xLTEtMA_0e79ffd2-d265-4d52-ba57-6bf4f6d461be"
      unitRef="usd">168191000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTctMy0xLTEtMA_40be6c5f-d615-48ac-b37b-a271374f9e6f"
      unitRef="usd">168541000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTgtMS0xLTEtMA_fd340054-f2e9-46d1-8926-d3eeb005445a"
      unitRef="usd">8829765000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjA5M2Q4OTIxYTIyNTQ1NzBiODlhYWQwNDI0ZjlhNDg2L3RhYmxlcmFuZ2U6MDkzZDg5MjFhMjI1NDU3MGI4OWFhZDA0MjRmOWE0ODZfMTgtMy0xLTEtMA_98166afc-252f-43dd-a72e-7cd335ad772d"
      unitRef="usd">7917263000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="id253887c65fb490bb3a75adbfae3b9f6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTE4MQ_a1db229e-abd9-4cae-a71c-3013c2d39879"
      unitRef="usd">5212000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="id253887c65fb490bb3a75adbfae3b9f6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY1OQ_ef946e8f-3073-4de9-b7ef-cd3c1954fd80"
      unitRef="usd">33650000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="ie3a230004914446ebc401ea9c9effdd8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNjA0NzMxMzk3OTU3MA_f29706c9-9dd8-4622-8309-71bc2bbc9fcb"
      unitRef="usd">17327000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DeferredOfferingCosts
      contextRef="ie3a230004914446ebc401ea9c9effdd8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY3NA_dbeda289-493d-4994-bcc2-93d0e5e5c93f"
      unitRef="usd">43700000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="id61c0e835e604a309d4b0804349af819_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY4Mw_18877fb7-8e6b-48eb-8804-2efb116b9018"
      unitRef="usd">5461000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="id61c0e835e604a309d4b0804349af819_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY4OQ_8cc04a87-c472-4b60-a66d-b955ad920620"
      unitRef="usd">35825000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="i606827500ec64b88b0b08567f4f6a0db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNTY5NA_11ab5ea0-909f-42d6-86f3-518cad5f8a41"
      unitRef="usd">36431000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i788aadfa599242a796deae74047ca158_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfMzA1MQ_ee8b3ea9-a2c6-4ad5-837f-08e72cb9aa84"
      unitRef="usd">21875000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="iaac6bcb52a00428d87b88838a3a4bb73_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfMzA3Mw_a5deddce-fe5f-4004-b22b-e386fb44a88b"
      unitRef="usd">6858000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <dva:AdditionalDebtPrincipalAmountDueToNewAgreement
      contextRef="ifcf13ba1953646bfbb5a0cec0cd092de_I20210226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODI0NjMzNzIzNTQxNg_55ec3835-7497-4261-b2e6-e4189bb3f6fe"
      unitRef="usd">1000000</dva:AdditionalDebtPrincipalAmountDueToNewAgreement>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i76a9d85fd0654e91a77f38adc13569bd_D20200609-20200609"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfMzE2Mw_0c18f69e-f77d-4688-b82e-c586a2f66fb2"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="ib6985ae730434382a11199004a394f1a_D20210226-20210226"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfMTgxNDE5NDE4ODU0NDU_7f0bf401-bbb0-4656-96ce-042a2f02ef31">2030-06-01</us-gaap:DebtInstrumentMaturityDate>
    <dva:DebtInstrumentOfferingPricePercentageOfFaceAmount
      contextRef="ib6985ae730434382a11199004a394f1a_D20210226-20210226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODI0NjMzNzIzNTQyOA_0b0ff165-f0e4-4f6d-84f0-b08c954861f8"
      unitRef="number">1.01750</dva:DebtInstrumentOfferingPricePercentageOfFaceAmount>
    <us-gaap:SeniorNotes
      contextRef="ic0dc9c50975b46389c8201b72173f3f0_I20200609"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODI0NjMzNzIzNTQwNA_0015c235-1f90-4ac7-8cb6-87425b08be09"
      unitRef="usd">1750000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i76a9d85fd0654e91a77f38adc13569bd_D20200609-20200609"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODI0NjMzNzIzNTQzOA_48974f5f-9d45-4609-98ad-731e2cda72f9"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i194f9194e246431c9dde99195297777e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNjA0NzMxMzk3OTU4NQ_ac421550-17b8-4092-a1c4-612d9db12b9a"
      unitRef="usd">8346000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:LineOfCredit
      contextRef="ic8c92060a34e484cb1a910bc6a98a92b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfODAwMA_e358cfc2-6a3a-4760-b93c-e1fb298f7578"
      unitRef="usd">871336000</us-gaap:LineOfCredit>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTkxMg_8714cc59-18c4-414b-84a2-257424b784d1">These cap agreements are designated as cash flow hedges and, as a result, changes in the fair values of the cap agreements are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTkyNg_08eaf46e-bc3f-4569-addc-a8c038e5a9e4">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of March&#160;31, 2021 and December&#160;31, 2020, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded OCI gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib9d50577324f44dd9a01b491e9e47a09_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0xLTEtMS0w_c08ba0f1-c887-4a89-aa62-24b50e662e97"
      unitRef="usd">3500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i59aadc5542964885b2a0e3bc85b2fdbc_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0zLTEtMS0w_7775edca-1b45-420e-a7cd-aae6f74908e5"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeInceptionDates
      contextRef="ibfd9c5748c524a73b8cf26558b198cb0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi01LTEtMS0w_4d64efea-0c00-4b14-949d-23244b9d352b">2020-06-30</us-gaap:DerivativeInceptionDates>
    <us-gaap:DerivativeMaturityDates
      contextRef="ibfd9c5748c524a73b8cf26558b198cb0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi03LTEtMS0w_4ba9b33a-5b75-4b0d-b5fd-ae1ef8394d0f">2024-06-30</us-gaap:DerivativeMaturityDates>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ie8ab840ca2984e1cbd4b736f943c4d22_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi05LTEtMS0w_8615f3e5-8854-4e15-b131-3b988f8ea68b"
      unitRef="usd">1377000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ie8ab840ca2984e1cbd4b736f943c4d22_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0xMS0xLTEtMA_967d256c-d12a-479f-a52e-ca6a00a52b84"
      unitRef="usd">6505000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ife4fde46bad1452eb6abb85e1eda2e52_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0xMy0xLTEtMA_b3d437f4-9127-4f80-8f5f-f5a29fe52d8b"
      unitRef="usd">9176000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3300c03f30af4697aeb5cc0111c808e9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RhYmxlOjFlNjZhNmU3MjYxNTQ0NzVhYWZjOTgwMzgzNTcxYzUxL3RhYmxlcmFuZ2U6MWU2NmE2ZTcyNjE1NDQ3NWFhZmM5ODAzODM1NzFjNTFfMi0xNS0xLTEtMA_8c63329b-432f-4af9-87b2-9bcfa15fcfbb"
      unitRef="usd">2671000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="id253887c65fb490bb3a75adbfae3b9f6_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTEyMQ_116908ca-055c-4227-bfac-67fdfa8a3f60"
      unitRef="number">0.0197</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTMyNg_f9be4c97-26b8-4669-b389-105771817dbc"
      unitRef="number">0.0308</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTM2OA_30fc0d50-882e-4098-9c03-c35480fca5e3"
      unitRef="number">0.0318</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTQzOA_f07021a2-e9ff-4a90-a744-07a5a571d7f5"
      unitRef="number">0.51</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if8d83ec226e84558a394e404422907ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTQ5Nw_c7cb3bd4-09a2-454d-9a18-4a4af071159f"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ifeb4f066dfab44019e66a8db209e19eb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfNzE0NjgyNTYwNjQ1Ng_c37e345f-2d60-4fff-80fc-b9e9433196cd"
      unitRef="usd">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i00538c1ebb6745ca9520ef56fcbcb7e0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82MS9mcmFnOjI1ODFlOTFlM2Q4ZDQxMTFhYjJkOGE2MTM0YTAzNTI0L3RleHRyZWdpb246MjU4MWU5MWUzZDhkNDExMWFiMmQ4YTYxMzRhMDM1MjRfOTgwOA_72381030-e68a-40c8-82a9-5fd0913f1642"
      unitRef="usd">64650000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LossContingencyDisclosures
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfMTUzNjY_78135a10-7d6a-4fb5-a32a-4083d8a27854">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;contingencies&lt;/span&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company&#x2019;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#x2019;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#x2019;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; suits, governmental investigations (which frequently arise from qui tam suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of March&#160;31, 2021 and December&#160;31, 2020, the Company&#x2019;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#x2019;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Governmental Inquiries and Related Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 U.S. Attorney Texas Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#x2019;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#x2019;s relationships with pharmaceutical manufacturers. The government&#x2019;s investigation covers the period from January 1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government&#x2019;s investigation and that included total monetary consideration of $63,700, as previously disclosed, of which $41,500 was an incremental cash payment and $22,200 was for amounts previously refunded, and all of which was previously accrued. The government&#x2019;s investigation is ongoing with respect to issues related to DaVita Rx&#x2019;s historic relationships with certain pharmaceutical manufacturers, and in July 2018 the Office of Inspector General (OIG) served the Company with a subpoena seeking additional documents and information relating to those relationships. The Company is continuing to cooperate with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2017 U.S. Attorney Colorado Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In November 2017, the U.S. Attorney&#x2019;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#x2019;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018 and May 2019, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2018 U.S. Attorney Florida Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In March 2018, DaVita Labs received two CIDs from the U.S. Attorney&#x2019;s Office, Middle District of Florida that were identical in nature but directed to the two different labs. According to the face of the CIDs, the U.S. Attorney&#x2019;s Office is conducting an investigation as to whether the Company&#x2019;s subsidiary submitted claims for blood, urine, and fecal testing, where there were insufficient test validation or stability studies to ensure accurate results, in violation of the FCA. In October 2018, DaVita Labs received a subpoena from the OIG in connection with this matter requesting certain patient records linked to clinical laboratory tests. On September 30, 2019, the U.S. Attorney&#x2019;s Office notified the U.S. District Court, Middle District of Florida, of its decision not to elect to intervene at this time in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Lorne Holland, et al. v. DaVita Healthcare Partners, Inc., et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The court then unsealed the complaint, which alleges violations of the FCA, by order dated the same day. In January 2020, the private party relators served the Company and DaVita Labs with an amended complaint. On February 24, 2020, the Company and DaVita Labs filed a motion to dismiss the amended complaint. On June 25, 2020, the court denied the motion to dismiss. The Company and DaVita Labs answered the complaint on July 23, 2020. The Company and DaVita Labs dispute these allegations and intend to defend this action accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 U.S. Attorney New Jersey Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In March 2020, the U.S. Attorney&#x2019;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#x2019;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#x2019;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. The Company is cooperating with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 California Department of Insurance Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020. The subpoena, as revised, requests information on a number of topics, including but not limited to the Company&#x2019;s communications with patients about insurance plans and financial assistance from the American &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Kidney Fund (AKF), analyses of the potential impact of patients&#x2019; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is cooperating with CDI in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 Department of Justice Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In October 2020, the Company received a CID from the Department of Justice pursuant to a False Claims Act investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is cooperating with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to qui tam complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#x2019;s reputation, required changes to the Company&#x2019;s business practices, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shareholder and Derivative Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Peace Officers&#x2019; Annuity and Benefit Fund of Georgia Securities Class Action Civil Suit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On February 1, 2017, the Peace Officers&#x2019; Annuity and Benefit Fund of Georgia filed a putative federal securities class action complaint in the U.S. District Court for the District of Colorado against the Company and certain executives.&#160;The complaint covers the time period of August 2015 to October 2016 and alleges, generally, that the Company and its executives violated&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;federal securities laws concerning the Company&#x2019;s financial results and revenue derived from patients who received charitable premium assistance from an industry-funded non-profit organization.&#160;The complaint further alleges that the process by which patients obtained commercial insurance and received charitable premium assistance was improper and "created a false impression of DaVita&#x2019;s business and operational status and future growth prospects."&#160;In November 2017, the court appointed the lead plaintiff and an amended complaint was filed on January 12, 2018. On March 27, 2018, the Company and various individual defendants filed a motion to dismiss. On March 28, 2019, the court denied the motion to dismiss. The Company answered the complaint on May 28, 2019. On January 31, 2020, the plaintiffs filed a motion for class certification and the Company filed its opposition on June 29, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company continues to dispute the allegations, in July 2020, it reached an agreement in principle to resolve this matter without admitting to any liability.&#160;Settlement of this matter was covered primarily with insurance proceeds. The Company contributed an amount that did not have a material impact on the Company&#x2019;s consolidated financial position, results of operations or cash flows. On April 13, 2021, the court granted final approval of the settlement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;In re DaVita Inc. Stockholder Derivative Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On August 15, 2017, the U.S. District Court for the District of Delaware consolidated three previously disclosed shareholder derivative lawsuits: the Blackburn Shareholder action filed on February 10, 2017, the Gabilondo Shareholder action filed on May 30, 2017, and the City of Warren Police and Fire Retirement System Shareholder action filed on June 9, 2017. The complaint covers the time period from 2015 to present and alleges, generally, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, corporate waste, and misrepresentations and/or failures to disclose certain information in violation of the federal securities laws in connection with an alleged practice to direct patients with government-subsidized health insurance into private health insurance plans to maximize the Company&#x2019;s profits. An amended complaint was filed in September 2017, and on December 18, 2017, the Company filed a motion to dismiss and a motion to stay proceedings in the alternative. On April 25, 2019, the court denied the Company's motion to dismiss. The Company answered the complaint on May 28, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the defendants continue to dispute the allegations, in July 2020, an agreement in principle was reached to resolve this matter without admitting to any liability. The Company&#x2019;s Board of Directors (Board) approved the settlement on October &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20, 2020. The court approved the settlement on January 29, 2021. As part of the settlement, the Company agreed to certain corporate governance policies, but did not make any financial contribution towards the settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the foregoing, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 7, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#x2019;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#x2019;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, or otherwise harm the Company&#x2019;s business, results of operations, financial condition, cash flows or reputation.&lt;/span&gt;&lt;/div&gt;</us-gaap:LossContingencyDisclosures>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i1298eb35e47242399f1ae29c789cb247_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNDAwNg_a3f7a75d-44a6-4178-970f-017061fb4797"
      unitRef="usd">63700000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i0196845c80ec4c118ab2c0f6b32fe811_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNDA0NA_d8b43827-1d8c-4059-b114-1559bc606718"
      unitRef="usd">41500000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i37f0d1d0eb764865859330a4621cb724_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNDA4Mw_609c4132-30b3-452a-bac5-0b57678178fd"
      unitRef="usd">22200000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <dva:CorporateIntegrityAgreementExpirationDate
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNzQ0NA_f1a51ec8-6406-45a7-a668-adfa920efbdf">2019-10-22</dva:CorporateIntegrityAgreementExpirationDate>
    <dva:LossContingencyNumberofLawsuitsConsolidatedIntoOne
      contextRef="i2a970640a33c4ad991ff8f3c6c172d83_D20170815-20170815"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfMTIzMjk_f4bd388b-5f94-4ea4-b41d-ff3e4df403d1"
      unitRef="number">3</dva:LossContingencyNumberofLawsuitsConsolidatedIntoOne>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfMTgxNDE5NDE4ODIyMjg_771f82ca-784d-4790-a21b-c5efc8c187a4">&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated outpatient dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $8,449.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:OtherCommitment
      contextRef="i2781197970dd4a92a8d85c696520a666_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl82Ny9mcmFnOjgzN2ViYjU0NjcxYjQ5MDE4NDg0Zjg4YzBlYzM2NjQ1L3RleHRyZWdpb246ODM3ZWJiNTQ2NzFiNDkwMTg0ODRmODhjMGVjMzY2NDVfNzE0NjgyNTU5NjczNw_4204c168-4541-4ada-b24d-338e8806cffe"
      unitRef="usd">8449000</us-gaap:OtherCommitment>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTgxNDE5NDE4NjE3NjI_4377360a-1a55-4f05-8a99-538a4013a96a">Shareholders' equity&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021, the Company granted 706 restricted and performance stock units with an aggregate grant-date fair value of $77,279 and a weighted-average expected life of approximately 3.5 years and 132 stock-settled stock appreciation rights with an aggregate grant-date fair value of $4,250 and a weighted-average expected life of approximately 4.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company had $230,270 in total estimated but unrecognized stock-based compensation expense under the Company's equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.5 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0f826db477234354ba1256988298cd45_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzM5Nw_2692b113-8e3a-4c47-8597-b3870f4d2f16"
      unitRef="shares">706000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted
      contextRef="i0f826db477234354ba1256988298cd45_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzQwNA_0737b8fa-b88c-4806-9d3f-bea7f265f460"
      unitRef="usd">77279000</dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0f826db477234354ba1256988298cd45_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzQxOA_4448899f-c915-4596-ac40-8c874a332526">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i5d49ed528d08456d847b8513e95864e5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzM4MQ_2ff5a89c-4225-43b5-a66b-0dc99eb65643"
      unitRef="shares">132000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted
      contextRef="i5d49ed528d08456d847b8513e95864e5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzM5MA_f3f9ea3a-4ac8-46c3-b03a-fe6c2bd3309c"
      unitRef="usd">4250000</dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5d49ed528d08456d847b8513e95864e5_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE0NjgyNTU4MzQxMQ_c58187e8-3df3-4d00-8c5f-4755fda81116">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTI2NDQzODM3MjI4MjQ_14cc45de-0798-4c6c-a35f-86bd2a3c6142"
      unitRef="usd">230270000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTI2NDQzODM3MjI4NTY_3c3d4f4e-ec75-4007-a8de-a726c606422e">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:TreasuryStockTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTI5Ng_ead75a6c-9f1f-4761-9433-c2126f4b22c7">&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's common stock repurchases during the three months ended March&#160;31, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Open market repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;322,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company repurchased 991 shares of its common stock for $108,892 at an average cost of $109.91 per share subsequent to March&#160;31, 2021 through April&#160;28, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on December 10, 2020, the Company's Board of Directors (Board) terminated all remaining prior share repurchase authorizations available to the Company and approved a new share repurchase authorization of $2,000,000. As of April&#160;28, 2021, the Company had a total of $1,498,730 available under the current authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company remains subject to share repurchase limitations including under the terms of its current senior secured credit facilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:TreasuryStockTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfMTI5Mg_6908868b-d9d5-4ce0-882a-f1ffb7d01af7">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's common stock repurchases during the three months ended March&#160;31, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Open market repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;322,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy0xLTEtMS0w_a59b307d-2d10-45df-b501-8bdd71c7de59"
      unitRef="shares">2949000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy0zLTEtMS04NTk_101b3352-8c93-464e-a49a-bad8ef97bd16"
      unitRef="usd">322333000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy0zLTEtMS0w_b86ee04a-250b-47a3-b8c5-9b1375a8c54f"
      unitRef="usdPerShare">109.28</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i5d7725640db9488db340c97bfa388a99_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy01LTEtMS0w_659a49a6-7980-492f-b1cc-e4d03e72be8e"
      unitRef="shares">4052000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5d7725640db9488db340c97bfa388a99_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy05LTEtMS04NDI_8df0b648-62eb-4b06-9250-a67be5298b68"
      unitRef="usd">303139000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i5d7725640db9488db340c97bfa388a99_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RhYmxlOjA3NmI5YmRlNTk3OTRmMThhNWE3MTVmZWU1ZDM5NWU5L3RhYmxlcmFuZ2U6MDc2YjliZGU1OTc5NGYxOGE1YTcxNWZlZTVkMzk1ZTlfMy03LTEtMS0w_9c8b6634-401d-4e90-826a-c2bd4e92977c"
      unitRef="usdPerShare">74.81</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i97d0c8af8a944946a42c942ce28c581d_D20210401-20210428"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNjU5_2a49f244-6e72-438d-b4f9-1c8b1853f2c0"
      unitRef="shares">991000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i97d0c8af8a944946a42c942ce28c581d_D20210401-20210428"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNjkz_f98ae82e-0613-47d5-a189-407440c2e85c"
      unitRef="usd">108892000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i97d0c8af8a944946a42c942ce28c581d_D20210401-20210428"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfNzE4_455922ce-ad24-4738-a58e-f37b2227adfe"
      unitRef="usdPerShare">109.91</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i8f9b78b5f5fc4575a3e804c564b6679b_I20201210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfODc5NjA5MzAyNjA5NA_d15cf830-2cfd-4a17-ab52-7dd1de499e89"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ifa346157c398428ab51f508528dc7f0d_I20210428"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84Mi9mcmFnOjcxYjJmMjg3NTUyYTQ4OWE4MTgzYmQwZDYwZGVlOWJjL3RleHRyZWdpb246NzFiMmYyODc1NTJhNDg5YTgxODNiZDBkNjBkZWU5YmNfOTk5_8d587f12-2b2e-4536-8f3d-9d2fe8b207d3"
      unitRef="usd">1498730000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RleHRyZWdpb246MjE4ZmQ2NjRhM2MwNGJiNjkwZjVjZTczM2EwNjI2NTNfMjg5_684ec2b8-4d0d-4820-9d53-3e22560e24bc">Accumulated other comprehensive loss&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(66,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,978)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(94,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassification into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(116,232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(122,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(127,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(140,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income. See Note 6 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RleHRyZWdpb246MjE4ZmQ2NjRhM2MwNGJiNjkwZjVjZTczM2EwNjI2NTNfMjg3_bce371e1-7c19-4939-a093-208261608622">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(66,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,978)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(94,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassification into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(116,232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(122,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(127,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(140,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id9a08055277f468fa3da1c205ef85947_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi0xLTEtMS0w_e0cdaa45-a216-4ac1-b3fb-10b648903dd0"
      unitRef="usd">-12466000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id4709116f7724bc9ad71c5bfd6776322_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi0zLTEtMS0w_98bfac4c-5dda-4f33-acd6-e752f20b35b0"
      unitRef="usd">-53688000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7a80756affc64b969267ec3c56bb81ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi01LTEtMS0w_5f3f555d-e4a5-40f6-9072-b9ccf2dbc291"
      unitRef="usd">-66154000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7913425dd41a462fb453af0206275331_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi03LTEtMS0w_e7ad1f2c-d67f-41f8-9c9f-aa51b26c4948"
      unitRef="usd">-1433000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7550f2fc99ab46e1b842231f6e90d788_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi05LTEtMS0w_5fba09e6-396c-4d9d-953c-15892645a343"
      unitRef="usd">-46065000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i798ec441c1634f7dbbe04fccf4900538_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMi0xMS0xLTEtMA_eb0e9c34-2bc6-4c07-90e7-b7872cc77cfc"
      unitRef="usd">-47498000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy0xLTEtMS0w_0f364e7a-164b-42c4-993d-f25330f3cf43"
      unitRef="usd">6505000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy0zLTEtMS0w_4b19822a-322e-4f0d-ba85-07670dce0653"
      unitRef="usd">-62544000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy01LTEtMS0w_8303a620-8e89-4e24-9791-f055aeda69ab"
      unitRef="usd">-56039000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy03LTEtMS0w_79a3f36b-5118-4dfa-804b-902a4e54c034"
      unitRef="usd">-17346000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy05LTEtMS0w_18b0bcad-ac24-4662-a9fa-3333535ea0b9"
      unitRef="usd">-81632000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfMy0xMS0xLTEtMA_a7b406f4-08ce-48b0-b02b-95b87859e260"
      unitRef="usd">-98978000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC0xLTEtMS0w_f9ec7114-ff50-4684-8974-a901b541df47"
      unitRef="usd">1623000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC0zLTEtMS0w_467ccfa2-6434-4994-be3e-5295c971ff37"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC01LTEtMS0w_5b91dbea-b01b-4cdc-90d2-2db3f0e0ec9c"
      unitRef="usd">1623000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC03LTEtMS0w_499fb317-5aa9-4e6b-8428-c33c4d5e83b0"
      unitRef="usd">-4328000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC05LTEtMS0w_ad5ca7e4-de71-4fc5-b85c-d83bbe9b6ec4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNC0xMS0xLTEtMA_230e8884-ba42-462e-b211-5634f06bf2ba"
      unitRef="usd">-4328000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS0xLTEtMS0w_93eaf987-26ad-40c6-850a-a669dfb66c73"
      unitRef="usd">4882000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS0zLTEtMS0w_ef372d3a-3f73-4e59-b4cc-16560216ee1f"
      unitRef="usd">-62544000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS01LTEtMS0w_a552f64d-aa90-49fa-a197-f2347c7f7e2f"
      unitRef="usd">-57662000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS03LTEtMS0w_9bfbf0b5-3ce4-4c59-aa12-202e385f800c"
      unitRef="usd">-13018000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS05LTEtMS0w_2b6ccc95-5058-4ba5-b7f9-3190b90068b3"
      unitRef="usd">-81632000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNS0xMS0xLTEtMA_bcd68b50-b61e-4af7-8130-caa53a435cb6"
      unitRef="usd">-94650000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi0xLTEtMS0w_d37d9f16-0a6a-4c1b-8dd5-fe92d573bb4c"
      unitRef="usd">1377000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi0zLTEtMS0w_4bf38440-083e-467a-9d14-1b9e041f94f5"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi01LTEtMS0w_bd24f9b3-5be0-433a-84e2-ff2923c93e00"
      unitRef="usd">1377000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi03LTEtMS0w_3c5e2103-f7eb-4b03-8fa1-941289f3251f"
      unitRef="usd">2163000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi05LTEtMS0w_e7453ec1-1d2c-475b-8ed0-9229efa6dd8d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNi0xMS0xLTEtMA_e16c6bea-35e6-4731-a906-bf3fcd6bfffc"
      unitRef="usd">2163000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy0xLTEtMS0w_6a720173-c39d-4b9c-b103-abd71e4bf710"
      unitRef="usd">344000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy0zLTEtMS0w_caf5e157-d675-4e63-b7ab-33d708e63f84"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy01LTEtMS0w_2e93b515-c8e2-4ea8-afb5-f3608ca5c8be"
      unitRef="usd">344000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy03LTEtMS0w_c70b8b73-a803-4cab-871f-f350afd5aeb5"
      unitRef="usd">540000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy05LTEtMS0w_869c4f7b-f950-47e7-b571-2ba8f82b1c5d"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfNy0xMS0xLTEtMA_9b5f3ff8-9106-43db-99fe-a4503345d06c"
      unitRef="usd">540000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1769c67713a3412db8c630fd11b1ad9e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC0xLTEtMS0w_59cb0160-1229-4b54-baf4-2826473a8543"
      unitRef="usd">1033000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i13c025194cdf4685ab2de573c52507b8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC0zLTEtMS0w_9c37bddc-2f76-4a99-b680-62dee892e520"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4e992d644be94534b183789d6b781637_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC01LTEtMS0w_0b1072b8-4438-459a-9719-10a1d4fef92d"
      unitRef="usd">1033000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie77923f15e8c4326b2d98942cac8ce95_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC03LTEtMS0w_2932c172-82e1-4337-b195-3ac3889c4ba0"
      unitRef="usd">1623000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic9a879e5293c48d1b816e4fe0c2b8a1e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC05LTEtMS0w_7fccd0ff-8190-4d62-ae2e-0374abb5e9fe"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i52a5f31b317347aa93d620b0347a1951_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOC0xMS0xLTEtMA_fd4b5b61-1032-41df-bb1d-e5cddff0d100"
      unitRef="usd">1623000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7639fee9f6714447997016db991f797c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS0xLTEtMS0w_d15bf753-8939-4cc2-bbe5-0ed9bd59c210"
      unitRef="usd">-6551000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i84115112998e4c6ab8350b671c96944b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS0zLTEtMS0w_b22e0da8-01ae-4f2f-b604-23107c25ef43"
      unitRef="usd">-116232000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1f5f0eab21a44845a44f238f8ff448c7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS01LTEtMS0w_6daf2059-ebaf-4529-a9ba-a1a047de78d9"
      unitRef="usd">-122783000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i009808e6a6064e15a4b9a0b821c2bdfa_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS03LTEtMS0w_b3409b30-6629-4081-b1cf-9248646bdb7b"
      unitRef="usd">-12828000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7b8ca49829314b1c86c5e23c209360a8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS05LTEtMS0w_1b53dc2d-5cb0-4308-96a8-2d3025481ab8"
      unitRef="usd">-127697000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6516fe61d14b40988955d5922b34c110_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RhYmxlOjRlOTAyYjFiNGRjMzQ0NWNhZDgxMDdiZjNhYTc0MmI0L3RhYmxlcmFuZ2U6NGU5MDJiMWI0ZGMzNDQ1Y2FkODEwN2JmM2FhNzQyYjRfOS0xMS0xLTEtMA_1a3b2fc8-f366-4869-afd1-95eae35f434f"
      unitRef="usd">-140525000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl84OC9mcmFnOjIxOGZkNjY0YTNjMDRiYjY5MGY1Y2U3MzNhMDYyNjUzL3RleHRyZWdpb246MjE4ZmQ2NjRhM2MwNGJiNjkwZjVjZTczM2EwNjI2NTNfMjk3_de9623c4-db20-426f-afb3-df6c6cb9dbe9">The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjUzNg_04a6d3af-3ba3-4f98-9b47-2477ed9d76e6">Acquisitions and divestitures&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Routine acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021, the Company acquired dialysis businesses consisting of two dialysis centers located outside the U.S. for a total of $3,668 in net cash, contingent earn-out obligations of $538 and deferred purchase price and liabilities assumed of $1,094. The assets and liabilities for these acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#x2019;s condensed consolidated financial statements, as are their operating results, from the designated effective dates of the acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial purchase price allocations for these transactions have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. In particular, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of intangibles, leases and certain other working capital items relating to several of these acquisitions are pending final quantification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill deductible for tax purposes associated with acquisitions completed during the three months ended March&#160;31, 2021 was $5,456.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired companies a total of up to approximately $40,173 if certain performance targets or quality margins are met over the next one year to five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. As of March&#160;31, 2021, the Company estimated the fair value of these contingent earn-out obligations to be $28,225, of which $11,613 is included in other current liabilities and the remaining $16,612 is included in other long-term liabilities in the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of changes in contingent earn-out obligations for the three months ended March&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i27908b3ff2f44d9283aa1440a2b3ae17_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTkx_f3a962a6-2a5b-42b5-b39a-57e402c7284a"
      unitRef="clinic">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5bfeeb71e92742cda00237cd50a46e64_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjUx_8d8e9f12-5691-449e-8530-e68e18052bb2"
      unitRef="usd">3668000</us-gaap:PaymentsToAcquireBusinessesGross>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="i5bfeeb71e92742cda00237cd50a46e64_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTQyOTM2NTExNzAxMDQ_348f5b74-fff3-48a1-96c2-f20ed6c30c12"
      unitRef="usd">538000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i5bfeeb71e92742cda00237cd50a46e64_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTQyOTM2NTExNzAxMDk_dd260f48-45a2-480c-8e89-0652891c498c"
      unitRef="usd">1094000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTQyOTM2NTExNzA0MTQ_11b41b73-3977-419d-8273-b026d27ee64b"
      unitRef="usd">5456000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="i73bc0a8523dd4554aa03d767a5adeba8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjA1NQ_214a2b10-a717-4f69-923a-aa5356a7b639"
      unitRef="usd">40173000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="i631f28de3213466e9bbd705c5fbefdc9_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjE0MA_5009fd44-3446-4439-b5ac-765e762f5479">P1Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="i57247936e4d94d5da5ca8c68117d7722_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjE0Ng_6b652b42-205a-423f-8bd9-5f4fdc4bd4fb">P5Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i355c4c0d9e274392b8117ea1ede7a7eb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjIyOQ_0d6014d1-babe-422a-808c-aa168bbc310f"
      unitRef="usd">28225000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if907602d375846b0b24b8a53b7ca0a19_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjI0Mg_965a0328-ba16-427a-9890-e9b8814aedc4"
      unitRef="usd">11613000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0e0275ee13fa4083b1696201c4b78acb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjMwNA_f4ae096e-3c2a-43e7-bbb3-226c05b45ac1"
      unitRef="usd">16612000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMjUzNQ_060b38cc-bd32-4789-9072-7cb468122cea">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of changes in contingent earn-out obligations for the three months ended March&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfMS0xLTEtMS0w_99f2b141-b165-4788-b9fb-407c641c74ff"
      unitRef="usd">30248000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfMi0xLTEtMS0w_dcff48a0-2d42-44e0-a425-38c9d10a1b1d"
      unitRef="usd">538000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfMy0xLTEtMS0w_57ce1fc0-64d3-4b1d-bfe9-0027dd3f4def"
      unitRef="usd">2080000</dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfNC0xLTEtMS0w_24b95f43-3872-4c95-98ef-5b6ffbf51f8e"
      unitRef="usd">214000</dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfNS0xLTEtMS0w_f67b806d-8a03-4ea2-bddc-b06948613096"
      unitRef="usd">267000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RhYmxlOjdjNzU2MzgxYjgxYzQ3YzliMmE4NWZmZGVkNmY2MjQyL3RhYmxlcmFuZ2U6N2M3NTYzODFiODFjNDdjOWIyYTg1ZmZkZWQ2ZjYyNDJfNi0xLTEtMS0w_44564232-c588-4983-aafc-60845288ebb7"
      unitRef="usd">28225000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfMTgxNDE5NDE4NjgwMDY_16293d4f-8ad6-4451-a407-b5ed88e63b0d">&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 19, 2019, the Company completed the sale of its DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. At close of the DMG sale, the Company's ultimate net sale proceeds remained subject to resolution of certain post-closing purchase price adjustments described in the equity purchase agreement, which adjustments were finalized in the fourth quarter of 2020. In the first quarter of 2020, the Company recognized $9,980 in additional tax benefits under the Coronavirus Aid, Relief, and Economic Security Act related to its period of DMG ownership, which were recognized as an adjustment to the Company's loss on sale of the DMG business.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85MS9mcmFnOjYzNmUzNjVjNGViZjRhOWVhNjUzMGNhNjQxZDdiYmMxL3RleHRyZWdpb246NjM2ZTM2NWM0ZWJmNGE5ZWE2NTMwY2E2NDFkN2JiYzFfNzE0NjgyNTU4OTM0Nw_eb2f2e20-fe20-4dff-a194-9d7bb767b9db"
      unitRef="usd">9980000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85Ny9mcmFnOjc2NmI4YWNhMmQxMTQzNTI4ZTVlMGFmYzkzN2NlMDY5L3RleHRyZWdpb246NzY2YjhhY2EyZDExNDM1MjhlNWUwYWZjOTM3Y2UwNjlfNDQ5_75daec62-a3f5-4e40-9cef-49bea5fd149e">Variable interest entities (VIEs)At March&#160;31, 2021, these condensed consolidated financial statements include total assets of VIEs of $300,849 and total liabilities and noncontrolling interests of VIEs to third parties of $207,527. There have been no material changes in the nature of the Company's arrangements with VIEs or its judgments concerning them from those described in Note 23 to the Company's consolidated financial statements included in the 2020 10-K.</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:Assets
      contextRef="i79e508f7f8044bb5bcad2876847bcc76_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85Ny9mcmFnOjc2NmI4YWNhMmQxMTQzNTI4ZTVlMGFmYzkzN2NlMDY5L3RleHRyZWdpb246NzY2YjhhY2EyZDExNDM1MjhlNWUwYWZjOTM3Y2UwNjlfMTMy_ae0b3614-7a67-42f2-bce0-f681b2191979"
      unitRef="usd">300849000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i79e508f7f8044bb5bcad2876847bcc76_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl85Ny9mcmFnOjc2NmI4YWNhMmQxMTQzNTI4ZTVlMGFmYzkzN2NlMDY5L3RleHRyZWdpb246NzY2YjhhY2EyZDExNDM1MjhlNWUwYWZjOTM3Y2UwNjlfMjE0_ec834a67-0d0a-4d20-ba3e-62aca628c8f8"
      unitRef="usd">207527000</us-gaap:Liabilities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90ZXh0cmVnaW9uOmQ0Nzk2YzM4M2JmZTQwMzU5MGM2NzYwZGQxNDRkMjU1XzQ1NTg_1370153f-c76e-4299-8122-531feff41776">Fair values of financial instruments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equities that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2021:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Quoted prices in&lt;br/&gt;active&#160;markets&lt;br/&gt;for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,349,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,349,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the three months ended March&#160;31, 2021, see Note 10 and the consolidated statement of equity, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stock which are held within a trust to fund existing obligations associated with several of the Company's non-qualified deferred compensation plans. These investments are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 4 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA) and revenue. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value. See Note 10 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of March&#160;31, 2021, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $170,000. See Note 17 and Note 24 to the Company's consolidated financial statements included in the 2020 10-K for further discussion of the Company&#x2019;s methodology for estimating the fair value of noncontrolling interests subject to put obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon bid and ask quotes for these instruments, typically a level 2 input. See Note 6 for further discussion of the Company's debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in these condensed consolidated financial statements at March&#160;31, 2021 at their approximate fair values due to the short-term nature of their settlements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90ZXh0cmVnaW9uOmQ0Nzk2YzM4M2JmZTQwMzU5MGM2NzYwZGQxNDRkMjU1XzQ1NzI_f5ffd73d-1b6e-427f-bd0e-55dcf40f4d2f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2021:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Quoted prices in&lt;br/&gt;active&#160;markets&lt;br/&gt;for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,349,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,349,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i495ea84f47aa48bcbf441d81513cb962_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzItMS0xLTEtMA_5ab2210b-7279-450a-93e5-17980d587fa8"
      unitRef="usd">34730000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3e5449f4136e4a069e013c4a12fa4b96_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzItMy0xLTEtMA_a7bdb1a3-505a-4631-b9b5-8930b9cdf1db"
      unitRef="usd">34730000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0f2d7535539145679656b6f1f8c6109d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzItNS0xLTEtMA_1a273ac2-7e53-462a-94a6-75828811f017"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1b44264ea668489b8330c31d2a995fa5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzItNy0xLTEtMA_c45f2289-b715-4b8f-9c31-cbd2090e84ca"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="id3cd95724eb3494bb6e72cb6132e8c7d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzMtMS0xLTEtMA_6940ddd8-ec81-4875-8410-3bbcfb29b743"
      unitRef="usd">9176000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i15e9456343284b0183c0a4c3be1bb14e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzMtMy0xLTEtMA_c8eb5593-7f9f-4796-bf8e-95e72b15f242"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2f92b2fa92fe417aa409a3b1a97cb245_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzMtNS0xLTEtMA_2d70a9ff-9e03-4378-875c-9737d3f33482"
      unitRef="usd">9176000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0a92bc0f852f4670a2b1907f3d705ae2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzMtNy0xLTEtMA_77cb44b9-c1c3-441e-a93c-f25527fdcbb7"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i495ea84f47aa48bcbf441d81513cb962_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzUtMS0xLTEtMA_678c424e-9619-4a36-a911-95f70407fa6c"
      unitRef="usd">28225000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3e5449f4136e4a069e013c4a12fa4b96_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzUtMy0xLTEtMA_0eb1c9dc-3015-4af6-9c81-1c4512a943bc"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0f2d7535539145679656b6f1f8c6109d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzUtNS0xLTEtMA_840890f9-6bbf-47bc-8683-074499984e87"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1b44264ea668489b8330c31d2a995fa5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzUtNy0xLTEtMA_6e9d416b-81a2-468f-a4c5-b34270e8d418"
      unitRef="usd">28225000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i495ea84f47aa48bcbf441d81513cb962_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzctMS0xLTEtMA_56798edd-fc2f-4283-9d2d-501c368fc023"
      unitRef="usd">1349160000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i3e5449f4136e4a069e013c4a12fa4b96_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzctMy0xLTEtMA_a2c5e1b0-545c-4e0b-ad5a-2470e6bd4b34"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i0f2d7535539145679656b6f1f8c6109d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzctNS0xLTEtMA_a8cf9640-3833-428f-81c0-67a2ac2a6472"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i1b44264ea668489b8330c31d2a995fa5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90YWJsZTpiZDg1ZjZiZTg2YTA0MzdlYjk3NWE3YmU5YjFmNjViNS90YWJsZXJhbmdlOmJkODVmNmJlODZhMDQzN2ViOTc1YTdiZTliMWY2NWI1XzctNy0xLTEtMA_ea7d3505-9ce0-4b39-a4c7-7f924292a50f"
      unitRef="usd">1349160000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90ZXh0cmVnaW9uOmQ0Nzk2YzM4M2JmZTQwMzU5MGM2NzYwZGQxNDRkMjU1XzQ1NjM_b8979e9d-f427-4573-8ebe-dddc35acd1bb">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA) and revenue. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDAvZnJhZzpkNDc5NmMzODNiZmU0MDM1OTBjNjc2MGRkMTQ0ZDI1NS90ZXh0cmVnaW9uOmQ0Nzk2YzM4M2JmZTQwMzU5MGM2NzYwZGQxNDRkMjU1XzM2MDI_7b5f2243-52c3-4306-81a0-7bedabcfe18f"
      unitRef="usd">170000000</dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwMjU_bd71cc65-463b-47a5-9876-9b32220ea798">Segment reporting&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its various ancillary services including its international operations (collectively, its ancillary services), and its corporate administrative support. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s separate operating segments include its U.S. dialysis and related lab services business, each of its ancillary services, its kidney care operations in each foreign sovereign jurisdiction, its other health operations in each foreign sovereign jurisdiction, and its equity method investment in the Asia Pacific joint venture (APAC JV). The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other ancillary services operating segments, including the international operating segments, have been combined and disclosed in the other segments category. See Note 25 to the Company's consolidated financial statements included in the 2020 10-K for further description of how the Company determines and measures results for its operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment net revenues, segment operating income (loss), and a reconciliation of segment operating income (loss) to consolidated income before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,556,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,579,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,583,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,611,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,589,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,616,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;261,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;261,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,851,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,877,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,820,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,841,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment operating income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;479,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;468,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating income to consolidated income from continuing &lt;br/&gt;&#160;operations before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;442,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;465,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(88,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt refinancing charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;Includes management fee revenue from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling equity investment or which are wholly-owned by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.077%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of assets by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.077%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,036,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,344,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,610,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,647,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,988,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for property and equipment by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.077%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwMTQ_5b629282-55ec-4ae9-84bb-92160617e3f9">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment net revenues, segment operating income (loss), and a reconciliation of segment operating income (loss) to consolidated income before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,556,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,579,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,583,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,611,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,589,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,616,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;261,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;261,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,851,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,877,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,820,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,841,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment operating income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;479,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;468,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating income to consolidated income from continuing &lt;br/&gt;&#160;operations before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;442,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;465,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(88,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt refinancing charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;Includes management fee revenue from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling equity investment or which are wholly-owned by third parties.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i332c7d42021f4f6da272ea3d938d6af0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzUtMS0xLTEtMA_fefc8eb8-844a-462e-9fa8-567bf26ab21e"
      unitRef="usd">2556259000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ieeec13c830464d468215c66930e23ec9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzUtMy0xLTEtMA_bc4000c6-b29f-4515-9af7-8a266785d99c"
      unitRef="usd">2579240000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i979f0469490346ea8c2367f07d1340a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzYtMS0xLTEtMA_3a245975-d7af-4d5c-937f-d1406cce32d2"
      unitRef="usd">26944000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia6fe8af182b14048858164d9709baa1d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzYtMy0xLTEtMA_beb20d25-2a11-43b0-a691-05fa45cff523"
      unitRef="usd">31941000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2601990fe363422986c39fb1866d5dcd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzktMS0xLTEtMA_f4eac59e-dc74-47ad-9b99-316abe7ce688"
      unitRef="usd">2583203000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4a051b6561614f1e8e342da9d47552e7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzktMy0xLTEtMA_93cdf517-f27e-4b7d-9d05-c9d2fc4c8f3b"
      unitRef="usd">2611181000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i332c7d42021f4f6da272ea3d938d6af0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzExLTEtMS0xLTA_2157aae7-a175-4a51-86cb-2aaac96cf20b"
      unitRef="usd">6616000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ieeec13c830464d468215c66930e23ec9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzExLTMtMS0xLTA_ea9c76ed-75fe-4b0f-a3a2-0baa2234077a"
      unitRef="usd">5141000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i979f0469490346ea8c2367f07d1340a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzEyLTEtMS0xLTA_8c2d1110-ac3c-4fe1-bf3d-2cc15a39fb2d"
      unitRef="usd">59000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ia6fe8af182b14048858164d9709baa1d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzEyLTMtMS0xLTA_54c302fb-6121-492e-99dc-811fae879e97"
      unitRef="usd">301000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i2601990fe363422986c39fb1866d5dcd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzEzLTEtMS0xLTA_010bf3ed-b254-4fe1-ad2b-696e7e2bd7fd"
      unitRef="usd">2589878000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a051b6561614f1e8e342da9d47552e7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzEzLTMtMS0xLTA_2130628a-3d4b-4f07-b131-0bffb232ff2d"
      unitRef="usd">2616623000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic9286623196349739c21994952f69f6a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE1LTEtMS0xLTA_ec282a46-37f3-4845-acc2-48d32af54b07"
      unitRef="usd">158328000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE1LTMtMS0xLTA_b56ec077-63de-45a0-a9c2-6fff11e41f9b"
      unitRef="usd">134041000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="ic9286623196349739c21994952f69f6a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE2LTEtMS0xLTA_8403bcbc-4787-4115-864e-1b3ff64a876a"
      unitRef="usd">98798000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE2LTMtMS0xLTA_aafe738e-99fd-42f7-bd00-d6905834eb06"
      unitRef="usd">122815000</us-gaap:OtherIncome>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic6e9959083a844ce9f5568612f3be925_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE3LTEtMS0xLTA_277f5eeb-2abe-4c93-a860-4eaf2bbc7771"
      unitRef="usd">4293000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i05a29181b883436aa54dd8cb74f27dfa_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE3LTMtMS0xLTA_4e758f8d-c34d-4f97-a1a8-c80f061625ef"
      unitRef="usd">4152000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ic9286623196349739c21994952f69f6a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE4LTEtMS0xLTA_73d3ec9c-3c7f-4787-a2ea-317a961ae60f"
      unitRef="usd">261419000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE4LTMtMS0xLTA_df025ba3-9edb-4596-a795-70bfe0d6f5d1"
      unitRef="usd">261008000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i063d84a2e30e427c986c99aacd98b664_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE5LTEtMS0xLTA_e0f409c1-4ddb-4b9c-8089-99da9c1f7c0e"
      unitRef="usd">2851297000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec56217c36c846509f6a12afa76de49b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzE5LTMtMS0xLTA_3257b8d7-ed07-42e4-815b-12af04e4a438"
      unitRef="usd">2877631000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d4cbc4b3cb3440baae8caf684d727be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIwLTEtMS0xLTA_b64fff91-8159-4c09-9da7-c97a58c24b4b"
      unitRef="usd">-31296000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb32ded36f5647b8bf00bcd206f6b64a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIwLTMtMS0xLTA_b843aaba-86c9-4e70-93f7-8d2b66da16e7"
      unitRef="usd">-36394000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIxLTEtMS0xLTA_0b9113a4-96ce-4b28-be33-1f5e7aa6a45e"
      unitRef="usd">2820001000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIxLTMtMS0xLTA_92c20f57-bc17-48ba-9c20-565f4850bfca"
      unitRef="usd">2841237000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2601990fe363422986c39fb1866d5dcd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIzLTEtMS0xLTA_9fa9d670-c183-4d63-b4ac-ea10b794c67f"
      unitRef="usd">479906000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4a051b6561614f1e8e342da9d47552e7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzIzLTMtMS0xLTA_17db06d4-5fbe-4bab-9619-616bd1e8dad7"
      unitRef="usd">491607000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic9286623196349739c21994952f69f6a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI0LTEtMS0xLTA_12ca73a1-f36c-41a5-b617-88c218250af1"
      unitRef="usd">-11860000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0cb84ddffa9645538d426c27c5907885_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI0LTMtMS0xLTA_f8e0bed1-69ea-42c0-ac79-1dc6faa8b428"
      unitRef="usd">-2646000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i063d84a2e30e427c986c99aacd98b664_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI1LTEtMS0xLTA_4d1bf4b0-6de3-478e-a79c-249838ab882d"
      unitRef="usd">468046000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iec56217c36c846509f6a12afa76de49b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI1LTMtMS0xLTA_f48442b6-7f68-442b-8335-53de91f8f6d8"
      unitRef="usd">488961000</us-gaap:OperatingIncomeLoss>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI3LTEtMS0xLTA_cde4260e-bcb0-4742-b915-f7cdd0995710"
      unitRef="usd">25444000</dva:SegmentReportingInformationCorporateExpenses>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI3LTMtMS0xLTA_8ecf61b6-99c0-4c74-a00a-9e73b3ba2596"
      unitRef="usd">23585000</dva:SegmentReportingInformationCorporateExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI4LTEtMS0xLTA_001d20d8-10bb-4554-a332-86638e91baf3"
      unitRef="usd">442602000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI4LTMtMS0xLTA_4e55b636-1c23-455c-af74-bcf91facba87"
      unitRef="usd">465376000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI5LTEtMS0xLTA_68892e38-83fe-4866-93b8-42c053a38dec"
      unitRef="usd">67014000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzI5LTMtMS0xLTA_a5e297bc-6fad-4fcd-a5af-5f7df7caaef3"
      unitRef="usd">88603000</us-gaap:InterestAndDebtExpense>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMwLTEtMS0xLTA_6145d9f6-6e0e-4c2c-a24b-c8b576bfeda5"
      unitRef="usd">0</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMwLTMtMS0xLTA_ca4600f0-e54e-4ae0-9248-67f4e83e2004"
      unitRef="usd">2948000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMxLTEtMS0xLTA_8a01de7c-dbfe-488d-b0cd-6673920909df"
      unitRef="usd">1168000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMxLTMtMS0xLTA_f414dce8-e7ac-4e73-a8b6-544abf15c950"
      unitRef="usd">-4350000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMyLTEtMS0xLTA_97b8df42-b071-43d8-84d9-32c8773a6177"
      unitRef="usd">376756000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTpkZmE1MGRlMzk5MGE0Njk4ODQwZmJmODA2ZTRlM2RiOS90YWJsZXJhbmdlOmRmYTUwZGUzOTkwYTQ2OTg4NDBmYmY4MDZlNGUzZGI5XzMyLTMtMS0xLTA_a8813ad7-d284-4bd9-918b-d7aaf7c84aac"
      unitRef="usd">369475000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwNDQ_0de2ce83-a943-44e0-94c6-5d240d9885a9">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.077%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzItMS0xLTEtOTE0Nw_340800d1-d6a3-4dfa-8b3e-9bccdaf82bb9"
      unitRef="usd">155946000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ifb49ac86f6b746d990ed1e8d57025774_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzItMy0xLTEtOTE0Nw_bc885670-4c9a-4e4c-93dd-ac1ccebc8984"
      unitRef="usd">146300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzMtMS0xLTEtOTE0Nw_721c8ff8-354a-48d3-9120-1b59af39110a"
      unitRef="usd">9755000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iaaaa1dbe5bd548efb96a1fb6dc9d1fdc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzMtMy0xLTEtOTE0Nw_4cd12b23-fad4-4ab7-a006-2121b1afcfe1"
      unitRef="usd">8379000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzQtMS0xLTEtOTE0Nw_91eb46fb-c787-4e0b-a9d7-6e20a101d9aa"
      unitRef="usd">165701000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo3Mzg1NjQ3MmIzMWM0N2Y1YWI4NjQwOGU0ZDk3MTc0NC90YWJsZXJhbmdlOjczODU2NDcyYjMxYzQ3ZjVhYjg2NDA4ZTRkOTcxNzQ0XzQtMy0xLTEtOTE0Nw_ab90a531-e02a-4ed6-9d02-f1c98950c0da"
      unitRef="usd">154679000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwMzQwOTY1MTE4NTc4_c7847db3-ffb1-4d9a-aee7-41a8fed2e7e5">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of assets by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.077%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,036,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,344,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,610,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,647,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,988,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="i7f587b5b943b44b8b00940ad481105ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzEtMS0xLTEtMA_80e64c1f-7c6b-4b6a-8613-c64228a50359"
      unitRef="usd">16036940000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="icab86a87e7ca432ca27ef7f2f0802e4e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzEtMy0xLTEtMA_6d980d11-29f3-45f2-a4cc-d5855d30e48c"
      unitRef="usd">15344647000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic553e5603c8a4d188a7de8da0d2f4c76_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzItMS0xLTEtMA_028dde15-727b-4a1f-964d-ee01e9505f7c"
      unitRef="usd">1610328000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2498e561a5854842a6d62e0b719f9b52_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzItMy0xLTEtMA_56d84149-c649-4cba-979a-3e6d1a45c542"
      unitRef="usd">1643869000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzMtMS0xLTEtMA_43faf222-1adf-4acd-886b-7e5d25cf65ad"
      unitRef="usd">17647268000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTplNzhjODVhYjYyMmY0Mzc4OTZkMTQ1MGRhYjkyYmUwOS90YWJsZXJhbmdlOmU3OGM4NWFiNjIyZjQzNzg5NmQxNDUwZGFiOTJiZTA5XzMtMy0xLTEtMA_e1f58e75-b88f-4a14-92df-681eaeb93dcc"
      unitRef="usd">16988516000</us-gaap:Assets>
    <dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90ZXh0cmVnaW9uOjhmYmQ3M2I1NDViNDQxNDNiNGYwMWM5YjFlY2ZhMDEyXzIwMzY_0e782bf9-2088-41c1-8508-53d9fa8c729b">Expenditures for property and equipment by reportable segment were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.077%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzItMS0xLTEtMA_e1674939-6bba-45d5-9c75-fbbfc334d93d"
      unitRef="usd">133804000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifb49ac86f6b746d990ed1e8d57025774_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzItMy0xLTEtMA_293dd5a1-c163-4cb1-94d9-be7ca2b51a3e"
      unitRef="usd">148763000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0080d6fc84a0474da771b6658f78e5dc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzMtMS0xLTEtMA_689db337-0e1a-42bc-9b62-38b2241b243b"
      unitRef="usd">11109000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iaaaa1dbe5bd548efb96a1fb6dc9d1fdc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzMtMy0xLTEtMA_38833ab3-8ad0-4482-ae98-51d73084b53e"
      unitRef="usd">6179000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzUtMS0xLTEtMA_54d1c4dd-5418-48b5-b155-63092c50a0ea"
      unitRef="usd">144913000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i059428af274a4ed49d0ec63df5d6adc9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMDMvZnJhZzo4ZmJkNzNiNTQ1YjQ0MTQzYjRmMDFjOWIxZWNmYTAxMi90YWJsZTo5YTcyY2QwNDc1MDk0MGQ5YTllMzk0YmNiNTgxY2ZlMi90YWJsZXJhbmdlOjlhNzJjZDA0NzUwOTQwZDlhOWUzOTRiY2I1ODFjZmUyXzUtMy0xLTEtMA_b8058e19-e9fd-4a10-9c08-b7d81b6ac229"
      unitRef="usd">154942000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMTIvZnJhZzplZGU4ODI0YzRmNzg0NzFmODFhYjM0MDc5MGEwYTU0Ni90ZXh0cmVnaW9uOmVkZTg4MjRjNGY3ODQ3MWY4MWFiMzQwNzkwYTBhNTQ2XzQxNDU_749bf623-d584-4ded-a829-58cac628434c">New accounting standards&lt;div style="margin-top:9pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards recently adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU No. 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU No. 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The adoption of ASU No. 2019-12 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjIyYzUyYzQ3ZDViYTQ1N2RhOTQxODRlNzY3MGNhN2U2L3NlYzoyMmM1MmM0N2Q1YmE0NTdkYTk0MTg0ZTc2NzBjYTdlNl8xMTIvZnJhZzplZGU4ODI0YzRmNzg0NzFmODFhYjM0MDc5MGEwYTU0Ni90ZXh0cmVnaW9uOmVkZTg4MjRjNGY3ODQ3MWY4MWFiMzQwNzkwYTBhNTQ2XzQxNTQ_fd2383d2-6a5d-4102-809b-3d1b134d0d0f">&lt;div style="margin-top:9pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards recently adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU No. 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU No. 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The adoption of ASU No. 2019-12 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720667900152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 26, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-14106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DAVITA INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0354549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2000 16th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-2100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DVA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720666960936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts', window );">Dialysis patient service revenues</a></td>
<td class="nump">$ 2,714,587<span></span>
</td>
<td class="nump">$ 2,713,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">105,414<span></span>
</td>
<td class="nump">127,956<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,820,001<span></span>
</td>
<td class="nump">2,841,237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PatientCareCosts', window );">Patient care costs</a></td>
<td class="nump">1,938,330<span></span>
</td>
<td class="nump">1,975,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">281,426<span></span>
</td>
<td class="nump">263,576<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">165,701<span></span>
</td>
<td class="nump">154,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment income</a></td>
<td class="num">(8,058)<span></span>
</td>
<td class="num">(17,843)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">2,377,399<span></span>
</td>
<td class="nump">2,375,861<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">442,602<span></span>
</td>
<td class="nump">465,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="num">(67,014)<span></span>
</td>
<td class="num">(88,603)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtPrepaymentRefinancingRedemptionCharges', window );">Debt refinancing charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,948)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss), net</a></td>
<td class="nump">1,168<span></span>
</td>
<td class="num">(4,350)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from continuing operations before income taxes</a></td>
<td class="nump">376,756<span></span>
</td>
<td class="nump">369,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">85,211<span></span>
</td>
<td class="nump">91,560<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income from continuing operations</a></td>
<td class="nump">291,545<span></span>
</td>
<td class="nump">277,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">291,545<span></span>
</td>
<td class="nump">287,895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="num">(54,142)<span></span>
</td>
<td class="num">(48,302)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 237,403<span></span>
</td>
<td class="nump">$ 239,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic net income from continuing operations</a></td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 1.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income</a></td>
<td class="nump">2.18<span></span>
</td>
<td class="nump">1.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income from continuing operations</a></td>
<td class="nump">2.09<span></span>
</td>
<td class="nump">1.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 1.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares for earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">109,014,000<span></span>
</td>
<td class="nump">124,902,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">113,852,000<span></span>
</td>
<td class="nump">126,895,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Amounts attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="nump">$ 237,403<span></span>
</td>
<td class="nump">$ 229,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net income from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 237,403<span></span>
</td>
<td class="nump">$ 239,593<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtPrepaymentRefinancingRedemptionCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment, refinancing and redemption charges related to long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtPrepaymentRefinancingRedemptionCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PatientCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PatientCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720668019496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 291,545<span></span>
</td>
<td class="nump">$ 287,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized gains (losses) on interest rate cap agreements:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Unrealized gains (losses)</a></td>
<td class="nump">4,882<span></span>
</td>
<td class="num">(13,018)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Reclassifications of net realized losses into net income</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized losses on foreign currency translation</a></td>
<td class="num">(62,544)<span></span>
</td>
<td class="num">(81,632)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(56,629)<span></span>
</td>
<td class="num">(93,027)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">234,916<span></span>
</td>
<td class="nump">194,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(54,142)<span></span>
</td>
<td class="num">(48,302)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to DaVita Inc.</a></td>
<td class="nump">$ 180,774<span></span>
</td>
<td class="nump">$ 146,566<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720666680696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 884,205<span></span>
</td>
<td class="nump">$ 324,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and equivalents</a></td>
<td class="nump">176,835<span></span>
</td>
<td class="nump">176,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">11,060<span></span>
</td>
<td class="nump">20,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">2,040,813<span></span>
</td>
<td class="nump">1,824,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">116,322<span></span>
</td>
<td class="nump">111,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">535,521<span></span>
</td>
<td class="nump">544,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">73,765<span></span>
</td>
<td class="nump">76,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">28,160<span></span>
</td>
<td class="nump">70,163<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,866,681<span></span>
</td>
<td class="nump">3,148,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,490,442<span></span>
</td>
<td class="nump">3,521,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">2,868,292<span></span>
</td>
<td class="nump">2,863,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">150,706<span></span>
</td>
<td class="nump">166,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">257,513<span></span>
</td>
<td class="nump">257,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">31,891<span></span>
</td>
<td class="nump">32,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">90,534<span></span>
</td>
<td class="nump">79,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,891,209<span></span>
</td>
<td class="nump">6,919,109<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">17,647,268<span></span>
</td>
<td class="nump">16,988,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES AND EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">348,105<span></span>
</td>
<td class="nump">434,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">846,710<span></span>
</td>
<td class="nump">810,529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">550,671<span></span>
</td>
<td class="nump">685,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">372,737<span></span>
</td>
<td class="nump">369,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">168,191<span></span>
</td>
<td class="nump">168,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">28,310<span></span>
</td>
<td class="nump">7,768<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,314,724<span></span>
</td>
<td class="nump">2,476,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">2,739,311<span></span>
</td>
<td class="nump">2,738,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">8,829,765<span></span>
</td>
<td class="nump">7,917,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">150,724<span></span>
</td>
<td class="nump">150,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">830,369<span></span>
</td>
<td class="nump">809,600<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,864,893<span></span>
</td>
<td class="nump">14,091,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,349,160<span></span>
</td>
<td class="nump">1,330,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">603,172<span></span>
</td>
<td class="nump">597,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,089,940<span></span>
</td>
<td class="nump">852,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, Value</a></td>
<td class="num">(322,333)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(122,783)<span></span>
</td>
<td class="num">(66,154)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total DaVita Inc. shareholders' equity</a></td>
<td class="nump">1,248,106<span></span>
</td>
<td class="nump">1,383,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests not subject to put provisions</a></td>
<td class="nump">185,109<span></span>
</td>
<td class="nump">183,186<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">1,433,215<span></span>
</td>
<td class="nump">1,566,752<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 17,647,268<span></span>
</td>
<td class="nump">$ 16,988,516<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720741403336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">$ 4,622,798<span></span>
</td>
<td class="nump">$ 4,480,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="nump">$ 69,691<span></span>
</td>
<td class="nump">$ 70,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">110,027<span></span>
</td>
<td class="nump">109,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">107,078<span></span>
</td>
<td class="nump">109,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">2,949<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation (related to long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations and capitalized assets classified as property, plant and equipment that are owned by the entity) that has been recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720667319464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 291,545<span></span>
</td>
<td class="nump">$ 287,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">165,701<span></span>
</td>
<td class="nump">154,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtRefinancingCharges', window );">Debt refinancing charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">23,595<span></span>
</td>
<td class="nump">19,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">18,688<span></span>
</td>
<td class="nump">103,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AdjustmentIncomeLossFromEquityMethodInvestments', window );">Equity investment income, net</a></td>
<td class="num">(2,924)<span></span>
</td>
<td class="num">(9,482)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash charges, net</a></td>
<td class="nump">3,979<span></span>
</td>
<td class="nump">5,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(224,274)<span></span>
</td>
<td class="num">(32,966)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(5,303)<span></span>
</td>
<td class="nump">1,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets', window );">Other receivables and prepaid and other current assets</a></td>
<td class="nump">13,756<span></span>
</td>
<td class="num">(24,965)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(6,521)<span></span>
</td>
<td class="nump">2,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(75,504)<span></span>
</td>
<td class="num">(24,045)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(126,330)<span></span>
</td>
<td class="num">(96,428)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">26,970<span></span>
</td>
<td class="nump">3,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="nump">62,719<span></span>
</td>
<td class="num">(32,616)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(11,793)<span></span>
</td>
<td class="nump">709<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">154,304<span></span>
</td>
<td class="nump">360,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions of property and equipment</a></td>
<td class="num">(144,913)<span></span>
</td>
<td class="num">(154,942)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisitions</a></td>
<td class="num">(3,668)<span></span>
</td>
<td class="num">(34,107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from asset and business sales</a></td>
<td class="nump">16,337<span></span>
</td>
<td class="nump">31,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchase of debt investments held-to-maturity</a></td>
<td class="num">(5,349)<span></span>
</td>
<td class="num">(5,049)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities', window );">Purchase of other debt and equity investments</a></td>
<td class="num">(1,779)<span></span>
</td>
<td class="num">(2,633)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Proceeds from debt investments held-to-maturity</a></td>
<td class="nump">5,349<span></span>
</td>
<td class="nump">5,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from sale of other debt and equity investments</a></td>
<td class="nump">11,879<span></span>
</td>
<td class="nump">3,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investments</a></td>
<td class="num">(3,200)<span></span>
</td>
<td class="num">(6,174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Distributions from equity method investments</a></td>
<td class="nump">978<span></span>
</td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(124,366)<span></span>
</td>
<td class="num">(162,625)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Borrowings</a></td>
<td class="nump">1,606,969<span></span>
</td>
<td class="nump">570,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Payments on long-term debt</a></td>
<td class="num">(698,298)<span></span>
</td>
<td class="num">(104,592)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred financing costs</a></td>
<td class="num">(8,346)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="num">(316,250)<span></span>
</td>
<td class="num">(321,798)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDistributionsToAffiliates', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(53,867)<span></span>
</td>
<td class="num">(58,131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net (payments) receipts related to stock purchases and awards</a></td>
<td class="num">(2,524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Net (payments) receipts related to stock purchases and awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">10,689<span></span>
</td>
<td class="nump">9,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchases of noncontrolling interests</a></td>
<td class="num">(1,095)<span></span>
</td>
<td class="num">(700)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">537,278<span></span>
</td>
<td class="nump">96,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(7,966)<span></span>
</td>
<td class="num">(14,978)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">559,250<span></span>
</td>
<td class="nump">279,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash of continuing operations at beginning of the year</a></td>
<td class="nump">501,790<span></span>
</td>
<td class="nump">1,208,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash of continuing operations at end of the year</a></td>
<td class="nump">1,061,040<span></span>
</td>
<td class="nump">1,488,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 559,250<span></span>
</td>
<td class="nump">$ 279,770<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdjustmentIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's proportionate share for the period of the undistributed net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdjustmentIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtRefinancingCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt refinancing charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtRefinancingCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in other current receivables and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDistributionsToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDistributionsToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720668015816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY (unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Non- controlling interests subject to put provisions</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Treasury stock</div></th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Non- controlling interests not subject to put provisions</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, start balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,180,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,566)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(255)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,228,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,133,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">$ 749,043<span></span>
</td>
<td class="nump">$ 1,431,738<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (47,498)<span></span>
</td>
<td class="nump">$ 185,833<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to DaVita Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (93,027)<span></span>
</td>
<td class="num">(93,027)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,027)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(320)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(320)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,565)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(303,139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (303,139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,052)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,947,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">720,053<span></span>
</td>
<td class="nump">1,671,331<span></span>
</td>
<td class="num">$ (303,139)<span></span>
</td>
<td class="num">(140,525)<span></span>
</td>
<td class="nump">185,498<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,052)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, start balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,330,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,259)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,349,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,566,752<span></span>
</td>
<td class="nump">1,383,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">597,073<span></span>
</td>
<td class="nump">852,537<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(66,154)<span></span>
</td>
<td class="nump">183,186<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">109,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to DaVita Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (56,629)<span></span>
</td>
<td class="num">(56,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,608)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(889)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(889)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,297)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,297)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(322,333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (322,333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 1,433,215<span></span>
</td>
<td class="nump">$ 1,248,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 603,172<span></span>
</td>
<td class="nump">$ 1,089,940<span></span>
</td>
<td class="num">$ (322,333)<span></span>
</td>
<td class="num">$ (122,783)<span></span>
</td>
<td class="nump">$ 185,109<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="nump">107,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestIncreaseFromContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest increase from contributions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestIncreaseFromContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasePurchaseOfInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease Purchase Of Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasePurchaseOfInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720660639576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed consolidated interim financial statements Condensed consolidated interim financial statements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</a></td>
<td class="text">Condensed consolidated interim financial statementsThe unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, certain fair value estimates and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (2020 10-K). Prior period classifications have been conformed to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662772072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition [Text Block]</a></td>
<td class="text">Revenue recognition<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's segment revenues by primary payor source:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">835,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">886,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">825,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,562,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,126&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,820,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,584,381&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256,856&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,841,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the &#8220;Other government&#8221; category to the &#8220;Medicare and Medicare Advantage&#8221; category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the three months ended March 31, 2020 has also been recast to conform to the current period presentation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant uncertainties associated with estimating revenue, which generally take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is </span></div>maintained for the Company&#8217;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.Other revenues. Other revenues consist of fees for management and administrative support services provided to outpatient dialysis businesses that the Company does not own or in which the Company owns a noncontrolling interest as well as revenues associated with the Company's non-dialysis ancillary services. Revenues associated with dialysis management services, integrated care services, clinical research programs, physician services, and end stage renal disease (ESRD) seamless care organizations are estimated and recognized in the period services are provided.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720660884376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share [Text Block]</a></td>
<td class="text">Earnings per share<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"/><td style="width:66.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.489%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,593&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic net income attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.92&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted net income attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662398856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in debt and equity securities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments in debt and equity securities</a></td>
<td class="text">Short-term and long-term investments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.465%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in mutual funds and common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,839&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,060&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,884&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,951&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held to maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#8217;s non-qualified deferred compensation plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720660707400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill by reportable segments were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"><tr><td style="width:1.0%"/><td style="width:39.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.145%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,287,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,787,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,891,209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,021,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,281&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,891,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not recognize any goodwill impairment charges during the three months ended March 31, 2021 and 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of the dynamic and evolving COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the ultimate severity and duration of the pandemic, further spread or resurgence of the virus (including as a result of the emergence of new strains of the virus), its impact on the chronic kidney disease (CKD) patient population and the Company's patient population, the availability, acceptance, impact and efficacy of COVID-19 vaccines and other treatments, or therapies, the pandemic&#8217;s continuing impact on the U.S. and global economies and unemployment, the responses of the Company's competitors to the pandemic and related changes in the marketplace, and the timing, scope and effectiveness of federal, state and local governmental responses. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.</span></div>Developments, events, changes in operating performance and other changes in circumstances since the dates of the Company&#8217;s last annual goodwill impairment assessments have not caused management to believe it is more likely than not that the fair values of any of the Company's reporting units would be less than their respective carrying amounts as of March&#160;31, 2021. Except for the Company's Germany kidney care reporting unit as described further in Note 10 to the Company's consolidated financial statements included in the 2020 10-K, none of the Company's various other reporting units were considered at risk of significant goodwill impairment as of March&#160;31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662311752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term debt</a></td>
<td class="text">Long-term debt<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,662,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.50% </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,666,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,708,836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,715,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,698,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,801,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,436,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition obligations and other notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021-2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">289,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022-2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,063,191&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,163,521&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount, premium and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,997,956&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,085,804&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(168,191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(168,541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,829,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,917,263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of March&#160;31, 2021.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">As of March&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities includes a discount of $5,212 and deferred financing costs of $33,650 and the carrying amount of the Company's senior notes includes a premium of $(17,327) and deferred financing costs of $43,700. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities included a discount of $5,461 and deferred financing costs of $35,825, and the carrying amount of the Company's senior notes included deferred financing costs of $36,431.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first three months of 2021, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $21,875 on Term Loan A and $6,858 on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2021, the Company completed an unregistered add-on offering of $1,000,000 aggregate principal amount to the existing 4.625% senior notes due June&#160;1, 2030 (the Additional 2030 Notes) pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Additional 2030 Notes were issued at an offering price of 101.750% of face amount, plus an interest payment advance to the Company for interest that would have accrued from December 1, 2020 (the last interest payment date) through the closing date. These Additional 2030 Notes will then bear full six months' semi-annual coupon interest payments beginning June 1, 2021. The terms of the Additional 2030 Notes, other than their issue date, offering price and first interest payment date, are identical to the terms of the $1,750,000 principal amount of the Company&#8217;s 4.625% Senior Notes due June 1, 2030 previously issued by the Company on June 9, 2020. The Additional 2030 Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. During the three months ended March&#160;31, 2021, the Company incurred $8,346 in fees and other professional expenses associated with this transaction, which were capitalized and will amortize over the term of the Additional </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2030 Notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company's 2019 interest rate cap agreements have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on equivalent amounts of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $871,336 outstanding principal balance of Term Loan A is subject to LIBOR-based interest rate volatility. These cap agreements are designated as cash flow hedges and, as a result, changes in the fair values of the cap agreements are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit risk-contingent features.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of March&#160;31, 2021 and December&#160;31, 2020, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:17.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended <br/>March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 for further details on amounts reclassified from accumulated other comprehensive loss and recorded as debt expense related to the Company&#8217;s interest rate cap agreements for the three months ended March&#160;31, 2021 and 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of the first quarter of 2021 was 1.97%, based on the current margins in effect for Term Loan A and Term Loan B-1 as of March&#160;31, 2021, as described above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s overall weighted average effective interest rate for the three months ended March&#160;31, 2021 was 3.08% and as of March&#160;31, 2021 was 3.18%.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company&#8217;s interest rates were fixed on approximately 51% of its total debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had an undrawn $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this facility is reduced by the amount of any letters of credit outstanding under this facility, but there were no such letters of credit outstanding as of March&#160;31, 2021. The Company also had approximately $64,650 of outstanding letters of credit under a separate bilateral secured letter of credit facility as of March&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720660678232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Contingencies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">contingencies</span><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from qui tam suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of March&#160;31, 2021 and December&#160;31, 2020, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. The government&#8217;s investigation covers the period from January 1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government&#8217;s investigation and that included total monetary consideration of $63,700, as previously disclosed, of which $41,500 was an incremental cash payment and $22,200 was for amounts previously refunded, and all of which was previously accrued. The government&#8217;s investigation is ongoing with respect to issues related to DaVita Rx&#8217;s historic relationships with certain pharmaceutical manufacturers, and in July 2018 the Office of Inspector General (OIG) served the Company with a subpoena seeking additional documents and information relating to those relationships. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018 and May 2019, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2018 U.S. Attorney Florida Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2018, DaVita Labs received two CIDs from the U.S. Attorney&#8217;s Office, Middle District of Florida that were identical in nature but directed to the two different labs. According to the face of the CIDs, the U.S. Attorney&#8217;s Office is conducting an investigation as to whether the Company&#8217;s subsidiary submitted claims for blood, urine, and fecal testing, where there were insufficient test validation or stability studies to ensure accurate results, in violation of the FCA. In October 2018, DaVita Labs received a subpoena from the OIG in connection with this matter requesting certain patient records linked to clinical laboratory tests. On September 30, 2019, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Middle District of Florida, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Lorne Holland, et al. v. DaVita Healthcare Partners, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The court then unsealed the complaint, which alleges violations of the FCA, by order dated the same day. In January 2020, the private party relators served the Company and DaVita Labs with an amended complaint. On February 24, 2020, the Company and DaVita Labs filed a motion to dismiss the amended complaint. On June 25, 2020, the court denied the motion to dismiss. The Company and DaVita Labs answered the complaint on July 23, 2020. The Company and DaVita Labs dispute these allegations and intend to defend this action accordingly.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020. The subpoena, as revised, requests information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is cooperating with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to a False Claims Act investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to qui tam complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder and Derivative Claims</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Peace Officers&#8217; Annuity and Benefit Fund of Georgia Securities Class Action Civil Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On February 1, 2017, the Peace Officers&#8217; Annuity and Benefit Fund of Georgia filed a putative federal securities class action complaint in the U.S. District Court for the District of Colorado against the Company and certain executives.&#160;The complaint covers the time period of August 2015 to October 2016 and alleges, generally, that the Company and its executives violated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal securities laws concerning the Company&#8217;s financial results and revenue derived from patients who received charitable premium assistance from an industry-funded non-profit organization.&#160;The complaint further alleges that the process by which patients obtained commercial insurance and received charitable premium assistance was improper and "created a false impression of DaVita&#8217;s business and operational status and future growth prospects."&#160;In November 2017, the court appointed the lead plaintiff and an amended complaint was filed on January 12, 2018. On March 27, 2018, the Company and various individual defendants filed a motion to dismiss. On March 28, 2019, the court denied the motion to dismiss. The Company answered the complaint on May 28, 2019. On January 31, 2020, the plaintiffs filed a motion for class certification and the Company filed its opposition on June 29, 2020. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company continues to dispute the allegations, in July 2020, it reached an agreement in principle to resolve this matter without admitting to any liability.&#160;Settlement of this matter was covered primarily with insurance proceeds. The Company contributed an amount that did not have a material impact on the Company&#8217;s consolidated financial position, results of operations or cash flows. On April 13, 2021, the court granted final approval of the settlement. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">In re DaVita Inc. Stockholder Derivative Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On August 15, 2017, the U.S. District Court for the District of Delaware consolidated three previously disclosed shareholder derivative lawsuits: the Blackburn Shareholder action filed on February 10, 2017, the Gabilondo Shareholder action filed on May 30, 2017, and the City of Warren Police and Fire Retirement System Shareholder action filed on June 9, 2017. The complaint covers the time period from 2015 to present and alleges, generally, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, corporate waste, and misrepresentations and/or failures to disclose certain information in violation of the federal securities laws in connection with an alleged practice to direct patients with government-subsidized health insurance into private health insurance plans to maximize the Company&#8217;s profits. An amended complaint was filed in September 2017, and on December 18, 2017, the Company filed a motion to dismiss and a motion to stay proceedings in the alternative. On April 25, 2019, the court denied the Company's motion to dismiss. The Company answered the complaint on May 28, 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the defendants continue to dispute the allegations, in July 2020, an agreement in principle was reached to resolve this matter without admitting to any liability. The Company&#8217;s Board of Directors (Board) approved the settlement on October </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20, 2020. The court approved the settlement on January 29, 2021. As part of the settlement, the Company agreed to certain corporate governance policies, but did not make any financial contribution towards the settlement.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the foregoing, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 7, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Noncontrolling interests subject to put provisions and other commitments</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated outpatient dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $8,449.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127163<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662163848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Long-term incentive compensation</a></td>
<td class="text">Shareholders' equity<div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company granted 706 restricted and performance stock units with an aggregate grant-date fair value of $77,279 and a weighted-average expected life of approximately 3.5 years and 132 stock-settled stock appreciation rights with an aggregate grant-date fair value of $4,250 and a weighted-average expected life of approximately 4.5 years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had $230,270 in total estimated but unrecognized stock-based compensation expense under the Company's equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.5 years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">Share repurchases</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's common stock repurchases during the three months ended March&#160;31, 2021 and 2020: </span></div><div style="margin-top:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"/><td style="width:27.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.774%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares repurchased</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount paid</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average paid per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares repurchased</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount paid</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average paid per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Open market repurchases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">322,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company repurchased 991 shares of its common stock for $108,892 at an average cost of $109.91 per share subsequent to March&#160;31, 2021 through April&#160;28, 2021. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on December 10, 2020, the Company's Board of Directors (Board) terminated all remaining prior share repurchase authorizations available to the Company and approved a new share repurchase authorization of $2,000,000. As of April&#160;28, 2021, the Company had a total of $1,498,730 available under the current authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company remains subject to share repurchase limitations including under the terms of its current senior secured credit facilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662392248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated other comprehensive (loss) income<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive income</a></td>
<td class="text">Accumulated other comprehensive loss<div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"/><td style="width:27.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,688)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,154)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,065)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,498)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,978)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,544)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,018)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,632)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(94,650)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,551)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116,232)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(122,783)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,828)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(127,697)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(140,525)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income. See Note 6 for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662281848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and divestitures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions and divestitures</a></td>
<td class="text">Acquisitions and divestitures<div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Routine acquisitions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company acquired dialysis businesses consisting of two dialysis centers located outside the U.S. for a total of $3,668 in net cash, contingent earn-out obligations of $538 and deferred purchase price and liabilities assumed of $1,094. The assets and liabilities for these acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#8217;s condensed consolidated financial statements, as are their operating results, from the designated effective dates of the acquisitions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial purchase price allocations for these transactions have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. In particular, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of intangibles, leases and certain other working capital items relating to several of these acquisitions are pending final quantification.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill deductible for tax purposes associated with acquisitions completed during the three months ended March&#160;31, 2021 was $5,456.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired companies a total of up to approximately $40,173 if certain performance targets or quality margins are met over the next one year to five years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. As of March&#160;31, 2021, the Company estimated the fair value of these contingent earn-out obligations to be $28,225, of which $11,613 is included in other current liabilities and the remaining $16,612 is included in other long-term liabilities in the Company&#8217;s consolidated balance sheet.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of changes in contingent earn-out obligations for the three months ended March&#160;31, 2021:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:74.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Discontinued operations</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company completed the sale of its DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. At close of the DMG sale, the Company's ultimate net sale proceeds remained subject to resolution of certain post-closing purchase price adjustments described in the equity purchase agreement, which adjustments were finalized in the fourth quarter of 2020. In the first quarter of 2020, the Company recognized $9,980 in additional tax benefits under the Coronavirus Aid, Relief, and Economic Security Act related to its period of DMG ownership, which were recognized as an adjustment to the Company's loss on sale of the DMG business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720661001528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable interest entities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable interest entities</a></td>
<td class="text">Variable interest entities (VIEs)At March&#160;31, 2021, these condensed consolidated financial statements include total assets of VIEs of $300,849 and total liabilities and noncontrolling interests of VIEs to third parties of $207,527. There have been no material changes in the nature of the Company's arrangements with VIEs or its judgments concerning them from those described in Note 23 to the Company's consolidated financial statements included in the 2020 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662380680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value of financial instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair value of financial instruments</a></td>
<td class="text">Fair values of financial instruments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equities that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2021:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:44.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted prices in<br/>active&#160;markets<br/>for identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the three months ended March&#160;31, 2021, see Note 10 and the consolidated statement of equity, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stock which are held within a trust to fund existing obligations associated with several of the Company's non-qualified deferred compensation plans. These investments are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 4 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA) and revenue. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value. See Note 10 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of March&#160;31, 2021, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $170,000. See Note 17 and Note 24 to the Company's consolidated financial statements included in the 2020 10-K for further discussion of the Company&#8217;s methodology for estimating the fair value of noncontrolling interests subject to put obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon bid and ask quotes for these instruments, typically a level 2 input. See Note 6 for further discussion of the Company's debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in these condensed consolidated financial statements at March&#160;31, 2021 at their approximate fair values due to the short-term nature of their settlements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720660827896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure</a></td>
<td class="text">Segment reporting<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its various ancillary services including its international operations (collectively, its ancillary services), and its corporate administrative support. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, each of its ancillary services, its kidney care operations in each foreign sovereign jurisdiction, its other health operations in each foreign sovereign jurisdiction, and its equity method investment in the Asia Pacific joint venture (APAC JV). The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other ancillary services operating segments, including the international operating segments, have been combined and disclosed in the other segments category. See Note 25 to the Company's consolidated financial statements included in the 2020 10-K for further description of how the Company determines and measures results for its operating segments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment net revenues, segment operating income (loss), and a reconciliation of segment operating income (loss) to consolidated income before income taxes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,556,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,579,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,583,203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,611,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,589,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,616,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,851,297&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,877,631&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,820,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,841,237&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,860)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">468,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488,961&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of segment operating income to consolidated income from continuing <br/>&#160;operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,444)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,014)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,603)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt refinancing charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,948)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Includes management fee revenue from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling equity investment or which are wholly-owned by third parties.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"><tr><td style="width:1.0%"/><td style="width:63.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.077%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.822%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,679&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of assets by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"><tr><td style="width:1.0%"/><td style="width:63.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.077%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.822%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,036,940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,344,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,610,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,647,268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,988,516&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for property and equipment by reportable segment were as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"><tr><td style="width:1.0%"/><td style="width:63.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.077%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.822%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,913&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,942&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662339896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New accounting standards<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Accounting Standards Update and Change in Accounting Principle</a></td>
<td class="text">New accounting standards<div style="margin-top:9pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards recently adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU No. 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU No. 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The adoption of ASU No. 2019-12 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=SL108384541-122693<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=d3e31137-122693<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720751468696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Condensed consolidated interim financial statements</a></td>
<td class="text">The unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, certain fair value estimates and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (2020 10-K). Prior period classifications have been conformed to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Short-term and Long-term Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held to maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's equity investments in mutual funds and common stock are held within a trust to fund existing obligations associated with several of the Company&#8217;s non-qualified deferred compensation plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Long-term debt</a></td>
<td class="text">These cap agreements are designated as cash flow hedges and, as a result, changes in the fair values of the cap agreements are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Accumulated other comprehensive Income</a></td>
<td class="text">The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA) and revenue. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards recently adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU No. 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU No. 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted for all entities. The adoption of ASU No. 2019-12 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662856280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Segment revenue by major payor (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_RevenuesbymajorpayorAbstract', window );"><strong>Revenues by major payor [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's segment revenues by primary payor source:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">835,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">886,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">825,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,562,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,126&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,820,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,584,381&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256,856&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,841,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenuesbymajorpayorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenues by major payor [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenuesbymajorpayorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720660858872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"/><td style="width:66.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.489%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,593&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic net income attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.92&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted net income attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662311752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in debt and equity securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.465%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in mutual funds and common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,839&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,060&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,884&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,951&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720660806904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill by Reportable Segments [Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill by reportable segments were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"><tr><td style="width:1.0%"/><td style="width:39.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.145%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,287,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,787,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,891,209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,021,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,281&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,891,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662748552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long-term Debt</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,662,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.50% </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,666,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,708,836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,715,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,698,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,801,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,436,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition obligations and other notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021-2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">289,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022-2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,063,191&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,163,521&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount, premium and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,997,956&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,085,804&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(168,191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(168,541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,829,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,917,263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of March&#160;31, 2021.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.09pt">As of March&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities includes a discount of $5,212 and deferred financing costs of $33,650 and the carrying amount of the Company's senior notes includes a premium of $(17,327) and deferred financing costs of $43,700. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities included a discount of $5,461 and deferred financing costs of $35,825, and the carrying amount of the Company's senior notes included deferred financing costs of $36,431.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of March&#160;31, 2021 and December&#160;31, 2020, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:17.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended <br/>March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662242520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share repurchases Share Repurchases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAbstract', window );"><strong>Treasury Stock, Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Class of Treasury Stock [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's common stock repurchases during the three months ended March&#160;31, 2021 and 2020: </span></div><div style="margin-top:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"/><td style="width:27.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.774%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares repurchased</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount paid</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average paid per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares repurchased</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount paid</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average paid per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Open market repurchases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">322,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662441608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated other comprehensive (loss) income (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Comprehensive income</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"/><td style="width:27.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,688)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,154)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,065)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,498)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,978)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,544)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,018)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,632)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(94,650)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,551)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116,232)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(122,783)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,828)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(127,697)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(140,525)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662327208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of changes in contingent earn-out obligations for the three months ended March&#160;31, 2021:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:74.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662441608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value of financial instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2021:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:44.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted prices in<br/>active&#160;markets<br/>for identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720660639016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment net revenues, segment operating income (loss), and a reconciliation of segment operating income (loss) to consolidated income before income taxes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,556,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,579,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,583,203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,611,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,589,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,616,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,851,297&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,877,631&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,820,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,841,237&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,860)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">468,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488,961&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of segment operating income to consolidated income from continuing <br/>&#160;operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,444)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,014)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,603)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt refinancing charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,948)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Includes management fee revenue from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling equity investment or which are wholly-owned by third parties.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Summary of Depreciation and Amortization Expense by Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"><tr><td style="width:1.0%"/><td style="width:63.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.077%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.822%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,679&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Summary of Assets by Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of assets by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"><tr><td style="width:1.0%"/><td style="width:63.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.077%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.822%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,036,940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,344,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,610,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,647,268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,988,516&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock', window );">Summary of Expenditures for Property and Equipment by Reportable Segment</a></td>
<td class="text">Expenditures for property and equipment by reportable segment were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.491%"><tr><td style="width:1.0%"/><td style="width:63.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.077%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.822%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,913&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,942&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of capital expenditures for property and equipment from segment to consolidated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720747215384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Segment Revenue by Payor (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 105,414<span></span>
</td>
<td class="nump">$ 127,956<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,820,001<span></span>
</td>
<td class="nump">2,841,237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(31,296)<span></span>
</td>
<td class="num">(36,394)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember', window );">Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">1,480,297<span></span>
</td>
<td class="nump">1,531,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">85,595<span></span>
</td>
<td class="nump">98,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember', window );">Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">187,243<span></span>
</td>
<td class="nump">171,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember', window );">Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">187,014<span></span>
</td>
<td class="nump">177,673<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember', window );">Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">886,977<span></span>
</td>
<td class="nump">865,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,034<span></span>
</td>
<td class="nump">10,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">17,837<span></span>
</td>
<td class="nump">23,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,562,875<span></span>
</td>
<td class="nump">2,584,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(27,003)<span></span>
</td>
<td class="num">(32,242)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">1,480,297<span></span>
</td>
<td class="nump">1,531,033<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">187,243<span></span>
</td>
<td class="nump">171,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">80,184<span></span>
</td>
<td class="nump">83,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">835,479<span></span>
</td>
<td class="nump">825,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,675<span></span>
</td>
<td class="nump">5,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">257,126<span></span>
</td>
<td class="nump">256,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(4,293)<span></span>
</td>
<td class="num">(4,152)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">85,595<span></span>
</td>
<td class="nump">98,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">106,830<span></span>
</td>
<td class="nump">94,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">51,498<span></span>
</td>
<td class="nump">39,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,034<span></span>
</td>
<td class="nump">10,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 11,162<span></span>
</td>
<td class="nump">$ 17,602<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720666160328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Numerators:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income from continuing operations attributable to DaVita Inc.</a></td>
<td class="nump">$ 237,403<span></span>
</td>
<td class="nump">$ 229,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net income from discontinued operations attributable to DaVita Inc.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 237,403<span></span>
</td>
<td class="nump">$ 239,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average shares outstanding during period</a></td>
<td class="nump">109,014,000<span></span>
</td>
<td class="nump">124,902,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Assumed incremental from stock plans</a></td>
<td class="nump">4,838,000<span></span>
</td>
<td class="nump">1,993,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares for diluted earnings per share calculation</a></td>
<td class="nump">113,852,000<span></span>
</td>
<td class="nump">126,895,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic net income from continuing operations</a></td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 1.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic net income (loss) from discontinued operations per share</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share attributable to DaVita Inc.</a></td>
<td class="nump">2.18<span></span>
</td>
<td class="nump">1.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income from continuing operations</a></td>
<td class="nump">2.09<span></span>
</td>
<td class="nump">1.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Diluted net income from discontinued operations per share</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to DaVita Inc.</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 1.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock-settled awards excluded from calculation</a></td>
<td class="nump">27,000<span></span>
</td>
<td class="nump">3,207,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720665797368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments in debt and equity securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">$ 8,221<span></span>
</td>
<td class="nump">$ 8,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">34,730<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">42,951<span></span>
</td>
<td class="nump">52,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesCurrent', window );">Debt securities, short-term investments</a></td>
<td class="nump">8,221<span></span>
</td>
<td class="nump">8,217<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total, short-term investments</a></td>
<td class="nump">11,060<span></span>
</td>
<td class="nump">20,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesNoncurrent', window );">Debt securities, long-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Total, long-term investments</a></td>
<td class="nump">31,891<span></span>
</td>
<td class="nump">32,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember', window );">Certificates of deposit and other time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">8,221<span></span>
</td>
<td class="nump">8,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">8,221<span></span>
</td>
<td class="nump">8,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember', window );">Investments in mutual funds and common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">34,730<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">34,730<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">2,839<span></span>
</td>
<td class="nump">11,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Long-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 31,891<span></span>
</td>
<td class="nump">$ 32,193<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720667238120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Changes in Goodwill by Reportable Segments (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 6,919,109<span></span>
</td>
<td class="nump">$ 6,787,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">5,456<span></span>
</td>
<td class="nump">130,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="num">(33,356)<span></span>
</td>
<td class="nump">9,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,891,209<span></span>
</td>
<td class="nump">6,919,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, before accumulated impairment charges</a></td>
<td class="nump">7,021,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">(130,573)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,891,209<span></span>
</td>
<td class="nump">6,919,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">6,309,928<span></span>
</td>
<td class="nump">6,287,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,309,928<span></span>
</td>
<td class="nump">6,309,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, before accumulated impairment charges</a></td>
<td class="nump">6,309,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,309,928<span></span>
</td>
<td class="nump">6,309,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">609,181<span></span>
</td>
<td class="nump">500,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">5,456<span></span>
</td>
<td class="nump">105,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="num">(33,356)<span></span>
</td>
<td class="nump">9,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">581,281<span></span>
</td>
<td class="nump">609,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, before accumulated impairment charges</a></td>
<td class="nump">711,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">(130,573)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 581,281<span></span>
</td>
<td class="nump">$ 609,181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720663391944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember', window );">Other Health Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Reportable Segments | segment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720741264472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 26, 2021</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt principal outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,063,191<span></span>
</td>
<td class="nump">$ 8,163,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DiscountAndDeferredFinanceCosts', window );">Discount and deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65,235)<span></span>
</td>
<td class="num">(77,717)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Carrying amount of long-term debt, net of unamortized discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,997,956<span></span>
</td>
<td class="nump">8,085,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168,191)<span></span>
</td>
<td class="num">(168,541)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,829,765<span></span>
</td>
<td class="nump">7,917,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,801,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember', window );">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 15,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,436,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Acquisition obligations and other notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayable', window );">Acquisition obligations and other notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152,531<span></span>
</td>
<td class="nump">164,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021-2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue', window );">Acquisition obligations and other notes payable, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember', window );">Financing lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 289,324<span></span>
</td>
<td class="nump">274,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2022-2038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR + 1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,662,500<span></span>
</td>
<td class="nump">1,684,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR + 1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,666,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,708,836<span></span>
</td>
<td class="nump">2,715,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR + 1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,698,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, table footnotes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,212<span></span>
</td>
<td class="nump">5,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,650<span></span>
</td>
<td class="nump">35,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, table footnotes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt Instrument, Unamortized Premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,700<span></span>
</td>
<td class="nump">$ 36,431<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition Obligations And Other Notes Payable, Fair Value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DiscountAndDeferredFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount, premium and deferred finance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DiscountAndDeferredFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011391&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720667360008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt Schedule of Derivative Instruments (Details) - 2019 Interest Rate Cap Agreements Effective June 30, 2020 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInceptionDates', window );">Derivative, effective date</a></td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeMaturityDates', window );">Derivative, expiration date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other Long-term Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">$ 9,176<span></span>
</td>
<td class="nump">$ 2,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember', window );">Debt Expense | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of debt expense reclassified from accumulated OCI into income</a></td>
<td class="nump">1,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</a></td>
<td class="nump">6,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember', window );">Term Loan Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts of interest rate agreements</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest rate margin</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInceptionDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the entity entered into the derivative contract, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInceptionDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeMaturityDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the derivative contract matures, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeMaturityDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720667511832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 26, 2021</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average effective interest rate at quarter end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average effective interest rate during quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Percentage of debt instruments bearing fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AdditionalDebtPrincipalAmountDueToNewAgreement', window );">Additional Debt Principal Amount Due To New Agreement</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount', window );">Debt Instrument Offering Price Percentage Of Face Amount</a></td>
<td class="nump">101.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Debt Instrument related fees, discounts, and other professional expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average effective interest rate during quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity on the revolving credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=dva_BilateralSecuredLetterOfCreditFacilityMember', window );">Bilateral Secured Letter Of Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 871,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average effective interest rate at quarter end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdditionalDebtPrincipalAmountDueToNewAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Debt Principal Amount Due To New Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdditionalDebtPrincipalAmountDueToNewAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Offering Price as Percentage Of Face Amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtInstrumentOfferingPricePercentageOfFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=dva_BilateralSecuredLetterOfCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=dva_BilateralSecuredLetterOfCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720665969640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 15, 2017</div></th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CorporateIntegrityAgreementPeriod', window );">Corporate Integrity Agreement Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CorporateIntegrityAgreementExpirationDate', window );">Corporate Integrity Agreement Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 22,  2019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember', window );">Commitments to provide operating capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Other potential commitments to provide operating capital to several dialysis centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember', window );">US Attorney Prescription Drug Investigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation Settlement, Amount Awarded to Other Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=dva_StockholderDerivativeLitigationMember', window );">Stockholder Derivative Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne', window );">Loss Contingency Number of Previously Disclosed Lawsuits Consolidated Into One</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember', window );">Incremental Cash Portion | US Attorney Prescription Drug Investigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation Settlement, Amount Awarded to Other Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember', window );">Cash Paid For Portion Previously Refunded | US Attorney Prescription Drug Investigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation Settlement, Amount Awarded to Other Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CorporateIntegrityAgreementExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Integrity Agreement Expiration Date, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CorporateIntegrityAgreementExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CorporateIntegrityAgreementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Integrity Agreement Period, in PnYnMnDn format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CorporateIntegrityAgreementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of Lawsuits Consolidated Into One.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=dva_StockholderDerivativeLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=dva_StockholderDerivativeLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720741644376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term incentive compensation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</a></td>
<td class="nump">$ 230,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</a></td>
<td class="text">1 year 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units and Performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares</a></td>
<td class="nump">706,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted', window );">Aggregate grant-date fair value</a></td>
<td class="nump">$ 77,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected life (in years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares</a></td>
<td class="nump">132,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted', window );">Aggregate grant-date fair value</a></td>
<td class="nump">$ 4,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected life (in years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, grant date fair value of options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720663460744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share repurchases Share Repurchase Table (Details) - Open Market Purchases - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">2,949<span></span>
</td>
<td class="nump">4,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="nump">$ 322,333<span></span>
</td>
<td class="nump">$ 303,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury Stock Acquired, Average Cost Per Share</a></td>
<td class="nump">$ 109.28<span></span>
</td>
<td class="nump">$ 74.81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720668168872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share repurchases (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 28, 2021</div></th>
<th class="th"><div>Dec. 10, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount', window );">Terminated Remaining Prior Share Repurchases Authorized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="nump">$ 108,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury Stock Acquired, Average Cost Per Share</a></td>
<td class="nump">$ 109.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 1,498,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Terminated Remaining Prior Share Repurchases Authorized, Amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720741624072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated other comprehensive (loss) income (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">$ (66,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(122,783)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(12,466)<span></span>
</td>
<td class="num">$ (1,433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Unrealized gains (losses)</a></td>
<td class="nump">6,505<span></span>
</td>
<td class="num">(17,346)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax benefit</a></td>
<td class="num">(1,623)<span></span>
</td>
<td class="nump">4,328<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Unrealized (losses) gains net</a></td>
<td class="nump">4,882<span></span>
</td>
<td class="num">(13,018)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification into net income</a></td>
<td class="nump">1,377<span></span>
</td>
<td class="nump">2,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="num">(344)<span></span>
</td>
<td class="num">(540)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(6,551)<span></span>
</td>
<td class="num">(12,828)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(53,688)<span></span>
</td>
<td class="num">(46,065)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Unrealized gains (losses)</a></td>
<td class="num">(62,544)<span></span>
</td>
<td class="num">(81,632)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Unrealized (losses) gains net</a></td>
<td class="num">(62,544)<span></span>
</td>
<td class="num">(81,632)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification into net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(116,232)<span></span>
</td>
<td class="num">(127,697)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(66,154)<span></span>
</td>
<td class="num">(47,498)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Unrealized gains (losses)</a></td>
<td class="num">(56,039)<span></span>
</td>
<td class="num">(98,978)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax benefit</a></td>
<td class="num">(1,623)<span></span>
</td>
<td class="nump">4,328<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Unrealized (losses) gains net</a></td>
<td class="num">(57,662)<span></span>
</td>
<td class="num">(94,650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification into net income</a></td>
<td class="nump">1,377<span></span>
</td>
<td class="nump">2,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="num">(344)<span></span>
</td>
<td class="num">(540)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">$ (122,783)<span></span>
</td>
<td class="num">$ (140,525)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720664110216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and divestitures Contingent Earn-out obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent Earn-out Obligations, Beginning balance</a></td>
<td class="nump">$ 30,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Acquisitions</a></td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations', window );">Foreign currency translation</a></td>
<td class="num">(2,080)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss', window );">Fair value remeasurements</a></td>
<td class="num">(214)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Payments</a></td>
<td class="num">(267)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent Earn-out Obligations, Ending balance</a></td>
<td class="nump">$ 28,225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Translation Adjustment For Contingent Earn-out Obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720667679000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and divestitures - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>clinic</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire businesses</a></td>
<td class="nump">$ 3,668<span></span>
</td>
<td class="nump">$ 34,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes associated with acquisitions</a></td>
<td class="nump">5,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Additional tax benefits recognized under the Coronavirus Aid, Relied, and Economic Security Act</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 9,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">11,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">16,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember', window );">Other companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">$ 28,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Other companies | EBITDA or Operating Income Performance Targets or Quality Margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Contingent earn-out obligations and liabilities assumed associated with acquisitions</a></td>
<td class="nump">$ 40,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Other companies | EBITDA or Operating Income Performance Targets or Quality Margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Dialysis and other businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire businesses</a></td>
<td class="nump">$ 3,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Contingent earn-out obligations and liabilities assumed associated with acquisitions</a></td>
<td class="nump">538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Deferred purchase price obligations</a></td>
<td class="nump">$ 1,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember', window );">Foreign Dialysis Centers | Dialysis and other businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | clinic</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition contingent consideration revenue earn-out period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720664157400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable interest entities - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 17,647,268<span></span>
</td>
<td class="nump">$ 16,988,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">14,864,893<span></span>
</td>
<td class="nump">$ 14,091,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">300,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">$ 207,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720666565304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 34,730<span></span>
</td>
<td class="nump">$ 44,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">34,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">28,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,349,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">9,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted prices in active&#160;markets&#160;for identical assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">34,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted prices in active&#160;markets&#160;for identical assets (Level 1) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant other observable&#160;inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant other observable&#160;inputs (Level 2) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">9,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">28,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,349,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662242520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value of financial instruments Fair Value of Financial Instruments (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple', window );">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</a></td>
<td class="nump">$ 170,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential increase decrease In fair value of Noncontrolling interests related to contractual Put obligations due to the change In Weighted Average EBITDA multiple.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720747299128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 105,414<span></span>
</td>
<td class="nump">$ 127,956<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,820,001<span></span>
</td>
<td class="nump">2,841,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">442,602<span></span>
</td>
<td class="nump">465,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SegmentReportingInformationCorporateExpenses', window );">Corporate administrative support</a></td>
<td class="num">(25,444)<span></span>
</td>
<td class="num">(23,585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="num">(67,014)<span></span>
</td>
<td class="num">(88,603)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtPrepaymentRefinancingRedemptionCharges', window );">Debt refinancing charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,948)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss), net</a></td>
<td class="nump">1,168<span></span>
</td>
<td class="num">(4,350)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from continuing operations before income taxes</a></td>
<td class="nump">376,756<span></span>
</td>
<td class="nump">369,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,562,875<span></span>
</td>
<td class="nump">2,584,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">257,126<span></span>
</td>
<td class="nump">256,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,851,297<span></span>
</td>
<td class="nump">2,877,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">468,046<span></span>
</td>
<td class="nump">488,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">2,583,203<span></span>
</td>
<td class="nump">2,611,181<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,589,878<span></span>
</td>
<td class="nump">2,616,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">479,906<span></span>
</td>
<td class="nump">491,607<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | External Sources</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">2,556,259<span></span>
</td>
<td class="nump">2,579,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,616<span></span>
</td>
<td class="nump">5,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">26,944<span></span>
</td>
<td class="nump">31,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">158,328<span></span>
</td>
<td class="nump">134,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">98,798<span></span>
</td>
<td class="nump">122,815<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">261,419<span></span>
</td>
<td class="nump">261,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(11,860)<span></span>
</td>
<td class="num">(2,646)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other&#8212;Ancillary services | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">4,293<span></span>
</td>
<td class="nump">4,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(31,296)<span></span>
</td>
<td class="num">(36,394)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(27,003)<span></span>
</td>
<td class="num">(32,242)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">$ (4,293)<span></span>
</td>
<td class="num">$ (4,152)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtPrepaymentRefinancingRedemptionCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment, refinancing and redemption charges related to long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtPrepaymentRefinancingRedemptionCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SegmentReportingInformationCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SegmentReportingInformationCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662154712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 165,701<span></span>
</td>
<td class="nump">$ 154,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">155,946<span></span>
</td>
<td class="nump">146,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 9,755<span></span>
</td>
<td class="nump">$ 8,379<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720751094232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment reporting - Summary of Assets by Segment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 17,647,268<span></span>
</td>
<td class="nump">$ 16,988,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">16,036,940<span></span>
</td>
<td class="nump">15,344,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 1,610,328<span></span>
</td>
<td class="nump">$ 1,643,869<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139720662071336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 144,913<span></span>
</td>
<td class="nump">$ 154,942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">133,804<span></span>
</td>
<td class="nump">148,763<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 11,109<span></span>
</td>
<td class="nump">$ 6,179<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>67
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MI&#.[!VS0V^$K=G\RM]]W(V+DO.Q$;%U=X-<MTM9UZ]-6O_#AI9SGVR?SY#
MK;_RO:WR:KF7.,YVT/K5X_E&)"SOP;P,B<420KW>(8PSG>_MY2=6;;+ML86R
M5B79X5KP4&CW -Q?*F6+$_>"<H?U[#]02P,$%     @ U8B=4H^,Y<H>!@
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MK/JZXFS)BQ( _W^44N\>R@G:7U/._@-02P,$%     @ U8B=4BJ1\ONX P
MT0H  !@   !X;"]W;W)K<VAE971S+W-H965T,RYX;6R-5E%OHS@0_BL6VH=6
MNBU@""%5$JE-LMI(VZ1JTM[#Z1X<< ):L'.VT^SNK[^QH30E#NH+8#/S^?O&
MX_$,CUS\E!FE"OTJ"R9'3J;4_M9U99+1DL@;OJ<,_FRY*(F"H=BY<B\H28U3
M6;C8\R*W)#ESQD,S]RC&0WY01<[HHT#R4)9$_+ZG!3^.'-]YFWC*=YG2$^YX
MN"<[NJ+J>?\H8.0V*&E>4B9SSI"@VY%SY]].?*P=C,5+3H_RY!MI*1O.?^K!
M/!TYGF9$"YHH#4'@]4HGM"@T$O#XKP9UFC6UX^GW&_HW(Q[$;(BD$U[\G:<J
M&SFQ@U*Z)8="/?'C=UH+ZFF\A!?2/-&QMO4<E!RDXF7M# S*G%5O\JL.Q(D#
MX-@=<.V VP[A!8>@=@B,T(J9D34EBHR'@A^1T-: IC],;(PWJ,F9WL:5$O W
M!S\UGBP7J^6/^?1N/9NBU1I>#[/%>H66W]!D^?#X-/L^6ZSF+S,T7\!XAJX.
MC!S27-'T&GU%SZLINOIRC;Z@G*%UQ@^2L%0.707,-+Z;U"SN*Q;X HL /7"F
M,HEF+*7I1W\7%#6R\)NL>]P)^$#$#0K\OQ#VL&_A,_F\N]=!)VBB'!B\X +>
M2A%%(?D5XELTX26<N$P?A5>*YBSA)47_W&VD$I#4_W8L%S;+A6:Y\,)R"SC^
MN<&U;47E&QE??<I?QWC@]\+>T'T]C9#%+.['@W>S#]1Z#;5>9R2>&12;(O]#
M4[2#(B/15<&EI/(:P9G.F:*"2H4$A LE9(_(3E 3.'G;$9>H63SJC,O%Q6UA
MJJ#Z)_K#.,:M()T;??4#SX_M0>HW//N=/)]H4A I\VV>$%WLI$X;!IO:T*]X
MZX!Q\^/R;O?/&/I>$+1D6(PB'-A%Q(V(^+/!KMG"#L.] X650643@K+D-X*<
M9[(P*FWLX_/X1K@7ABW^%K/8CP)L5S!H% PZ%2Q51@5*/AQ7+<5&='#.H!=%
M>- B:C$;!![NVXGZWGL5]SJIKKDB18OJY9RHP4YIX" <^%&+K<7.'X1Q="&]
M_9-+Q^^D^X-*>=LJA!5=1)02^>:@R*:@2&<WAWFF!"\ 9->4"/LEXUMV(?3#
M]JFUV84Q[,,%7?A=%^[4]2E%4_*2*Z(+_XU5!#XKO'[L]?OMG+?9A1$D74N$
M>](<E%3L3,\D(5<.3%47:C/;]&5WIAMIS=_K?LTT'>\P5;,'U^5.E].";@'2
MN^G#'2"J_JD:*+XW+<B&*VAHS&<&/2<5V@#^;SE7;P.]0-/%CO\'4$L#!!0
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M) $=X]WCL(J92-QR"1XR/#[RN)>Z4,C(GP=^=>9M;,>E(-;V<9@E&"+$H_.
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M=1RVI0E.?-EW0 0+(^*K,A*^6B$EJQ(VACOJ'7T(%FG*+9<Z<!)!M>ZIQ_@
M"1Z&Q&T%R&VJIQ<1X#Q)M]/^":.4L7$V<QAZGCT?T,"/=CY-T>2R/?K?GUU"
MX5ZI3?M>[@$J!EV[C_]M IP02A-AB788QC&)/.=7?$ %?PTJ+N5W"%0$9>1[
M5&\D"-?Y2E7UK]TAG'ER:G=0@;:MW/A<R&7(!(MB#SWX0 \>[I*\J;W4YO^E
M=VZW1 2Z;>OPP&G'B/ MY>#549A2N^<0\+8#*YPQ2JQ71:[3NCA.(L_+#3[P
MAX=;(ZNJZ$]I/9(CZRV;Y[C#9>D^[I@>O)%M7X?_(:O[K*RA,%_#4/P^@9FJ
MW1OFW871V^XE[9TV1A?=QXV2$-NM ?R^UMH\7[3O??OW_.?_ 5!+ P04
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MS=)@OZ(UAO1HH($NF:_@D(_DF/N([AP!*I0LYV.U]CE33TO75B!:!3?JZ$<
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M9M,1V/8!T6[(U.'27AGB)T#X+7DJHO4,?+XVAKJ-5]"_XI;_ E!+ P04
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MDND7X/M::]>_^ V&?TDN_P%02P,$%     @ U8B=4N80/M;8"@  AQT  !D
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M0O,$@//1C$,WIFD8:K8[Y,*^W<$XYTV$2 N[BL%YM=!^J2N#9(? /630DQ>
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;)U6VV[C-A#]E8$18%M
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M;#8O$V+BNQ(5IP]AEV^UPY<AB!T^Q6#\!?R^T^C[J'B"Z7%?_PM02P,$%
M  @ U8B=4N9;@-0B!P  8Q$  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N
M>&ULK5AK<]LV%OTK&*UG-YYA]+0=)6M[QH\VR4X]S>31?MC9#Q!Y*:$% 08
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M\%%%%18#36Z4C @N.,K@TG0%^!-KV2!*D/+9,) UJ1NUS>?*\0[PNSW[Y)A
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M);6+2]KQ%50J<JR9&R)"'@G3>2&4JR]6<6'8$Y<=Y5L;TBFA:7T#]\*0'<"
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MT'@P*@+0W;7=3:S:^JMRI2Q=O-YLZ*5#[3;0^EHI>YPX@O[MG/\+4$L#!!0
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MO$><[W$7#6YZ!K<//XQV)<%776!QZA^SQE9H>A"Z2"\"_A#V&OJ]+J1)VKN
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MVV2[7.#Z+K4CP/>Y4G9X<0K&/P0N_@-02P,$%     @ U8B=4K07QJQ6!@
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MNF$[WMIA^/XV@ *RZ,"5'@6FT;>K]*BA@C.V 29!6QM @8O4SD5S- ZONBF
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M/;"Y.R"'EZ4<T,@'[I8Y()+;*[T]PM%M@KO[JR:AOOU5 5 5=JCN#,7A=:D
M7(J!.V4!/!1OMR4HNKTP=H2N.5L1,<CYC+L]>T,"@"KVV!&TQ>202E4 )L7
M7;, &(JWZYI%MQGFF/E>.QA=,>KW]FFB\2/QL3 574H:MF<-4I;M60$L%4>R
M=%=A+8"98F!F"F"F.):9&P6O3BU@+$C;[08Q5SCMFF+<.%"C'ZUY=<ZH0+-L
MF:KU293Z;GV6Z;PZP=.Z?X$_7JY/)(&:]0&IZR"?1VF!8OFH53JGKD[8?'WF
M:'VALJ?JV,Y#IE265!\7,@AE7@KH[Q^S3&TOR@GJDU_3_P%02P,$%     @
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M6(3H(Y-  (C%,2MJ%#81MI\IC235#%&-?N94PB/$LJ@IK&Y#?A>/?G< [M>
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M3LL;+9;%V>!,:"W2XG+!:,2D60#O8P&?0-6-.6ZL#[#'_P)02P,$%     @
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MBP>5?8&>;R7M>?7 'I&;;ZCY/U!+ P04    " #5B)U2.8ESB-$#  "*#
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M*KN YI=2FNW .F@_/R9_ U!+ P04    " #5B)U28JU9"-,"  #\!@  &0
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MPQZUV) (GY)$^+@MDL6L?XN$#9#PB8&$+:#QPR!H+V&;W=C3&]4>Q09(^/1
MPD=MDBQ6_9LDO'<,=@HLX:,V23:KWDT2-G#"'P9.^*A-DLVJ=Y.$#:+P>Q%5
M!S@\WCD\?*L5V@P]UT?MSVYG[X@ZIV)9GMQ+G<H-4]79;O.T^77@NCP3;SV_
M@9>SZHS?A*E^<K@G8EDLV8PN=$CW(M3:1'6*7]THOBX/PN=<*9Z7ERM*$BH*
M _U^P;G:W10--+^E3/\'4$L#!!0    ( -6(G5+F.U\"R@(  $L'   9
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M$3X7;0C]#PA7-!I&[1"#!F)P&H)Q339,E(#MJ@!F2EV=?!O!H(6@TVT'&#8
MPY, "[8[JC=LT>L/VO5&C=[H_VH0+_,_"G#TH0#ID-+>7USA08,K0&>^C1N2
MJ%+:JM<UJ\U+,:L:Y/OVZIG!OH#WPA !*S2-K@=8C;IJW=7$JK5OETMEL?GZ
M88ZO'6BW ;^OE++[B1-HWL_I;U!+ P04    " #5B)U29 'AF.4$  "-$P
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MW697@10RX0&Z9T&FN'F&8C"'TO#WTG!WEL3?6Y+Q>.0>3G18)3KL3/0+)*!
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M*S<7@D^%*0;@^9G&]^)ZIUB,;1;?Q_\"4$L#!!0    ( -6(G5(P9M0V8P(
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MG0.=%XK*UR]<@.&E2_\ 4$L#!!0    ( -6(G5(JXE'3<@8  &D@   9
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M>1#&0+]?<*YV&Q/ _7,8_@%02P,$%     @ U8B=4EL/_SE[ @  [ 8  !D
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M*4F2+ LC@(45) F&P-.((Y@"T( A2=*>@P?G4;PYI^+M+T"37U!+ P04
M" #5B)U2EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M_R?5Y7QONC[^LOP^.7I[+S@'^)/@\0M02P,$%     @ U8B=4B%=IR;- 0
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M<',O87!P+GAM;%!+ 0(4 Q0    ( -6(G5)GKI!?[P   "L"   1
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M965T,BYX;6Q02P$"% ,4    " #5B)U2*I'R^[@#  #1"@  &
M    @(''$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
MU8B=4CMMT)^$!P  \Q\  !@              ("!M1<  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( -6(G5(!;UB"> ,  #H+   8
M          " @6\?  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    " #5B)U2*:TLY:@(  #5)@  &               @($=(P  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ U8B=4N )XY8S"   PR@
M !@              ("!^RL  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+
M 0(4 Q0    ( -6(G5)OC!9;A@0  $$+   8              " @60T  !X
M;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #5B)U2D23>D&@&
M   %#P  &               @($@.0  >&PO=V]R:W-H965T<R]S:&5E=#DN
M>&UL4$L! A0#%     @ U8B=4H/666Q@!   " L  !D              ("!
MOC\  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #5B)U2
MYRB;Z 4$  #1"0  &0              @(%51   >&PO=V]R:W-H965T<R]S
M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( -6(G5+,3ML+KP4  )X,   9
M      " @9%(  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ U8B=4N80/M;8"@  AQT  !D              ("!=TX  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " #5B)U2U B'\"06  !\00
M&0              @(&&60  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( -6(G5+:CO3^O 0   @,   9              " @>%O  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ U8B=4K@W<,^$
M P  Z <  !D              ("!U'0  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    " #5B)U2YEN U"('  !C$0  &0
M@(&/>   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( -6(
MG5(@;B84W (  %D&   9              " @>A_  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ U8B=4C)#FO3>"   NA<  !D
M         ("!^X(  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    " #5B)U2<&:6F=8&  "X$0  &0              @($0C   >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( -6(G5+([Z<WIP0  &4*
M   9              " @1V3  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ U8B=4GR')7:C"P  +!\  !D              ("!^Y<
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " #5B)U2,23(
MXLH#  !/"   &0              @('5HP  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( -6(G5+]U?UNK ,  /D(   9
M  " @=:G  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
MU8B=4AW_;ZI$ P  <P<  !D              ("!N:L  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    " #5B)U2\2($F50#  !'!P  &0
M            @($TKP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( -6(G5)DF1L7;@8   00   9              " @;^R  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ U8B=4L/SH8ZL @
M @8  !D              ("!9+D  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    " #5B)U2J(%O;"4#   &!P  &0              @(%'
MO   >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( -6(G5(G
M:GLSN@(  -L%   9              " @:._  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ U8B=4F/;.><B P  W08  !D
M     ("!E,(  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -6(G5*VMZ&E?P0  *@4   9              "
M@03;  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ U8B=
M4I56KZYV @  3P8  !D              ("!NM\  'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    " #5B)U2ORXDVX0'  #P)0  &0
M        @(%GX@  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( -6(G5*?1_E&Y ,  ( +   9              " @2+J  !X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ U8B=4A?J_FU1!0  S!8
M !D              ("!/>X  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    " #5B)U2.KH-0,0#  !/#0  &0              @('%\P
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( -6(G5(YB7.(
MT0,  (H,   9              " @<#W  !X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ U8B=4F*M60C3 @  _ 8  !D
M ("!R/L  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " #5
MB)U2$?)P[C4#  #U"   &0              @('2_@  >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( -6(G5)6$F]L&04  %<9   9
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M970T.2YX;6Q02P$"% ,4    " #5B)U2,&;4-F,"  #U!   &0
M    @('B%@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M -6(G5(JXE'3<@8  &D@   9              " @7P9 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ U8B=4E%S6IW- @  10@  !D
M             ("!)2 ! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    " #5B)U26P__.7L"  #L!@  &0              @($I(P$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( -6(G5(D>B'3U0(
M &8(   9              " @=LE 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ U8B=4AA@1GLB P  #A(   T              ( !
MYR@! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #5B)U2EXJ[',     3 @
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8;6Q02P4&     #X /@#I$   #38!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>213</ContextCount>
  <ElementCount>360</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>68</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Condensed consolidated interim financial statements Condensed consolidated interim financial statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements</Role>
      <ShortName>Condensed consolidated interim financial statements Condensed consolidated interim financial statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Revenue Recognition Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionRevenueRecognition</Role>
      <ShortName>Revenue Recognition Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Earnings per share (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.davita.com/role/EarningspershareNotes</Role>
      <ShortName>Earnings per share (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Investments in debt and equity securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Investmentsindebtandequitysecurities</Role>
      <ShortName>Investments in debt and equity securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113105 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2117106 - Disclosure - Long-term debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Longtermdebt</Role>
      <ShortName>Long-term debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2122107 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2124108 - Disclosure - Shareholders' equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Shareholdersequity</Role>
      <ShortName>Shareholders' equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - Accumulated other comprehensive (loss) income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Accumulatedothercomprehensivelossincome</Role>
      <ShortName>Accumulated other comprehensive (loss) income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2132110 - Disclosure - Acquisitions and divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Acquisitionsanddivestitures</Role>
      <ShortName>Acquisitions and divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2136111 - Disclosure - Variable interest entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Variableinterestentities</Role>
      <ShortName>Variable interest entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2138112 - Disclosure - Fair value of financial instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Fairvalueoffinancialinstruments</Role>
      <ShortName>Fair value of financial instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2142113 - Disclosure - Segment reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Segmentreporting</Role>
      <ShortName>Segment reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2148114 - Disclosure - New accounting standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Newaccountingstandards</Role>
      <ShortName>New accounting standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies</Role>
      <ShortName>Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Revenue Recognition Segment revenue by major payor (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables</Role>
      <ShortName>Revenue Recognition Segment revenue by major payor (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2308302 - Disclosure - Earnings per share Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningspershareEarningsPerShareTables</Role>
      <ShortName>Earnings per share Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2311303 - Disclosure - Investments in debt and equity securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables</Role>
      <ShortName>Investments in debt and equity securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Investmentsindebtandequitysecurities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2314304 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Goodwill</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2318305 - Disclosure - Long-term debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtTables</Role>
      <ShortName>Long-term debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Longtermdebt</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - Share repurchases Share Repurchases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SharerepurchasesShareRepurchasesTables</Role>
      <ShortName>Share repurchases Share Repurchases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2330307 - Disclosure - Accumulated other comprehensive (loss) income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables</Role>
      <ShortName>Accumulated other comprehensive (loss) income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Accumulatedothercomprehensivelossincome</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2333308 - Disclosure - Acquisitions and divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsanddivestituresTables</Role>
      <ShortName>Acquisitions and divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Acquisitionsanddivestitures</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2339309 - Disclosure - Fair value of financial instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairvalueoffinancialinstrumentsTables</Role>
      <ShortName>Fair value of financial instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Fairvalueoffinancialinstruments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2343310 - Disclosure - Segment reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingTables</Role>
      <ShortName>Segment reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Segmentreporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Revenue Recognition Segment Revenue by Payor (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails</Role>
      <ShortName>Revenue Recognition Segment Revenue by Payor (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails</Role>
      <ShortName>Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - Investments in debt and equity securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail</Role>
      <ShortName>Investments in debt and equity securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2415404 - Disclosure - Goodwill - Changes in Goodwill by Reportable Segments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail</Role>
      <ShortName>Goodwill - Changes in Goodwill by Reportable Segments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2416405 - Disclosure - Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillNarrativeDetails</Role>
      <ShortName>Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2419406 - Disclosure - Long-term debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtDetail</Role>
      <ShortName>Long-term debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/LongtermdebtTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2420407 - Disclosure - Long-term debt Schedule of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails</Role>
      <ShortName>Long-term debt Schedule of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - Long-term debt - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtAdditionalInformationDetail</Role>
      <ShortName>Long-term debt - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2423409 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2426410 - Disclosure - Long-term incentive compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermincentivecompensationDetails</Role>
      <ShortName>Long-term incentive compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2427411 - Disclosure - Share repurchases Share Repurchase Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails</Role>
      <ShortName>Share repurchases Share Repurchase Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/SharerepurchasesShareRepurchasesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2428412 - Disclosure - Share repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SharerepurchasesDetails</Role>
      <ShortName>Share repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/SharerepurchasesShareRepurchasesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2431413 - Disclosure - Accumulated other comprehensive (loss) income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail</Role>
      <ShortName>Accumulated other comprehensive (loss) income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2434414 - Disclosure - Acquisitions and divestitures Contingent Earn-out obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails</Role>
      <ShortName>Acquisitions and divestitures Contingent Earn-out obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2435415 - Disclosure - Acquisitions and divestitures - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail</Role>
      <ShortName>Acquisitions and divestitures - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2437416 - Disclosure - Variable interest entities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail</Role>
      <ShortName>Variable interest entities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2440417 - Disclosure - Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail</Role>
      <ShortName>Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2441418 - Disclosure - Fair value of financial instruments Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails</Role>
      <ShortName>Fair value of financial instruments Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2444419 - Disclosure - Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail</Role>
      <ShortName>Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2445420 - Disclosure - Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail</Role>
      <ShortName>Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2446421 - Disclosure - Segment reporting - Summary of Assets by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail</Role>
      <ShortName>Segment reporting - Summary of Assets by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="dva-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2447422 - Disclosure - Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail</Role>
      <ShortName>Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="dva-20210331.htm">dva-20210331.htm</File>
    <File>dva-20210331.xsd</File>
    <File>dva-20210331_cal.xml</File>
    <File>dva-20210331_def.xml</File>
    <File>dva-20210331_lab.xml</File>
    <File>dva-20210331_pre.xml</File>
    <File>dva-33121ex31110xq.htm</File>
    <File>dva-33121ex31210xq.htm</File>
    <File>dva-33121ex32110xq.htm</File>
    <File>dva-33121ex32210xq.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dva-20210331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>73
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dva-20210331.htm": {
   "axisCustom": 0,
   "axisStandard": 27,
   "contextCount": 213,
   "dts": {
    "calculationLink": {
     "local": [
      "dva-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dva-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "dva-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dva-20210331_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dva-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "dva-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 492,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 22,
    "http://www.davita.com/20210331": 2,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 29
   },
   "keyCustom": 27,
   "keyStandard": 333,
   "memberCustom": 30,
   "memberStandard": 38,
   "nsprefix": "dva",
   "nsuri": "http://www.davita.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.davita.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Earnings per share (Notes)",
     "role": "http://www.davita.com/role/EarningspershareNotes",
     "shortName": "Earnings per share (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Investments in debt and equity securities",
     "role": "http://www.davita.com/role/Investmentsindebtandequitysecurities",
     "shortName": "Investments in debt and equity securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113105 - Disclosure - Goodwill",
     "role": "http://www.davita.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117106 - Disclosure - Long-term debt",
     "role": "http://www.davita.com/role/Longtermdebt",
     "shortName": "Long-term debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122107 - Disclosure - Commitments and Contingencies",
     "role": "http://www.davita.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124108 - Disclosure - Shareholders' equity",
     "role": "http://www.davita.com/role/Shareholdersequity",
     "shortName": "Shareholders' equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - Accumulated other comprehensive (loss) income",
     "role": "http://www.davita.com/role/Accumulatedothercomprehensivelossincome",
     "shortName": "Accumulated other comprehensive (loss) income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132110 - Disclosure - Acquisitions and divestitures",
     "role": "http://www.davita.com/role/Acquisitionsanddivestitures",
     "shortName": "Acquisitions and divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136111 - Disclosure - Variable interest entities",
     "role": "http://www.davita.com/role/Variableinterestentities",
     "shortName": "Variable interest entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138112 - Disclosure - Fair value of financial instruments",
     "role": "http://www.davita.com/role/Fairvalueoffinancialinstruments",
     "shortName": "Fair value of financial instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142113 - Disclosure - Segment reporting",
     "role": "http://www.davita.com/role/Segmentreporting",
     "shortName": "Segment reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148114 - Disclosure - New accounting standards",
     "role": "http://www.davita.com/role/Newaccountingstandards",
     "shortName": "New accounting standards",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)",
     "role": "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies",
     "shortName": "Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Revenue Recognition Segment revenue by major payor (Tables)",
     "role": "http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables",
     "shortName": "Revenue Recognition Segment revenue by major payor (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308302 - Disclosure - Earnings per share Earnings Per Share (Tables)",
     "role": "http://www.davita.com/role/EarningspershareEarningsPerShareTables",
     "shortName": "Earnings per share Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311303 - Disclosure - Investments in debt and equity securities (Tables)",
     "role": "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables",
     "shortName": "Investments in debt and equity securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314304 - Disclosure - Goodwill (Tables)",
     "role": "http://www.davita.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318305 - Disclosure - Long-term debt (Tables)",
     "role": "http://www.davita.com/role/LongtermdebtTables",
     "shortName": "Long-term debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - Share repurchases Share Repurchases (Tables)",
     "role": "http://www.davita.com/role/SharerepurchasesShareRepurchasesTables",
     "shortName": "Share repurchases Share Repurchases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330307 - Disclosure - Accumulated other comprehensive (loss) income (Tables)",
     "role": "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables",
     "shortName": "Accumulated other comprehensive (loss) income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333308 - Disclosure - Acquisitions and divestitures (Tables)",
     "role": "http://www.davita.com/role/AcquisitionsanddivestituresTables",
     "shortName": "Acquisitions and divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339309 - Disclosure - Fair value of financial instruments (Tables)",
     "role": "http://www.davita.com/role/FairvalueoffinancialinstrumentsTables",
     "shortName": "Fair value of financial instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343310 - Disclosure - Segment reporting (Tables)",
     "role": "http://www.davita.com/role/SegmentreportingTables",
     "shortName": "Segment reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Revenue Recognition Segment Revenue by Payor (Details)",
     "role": "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
     "shortName": "Revenue Recognition Segment Revenue by Payor (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5a1a9b926a0d4f38a1427bdd4d8a03a8_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409402 - Disclosure - Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)",
     "role": "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails",
     "shortName": "Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412403 - Disclosure - Investments in debt and equity securities (Detail)",
     "role": "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail",
     "shortName": "Investments in debt and equity securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415404 - Disclosure - Goodwill - Changes in Goodwill by Reportable Segments (Detail)",
     "role": "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
     "shortName": "Goodwill - Changes in Goodwill by Reportable Segments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "if227b8854b5d464699191a415580aefe_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ic7ea4fefb3604f5383d022830fb054b2_D20210101-20210331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416405 - Disclosure - Goodwill - Narrative (Details)",
     "role": "http://www.davita.com/role/GoodwillNarrativeDetails",
     "shortName": "Goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ic7ea4fefb3604f5383d022830fb054b2_D20210101-20210331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419406 - Disclosure - Long-term debt (Detail)",
     "role": "http://www.davita.com/role/LongtermdebtDetail",
     "shortName": "Long-term debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ibfd9c5748c524a73b8cf26558b198cb0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInceptionDates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420407 - Disclosure - Long-term debt Schedule of Derivative Instruments (Details)",
     "role": "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
     "shortName": "Long-term debt Schedule of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ibfd9c5748c524a73b8cf26558b198cb0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInceptionDates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
     "shortName": "CONSOLIDATED BALANCE SHEETS (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongtermDebtWeightedAverageInterestRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - Long-term debt - Additional Information (Detail)",
     "role": "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
     "shortName": "Long-term debt - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtPercentageBearingFixedInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:CorporateIntegrityAgreementExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423409 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "role": "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:CorporateIntegrityAgreementExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426410 - Disclosure - Long-term incentive compensation (Details)",
     "role": "http://www.davita.com/role/LongtermincentivecompensationDetails",
     "shortName": "Long-term incentive compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427411 - Disclosure - Share repurchases Share Repurchase Table (Details)",
     "role": "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails",
     "shortName": "Share repurchases Share Repurchase Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i10c4791cf6ba4a86b77423645f037cbe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i8f9b78b5f5fc4575a3e804c564b6679b_I20201210",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428412 - Disclosure - Share repurchases (Details)",
     "role": "http://www.davita.com/role/SharerepurchasesDetails",
     "shortName": "Share repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i8f9b78b5f5fc4575a3e804c564b6679b_I20201210",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431413 - Disclosure - Accumulated other comprehensive (loss) income (Detail)",
     "role": "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
     "shortName": "Accumulated other comprehensive (loss) income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "id9a08055277f468fa3da1c205ef85947_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434414 - Disclosure - Acquisitions and divestitures Contingent Earn-out obligations (Details)",
     "role": "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails",
     "shortName": "Acquisitions and divestitures Contingent Earn-out obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ic18b74cd22f64bb6a271a9b6e6622ce0_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435415 - Disclosure - Acquisitions and divestitures - Additional Information (Detail)",
     "role": "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
     "shortName": "Acquisitions and divestitures - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437416 - Disclosure - Variable interest entities - Additional Information (Detail)",
     "role": "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail",
     "shortName": "Variable interest entities - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i79e508f7f8044bb5bcad2876847bcc76_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440417 - Disclosure - Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)",
     "role": "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
     "shortName": "Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i495ea84f47aa48bcbf441d81513cb962_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441418 - Disclosure - Fair value of financial instruments Fair Value of Financial Instruments (Details)",
     "role": "http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails",
     "shortName": "Fair value of financial instruments Fair Value of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444419 - Disclosure - Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail",
     "shortName": "Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:SegmentReportingInformationCorporateExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445420 - Disclosure - Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
     "shortName": "Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i83ace2d9a80b49a781f3dc1d05d81e8e_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446421 - Disclosure - Segment reporting - Summary of Assets by Segment (Detail)",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
     "shortName": "Segment reporting - Summary of Assets by Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i7f587b5b943b44b8b00940ad481105ea_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447422 - Disclosure - Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
     "shortName": "Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i2058335a1b7247e6a815bdb715707fbc_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ic075cfce513548e597924c070afcd2ae_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "ic075cfce513548e597924c070afcd2ae_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Condensed consolidated interim financial statements Condensed consolidated interim financial statements",
     "role": "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements",
     "shortName": "Condensed consolidated interim financial statements Condensed consolidated interim financial statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Revenue Recognition Revenue Recognition",
     "role": "http://www.davita.com/role/RevenueRecognitionRevenueRecognition",
     "shortName": "Revenue Recognition Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20210331.htm",
      "contextRef": "i5af01fc689b6433ba048ba2cb0109abe_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 68,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dva_A2019InterestRateCapAgreementsEffectiveJune302020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Interest Rate Cap Agreements Effective June 30, 2020.",
        "label": "2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]",
        "terseLabel": "2019 Interest Rate Cap Agreements Effective June 30, 2020"
       }
      }
     },
     "localname": "A2019InterestRateCapAgreementsEffectiveJune302020Member",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.",
        "label": "Acquisition Obligations And Other Notes Payable",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayable",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayableFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Obligations And Other Notes Payable, Fair Value.",
        "label": "Acquisition Obligations And Other Notes Payable, Fair Value",
        "terseLabel": "Acquisition obligations and other notes payable, fair value"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayableFairValue",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdditionalDebtPrincipalAmountDueToNewAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Debt Principal Amount Due To New Agreement",
        "label": "Additional Debt Principal Amount Due To New Agreement",
        "terseLabel": "Additional Debt Principal Amount Due To New Agreement"
       }
      }
     },
     "localname": "AdditionalDebtPrincipalAmountDueToNewAgreement",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdjustmentIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the entity's proportionate share for the period of the undistributed net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.",
        "label": "Adjustment Income Loss From Equity Method Investments",
        "negatedLabel": "Equity investment income, net"
       }
      }
     },
     "localname": "AdjustmentIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_BilateralSecuredLetterOfCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bilateral Secured Letter Of Credit",
        "label": "Bilateral Secured Letter Of Credit Facility [Member]",
        "terseLabel": "Bilateral Secured Letter Of Credit Facility"
       }
      }
     },
     "localname": "BilateralSecuredLetterOfCreditFacilityMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition contingent consideration revenue earn-out period.",
        "label": "Business Acquisition Contingent Consideration Revenue Earnout Period",
        "terseLabel": "Earn-out consideration payment period"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.",
        "label": "Business Combination Contingent Consideration Acquisitions",
        "verboseLabel": "Contingent earn-out obligations and liabilities assumed associated with acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitions",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss",
        "label": "Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss",
        "negatedTerseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_CashPaidForPortionPreviouslyRefundedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid For Amounts Previously Refunded [Member]",
        "label": "Cash Paid For Portion Previously Refunded [Member]",
        "terseLabel": "Cash Paid For Portion Previously Refunded"
       }
      }
     },
     "localname": "CashPaidForPortionPreviouslyRefundedMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit, commercial paper, and money market funds.",
        "label": "Certificates Of Deposit Commercial Paper And Money Market Funds [Member]",
        "terseLabel": "Certificates of deposit and other time deposits"
       }
      }
     },
     "localname": "CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CommercialPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Payors in healthcare industry.",
        "label": "Commercial Payors [Member]",
        "terseLabel": "Commercial Payors"
       }
      }
     },
     "localname": "CommercialPayorsMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CommitmentsToProvideOperatingCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments to provide operating capital.",
        "label": "Commitments To Provide Operating Capital [Member]",
        "terseLabel": "Commitments to provide operating capital"
       }
      }
     },
     "localname": "CommitmentsToProvideOperatingCapitalMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CorporateIntegrityAgreementExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Integrity Agreement Expiration Date, in CCYY-MM-DD format.",
        "label": "Corporate Integrity Agreement Expiration Date",
        "terseLabel": "Corporate Integrity Agreement Expiration Date"
       }
      }
     },
     "localname": "CorporateIntegrityAgreementExpirationDate",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_CorporateIntegrityAgreementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Integrity Agreement Period, in PnYnMnDn format.",
        "label": "Corporate Integrity Agreement Period",
        "terseLabel": "Corporate Integrity Agreement Period"
       }
      }
     },
     "localname": "CorporateIntegrityAgreementPeriod",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_DebtExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt expense.",
        "label": "Debt Expense [Member]",
        "terseLabel": "Debt Expense"
       }
      }
     },
     "localname": "DebtExpenseMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DebtInstrumentOfferingPricePercentageOfFaceAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Offering Price as Percentage Of Face Amount.",
        "label": "Debt Instrument Offering Price Percentage Of Face Amount",
        "terseLabel": "Debt Instrument Offering Price Percentage Of Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentOfferingPricePercentageOfFaceAmount",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_DebtPrepaymentRefinancingRedemptionCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt prepayment, refinancing and redemption charges related to long-term debt.",
        "label": "Debt Prepayment Refinancing Redemption Charges",
        "negatedLabel": "Debt refinancing charges",
        "negatedTerseLabel": "Debt refinancing charges"
       }
      }
     },
     "localname": "DebtPrepaymentRefinancingRedemptionCharges",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DebtRefinancingCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt refinancing charges.",
        "label": "Debt Refinancing Charges",
        "terseLabel": "Debt refinancing charges"
       }
      }
     },
     "localname": "DebtRefinancingCharges",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DiscountAndDeferredFinanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount, premium and deferred finance costs.",
        "label": "Discount And Deferred Finance Costs",
        "negatedLabel": "Discount and deferred financing costs"
       }
      }
     },
     "localname": "DiscountAndDeferredFinanceCosts",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EBITDA operating income performance targets or quality margins.",
        "label": "E B I T D A Operating Income Performance Targets Or Quality Margins [Member]",
        "terseLabel": "EBITDA or Operating Income Performance Targets or Quality Margins"
       }
      }
     },
     "localname": "EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ExternalSourcesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External sources.",
        "label": "External Sources [Member]",
        "terseLabel": "External Sources"
       }
      }
     },
     "localname": "ExternalSourcesMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease [Member]",
        "label": "Finance Lease [Member]",
        "verboseLabel": "Financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation Adjustment For Contingent Earn-out Obligations.",
        "label": "Foreign Currency Translation Adjustment For Contingent Earn Out Obligations",
        "negatedTerseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ForeignDialysisCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign dialysis and other medical businesses.",
        "label": "Foreign Dialysis Centers [Member]",
        "terseLabel": "Foreign Dialysis Centers"
       }
      }
     },
     "localname": "ForeignDialysisCentersMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in other current receivables and other current assets.",
        "label": "Increase Decrease In Other Current Receivables And Other Current Assets",
        "negatedLabel": "Other receivables and prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_IncrementalCashPortionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Cash Portion [Member]",
        "label": "Incremental Cash Portion [Member]",
        "terseLabel": "Incremental Cash Portion"
       }
      }
     },
     "localname": "IncrementalCashPortionMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_LossContingencyNumberofLawsuitsConsolidatedIntoOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of Lawsuits Consolidated Into One.",
        "label": "Loss Contingency Number of Lawsuits Consolidated Into One",
        "terseLabel": "Loss Contingency Number of Previously Disclosed Lawsuits Consolidated Into One"
       }
      }
     },
     "localname": "LossContingencyNumberofLawsuitsConsolidatedIntoOne",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "dva_MedicaidandManagedMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Managed Medicaid Member.",
        "label": "Medicaid and Managed Medicaid [Member]",
        "terseLabel": "Medicaid and Managed Medicaid"
       }
      }
     },
     "localname": "MedicaidandManagedMedicaidMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MedicareandMedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare and Medicare Advantage",
        "label": "Medicare and Medicare Advantage [Member]",
        "terseLabel": "Medicare and Medicare Advantage"
       }
      }
     },
     "localname": "MedicareandMedicareAdvantageMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MutualFundsAndCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual Funds And Common Stock [Member]",
        "label": "Mutual Funds And Common Stock [Member]",
        "terseLabel": "Investments in mutual funds and common stock"
       }
      }
     },
     "localname": "MutualFundsAndCommonStockMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_NoncontrollingInterestIncreaseFromContributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest increase from contributions.",
        "label": "Noncontrolling Interest Increase From Contributions",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromContributions",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_OpenMarketPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Purchases Member.",
        "label": "Open Market Purchases [Member]",
        "terseLabel": "Open Market Purchases"
       }
      }
     },
     "localname": "OpenMarketPurchasesMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other companies.",
        "label": "Other Companies [Member]",
        "terseLabel": "Other companies"
       }
      }
     },
     "localname": "OtherCompaniesMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherGovernmentPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other government payors in healthcare industry.",
        "label": "Other Government Payors [Member]",
        "terseLabel": "Other Government Payors"
       }
      }
     },
     "localname": "OtherGovernmentPayorsMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherReportingUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Reporting Units [Member]",
        "label": "Other Reporting Units [Member]",
        "terseLabel": "Other Health Operations"
       }
      }
     },
     "localname": "OtherReportingUnitsMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherSourcesofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).",
        "label": "Other Sources of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSourcesofRevenueMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_PatientCareCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.",
        "label": "Patient Care Costs",
        "terseLabel": "Patient care costs"
       }
      }
     },
     "localname": "PatientCareCosts",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential increase decrease In fair value of Noncontrolling interests related to contractual Put obligations due to the change In Weighted Average EBITDA multiple.",
        "label": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple",
        "terseLabel": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple"
       }
      }
     },
     "localname": "PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of capital expenditures for property and equipment from segment to consolidated.",
        "label": "Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]",
        "terseLabel": "Summary of Expenditures for Property and Equipment by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "label": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "terseLabel": "Dialysis patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_RevenuesbymajorpayorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues by major payor [Abstract]",
        "label": "Revenues by major payor [Abstract]",
        "terseLabel": "Revenues by major payor [Abstract]"
       }
      }
     },
     "localname": "RevenuesbymajorpayorAbstract",
     "nsuri": "http://www.davita.com/20210331",
     "xbrltype": "stringItemType"
    },
    "dva_SegmentReportingInformationCorporateExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.",
        "label": "Segment Reporting Information Corporate Expenses",
        "negatedLabel": "Corporate administrative support"
       }
      }
     },
     "localname": "SegmentReportingInformationCorporateExpenses",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SegmentRevenuebyMajorPayorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Revenue by Major Payor [Abstract]",
        "label": "Segment Revenue by Major Payor [Abstract]",
        "terseLabel": "Segment Revenue by Major Payor [Abstract]"
       }
      }
     },
     "localname": "SegmentRevenuebyMajorPayorAbstract",
     "nsuri": "http://www.davita.com/20210331",
     "xbrltype": "stringItemType"
    },
    "dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty member.",
        "label": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]",
        "terseLabel": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty"
       }
      }
     },
     "localname": "SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One.",
        "label": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]",
        "terseLabel": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One"
       }
      }
     },
     "localname": "SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorSecuredCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior secured credit facilities.",
        "label": "Senior Secured Credit Facilities [Member]",
        "terseLabel": "Senior Secured Credit Facilities"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilitiesMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, grant date fair value of options granted.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Grant Date Fair Value Of Options Granted",
        "terseLabel": "Aggregate grant-date fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_StockholderDerivativeLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholder Derivative Litigation [Member]",
        "label": "Stockholder Derivative Litigation [Member]",
        "terseLabel": "Stockholder Derivative Litigation"
       }
      }
     },
     "localname": "StockholderDerivativeLitigationMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TemporaryEquityDecreasePurchaseOfInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease Purchase Of Interests",
        "label": "Temporary Equity, Decrease Purchase Of Interests",
        "negatedTerseLabel": "Partial purchases"
       }
      }
     },
     "localname": "TemporaryEquityDecreasePurchaseOfInterests",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions"
       }
      }
     },
     "localname": "TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "label": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityRedeemableNoncontrollingInterestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests Temporary Equity [Member]",
        "label": "Temporary Equity Redeemable Noncontrolling Interests [Member]",
        "terseLabel": "Non- controlling interests subject to put provisions"
       }
      }
     },
     "localname": "TemporaryEquityRedeemableNoncontrollingInterestsMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan A.",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A"
       }
      }
     },
     "localname": "TermLoanAMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanB1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B-1.",
        "label": "Term Loan B-1 [Member]",
        "terseLabel": "Term Loan B-1"
       }
      }
     },
     "localname": "TermLoanB1Member",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terminated Remaining Prior Share Repurchases Authorized, Amount.",
        "label": "Terminated Remaining Prior Share Repurchases Authorized, Amount",
        "terseLabel": "Terminated Remaining Prior Share Repurchases Authorized, Amount"
       }
      }
     },
     "localname": "TerminatedRemainingPriorShareRepurchasesAuthorizedAmount",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_USAttorneyPrescriptionDrugInvestigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Attorney Prescription Drug Investigation [Member]",
        "label": "US Attorney Prescription Drug Investigation [Member]",
        "terseLabel": "US Attorney Prescription Drug Investigation"
       }
      }
     },
     "localname": "USAttorneyPrescriptionDrugInvestigationMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_USDialysisAndRelatedLabServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US dialysis \u200band \u200brelated \u200blab\u200b services\u200b.",
        "label": "U S Dialysis And Related Lab Services [Member]",
        "terseLabel": "U.S. dialysis"
       }
      }
     },
     "localname": "USDialysisAndRelatedLabServicesMember",
     "nsuri": "http://www.davita.com/20210331",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r359",
      "r360",
      "r365",
      "r366",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r359",
      "r360",
      "r365",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r171",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r191",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r171",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r191",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r297",
      "r299",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r297",
      "r299",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r286",
      "r297",
      "r299",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r286",
      "r297",
      "r299",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r17",
      "r31",
      "r202",
      "r203"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r27",
      "r467",
      "r490"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r66",
      "r73",
      "r76",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r68",
      "r73",
      "r76",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r70",
      "r72",
      "r73",
      "r493",
      "r518",
      "r521"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income Loss [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r69",
      "r73",
      "r76",
      "r127",
      "r128",
      "r129",
      "r364",
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r313",
      "r314",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r300",
      "r302",
      "r319",
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-settled stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r166",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other\u2014Ancillary services",
        "verboseLabel": "Other\u2014Ancillary services"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive stock-settled awards excluded from calculation"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r69",
      "r73",
      "r76",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "verboseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r122",
      "r179",
      "r186",
      "r193",
      "r211",
      "r359",
      "r365",
      "r409",
      "r465",
      "r489"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r19",
      "r20",
      "r61",
      "r122",
      "r211",
      "r359",
      "r365",
      "r409"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r304",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r381",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Condensed consolidated interim financial statements"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r296",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r296",
      "r298",
      "r337",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible for tax purposes associated with acquisitions"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r339",
      "r341",
      "r342",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Deferred purchase price obligations"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "auth_ref": [
      "r116",
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r116",
      "r349"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "periodEndLabel": "Contingent Earn-out Obligations, Ending balance",
        "periodStartLabel": "Contingent Earn-out Obligations, Beginning balance"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r340",
      "r343",
      "r346"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent earn-out obligations",
        "verboseLabel": "Contingent earn-out obligations"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r15",
      "r40",
      "r119"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r114",
      "r119",
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash of continuing operations at end of the year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash of continuing operations at beginning of the year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r114",
      "r412"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and contingencies:"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Noncontrolling interests subject to put provisions and other commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r30",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common Stock, Value, Issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r79",
      "r81",
      "r82",
      "r92",
      "r482",
      "r507"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to DaVita Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r79",
      "r81",
      "r91",
      "r355",
      "r356",
      "r370",
      "r481",
      "r506"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r79",
      "r81",
      "r90",
      "r354",
      "r370",
      "r480",
      "r505"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Comprehensive income:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r89",
      "r98",
      "r479",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Accumulatedothercomprehensivelossincome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Accumulated other comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r466",
      "r468",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "LIBOR plus interest rate margin"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r28",
      "r243",
      "r468",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Total debt principal outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.",
        "label": "Debt Instrument, Description of Variable Rate Basis",
        "terseLabel": "Debt Instrument, Description of Variable Rate Basis"
       }
      }
     },
     "localname": "DebtInstrumentDescriptionOfVariableRateBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r408"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Fair Value Disclosure [Abstract]",
        "terseLabel": "Debt Instrument, table footnotes"
       }
      }
     },
     "localname": "DebtInstrumentFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Debt Instrument related fees, discounts, and other professional expenses"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r49",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Debt interest rate during period",
        "verboseLabel": "Weighted average effective interest rate during quarter"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r50",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.",
        "label": "Debt Instrument, Maturity Date, Description",
        "terseLabel": "Debt instrument, maturity date, description"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r52",
      "r124",
      "r252",
      "r253",
      "r254",
      "r255",
      "r423",
      "r424",
      "r425",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r423",
      "r425"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r423",
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "negatedTerseLabel": "Debt Instrument, Unamortized Premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]",
        "terseLabel": "Senior Secured Credit Facilities"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r123",
      "r325",
      "r332",
      "r333",
      "r334"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r60",
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r117",
      "r232"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r373",
      "r374",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts of interest rate agreements"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r63",
      "r64",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r62",
      "r65",
      "r383",
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative asset, fair value, gross asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInceptionDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the entity entered into the derivative contract, in CCYY-MM-DD format.",
        "label": "Derivative, Inception Date",
        "terseLabel": "Derivative, effective date"
       }
      }
     },
     "localname": "DerivativeInceptionDates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r382",
      "r384",
      "r388",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r378",
      "r382",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r387",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "verboseLabel": "Amount of debt expense reclassified from accumulated OCI into income"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeMaturityDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the derivative contract matures, in CCYY-MM-DD format.",
        "label": "Derivative, Maturity Date",
        "terseLabel": "Derivative, expiration date"
       }
      }
     },
     "localname": "DerivativeMaturityDates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r372",
      "r375",
      "r376",
      "r378",
      "r380",
      "r386",
      "r388",
      "r392",
      "r394",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r121",
      "r126",
      "r372",
      "r375",
      "r378",
      "r380",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Long-term incentive compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Shareholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "terseLabel": "Diluted net income from discontinued operations per share"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r13",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Discontinued operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Acquisitionsanddivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r93",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r147",
      "r150",
      "r156",
      "r157",
      "r158",
      "r162",
      "r163",
      "r483",
      "r508"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income",
        "totalLabel": "Basic net income per share attributable to DaVita Inc."
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r93",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r150",
      "r156",
      "r157",
      "r158",
      "r162",
      "r163",
      "r483",
      "r508"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income",
        "totalLabel": "Diluted net income per share attributable to DaVita Inc."
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r121",
      "r159",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Numerators:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r133",
      "r141",
      "r143",
      "r165",
      "r212",
      "r251",
      "r256",
      "r313",
      "r314",
      "r315",
      "r326",
      "r327",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "verboseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r398",
      "r435",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r400",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Fairvalueoffinancialinstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r287",
      "r288",
      "r293",
      "r295",
      "r398",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted prices in active\u00a0markets\u00a0for identical assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r287",
      "r288",
      "r293",
      "r295",
      "r398",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant other observable\u00a0inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r398",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant unobservable inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r435",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r402",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r401",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r121",
      "r405",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r427",
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r428",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Finance lease, weighted average discount rate, percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r216",
      "r218",
      "r464"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency and other adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r219",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, before accumulated impairment charges"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r219",
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedTerseLabel": "Accumulated impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r117",
      "r217",
      "r222",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "terseLabel": "Divestitures"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "terseLabel": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Domain]",
        "terseLabel": "Health Care Organization, Revenue Sources [Domain]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r205",
      "r208",
      "r471"
     ],
     "calculation": {
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesCurrent": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as current.",
        "label": "Debt Securities, Held-to-maturity, Current",
        "terseLabel": "Debt securities, short-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesNoncurrent": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.",
        "label": "Debt Securities, Held-to-maturity, Noncurrent",
        "terseLabel": "Debt securities, long-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Amounts attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r95",
      "r118",
      "r136",
      "r137",
      "r138",
      "r139",
      "r155",
      "r158",
      "r353"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net income from continuing operations",
        "verboseLabel": "Net income from continuing operations attributable to DaVita Inc."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r125",
      "r179",
      "r185",
      "r189",
      "r192",
      "r195"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r122",
      "r132",
      "r179",
      "r185",
      "r189",
      "r192",
      "r195",
      "r211",
      "r354",
      "r409"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r84",
      "r93",
      "r132",
      "r136",
      "r137",
      "r138",
      "r139",
      "r150",
      "r156",
      "r157",
      "r475",
      "r477",
      "r483",
      "r501"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Basic net income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r84",
      "r93",
      "r132",
      "r136",
      "r137",
      "r138",
      "r139",
      "r150",
      "r156",
      "r157",
      "r158",
      "r483",
      "r501",
      "r504",
      "r508"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Diluted net income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r11",
      "r12",
      "r336",
      "r502"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income from discontinued operations, net of tax",
        "verboseLabel": "Additional tax benefits recognized under the Coronavirus Aid, Relied, and Economic Security Act"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r10",
      "r11",
      "r354"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net income from discontinued operations",
        "verboseLabel": "Net income from discontinued operations attributable to DaVita Inc."
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r87",
      "r93",
      "r154",
      "r156",
      "r157",
      "r483",
      "r502",
      "r504",
      "r508"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Basic net income (loss) from discontinued operations per share"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r86",
      "r117",
      "r176",
      "r210",
      "r476",
      "r500"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity investment income"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r142",
      "r143",
      "r177",
      "r324",
      "r331",
      "r335",
      "r509"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r57",
      "r472",
      "r499"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r158"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Assumed incremental from stock plans"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r229",
      "r230"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDebtExpense": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest and Debt Expense",
        "negatedLabel": "Debt expense"
       }
      }
     },
     "localname": "InterestAndDebtExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r171",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r191",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Elimination",
        "verboseLabel": "Elimination of intersegment revenues"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersubsegmentEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in subsegment consolidation.",
        "label": "Intersubsegment Eliminations [Member]",
        "terseLabel": "Intersubsegment Eliminations"
       }
      }
     },
     "localname": "IntersubsegmentEliminationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r16",
      "r59"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]",
        "terseLabel": "Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r523",
      "r533",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]",
        "terseLabel": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r534",
      "r535",
      "r538",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r534",
      "r535",
      "r538",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Equity method and other investments"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r209",
      "r462",
      "r486",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments in debt and equity securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Investmentsindebtandequitysecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r45",
      "r122",
      "r187",
      "r211",
      "r360",
      "r365",
      "r366",
      "r409"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r37",
      "r122",
      "r211",
      "r409",
      "r470",
      "r496"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r122",
      "r211",
      "r360",
      "r365",
      "r366",
      "r409"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r28",
      "r468",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term Line of Credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity on the revolving credit facilities"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation Settlement, Amount Awarded to Other Party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.davita.com/role/LongtermdebtDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.davita.com/role/LongtermdebtDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "negatedLabel": "Less current portion",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/LongtermdebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Carrying amount of long-term debt, net of unamortized discounts"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Percentage of debt instruments bearing fixed interest rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Longtermdebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r52",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Long-term debt, weighted average interest rate, at point in time",
        "verboseLabel": "Weighted average effective interest rate at quarter end"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r240",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r18",
      "r46"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short-term investments",
        "totalLabel": "Total, short-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term investments",
        "totalLabel": "Total, long-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Short-term and Long-term Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r13",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Acquisitionsanddivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r58",
      "r122",
      "r211",
      "r409",
      "r469",
      "r495"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests not subject to put provisions"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r257"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r256",
      "r357",
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedLabel": "Partial purchases"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r114",
      "r115",
      "r118"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r12",
      "r77",
      "r80",
      "r88",
      "r118",
      "r122",
      "r132",
      "r136",
      "r137",
      "r138",
      "r139",
      "r142",
      "r143",
      "r155",
      "r179",
      "r185",
      "r189",
      "r192",
      "r195",
      "r211",
      "r409",
      "r478",
      "r503"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to DaVita Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r77",
      "r80",
      "r142",
      "r143",
      "r362",
      "r369"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r247",
      "r362",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to DaVita Inc."
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r130",
      "r131",
      "r134",
      "r135",
      "r144",
      "r145",
      "r146",
      "r213",
      "r214",
      "r281",
      "r282",
      "r283",
      "r284",
      "r316",
      "r328",
      "r329",
      "r330",
      "r447",
      "r448",
      "r449",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Newaccountingstandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest Items [Abstract]",
        "terseLabel": "Changes in noncontrolling interest from:"
       }
      }
     },
     "localname": "NoncontrollingInterestItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r256",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non- controlling interests not subject to put provisions"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r179",
      "r185",
      "r189",
      "r192",
      "r195"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r14",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Other potential commitments to provide operating capital to several dialysis centers"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Commitments and Contingencies:"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Unrealized gains (losses) on interest rate cap agreements:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r67",
      "r70",
      "r410",
      "r411",
      "r413"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Unrealized losses on foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r73",
      "r414",
      "r416",
      "r420"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Unrealized gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r73",
      "r83",
      "r414",
      "r416",
      "r420"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "totalLabel": "Unrealized (losses) gains net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Related income tax benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r83",
      "r89",
      "r251",
      "r414",
      "r419",
      "r420",
      "r479",
      "r504"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive loss",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [
      "r70",
      "r74",
      "r75",
      "r379"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax",
        "negatedLabel": "Reclassifications of net realized losses into net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r68",
      "r70",
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r68",
      "r70",
      "r396"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax",
        "terseLabel": "Unrealized gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r510"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r21",
      "r22",
      "r47"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term investments classified as other.",
        "label": "Other Long-term Investments [Member]",
        "terseLabel": "Long-term Investments"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash charges, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Long-term Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (loss), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDistributionsToAffiliates": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Payments of Distributions to Affiliates",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDistributionsToAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Net (payments) receipts related to stock purchases and awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecurities": {
     "auth_ref": [
      "r104",
      "r206"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.",
        "label": "Payments to Acquire Available-for-sale Securities",
        "negatedLabel": "Purchase of other debt and equity investments"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r105",
      "r344"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedLabel": "Acquisitions",
        "verboseLabel": "Cash paid to acquire businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "auth_ref": [
      "r103",
      "r206"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.",
        "label": "Payments to Acquire Held-to-maturity Securities",
        "negatedLabel": "Purchase of debt investments held-to-maturity"
       }
      }
     },
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions of property and equipment",
        "verboseLabel": "Expenditures for property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Purchases of noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred Stock, Value, Issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r19",
      "r38",
      "r39"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates",
        "terseLabel": "Contributions from noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "auth_ref": [
      "r101",
      "r113"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "terseLabel": "Distributions from equity method investments"
       }
      }
     },
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "auth_ref": [
      "r107",
      "r312"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised",
        "terseLabel": "Net (payments) receipts related to stock purchases and awards"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r99",
      "r206"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.",
        "label": "Proceeds from Sale and Maturity of Held-to-maturity Securities",
        "terseLabel": "Proceeds from debt investments held-to-maturity"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r100",
      "r206"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.",
        "label": "Proceeds from Sale of Available-for-sale Securities",
        "terseLabel": "Proceeds from sale of other debt and equity investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from asset and business sales"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r12",
      "r77",
      "r80",
      "r112",
      "r122",
      "r132",
      "r142",
      "r143",
      "r179",
      "r185",
      "r189",
      "r192",
      "r195",
      "r211",
      "r354",
      "r361",
      "r363",
      "r369",
      "r370",
      "r409",
      "r484"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r24",
      "r25",
      "r233",
      "r497"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of depreciation (related to long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations and capitalized assets classified as property, plant and equipment that are owned by the entity) that has been recognized in the income statement.",
        "label": "Property, Plant, and Equipment, Owned, Accumulated Depreciation",
        "terseLabel": "Property and equipment, accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOwnedAccumulatedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r73",
      "r76",
      "r414",
      "r418",
      "r420"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Reclassification into net income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r76",
      "r83",
      "r414",
      "r418",
      "r420"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "totalLabel": "Reclassification from accumulated other comprehensive income into net income net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r71",
      "r75"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "negatedLabel": "Related income tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r186",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Assets by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r185",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r187",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Depreciation and Amortization Expense by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r245",
      "r246",
      "r248",
      "r249"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r245",
      "r246",
      "r248",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r294",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r294",
      "r431",
      "r433",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments of Debt and Lease Obligation",
        "negatedTerseLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r23",
      "r119",
      "r120",
      "r463",
      "r492"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash and equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "verboseLabel": "Restricted stock units and Performance stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r33",
      "r256",
      "r317",
      "r494",
      "r517",
      "r521"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r133",
      "r141",
      "r143",
      "r212",
      "r313",
      "r314",
      "r315",
      "r326",
      "r327",
      "r514",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r170",
      "r171",
      "r184",
      "r190",
      "r191",
      "r197",
      "r198",
      "r200",
      "r271",
      "r272",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Dialysis patient service revenues",
        "verboseLabel": "Patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r273",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionRevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r85",
      "r122",
      "r170",
      "r171",
      "r184",
      "r190",
      "r191",
      "r197",
      "r198",
      "r200",
      "r211",
      "r409",
      "r484"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving line of credit"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r73",
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r337",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r52",
      "r124",
      "r252",
      "r253",
      "r254",
      "r255",
      "r423",
      "r424",
      "r425",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r372",
      "r375",
      "r376",
      "r378",
      "r380",
      "r386",
      "r388",
      "r392",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r225",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]",
        "verboseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r225",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill by Reportable Segments [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r179",
      "r182",
      "r188",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r304",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Class of Treasury Stock [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesShareRepurchasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r28",
      "r468",
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentContinuingOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity expected to operate in the foreseeable future.",
        "label": "Continuing Operations [Member]",
        "terseLabel": "Continuing Operations"
       }
      }
     },
     "localname": "SegmentContinuingOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations [Member]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "SegmentDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r166",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r200",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations.",
        "label": "Operating Activities [Domain]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r166",
      "r168",
      "r169",
      "r179",
      "r183",
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting Disclosure"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Segmentreporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r473",
      "r498"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Dialysis and other businesses"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r301",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r309",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Weighted-average expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r538",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r9",
      "r166",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r200",
      "r225",
      "r235",
      "r237",
      "r238",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r56",
      "r127",
      "r128",
      "r129",
      "r133",
      "r141",
      "r143",
      "r165",
      "r212",
      "r251",
      "r256",
      "r313",
      "r314",
      "r315",
      "r326",
      "r327",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]",
        "terseLabel": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r165",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r251",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock award plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r256",
      "r303",
      "r308"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "negatedTerseLabel": "Stock award plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r30",
      "r35",
      "r36",
      "r122",
      "r204",
      "r211",
      "r409"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total DaVita Inc. shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r122",
      "r127",
      "r128",
      "r129",
      "r133",
      "r141",
      "r211",
      "r212",
      "r256",
      "r313",
      "r314",
      "r315",
      "r326",
      "r327",
      "r351",
      "r352",
      "r368",
      "r409",
      "r414",
      "r415",
      "r420",
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r421",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r421",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r421",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfDerivativeInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Derivative Instruments [Abstract]",
        "terseLabel": "Summary of Derivative Instruments [Abstract]"
       }
      }
     },
     "localname": "SummaryOfDerivativeInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Temporary equity"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r54",
      "r122",
      "r211",
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Temporary equity, ending balance",
        "periodStartLabel": "Temporary equity, start balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]",
        "terseLabel": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction [Domain]"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury Stock Acquired, Average Cost Per Share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury Stock, Common, Shares"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r55",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r30",
      "r251",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Purchase of treasury stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)",
        "verboseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "Share repurchases"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Shareholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r55",
      "r258",
      "r261"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury Stock, Value"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Value [Abstract]",
        "terseLabel": "Treasury Stock, Value [Abstract]"
       }
      }
     },
     "localname": "TreasuryStockValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r251",
      "r256",
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchase of treasury stock",
        "terseLabel": "Treasury Stock, Value, Acquired, Cost Method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable interest entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/Variableinterestentities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r359",
      "r360",
      "r365",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r149",
      "r158"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares for diluted earnings per share calculation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r147",
      "r148"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "terseLabel": "Weighted average shares outstanding during period"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares for earnings per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r147",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=27011391&loc=d3e105025-122735"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127163"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127197"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/subtopic&trid=2208821"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611322-123010"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r544": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r545": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r546": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r547": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r548": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r549": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>74
<FILENAME>0000927066-21-000074-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927066-21-000074-xbrl.zip
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MU/YKV:?9N-@<XZ#2NE<(HA0+FC"/O"54&^^H7<I6E<&U/NT6DEQ9*QEV:<3
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M,Q*EQ0]2JLF1W!"-%;9*44:%,1P84SDK620RU;!8<N12L*O(V$A0KY@A@:+
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M=?15O]O-!VGV2VT[!T,'@FY#L?:4R>*M<N9+NMOX9I7DKY]*&+./7A!K%"4
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M=[]("\!U&Q>-[F&WOMG.#X_?H;V=]^U6L_6Y<=QN-W:VNXV=PRX\R_GAG;2
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M(<0U(\I$(IEAP3/M47""^IAN;>.=KED(W; 0*BRT$A;Z>LM" EF/A3;@L1;
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MY3S,5:R2YH)ZI6*D@'IQH)XH[H><4D13(-SP)$?R<BR1%(S@AD0F%,>\;G9
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M>W_UN3U+3U-]&H[=Q^A'C5&_^G@R'C5.!OW/[6$^R^PF:9QOTF'72AH7<Z-
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M3(H21^(LYH92AZVDTD?*HG8JJH*'*XJ'XIP;)BXL 6Z8/-!"[IU#+FB)@DI
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MMT!O@=[O0R]UQ$C.+<,J<&N3=L1QY[EW.$B:=('>-8#>O\^@UPGK<Q8()'$
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MT@Y+E*1S$CM-<5!K#>X%L-82L)()02ON8/IR[BRU!EL/%)41F206?)F'=!;
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M/>OP<]YSR?&T,+VO9A,_>NG6(T^;/_JP8IX^W\GSY]?W$2=/-!/()8,19\Z
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M"Q+0B9JF)/5'IS7@J]])A5Q_OKJ3P[RF'O#O,-;USHS^=!SO6QST@QT>?Q]
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MH^U>V+.#3['B$:__.VZ/3L^U%KCX"BB5;?<.!C:OE-O#81P-<VA2IP]K5#R
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MW^K3[GK1N*O\XP7D;@UR?R^ 7,(A,?@?.2]XWK ?D7.&(B5MB%10@Y,K%*Y
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MVHS3K'P]I]G.I2EI:P%NQMY%H9+I*COR?9>-A^T;SS,]<-G(VX@O+M/C3)_
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M 7LVJ6 Q5?4WS'<-3C<!I_..O5"$HF @6@"-;(% X:!(VERBPH+2J+#( _8
M3CW.+C: _W5=CO8!,/5=F IKIOX!3-VY@,DQHQQL!P/D@1C1 DE-! K!4*ZD
M=E*KY*YD%Y//UDS]$)CZ+JR&-5/_ *;NF!$,6^*-09SEL<LMEDAA'A"V&OM<
M! ,2.Q4X65)S^DZ8^C'=+KP<CN#705:76+=U2MPPA7-J=SSYGF:/C\')<<N&
MQ65-:EJD:D[K>7-8!R-89#]EQORAR\&K8;4R&?#W J;VGG<O( (C2KMH4,2
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M2'73@*1@,M!<(@/G!Z8DD4@ZYQ'V7KD<<,J:L+Z%>_A,G.<R=T6PDNF<">9
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MU#!+F&*B6"V6OJ6;AE4V)3JQ>JFG51NHA[^QJ=^CNP*^\?)7&I]O4K0[<"E
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M]VB:WG:J#STRP( ?D0XPUR>Z?Z;/JXW?YD4DR,=F;!5??M.E/_TO,X(1+Y/
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M(9F#/?3 ,Z=1#(\F/B4H5A<P+HDZ7X&$3E:!KN +U5$$FK/LR+O#VJBHG?*
M%-6D#Y#3HE:3E]7)56TA:\E;1CZ"4)W-5=LH\0YZY(_ -(%SC3@V/*G=H-D0
MS.LR6A%-/'_,BBSK-,IF]'K,:?QJ)-34G[0Q=2*@:A ](QU% XIB(B9* F5?
ML%N\!H-G;K[PG!XEF$T^WAA$5 -_G&;RU5ZX&%FZMVX8K\<2+P# MI%'H[+Z
MB&HEX3"E:OIX5W5!T/Y8?GK31%'MAQEGS0STZA%SU_G>X8=<>AU8 >:7I0$Q
M7BBDG;-(2YM3Z;E6GBURU^IK1I&Q NC!P[.DN-35'R8G,%D8I%KJ<[U2/>K*
ME$N3AY/^<5GH?>ULB(QL^[JJRE#6\+"Q7V>%#@>'*+$I?.AC%&G4J.'-P VI
M2D."K%:(54?>CY\LU%2Y0F<M[J (AE*;F)!O*8*!Q:80ZEI%,&XRK-Q4Y-M&
MO?HS3L6MSU5M<GQ?YBHWL2+KN=[Z7,5FCM=S_1$T<)]P@(KKC?J5*K!7%'NM
MO54_I[B<N(VV4Q=7=8WR4NNO?O6K:M6IY8)S-J]UO0N7A\EGF32TK%7.;H.:
M[ND&O9S:K'.;<$W$N %EW8O=V!LVMW:UY_''H,R]V(G:6]OZ<:/9\X@WX\6<
MU^,Q;\3GTW)4W^C<_D[<I%[G:F_3=L<#=XT]NM;"']4&_N5M7(O+]I_O9(>Z
MO+R1TR.GM!OK,6M:N\BL3>ARZX^[B2)T6XW3[K)<=[H GO=IWK2%S&,M['[C
MY3^4NNU&.9YS(2AA@3'GE,ZQ80I[Y9G0N;J56,GV0F8K>KU;U?QA1$PVY=I?
M]O>.WQ_MG?Q-=X_??=X[>)WO??GGZ-W;]\?[!X=GNU\.X?OV,\S_\X5R[6__
M)GLG+PC,YWSO^ 7>VWY-]V*I]I-=OK^]]65_>Q?O?7EYO'?P,NR63:GV-_G9
M!YM+H_. D952(*9E[%)<$$28X7DLN^^5V'A*>_R2],<;%FN_*8?<HP94]T$$
M?B?C+TTIX$IK9SEG1!5,2FZ(SCTU-OX4G+%?R?'?V7MY=5CTLW@__>9TY+7;
M'_S3Q O%# -\[],*?C;;?YFRO1"">V<U ICFB)$\%J>T#GC?%T$PE4O/0178
M7,+Q_[J.6KF*C+:J G9Y:G!PRG+!I.6$:4&-M($4G$N#E;0F7\I55Z4&7RY/
M=]H"R3$KN%ISTG4X"4\YB;F"^> URFV>(V8P0XHIAPCH0@ST(LI)+*CQ&\U_
MJZV)A=I$:V9Z4,S4S;!?\]*U>(G.>,EH92C5B!L!4LGD#AD>0"IY[(.DBKD\
MS'B)_0Q>6INZ:U-WOO"MU$:RW&JB)//8&L>,H$50C%KF"+G=DE9+@A#_T.7@
MU;"J_O*SZ+"7H^')EK63DUA0PKO]YSL[@_%P)X6.3F\K_JR#W??\VER^(4+Q
M*4+) O- /4=@Z# $Y\^1P10C:I2407I=Q/)9N$?%Q0+,#]M47@/E&BCO#"A3
M8.SS;MQ\C7U_#T:^3M5M47-_T,F9V!J5L=!(MU3!,P\O]0?Z\QHC;^A2[#36
M585PA!<6.4QB5HX*2/-80DL7.L_A1Q-K3A8]GG]W4]TU2JY1\CZC9/ L.,\*
MHQUFP".FT,9(#@:/T\1S<JLW)S&ZZY\8W-7-;TG7*6NTNRG:S?K=&NH8%8$A
MA8E +,@<R5C?)7 0?0'.T$6=4/6PN)B!N$:[-=H](K2C-,]M3@/-8R*9$MH;
M;FV.,;8RE_YV6C:LT>[6T6YOIMM)6U!*E$&,QN[>.B@DA2%(&1LT&,<V&$ [
MTBO$Q3+]*XIV2_H6W[L. F^\3X4I,I72@<-DE'(%G1_KLI\**;35$T8=OU&=
MR:MGGJ.E*<A]L)OJ:E]M')ZNYM.*4U6B.MWXQOF2;?;R]0I[I7FDTF7WK #'
MP9)]N=!L=)9//;]E38+GUUL^C^O"'+'>5>BTD_C?B1[!>&TGB>Q,W[1PX+<U
M$607:E<,!X<Q=35>\;]M5K]5+[Y;//#>W^Q_1ZKUB_/=UQ\P+E0NK48YYQ8Q
M HHE;+5%A0@N:*EI*/*-IWA3770S_JNWO/=QS1;=UL:1\Q:[.RQ42;F\:DR"
M@,J.2A/I]]K-9U><(V,9A%@OYMJ<>4/TNCGC?5-5@RLX<%VQ\VL,N!MK'01E
M/+-*(%+$NH-%H9"A4B$<PQRQQ,(9N_&4;N87VV3\JRXN=&GJ_\UI0%)M/7%*
MRQS 5PN) W46NYP[B;V\I!3E&GR_X>S)_M8'F@>;.PYF?*S[SW(ED0*K!5G*
MF83/-/<TGCU><O;W#02O5Q=LN2;75)L/Y>=:VG3ZL/?/[X[$#QH2GU64?^9U
MA+:7<:)K2J\I/=4B#KF 7=4$>16B,:=RI 5C*!>::RZP$X%O/.47+;E43#ZJ
MI*E+6#(&'B;E9T>ZZ07D1OIL<+.>/]))ZBTAA9>,<QD;)GB6,U#G5"Z\ON5:
M<"]K.^!\M\[2?#8<C5)-F^?Z%#X9G]]WK\?W$#O?._M@A374.*!N!13/.'-(
M:0S"73/0L03&7(4K._V,_*=A_U.LZY,*9\5RA[4%=OVN>IM9?5:@5X)=GHKL
MM)T_RJK]7BS>#2]S$SLKX#TK A^)LN_'@&)59PK=JD-+1@2;8))L0\#K!-HW
MNJ(P+.1% 8:'82S'RA>%ELZ07'GXY7HE#8%+;23EL^'(51?;U+RJ%]22\OYL
M-0\CP>-V.F4>PUH./U@J/&4\(.**'+$ R!VU$F245V A8%58M_%T,+Q(P-7$
M'GV%=BY56^L*="TJPA$/:VB<D_DW0<<\YU1:[(TI!.-6*TYR'W@1K+%&^/PV
MT'%-59<AXN$9B']!J(0=SI$OI 9%UTHDB58H]H=0F 9<,++QM&"]8DD_F4@G
M7<JY2%<U#FE PU.=C&531C<A&-A3@*P?ZCPSA<#+"?$Z)=33:1)B.;%,.&XT
MX\)IQ;!D7A0BMUKXXD,A-KZJKMQ1&6DQ7>9=Z$;UCE_\MYW3CZW"&.-TGK>5
M(.UY;,+>3W6#[SJ@>N^\9=/#+WL$QC_^&\#9?GYW_)KO;K]@>]OPS/$A>_?E
M&8R]2R)@+[+I_O8N??_V/^7>P6L8^V6YM_WQ++X+YG>ROWUTO/O'/\>[7]Z1
MO>U_PN[!WU_VCM]] &N(<HUS)%P!?!H,1YK&R)I<4B<U$9*S&EU3D?2MB(W"
M ?'''C] ^PR>E@(DMS2%TD$Y+,.%0HUW0>4@3D[*<5,,=>#NDN2SG_/RY?LP
MK7MJ04><XMMB=/OEI=2_?M@+Q$&HL@46H,$YIGPNB2=!!L6]4PSL\/M2M_-$
M'P]CML5ES9% 8_>#2=/,)MUU'48/[R"5LP7%Y7"D3^JKK1-]GAG?+?"LW?&D
M&M?]T&95?N%-3[)?RE]K//2?866#^B! 4>\,KIO#S(:CM/=1:@Y'52\YC.L"
MG^-49#SUYFAJD-=]O6LQ.M)EY>MYC?7'V$1T7+N53Y.#MBXI#/L9IQIB46#8
MNM]A9NW47-EV'DL^F].1'S=]>^#!SD1'TRZ$55Q"_5C\8!?DL4U%2&?3CZMI
M'H@-QO5D?#2L>Q6F5U]\]_"T'*2A8XO44:UA9J?P.GC#])1.TIOZ\&Y].!BF
M:L2U4[W]8.!M;-I2GS.0RZ<2?H_G]ZF$'?D]'> OY:?F[;#2T5#7SGI03_LP
M1+/PT=5[ 6\:Q7+SH_IF<C/;&<2VOV7= N9*^DJT90'-_,B6=</UN%TWH*KL
M=#B.;=]BI[J^+D_JB]&1#Y/4B&'ARUU*L]/5+7RIN<NM1S/G%^=WWUPV70MD
M"'R0?)!E+&E]!-\"^Z.AS50NU\$^1QH%VBBK1'4C(" X@MAS8#BILKX^JR9@
MM/? O#BIVUW4>]7[T;(@C?@D=1&RUU@VD"1@P,F=2L=FI^:8I1Q\\M5XV@_L
MEQK60N0A^ (<!VQTU>!NLX9ZG%_K&Y+8)@4>FW9JZ*7N2V!39/T2U )=\]W"
M6V(3LD37+=W7]#Y7EGS6I2R>=^7[ =5EUN'UU2EP(A#(IW+8GX$ T,*OG391
M?4"K6&5]:+V/,ZLZ_226SQ+^4OG.C:CQ_>'9O,U<1T]4=:=,,&83@UL_2E70
M+[RQ";B88FTK%Z8]I2-:U%TXN^Y*Y^,-#YQ?57LM@_XT'"4_$\PXAL1'9H#7
MF/2W^(YY[U+JTQGC/:R.335A!KH:#N#+YUD\A6CGN\WL4M_IE76MER%H[3^>
M!9:T>Y/Z<,'1GC:X>=W]Z8&P:-QDXS*V<TAA*4?ER#4 $%\%-%S&SIUUL]R3
MN*@1H.)F]O:H[*?>)I6?304PN)]FL63Z)MZ%M!O3[M]T>]-&UC?$D3K:(]33
M?@ N(5CZ9=AY9:_1#=I-:2)WHC2I16O63AF.)5%].D0[GEQH%QFGX)=,HE>S
M8'3E?'6CTM/QJ[7_J!XQ3B:6\8^\UWA_C&\?BJO?[+0]ZY]'!LJJ2']65W'O
M!\.+^P8CE]-]B](O]E-([!G_$ ,7/D=%(!UOLR=-VUD8/JE/O99N3[3S\+]6
M3ZKI^.7@**DV,-7)X#3Z&VQ=YWR06@VD%UV;S)HB[=$/UDCY$D@C00N(VE;&
MA%;M^RI\U'Q\G@8#R!OV4ZA!R\YQE]:MXRZ73SA?V)UU[[BOV9SKWG$KM\QU
M[[CK]H[[J@-CP>%A6>S?BC4W*F?>6.T*(SCEU-'@F+G2X7%'&]RQ D^&H-1H
MD#Y.G^C#VJG0E1,AZGL]V&D0M>/&Z3 8#M#TN6C1NF2E@]BKHN(X #'=;\0=
MR)WAJ'FL_LMDT.BEM6G?OB?V^YA$"1?%&OP=E.IF. U'7(9Q:@$\$Y:GJ2?5
M[W53\SH:T>L1B-]J7"]CJB^UXO;W=FF-%9N,N[JO4ORVF51QJ5&#C>J_C1>J
M+^M0YUYSN]D(XZF1!Q9Z/[WI&#@KV;ZQ1S(<T>P&=J'-?>Q)-!P,?'V#E131
MJ?(SF^I]M)UG;6Z215Q;*Z>M]VEJBDSMXM8<OLKJZUAR5]A/<8]G7J_I3D\[
MJEU[-YMX?Q23?YY@NLE_Y(;>T$Y_WFS@']WMVAE$CU+9="'^JPF4_W.V-?>*
MCNI9N&B9I/-_DN[XXK=2X= B^WOS#2C^H$>.!J#,'OC/8.SL="GF+KT83Z)'
M[Z4W8&0!.L7Y]K)M_0\<</;7YU[VZM7S[)?I[[^"B00T"RQSCH9G@]B:?&*J
MTI7QV7E_<R_:/1Y4Z]A3\GGYJ>QWUPS N9T<3-DOSW>V?YT9;'-[-34I]T,
M8.ME>\.$:X-LNZS&H[+NKYDVM'8K=%R 9>K]Y":V;JN>!>_2+>M+,$]@DK4@
MV8(1?GGY?.O7>0Z.3P+G#YI.F;[EZV213#>CE1LQT&^4):LJ97L8W_DDI-=U
MY%;;!+X!V,Z,TZ>C#O[4KM[TZN3L//.QJW9R8LQ/%V32\B23VKR!YX_*T\9_
M< IJQXFV?I)R?T T#"91<H&M-[JPB9T0Q_G=^92\+E%,)<=[?7S_@:$B'23?
M1E[$\._AY/ H6Z@>C&5R(D__"G\1\^%EK>N^[B7N/WN;!&R\-!^/^[ZY2V@[
M\*5#27<&D=9:P&[-VZJ:S+H/?G5EM>]'CQO3-)UG!*RITA#;B961D%H!<9/H
M#DR4](9RSP1AH*RI@+4GR@JIK"%,Q&M@+( MXS5P_.&[@N#:1;V9;EH=X+%U
MIJ,'Y6"8"D3\&?T:*Q/S\;,OD_>VM\[V#C]H&H06W"'&=($8%A(ID0<$AY 7
M.!@F8L'7@O;$DA"XQ)JG48$"W:H?O5'I:C[Z7X ^:@%_HQ@@K K)N)6Y!PT=
M8ZD-L7DH#"7!2XS75'('5)+O;7UPTC JB4#828M8SA4R&#.$.5?&%GDAL-QX
MRG"L"WPQ,NBL!6Y;7Z7%.ZW8/K65!Q%Z;D(F5(3<89=[(PHF"RZYHC37K"#8
M&L"7-9G< 9FPW;,/1:XLPY0@FAN*&"<:&6TYR@T7A9  +L&!8DAZY#(R2:[E
MQI?; 9;ZWC/B2K(OZ@[>-;Z<S4-0XP"^ICB/=\N#PV%4=A9O&!KQV4EEG6H_
MT\&.0!4;QI"G)<I&*XVO4CKJY<"7_C/I)P54)EE=JWQQB3N#-!_8E#_\(.EP
MO^SO_/%KNO3V;DYSJ W3J)2>#L'PAZ_XCTF)FWK=,S>TDVEP#;RV9H*X#_7\
M8[_387,O,+>B^8NK6KV,WI3F"3ML;E_K22SH=DD!*1=V_GZ9RU\Q<\2"F?,\
M3DJ[X8I9.GMP)@MJY]4F1]?2F*ZI)IL%XDL7;(N\-4Z\V;%$DJX^O=5IK9(C
MK_OCHQ1:,@PAYH]7C8<I/M,PW?^4+NTL?&O.'JA\RM"\+.!GN;V6 N\[P1P=
MYIY[3XHY21<\;=9L_[Q5CR\S13KV8_/C*VTBV40'V)LF5J4';[>;4^,2OE']
M6F/!7[MOLE=E\"FCH/Y2^^NO:<ZI#S>L=FMR.*G&-6;$!W=U A U;TYT[="=
M[>QT,JHF>F:!@?EWB?GY[Y8*%J#A A_'.=7O7KC2C8497+I^GR:) 1*TBYDF
M('2F&N&R8\;T2VW:1/;F>*<[TSK^.A=I7=QJ2P]<G.VMXUCVD(!,+@#92YA3
MZ?2*X5C=U2A.M\MCU8S8QV?#2.[5=5TKNZ5S $A=N&M7GBSB.BX@GEP2X4 (
MS0UQI&%7CNH(DH:GXLMG47-]F!B\V<:K^RD3^>@PGUY#QYE^'8T7G3J+X*,;
MGZI/#M=E6-AQ5\&/)^4X3KKCG3']X1 4K)CU[6LP"CXN=QS?DBZJDT.]DS14
M#JI)G%R9?!&1PS_IU&\\.0CB-6O-P='!/XGW#7&* /!QZV*1D<1JM6<_<?(L
M"*?=&P"HA##[H ,UDNNR0^^H/M-C!UUIF?L^L7$#["DZ*2UPIK'5\8C3 !T@
MPX_U^5KX,9% ?X;I<=UPQ/L#0/?3<>/MR7L=,+[R6 ?#<5UZ9?K-*1D^'TY&
MXZNHL]=F74;;I8K+BQ$8<8_[K1(;H?<3J(YU*1!8=HH1;7Q"S1; (*L5X):V
MP7^.6+Z9O8K;EOUWO%T< 'EZ,!?AKY\V6RKX[YGZ$&VP05*KH^1LOGN7<%7+
M&QO/,6YX-&HKF&YSVK&J3C]>JLVB1_H^WH/-QZ(U?-"+<22I]%$*$ZJ'J,!6
MA5_/$Y.T3LB9*#Y-9:[\-((GW<-5RZR'%*?58:OFF@MLL3K*>#K71.DSGSE;
M$LQU8;!0]A.#G@Q;;<N5U0D86$VPV;)7_&<"ITYX=_AZ'P&&6W:Y,-Y"4MK"
M-. @(VPM;'[,5*_-+UJ_[.I!FCO/-BBLXR&O;:H8E9UFY$/Z*?)<X]'0K13H
MGS\D\X?D"UI#?.=_@ WAQ]54'%J"NK[UTUG2-4SOY*-("G=7>;X@LHU/4J<6
MZFUJKX[O2Y*A#<:\>I8O=#5>O!7ZTP\&U7G_DQZ4NJ;FN:G5$TMB;\X) /_?
MFE- ?J6=TZX7+A<6E8OC860ED#1)+]*C%*I7^QJ:JY?S*EZW-WPR_36+)=Y.
MX4VSH/]1[?"8E02KE9'$L/"$;;3S*/<"2'X4&W# ?$:GPZ1/Q((.ARD)9*L=
MH3[M&#DW<QOYV*LV]ON^[=RUJ_J$S!*=W2?]9#KGZ92G,YYUTMU.=2D>ES/Q
MR^OH<PY8<^RM1 7+"\2X%D@7A43:!:UB;K!Q8>/I5#,DM<JUF":UQ.2KC;RI
MS^^QN:L KY^#(@9T"O"0;<=DW#H!I?8W@E8>>6RUD'L+-)E^5]/X^@)^>;Z]
M$QVE@_&";K)P%_^FA<;OP.K-#%Y6>XQK0^0TRHJ$FU/D+;L&PDS/:#]/7JWH
MQDZW9PT\5XOXK+.Z6DZ"X0L8'<W1: &D2.++RR_&O)_)8)H&5>-S;?-4L73;
M9)PLNWH;04EJ,#M>30]2Q%0L%QGSO*V?F5I;B=U@W]9AR5>$)>-U6/(Z+'D=
MEOQ8PI*_&F:\$)9<8)\SPG6A,67!&*4(IB)W!?Q_4(JN8%AR<V'R<A+CV;;^
MYV6ZQ]#]\ZH3SSO-9*U38E)V:R-O&J$T]6 E%V$3X-L10G5J;WMA.KO'[,IL
M-QS,<@)3DG)I)N-VS"2C_N?EU]7!),D?@0XXKS?]9U+%^.D54_MF;M]%%]/"
MQ=94#5F^JNZ]E[X8!GGC ,C=QEC](QJOV2_;NW_\F@+-C_0GWW&NPY8WE%K'
M24Z H$]CWBG\.DMNMT-7@]*BFWJ:<;\%UF(J7 AJZ,!'AWMSAWE07Q]<*RH1
M\VE48O*M1>_TS$<=+=6Y#4[FMF_]C*Y,.]2FQ<&"XU8^C]B:'.%1D8YWIM%/
MVR3(OGKU_"YLKQ60.?\G@_^[5V"Q\72K'T7BX7P\/JCST9QH4B.GETNI8H4?
MS,7SG\2Q4M;C '1RW1!\^EKM*6V379M\C&G0ZB_#YL)*ISNLYN.%4M(@5,H4
MUIPR3 >3*B:VAE2_H8VF3^D8NFK>EBYS:\E:AQ3-HE=CZ$'#)-.2&0U?Q+6W
MB2*G1[H182T/)]$#5)L23J8&6DIR&* ZABC&/TZJ:F9639-?ZB\FO_ GWQ^>
MILK24Z]VDY,*<[D0EU GJG9S!KK;'J.#RA"Q*$8FI!O*=)F4=FTALGB6AS_+
MLXAOJ ]@]@Z3\G%B&NYH&J.QI)))+X8RG<\<:O7%>QRPS>V?NMC;&P SNX/8
M!,)M#'"P*^O%Q)QD/VH*L$13N^P@;W<I-;$E!V%"=)LTN!@'!MB?8E&R@3\<
M-G0X7U/EU-?ER5)3A(1G<_C3;D*JM9&F.K??<%A]-TM&ZL58M3A80\,U\L6+
MUK&N-9Z9T3R7C:5C[" L]!"VIYI;W/SC381DU>0OG\]_,T:676;DC_SII,TF
M;JJ8N$:QJBY[YF(Z55*/^Y-TMYA$2K-G<:/K+/$Z\"4-U\JK7O-3Z3HI0//1
M/EF2:]V*.REC&W@^)C?/IPHU5\TMK"S=LY/D5JG:^U SA.U-O-MXDYL4N8$^
M;!S"TRBDV2O;\^EE<W1='WF2['J:9P\L&B5N6P>^K:W?S.=!9"^]B<;0$8CS
M6%LC57%H>^8TJM.]DG!7J<-_^AB-45^HC*86R=9@,$F%!V'MSY+:-:ZM'*",
M/_P0EJBS-[%L81VA]#PV48G:9&2(.N?G#3Q_MRIT]ZJV5@*;N+]O7W)[EUNC
MRZ=9&%\UVXO44*:]]9Q=M#8PL23(8=HV86G$X1*.KT5$<R559\E$#76S+C%R
M,'>_VU&.D[2?"?]9#!V/D-@),BG:..-X']_+#NO@VUBVXH(P2M>^@#FS633W
M]_Y'UZ^[E*&7NVU^4D6[Y;2XA$IB7FG7V%HFD6;BLPD3:NIOI#);H$N-D@V8
M)-/4@WUV-)R9AR#QX'6UTC?R)^7DY(+W.OGZZ^I0J(XR3\G2(((B_0/5ZT'Y
MI;9$EI%7VUJI#=Z8$DB28572IVI),IWAT+2ACK,*7#-G1]-9Z3KSC_&UY0F\
MZ+0!Z0T[\K64;++OXJ<^::3);DOFZT5YG\3T:9/:%4\)>'O2>/T;)6DT/!NG
M?.<4D%YM;M1[L3RLN([4T&#KEH/6A.Q[[;)ZS\H0FG(S%X,_ZBR !#+#64@+
M)FWZW/[T&E_TFG"P16YL5?BH5WXJW205I(_1&'JFBBX)1NF.+;NV\<WC3BZ+
M,TF!LLW8=91+L[[YHDC37;HPVU0B*J%K!+^D^7>2][IIA/&Q5/OJM+TFJ0-=
M8E2-:@-=[I4(WW@Z+<?4\5+41E[5'$8;FM/UW/0Z"19QA\L8V:?MD:\)<)I,
M&2/_1B6@S6E= Z Q4>>B!=M:/=I%%\_TLO!\&JQ\WF#$+%FH]H)VAD@Q\9\2
M@<#[8*=AHYJ0AJ[#,^J_"X0U=6HV4Z\K.R7 <:5+QO&BGMIZ7 =+X34:Q<,4
ML>F[]WLMQ?2FJ!NK![;X4/M78_Y6Z _/:K:I[V<Q[79,J-D&%/Q!.WJ_+@_^
M:1:O/\MJO6?$>)4^N1/S:5I788KA?S,>VH^-+MW1HV>Y97>N)C:J$.:]Q>R0
M:VAJVV IGS6E06?T=+.&+T0KD1<LUY1:IIU2. 09J"TL%L1)6N?TY1)SU/[0
MS>G;V7MYG?X",>QFH9ST7IK-,+QJREP\[ZQA9S >[@]F?6'R1Q:)LWNP\V7W
M^..'P(RC4AK$@V*(><V08=BA$*AG+K"<.KSQ-/4\NYC6MRP_N+YJ:SC"S3BB
MK37R)-'8L[ZV'\UD-,CFC-&:G*8ZPLS"R;O$^T<$Y.$ [(>K'HX2F4Z?FXK1
MIK;L6QVS?K(_8]V:6C%[60*9_^7'35'8[,UY-?8G5[XBR=S:V2[:@."OV"9)
M+VW-DFE-G4LL$C-J<X("*#LV!?B[2>SQ,1G$XK*9'P"C'M5^#VV: GA)E@S[
MO:C95=%_6W7=(W8:3G<6XPOKG8'O3"O\S&)>?XN>-%WV8SWV1@JG,YZ:9]T0
MEF4Q_I>9!DOK[C0[X*8NJOJ5T<O3L0#B=V=N/=1D/L2J"HW[:29IZYRT)D[Z
MPJ=U],LXUO3[7)[ "$O%:&TJQ#R/JQ7:A1"@EN*&G8H06'9I>%Z=6Q9 78>:
MSOX.FOOYG/>L,;IA7; ;B<DZ KN.K[Y4SVU>_^_JEC3>>R7AN^IFQWR87BM<
M7^&\7,L\2S%?M2[Z[1IG]RBF-/FL=8%N3UV@OZ2__=HH86T&04=1G5VXKH.X
MK@CB(NL@KG40USJ(Z[$$<=W#H"R2=U.9IMZXRU!_FCBFVMY>6[.[U/FO+WC;
MHEBK,R,;96^F.-;Z5ZU%1?TYW:S5";.UJ^(DMK%H:U[5CH=NU!:,6E^2+O@)
M'L+=6JH8<V^+_B4/QV*, NCX/@5!])I@K*8721-@L:S(XRSXX(K6"S>H-;FD
MRF1TC=5=!]QD6MAS5MX[W15?+"6PO"9WV_<D^9-KS2]=]M=Q)TT4_7FJ[AW#
MO/JE'W5J8$:0 KUX>.X]:FL43 O UU$=H7;41S<9_*&Q\&9Z7K,EF]G+Q?U=
M8,I8@[R]+X_9R]/(MFFOA"5ES5-+C)EW'O8L14E,QE-C,=9XG0W1S'T=G/43
MYKQ_C1"I>1I8B-R*'[6%^=O&#]/PW%EIW.NWG%A:N[4IU=MI<',!"2[6ZY@M
MHPW^VQO"),$ ;AR-XQB?<=A,MAS-A?.,YE?6M"*(<6'30.,FWJJ.HJF5AF[7
M@V^.\;C0\Z<7:QD/IOO6=9!/2Q+7O5H7MWF^B5*[R[,2.'.1+FT07DRWB;6G
MXLFE\L[1N3-JW$C1#SLY24B6  @,D$$;!=0)@YFN(;YR,+U(FM5:KH!=TR53
MK&21YNT_G\8*/;UIDZS9E]LXT5%[V]A]NGN[&$]P,DK112V<G$6(KL.9KHA+
MNN0^HC>O0;0-FF8G4.]P&P_UU8:1/[:;8:?'W:R3X0&\X5E_:#\^.@?SX6>P
MLCC\E^UO[YSO'A]^$ ('2:Q&0C*'F(A-R DVR'(?K+18"LTN="N\SWI@AR+N
MF6 Z6%0[CG0U*Z,R:V#6:>N8O*TIFR,[&XY2A3HXR+AC60R^2)A5AJ;%&Q@E
MO:YU 6PY=\4$HJPMUN+*F'12SL#"+PL<3=#7EFI8(L6&9U&M;-X3_>/].,$(
MG+$+=UO':MJR+P+N7(FQ%*'9]LQI"E=]>TMD(B3&2B@P-AW3BFCI)+>%*CC)
M=5$4M] 2.5'@C  ?;P'+:5_MOSF\Y\O>V0=&<F9Q(6-K>(R8=AK!J Y1*KV4
M>6%!+=AX*GN,J0N77DMD3+=UY_5;$DNRLBV)Y>:E;8%_K 2=B<W]$!D7%)(D
MN9MB^L^'U;A*%W+/=.7=GTT(]8J(6+9;MI0=J?D_)R#R*%#=.;R'[;]]P>"9
M+^].7I^]WWYW]OZ/?_K[;_]SO$C9D9IW3]Z=[V];O'?PGR/@!OX.1.G^]E[Y
M?OO9Q[WC9Q_?O_V;OSO9FQ.Q>\<OZ-[QS@=&A:!%KA'6G",6<HZD5@IQ*C7+
M,=6JT(NYB:H@I/ D8*: "[@#>E66%D#]+"@NY:)([ER)5O]N(/1B#]LNERSU
MOGWUM?=5]J>8$&0BB:8KLY:*[YD*L#T9M39*NO_/4KV3*JMO09>T!)PW5-OP
MH$NE8NWN7:P3#@IBX0P3@E!&.3,:$UXH*8F2UC&^%$06@D7F,66&%UU$V9K5
ML7EV?@%24@'H%XFP=P854'W"F211#\!6WT^=#*H_X@JKG<&?Z6I_503L3X>A
MCH!ENU]V.0A84BAB,*9(>JH1 S&()%<"&2I%'I@#IB\VGHJ\N!A3$M6P&'W4
M]$D 4S!I/-'97$6^2O33J6)V>!@;#D>O=#P-E+(=@RY'L6#AQ-^TF<%WDM^U
M%+08J90HSGR=*,TB42::BY6#7L(:_XE+W ]=<O1K.JSI\/79WM:'7%!A9 #U
M3L;B]J#:(>5H0,9K$4C! RMRH$/1(^*BIM=$8-08Z1W2L8#6H4^.DD2?_3+X
MBV; 52K2-Y'78NR;FXQBQ:FE./<M)#6EI*VJFIS4M/2B6>.!'YW@QTU'G_>W
M/C#&I%0J(*LP:%5<%4A;EB-II6":4L()X!EH(8MJ4!9/JK9*;R8'>6QVYSB1
M+I>,%TXR(&2.J0?-J&#^.D!T2V)P+>RN$'9L]_4'$@+74@&^$ +$00V/U<P,
MRIU5RIN"@S6T\113<A%ADD1#]16H:^1;1!,XQZ9Z?\2>'R;M;H'(UM)N-0B1
M[VY]"#0HKZ/"I:U$K+ 4F1Q^#;ZPQ#A*<V4WGK(>X4M:=-R^L/LFZEH+N[L5
M=H!GEDLLA9>(ND 1<WF4<SP@)C@/3DN,H_+.+A-V]RT6]-(.]_/F[)&^62<C
M2;7UQ"DM<\.4%A('ZBQV.7<2>^EOP</[HHDZ:'I/+)?P>\,46>%=(O_J('9^
MZWX>?6I[P_$[#_.VP\-!C*5^M*"Z>[!#]K9??XG^Y=WC';9[_/H#9M8R[CS*
MA0)4M85%F@([R,(XHJDM,",;3PG-P8A8@JOQ^C1UVXOA+2?I;B.&2DT&H^EV
M-VK 18=1>R>;I12DA<#MYNIB[ONILV!#%8TZ<3H!PH:1ZX#W^>#N&MRK.D"Y
MF4U]4]^^.-4RF8F%K!4+(W^BRY3;.\NY_I'U=J^2!3^,#6I5]^5PU/PI?N^Q
MR8=%CM@[>/>!6NI88!YY^_^S]Z9-;27+%NA?41#WQ7-'J.B:!_<-1] &^]*O
M)=JVW#[PA:C1"&O@2,(8?OW+VEM"8IX$2+!/'-.@K3U55:Y<F96# L*+L4)6
M@X!8167N& <\. +AO:6">.I=^M8@VB&LI,)+^WJW#C9%\_MNM$$)"XAF$LD*
M7A)D8%B1IX3*Q!VE7KV0#?D"%HI8D1(/AQ=V*!YQS7W)>2"'';!>SJR^/X^+
MVB*O>1$VON]*@[66VJ%@ L")C\ W-06SA:3D5,#$IKLLP@6AE:V]V2[L99T'
ML#AR4OA)')[3Y3F,(M?H+S3VS!JMA;ONP104( >(O[U5UK6\?,#&CSM)Z,FM
M29#/D?H'P_AV\LL?.52V8X_?MGO%ZQ<G_3&^^#@+**<._<SU#(!/CF-$B]N5
MA\=),8:M4L5S7LQH /_"Y,;CE)G5(F7F]U&X>(RJ5<6O/HQ7R97'KKLL@1.U
MN-=EKS_&J9S_P[)5(MDC/*S0][OJ#2.+J5Z2A]6KAMWW>9[^654I0G-]5N!P
M]'Y7O>%9]>V$]O<"$$I0 -C)>%88I:>9> 7?>(MKI("MR?5.OYHK"9S[+CWX
ME;]],6K]/$Z5$#5O[:%N"L#!I?*X'.LGU62FQ>;/OW$U.!2?&9R'+J'I5\=Z
M,*M-^&ZMB%6LY;?]8ZF&[TN993=E&>$6B^GF=W\] UCV"*\=V'8U<G<<N;'W
M* _=-*-S'ECVXH:JDM)*2A=72F]0JL[Z'[G[6R^@\3-['V-*UXU#]AD]S2B8
MF^SW8A2V#F*O!L;LCSBZU&MT?AG0F]_^RO5Q?HG@VB4#5(0"+-((W2V@A6#/
ME2$^26>YU=*!O4*9Y")AIOP57K1[;HR=<;*52+KFRT+9R[ZUM;?=_=79VE]C
MS>ZFV.["<[1^L*W6YVZCM;?7_+;!&JU_NSO?OI*=]89H?OLJ)N? O0YWZ%?9
M6/=T>[_3WOGXE6RUO&A^W/ZU]7&#;+?\K^:WG<Y.Z]\?C9,?9*?528UC_.OO
MUL:H\04?[5IA',,J(!H(1ER$A)R V=(N!$6\"E&8E7>T;BY)FA@G#YR3G;G)
M2SY:R,WMY>4Z&+\)O<ZK@L>5^T4#QO]YM&F\P_0M$MQ=W/M_-JPK(UO&4)>W
M-!MQM+?\T7I/#7HG8]#C<)]=F"7'F*!(>\,0ESPBRXU%S@8=DU$NY' 81FF=
M,58A7X5\KPKY_HF#@F#-%P'IM2@W ;BQH9)Q;OH8BU'/==F0[FC7:1DCYA91
M@1WBRC+DM!?(.,*4L/ K3ROO"#:K5+\RE*MLO%LG+2A%A>0X.,.U#HYQ[$%#
M)LMTSD(MI!Y/I!Y7-MYB@  Y!0$I3.8V$BFCP<8S%&P\XCV*/& 6%751QQQ!
MCL7%9(:7C0$5TWGM3&=1L*ZR\>8">N+4QEO?W-4A82>Y1I)&(#\NYXD"#T)6
M*A<%-=I)#38>9G7"*N]6A7RO"_FNL/$>B("5C?=$2,=.Z9WQ &22<<0Q"8A'
M@Y&FTJ*<'0A_4:.47WFG^*HFRP)RQ4[D[T7HZ74EF18^5'C:_?QTP_^.&>-&
M!>RU32!ZN82.M)QZ _\BU3FC+XQ=+GSB<N%47Y\Q_H(MK/NG2^Y_%;L4;*1$
M.4<23"+$F0[(\600 ?$B6K!$/5YY9\Q%(9J4.!\7*#X3]IW;+]TEP7 .\UT1
MT/FLB1\GN\EH&S6-"$O"4"[[ABS1!I!6<5"+-&KAL_M,U[6YI!! +F;=.\VN
M\_WAZ,9<_BNT\@.7Q:O5R@_)H.:[7 A#89"1#134JV(:6:$C2DPY2JFR(5<4
MS-[3RU!AVMP@]S,JF[GGI,S+\CLF'>V+-C_EL;(+3R[NOV2IUQM%^>7<'>Q,
MHR0\VS%SFB1S3=^;W%R^W2O;HW8ZL]FI@W9_,K93U5JSAX!8@W'OUR'(G6UW
MBI27L^W3RZ((D^X*N?7\T0W7NFL%#IV,4]J)))+G0@G+HL;< ZL&HJ:,*[+$
M,0$YO3=V%X+[^?1Y_RD[LZ^-GQIDN0B4(Z\6ON$[HKF_)AHG:\?YO\VUW4"$
M3YIA1'T"GFR)0M8)BE0()$1N3-1%J M(1_YWL49HK2PJ<(F,7BPJ8,?YX7=<
M.6!E<4F$\LQHP'!X/I($UKG<AE<)AW%]@8=H_<M7SN>)<$V7T/0[KWXQM7Z(
M71V$5HE01!T0 BZ81#JQ@$R@*6I'L0JY(%"=&UU7[+):+*=X-$W\]X>Y8>'H
M'-QDTCCIUY$;[9U/<H65V,G]+K[OE7G]-Z!7Z .X3YO-%@4(VH/Q,3LZUXJ@
MA-DS33\N7'_:9F,XTR!@^EH9N:=\>/R.P]@K8#NW#<PE$7*O@U$M69^[9;3C
M91GD5QA\KZ^%&;NZA=D=:A/KT]K$5=^SJN]9U?=L:?N>+5II<;-:>Z;:XEEK
M#>)>[ T!^C=[N5%.[D>S*,47MMY/F,KFKZV/.\ JMO%VJ[G?6/_<WM[?%HV/
MVV2;?F6-D^9>8WT;J.K7D_-,I;&_P7>ZGVAS__->@S:.FA__:C?W?QSM[/^[
M#_<[:="-H^;^)FVVF@F8D-B5@/J>.IVK? '1U10#21$,L4BID#A2[OSY:N%$
M.6FP2]0;RK-;(:HD632)"^^U2>=+-:QY?]@]+-MBE0VF_.Q,%*U][E$]_,;'
MN*[DP9E")6,#^*DJ@,R,QZ1%P_EUF?N8MS+_>\6+D^TZ'YDBD2#EB4'<,(,L
M-@R&6%,)@*$EI1?J@CQQY0JZRHRZ9^4*2NG<4^O-JB;J,4H6F/L6$+BV%@0U
M]QN"9WE8+NY7:>3I'[9:!8^Y"FY7&*8J75&5KEC\TA67;,,O]@ANCCMU%09/
MT8T8U'_Q1]&Q^&RKM0<.R*L:V _] ?S9*X:R],/YX^*/T0 NVBD;V!3C'/8/
MAZ-JH.^=7C_E_\5X%C91.>RSED#Q26D;/4EYC*4;QPH)*B18[H%^$!*\@A(<
M?T:PQXMM?&<[N0/4X\7F5J')BQN:_.8.N^+!6*RQ$%2IQ*5.E@5+/,4B)BT,
M5Y-XBHO)&+FE-?QVA^WQ6SKRFG&TE5KVU\+LB=_3F3<.6_[<V6JM'6_O?V@W
M/W[>;YQ\PLUOS;V=]>^_&NNAO;/?W-MN>=SH;N+S8<O-CU]%8_VO=N/;)M[Y
M"%=?AV>E'WYLK6\<->E?W0;]L-<\^037_IP:[9G*(Q'[8"T7N5FTS,U-"'(L
M.42*G V#60AXY1VA=2XO-I3[;>%"EJN\C K\'@?\N,*&$)F4RALWQN:Z/,*E
M()62C-(*_)8&_*9Y^4:[9#WW2(1@$4^,(>N#1%$)FBAV3#@ /\'J4E_,RZ_
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M,(M84@SQ* QRW'M$I) PLS)&DN:7IE#!Q(N"B65)<*A@XGXP,=VYL$+0)'E
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MN*UZ7B]'>VU8^W=9"<E@)3$-3 G-I</PZ$X#[7#*6VR)J5;"4Z\$W/B^:Z0
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MJ=&+HR/>!(\8SM$<-DED\OXC\5P0:@UGSB^BT5M!5 51SQ756D'4XT/4S*Z
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M+HQ$5AF!%'8IXB"3"*04>8SGY3NN8O)>;=I#;NX]3P_5*T9:R8+FH)X9CAP
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M&>*Y_.>7__=YWO_ICX]__/SW_^M]>/=K[Z??_Z__T^\_NEA9[^=_?X'G_K8
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MU[\6;0<Z35Z0>CJD(,#9'A5@+ ]N'I)5M </N14#AYS@\EB6&MI,.*B>L$C
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MD!0M[ X>04<!C5.4D.Z!G!OX$5^YJ8,#H8,F?&Z (VJRY1*A"+Y<*I<(L)B
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M?N!?<UL)L'D8K.-%*F*\8%W<8:IH92^+0.[ARN3EC@^"41U-6!8KP/<Y(&U
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M?E"7A5B^8>G*=%DIMP S=/$(/PU6A6(;GE,L5.-B2BU:4#(2Y3%Q1\9P^7\
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M']G(.=E%/ELI[JJTQ&855^[ ,J+-%.JC)?-W=A^CG<+]2A8\GEY+5#>TFUQ
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M0"TL=/$#)]6>J%X3V:.,#FJ9A@, )N\C274JJ(V4;) +0>6'P_D0TAWF!J:
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M<KZ15U/"HJ<*I2\S0;N1 YMN%H4NG&,9A;IQYM7(O!14#V"),V54DN6:H[>
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M?I^"X:A%\T#NTEWQC$W2>!>2/*CSJWD[:?F^[>(^2LK08B,*0Q'Q@S=$VZ6
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M+*3.'[J>!8,V_3(-ZKVG*$*\#,O+]N5#4-&R [S,P35. S\!LL2:PJFI!)O
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M2PFCJN[!\\30:*@QU&P,:1YJ.(:NS$'U\UPCY\C(&1@U#/+GP<[)M2U-&15
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M -/,N/ <KXL@6F$W3/@HA?@FGQ8H,T7I'O8!9/$H\&$VX &4 I)S[0!$4)2
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M67KO6R49ILK6JX-P;PC!^8 XO4I/H5R%1364GT3(SR(%+Q&*M\L@\6--H"\
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M/W(&4]X?C!P^Z9OCOA@-1UV;C\3P7V;?>O4HR;\XA6]U""<*O[5MO'XAP27
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MU@T+UO2FZ>T)]-8[L(%(@^CMO"_G)SW#U)5JGF#YMT53=Z,X=*<)E:9A<<!
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MYV= B:INK4B UN@E]W7(+F2)HF E0L!JJ7T#R,$0/T$Y&"^0();PDD7$!(G
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MF5YML)\?$JB[1'&W2?+3- ^6GZ"8"SBI\)Q]63$:BHT.5T59IHY/.))3U1;
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M(QPWLI,H<@,_C9K8OEQW??9S$ LV3EO>VP'N@7)\ Y]@2KDI,]?GONUR#^:
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MGQA$[/H4/%P(&-O>&H@;X8.<PA'+ "@(]0N@MYD+M! +OD1&IUVO@Q#/RF6
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M2.QD8BA*$!D4^(X",E%/1_8"CF,/WD#:BTK#*4A#5*HR-4LJ5_-0*&4LWV\
M!^5<06$6R$?AIP"U2LH^HIXB!'"$#TAFIJ7BTPSV(<$$(:#*$-4$I:/OA*54
MX@D1.W"0?P&V?TBQY B*+#\(I/D?< @B).;"1SV[D^DAG?R@Z)"F*6(7Q6\'
M5C1/0!0'X7UAXX 1^*3 "E-Q'RC@JGRE#A[3CHC@0)[*<^X]:+/,O&4?W>@+
M^U'-H&",YQ\SN]?_^R))' >;OSL8UW7^^LJU+'M@V?V1,YCR_F#D\$G?'/?%
M:#CJVGPDAO\R^^-7IQ>C6S$8M*F/B'3D*$4[@ *LV/_WV]M?V!+T3B#9,TB@
MB+*DNW![OTARH,$+F]+P@#T#-(KX5S*8&&E_]!%Q4ZH[8R)-@>/B&"@[B5--
M[!W_)Y 5Z)VV =IMRN\;^7N8FQ=&_Z6F3YE3,K]+5H*7ZM>($ES1BM]3YI\?
M*X]"23B#>LV=/Y((5=O]&X)1221FB8<3RZQ$%&4HF, H(SXD_=W'W*"8W%[B
MCGL)C]-T0=@W"+8EG:ID_D2X<3=:T-I F;?C@AS,WT\^-!)I=)Q2;E((D)&R
M#C7X!R'9,C(L&1VXUQG&(><G9YBGA/G8,0._4%1*GAY%7@!29192XJ:')YV#
M6:,()0*RI(\B9:4FO\(D''_IH8C8\6%1R-88P9:29D&GV3D61'\ K_.582G\
M#/FN3[1 MD L[(4/X)W?O^ZPE9=(4S-?*7'0@VLE$U4X46XI1-PCZS$2WNS:
MR5JAP<"5""43_)01,5)V)#E!"2^R[Z((H4:JPE0:T*D"P+'SJS09Y *60L3Y
M09\J \6S'4>M-]@N?1G\"B82V?@YC^WA*S1<?6)87Y[#&6E$I1.]1 "%8S>5
MSDI3^<WX9*1'.;Q>VK28&VC;J&+A-"!:0/2M4!Q>H8!_W3:6 LD>B?Q\ N&"
MI=RL[IM4[-&?YIL<-JB.*#9#KA(V![P4I%Z*1B0:G+OTH$*A0A$Q&E(&O5O)
M*P,4&<0Z&! !J/U2M9P*CF*/@3GF2*TH+B^\RJK1-Y%]4++=B^)7XIXF1<J(
M%D'B2;_&E)R*$;HAI,;E1H$RV9&Z.C (C74RZ^$T2?"D@6D[RFM(_A[4_7A(
MHKBD$%2BF^$I4@.'QK W.B0U<-@WK,'@!1*M)OWG3[;K&H/!\.+76CG5K#W%
M4G3NFE,I,^&TH#['6/P\)8X\@!63!I\YIV%OC9OS@?,[80NJ:ED$=5>#^B@D
M707.9WTRG ]RKQS4'<.([<W"NH#4H?>/.J:F EW0)1_,4]I6G&=\8'M" 'NC
M POWMBA85=-;<[;6.[10M*8W36^'T-MPTC1Z:YT^^.R]E4Y !_\0473#?G[H
MOJQP4;9Y9[3GMNR@C.KVML\8]!O4/T/W-MGH,%6CB:=&SI&1TQ\W"#EG</X\
M<$:/J#]?DX^B@VSL2F$,.GGO@I+WGMJ,0N>@-@J=ETK&UO!IG:,T&3<*G9=*
MQCVKJ8G49ZL$ML\)\3X/G*50R$BHU,L=2F!=>Z% 1SLZ")VQ'*F__T8+DO'@
ML"ZRU?=_8E-?$_)E$/*HKGFB"5D3<A,)>5*WO.*)"?D,5+OV!<[(^Z6"@K?C
M"FEGDLI3JO*VSQ..B0FF]:9I5[(O6LA18TECZ8*P= ;'SP-7<*VY7BHY&0[*
M,WZ"OG-1CLS:VV^T5'D&_\-IW?'/9[5I*FXM%3^#\T%3<6.P>:E4/*E[IW1:
M*CX#S:_5@44_/%_)&<IOD\3WL%)8Q\0J)PKN\(D]T6/:./ZUAD;_2;?"SP&J
M WC\!*#ZMDK"ZA':;5P0<8Z,NJJ^)DY-G$<BSK$FSF<DSH9J9E7:.PRW6AB,
M"Y^$$A#C7<GE1T<'591ZJXJUPNN2I2_+G6,!+JR0CE64HF0I2Z #]=A8^E(P
M1Q98ID*QLK*4*H0\8T3A6%<ZP1(/#2Z39!GCWO"@,DE#8]([N#O\_N_Z1G^R
M_^LGU!X:OT!#>ESL<1K23\ZRIH^NO_-0L1)=>N<8(.X^*T5.SI B=845 ,+/
M52NSZJHJ[:TZ8 X.]/LT*'A"TUM[Z*TW[)Z.WBXKO$(&^KVK6B];EX@XA QT
M%8(70<YIJA!<UB7<+UX"\N%M4+E*_64% )L'IDDV2#$Z;P2=L%S6!62 OJUB
M^=4)RJQS9#TM**AQE&K6EB4M"_*Z8-SVS*<G7;T,;B]+FY'6S@_%'C\SNM&J
MT[KGLC2<JTFWNIJMM9LC(V=LG00YE^@CV9(:Q99@E^87&6B_2&.1,^IIO\B1
M_"*_E+KQ/=J)[[(T!W.H?2.-1M I:]=?@'/DQU([TP,MOTJ!GQ><$_4<\&DT
MDUZ9H]K'^?/!IAUY@9I)+IQ)S''= )7&<$JMR/$6!84_1Q2X>FD?;8%5(+M0
MWU#7=_=.J%!M20#%IQ0RN_DC? IX2^+]C[PX7"OV;^YUR[ H_HO+=9V_OG(M
MRQY8=G_D#*:\/Q@Y?-('^A>CX:AK\Y$8_LL<F*_2IQ9A'J,Y%]?34/ OUWP&
M6[SAWIK?1Z^^*Q,<4%L*]HF!@*\+L^\IV7+7/O:WSRYG1/3PO2^' 9KQ!CNX
MNW8%G'R8S:ZGW".G<+3 [N<\#+DOVV.KEN7S>2CFF/M 5^+<CA/N%7NBMZR-
M^'MLN^ZXTN\M>9BZO6]V><]O^SS!(\$\5[:/QTN_4,P\86-3<63Z)&0E&':P
M0_R"WR'$EDLW5K",HL!V.3ZT=N,%S!H#75%W;SL4L* .-N1>"\_#G[:20NL@
M_()KL/D*D4I]ZRD7N+C:C9EQ0>+/!#O=R^[S<@$PFXQK(#E/PQT7V]&[$;N#
M$>3[HX;EZ[1)NFPK3NG)Y<_7"]=>4*?R]2+PO/MK;,]#EZ3QP@T=MN+D$S!8
MRXCC=]BR%P42>ZL@QNY!96I'FEDEH;U FD#BV1<KPA;"VX8(Q5-S_Q[1CGA:
M\C^"$#"E )@A!(=CPZ.%NU+D".\*MQ"8=C<RV&=J,E\B"VI+06O$FQY\XRJ)
MY8UV)+>"2,5AXJL(;3>B.VS9L%ZN^AJ7<:]Z+U$-J]$;6&,$!$O\@^0&KXA6
MPG9G+KJ# .R!@R0)NXL1OM1]7G"@%C7*+J_"8#]B*WK%D0#KXKU40,O?W!=
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M#1FW8)<PLH-%&(8/V8IIIM*$6;;X[3Z+?W!L_/"[2L_TV,R:7ED@JF@RW_%
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M!?!P],ABR>B /"#\"<3S1]"9AS#FBO$G N525\HPG4&'&7G(,N/S 8_'?"H
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M55, YH/QCF3KR^"FX(B5:.VBLBABB5*!)GN:6U%YI+%W#1"UTU;K"M"*IFQ
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MRB4K;K6)3&7?I&=;52Z.J3KZ:'B_7;AZ/)Q4JZ2N96$2AU_1.*<N&RV<C02
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MEHK9E*U T )#;D&I%D%,'0?8R"0R!($L*4$*-B:R4))GZ*6P6HELVW2[V3S
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M^L+Z0*E D;DA0P)6[V/KD3=]96BOJ@M12DWL_8T1/F)BM-'"P:(,Y]ALUC9
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MN(B!5!VAUJ[5#, B$QF40HFU:G;3@,M5J(X5<-F=[M>%7^ZM@X:=^&9!19N
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M9U2FA19T;:8G&"T99(]GH+F:PI,G0UW*)F$$*[ <?I?;3]?+F]J^XFT0.+2
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M;&Q.B06$VJLN2>:YM+0O>B-X#!J6.S,=(!QA+=RG8$T<0%$-@@E6P)J_09L
M:VEDK$5VK-/V]NH=MM1- [MC/< HE-)&(3,<-2V:0C"0-4[&$;CHM?-M+FX/
M3)I[#^4?$&>V44F+JB8P_O3Z?/C''.!\<^6NV&P]9V"C8AI-9+$VGX($X+26
M1@;=@B<KT1S>ANE(6\NU3?86=0,[YF<XK\E/'SXAWC2\G<X9,AE4/@A3.P(1
MI. =(R,-LP7O:#]N08%U@)Z"+=*)L!N$@:W"M=C2-D#6TMQ8#^TX]D8W*MR
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M+?5Q$]+6)5/N>G*G=5(VGL)2<13M0&89L@Y$ 5)*1(S%>F.X+,D@]C8=I,N
M\;=7&356Y, ]6A9MC$S+E&LU+6#6>1Z\DD+Z ]2#>-M=993KCYWE_?73._@V
M_7;4'Z3^9SCOV5H$%7UD6==BR3PD%B)$1OI0M'![$+I1*M4F\(X=9[T;.^Z.
MFN]$%1T7 _S^ME6L5Y!F%5UJ_;GA;_C'U=+;,T(+"(JS6D67:24#[?2TRMJ
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MIR=];VSP71R+W-6 R=I:O$9EXKY7A7GI!(G!2%X@YBSL!@S8:+!'KOGN!=K
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MZ? H;I7V(4LW(G\PMTJ7L1;<JCWNOM ?5T&[Y#MF<.0-8*J5T&I0&P13E]8
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M_--J\ZLN+=F/HAA=(%E6#X8+ Y(&&0DI&AZ2L+C=[^_T)+I](*X6,#R#T\G
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MUIS?G'/-E9"_DT>!D[>55)0 BD,4%((4@@! 'J?B4%%0@-_5TE!2N:,(4%
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MK!'WWOJ]&E[2<T7O*::0%MXN$9/"A\V7@@P:=PT0[Z9>C:H9K[Z-]L_EW;B
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M:-?#+6\06SVK3]7S$LE ?)=>LY"QU187[SNY"/@5'^'-S00R (LA UN[,)(
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M8;;5CU+EWX5$V.I')LT7-!06=^-F,ZLI:KV9GQ$-';]8N8^44DZZ$*\C:,B
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M2TLYG_=!+J%T_2?7);! U.JZ"QFX'TL&Y'-$_]3V=5SA62.VQ3.OCJT3D3?
M[]7)_F5'*@O&FF[/,0FY1094&/NF'GAV5MDPW]Q5@DDRZKU!A&@0G8@M\V2
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M#&]G[C[1&+NM-142:S'R0\>\E;LDOWR]KU36<=-8JD^LY_KS_7L.L/1LUNO
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MC*S9/J>>-,?'VB-BQD:K&]0$@;RU>1"J@$VI>R#C6D6?M7A+P@M)8'*G_<B
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M3/KNY&$2T,$@1C4(PA^<LC3AV88W_9#5::IP\'ZX>WGA:SCM0A_(LR=T?_K
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MT-GL\=__/<'_.3\0I?]_ 5!+ P04    " #5B)U21/S>M:/I  #S? D %
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M==S[X>MF_Z$O=>I 26_=S"YN)4X<+]T6>:EW?MU0GU_DYJ/Z0K\O!,4PII@
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MMD$5IRDC"68I6WR3!5O;$ORU<#=TU)4YYC%1MY9PM\/E.' 3$J,88PQD2@1
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M9H )K !!,DH9Y(I0IQ(?=F+GML08K8$6]! (Y^A^2Z#CB$0$10CH_VJ@->H
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MU9U.?&;8Y-QEN#6=; RYORNT/R97_.G-^H'FJP6D:1K'DH"4A@0@#$- N"(
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M.?N+W+RFY=<[<RDGI'CU]&LIQ?O5Q\?J-'%U?VL:D=?9J7HOG84HA2!FVL-
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MGSM?JXRCZ]S8Z=>55F^9_Y?VDNYIOBJ#'Y;KLI3ECX&>>FW1Z:#07X" T\>
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M'EC@X?_"[;2X%[AVZ[7[].5;_R.#:QBL'Q[6JZK6YU%/M 4E<0C#) 4,9RE
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MF];:=P)U!Q>9=1@4.V]I'*A')E2/* \(<',%S&^@F[7TB0/>7%$Y#GQS?L/
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M:6RH(C)W/J$$)-:;\H@IF7&G3H+6DN?&&ZWB)N6QTCR01G7GTU1[Z.UX9!1
M1V:6'9:MTD&M];-^S:/<2SNCY9-_[(5/RDC.F!QRE/L+!KJ)6U;*?VSUO'MK
M^E(U>R".40S3B !"PJS>:3*49 "S+%50BCB,G-K,GY0R-S;:*QE46CIZ+B>!
MM/1;KH5G;*_E )D1]HZ]$'AU6$X*FM9=Z;/UR%GI_?# ,D'RX7%=T.+)E&+=
M/.TRN188828542"*A-X<4B'U_D5%0$61P@)1I/>'3E5JS@B:V]3_96"UA;-
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MF9=^Q_(X(@Q;(+\J,6?K=:6KII&-':G3">5<2[2W31OV)KIL5S!#ZI0529%
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MN)*=Q>+CKN!X?;*$+5N7#$-JZ!HB8B-/1*(ARXT%GXI<,IUOX^&^^Q=DORC
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M+9309>:7FC1,D %;LNC')>U.;'?@#[A:*%UYI@$,G!@WDHH(]CC<=?Z,8GM
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MM"4EH<08UY#G!;45(C-HW@(&<2)(FMO.MPGR<E[TC38U\[DM+KT7\M*YUP"
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M-E)ZYH*?@M'-YK@6G-C?^ $N$8K"]"$0-(/[U#CCYFOW:'J4G=UW[<"LI]8
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MDD8(DG#").2JWC_@J"N[D^Z'J[O;34,3??CF1*L'H23*L3;FORI2PQ\9-WL
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M@J4L2J22,BMR+]*Z..+4R,H8C2M;GT%TVG_4SG^N%DH[]T-V1]R-I8+B&-O
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M) O;D6XQQ9MUS\ADM=<S5GBKYUFG9-/WK57CO=GHVS3^W0!F/329KR$/W8R
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MX8P9O9@"$I1+B$1<4"H82PGQ(;573[\VUK+& 6.='P6]ALR-8P8#,3*);#$
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M-]_--H*YL"P/&1,R%[ZV;H&<(GG+HE!$%CR"1I\3A639NB:A_S/P-F[6M8<
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MS)WXOE0F2>M03!1D4"L3/$BRKY',K=;&1<9$8 UOR]^@9MP9.(-N88?*N@/
M7$>["-HYQ16Y]H;$85R&P"A8M-&E8J7D7#4!RM/M2[.I,4-ZPGO+MH-#W@_+
M.M)I_>W#+,SKS)J:3OA2LZS587/9AZR3 I:#!^55'8=:.Y(AP\+)9Y-MNL4\
M1-3(@UT&W9<&$GT']N5RU.7;6C[ZL;:T>5]^H]VVBFNBB&)I<X%$3AJHX@WX
M4"VFB"I+5-JT:4#P(%4C#U@9TF4>3/@=(.D-*6%^,J4]=BLA6@RO_C@OMOG+
M8I%_G\YF$R(M1642!.]J)8UT$$4=Q*L,RU9)9*S)C8M=B!MY',J@GL_ JN@"
M7I>3U][,CTJ9SJ9AC:M/9W$US=.PG.**F%VDS:MDE/^OQ72^_AN]O394F+ B
MK&-&@JUCGY4IM3$<!DA<>8T&E0NJ#>X.H'KD&2L#9Y.>1WD=(/6N+'TMQ+I(
MU!ON G<*$ 6Y!2&&VM'%0,FT($,BK\$V,8$/DS7RG)7&AR1[BK\#,%U)>5QA
M@AD4&0/9;FGJ /N"X)TP$%%A<LE2N-+&+[N+FI$GJPR=PCQ(V!T@YG*#+T9J
MSX2 HJ6D^(-SB([4JKU%M$9RUN8D]FG^U(^0VMY+I!U 82N"B?-%9(L>9-B4
M^ZH$'DT@TI7FAA7K99,*V>WC1^Z;/7B^Z$GB["!1]'8:(OE;=1LDS^K3>I'^
M\7DQ(ZFOMH.-+T7#3 E1NP*VGO@JE *BCA:DCRPIAU[%)O=Z=R6PFYXH;:H8
MF^BI!R-T7F_P(7RK3ME%NM4*11&FU("A5H<;H2 PH8F+I"7SY*69)A,([R9G
MW K&-JJ_I^[C #UT@*:-BW9%7M_9"#F$9,':0#NSQTA&611@T99BD@JHV]TF
MO4W/N+;J6? TA"8Z -2KTR^SQ3?$CSC;7%>ZS5!PRB8=$)@1]5:,*N +B^!*
M$!$Y>F^:N$^/4C9N7>.S@&Q8[70 M^LI_PM^OEUPDZ)PWD@#-H9:6JXY>*$%
M2,NU5((\",::F+$'R1JW]O%YK-EP>ND 96\7\Y-C7)Z^Q+C>E)M_F=9PHK+V
M/LZF)]L.U!?,%<:M%CE35!O)8K-4P$5+@9&*$74PAN*E)H[_4Z@<M[+R63#8
M3FL=0)+<S^49YBM%.9>%%TI%P94'[S)61C@XY@Q@85I'$X313;ITWDO1N"69
MSQ4,#*"-#F!UAT<@+<KLL(#05H'BVD.(O$"6*48IG-1M[ESNZ: URWP]C\TZ
M3/X=Y,?NV?FO'@"48(OBM6>RY$ !C  ?A 07N'0E&N="DU3%HY2-6ZHYIE^V
MIW9Z,%@[;?*3D VS-<GLZK0/)1-]E3<5]-DE(5/QNDE]^6[DC5L"VI$S]B0]
M=8"^FTF;*^NHI!!=\ )$8(P64W(0@JYI',ZR9<4EW>Y,^4Z21JX8'26+MJ="
M.H#6R_/'7OJ45[E""J&E]#QP!H$; 2H[LM,^D&_@LZ7%$I673:Y>/4+7R-6D
MSP*R(573 =*N4#])3 5O21A&,%?O_S"(F!)XCK1 A,@Q-DF87:%AY+K1YW;S
MGR3R#OS[%XO3T^FV]G#3"*L.8CO!>2)6OH_<^GZ"*S#[Q&LG!D]&-RM.P8NJ
M%3\N%L>\M&VJ\YY$Y<B%H<^"N'9JZ\""?<2,>+JY>W]GA[ZM'"^ZSFRGQTVT
MUADY&BCU>HG"8,#5SFI<!"VK/)-O,C9I'V+'/4]OB)U;G5T:*[(#L-Y>X/LT
M4;T4M]4:BRWU[$37@@-3_0P? 06F8'1$XYI$ML.R,7*]]+.8X!$5WP'L/UP\
M=R.&;><OZ0I%7A3CZUQS38)\Y!B=A<1RREEHXWF3&/D.6L;NZ3<>-&YW"3A(
M3QU K>Y7B_D5^FE3H2 ?R;%F@NC7@;QK)2*D0)N#0!VR:7*$<9.0L4LNNP'9
M01KJ &%'.6\J5</L0YCF-_/S=.85MB8D &V5+2!5*J 8<>2,EI!)7"(9K@UK
MT@7P<=+&GB72#0H'UF('N/R(ZS"=8WX5EG.2UNHHI;/3LTVMUTLLTS1=3U02
MTB'RVANQ3MQ2!1QR T:X:+Q+T88F_N+CI(T]):0;7 ZLQ0YP>5RG:9TMOUVQ
M^,*C)Y.O@&E)*TL7"A,S<V"+ET(XX6-L4J9RFY2Q!WET@[L#M73H:(/C(8NC
M+A;,3@-Y="0?5M6Q#:%VY4O208C!U+FB.@C+4(M6#3*?0N?8$SFZ 6I+_79@
M+6]+>I)TE)X7!['HS4W)>D@@-6@14!A)FX!_IBS/V,,XN@'A@5KJX"CGU^E\
ML=R(\'R03>8H6#VI=,I2%.9<!&\<@@BI1*RAF6O2UN,F(>,68G6$L8,TU*4E
MVVM@F"J86?5QI2RU*HAOCA0XB"312<?1B2;]UX8A?]SJKH[0/ (:.K"RCYTM
M3&QFL3K98*6HC<FR!?*J#=1!!2X*EI1H4@_[&&$C-R)Y[D*,PY7SHT[=^K#1
MQV=<3U.876=FH!%<UY_P+/.X'F#J.8=S<<D=:JZ@#A"G#9O^\-)F2$X*6PJ7
MV3=)<SS'<*Y[&W>^_WV.^5K6BO1<NY'1PR<Y*9Z<SU#': "Y,6G3Z@/0*!*4
M(,&4YVVF^A"U8Q\+#HRPG5NO#J;!#IQ0$AT9A+?3K[5B\WHGQRL<'IU6%^2?
M6PX9UX+DQJ&8(FLS1P&^) ^L-J>*17AEFI2M/9W4L8\4&P.TL>XZ0.?U\W;:
MM=XO-U+-FP3L!UQ^^DRJF.B .C&=P""YNHJ+>CW5!& )O69%>7R.4HG[R!O[
M2+&YF1Q<1]TA;\/"ZNAL_7FQG/X3\X0<)%,<9JBG[Z""("LO:I.O&%(63AKA
MFX0E#Y,U]B'ALR+M()UTBK WJ]49<>(QY5"M=-29.)%9062Z#H+G.C RV"8W
MZ8YV/TEC'P..@*P]=-$!JJ[49]QKBM'S;)-PX$-.H-!&B$$'"#J)+))T7#2Y
MQ[(#;6.?XC7&V=#:Z0MPMRRRY998L06R#TC>IB!1<2'!<A.ED.0)R"8'<P_0
M-/8)W?,!["!M] BL<X,LLA'6*0<I$@=*<@U.UINK7J?HDN/D33X+J)ZP,S8\
MCGMN0.VAA1[!]/YLO:*0N1ZO3*(D\93D(!(+Q OM[C$F#<I(EU/FP=LV\\X?
M(&KL<['GAM6^^N@ 6]<JP\X9V_ T"=(8H6@K%\%'4$4%\(EEX&@IW"W%B#:3
M0.ZE:.0N!\UA-8PJ!L-4LZ.J3\?TYZ^OWAU_>O_ZQ=&GO[Y^^_[OWT]W#CRE
M>N3#!SZ@>@HKPY]-O0BKSZ]GB]^_-VV/4F>5DH%B:4]311H(2E+0I[B*3(C(
M71/WXB&B#J\T.?_LX^U82D%VU4L-7A%WFXH_)SF#I 4:6R?DJB9-9J^3T<WI
MT6$8N%W'L;>L.]C+OHOEHA?645I/OVYJ #[A2?W)T1_3U:1(Y,R&"#XG5N<-
M1G#19\B1Z<@+X[E-6<:.]'6"K3T@<!^:!M1'#S#;DGX'4R\7IV$ZGV3A1;'6
M0TY(_ A#VW7,"$;)(!R%'-&U*6I[A+!.@#4D&FXB;DC5] .UVHMATYN!@M=S
MWA;SU:]X&G$Y$=X)FRR"Q)CJV90@YQ 3^9TQ$SLH;6E30/XX;2,#;E PW(VT
MP333#]BV74#.2&"W&$K1&&<,Q33:"=H,8H1HN8"$BOZQ3%C>IN3I,<I&KI5X
M!J -I)4>8':Q#U#0A6_HR]5$))F,LH'TSJO)K]XJXPZR<R*@HQBWS92^VZ1T
M4G0SH.^UGY0[P,D[7-?@YL-R\75*8?,OWWY;U5*A.U;976OC>].BZ*-)GA9;
MIC\49@N!Q #D2=3UPHAWW@);PY#?B<NV)X@6HVNT QP3NV6ZKK<6)U+Y8(.P
M((O#.O$G@T.5@"<1I>6.!=X$B]])&!=/8P#@=EWL/MK8&T=?<1D7@_4F^:^S
M\^'0QXN/2(YGFLZ0A/K]8NSQ8D<!?Y_SF%((4D6*KQ+6C+6IWH,#6LB&5K8,
MC7RZ%LR,NWMW@.[1$=*!O;U:T'ZU?/AH7LO>EUB_KKU\,3')4N8@3.WERU&#
MBZ% 82A8XK31Q2;&>$?ZQK74XP/I5F?FX;4Z(ECSUS"I#?,_8MF>)<Y/7GP.
MRQ-<38IPH027P!57I^86#:'X.D\[.).32N7FE)];!V+W?_JX%K(;5 TD_@ZL
MW>:$^)= 4JJM,G"^VEZ54-[D(JV&* QQP7.]31X36 HBO3!9,-ND2O)N<L:]
M1- -Z@;460?(N]4K_]4?E1?\!>>TJM8391,S4D:P;G.?'!T$42P([F3B2GJ%
M3<ZB'Z%KW&L&W6%Q2"V.O)]^E^UW8;XF#6SO>_^*Z\\+8O,KGLM_$I@-)!T!
M+@1.EEY*<()GL,(GRZU6D>VRT3[QL>->1N@&?ZT5=FC+LN&&"-5>%R30+8OG
MJVN24RXQ9P?%%D,BXP9\%!RRMEQKM$4UG,)]%T7CWEWH!I;#:JX+$!+YM; 0
M7^+V[RM".V^+>BDQ)4V.RCA@H=:N.J4@)AF >-(\*2V];[)E[T[BN#<@NH-I
M(]UVX%W>YHS"_#H48D5RQ^G7S0%9U"X2.PAI,]F77!*(+BF*_>N$"%U2P291
MSB[$C9N_:06,1_%WH)8ZM9C5"YG3+]6I3FB"-K7;I#%UD&$-TX(+'HJ4QAEI
M0DY-ZFT>I&K<O,YH:-M7+Z/"K+J^=TALT^YT.]'P^^*IO:NN_F3;(&-BI'4H
M):VA2.ZP"K)05!83F!*=X4H9[]4.H<MA5(R;U6F,N6=64J=V[](-OL:82"%'
M)AUP'T/M4.#!*U< L_8R8+2Q3>>K'>D;-\,SFBT\7%>=@O#"I?@0OFW\"<:4
M"MEJ*+6S 45@%D(0!9(7Q1O!-<]->GH_2MFXJ9W17;Y]]--EI/'J],ML\0WQ
M(VYZ4%T=Z2E9<$QE!/2)HO_"#-ET9*!9ILA?"LZQR>R7IQ Y;BIG-!@.I+4N
M$7G5N[C*&!>,EV02I,0IM(K(ZVFW XV%*5V$D_&9X'@/A>/F:\;=BP_45Y=
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MQ7.>]#Z1_$Z&EC8]Z6VIT0X,[M6=IDYM(E[)\W^[F)\<X_*T]NZ9\!"]3**
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MI(,E<[?_MCD#N'3B!+J<6*:U7[RE4" I<(E+D-&40+Y7\&V:Y.Q 6V]G?^V
M.[2B.L#>1<_V"V8NQ/CZ9K7=?6'&1=&2UL4*F6F'<IF" $?,!U8EH(3E1IID
M>)-#OJ$8&'DPZM#(6G2@YE';^=?RJ'ND>E]EWJ0$H0,:!*:UK+,*%$7*UH+-
MA3G%><CJ1K7YG25J3WSLR"-/&R&OM?P[MYW?BYU6$\&08RD.DJIS6F-!"*%D
M("_%U\NXNK2I?]B1OI'GG(YH^?954A=S2FXR]F+3$OS-_&:97?92&T, T=)$
MJ&D.$J,T4$KD07D12;;/@;Y[Z!MYNNDSHV\()75@^:[UL]AP<)3(TU[6:*W>
M&%]_7N1)4C9SH3RX0,M*95V 9*? .*Y1!/(?9)N[6SL0-^X(L>>,609751?&
M[QI7V_39!5L3':R).B'A(@A:KU5043'R(J2PP3",HDGF\P&:QAT2-AK<#E!,
M%R@;J.S,R3K1(#BP,M0Z3ITA9"'!I&PX!L71-VF_]8Q5ALW<PX'+8D?0:"=%
MVP_6JHG$<_ <(4E.*U/K"+XD!^@$-TKR;'23CE\'EQ$^YX2M0W WF/0[GBVQ
MF&><KS#3@EDM9M-<S?"TKICI:=E.VPNSU8585T]\^W7^=QM)T9:@(299/*/(
M!AJ <4R?\PN]\(_+\(C9;(PV-7!V%!X5VM"=IU4B+&JM;"S*-VK1<(.2@\N7
MEB=A/OWG1HLO+B5<[<T\?[BBX??E]86P+ZW$JHZUFRW(\\%+NB:V&&F-3F"K
MF5 E:/",UYM&Q5*PIQ6*)E<2AV9DW-3X88B[5= TII('B]S[,MP/O?L#O2/5
M0;0CV.^=Z.K!C#]=@ -9\Z.4ZLW%C?>[?<SE(I/!2:ND!,FL!F55)J=$()"&
MO"Y<>XNMNGC>0]*A]OV7L)JNWI<;#_BV_?/[@F9&HK$^@M.<K$L(Q'@0"9RQ
M&0L7GF79@O'=R!O7%@^$EYM&N8%F.DB27C2&_H#+C<]_DQV3(CG\FO:MG!A)
M3&X8*Y"RC3GZ)(1I<G?K$;K&/8YLA+ A==$!M'X-RW_@)D7Q"=/9<C.^?,O2
MQ'&N12X!I-2;4WH)D:$ 3VPPH63FNDGV\WZ2QDT@-0+40!KH $LOR?'X2NKX
M>L' %8-;3#8R"'"ESFFM'84=LQPT#U8+L:FD;H&E^TD:-RG4"$L#:: #+-UQ
M4^3NK3QQ03;6(UCM HE+UYM-2=<$:N)9HI=MKE/L2N"X)>F-<-9$.QV@[G68
M+C<GFU>"]C=S$MC9]PCJVR24PK'>PF:,?$:%2$PYHR!X+13'H@,V<;=VHF[<
MXN]&>!M>+QV [1W^?D5<R\6<ODQ70O5;BXGXL,HI#L;[6M3&JB>@2* \Q2!S
MX02;)I7;3R1TW#+N1A!LJJT^TWD?\2O.S_#*I8C;K^R1C=OI8P=(ICV=_&8G
M&^1B\<W$%*F+)T>>EIG7R0%+0B9IO"6#]4.<;)Q+\++@EC[R[]/UYQ=GJS7Y
M ,LK[J;S+"1:6QA-JCU+ZH#[9,$$S@QSJ$J;)HJ[$MC;2<13$')[?E@#I?PH
M)ND3GE0CO-S^('X[#?^U6'X)WQ;+S5"2?8X+]GA($W/U--8.-%ZUROZ<A-75
M1WT_*_.:F6@]6%XO;7AEP<F$$%/)/C!/T65Z1+"//>/@!,1T%4Y.EK5N:W/P
M=OZLC;2^KP(MN?*998I_G0 5-<7$* 6(8"TZPY54369;[$3=.'9I4.7?2DH,
MKI4?S#9]O%C 'ZI,7]9IC[-![=+=#VAIDW9@:0![=/-AOU9@?K@.S)"LR^C
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MN#R]XG&><R*TLU%E"U)Q<A&\]>!-\*"5TEFHX+AMDEFXGZ1Q#U4;@6I@372
MJ4T'SK>+^<G=W"2%R- &"$63D+RGT*4DBEH\"\XG)95N<F+R,%GC'H8VQM:
M&ND 7[=CFK>7K4%59AD#D\#1VRHE"4[43J%>DV,J)/FI38S6 S3ULA6V"  /
M4T '6/HKSO+QXM>PKFF5*^F5B4Y96<DCK82:5LE>U$RN YFCBU$R6V23"SGW
M$=2+8WZ@QF_-FAQ _!W Z&9V[O77=]-)9BB0.TMFM=9.:X>5!P5%.<.9%5Z4
M)K;H+F)Z,T+#P.=@L7?1F.2N@Z2)P!!<"A:08D]0+!(75FL0.L?D25XHFQ1'
MW$5,+W[WL. Y6.P=5#'>9S]?G"VK:"<F%R2R%7BG*"0MI@ %H1JRMII))<F6
M-JE/?(2N7ISMY]G,]E%&!WO:7>OC@A67-990,H3->"Q-?F38M(&2ON04G<(V
M;=4?H&G<=B'/::3V44+'MNK=8I[..4J\UM4&!W83E&3.(<9ZV\PKQ9FR6:@F
M%Z8>)VW<%A_/;;'V5$FG1NL*-T2YC,P:<$R3;RA%HO@W!!#&\,P=&>'2I,C@
M8;)V I?]T< UH"KZG+_RE\4B_SZ=[5/^=/FK Q0WW4W&0*5+%Q]^-,]OB+;Y
MR93T>;.(][(6A;#B?(@<@F'DX3#RH[V3""4$PE'2%,8W:83W)"H/-3$7#[NK
MB!E5D98Q"US7JC]E KAH,[!HBPSH(JHF92</T#1NXJ@=?FZ:FZ'4TF<QY@5W
M>]>/W_B  >U.PSKPIZ''.^]M;88GB/-:":?)'\X&(I=%9+12MYFK]ZS6Y_O@
MBDOY7\)<>*:$QP0Y)5Y;\GIPM>U:=D)YD^A[M<OD[Z>?V-Y/TX]D?9Z"G_OG
MB1RFEKZMSXO/M?7D:CJ_>"%^V[:%WGIY)^<%JWO6A._SE 'MV-[,C6+L:)=4
MGEL)TGI%8#6)'&F"5U0BRQ1Y-J+)??>QC=WF\%(E9H*C79SK6%<J1:9.)T&Q
M">WDJ$(LJ4D)P3WT_$A&[BFXV<'(/5D=79RX?"+M;#KH_G)&ZQU7JXOEO:EG
M=3%%6;P!@2F1M^@U.$Z1J53**:TUQC9'OP]2-2[&!M'\330-IH0.\D[GM+]<
MG(;I?!)=38XX!87Y2,1G =YR$I#@,@2#4NHF::9K5(R,F.&T>Q,W>XMZY,K<
MWSZ]G(;9M]6T5HY^Q#J^JS[^$RZ_3A->%&/1@K+620\FNGH"63-DIF1 &W+B
M(L> N]3G[O2PD2&ROR(7+:7:@3DYFLTV-7L7B^:<"XXL9V<CE%*OJQ;:P6-P
M"!R#X:GDQ$238[>[R1FWIN1P] PH[ X@<[$Q?T_>ER =!LT@Y8Q 7A\#^LZ#
M,$Z&&*V(I4DKMUN4C R4!K[+8<+N""T?%[/9Z\7R][#,$RTSF<- ,$^*@THZ
M0,R!.-*%)<<Q"]&DY.@.6OJ(J/;4[CU8V5?4':%E4HI@5I(*,V=U_"WMI2$J
M#083P^R=#[[I^48?N-A;D_<@XTEBW1L.7W Y763RRY?K04%QE/[[;$I$O#Q;
M3N<G'S9/F<C(>)"2C"NOMQ4,!B#'/H!WG#&=M+KEQ0Z<GKJ#J'&WH5;@.5C\
M'=F7OR^GZS7.WY=R[L@?+SZ%NG-?!)&_S:?K2<H1C=(1LH^9I,8-!&0UF65C
MB-;3(FJ*K9VH'+=FMA78AE=01^@C0>'T9+XMKTO?CI=AOIIM5/87"C$V$PQE
M*L+RA" *DA_ 4H&0 Y*A]I;X5$5ATP*'QTD<M[2V%>X&5LW30>>WH)OCR0;U
MPWM6*$JB+9\"6.,H@&7$0R2[34O(6*M5,3XUN2SR),^J6?EL,\_J*6(]T+-Z
M-<^#0N(ORPIKGK1Q%*B"D*Q>^R167*AY+.F9Y9SQ$IJ4Q%ZCH@_/:=AP[.GB
M[6BK>G/Z)52G[RBEL].SS4Z\?:DFL#;F,">C,YI:K^DEJ'JQUV4*+K1F+/+"
M@VH;J3U*81\.TK"8&E8M'>Y2@7O&10Q@D[9D3DL&+XD1PY(()D:595/7NP_O
M9EC0/$FH@^Y136J$WH5E'3CQ%;>E,H?4*M[ZJ &K?1XF<Y22'HJ96"E)@M],
M4. Y@=?D\)#C:ESR0DG>I'ROBY(>+P-&+R+X4A<!CP8BD\2\+U)%$3@+SU6[
M^*.5]#P%-[N6]#Q%'1WX10]7&Q2+F8()A,23!R6S(E&9#!1?%&.X5S*V*<?X
M\0IZGJ3W)Q7T/$4)/2#JVO&R"=Y*;VL"M>AZ64E##"&#M051)H/89KK0#U/0
M\R3M/EC0\Q11CUS0LZD:V-8(3^<G-?6YNNP"%Y.TEA'_M;XIZP N48 9R47D
M/%NDT'*'(IY[']!3X<Z3%+886GH=F(K;88&4V<2@%!A; J@00KTV60 -3UJK
M5$S^_W/EQ2&;S&'"[@@M-Q(#S.G@G'50-#.@M"'IA)S!Z*(+%L98:M*IXVYR
M^G!_]]3Q@\F9O03> 6S>G573^+Z<SW.<GUQLOY,HDRA:DM//(UE+8<@2JUQ
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MPYU\@["\4^C<S"OC"J,3 :*N_@AZ"S%Z"9S<$T]/RH8U.=P>)VE<!32,R/?
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M]%S$V (TVT2,700S/%*.9G$/\-A*F/H/G%Q^66)^]1WG9)IM=^FYT#H[(W6
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M.[J!PC&BFS7@X\AX6!$?)OG7V7RSA@]S_#Z972^N?I#Q?5VMQ9NR9K0I>R/
M:OJBN*4%V12@J*"#BEH8LP\Z]G_CN-[9<%AIQ.,1D;.8+R]^(Y?C<B4-6M]:
MJQ9MF/4!04NU&B DP ='SF0=ZU$B\P;W*6^AIV\=-O3=PX-F]^O'A<MP-LD
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M=.2719YC&PWUD)+A%-.=?;=M ;Z:S\/T<A406[S^\9,-N(K'KR^86);<.6%
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M99)9W1YV3Q X[LWX6:$WE)A>1MASN!!GPW!FR]#E@YX+5M=)EXQ.M=HT2,E
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M8.+%&G)Y\S[5$SL?WC$XCA'?;$A>=J!ZUA&+6RYM!2UN%L18#E8I!I;Q.@X
M#83D%6!*11DOG6Q3X_TL92-;3XV0U48P'2#M"=O@M]NJXEA(J=0$$>08:[</
MXEB@W:.T-59H0TY&FZC2'L2-G/=S;B-K:'%U ,%-,DC-6[IIJ/@?D^67-]>+
MY>PKSM]-T]5UKI?CBP72__/G\-<%+YQC,HR6J!+QD+@9,GUKT#-A'0LA[7/;
M>T1ZY<&T=A&,&! P/V59MI5>!P!=>='KM**+F'VV! [P)M?+IZ+)8$5%7Y)5
M6I+MU09X6S1T$9]H!ZACN=T!4&[2VBZ\M45$081Z$J7B!' OLP->7-%D%\0D
MFMSJW1#05S9W*YUS&)^/Q\=L&:Z&S2.XRW.\X"PZM$S5B5NR=M#($&*=T<D3
M*[2@+'R3 04[:.DKA7IXQ7(B]T<.$CS!GS>S>>W.LL15>CB=LQ<Z,CI#M0.?
M$RE.DQQ$AC5E0FMN#&<8'RB@G;&#0]ZY%WKTBT-/4]8?#BF_AM04+S<70L,U
M?'\US;]@7&X6<D$G+*+A!I@EZI6J5TN:.S &;2)VF81-:O-VD[,7NLR+0]>
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M<%E*V^:NL_^0U3'H&9#9'4!F+Q=81B4501UH<:QFE-,VL$C;P%OAN<^H<Y/
MP=\S9'62]3.TN#J X-JUOFL3;(UQ3M5QO][60]X3>^I(C6A0%>F\=J&)MKI'
M1A=GW(!B?JB\CN=Y-XBY**'H7$0"SE(=-N3(J64:0?."Z+,-6C5$RK@(.46
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MT',&GY9$8<3%&B8LDTJ#3*!/_N::P#"-77AKF%[O'8:AW^[)14;2M7T+VN\
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M&B[9O7NQFZIFV[=_LX3,L+0M]>XEN]K<SDNV\K>X\K.7CT?_ 5!+ 0(4 Q0
M   ( -6(G5+WB]"4$@0" ' H&@ 0              "  0    !D=F$M,C R
M,3 S,S$N:'1M4$L! A0#%     @ U8B=4D0+N?2L$0  .*H  !
M     ( !0 0" &1V82TR,#(Q,#,S,2YX<V102P$"% ,4    " #5B)U2QEH7
M>'(D  !2=P$ %               @ $:%@( 9'9A+3(P,C$P,S,Q7V-A;"YX
M;6Q02P$"% ,4    " #5B)U2=+SZ:D%B  !$$@0 %               @ &^
M.@( 9'9A+3(P,C$P,S,Q7V1E9BYX;6Q02P$"% ,4    " #5B)U2#:Y(]XEF
M  "0?@  $P              @ $QG0( 9'9A+3(P,C$P,S,Q7V<Q+FIP9U!+
M 0(4 Q0    ( -6(G5)$_-ZUH^D  /-\"0 4              "  >L# P!D
M=F$M,C R,3 S,S%?;&%B+GAM;%!+ 0(4 Q0    ( -6(G5*:KJ\<2(L  / >
M!@ 4              "  <#M P!D=F$M,C R,3 S,S%?<')E+GAM;%!+ 0(4
M Q0    ( -6(G5),-;45]0<  (,D   6              "  3IY! !D=F$M
M,S,Q,C%E>#,Q,3$P>'$N:'1M4$L! A0#%     @ U8B=4LK57.'/!P  YB(
M !8              ( !8X$$ &1V82TS,S$R,65X,S$R,3!X<2YH=&U02P$"
M% ,4    " #5B)U2RO BYUT%   _%@  %@              @ %FB00 9'9A
M+3,S,3(Q97@S,C$Q,'AQ+FAT;5!+ 0(4 Q0    ( -6(G5+'20P=0P4  -<4
M   6              "  ?>.! !D=F$M,S,Q,C%E>#,R,C$P>'$N:'1M4$L%
3!@     +  L U0(  &Z4!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
